PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Richard, G; Smith, LE; Bailey, RA; Itin, P; Hohl, D; Epstein, EH; DiGiovanna, JJ; Compton, JG; Bale, SJ				Richard, G; Smith, LE; Bailey, RA; Itin, P; Hohl, D; Epstein, EH; DiGiovanna, JJ; Compton, JG; Bale, SJ			Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis	NATURE GENETICS			English	Article							GAP JUNCTION PROTEINS; MOLECULAR-CLONING; EXPRESSION; SKIN; EPIDERMIS; DEAFNESS; FAMILY; MODULATION; LINKAGE	Erythrokeratodermia variabilis (EKV, OMIM 133200) is an autosomal dominant genodermatosis with considerable intra- and interfamilial variability(1). It has a disfiguring phenotype characterized by the independent occurrence of two morphologic features: transient figurate red patches and localized or generalized hyperkeratosis (Fig. 1). Both features can be triggered by external factors such as trauma to the skin. After initial linkage to the RH locus on 1p (refs 2,3). EKV was mapped to an an interval of 2.6 cM on 1p34-p35. and a candidate gene (GJA4) encoding the gap junction protein alpha-4 (connexin 31. Cx31) was excluded by sequence analysis(4). Evidence in mouse suggesting that the EKV region harbours a cluster of epidermally expressed connexin genes(5,6) led us to characterize the human homologues of GJB3 (encoding Cx31) and GJB5 (encoding Cx31.1). GJB3, GJB5 and GJA4 were localized to a 1.1-Mb YAC in the candidate interval. We detected heterozygous missense mutations in GJB3 in four EKV families leading to substitution of a conserved glycine by charged residues (G12R and G12D). or change of a cysteine (C865). These mutations are predicted to interfere with normal Cx31 structure and function, possibly due to a dominant inhibitory effect. Our results implicate Cx31 in the pathogenesis of EKV, and provide evidence that intercellular communication mediated by Cx31 is crucial for epidermal differentiation and response to external factors.	NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Basel, Dept Dermatol, Basel, Switzerland; Beaumont Hosp, Dept Dermatol, Lausanne, Switzerland; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94143 USA; Brown Univ, Rhode Isl Hosp, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Basel; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Bale, SJ (corresponding author), NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA.			DiGiovanna, John J./0000-0002-2750-2313				BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BRISSETTE JL, 1994, P NATL ACAD SCI USA, V91, P6453, DOI 10.1073/pnas.91.14.6453; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BUTTERWECK A, 1994, EUR J CELL BIOL, V65, P152; DACOSTA SM, 1925, ACTA DERM-VENEREOL, V6, P255; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Deschenes SM, 1997, J NEUROSCI, V17, P9077; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; GUO HM, 1992, J INVEST DERMATOL, V99, P460, DOI 10.1111/1523-1747.ep12616154; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HENNEMANN H, 1992, EUR J CELL BIOL, V57, P51; HENNEMANN H, 1992, J BIOL CHEM, V267, P17225; HOH JH, 1991, J BIOL CHEM, V266, P6524; ITIN P, 1992, HAUTARZT, V43, P500; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; Larson DM, 1997, AM J PHYSIOL-CELL PH, V272, pC405, DOI 10.1152/ajpcell.1997.272.2.C405; MasgrauPeya E, 1997, J HISTOCHEM CYTOCHEM, V45, P1207, DOI 10.1177/002215549704500904; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RISEK B, 1992, DEVELOPMENT, V116, P639; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; VANDERSCHROEFF JG, 1984, HUM GENET, V68, P165, DOI 10.1007/BF00279308; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	30	264	284	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					366	369		10.1038/3840	http://dx.doi.org/10.1038/3840			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843209				2022-12-27	WOS:000077199600024
J	Chen, H; Lun, Y; Ovchinnikov, D; Kokubo, H; Oberg, KC; Pepicelli, CV; Gan, L; Lee, B; Johnson, RL				Chen, H; Lun, Y; Ovchinnikov, D; Kokubo, H; Oberg, KC; Pepicelli, CV; Gan, L; Lee, B; Johnson, RL			Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome	NATURE GENETICS			English	Article							SONIC-HEDGEHOG; MOUSE; DOMAIN; GENES; EXPRESSION; POLARITY; REGION; CNS	Dorsal-ventral limb patterning in vertebrates is thought to be controlled by the LIM-homeodomain protein Lmx1b which is expressed in a spatially and temporally restricted manner along the dorsal-ventral limb axis(1,2). Here we describe the phenotype resulting from targeted disruption of Lmx1b. Our results demonstrate that Lmx1b is essential for the specification of dorsal limb fates at both the zeugopodal and autopodal level with prominent phenotypes including an absence of nails and patellae. These features are similar to those present in a dominantly inherited human condition called nail patella syndrome(3) (NPS), which also has renal involvement. Mouse Lmx1b maps to a region syntenic to that of the NPS gene(4), and kidneys of Lmx1b mutant mice exhibit pathological changes similar to that observed in NPS (refs 5,6), Our results demonstrate an essential function for Lmx1b in mouse limb and kidney development and suggest that NPS might result from mutations in the human LMX1B gene.	Univ Texas, MD Anderson Cancer Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Harvard Univ, Dept Cellular & Mol Biol, Biolabs, Cambridge, MA 02138 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Harvard University	Johnson, RL (corresponding author), Univ Texas, MD Anderson Cancer Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	rjohnson@odin.mdacc.tmc.edu	Ovchinnikov, Dmitry/J-7963-2014	Ovchinnikov, Dmitry/0000-0001-9603-8385; Oberg, Kerby/0000-0002-1241-4273				Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cygan JA, 1997, DEVELOPMENT, V124, P5021; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DELPOZO E, 1970, AM J CLIN PATHOL, V54, P845; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Hogan B, 1994, MANIPULATING MOUSE E; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Jones K. L., 1997, SMITHS RECOGNIZABLE; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; JOYNER AL, 1987, GENE DEV, V1, P521; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; McIntosh I, 1997, AM J HUM GENET, V60, P133; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MORITA T, 1973, ARCH INTERN MED, V131, P271, DOI 10.1001/archinte.131.2.271; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; PARR BA, 1993, DEVELOPMENT, V119, P247; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; PILZ A, 1994, GENOMICS, V21, P104, DOI 10.1006/geno.1994.1230; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIDDLE RD, 1995, CELL, V83, P61; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0	29	373	378	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					51	55		10.1038/ng0598-51	http://dx.doi.org/10.1038/ng0598-51			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590288				2022-12-27	WOS:000073346700016
J	El Meziane, A; Lehtinen, SK; Hance, N; Nijtmans, LGJ; Dunbar, D; Holt, IJ; Jacobs, HT				El Meziane, A; Lehtinen, SK; Hance, N; Nijtmans, LGJ; Dunbar, D; Holt, IJ; Jacobs, HT			A tRNA suppressor mutation in human mitochondria	NATURE GENETICS			English	Article							PROTEIN-SYNTHESIS; TRANSFER-RNAS; DNA; ENCEPHALOMYOPATHIES; ANTICODON; DISEASES; MYOPATHY; PEDIGREE; DEAFNESS; DEFECTS	Mitochondrial mutations are associated with a wide spectrum of human diseases(1,2). A common class of point mutations affects tRNA genes, and mutations in the tRNA-leu(UUR) gene (MTTL1) are the most frequently detected. In earlier studies, we showed that lung carcinoma cybrid cells containing high levels (greater than 95%) of mutated mtDNA from a patient with the pathological nucleotide pair (np) 3243 tRNA-leu(UUR) mutation can remain genotypically stable over time, and exhibit severe defects in mitochondrial respiratory metabolism(3,4). From such a cybrid containing 99% mutated mtDNA, we have isolated a spontaneous derivative that retains mutant mtDNA at this level but which has nevertheless reverted to the wild-type phenotype, based on studies of respiration, growth in selective media, mitochondrial protein synthesis and biogenesis of mitochondrial membrane complexes. The cells are heteroplasmic for a novel anticodon mutation in tRNA-leu(CUN) at np 12300, predicted to generate a suppressor tRNA capable of decoding UUR leucine codons. The suppressor mutation represents approximately 10% of the total mtDNA, but was undetectable in a muscle biopsy sample taken from the original patient or in the parental cybrid. These results indicate that the primary biochemical defect in cells with high levels of np 3243 mutated mtDNA is the inability to translate UUR leucine codons.	Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; Univ Cadi Ayyad, Fac Sci & Tech, Dept Biol, Marrakech, Morocco; Univ Dundee, Sch Med, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Tampere University; Cadi Ayyad University of Marrakech; University of Dundee; University of Glasgow	Jacobs, HT (corresponding author), Univ Tampere, Inst Med Technol, POB 607, FIN-33101 Tampere, Finland.		Jacobs, Howard T/G-2434-2011; Dunbar, Donald R/A-7093-2012	holt, ian/0000-0001-5468-0193; Jacobs, Howard/0000-0003-1895-6003				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CARBON J, 1970, J MOL BIOL, V52, P571, DOI 10.1016/0022-2836(70)90420-1; Chiu YH, 1997, GENETICS, V145, P707; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Dunbar DR, 1996, HUM MOL GENET, V5, P123, DOI 10.1093/hmg/5.1.123; Fadic R, 1996, SEMIN NEUROL, V16, P11, DOI 10.1055/s-2008-1040954; HECKMAN JE, 1980, P NATL ACAD SCI-BIOL, V77, P3159, DOI 10.1073/pnas.77.6.3159; JEANFRANCOIS MJB, 1994, AUST NZ J MED, V24, P188, DOI 10.1111/j.1445-5994.1994.tb00556.x; Kaufmann P, 1996, ANN NEUROL, V40, P172, DOI 10.1002/ana.410400208; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murgola Emanuel J., 1995, P491; Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9; PAGES D, 1991, NUCLEIC ACIDS RES, V19, P867, DOI 10.1093/nar/19.4.867; Reid FM, 1997, HUM MOL GENET, V6, P443, DOI 10.1093/hmg/6.3.443; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Yokoyama Shigeyuki, 1995, P207	25	86	87	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					350	353						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537417				2022-12-27	WOS:000072755500017
J	Watanabe, A; Takeda, K; Ploplis, B; Tachibana, M				Watanabe, A; Takeda, K; Ploplis, B; Tachibana, M			Epistatic relationship between Waardenburg syndrome genes MITF and PAX3	NATURE GENETICS			English	Article							SYNDROME TYPE-I; ALVEOLAR RHABDOMYOSARCOMA; TRANSCRIPTIONAL ACTIVATOR; FUSION PROTEIN; PAIRED DOMAIN; MUTATIONS; EXPRESSION; IDENTIFICATION; MECHANISMS; BINDING	Waardenburg syndrome (WS) is a hereditary disorder that causes hypopigmentation and hearing impairment. Depending on additional symptoms, WS is classified into four types(1): WS1, WS2, WS3 and WS4. Mutations in MITF (microphthalmia-associated transcription factor) and PAX3, encoding transcription factors, are responsible for WS2 and WS1/WS3, respectively(1). We have previously shown that MITF transactivates the gene for tyrosinase, a key enzyme for melanogenesis, and is critically involved in melanocyte differentiation(2). Absence of melanocytes affects pigmentation in the skin, hair and eyes, and hearing function in the cochlea(3). Therefore, hypopigmentation and hearing loss in WS2 are likely to be the results of an anomaly of melanocyte differentiation caused by MITF mutations(4,5). However, the molecular mechanism by which PAX3 mutations cause the auditory-pigmentary symptoms in WS1/WS3 remains to be explained. Here we show that PAX3, a transcription factor with a paired domain and a homeodomain, transactivates the MITF promoter. We further show that PAX3 proteins associated with WS1 in either the paired domain or the homeodomain fail to recognize and transactivate the MITF promoter. These results provide evidence that PAX3 directly regulates MITF, and suggest that the failure of this regulation due to PAX3 mutations causes the auditory-pigmentary symptoms in at least some individuals with WS1.	Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Tachibana, M (corresponding author), Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, 5 Res Court,Rm 2A31, Rockville, MD 20850 USA.							BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; CHALEPAKIS G, 1994, NUCLEIC ACIDS RES, V22, P3131, DOI 10.1093/nar/22.15.3131; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P3685, DOI 10.1073/pnas.91.9.3685; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Fuse N, 1996, BIOCHEM BIOPH RES CO, V219, P702, DOI 10.1006/bbrc.1996.0298; GUAZZI S, 1994, EMBO J, V13, P3339, DOI 10.1002/j.1460-2075.1994.tb06636.x; HOTH CF, 1993, AM J HUM GENET, V52, P455; JONES DH, 1990, BIOTECHNIQUES, V8, P178; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; LALWANI AK, 1995, AM J HUM GENET, V56, P75; Latchman DS, 1996, NEW ENGL J MED, V334, P28, DOI 10.1056/NEJM199601043340108; MACINA RA, 1995, GENOMICS, V26, P1, DOI 10.1016/0888-7543(95)80076-X; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; Nobukuni Y, 1996, AM J HUM GENET, V59, P76; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEMENZA GL, 1994, HUM MUTAT, V3, P180, DOI 10.1002/humu.1380030304; SUBLETT JE, 1995, ONCOGENE, V11, P545; TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131	25	215	224	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					283	286		10.1038/ng0398-283	http://dx.doi.org/10.1038/ng0398-283			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500554				2022-12-27	WOS:000072325000030
J	Hacia, JG; Makalowski, W; Edgemon, K; Erdos, MR; Robbins, CM; Fodor, SPA; Brody, LC; Collins, FS				Hacia, JG; Makalowski, W; Edgemon, K; Erdos, MR; Robbins, CM; Fodor, SPA; Brody, LC; Collins, FS			Evolutionary sequence comparisons using high-density oligonucleotide arrays	NATURE GENETICS			English	Article							HYBRIDIZATION; BRCA1; STRATEGY; GENES	We explored the utility of high-density oligonucleotide arrays (DNA chips) for obtaining sequence information from homologous genes in closely related species. Orthologues of the human BRCA1 exon 11, all approximately 3.4 kb in length and ranging from 98.2% to 83.5% nucleotide identity, were subjected to hybridization-based and conventional dideoxysequencing analysis. Retrospective guidelines for identifying high-fidelity hybridization-based sequence calls were formulated based upon dideoxysequencing results. Prospective application of these rules yielded base-calling with at least 98.8% accuracy over orthologous sequence tracts shown to have approximately 99% identity. For higher primate sequences with greater than 97% nucleotide identity, base-calling was made with at least 99.91% accuracy covering a minimum of 97% of the sequence. Using a second-tier confirmatory hybridization chip strategy, shown in several cases to confirm the identity of predicted sequence changes, the complete sequence of the chimpanzee. gorilla and orangutan orthologues should be deducible solely through hybridization-based methodologies. Analysis of less highly conserved orthologues can still identify conserved nucleotide tracts of at least 15 nucleotides and can provide useful information for designing primers. DNA-chip based assays can be a valuable new technology for obtaining high-throughput cost-effective sequence information from related genomes.	Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; Affymetrix, Santa Clara, CA 95051 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Affymetrix	Collins, FS (corresponding author), Natl Human Genome Res Inst, NIH, Bldg 49-3A14, Bethesda, MD 20892 USA.		Makalowski, Wojciech/I-2843-2016	Makalowski, Wojciech/0000-0003-2303-9541	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG001323] Funding Source: NIH RePORTER; NHGRI NIH HHS [5POLHGO1323-03] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BROUDE NE, 1994, P NATL ACAD SCI USA, V91, P3072, DOI 10.1073/pnas.91.8.3072; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.0.CO;2-A; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Hoheisel JD, 1996, NUCLEIC ACIDS RES, V24, P430, DOI 10.1093/nar/24.3.430; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Li W. H, 1997, MOL EVOLUTION; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; McConkey EH, 1997, TRENDS GENET, V13, P350, DOI 10.1016/S0168-9525(97)01226-2; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner N, 1997, NAT BIOTECHNOL, V15, P537, DOI 10.1038/nbt0697-537; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Szabo CI, 1996, HUM MOL GENET, V5, P1289, DOI 10.1093/hmg/5.9.1289; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913	19	87	109	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					155	158		10.1038/ng0298-155	http://dx.doi.org/10.1038/ng0298-155			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462745				2022-12-27	WOS:000071779500024
J	Garrick, D; Fiering, S; Martin, DIK; Whitelaw, E				Garrick, D; Fiering, S; Martin, DIK; Whitelaw, E			Repeat-induced gene silencing in mammals	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; TRANSGENIC MICE; DNA-METHYLATION; EXPRESSION; ARABIDOPSIS; SUSCEPTIBILITY; INACTIVATION; RECOMBINASE; DROSOPHILA; PETUNIA	In both plants(1-3) and Drosophila melanogaster(4,5), expression from a transgenic locus may be silenced when repeated transgene copies are arranged as a concatameric array. This repeat-induced gene silencing is frequently manifested as a decrease in the proportion of cells that express the transgene, resulting in a variegated pattern of expression. There is also some indication that, in transgenic mammals, the number of transgene copies within an array can exert a repressive influence on expression, with several mouse studies reporting a decrease in the level of expression per copy as copy number increases(6-8). However, because these studies compare different sites of transgene integration as well as arrays with different numbers of copies, the expression levels observed may be subject to varying position effects as well as the influence of the multicopy array. Here we describe use of the lox/Cre system of site-specific recombination to generate transgenic mouse lines in which different numbers of a transgene are present at the same chromosomal location, thereby eliminating the contribution of position effects and allowing analysis of the effect of copy number alone on transgene silencing. Reduction in copy number results in a marked increase in expression of the transgene and is accompanied by decreased chromatin compaction and decreased methylation at the transgene locus. These findings establish that the presence of multiple homologous copies of a transgene within a concatameric array can have a repressive effect upon gene expression in mammalian systems.	Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Sydney; Fred Hutchinson Cancer Center	Whitelaw, E (corresponding author), Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia.		GARRICK, David/O-5734-2019; Garrick, David/F-1728-2017	GARRICK, David/0000-0001-7422-7986; Garrick, David/0000-0001-7422-7986; Fiering, Steven/0000-0003-0624-974X				ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; BRESNICK EH, 1994, P NATL ACAD SCI USA, V91, P1314, DOI 10.1073/pnas.91.4.1314; DAVIS BP, 1988, GENE DEV, V2, P13, DOI 10.1101/gad.2.1.13; DECARVALHO F, 1992, EMBO J, V11, P2595, DOI 10.1002/j.1460-2075.1992.tb05324.x; Dorer DR, 1997, TRANSGENIC RES, V6, P3, DOI 10.1023/A:1018460413680; Dorer DR, 1994, CELL, V77, P1; Garrick D, 1996, NUCLEIC ACIDS RES, V24, P4902, DOI 10.1093/nar/24.24.4902; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; INGELBRECHT I, 1994, P NATL ACAD SCI USA, V91, P10502, DOI 10.1073/pnas.91.22.10502; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LINN F, 1990, MOL GEN GENET, V222, P329, DOI 10.1007/BF00633837; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; MEYER P, 1993, PLANT J, V4, P89, DOI 10.1046/j.1365-313X.1993.04010089.x; NEUHUBER F, 1994, MOL GEN GENET, V244, P230, DOI 10.1007/BF00285450; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PONDEL MD, 1992, NUCLEIC ACIDS RES, V20, P5655, DOI 10.1093/nar/20.21.5655; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; Robertson G, 1996, NUCLEIC ACIDS RES, V24, P1465, DOI 10.1093/nar/24.8.1465; ROBERTSON G, 1995, P NATL ACAD SCI USA, V92, P5371, DOI 10.1073/pnas.92.12.5371; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; Sabl JF, 1996, GENETICS, V142, P447; SCHEID OM, 1991, MOL GEN GENET, V228, P104, DOI 10.1007/BF00282454; SHARPE JA, 1993, P NATL ACAD SCI USA, V90, P11262, DOI 10.1073/pnas.90.23.11262; Sutherland HGE, 1997, MOL CELL BIOL, V17, P1607, DOI 10.1128/MCB.17.3.1607; URIELISHOVAL S, 1982, FEBS LETT, V146, P148, DOI 10.1016/0014-5793(82)80723-0; WHITELAW E, 1986, EMBO J, V5, P2915, DOI 10.1002/j.1460-2075.1986.tb04587.x; Ye F, 1996, P NATL ACAD SCI USA, V93, P10881, DOI 10.1073/pnas.93.20.10881	31	504	540	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					56	59		10.1038/ng0198-56	http://dx.doi.org/10.1038/ng0198-56			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425901				2022-12-27	WOS:000071259600022
J	Samadashwily, GM; Raca, G; Mirkin, SM				Samadashwily, GM; Raca, G; Mirkin, SM			Trinucleotide repeats affect DNA replication in vivo	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; AGAROSE-GEL ELECTROPHORESIS; HUMAN HEREDITARY-DISEASES; CGG TRIPLET REPEATS; SYNTHESIS IN-VITRO; ESCHERICHIA-COLI; DELAYED REPLICATION; MISMATCH REPAIR; SWITCH REGION; CTG	(CCG)(n).(CCG)(n) and (CTG)(n).(CAG)(n) repeats of varying length were cloned into a bacterial plasmid, and the progression of the replication fork through these repeats was followed using electrophoretic analysis of replication intermediates. We observed stalling of the replication fork within repeated DNAs and found that this effect depends on repeat length, repeat orientation relative to the replication origin and the status of protein synthesis in a cell. Interruptions within repeated DNAs, similar to those observed in human genes, abolished the replication blockage. Our results suggest that the formation of unusual DNA structures by trinucleotide repeats in the lagging-strand template may account for the observed replication blockage and have relevance to repeat expansion in humans.	UNIV ILLINOIS, DEPT MOL GENET, CHICAGO, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital			Mirkin, Sergei/A-7310-2010; Mirkin, Sergei/AAR-7226-2020	Mirkin, Sergei/0000-0003-4576-7582				AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; Bowater RP, 1996, J MOL BIOL, V264, P82, DOI 10.1006/jmbi.1996.0625; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CLEWELL DB, 1972, J BACTERIOL, V110, P667, DOI 10.1128/JB.110.2.667-676.1972; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GACY AM, 1995, CELL, V81, P533; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; JODICE C, 1994, AM J HUM GENET, V54, P959; Kang S, 1996, J MOL BIOL, V258, P543, DOI 10.1006/jmbi.1996.0266; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; KOHWI Y, 1993, NUCLEIC ACIDS RES, V21, P5651; Kornberg A., 1992, DNA REPLICATION; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; KURYAVYI VV, 1995, NAT GENET, V9, P339, DOI 10.1038/ng0495-339; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; MITCHELL JE, 1995, NUCLEIC ACIDS RES, V23, P1876, DOI 10.1093/nar/23.11.1876; Ohshima K, 1996, J BIOL CHEM, V271, P1853, DOI 10.1074/jbc.271.4.1853; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; SAMADASHWILY GM, 1993, EMBO J, V12, P4975, DOI 10.1002/j.1460-2075.1993.tb06191.x; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Subramanian PS, 1996, AM J HUM GENET, V59, P407; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; WEBB T, 1992, AM J MED GENET, V43, P1057, DOI 10.1002/ajmg.1320430633; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Yu A, 1997, BIOCHEMISTRY-US, V36, P3687, DOI 10.1021/bi9625410; YU AD, 1995, NUCLEIC ACIDS RES, V23, P2706, DOI 10.1093/nar/23.14.2706; Zheng MX, 1996, J MOL BIOL, V264, P323, DOI 10.1006/jmbi.1996.0643	50	271	275	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					298	304		10.1038/ng1197-298	http://dx.doi.org/10.1038/ng1197-298			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354793				2022-12-27	WOS:A1997YD66700023
J	Burch, GH; Gong, Y; Liu, WH; Dettman, RW; Curry, CJ; Smith, L; Miller, WL; Bristow, J				Burch, GH; Gong, Y; Liu, WH; Dettman, RW; Curry, CJ; Smith, L; Miller, WL; Bristow, J			Tenascin-X deficiency is associated with Ehlers-Danlos syndrome	NATURE GENETICS			English	Letter							EXTRACELLULAR-MATRIX PROTEIN; STEROID 21-HYDROXYLASE DEFICIENCY; CLASS-III REGION; PRO-ALPHA-2(I) CHAIN; FIBRONECTIN; GENE; REPEATS; TISSUE; FIBRINOGEN; HAPLOTYPES	The tenascins are a family of large extracellular matrix proteins with at least three members: tenascin-X (TNX)(1-3), tenascin-C (TNC, or cytotactin)(4-6) and tenascin-R (TN-R, or restrictin)(7,8). Although the tenascins have been implicated in a number of important cellular processes, no function has been clearly established for any tenascin(9). We describe a new contiguous-gene syndrome, involving the CYP21B and TNX genes, that results in 21-hydroxylase deficiency and a connective-tissue disorder consisting of skin and joint hyperextensibility, vascular fragility and poor wound healing. The connective tissue findings are typical of the Ehlers-Danlos syndrome (EDS)(10). The abundant expression of TNX in connective tissues(2,11-13) is consistent with a role in EDS, and our patient's skin fibroblasts do not synthesize TNX protein in vitro or in vivo. His paternal allele carries a novel deletion arising from recombination between TNX and its partial duplicate gene, XA(14), which precludes TNX synthesis. Absence of TNX mRNA and protein in the proband, mapping of the TNX gene and HLA typing of this family suggest recessive inheritance of TNX deficiency and connective-tissue disease. Although the precise role of TNX in the pathogenesis of EDS is uncertain, this patient's findings suggest a unique and essential role for TNX in connective-tissue structure and function.	UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, METAB RES UNIT, SAN FRANCISCO, CA 94143 USA; VALLEY CHILDRENS HOSP, DEPT MED GENET, FRESNO, CA 93703 USA; UNIV WASHINGTON, SCH MED, DEPT MED, SEATTLE, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle			Miller, Walter L/J-3696-2012	Dettman, Robert/0000-0002-3074-5922	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02695] Funding Source: Medline; NIDDK NIH HHS [DK37922] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRISTOW J, 1993, J BIOL CHEM, V268, P12919; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; BYERS PH, 1994, J INVEST DERMATOL, V103, pS47, DOI 10.1038/jid.1994.9; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; COLLIER S, 1989, EMBO J, V8, P1393, DOI 10.1002/j.1460-2075.1989.tb03520.x; DePaepe A, 1997, AM J HUM GENET, V60, P547; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1984, NATURE, V311, P267, DOI 10.1038/311267a0; EYRE DR, 1985, J BIOL CHEM, V260, P1322; Forsberg E, 1996, P NATL ACAD SCI USA, V93, P6594, DOI 10.1073/pnas.93.13.6594; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; GEFFROTIN C, 1995, EUR J BIOCHEM, V231, P83, DOI 10.1111/j.1432-1033.1995.0083f.x; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; HAUSSER I, 1994, HUM GENET, V93, P394; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; MATSUMOTO K, 1992, IMMUNOGENETICS, V36, P400; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; MATSUMOTO K, 1992, GENOMICS, V12, P485, DOI 10.1016/0888-7543(92)90438-X; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; NORENBERG U, 1992, NEURON, V8, P849, DOI 10.1016/0896-6273(92)90199-N; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; SINNOTT P, 1990, P NATL ACAD SCI USA, V87, P2107, DOI 10.1073/pnas.87.6.2107; SMITH LT, 1992, AM J HUM GENET, V51, P235; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436; WIRTZ MK, 1987, J BIOL CHEM, V262, P16376	31	262	266	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					104	108		10.1038/ng0997-104	http://dx.doi.org/10.1038/ng0997-104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288108				2022-12-27	WOS:A1997XU72400028
J	Grobet, L; Martin, LJR; Poncelet, D; Pirottin, D; Brouwers, B; Riquet, J; Schoeberlein, A; Dunner, S; Menissier, F; Massabanda, J; Fries, R; Hanset, R; Georges, M				Grobet, L; Martin, LJR; Poncelet, D; Pirottin, D; Brouwers, B; Riquet, J; Schoeberlein, A; Dunner, S; Menissier, F; Massabanda, J; Fries, R; Hanset, R; Georges, M			A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle	NATURE GENETICS			English	Letter							MUSCULAR HYPERTROPHY; BELGIAN WHITE; GENOME; MAPS; LOCI; CONSTRUCTION; DETERMINISM; BREED	An exceptional muscle development commonly referred to as 'double-muscled' (Fig. 1) has been seen in several cattle breeds and has attracted considerable attention from beef producers. Double-muscled animals are characterized by an increase in muscle mass of about 20%, due to general skeletal-muscle hyperplasia-that is, an increase in the number of muscle fibers rather than in their individual diameter(1). Although the hereditary nature of the double-muscled condition was recognized early on, the precise mode of inheritance has remained controversial; monogenic (dominant and recessive), oligogenic and polygenic models have been proposed(2). In the Belgian Blue cattle breed (BBCB)(4), segregation analysis performed both in experimental crosses(3) and in the outbred population suggested an autosomal recessive inheritance. This was confirmed when the muscular hypertrophy (mh) locus was mapped 3.1 cM from microsatellite TCLA44 on the centromeric end of bovine chromosome 2 (ref. 5). We used a positional candidate approach to demonstrate that a mutation in bovine MSTN, which encodes myostatin, a member of the TGF beta superfamily, is responsible for the double-muscled phenotype. We report an 11-bp deletion in the coding sequence for the bioactive carboxy-terminal domain of the protein causing the muscular hypertrophy observed in Belgian Blue cattle.	UNIV LIEGE,FAC VET MED,DEPT GENET,B-4000 LIEGE,BELGIUM; UNIV COMPLUTENSE MADRID,DPTO PROD ANIM,GENET LAB,E-28040 MADRID,SPAIN; INRA,GENET QUANTITAT & APPL STN,F-78352 JOUY EN JOSAS,FRANCE; TECH UNIV MUNICH,D-85350 FREISING,GERMANY	University of Liege; Complutense University of Madrid; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Technical University of Munich			Schoeberlein, Andreina/H-8413-2019; Dunner, Susana/H-3124-2015; Schoeberlein, Andreina/C-8688-2009; Royo, Luis/B-4024-2012	Schoeberlein, Andreina/0000-0002-6716-9551; Schoeberlein, Andreina/0000-0002-6716-9551; Royo, Luis/0000-0002-5939-3000; grobet, Luc/0000-0003-0724-4369; Fries, Ruedi/0000-0002-4657-1787; Georges, Michel/0000-0003-4124-2375				CHARLIER C, 1995, MAMM GENOME, V6, P788, DOI 10.1007/BF00539005; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORNELIS F, 1992, GENOMICS, V13, P820, DOI 10.1016/0888-7543(92)90159-P; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dunner S, 1997, MAMM GENOME, V8, P430, DOI 10.1007/s003359900462; GEORGES M, 1995, GENETICS, V139, P907; HANSET R, 1991, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, P467; HANSET R, 1985, GENET SEL EVOL, V17, P369, DOI 10.1186/1297-9686-17-3-369; HANSET R, 1985, GENET SEL EVOL, V17, P359, DOI 10.1186/1297-9686-17-3-359; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Hunter KW, 1996, GENOME RES, V6, P290, DOI 10.1101/gr.6.4.290; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LENSTRA JA, 1993, ANIM GENET, V24, P33, DOI 10.1111/j.1365-2052.1993.tb00916.x; LIBERT F, 1993, GENOMICS, V18, P270, DOI 10.1006/geno.1993.1465; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC., 1996, GROWTH FACTORS CYTOK, P357, DOI [10.1016/s1874-5687(96)80016-4, DOI 10.1016/S1874-5687(96)80016-4]; MENISSIER F, 1982, CURR TOP VET ANIM SC, V16, P387; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; SOLINASTOLDO S, 1995, GENOMICS, V27, P489, DOI 10.1006/geno.1995.1081; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; [No title captured]; [No title captured]	23	1136	1333	6	160	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					71	74		10.1038/ng0997-71	http://dx.doi.org/10.1038/ng0997-71			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288100				2022-12-27	WOS:A1997XU72400020
J	Kalchman, MA; Koide, HB; McCutcheon, K; Graham, RK; Nichol, K; Nishiyama, K; KazemiEsfarjani, P; Lynn, FC; Wellington, C; Metzler, M; Goldberg, YP; Kanazawa, I; Gietz, RD; Hayden, MR				Kalchman, MA; Koide, HB; McCutcheon, K; Graham, RK; Nichol, K; Nishiyama, K; KazemiEsfarjani, P; Lynn, FC; Wellington, C; Metzler, M; Goldberg, YP; Kanazawa, I; Gietz, RD; Hayden, MR			HIP1, a human homologue of S-cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; REPEAT LENGTH; LEUCINE-ZIPPER; DISEASE; PROTEIN; GENE; EXPRESSION; CYTOSKELETON; EXPANSION; IDENTIFY	Huntington disease (HD) is associated with the expansion of a polyglutamine tract, greater than 35 repeats, in the HD gene product, huntingtin. Here we describe a novel huntingtin interacting protein, HIP1, which co-localizes with huntingtin and shares sequence homology and biochemical characteristics with Sla2p, a protein essential for function of the cytoskeleton in Saccharomyces cerevisiae. The huntingtin-HIP1 interaction is restricted to the brain and is inversely correlated to the polyglutamine length in huntingtin. This provides the first molecular link between huntingtin and the neuronal cytoskeleton and suggests that, in HD, loss of normal huntingtin-HIP1 interaction may contribute to a defect in membrane-cytoskeletal integrity in the brain.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V6T 1Z4,CANADA; UNIV TOKYO,FAC MED,DEPT CLIN NEUROL & NEUROSCI,TOKYO 113,JAPAN; UNIV MANITOBA,FAC MED,DEPT HUMAN GENET,WINNIPEG,MB R3E 0W3,CANADA	University of British Columbia; University of Tokyo; University of Manitoba			Hayden, Michael R/D-8581-2011; Metzler, Markus/AAS-2066-2021; Graham, Rona K/R-7358-2018	Hayden, Michael R/0000-0001-5159-1419; Metzler, Markus/0000-0002-4523-1676; Graham, Rona K/0000-0003-3722-6241; Lynn, Francis/0000-0001-9318-1063				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ARAI M, 1994, J NEUROSCI RES, V38, P348, DOI 10.1002/jnr.490380313; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Bhide PG, 1996, J NEUROSCI, V16, P5523; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GIETZ RD, 1996, IN PRESS CELL BIOL L; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; HARPER PS, 1991, HUNTINGTONS DIS, P31; Hayden MR, 1981, HUNTINGTONS CHOREA, P59, DOI [10.1007/978-1-4471-1308-9_5, DOI 10.1007/978-1-4471-1308-9_5]; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; *HUNT DIS COLL RES, 1993, CELL, V72, P971; JOHN M, 1994, J BIOL CHEM, V269, P16247; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Koshy B, 1996, HUM MOL GENET, V5, P1311, DOI 10.1093/hmg/5.9.1311; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; MacLennan D H, 1987, Soc Gen Physiol Ser, V41, P287; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; NA S, 1995, J BIOL CHEM, V270, P375; Nasir J, 1996, HUM MOL GENET, V5, P1431, DOI 10.1093/hmg/5.Supplement_1.1431; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PEARLMAN JA, 1994, FEBS LETT, V354, P183, DOI 10.1016/0014-5793(94)01119-2; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; REES DJ, 1990, NATURE, V347, P18; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SHULL GE, 1985, NATURE, V316, P33; Sirover MA, 1996, LIFE SCI, V58, P2271, DOI 10.1016/0024-3205(96)00123-3; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Suzuki T, 1996, BIOCHEM BIOPH RES CO, V219, P708, DOI 10.1006/bbrc.1996.0299; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P100; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Wood J. D., 1996, American Journal of Human Genetics, V59, pA295; WOOD JD, 1996, HUM MOL GENET, V5, P418; Zoghbi HY, 1996, NAT GENET, V14, P237, DOI 10.1038/ng1196-237	49	310	319	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					44	53		10.1038/ng0597-44	http://dx.doi.org/10.1038/ng0597-44			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140394				2022-12-27	WOS:A1997WX02400021
J	Vage, DI; Lu, DS; Klungland, H; Lien, S; Adalsteinsson, S; Cone, RD				Vage, DI; Lu, DS; Klungland, H; Lien, S; Adalsteinsson, S; Cone, RD			A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes	NATURE GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; MSH RECEPTOR; MOUSE; GENE; MICE; CLONING; PROTEIN; LOCUS; CELLS	Agouti and extension are two genes that control the production of yellow-red (phaeomelanin) and brown-black (eumelanin) pigments in the mammalian coat(1). Extension encodes the melanocyte-stimulating hormone receptor (MC1R)(2,3) while agouti encodes a peptide antagonist of the receptor(4-6). In the mouse, extension is epistatic to agouti(7,8), hence dominant mutants of the MC1R encoding constitutively active receptors are not inhibited by the agouti antagonist, and animals with dominant alleles of both loci remain darkly pigmented, In the fox the proposed extension locus is not epistatic to the agouti locus(9,10). We have cloned and characterized the MC1R and the agouti gene in coat colour variants of the fox (Vulpes vulpes). A constitutively activating C125R mutation in the MC1R was found specifically in darkly pigmented animals carrying the Alaska Silver allele (E(A)). A deletion in the first coding exon of the agouti gene was found associated with the proposed recessive allele of agouti in the darkly pigmented Standard Silver fox (aa). Thus, as in the mouse, dark pigmentation can be caused by a constitutively active MC1R, or homozygous recessive status at the agouti locus. Our results, demonstrating the presence of dominant extension alleles in foxes with significant red coat colouration, suggest the ability of the fox agouti protein to counteract the signalling activity of a constitutively active fox MC1R.	OREGON HLTH SCI UNIV, VOLLUM INST ADV BIOMED RES, PORTLAND, OR 97201 USA; AGR UNIV NORWAY, DEPT ANIM SCI, N-1432 AS, NORWAY; AGR UNIV NORWAY, NORDIC GENE BANK FARM ANIM, N-1432 AS, NORWAY	Oregon Health & Science University; Norwegian University of Life Sciences; Norwegian University of Life Sciences			Våge, Dag Inge/AAD-5178-2020	Våge, Dag Inge/0000-0003-2568-1554	NIAMS NIH HHS [AR42415] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042415] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADALSTEINSSON S, 1987, J HERED, V78, P235, DOI 10.1093/oxfordjournals.jhered.a110373; Ashbrook FG., 1937, YRB AGR, P1379; BATEMAN N, 1961, J HERED, V52, P186, DOI 10.1093/oxfordjournals.jhered.a107062; BLANCHARD SG, 1995, BIOCHEMISTRY-US, V34, P10406, DOI 10.1021/bi00033a012; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.3.CO;2-5; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; SEARLE AG, COMP GENETICS COAT C, P67; SOLCA F, 1989, J BIOL CHEM, V264, P14277; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223; WOLFF GL, 1978, J HERED, V69, P295, DOI 10.1093/oxfordjournals.jhered.a108953; ZEMEL MB, 1995, P NATL ACAD SCI USA, V92, P4733, DOI 10.1073/pnas.92.11.4733	24	175	187	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					311	315		10.1038/ng0397-311	http://dx.doi.org/10.1038/ng0397-311			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054949				2022-12-27	WOS:A1997WK38600026
J	Shi, ZZ; Habib, GM; Rhead, WJ; Gahl, WA; He, XW; Sazer, S; Lieberman, MW				Shi, ZZ; Habib, GM; Rhead, WJ; Gahl, WA; He, XW; Sazer, S; Lieberman, MW			Mutations in the glutathione synthetase gene cause 5-oxoprolinuria	NATURE GENETICS			English	Article							SCHIZOSACCHAROMYCES-POMBE; INBORN ERROR; FIBROBLASTS; DEFICIENCY; EXPRESSION; PATIENT		BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030; UNIV IOWA,COLL MED,DEPT PEDIAT,IOWA CITY,IA 52242; NICHHD,HERITABLE DISORDERS BRANCH,NIH,BETHESDA,MD 20892	Baylor College of Medicine; Baylor College of Medicine; University of Iowa; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049119] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES07827] Funding Source: Medline; NIGMS NIH HHS [GM49119] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASTOR MB, 1984, BRIT J RADIOL, V57, P717, DOI 10.1259/0007-1285-57-680-717; BEUTLER E, 1976, NEW ENGL J MED, V295, P441, DOI 10.1056/NEJM197608192950809; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; GALI RR, 1995, BIOCHEM J, V310, P353, DOI 10.1042/bj3100353; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JAIN A, 1994, J PEDIATR-US, V124, P229, DOI 10.1016/S0022-3476(94)70309-4; JELLUM E, 1970, SCAND J CLIN LAB INV, V26, P327, DOI 10.3109/00365517009046241; KAVANAGH TJ, 1994, EXP CELL RES, V212, P69, DOI 10.1006/excr.1994.1119; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LARSSON A, 1981, ACTA PAEDIATR SCAND, V70, P301, DOI 10.1111/j.1651-2227.1981.tb16556.x; LARSSON A, 1983, CLIN CHIM ACTA, V135, P57, DOI 10.1016/0009-8981(83)90388-1; LARSSON A, 1990, GLUTATHIONE METABOLI, P359; MAJERUS PW, 1971, J CLIN INVEST, V50, P1637, DOI 10.1172/JCI106652; MEISTER A, 1985, METHOD ENZYMOL, V113, P393; Meister A., 1995, METABOLIC BASIS INHE, P1461; MOHLER DN, 1970, NEW ENGL J MED, V283, P1253, DOI 10.1056/NEJM197012032832304; MUTOH N, 1988, BIOCHEM BIOPH RES CO, V151, P32, DOI 10.1016/0006-291X(88)90555-4; MUTOH N, 1991, BIOCHEM BIOPH RES CO, V181, P430, DOI 10.1016/S0006-291X(05)81437-8; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Shi ZZ, 1996, ARCH BIOCHEM BIOPHYS, V331, P215, DOI 10.1006/abbi.1996.0301; SPIELBERG SP, 1977, J PEDIATR-US, V91, P237, DOI 10.1016/S0022-3476(77)80819-6; SPIELBERG SP, 1978, J CLIN INVEST, V61, P1417, DOI 10.1172/JCI109060	22	67	68	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					361	365		10.1038/ng1196-361	http://dx.doi.org/10.1038/ng1196-361			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896573				2022-12-27	WOS:A1996VQ14600038
J	Zhong, F; McCombs, CC; Olson, JM; Elston, RC; Stevens, FM; McCarthy, CF; Michalski, JP				Zhong, F; McCombs, CC; Olson, JM; Elston, RC; Stevens, FM; McCarthy, CF; Michalski, JP			An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland	NATURE GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; GLUTEN-SENSITIVE ENTEROPATHY; HUMAN GENOME; SUSCEPTIBILITY; LOCUS; DETERMINANTS; POLYMORPHISM; COMPLEX; TRAITS; REGION		UNIV S ALABAMA,DEPT INTERNAL MED,CTR CANC,MOBILE,AL 36688; CASE WESTERN RESERVE UNIV,DEPT EPIDEMIOL & BIOSTAT,CLEVELAND,OH 44109; UNIV COLL GALWAY,DEPT MED,GALWAY,IRELAND	University of South Alabama; Case Western Reserve University; Ollscoil na Gaillimhe-University of Galway					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040552, R01DK047691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47691, DK 40552] Funding Source: Medline; NIGMS NIH HHS [GM 28356] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; Bidwell J L, 1990, Baillieres Clin Haematol, V3, P355, DOI 10.1016/S0950-3536(05)80055-1; CHUMAKOV IM, 1995, NATURE, V377, P175; CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; CORDELL HJ, 1995, AM J HUM GENET, V57, P92; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; ELSTON RC, IN PRESS GENET EPIDE; ERLICH HA, 1991, BAILLIERE CLIN ENDOC, V5, P395, DOI 10.1016/S0950-351X(05)80138-7; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; GREENBERG DA, 1982, AM J HUM GENET, V34, P263; GREENBERG DA, 1981, AM J MED GENET, V8, P205, DOI 10.1002/ajmg.1320080211; HERNANDEZ JL, 1991, GENET EPIDEMIOL, V8, P13, DOI 10.1002/gepi.1370080103; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; MACAUBAS C, 1995, HUM IMMUNOL, V42, P209, DOI 10.1016/0198-8859(94)00101-U; MAKI M, 1995, GUT, V36, P239, DOI 10.1136/gut.36.2.239; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; MICHALSKI JP, 1994, AM J MED SCI, V307, P204, DOI 10.1097/00000441-199403000-00007; Michalski JP, 1996, TISSUE ANTIGENS, V47, P127, DOI 10.1111/j.1399-0039.1996.tb02525.x; MORTON NE, 1983, AM J HUM GENET, V35, P201; MYLOTTE M, 1973, BMJ-BRIT MED J, V1, P703, DOI 10.1136/bmj.1.5855.703; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; OLSON JM, IN PRESS HUM HEREDIT; PAGE SR, 1994, Q J MED, V87, P631; PENA AS, 1978, GASTROENTEROLOGY, V75, P230; POLANCO I, 1981, GENETICS COELIAC DIS, P221; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; *SAGE, 1994, STAT AN GEN EP REL 2; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; TODD JA, 1992, SPRINGER SEMIN IMMUN, V14, P33; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	36	150	153	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					329	333		10.1038/ng1196-329	http://dx.doi.org/10.1038/ng1196-329			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896565				2022-12-27	WOS:A1996VQ14600030
J	Pinkel, D; Seagraves, R; Sudar, D; Clark, S; Poole, I; Kowbel, D; Collins, C; Kuo, WL; Chen, C; Zhai, Y; Dairkee, SH; Ljung, BM; Gray, JW; Albertson, DG				Pinkel, D; Seagraves, R; Sudar, D; Clark, S; Poole, I; Kowbel, D; Collins, C; Kuo, WL; Chen, C; Zhai, Y; Dairkee, SH; Ljung, BM; Gray, JW; Albertson, DG			High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; HUMAN UROEPITHELIAL CELLS; IN-SITU HYBRIDIZATION; INDEPENDENT AMPLIFICATION; CHROMOSOME 20Q13; REGIONS; LINES; PATTERNS; TUMORS; MDM2	Gene dosage variations occur in many diseases. In cancer, deletions and copy number increases contribute to alterations in the expression of tumour-suppressor genes and oncogenes, respectively. Developmental abnormalities, such as Down, Prader Willi, Angelman and Cri du Chat syndromes, result from gain or loss of one copy of a chromosome or chromosomal region. Thus, detection and mapping of copy number abnormalities provide an approach for associating aberrations with disease phenotype and for localizing critical genes. Comparative genomic hybridization(1) (CGH) was developed for genome-wide analysis of DNA sequence copy number in a single experiment. In CGH, differentially labelled total genomic DNA from a 'test' and a 'reference' cell population are cohybridized to normal metaphase chromosomes, using blocking DNA to suppress signals from repetitive sequences. The resulting ratio of the fluorescence intensities at a location on the 'cytogenetic map', provided by the chromosomes, is approximately proportional to the ratio of the copy numbers of the corresponding DNA sequences in the test and reference genomes, CGH has been broadly applied to human and mouse malignancies. The use of metaphase chromosomes, however, limits detection of events involving small regions (of less than 20 Mb) of the genome, resolution of closely spaced aberrations and linking ratio changes to genomic/genetic markers. Therefore, more laborious locus-by-locus techniques have been required for higher resolution studies(2-5). Hybridization to an array of mapped sequences instead of metaphase chromosomes could overcome the limitations of conventional CGH (ref, 6) if adequate performance could be achieved. Copy number would be related to the test/reference fluorescence ratio on the array targets, and genomic resolution could be determined by the map distance between the targets, or by the length of the cloned DNA segments. We describe here our implementation of array CGH, We demonstrate its ability to measure copy number with high precision in the human genome, and to analyse clinical specimens by obtaining new information on chromosome 20 aberrations in breast cancer.	Univ Calif San Francisco, Ctr Canc, Canc Genet Program, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Vysis Inc, Downers Grove, IL USA; Calif Pacific Med Ctr, Geraldine Brush Canc Res Inst, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Pacific Medical Center; University of California System; University of California San Francisco; MRC Laboratory Molecular Biology	Pinkel, D (corresponding author), Univ Calif San Francisco, Ctr Canc, Canc Genet Program, Box 0808, San Francisco, CA 94143 USA.		Dairkee, Shanaz Hashmi/D-6743-2012	Sudar, Damir/0000-0002-2510-7272; Dairkee, Shanaz/0000-0002-2073-9684	NCI NIH HHS [P50 CA 58207, CA 45919] Funding Source: Medline; NICHD NIH HHS [HD 17665] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA045919, P50CA058207] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTSON DG, 1995, CAENORHABDITIS ELEGA, P339; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Barlund M, 1997, GENE CHROMOSOME CANC, V20, P372, DOI 10.1002/(SICI)1098-2264(199712)20:4<372::AID-GCC8>3.0.CO;2-Z; Bench AJ, 1998, GENOMICS, V49, P351, DOI 10.1006/geno.1998.5231; Bieche I, 1996, CANCER RES, V56, P3886; Brinkmann U, 1996, GENOME RES, V6, P187, DOI 10.1101/gr.6.3.187; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Courjal F, 1996, BRIT J CANCER, V74, P1984, DOI 10.1038/bjc.1996.664; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KARLSEDER J, 1994, GENE CHROMOSOME CANC, V9, P42, DOI 10.1002/gcc.2870090108; KIM JH, 1996, AMERASIA J, V22, P93, DOI 10.17953/amer.22.1.l3824k6j878388gq; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mohapatra G, 1997, GENE CHROMOSOME CANC, V20, P311, DOI 10.1002/(SICI)1098-2264(199712)20:4<311::AID-GCC1>3.0.CO;2-4; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; PRESS WH, 1994, NUMERICAL RECIPES C, P636; Reifenberger G, 1996, CANCER RES, V56, P5141; REZNIKOFF CA, 1994, GENE DEV, V8, P2227, DOI 10.1101/gad.8.18.2227; SALINASTOLDO S, 1997, P NATL ACAD SCI USA, V94, P3854; Savelieva E, 1997, ONCOGENE, V14, P551, DOI 10.1038/sj.onc.1200868; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; STOKKE T, 1995, GENOMICS, V26, P134, DOI 10.1016/0888-7543(95)80092-Z; TANNER MM, 1994, CANCER RES, V54, P4257; Tanner MM, 1995, CLIN CANCER RES, V1, P1455; Tanner MM, 1996, CANCER RES, V56, P3441; Wang PW, 1998, GENE CHROMOSOME CANC, V21, P75, DOI 10.1002/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; WITTRUP KD, 1994, CYTOMETRY, V16, P206, DOI 10.1002/cyto.990160304	31	1606	1752	3	126	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					207	211		10.1038/2524	http://dx.doi.org/10.1038/2524			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771718				2022-12-27	WOS:000076231300027
J	Jones, PL; Veenstra, GJC; Wade, PA; Vermaak, D; Kass, SU; Landsberger, N; Strouboulis, J; Wolffe, AP				Jones, PL; Veenstra, GJC; Wade, PA; Vermaak, D; Kass, SU; Landsberger, N; Strouboulis, J; Wolffe, AP			Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription	NATURE GENETICS			English	Article							CHROMATIN STRUCTURE; GENE; ISLAND	CpG methylation in vertebrates correlates with alterations in chromatin structure and gene silencing(1-4). Differences in DNA-methylation status are associated with imprinting phenomena and carcinogenesis(5-10). In Xenopus laevis oocytes, DNA methylation dominantly silences transcription through the assembly of a repressive nucleosomal array(11). Methylated DNA assembled into chromatin binds the transcriptional repressor MeCP2 which cofractionates with Sin3 and histone deacetylase. Silencing conferred by MeCP2 and methylated DNA can be relieved by inhibition of histone deacetylase, facilitating the remodeling of chromatin and transcriptional activation. These results establish a direct causal relationship between DNA methylation-dependent transcriptional silencing and the modification of chromatin.	NICHHD, Mol Embryol Lab, NIH, Bethesda, MD 20892 USA; Janssen Res Fdn, Dept Expt Mol Biol, B-2340 Beerse, Belgium; Univ Varese, Dipartimento Biol Strutturale & Funz, I-2100 Varese, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johnson & Johnson	Wolffe, AP (corresponding author), NICHHD, Mol Embryol Lab, NIH, Bethesda, MD 20892 USA.	awlme@helix.nih.gov	Veenstra, Gert Jan C./D-4963-2012; Wade, Paul A/D-2374-2019; Strouboulis, John/U-4459-2019	Veenstra, Gert Jan C./0000-0002-7787-4940; Wade, Paul A/0000-0002-6042-357X; Landsberger, Nicoletta/0000-0003-0820-3155; Strouboulis, John/0000-0002-6133-2872				Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Baylin SB, 1998, ADV CANCER RES, V72, P141; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; BUSCHHAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177, DOI 10.1073/pnas.84.5.1177; Davey C, 1997, J MOL BIOL, V267, P276, DOI 10.1006/jmbi.1997.0899; DePinho RA, 1998, NATURE, V391, P533, DOI 10.1038/35257; GODE JS, 1990, J BIOL CHEM, V271, P24325; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; GRUENBAUM Y, 1983, P NATL ACAD SCI-BIOL, V80, P4919, DOI 10.1073/pnas.80.16.4919; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; JOENS PA, 1997, P ANTL ACAD SCI US, V94, P2103; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; Landsberger N, 1997, EMBO J, V16, P4361, DOI 10.1093/emboj/16.14.4361; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; NAN X, 1997, CELL, V88, P1; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Wong JM, 1998, EMBO J, V17, P520, DOI 10.1093/emboj/17.2.520; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zingg JM, 1997, CARCINOGENESIS, V18, P869, DOI 10.1093/carcin/18.5.869	30	2015	2073	3	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					187	191		10.1038/561	http://dx.doi.org/10.1038/561			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620779				2022-12-27	WOS:000073865100030
J	Bork, P; Koonin, EV				Bork, P; Koonin, EV			Predicting functions from protein sequences - where are the bottlenecks?	NATURE GENETICS			English	Article							YEAST CHROMOSOME-III; POSITIONAL CLONING; FRIEDREICHS-ATAXIA; ESCHERICHIA-COLI; SYNDROME GENE; OBESE GENE; WW DOMAIN; DATABASES; DYSTROPHIN; REPEATS	The exponential growth of sequence data does not necessarily lead to an increase in knowledge about the functions of genes and their products. Prediction of function using comparative sequence analysis is extremely powerful but, if not performed appropriately, may also lead to the creation and propagation of assignment errors. While current homology detection methods can cope with the data flow, the identification, verification and annotation of functional features need to be drastically improved.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; NCBI, NIH, Bethesda, MD USA	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; National Institutes of Health (NIH) - USA	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	bork@embl-heidelberg.de	Bork, Peer/F-1813-2013	Bork, Peer/0000-0002-2627-833X				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bhatia U, 1997, SCIENCE, V276, P1724, DOI 10.1126/science.276.5319.1724; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Bork P, 1996, TRENDS GENET, V12, P425, DOI 10.1016/0168-9525(96)60040-7; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Bork P, 1996, METHOD ENZYMOL, V266, P162; BORK P, 1992, NATURE, V358, P287, DOI 10.1038/358287a0; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; BORK P, 1995, MOL MICROBIOL, V16, P955, DOI 10.1111/j.1365-2958.1995.tb02321.x; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fickett J W, 1995, J Comput Biol, V2, P117, DOI 10.1089/cmb.1995.2.117; Fischer D, 1997, P NATL ACAD SCI USA, V94, P11929, DOI 10.1073/pnas.94.22.11929; FITCH WM, 1995, PHILOS T ROY SOC B, V349, P93, DOI 10.1098/rstb.1995.0095; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Koenig M, 1997, CURR OPIN NEUROBIOL, V7, P689, DOI 10.1016/S0959-4388(97)80090-6; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; KOONIN EV, 1994, EMBO J, V13, P493, DOI 10.1002/j.1460-2075.1994.tb06287.x; Koonin EV, 1996, NAT GENET, V12, P237, DOI 10.1038/ng0396-237; Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; MADEJ T, 1995, FEBS LETT, V373, P13, DOI 10.1016/0014-5793(95)00977-H; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morozov V, 1997, TRENDS BIOCHEM SCI, V22, P417, DOI 10.1016/S0968-0004(97)01128-6; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Neuwald AF, 1998, J MOL MED, V76, P3, DOI 10.1007/s109-1998-8098-0; Neuwald AF, 1997, CURR BIOL, V7, P465; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Rost B, 1997, COMPUT APPL BIOSCI, V13, P345; Rost B, 1997, J MOL BIOL, V270, P471, DOI 10.1006/jmbi.1997.1101; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Schultz J, 1997, PROTEIN SCI, V6, P249; SCHULTZ J, IN PRESS P NATL ACAD; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Smith RF, 1996, GENOME RES, V6, P653, DOI 10.1101/gr.6.8.653; Smith TF, 1997, J COMPUT BIOL, V4, P217, DOI 10.1089/cmb.1997.4.217; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 1996, CURR BIOL, V6, P279, DOI 10.1016/S0960-9822(02)00478-5; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; WOOTTON JC, 1994, CURR OPIN STRUC BIOL, V4, P413, DOI 10.1016/S0959-440X(94)90111-2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	74	249	288	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					313	318		10.1038/ng0498-313	http://dx.doi.org/10.1038/ng0498-313			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537411				2022-12-27	WOS:000072755500011
J	He, LZ; Guidez, F; Tribioli, C; Peruzzi, D; Ruthardt, M; Zelent, A; Pandolfi, PP				He, LZ; Guidez, F; Tribioli, C; Peruzzi, D; Ruthardt, M; Zelent, A; Pandolfi, PP			Distinct interactions of PML-RAR alpha and PLZF-RAR alpha with co-repressors determine differential responses to RA in APL	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACID RECEPTOR-ALPHA; TRANS-RETINOIC ACID; ZINC FINGER GENE; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTIONAL PROPERTIES; HISTONE DEACETYLASE; FUSION PROTEINS; DNA-BINDING; TRANSLOCATION	Acute promyelocytic leukaemia (APL), associated with chromosomal translocations involving the retinoic acid receptor alpha gene (RARA) and the PML gene, is sensitive to retinoic acid (RA) treatment, while APL patients harbouring translocations between RARA and the PLZF gene do not respond to RA. We have generated PML-RARA and PLZF-RARA transgenic mice and show here that these fusion proteins play a critical role in leukaemogenesis and in determining responses to RA in APL, because PLZF-RARA transgenic mice develop RA-resistant leukaemia, while PML-RARA mice are responsive to RA treatment. We demonstrate that both PML-RAR alpha and PLZF-RAR alpha fusion proteins can act as transcriptional repressors and are able to interact with nuclear receptor transcriptional co-repressors, such as SMRT. PLZF-RAR alpha, but not PML-RAR alpha, can form, via its PLZF moiety, co-repressor complexes which are insensitive to RA. Histone deacetylase inhibitors such as Trichostatin A (TSA), in combination with RA, can overcome the transcriptional repressor activity of PML-RAR alpha and PLZF-RAR alpha as well as the unresponsiveness of PLZF-RAR alpha-expressing leukaemic cells to RA. Thus, our findings unravel a crucial role for transcriptional silencing in APL pathogenesis and resistance to RA in APL.	Sloan Kettering Inst, Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Inst Canc Res, Chester Beatty Labs, Leukaemia Res Fund Ctr, London SW3 6JB, England; Ist Europeo Oncol, Milan, Italy; Univ Frankfurt, Med Klin 3, Dept Haematol, D-6000 Frankfurt, Germany	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; IRCCS European Institute of Oncology (IEO); Goethe University Frankfurt	Pandolfi, PP (corresponding author), Sloan Kettering Inst, Mem Sloan Kettering Canc Ctr, Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		Guidez, Fabien/B-3750-2009; Zelent, Arthur/B-3532-2009; Guidez, Fabien/P-4220-2019	Guidez, Fabien/0000-0003-1380-4473; Ruthardt, Martin/0000-0003-1021-3811; Zelent, Arthur/0000-0002-7968-9888; TRIBIOLI, CARLA/0000-0003-2544-476X	NCI NIH HHS [CA-08748, CA 74031] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074031, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; CASTAIGNE S, 1990, BLOOD, V76, P1704; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN SJ, 1993, J CLIN INVEST, V91, P2260, DOI 10.1172/JCI116453; CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; DERMIME S, 1993, BLOOD, V82, P1573; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding W., 1997, Blood, V90, p415A; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Fenaux P, 1997, SEMIN ONCOL, V24, P92; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Goldman J M, 1997, Curr Opin Hematol, V4, P277; GRIGNANI F, 1994, BLOOD, V83, P10; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gudas Lorraine J., 1994, P443; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; JANSEN JH, 1995, P NATL ACAD SCI USA, V92, P7401, DOI 10.1073/pnas.92.16.7401; Jansen JH, 1996, BLOOD, V88, P3421; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kalantry S, 1997, J CELL PHYSIOL, V173, P288, DOI 10.1002/(SICI)1097-4652(199711)173:2<288::AID-JCP38>3.3.CO;2-Q; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; LAFAGEPOCHITALOFF M, 1995, BLOOD, V85, P1169, DOI 10.1182/blood.V85.5.1169.1169; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LEA MA, 1995, ANTICANCER RES, V15, P879; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Licht JD, 1996, ONCOGENE, V12, P323; LICHT JD, 1995, BLOOD, V85, P1083, DOI 10.1182/blood.V85.4.1083.bloodjournal8541083; LONGO L, 1990, J EXP MED, V172, P1571, DOI 10.1084/jem.172.6.1571; NERVI C, 1992, CANCER RES, V52, P3687; Pandolfi PP, 1996, HAEMATOLOGICA, V81, P472; PANDOLFI PP, 1992, EMBO J, V11, P1397, DOI 10.1002/j.1460-2075.1992.tb05185.x; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; ROUSSELOT P, 1994, ONCOGENE, V9, P545; Ruthardt M, 1997, MOL CELL BIOL, V17, P4859, DOI 10.1128/MCB.17.8.4859; Sambrook J., 2002, MOL CLONING LAB MANU; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; SMITH MA, 1992, J CLIN ONCOL, V10, P839, DOI 10.1200/JCO.1992.10.5.839; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510	59	483	511	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					126	135		10.1038/ng0298-126	http://dx.doi.org/10.1038/ng0298-126			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462740				2022-12-27	WOS:000071779500019
J	Darvasi, A				Darvasi, A			Experimental strategies for the genetic dissection of complex traits in animal models	NATURE GENETICS			English	Article							GENOME-WIDE SEARCH; COLON-TUMOR SUSCEPTIBILITY; CONTROLLING BRISTLE SCORE; MARKER LOCI; QUANTITATIVE TRAITS; DROSOPHILA-MELANOGASTER; CONFIDENCE-INTERVALS; CHROMOSOME SECTIONS; DETERMINING LINKAGE; MULTIPLE-SCLEROSIS	Current success in detecting complex trait loci in general, and quantitative trait loci (QTLs) using model organisms in particular, has attracted major biological and biomedical interest. The potential ability to identify genes and their function provides opportunities for new diagnostics and treatments of complex genetic diseases. Despite the success in gene mapping, however, cloning of complex trait loci or QTLs is not straightforward. A major obstacle lies in achieving fine mapping resolution for the detected loci. Compared to the rapid development of sophisticated statistical and molecular tools, development and analysis of experimental designs for various stages in QTL mapping experiments have barely been considered. In this study, novel and existing experimental strategies for QTL analysis are presented and evaluated.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Darvasi, A (corresponding author), SmithKline Beecham Pharmaceut, NSFP 3rd Ave, Harlow CM19 5AW, Essex, England.							Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BERRETTINI WH, 1994, NAT GENET, V7, P54, DOI 10.1038/ng0594-54; BREESE E. L., 1957, HEREDITY, V11, P373, DOI 10.1038/hdy.1957.30; CHANGJIAN J, 1995, GENETICS, V140, P1111; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; DARVASI A, 1993, GENETICS, V134, P943; DARVASI A, 1994, THEOR APPL GENET, V89, P351, DOI 10.1007/BF00225166; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; DARVASI A, 1995, GENETICS, V141, P1199; DARVASI A, 1994, GENETICS, V138, P1365; DAVIES RW, 1971, GENETICS, V69, P363; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; ESHED Y, 1995, GENETICS, V141, P1147; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; FRANKEL WN, 1995, MAMM GENOME, V6, P839, DOI 10.1007/BF00292432; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALEY CS, 1995, TRENDS GENET, V11, P488, DOI 10.1016/S0168-9525(00)89158-1; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Kemp SJ, 1997, NAT GENET, V16, P194, DOI 10.1038/ng0697-194; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; KOROL AB, 1995, GENETICS, V140, P1137; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEBOWITZ RJ, 1987, THEOR APPL GENET, V73, P556, DOI 10.1007/BF00289194; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; MANGIN B, 1994, GENETICS, V138, P1301; MCCOUCH SR, 1995, TRENDS GENET, V11, P482, DOI 10.1016/S0168-9525(00)89157-X; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; MOTRO U, 1993, THEOR APPL GENET, V85, P658, DOI 10.1007/BF00225002; PATERSON AH, 1990, GENETICS, V124, P735; RAPP JP, 1995, HYPERTENSION, V25, P1121, DOI 10.1161/01.HYP.25.6.1121; Rothschild M, 1996, P NATL ACAD SCI USA, V93, P201, DOI 10.1073/pnas.93.1.201; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SHRIMPTON AE, 1988, GENETICS, V118, P437; SHRIMPTON AE, 1988, GENETICS, V118, P445; SILVER LM, 1995, MOUSE GNEETICS CONCE; SOLLER M, 1976, THEOR APPL GENET, V47, P35, DOI 10.1007/BF00277402; STUBER CW, 1995, TRENDS GENET, V11, P477, DOI 10.1016/S0168-9525(00)89156-8; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Visscher PM, 1996, GENETICS, V143, P1013; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	63	406	412	1	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					19	24		10.1038/ng0198-19	http://dx.doi.org/10.1038/ng0198-19			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425894				2022-12-27	WOS:000071259600015
J	Guillam, MT; Hummler, E; Schaerer, E; Wu, JY; Birnbaum, MJ; Beermann, F; Schmidt, A; Deriaz, N; Thorens, B				Guillam, MT; Hummler, E; Schaerer, E; Wu, JY; Birnbaum, MJ; Beermann, F; Schmidt, A; Deriaz, N; Thorens, B			Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2	NATURE GENETICS			English	Article							BETA-CELLS; GLUCOSE-TRANSPORTER; INSULIN-SECRETION; RAT PANCREAS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; MOUSE; HYPERGLYCEMIA; SIGNAL	Glut-2 is a low-affinity transporter present in the plasma membrane of pancreatic beta-cells, hepatocytes and intestine and kidney absorptive epithelial cells of mice(1). In beta-cells, Glut-2 has been proposed to be active in the control of glucose-stimulated insulin secretion (GSIS; ref. 2), and its expression is strongly reduced in glucose-unresponsive islets from different animal models of diabetes(2-4). However, recent investigations have yielded conflicting data on the possible role of Glut-2 in GSIS. Whereas some reports have supported a specific role for Glut-2 (refs 5,6), others have suggested that GSIS could proceed normally even in the presence of low(7) or almost undetectable(8) levels of this transporter. Here we show that homozygous, but not heterozygous, mice deficient in Glut-2 are hyperglycaemic and relatively hypo-insulinaemic and have elevated plasma levels of glucagon, free fatty acids and beta-hydroxybutyrate. In vivo, their glucose tolerance is abnormal. In vitro, beta-cells display loss of control of insulin gene expression by glucose and impaired GSIS with a loss of first phase but preserved second phase of secretion, while the secretory response to non-glucidic nutrients or to D-glyceraldehyde is normal. This is accompanied by alterations in the postnatal development of pancreatic islets, evidenced by an inversion of the alpha- to beta-cell ratio. Glut-2 is thus required to maintain normal glucose homeostasis and normal function and development of the endocrine pancreas. Its absence leads to symptoms characteristic of non-insulin-dependent diabetes mellitus.	UNIV LAUSANNE,INST PHARMACOL & TOXICOL,CH-1005 LAUSANNE,SWITZERLAND; NATL TAIWAN UNIV HOSP,DEPT FAMILY MED,TAIPEI,TAIWAN; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; SWISS INST EXPT CANC RES,CH-1066 EPALINGES,SWITZERLAND	University of Lausanne; National Taiwan University; National Taiwan University Hospital; Howard Hughes Medical Institute; University of Pennsylvania; Swiss Institute Experimental Cancer Research				Birnbaum, Morris/0000-0001-9972-8680				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067; GIROIX MH, 1991, DIABETES, V40, P227, DOI 10.2337/diabetes.40.2.227; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; HOPCROFT DW, 1985, HORM METAB RES, V17, P559, DOI 10.1055/s-2007-1013606; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; KERVRAN A, 1980, DIABETES, V29, P673, DOI 10.2337/diabetes.29.9.673; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; MA YH, 1995, EUR J ENDOCRINOL, V132, P370, DOI 10.1530/eje.0.1320370; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Offield MF, 1996, DEVELOPMENT, V122, P983; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; PHILIPPE J, 1994, DIABETES, V43, P523, DOI 10.2337/diabetes.43.4.523; RAHIER J, 1983, DIABETOLOGIA, V24, P366; RHOTEN WB, 1980, AM J PHYSIOL, V239, pE57, DOI 10.1152/ajpendo.1980.239.1.E57; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SUZUE K, 1989, NUCLEIC ACIDS RES, V17, P10099, DOI 10.1093/nar/17.23.10099; SWENNE I, 1985, DIABETES, V34, P803, DOI 10.2337/diabetes.34.8.803; TAL M, 1992, P NATL ACAD SCI USA, V89, P5744, DOI 10.1073/pnas.89.13.5744; THORENS B, 1992, INT REV CYTOL, V137A, P209; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; VALERA A, 1994, J BIOL CHEM, V269, P28543; WEIHEL ER, 1979, STEREOLOGICAL METHOD, P101; ZHOU YP, 1995, ENDOCRINOLOGY, V136, P3546, DOI 10.1210/en.136.8.3546	30	310	318	1	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					327	330		10.1038/ng1197-327	http://dx.doi.org/10.1038/ng1197-327			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354799				2022-12-27	WOS:A1997YD66700029
J	Splawski, I; TristaniFirouzi, M; Lehmann, MH; Sanguinetti, MC; Keating, MT				Splawski, I; TristaniFirouzi, M; Lehmann, MH; Sanguinetti, MC; Keating, MT			Mutations in the hminK gene cause long QT syndrome and suppress I-Ks function	NATURE GENETICS			English	Article							DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; K(V)LQT1; PROTEINS; SUBUNIT; FORM; KR	Ion-channel beta-subunits are ancillary proteins that co-assemble with alpha-subunits to modulate the gating kinetics and enhance stability of multimeric channel complexes(1,2). Despite their functional importance, dysfunction of potassium-channel beta-subunits has not been associated with disease. Recent physiological studies suggest that KCNE1 encodes beta-subunits (hminK) that co-assemble with KvLQT1 alpha-subunits to form the slowly activating delayed rectifier K+ (I-Ks) channel(3,4). Because KVLQT1 mutations cause arrhythmia susceptibility in the long QT syndrome (LQT)(5-7), we hypothesized that mutations in KCNE1 also cause this disorder. Here, we define KCNE1 missense mutations in affected members of two LQT families. Both mutations (S74L, D76N) reduced I-Ks by shifting the voltage dependence of activation and accelerating channel deactivation, D76N hminK also had a strong dominant-negative effect, The functional consequences of these mutations would be delayed cardiac repolarization and an increased risk of arrhythmia. This is the first description of KCNE1 as an LQT gene and confirms that hminK is an integral protein of the I-Ks channel.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; UNIV UTAH,ECCLES PROGRAM HUMAN MOL BIOL & GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112; UNIV UTAH,DIV CARDIOL,SALT LAKE CITY,UT 84112; UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; SINAI HOSP,ARRHYTHMIA CTR,DETROIT,MI 48235	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah			Sanguinetti, Michael/AAN-2615-2020		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052338] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00064] Funding Source: Medline; NHLBI NIH HHS [R01 HL48074, P50-HL52338-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; SWANSON R, 1993, SEMIN NEUROSCI, V5, P117; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017	17	602	622	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					338	340		10.1038/ng1197-338	http://dx.doi.org/10.1038/ng1197-338			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354802				2022-12-27	WOS:A1997YD66700032
J	Maw, MA; Kennedy, B; Knight, A; Bridges, R; Roth, KE; Mani, EJ; Mukkadan, JK; Nancarrow, D; Crabb, JW; Denton, MJ				Maw, MA; Kennedy, B; Knight, A; Bridges, R; Roth, KE; Mani, EJ; Mukkadan, JK; Nancarrow, D; Crabb, JW; Denton, MJ			Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa	NATURE GENETICS			English	Article							TOCOPHEROL TRANSFER PROTEIN; LINKAGE ANALYSIS; HUMAN GENOME; VITAMIN-A; CLONING; HOMOLOGY; LOCALIZATION; EXPRESSION; LOCUS; CDNA	Inadequate levels of all-trans-retinol in the blood cause retinal dysfunction; hence, genes implicated in retinal vitamin-A metabolism represent candidates for inherited retinal degenerations(1,2). In the current study, molecular genetic analysis of a consanguineous pedigree segregating for non-syndromic autosomal recessive retinitis pigmentosa (arRP) indicated that the affected siblings were homozygous by descent for a G4763A nucleotide substitution in RLBP1, the gene encoding cellular retinaldehyde-binding protein (CRALBP). This substitution is predicted to replace an arginine with glutamine at residue 150. CRALBP is not expressed in photoreceptors but is abundant in the retinal pigment epithelium (RPE) and Muller cells of the neuroretina, where it carries 11-cis-retinol and 11-cis-retinaldehyde(3-5). When expressed in bacteria, recombinant CRALBP (rCRALBP) containing the R150Q substitution was less soluble than wild-type rCRALBP. Mutant rCRALBP was purified from the soluble cell lysate and the protein structure was verified by mass spectrometry. The mutant protein lacked the ability of bind 11-cis-retinaldehyde. These findings suggest that arRP in the current pedigree results from a lack of functional CRALBP, presumably leading to disruption of retinal vitamin-A metabolism.	W ALTON JONES CELL SCI CTR,PROT CHEM FACIL,LAKE PLACID,NY 12946; LITTLE FLOWER MED RES CTR,ANGAMALLY 683572,KERALA,INDIA; WOLSTON PK HOSP,QUEENSLAND CTR SCHIZOPHRENIA RES,BRISBANE,QLD,AUSTRALIA		Maw, MA (corresponding author), UNIV OTAGO,DEPT BIOCHEM,POB 56,DUNEDIN,NEW ZEALAND.		kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689; Mukkadan, Joseph Kurien/0000-0003-4032-4301	NEI NIH HHS [EY06603, F32 EY06807] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006807] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Algvere PV, 1997, ACTA OPHTHALMOL SCAN, V75, P1; ARITA M, 1995, BIOCHEM J, V306, P437, DOI 10.1042/bj3060437; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; BOLHUIS PA, 1993, BIOCHIM BIOPHYS ACTA, V1182, P142, DOI 10.1016/0925-4439(93)90134-M; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Chinen K, 1996, CYTOGENET CELL GENET, V73, P218, DOI 10.1159/000134342; COTRAN PR, 1990, EXP EYE RES, V51, P15, DOI 10.1016/0014-4835(90)90164-P; CRABB JW, 1988, J BIOL CHEM, V263, P18688; CRABB JW, 1991, J BIOL CHEM, V266, P16674; CRABB JW, 1997, TECHNIQUES MOL BIOL, V89, P91; DELVECCHIO RL, 1994, J BIOL CHEM, V269, P19639; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; GAL S, 1997, NAT GENET, V17, P1994; GU MX, 1992, P NATL ACAD SCI USA, V89, P2980, DOI 10.1073/pnas.89.7.2980; INTRES R, 1994, J BIOL CHEM, V269, P25411; KAPRON JT, IN PRESS PROTEIN SCI; KEMP CM, 1988, EXP EYE RES, V46, P185, DOI 10.1016/S0014-4835(88)80076-9; KNOWLES JA, 1994, HUM MOL GENET, V3, P1401, DOI 10.1093/hmg/3.8.1401; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUCK LA, IN PRESS TECHNIQUES, V8; MAW M, IN PRESS HUM MUTAT; SAARI JC, 1994, BIOCHEMISTRY-US, V33, P3106, DOI 10.1021/bi00176a045; Saari John C., 1994, P351; SATO Y, 1993, J BIOL CHEM, V268, P17705; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SPARKES RS, 1992, GENOMICS, V12, P58, DOI 10.1016/0888-7543(92)90406-I; *WHIT I BIOM RES, 1996, MIT CTR GEN RES	30	246	253	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					198	200		10.1038/ng1097-198	http://dx.doi.org/10.1038/ng1097-198			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326942				2022-12-27	WOS:A1997XZ55500028
J	Wells, RA; Catzavelos, C; KamelReid, S				Wells, RA; Catzavelos, C; KamelReid, S			Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia	NATURE GENETICS			English	Letter							PML-RAR-ALPHA; T(15-17) TRANSLOCATION; INSITU HYBRIDIZATION; LEUKEMIA FUSES; COILED-COIL; CELL-LINE; MITOSIS; SPINDLE; GENE; LOCALIZATION	Acute promyelocytic leukaemia (APL) is uniquely associated with chromosomal translocations that disrupt the gene encoding the retinoic acid receptor, RARA. In more than 99% of cases, this disruption results in the formation of a PML-RARA gene fusion(1-4). Two rare variants of APL have been described, in which RARA is fused to one of two other genes, PLZF(5) and NPM6, Although RARA dysregulation is evidently important in APL, the role of the various fusion partners remains unclear. We have characterized a fourth APL gene fusion, which links exons encoding the retinoic acid and DNA-binding domains of RARA to 5' exons of NuMA, a gene that encodes the nuclear mitotic apparatus protein(7,8). The NuMA-RARA fusion protein exists in sheet-like nuclear aggregates with which normal NuMA partly co-localizes. In contrast to t(15;17) APL, the intracellular distribution of PML is normal in these cells. Our results suggest that interference with retinoid signalling, and not disruption of PML organization, is essential to the APL phenotype and implicates for the first time an element of the mitotic apparatus in the molecular pathogenesis of human malignancy.	UNIV TORONTO,TORONTO HOSP,DEPT HEMATOL,TORONTO,ON M5G 1L5,CANADA; UNIV TORONTO,DEPT CELLULAR & MOL PATHOL,TORONTO,ON M5G 1L5,CANADA; UNIV TORONTO,DEPT MED,TORONTO,ON M5G 1L5,CANADA; TORONTO HOSP,DEPT PATHOL,TORONTO,ON M5G 1L5,CANADA; PRINCESS MARGARET HOSP,ONTARIO CANC INST,TORONTO,ON M5G 1L5,CANADA; SUNNYBROOK HLTH SCI CTR,DEPT LAB MED,TORONTO,ON M4N 3M5,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center				Kamel-Reid, Suzanne/0000-0002-4386-0292				AKALAY M, 1991, P NATL ACAD SCI USA, V88, P1977; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; BOYLE AL, 1992, GENOMICS, V12, P106, DOI 10.1016/0888-7543(92)90412-L; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; COMPTON DA, 1995, J CELL SCI, V108, P621; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; GuethHallonet C, 1996, EXP CELL RES, V225, P207, DOI 10.1006/excr.1996.0171; HARBORTH J, 1995, EMBO J, V14, P2447, DOI 10.1002/j.1460-2075.1995.tb07242.x; *ISCN, 1978, CYTOGENET CELL GENET, V21, P309; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Koken M., 1996, Blood, V88, p553A; LANOTTE M, 1991, BLOOD, V77, P1080; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Sambrook J., 2002, MOL CLONING LAB MANU; TANG TK, 1994, J CELL SCI, V107, P1389; TANG TK, 1993, J CELL SCI, V104, P249; TSAI S, 1992, GENE DEV, V6, P2258, DOI 10.1101/gad.6.12a.2258; TSAI S, 1993, P NATL ACAD SCI USA, V90, P7153, DOI 10.1073/pnas.90.15.7153; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wells RA, 1996, LEUKEMIA, V10, P735; YANG CH, 1992, J CELL BIOL, V116, P1303, DOI 10.1083/jcb.116.6.1303	30	205	212	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					109	113		10.1038/ng0997-109	http://dx.doi.org/10.1038/ng0997-109			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288109				2022-12-27	WOS:A1997XU72400029
J	Chesi, M; Nardini, E; Brents, LA; Schrock, E; Ried, T; Kuehl, WM; Bergsagel, PL				Chesi, M; Nardini, E; Brents, LA; Schrock, E; Ried, T; Kuehl, WM; Bergsagel, PL			Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3	NATURE GENETICS			English	Article							BREAKPOINTS; REARRANGEMENTS; LYMPHOMA; FGFR-3; GENE		NCI, MED BRANCH, DEPT GENET, BETHESDA, MD 20889 USA; CORNELL UNIV, COLL MED, DIV HEMATOL & ONCOL, DEPT MED, NEW YORK, NY 10021 USA; NIH, NATL CTR HUMAN GENOME RES, DIAGNOST DEV BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)			Bergsagel, Peter Leif/A-7842-2011	Bergsagel, Peter Leif/0000-0003-1523-7388	NATIONAL CANCER INSTITUTE [K01CA074265] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA074265-03, K01 CA074265-04, K01 CA074265-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLOUCHE M, 1995, LEUKEMIA, V9, P937; BAXENDALE S, 1993, NAT GENET, V4, P181, DOI 10.1038/ng0693-181; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; CALIGARISCAPPIO F, 1991, BLOOD, V77, P2688; Chesi M, 1996, BLOOD, V88, P674, DOI 10.1182/blood.V88.2.674.bloodjournal882674; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Davis LG, 1994, BASIC METHODS MOL BI; DEBOER CJ, 1993, CANCER RES, V53, P4148; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Francomano C. A., 1996, American Journal of Human Genetics, V59, pA25; Johnston CL, 1995, J BIOL CHEM, V270, P30643, DOI 10.1074/jbc.270.51.30643; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KEEGAN K, 1991, ONCOGENE, V6, P2229; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; Kuehl WM, 1996, CANCER RES, V56, P4370; LAI JL, 1995, BLOOD, V85, P2490, DOI 10.1182/blood.V85.9.2490.bloodjournal8592490; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; SAWYER JR, 1995, CANCER GENET CYTOGEN, V82, P41, DOI 10.1016/0165-4608(94)00284-I; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; TANIWAKI M, 1994, BLOOD, V84, P2283, DOI 10.1182/blood.V84.7.2283.bloodjournal8472283; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1996, MOL CELL BIOL, V16, P4081; WILLIAMS ME, 1993, LEUKEMIA, V7, P1437	31	553	613	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1997	16	3					260	264		10.1038/ng0797-260	http://dx.doi.org/10.1038/ng0797-260			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207791	Green Accepted			2022-12-27	WOS:A1997XG60900021
J	Schmidt, L; Duh, FM; Chen, F; Kishida, T; Glenn, G; Choyke, P; Scherer, SW; Zhuang, ZP; Lubensky, I; Dean, M; Allikmets, R; Chidambaram, A; Bergerheim, UR; Feltis, JT; Casadevall, C; Zamarron, A; Bernues, M; Richard, S; Lips, CJM; Walther, MM; Tsui, LC; Geil, L; Orcutt, ML; Stackhouse, T; Lipan, J; Slife, L; Brauch, H; Decker, J; Niehans, G; Hughson, MD; Moch, H; Storkel, S; Lerman, MI; Linehan, WM; Zbar, B				Schmidt, L; Duh, FM; Chen, F; Kishida, T; Glenn, G; Choyke, P; Scherer, SW; Zhuang, ZP; Lubensky, I; Dean, M; Allikmets, R; Chidambaram, A; Bergerheim, UR; Feltis, JT; Casadevall, C; Zamarron, A; Bernues, M; Richard, S; Lips, CJM; Walther, MM; Tsui, LC; Geil, L; Orcutt, ML; Stackhouse, T; Lipan, J; Slife, L; Brauch, H; Decker, J; Niehans, G; Hughson, MD; Moch, H; Storkel, S; Lerman, MI; Linehan, WM; Zbar, B			Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; MEDULLARY-THYROID CARCINOMA; RET PROTOONCOGENE; CELL CARCINOMA; C-MET; TRANSFORMING GENE; POINT MUTATION; GROWTH-FACTOR; SEQUENCE; RECEPTOR	Hereditary papillary renal carcinoma (HPRC) is a recently recognized form of inherited kidney cancer characterized by a predisposition to develop multiple, bilateral papillary renal tumours(1-4). The pattern of inheritance of HPRC is consistent with autosomal dominant transmission with reduced penetrance. HPRC is histologically and genetically distinct from two other causes of inherited renal carcinoma, von Hippel-Lindau disease (VHL) and the chromosome translocation (3;8)(5-6). Malignant papillary renal carcinomas are characterized by trisomy of chromosomes 7, 16 and 17, and in men, by loss of the Y chromosome(7), Inherited and sporadic clear cell renal carcinomas are characterized by inactivation of both copies of the VHL gene by mutation, and/or by hypermethylation(8-11). We found that the HPRC gene was located at chromosome 7q31.1-34 in a 27-centimorgan (cM) interval between D7S496 and D7S1837. We identified missense mutations located in the tyrosine kinase domain of the MET gene in the germline of affected members of HPRC families and in a subset of sporadic Family: papillary renal carcinomas. Three mutations in the MET gene are located in codons that are homologous to those in c-kit and RET, proto-oncogenes that are targets of naturally-occurring mutations. The results suggest that missense mutations located in the MET proto-oncogene lead to constitutive activation of the MET protein and papillary renal carcinomas.	NCI, IMMUNOBIOL LAB, FREDERICK CANC RES & DEV CTR, FREDERICK, MD 21702 USA; NIH, GENET EPIDEMIOL BRANCH, BETHESDA, MD 20892 USA; NIH, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA; HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; NCI, PATHOL LAB, NIH, BETHESDA, MD 20892 USA; NCI, LAB GEN DIVERS, FREDERICK CANC RES & DEV CTR, FREDERICK, MD 21702 USA; KAROLINSKA HOSP, DEPT SURG, S-10401 STOCKHOLM, SWEDEN; CREDIT VALLEY HOSP, DEPT LAB MED, MISSISSAUGA, ON, CANADA; UNIV AUTONOMA BARCELONA, INST BIOL FONAMENTAL, E-08193 BARCELONA, SPAIN; HOSP COMARCAL SANTIAGO APOSTOL, BURGOS, SPAIN; HOP NECKER ENFANTS MALAD, LAB NEUROONCOL, PARIS, FRANCE; UNIV UTRECHT HOSP, UTRECHT, NETHERLANDS; NIH, SURG BRANCH, BETHESDA, MD 20892 USA; UNIV HAMBURG, KRANKENHAUS EPPENDORF, D-2000 HAMBURG, GERMANY; UNIV MAINZ, DEPT HEMATOL & ONCOL, D-6500 MAINZ, GERMANY; INST PATHOL, WUPPERTAL, GERMANY; VET AFFAIRS, MINNEAPOLIS, MN 55362 USA; VET AFFAIRS, NORTHPORT, NY 11768 USA; UNIV BASEL, INST PATHOL, BASEL, SWITZERLAND	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Karolinska Institutet; Karolinska University Hospital; University of Toronto; Trillium Health Partners; Credit Valley Hospital; Autonomous University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Utrecht University; Utrecht University Medical Center; National Institutes of Health (NIH) - USA; University of Hamburg; Johannes Gutenberg University of Mainz; University of Basel	Schmidt, L (corresponding author), SAIC FREDERICK, INTRAMURAL RES SUPPORT PROGRAM, FREDERICK, MD 21702 USA.		Dean, Michael C/G-8172-2012; Scherer, Stephen W./B-3785-2013; Dean, Michael/R-7501-2019; Tsui, Lap-chee/A-1081-2010; RICHARD, Stéphane/O-1005-2017; Allikmets, Rando/ABD-4533-2021	Dean, Michael C/0000-0003-2234-0631; Scherer, Stephen W./0000-0002-8326-1999; RICHARD, Stéphane/0000-0002-9859-9773; Brauch, Hiltrud/0000-0001-7531-2736; Casadevall, Carme/0000-0001-6458-8972				Bergerheim Ulf S. R., 1996, Journal of Urology, V155, p543A; BERNADES P, 1972, SEM HOP PARIS, V48, P2813; Bernues M, 1995, CANCER GENET CYTOGEN, V84, P123, DOI 10.1016/0165-4608(95)00044-5; BIANCHI AB, 1990, P NATL ACAD SCI USA, V87, P6902, DOI 10.1073/pnas.87.17.6902; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOLINO A, 1995, ONCOGENE, V10, P2415; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; CHOYKE PL, IN PRESS J COMPUTER; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DIRENZO MF, 1992, ONCOGENE, V7, P2549; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; ENG C, 1995, ONCOGENE, V10, P509; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; KOVACS G, 1993, ADV CANCER RES, V62, P89, DOI 10.1016/S0065-230X(08)60316-4; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; MELONI AM, 1993, CANCER GENET CYTOGEN, V65, P1, DOI 10.1016/0165-4608(93)90050-V; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Piao XH, 1996, BLOOD, V87, P3117, DOI 10.1182/blood.V87.8.3117.bloodjournal8783117; PONZETTO C, 1991, ONCOGENE, V6, P553; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Schmidt L, 1995, Cancer J Sci Am, V1, P191; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Stuart ET, 1996, CELL GROWTH DIFFER, V7, P405; TAKAHASHI M, 1989, ONCOGENE, V4, P805; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743, DOI 10.1002/j.1460-2075.1988.tb03003.x; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145; WEIER HUG, 1991, HUM GENET, V87, P489; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; WIRSCHUBSKY Z, 1984, INT J CANCER, V33, P477, DOI 10.1002/ijc.2910330410; ZBAR B, 1994, J UROLOGY, V151, P561, DOI 10.1016/S0022-5347(17)35015-2; ZBAR B, 1995, J UROLOGY, V153, P907, DOI 10.1016/S0022-5347(01)67601-8	41	1101	1164	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					68	73		10.1038/ng0597-68	http://dx.doi.org/10.1038/ng0597-68			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140397				2022-12-27	WOS:A1997WX02400024
J	Shoemaker, DD; Lashkari, DA; Morris, D; Mittmann, M; Davis, RW				Shoemaker, DD; Lashkari, DA; Morris, D; Mittmann, M; Davis, RW			Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSFORMATION; DISRUPTION; SEQUENCE; ARRAYS; GENES; PCR	A quantitative and highly parallel method for analysing deletion mutants has been developed to aid in determining the biological function of thousands of newly identified open reading frames (ORFs) in Saccharomyces cerevisiae. This approach uses a PCR targeting strategy to generate large numbers of deletion strains. Each deletion strain is labelled with a unique 20-base tag sequence that can be detected by hybridization to a high-density oligonucleotide array. The tags serve as unique identifiers (molecular bar codes) that allow analysis of large numbers of deletion strains simultaneously through selective growth conditions. Hybridization experiments show that the arrays are specific, sensitive and quantitative. A pilot study with 11 known yeast genes suggests that the method can be extended to include all of the ORFs in the yeast genome, allowing whole genome analysis with a single selective growth condition and a single hybridization.	STANFORD UNIV, BECKMAN CTR, DEPT BIOCHEM, MED CTR, STANFORD, CA 94305 USA; AFFYMETRIX, SANTA CLARA, CA 95051 USA	Stanford University; Affymetrix								BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; JIMENEZ A, 1980, NATURE, V287, P869, DOI 10.1038/287869a0; LASHKARI DA, 1995, P NATL ACAD SCI USA, V92, P7912, DOI 10.1073/pnas.92.17.7912; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; LOCKHART D, IN PRESS NATURE BIOT; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sherman F., 1986, METHODS YEAST GENETI; SMITH V, 1995, P NATL ACAD SCI USA, V92, P6479, DOI 10.1073/pnas.92.14.6479; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310	17	428	705	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					450	456		10.1038/ng1296-450	http://dx.doi.org/10.1038/ng1296-450			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944025				2022-12-27	WOS:A1996VV73000021
J	Pulst, SM; Nechiporuk, A; Nechiporuk, T; Gispert, S; Chen, XN; LopesCendes, I; Pearlman, S; Starkman, S; OrozcoDiaz, G; Lunkes, A; DeJong, P; Rouleau, GA; Auburger, G; Korenberg, JR; Figueroa, C; Sahba, S				Pulst, SM; Nechiporuk, A; Nechiporuk, T; Gispert, S; Chen, XN; LopesCendes, I; Pearlman, S; Starkman, S; OrozcoDiaz, G; Lunkes, A; DeJong, P; Rouleau, GA; Auburger, G; Korenberg, JR; Figueroa, C; Sahba, S			Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2	NATURE GENETICS			English	Article							HUNTINGTONS-DISEASE; MOLECULAR ANALYSIS; CAG REPEAT; GENE; MUTATIONS; ATROPHY; FAMILY; DYSTROPHY; ALLELES; SCA2	The gene for spinocerebellar ataxia type 2 (SCA2) has been mapped to 12q24.1. A 1.1-megabase contig in the candidate region was assembled in P1 artificial chromosome and bacterial artificial chromosome clones. Using this contig, we identified a CAG trinucleotide repeat with CAA interruptions that was expanded in patients with SCA2. In contrast to other unstable trinucleotide repeats, this CAG repeat was not highly polymorphic in normal individuals. In SCA2 patients, the repeat was perfect and expanded to 36-52 repeats. The most common disease allele contained (CAG)(37), one of the shortest expansions seen in a CAG expansion syndrome. The repeat occurs in the 5'-coding region of SCA2 which is a member of a novel gene family.	UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,DIV NEUROL,LOS ANGELES,CA 90048; UNIV DUSSELDORF,DEPT NEUROL,D-4000 DUSSELDORF 1,GERMANY; ROSWELL PK CANC INST,DEPT HUMAN GENET,BUFFALO,NY 14263; UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90069; LENIN HOSP,NEUROL SERV,HOLGUIN,CUBA; MCGILL UNIV,MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL,PQ H3G 1A4,CANADA; UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,DIV MED GENET,LOS ANGELES,CA 90048	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Heinrich Heine University Dusseldorf; Roswell Park Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pulst, SM (corresponding author), UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,BURNS & ALLEN RES INST,LOS ANGELES,CA 90048, USA.		Lopes-Cendes, Iscia/B-9416-2013	Lopes-Cendes, Iscia/0000-0002-6221-6822				BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; CHUNG MY, 1993, NAT GENET, V5, P252; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DURR A, 1995, CLIN NEUROSCI, V3, P12; FILLA A, 1995, NEUROLOGY, V45, P793, DOI 10.1212/WNL.45.4.793; Flanigan K, 1996, AM J HUM GENET, V59, P392; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GACY AM, 1995, CELL, V81, P533; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Gispert S, 1995, Am J Hum Genet, V57, P972; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; GUDMUNDSSON KR, 1969, ACTA NEUROL SCAND, V45, P114; HUYNH DP, 1994, HUM MOL GENET, V3, P1075, DOI 10.1093/hmg/3.7.1075; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KORENBERG JR, 1995, CYTOGENET CELL GENET, V69, P196, DOI 10.1159/000133962; KRAUTER K, 1995, NATURE, V377, P321; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LARIN Z, 1990, GENET RES, V56, P203, DOI 10.1017/S0016672300035308; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; Nechiporuk A, 1996, NEUROLOGY, V46, P1731, DOI 10.1212/WNL.46.6.1731; Nechiporuk T, 1996, HUM GENET, V97, P462; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; RALSTON ML, 1978, TECHNOMETRICS, V20, P7, DOI 10.2307/1268154; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; YAMAKAWA K, 1995, HUM MOL GENET, V4, P709, DOI 10.1093/hmg/4.4.709; 1993, CELL, V72, P971	40	908	938	1	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					269	276		10.1038/ng1196-269	http://dx.doi.org/10.1038/ng1196-269			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896555				2022-12-27	WOS:A1996VQ14600020
J	Southgate, CD; Chishti, AH; Mitchell, B; Yi, SJ; Palek, J				Southgate, CD; Chishti, AH; Mitchell, B; Yi, SJ; Palek, J			Targeted disruption of the murine erythroid band 3 gene results in spherocytosis and severe haemolytic anaemia despite a normal membrane skeleton	NATURE GENETICS			English	Letter							ANION-EXCHANGER; BINDING; CELL; EXPRESSION; PROTEINS; SITE				Southgate, CD (corresponding author), TUFTS UNIV,SCH MED,ST ELIZABETHS MED CTR,DEPT BIOMED RES,BOSTON,MA 02135, USA.				NATIONAL CANCER INSTITUTE [P01CA066263] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037462, R01HL051445] Funding Source: NIH RePORTER; NCI NIH HHS [CA66263] Funding Source: Medline; NHLBI NIH HHS [HL37462, HL51445] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALPER SL, 1988, J BIOL CHEM, V263, P17092; ALPER SL, 1991, ANNU REV PHYSIOL, V53, P549, DOI 10.1146/annurev.physiol.53.1.549; DANILOV YN, 1990, J BIOL CHEM, V265, P2556; HANSPAL M, 1987, J CELL BIOL, V105, P1417, DOI 10.1083/jcb.105.3.1417; HANSPAL M, 1992, EUR J CELL BIOL, V58, P313; Hogan B, 1994, MANIPULATING MOUSE E; Inaba M, 1996, J CLIN INVEST, V97, P1804, DOI 10.1172/JCI118610; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; KOPITO RR, 1987, J BIOL CHEM, V262, P8035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARIDES E, 1987, CELL, V51, P345, DOI 10.1016/0092-8674(87)90631-3; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; LIU SC, 1981, J CLIN INVEST, V68, P597, DOI 10.1172/JCI110293; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LU SE, 1995, BLOOD PRINCIPLES PRA; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; OKOYE VCN, 1985, SCIENCE, V227, P169, DOI 10.1126/science.3880920; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; TANNER MJA, 1993, SEMIN HEMATOL, V30, P34; WOODS CM, 1986, J CELL BIOL, V103, P1789, DOI 10.1083/jcb.103.5.1789	20	120	120	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					227	230		10.1038/ng1096-227	http://dx.doi.org/10.1038/ng1096-227			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841202				2022-12-27	WOS:A1996VL44600036
J	Xu, TS; Bianco, P; Fisher, LW; Longenecker, G; Smith, E; Goldstein, S; Bonadio, J; Boskey, A; Heegaard, AM; Sommer, B; Satomura, K; Dominguez, P; Zhao, CY; Kulkarni, AB; Robey, PG; Young, MF				Xu, TS; Bianco, P; Fisher, LW; Longenecker, G; Smith, E; Goldstein, S; Bonadio, J; Boskey, A; Heegaard, AM; Sommer, B; Satomura, K; Dominguez, P; Zhao, CY; Kulkarni, AB; Robey, PG; Young, MF			Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; PROTEOGLYCANS BIGLYCAN; HUMAN SKELETAL; BONE; DECORIN; EXPRESSION; HISTOMORPHOMETRY; FRAGILITY; LETHALITY; COLLAGEN	The resilience and strength of bone is due to the orderly mineralization of a specialized extracellular matrix (ECM) composed of type I collagen (90%) and a host of non-collagenous proteins that are, in general, also found in other tissues. Biglycan (encoded by the gene Bgn) is an ECM proteoglycan that is enriched in bone(1-3) and other non-skeletal connective tissues. in vitro studies indicate that Bgn may function in connective tissue metabolism by binding to collagen fibrils(4) and TGF-beta (refs 5,6), and may promote neuronal survival(7). To study the role of Bgn in vivo, we generated Bgn-deficient mice. Although apparently normal at birth, these mice display a phenotype characterized by a reduced growth rate and decreased bone mass due to the absence of Bgn. To our knowledge, this is the first report in which deficiency of a non-collagenous ECM protein leads to a skeletal phenotype that is marked by low bone mass that becomes more obvious with age. These mice may serve as an animal model to study the role of ECM proteins in osteoporosis.	NIDR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA; Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy; Univ Rome, I-00161 Rome, Italy; NIDR, Gene Targeting & Res Core Facil, NIH, Bethesda, MD 20892 USA; Univ Michigan, Sch Med, Dept Orthopaed, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Hosp Special Surg, Mineralized Tissue Res Sect, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of L'Aquila; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Young, MF (corresponding author), Bldg 30,Room 106,30 Convent Dr,MSC 4320, Bethesda, MD 20892 USA.	young@yoda.nidr.nih.gov	Dominguez, Pedro/A-8266-2012; Robey, Pamela Gehron/H-1429-2011	Dominguez, Pedro/0000-0003-4788-1071; Robey, Pamela Gehron/0000-0002-5316-5576; Young, Marian F/0000-0003-0929-8854; Boskey, Adele/0000-0002-6181-2219; Heegaard, Anne-Marie/0000-0003-2754-0800				Andersson G, 1995, ACTA ORTHOP SCAND, V66, P189, DOI 10.3109/17453679509157689; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; BONADIO J, 1993, J CLIN INVEST, V92, P1697, DOI 10.1172/JCI116756; BOSKEY AL, 1992, CELL MATER, V2, P209; Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; FISHER LW, 1983, J BIOL CHEM, V258, P6588; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Kappler J, 1997, EUR J NEUROSCI, V9, P306, DOI 10.1111/j.1460-9568.1997.tb01401.x; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; LEWIS DB, 1993, P NATL ACAD SCI USA, V90, P11618, DOI 10.1073/pnas.90.24.11618; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LOVE PE, 1992, P NATL ACAD SCI USA, V89, P9929, DOI 10.1073/pnas.89.20.9929; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; Takahashi T, 1996, LAB INVEST, V74, P827; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VETTER U, 1993, INT CONGR SER, V1014, P143; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	33	476	493	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					78	82		10.1038/1746	http://dx.doi.org/10.1038/1746			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731537				2022-12-27	WOS:000075671400025
J	Cummings, CJ; Mancini, MA; Antalffy, B; DeFranco, DB; Orr, HT; Zoghbi, HY				Cummings, CJ; Mancini, MA; Antalffy, B; DeFranco, DB; Orr, HT; Zoghbi, HY			Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; ESCHERICHIA-COLI; NEURODEGENERATIVE DISEASES; MOLECULAR CHAPERONES; GLUTAMINE REPEATS; HSP70; DEGRADATION; HOMOLOG; INVOLVEMENT; UBIQUITIN	Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by expansion of a polyglutamine tract in ataxin-1. In affected neurons of SCA1 patients and transgenic mice, mutant ataxin-1 accumulates in a single, ubiquitin-positive nuclear inclusion. In this study, we show that these inclusions stain positively for the 205 proteasome and the molecular chaperone HDJ-2/HSDJ. Similarly, HeLa cells transfected with mutant ataxin-1 develop nuclear aggregates which colocalize with the 205 proteasome and endogenous HDJ-2/HSDJ. Overexpression of wild-type HDJ-2/HSDJ in HeLa cells decreases the frequency of ataxin-1 aggregation. These data suggest that protein misfolding is responsible for the nuclear aggregates seen in SCA1, and that over-expression of a DnaJ chaperone promotes the recognition of a misfolded polyglutamine repeat protein, allowing its refolding and/or ubiquitin-dependent degradation.	Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Pittsburgh, Dept Biol Sci & Pharmacol, Pittsburgh, PA USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.			Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X	NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022920, R01NS022920, R01NS027699] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Attaix D, 1997, MOL BIOL REP, V24, P95, DOI 10.1023/A:1006806103675; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Bush KT, 1997, J BIOL CHEM, V272, P9086; CHELLAIAH A, 1993, BIOCHIM BIOPHYS ACTA, V1174, P111, DOI 10.1016/0167-4781(93)90103-K; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; MATILLA T, 1997, NATURE, V389, P974; OH S, 1993, BIOCHIM BIOPHYS ACTA, V1174, P114, DOI 10.1016/0167-4781(93)90104-L; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHERMAN MY, 1992, EMBO J, V11, P71; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; STRAUS DB, 1988, GENE DEV, V2, P1851, DOI 10.1101/gad.2.12b.1851; Tang YT, 1997, MOL BIOL CELL, V8, P795, DOI 10.1091/mbc.8.5.795; Welch WJ, 1998, NATURE, V392, P23, DOI 10.1038/32049; Wisniewski T, 1997, NEUROBIOL DIS, V4, P313, DOI 10.1006/nbdi.1997.0147; ZHOU M, 1996, J BIOL CHEM, V271, P247; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	44	690	715	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					148	154		10.1038/502	http://dx.doi.org/10.1038/502			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620770				2022-12-27	WOS:000073865100021
J	Gasser, T; Muller-Myhsok, B; Wszolek, ZK; Oehlmann, R; Calne, DB; Bonifati, V; Bereznai, B; Fabrizio, E; Vieregge, P; Horstmann, RD				Gasser, T; Muller-Myhsok, B; Wszolek, ZK; Oehlmann, R; Calne, DB; Bonifati, V; Bereznai, B; Fabrizio, E; Vieregge, P; Horstmann, RD			A susceptibility locus for Parkinson's disease maps to chromosome 2p13	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; LINKAGE ANALYSIS; GENETIC-LINKAGE; HUMAN GENOME; LEWY BODY; INHERITANCE	Parkinson's disease (PD) is a common degenerative neurologic disorder, which is pathologically characterized by a selective degeneration of dopaminergic neurons of the substantia nigra pars compacta, and the presence of characteristic eosinophilic inclusions, known as Lewy-bodies in affected brain areas(1). The cause of PD is unknown but, in recent years, genetic factors have been implicated in the aetiology of the disease(2). Firstly, clinico-genetic, epidemiologic and twin studies revealed inheritable effects(3) and questioned earlier studies which had denied such influences(4). Secondly, several family studies suggested autosomal-dominant inheritance of syndromes which, to variable degrees, resembled sporadic PD clinically(5) and in some cases also neuropathologically(6,7). Recently, a disease locus has been mapped to chromosome 4q21-22 in a large Mediterranean pedigrees, in which disease expression is clinically and pathologically within the spectrum of sporadic PD; being atypical only for a relatively young mean age at onset of 46 years and rapid course of 10 years from onset to death(9). In affected individuals of this family and of three unrelated Greek kindreds, a putative disease-causing mutation has been identified in the gene encoding alpha-synuclein(10). With the first variant being defined, genetic heterogeneity has become apparent, as in other families parkinsonism was not linked to the 4q-locus(11) and was not associated with the alpha-synuclein mutation (unpublished data). We describe a different genetic locus that appears to be involved in the development of parkinsonism closely resembling sporadic PD including a similar mean age of onset (59 years in the families, 59.7 years in sporadic PD; ref. 12). This locus was detected in a group of families of European origin. In two of these families, there is genetic evidence for a common founder. The penetrance of the mutation appears to be low, most likely below 40%. This is compatible with a possible role of this locus not only in familial, but also in typical (sporadic) PD.	Univ Munich, Klinikum Grosshadern, Neurol Klin, D-8000 Munich, Germany; Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; Univ Nebraska, Med Ctr, Dept Internal Med, Neurol Sect, Omaha, NE USA; Univ British Columbia, Ctr Neurodegenerat Disorders, Vancouver, BC V5Z 1M9, Canada; Univ Roma La Sapienza, Dipartimento Sci Neurol, Rome, Italy; Univ Lubeck, Neurol Klin, D-2400 Lubeck, Germany	University of Munich; Bernhard Nocht Institut fur Tropenmedizin; University of Nebraska System; University of Nebraska Medical Center; University of British Columbia; Sapienza University Rome; University of Lubeck	Gasser, T (corresponding author), Univ Munich, Klinikum Grosshadern, Neurol Klin, D-8000 Munich, Germany.	tgasser@brain.nefo.med.uni-muenchen.de	Wszolek, Zbigniew K./AAB-1431-2019; Gasser, Thomas/GNH-5293-2022; Müller-Myhsok, Bertram/A-3289-2013	Gasser, Thomas/0000-0002-1069-1146; 				ALEXI T, 1993, NEUROSCIENCE, V55, P903, DOI 10.1016/0306-4522(93)90307-2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Denson MA, 1997, ANN NEUROL, V42, P638, DOI 10.1002/ana.410420415; DENSON MA, 1995, PARKINSONISM RELAT D, V1, P1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DiRocco A, 1996, ADV NEUROL, V69, P3; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; DUVOISIN RC, 1969, PROGR NEUROGENETICS, P492; Gasser T, 1997, SCIENCE, V277, P388; GASSER T, 1994, ANN NEUROL, V36, P387, DOI 10.1002/ana.410360310; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; HOFMANN K, 1994, GENOMICS, V24, P20, DOI 10.1006/geno.1994.1577; JELLINGER K, 1990, ADV NEUROL, V53, P1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Mark MH, 1996, ADV NEUROL, V69, P315; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1986, GENET EPIDEMIOL, P251; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; VIEREGGE P, 1994, J NEURAL TRANSM-PARK, V8, P1, DOI 10.1007/BF02250916; WARD CD, 1990, ADV NEUROL, V53, P245; Wood N, 1997, J NEUROL NEUROSUR PS, V62, P305, DOI 10.1136/jnnp.62.4.305; Wszolek Z K, 1997, Parkinsonism Relat Disord, V3, P125, DOI 10.1016/S1353-8020(97)00013-8; WSZOLEK ZK, 1995, NEUROLOGY, V45, P502, DOI 10.1212/WNL.45.3.502; WSZOLEK ZK, 1993, NERVENARZT, V64, P331	29	382	394	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					262	265		10.1038/ng0398-262	http://dx.doi.org/10.1038/ng0398-262			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500549				2022-12-27	WOS:000072325000025
J	Jhappan, C; Morse, HC; Fleischmann, RD; Gottesman, MM; Merlino, G				Jhappan, C; Morse, HC; Fleischmann, RD; Gottesman, MM; Merlino, G			DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus	NATURE GENETICS			English	Article							DEPENDENT PROTEIN-KINASE; SEVERE COMBINED IMMUNODEFICIENCY; STRAND-BREAK-REPAIR; ATAXIA-TELANGIECTASIA GENE; V(D)J RECOMBINATION; CATALYTIC SUBUNIT; TRANSGENIC MICE; MUTATION; PHOSPHODIESTERASE; REQUIREMENT	Severe combined immunodeficiency (SCID) mice(1) are defective in their ability to rearrange their variable (V), diversity (D) and joining (J) genetic elements to generate functional immuno-globulin tig) and T-cell receptor (TCR) molecules; as a result, they lack mature B and T cells(2). These mice are highly sensitive to ionizing radiation, suggesting that the product of the scid gene plays a critical role in both V(D)I recombination and DNA double-strand break repair(3-5). Recent studies suggest that the SCID defect lies in the gene encoding the catalytic subunit of DNA-dependent protein kinase (DNA-PK; refs 6-8), a nuclear protein made up of the Ku 70 and Ku 86 subunits as well as the large catalytic subunit, DNA-PKcs(9,10). Other reports have implied that the SCID phenotype correlates with nonsense mutations at the extreme 3' end of Prkdc, the DNA-PKcs gene(11-14). The identity of the gene remains in doubt, however, because the consequences of genetic inactivation of Prkdc have not been determined. This study shows that complete inactivation of Prkdc in a novel insertional mouse mutant recapitulates the SCID phenotype and that Prkdc and scid are allelic, Significantly, DNA-PKcs null mice demonstrate complete penetrance of thymic lymphoblastic lymphomas, strongly suggesting that Prkdc functions in mice as a T-cell tumour suppressor and, by virtue of its association with DNA repair and recombination, belongs to the 'caretaker' class of tumour-suppressor genes that includes ATM, BRCA1 and BRCA2 (ref. 15).	NIAID,IMMUNOPATHOL LAB,NIH,BETHESDA,MD 20892; NCI,CELL BIOL LAB,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jhappan, C (corresponding author), NCI,MOL BIOL LAB,NIH,37 CONVENT DR,BETHESDA,MD 20892, USA.			Morse, Herbert/0000-0002-9331-3705				Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; CARROLL AM, 1989, J IMMUNOL, V143, P1087; CUSTER RP, 1985, AM J PATHOL, V120, P464; Danska JS, 1996, MOL CELL BIOL, V16, P5507; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; MILLER RD, 1995, P NATL ACAD SCI USA, V92, P10792, DOI 10.1073/pnas.92.23.10792; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shin EK, 1997, J IMMUNOL, V158, P3565; STRADA SJ, 1984, ADV CYCLIC NUCL PROT, V16, P13; SUORANTA K, 1984, J BIOL CHEM, V259, P6964; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	30	118	120	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					483	486		10.1038/ng1297-483	http://dx.doi.org/10.1038/ng1297-483			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398856				2022-12-27	WOS:A1997YJ92400035
J	PetrijBosch, A; Peelen, T; vanVliet, M; vanEijk, R; Olmer, R; Drusedau, M; Hogervorst, FBL; Hageman, S; Arts, PJW; Ligtenberg, MJL; MeijersHeijboer, H; Klijn, JGM; Vasen, HFA; Cornelisse, CJ; vantVeer, LJ; Bakker, E; vanOmmen, GJB; Devilee, P				PetrijBosch, A; Peelen, T; vanVliet, M; vanEijk, R; Olmer, R; Drusedau, M; Hogervorst, FBL; Hageman, S; Arts, PJW; Ligtenberg, MJL; MeijersHeijboer, H; Klijn, JGM; Vasen, HFA; Cornelisse, CJ; vantVeer, LJ; Bakker, E; vanOmmen, GJB; Devilee, P			BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients	NATURE GENETICS			English	Article							EARLY-ONSET BREAST; OVARIAN-CANCER; FAMILIES; GENE	To date, more than 300 distinct small deletions, insertions and point mutations, mostly leading to premature termination of translation(1), have been reported in the breast/ovarian-cancer susceptibility gene BRCA1. The elevated frequencies of some mutations in certain ethnic subpopulations(2-4) are caused by founder effects(5,6), rather than by mutation hotspots. Here we report that the currently available mutation spectrum of BRCA1 has been biased by PCR-based mutation-screening methods, such as SSCP, the protein truncation test (PTT) and direct sequencing, using genomic DNA as template. Three large genomic deletions that are not detected by these approaches comprise 36% of all BRCA1 mutations found in Dutch breast-cancer families to date. A 510-bp Alu-mediated deletion comprising exon 22 was found in 8 of 170 breast-cancer families recruited for research purposes and in 6 of 49 probands referred to the Amsterdam Family Cancer Clinic for genetic counselling. In addition, a 3,835-bp Alu-mediated deletion encompassing exon 13 was detected in 6 of the 170 research families, while an deletion of approximately 14 kb was detected in a single family. Haplotype analyses indicated that each recurrent deletion had a single common ancestor.	LEIDEN UNIV,MED CTR,DEPT HUMAN GENET,NL-2300 RA LEIDEN,NETHERLANDS; LEIDEN UNIV,MED CTR,DEPT PATHOL,NL-2300 RA LEIDEN,NETHERLANDS; NETHERLANDS CANC INST,DEPT PATHOL,NL-1066 CX AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,FAMILY CANC CTR,NL-1066 CX AMSTERDAM,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,NL-6500 HB NIJMEGEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,NL-3000 DR ROTTERDAM,NETHERLANDS; DR DANIEL DEN HOED CANC CTR,NL-3008 AE ROTTERDAM,NETHERLANDS; FAMILY CANC CTR,ROTTERDAM,NETHERLANDS; FDN DETECT HEREDITARY TUMOURS,LEIDEN,NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Netherlands Cancer Institute; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute			Ligtenberg, Marjolijn/N-9666-2013; DEVILEE, PETER/ABR-2140-2022; Bakker, Egbert/D-3525-2009	Ligtenberg, Marjolijn/0000-0003-1290-1474; Bakker, Egbert/0000-0002-2843-7357; Vasen, Hans/0000-0003-2682-2603				Caligo MA, 1996, ONCOGENE, V13, P1483; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; Durocher F, 1996, J MED GENET, V33, P814, DOI 10.1136/jmg.33.10.814; EASTON DF, 1993, AM J HUM GENET, V52, P678; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Hamann U, 1997, GENE CHROMOSOME CANC, V18, P126, DOI 10.1002/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.3.CO;2-O; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; INOUE R, 1995, CANCER RES, V55, P3521; Katagiri T, 1996, HUM MUTAT, V7, P334, DOI 10.1002/(SICI)1098-1004(1996)7:4<334::AID-HUMU7>3.0.CO;2-8; NAROD SA, 1995, AM J HUM GENET, V56, P254; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Peelen T, 1997, AM J HUM GENET, V60, P1041; Peelen T, 1996, EUR J HUM GENET, V4, P225; Puget N, 1997, CANCER RES, V57, P828; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	25	350	360	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					341	345		10.1038/ng1197-341	http://dx.doi.org/10.1038/ng1197-341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354803	Green Published			2022-12-27	WOS:A1997YD66700033
J	Simon, DB; Bindra, RS; Mansfield, TA; NelsonWilliams, C; Mendonca, E; Stone, R; Schurman, S; Nayir, A; Alpay, H; Bakkaloglu, A; RodriguezSoriano, J; Morales, JM; Sanjad, SA; Taylor, CM; Pilz, D; Brem, A; Trachtman, H; Griswold, W; Richard, GA; John, E; Lifton, RP				Simon, DB; Bindra, RS; Mansfield, TA; NelsonWilliams, C; Mendonca, E; Stone, R; Schurman, S; Nayir, A; Alpay, H; Bakkaloglu, A; RodriguezSoriano, J; Morales, JM; Sanjad, SA; Taylor, CM; Pilz, D; Brem, A; Trachtman, H; Griswold, W; Richard, GA; John, E; Lifton, RP			Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III	NATURE GENETICS			English	Article							EPITHELIAL SODIUM-CHANNEL; THICK ASCENDING LIMB; HYPOKALEMIC ALKALOSIS; MOLECULAR-GENETICS; HUMAN HYPERTENSION; HENLE LOOP; KIDNEY; DNA; COTRANSPORTER; HETEROGENEITY	Analysis of patients with inherited hypokalaemic alkalosis resulting from salt-wasting has proved fertile ground for identification of essential elements of renal salt homeostasis and blood-pressure regulation. We now demonstrate linkage of this phenotype to a segment of chromosome 1 containing the gene encoding a renal chloride channel, CLCNKB. Examination of this gene reveals loss-of-function mutations that impair renal chloride reabsorption in the thick ascending limb of Henle's loop. Mutations in seventeen kindreds have been identified, and they include large deletions and nonsense and missense mutations. Some of the deletions are shown to have arisen by unequal crossing over between CLCNKB and the nearby related gene, CLCNKA. Patients who harbour CLCNKB mutations are characterized by hypokalaemic alkalosis with salt-wasting, low blood pressure, normal magnesium and hyper-or normocalciuria; they define a distinct subset of patients with Bartter's syndrome in whom nephrocalcinosis is absent. These findings demonstrate the critical role of CLCNKB in renal salt reabsorption and blood-pressure homeostasis, and demonstrate the potential role of specific CLCNKB antagonists as diuretic antihypertensive agents.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED,BOYER CTR MOL MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOYER CTR MOL MED,NEW HAVEN,CT 06510; HOSP SANTA MARIA,UNIDADE NEFROL PEDIAT,LISBON,PORTUGAL; UNIV S FLORIDA,ALL CHILDRENS HOSP,DEPT PEDIAT,ST PETERSBURG,FL 33701; UNIV ISTANBUL,DEPT PEDIAT NEPHROL,ISTANBUL,TURKEY; HACETTEPE UNIV,CHILDRENS HOSP,DEPT PEDIAT NEPHROL,ANKARA,TURKEY; HOSP CRUCES,DEPT PEDIAT,BARACALDO,SPAIN; HOSP UNIV 12 OCTUBRE,DEPT MED,MADRID,SPAIN; KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PEDIAT,RIYADH 11211,SAUDI ARABIA; CHILDRENS HOSP,DEPT NEPHROL,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; UNIV WALES HOSP,INST MED GENET,CARDIFF CF4 4XW,S GLAM,WALES; RHODE ISL HOSP,DEPT PEDIAT NEPHROL,PROVIDENCE,RI 02903; SCHNEIDER CHILDRENS HOSP,ALBERT EINSTEIN COLL MED,DEPT PEDIAT,NEW HYDE PK,NY 11040; CHILDRENS HOSP SAN DIEGO,DEPT PEDIAT,SAN DIEGO,CA 92123; UNIV FLORIDA,DEPT PEDIAT,GAINESVILLE,FL 32610; UNIV ILLINOIS,DEPT PEDIAT,CHICAGO,IL 60612	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Universidade de Lisboa; Hospital Santa Maria; State University System of Florida; University of South Florida; Istanbul University; Hacettepe University; Hospital Universitario Cruces; Hospital Universitario 12 de Octubre; King Faisal Specialist Hospital & Research Center; Cardiff University; Lifespan Health Rhode Island; Rhode Island Hospital; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yeshiva University; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Stone, Rosario/0000-0002-7939-836X				ADACHI S, 1994, J BIOL CHEM, V269, P17677; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; GILL JR, 1978, AM J MED, V65, P766, DOI 10.1016/0002-9343(78)90794-5; GREGER R, 1983, PFLUG ARCH EUR J PHY, V396, P325, DOI 10.1007/BF01063938; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; JENTSCH TJ, 1996, BIOESSAYS, V19, P117; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MATSUMOTO J, 1989, AM J ROENTGENOL, V152, P1251, DOI 10.2214/ajr.152.6.1251; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1985, ANAL HUMAN GENETIC L; Reeves W B, 1994, Adv Nephrol Necker Hosp, V23, P177; SaitoOhara F, 1996, GENOMICS, V36, P372, DOI 10.1006/geno.1996.0479; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; VANDEWALLE A, 1995, AM J PHYSIOL, V272, pF678; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436	28	685	722	0	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					171	178		10.1038/ng1097-171	http://dx.doi.org/10.1038/ng1097-171			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326936				2022-12-27	WOS:A1997XZ55500022
J	Steck, PA; Pershouse, MA; Jasser, SA; Yung, WKA; Lin, H; Ligon, AH; Langford, LA; Baumgard, ML; Hattier, T; Davis, T; Frye, C; Hu, R; Swedlund, B; Teng, DHF; Tavtigian, SV				Steck, PA; Pershouse, MA; Jasser, SA; Yung, WKA; Lin, H; Ligon, AH; Langford, LA; Baumgard, ML; Hattier, T; Davis, T; Frye, C; Hu, R; Swedlund, B; Teng, DHF; Tavtigian, SV			Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers	NATURE GENETICS			English	Article							HUMAN GLIOBLASTOMAS; PROSTATE-CANCER; MXI1 GENE; LONG ARM; HETEROZYGOSITY; AMPLIFICATION; PROGRESSION; SEQUENCES; REGIONS; LOCI	Deletions involving regions of chromosome 10 occur in the vast majority (>90%) of human glioblastoma multiformes. A region at chromosome 10q23-24 was implicated to contain a tumour suppressor gene and the identification of homozygous deletions in four glioma cell lines further refined the location. We have identified a gene, designated MMAC1, that spans these deletions and encodes a widely expressed 5.5-kb mRNA. The predicted MMAC1 protein contains sequence motifs with significant homology to the catalytic domain of protein phosphatases and to the cytoskeletal proteins, tensin and auxilin. MMAC1 coding-region mutations were observed in a number of glioma, prostate, kidney and breast carcinoma cell lines or tumour specimens. Our results identify a strong candidate tumour suppressor gene at chromosome 10q23.3, whose loss of function appears to be associated with the oncogenesis of multiple human cancers.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PATHOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANCER CTR,BRAIN TUMOUR CTR,HOUSTON,TX 77030; MYRIAD GENET INC,SALT LAKE CITY,UT 84108	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Myriad Genetics, Inc	Steck, PA (corresponding author), UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT NEUROONCOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NATIONAL CANCER INSTITUTE [P01CA055261, R55CA056041, R01CA056041] Funding Source: NIH RePORTER; NCI NIH HHS [CA56041, CA55261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBAROSA R, 1995, HUM GENET, V95, P709; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; EAGLE LR, 1995, NAT GENET, V9, P249, DOI 10.1038/ng0395-249; ENG C, 1994, J MED GENET, V31, P458, DOI 10.1136/jmg.31.6.458; FULTS D, 1990, CANCER RES, V50, P5784; GRAY IC, 1995, CANCER RES, V55, P4800; HERBST RA, 1994, CANCER RES, V54, P3111; HERMAN JG, 1995, CANCER RES, V55, P4520; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LOUIS DN, 1995, TRENDS GENET, V11, P412, DOI 10.1016/S0168-9525(00)89125-8; MORITA R, 1991, CANCER RES, V51, P5817; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; NIHEI N, 1995, GENE CHROMOSOME CANC, V14, P112, DOI 10.1002/gcc.2870140205; PEIFFER SL, 1995, CANCER RES, V55, P1922; PERSHOUSE MA, 1993, CANCER RES, V53, P5043; Petersen I, 1997, BRIT J CANCER, V75, P79, DOI 10.1038/bjc.1997.13; RAHSEED BK, 1992, GENE CHROMOSOME CANC, V5, P75; RANSOM DT, 1992, GENE CHROMOSOME CANC, V5, P357, DOI 10.1002/gcc.2870050412; REMPEL SA, 1993, CANCER RES, V53, P2386; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; STECK PA, 1995, GENE CHROMOSOME CANC, V12, P255; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; TOKIYOSHI K, 1996, J CLIN PATHOL MOL PA, V49, P218; Trybus TM, 1996, CANCER RES, V56, P2263; VONDEIMLING A, 1992, J NEUROSURG, V77, P295, DOI 10.3171/jns.1992.77.2.0295	30	2340	2584	2	94	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					356	362		10.1038/ng0497-356	http://dx.doi.org/10.1038/ng0497-356			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090379				2022-12-27	WOS:A1997WQ38900012
J	Hemminki, A; Tomlinson, I; Markie, D; Jarvinen, H; Sistonen, P; Bjorkqvist, AM; Knuutila, S; Salovaara, R; Bodmer, W; Shibata, D; delaChapelle, A; Aaltonen, LA				Hemminki, A; Tomlinson, I; Markie, D; Jarvinen, H; Sistonen, P; Bjorkqvist, AM; Knuutila, S; Salovaara, R; Bodmer, W; Shibata, D; delaChapelle, A; Aaltonen, LA			Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis	NATURE GENETICS			English	Article							SOLID TUMORS; CANCER	Many human cancer susceptibility genes have been successfully mapped by genetic linkage studies(1). One that has so far eluded researchers is that for Peutz-Jeghers (P-J) syndrome, a condition characterized by intestinal hamartomatous polyposis and melanin spots of the lips, buccal mucosa and digits(2,3). A dramatically elevated risk of malignancy has also been documented(4). Gastrointestinal tumours as well as cancers of the breast, ovary, testis and uterine cervix appear to be overrepresented in families with this syndrome(4,5). The nature of hamartomatous polyps is equivicol. Hamartomas are usually considered histologically benign(6), but in the case of Peutz-Jeghers patients, there are reports of adenomatous and malignant changes in the polyps, and the possibility of a hamartoma-carcinoma sequence has been discussed(5,7,8). A search for a putative tumour suppressor locus was made using comparative genomic hybridization (CGH) of Peutz-Jeghers polyps, combined with loss of heterozygosity (LOH) study. Genetic linkage analysis in 12 families using markers from a deletion site demonstrated the presence of a high-penetrance locus in distal 19p with a multipoint lod score of 7.00 at marker D19S886 without evidence of genetic heterogeneity. The study demonstrates the power of CCH combined with LOH analysis in identifying putative tumour suppressor loci, and provides molecular evidence of malignant potential in hamartomas.	UNIV HELSINKI,DEPT MED GENET,HAARTMAN INST,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,DEPT PATHOL,HAARTMAN INST,FIN-00014 HELSINKI,FINLAND; IMPERIAL CANC RES FUND,CANC GENET LAB,LONDON WC2A 3PX,ENGLAND; DUNEDIN SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND; UNIV HELSINKI,CENT HOSP,DEPT SURG 2,FIN-00290 HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND; UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033	University of Helsinki; University of Helsinki; Cancer Research UK; University of Otago; University of Helsinki; Helsinki University Central Hospital; University of Southern California			Aaltonen, Lauri/A-5375-2010; Markie, David/I-7893-2019	Aaltonen, Lauri/0000-0001-6839-4286; Bodmer, Walter/0000-0001-6244-9792; Markie, David/0000-0001-5452-9194				COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Defago MR, 1996, ENDOSCOPY, V28, P267, DOI 10.1055/s-2007-1005447; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; HIZAWA K, 1993, DIS COLON RECTUM, V36, P953, DOI 10.1007/BF02050632; JEGHERS H, 1949, NEW ENGL J MED, V241, P992; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; Peutz JL, 1921, NEDERL MAANDSCHR GEN, V10, P134; PHILLIPS RK, 1994, FAMILIAL ADENOMATOUS; ROSAI J, 1996, ACKERMANS SURGICAL P; SHIBATA D, 1992, AM J PATHOL, V141, P539; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676	15	342	364	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					87	90		10.1038/ng0197-87	http://dx.doi.org/10.1038/ng0197-87			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988175				2022-12-27	WOS:A1997WA37300027
J	vanWezel, T; Stassen, APM; Moen, CJA; Hart, AAM; vanderValk, MA; Demant, P				vanWezel, T; Stassen, APM; Moen, CJA; Hart, AAM; vanderValk, MA; Demant, P			Gene interaction and single gene effects in colon tumour susceptibility in mice	NATURE GENETICS			English	Article							RECOMBINANT CONGENIC STRAINS; INTESTINAL NEOPLASIA; MAJOR MODIFIER; MOUSE; LOCUS; TRAITS; LINKAGE; CANCER; TOOL; TIME	To dissect the multigenic control of colon tumour susceptibility in the mouse(1) we used the set of 20 CcS/Dem (CcS) recombinant congenic (RC) strains(2). Each CcS strain carries a unique, random subset of approximately 12.5% of the genome of strain STS/A (STS) on the genetic background of BALB/cHeA (BALB/c)(3). Previously, applying a protocol of 26 injections of 1,2-dimethylhydrazine (DMH), we detected two susceptibility loci, Scc1 and Scc2, on chromosome 2 (refs 4, 5). Using a shorter tumour-induction procedure, combining DMH and N-ethyl-N-nitrosourea (ENU) treatment, we demonstrate that BALB/c, STS and most CcS strains are relatively resistant. The strain CcS-19, however, is susceptible, probably due to a combination of BALB/c and STS alleles at several loci. Analysis of 192 (BALB/c x CcS-19) F2 mice revealed, in addition to the Scc1/Scc2 region, three new susceptibility loci: Scc3 on chromosome 1, Scc4 on chromosome 17 and Scc5 on chromosome 18. Scc4 and Scc5 have no apparent individual effect, but show a strong reciprocal interaction. Their BALB/c and STS alleles are not a priori susceptible or resistant but the genotype at one locus determines the effect of the allele at the second locus and vice versa. These findings and the accompanying paper on lung tumour susceptibility(6) show that interlocus interactions are likely to be an important component of tumour susceptibility.	NETHERLANDS CANC INST,DIV MOL GENET,NL-1066 CX AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,DIV RADIOTHERAPY,NL-1066 CX AMSTERDAM,NETHERLANDS	Netherlands Cancer Institute; Netherlands Cancer Institute			van Wezel, Tom/A-9599-2008; van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/Z-3092-2019	van Wezel, Tom/0000-0001-5773-7730; van Wezel, Tom/0000-0001-5773-7730				AVNER P, 1994, NAT GENET, V7, P3, DOI 10.1038/ng0594-3; CHEVERUD JM, 1995, GENETICS, V139, P1455; COUPLAND G, 1995, TRENDS GENET, V11, P393, DOI 10.1016/S0168-9525(00)89122-2; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Demant P, 1992, Semin Cancer Biol, V3, P159; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; DESCHNER EE, 1979, CANCER LETT, V8, P23, DOI 10.1016/0304-3835(79)90018-1; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; FIJNEMAN RJA, 1995, CANCER RES, V55, P3179; FRENKEL WN, 1995, MAMM GENOME, V6, P830; GLASER KB, 1993, TRENDS PHARMACOL SCI, V14, P92, DOI 10.1016/0165-6147(93)90071-Q; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LARK KG, 1995, P NATL ACAD SCI USA, V92, P4656, DOI 10.1073/pnas.92.10.4656; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MOEN CJA, 1992, ONCOGENE, V7, P563; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; MOEN CJA, 1991, MAMM GENOME, V1, P217, DOI 10.1007/BF00352328; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; RISCH N, 1993, AM J HUM GENET, V53, P702; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Stassen APM, 1996, MAMM GENOME, V7, P55, DOI 10.1007/s003359900013; WU S, 1992, J CELL BIOL, V115, P187	27	121	121	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					468	470		10.1038/ng1296-468	http://dx.doi.org/10.1038/ng1296-468			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944029				2022-12-27	WOS:A1996VV73000025
J	LoTenFoe, JR; Rooimans, MA; BosnoyanCollins, L; Alon, N; Wijker, M; Parker, L; Lightfoot, J; Carreau, M; Callen, DF; Savoia, A; Cheng, NC; vanBerkel, CGM; Strunk, MHP; Gille, JJP; Pals, G; Kruyt, FAE; Pronk, JC; Arwert, F; Buchwald, M; Joenje, H				LoTenFoe, JR; Rooimans, MA; BosnoyanCollins, L; Alon, N; Wijker, M; Parker, L; Lightfoot, J; Carreau, M; Callen, DF; Savoia, A; Cheng, NC; vanBerkel, CGM; Strunk, MHP; Gille, JJP; Pals, G; Kruyt, FAE; Pronk, JC; Arwert, F; Buchwald, M; Joenje, H			Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA	NATURE GENETICS			English	Article							COMPLEMENTATION GROUPS; ANEMIA-REGISTRY; PROTEIN; LOCALIZATION; DIAGNOSIS; CYTOPLASM; FACC		FREE UNIV AMSTERDAM, DEPT HUMAN GENET, NL-1081 BT AMSTERDAM, NETHERLANDS; HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; UNIV TORONTO, DEPT MOL & MED GENET, TORONTO, ON M5S 1A1, CANADA; WOMENS & CHILDRENS HOSP, DEPT CYTOGENET & MOL GENET, ADELAIDE, SA 5006, AUSTRALIA; IRCCS OSPED CSS, SERV GENET MED, I-71013 SAN GIOVANNI ROTONDO, ITALY	Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Womens & Childrens Hospital Australia			Strunk, Mark HP/K-3597-2014; Savoia, Anna/B-6463-2014; Pals, Gerard/A-5198-2011; Savoia, Anna/AIC-4560-2022; Callen, David F/G-1975-2012; Strunk, Mark/I-2423-2017	Strunk, Mark HP/0000-0002-8619-3979; Savoia, Anna/0000-0002-2407-2696; Savoia, Anna/0000-0002-2407-2696; Strunk, Mark/0000-0002-8619-3979; Kruyt, Frank/0000-0002-2445-9380; Callen, David/0000-0002-6189-9991; Carreau, Madeleine/0000-0002-0582-6114; Pals, Gerard/0000-0003-4091-7115; Gille, Johan/0000-0003-4526-298X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987, R01HL032987, R01HL050131] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50131, HL32987] Funding Source: Medline; Telethon [E.0364] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; BUCHWALD M, 1989, FANCONI ANEMIA CLIN, P226; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; FANTES JA, 1992, AM J HUM GENET, V51, P1286; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P633; GIAMPIETRO PF, 1993, PEDIATRICS, V91, P1116; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HURST HC, 1994, PROTEIN PROFILE, V1, P123; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1996, HUM GENET, V97, P280, DOI 10.1007/BF02185753; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V358, P434, DOI 10.1038/358434a0; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Young NS., 1994, APLASTIC ANEMIA ACQU, P275; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975	27	291	294	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					320	323		10.1038/ng1196-320	http://dx.doi.org/10.1038/ng1196-320			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896563				2022-12-27	WOS:A1996VQ14600028
J	Quignon, F; De Bels, F; Koken, M; Feunteun, J; Ameisen, JC; de The, H				Quignon, F; De Bels, F; Koken, M; Feunteun, J; Ameisen, JC; de The, H			PML induces a novel caspase-independent death process	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; CELL-DEATH; GROWTH-SUPPRESSOR; RAR-ALPHA; NUCLEAR-BODIES; DNA-DAMAGE; PROTEIN; APOPTOSIS; BAX; EXPRESSION	PML nuclear bodies (NBs) are nuclear matrix-associated structures altered by viruses and oncogenes. We show here that PML overexpression induces rapid cell death, independent of de novo transcription and cell cycling. PML death involves cytoplasmic features of apoptosis in the absence of caspase-3 activation, and caspase inhibitors such as zVAD accelerate PML death, zVAD also accelerates interferon (IFN)-induced death, suggesting that PML contributes to IFN-induced apoptosis. The death effector BAX and the cdk inhibitor p27KIP1 are novel NB-associated proteins recruited by PML to these nuclear domains, whereas the acute promyelocytic leukaemia (APL) PML/RAR alpha oncoprotein delocalizes them. Arsenic enhances targeting of PML BAX and p27KIP1 to NBs and synergizes with PML and IFN to induce cell death. Thus, cell death susceptibility correlates with NE recruitment of NE proteins. These findings reveal a novel cell death pathway that neither requires nor induces caspase-3 activation, and suggest that NBs participate in the control of cell survival.	Univ Paris 07, Hop St Louis, Inst Hematol,CNRS UPR 9051, Lab Associe Comite Paris Ligue Contre Canc, F-75475 Paris 10, France; Hop Bichat, INSERM CJF 9707, F-75877 Paris, France; Inst Gustave Roussy, CNRS URA 1967, F-94805 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	de The, H (corresponding author), Univ Paris 07, Hop St Louis, Inst Hematol,CNRS UPR 9051, Lab Associe Comite Paris Ligue Contre Canc, 1 Av C Vellefaux, F-75475 Paris 10, France.	ameisen@caramail.com; dethe@chu-stlouis.fr	koken, marcel/J-8154-2012; koken, marcel/N-1349-2019; Feunteun, Jean/AAZ-1267-2020; Quignon, Frédérique/P-4249-2017	koken, marcel/0000-0002-0839-0125; Feunteun, Jean/0000-0003-1212-9189				Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; BAZARBACHI A, IN PRESS BLOOD; Borden KLB, 1997, FEBS LETT, V418, P30, DOI 10.1016/S0014-5793(97)01344-6; Borden KLB, 1998, J VIROL, V72, P3819, DOI 10.1128/JVI.72.5.3819-3826.1998; Chan JYH, 1997, BIOCHEM BIOPH RES CO, V240, P640, DOI 10.1006/bbrc.1997.7692; CHELBIALIX M, IN PRESS ONCOGENE; Chen GQ, 1997, BLOOD, V89, P3345; DANIEL MT, 1993, BLOOD, V82, P1858; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Estaquier J, 1997, BLOOD, V90, P1618, DOI 10.1182/blood.V90.4.1618.1618_1618_1625; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Gianni M, 1998, BLOOD, V91, P4300, DOI 10.1182/blood.V91.11.4300.411k41_4300_4310; Gongora C, 1997, J BIOL CHEM, V272, P19457, DOI 10.1074/jbc.272.31.19457; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; Han J., 1995, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jiang WQ, 1997, CELL GROWTH DIFFER, V8, P513; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Le XF, 1998, ONCOGENE, V16, P1839, DOI 10.1038/sj.onc.1201705; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; MADANI A, 1995, ONCOGENE, V10, P2259; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Monney L, 1998, J BIOL CHEM, V273, P6121, DOI 10.1074/jbc.273.11.6121; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Okura T, 1996, J IMMUNOL, V157, P4277; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Quignon F, 1997, BBA-REV CANCER, V1333, pM53, DOI 10.1016/S0304-419X(97)00025-5; Stadler M, 1995, ONCOGENE, V11, P2565; STUURMAN N, 1997, CELL MOL BIOL LETT, V2, P137; Testa U, 1998, J CLIN INVEST, V101, P2278, DOI 10.1172/JCI1332; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	54	330	339	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					259	265		10.1038/3068	http://dx.doi.org/10.1038/3068			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806544				2022-12-27	WOS:000076698100019
J	Litingtung, Y; Lei, L; Westphal, H; Chiang, C				Litingtung, Y; Lei, L; Westphal, H; Chiang, C			Sonic hedgehog is essential to foregut development	NATURE GENETICS			English	Article							MAMMALIAN LUNG DEVELOPMENT; MORPHOGENESIS; MESENCHYME; DIFFERENTIATION; MALFORMATIONS; EPITHELIUM; INDUCTION; GENES	Congenital malformation of the foregut is common in humans, with an estimated incidence of 1 in 3000 live births(1), although its aetiology remains largely unknown. Mice with a targeted deletion of Sonic hedgehog (Shh) have foregut defects that are apparent as early as embryonic day 9.5, when the tracheal diverticulum begins to outgrow. Homozygous Shh-null mutant mice show oesophageal atresia/stenosis, tracheo-oesophageal fistula and tracheal and lung anomalies, features similar to those observed in humans with foregut defects. The lung mesenchyme shows enhanced cell death, decreased cell proliferation and downregulation of Shh target genes. These results indicate that Shh, is required for the growth and differentiation of the oesophagus, trachea and lung, and suggest: that mutations in SHH and its signalling components may be involved in foregut defects in humans.	Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chiang, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell Biol, 1161 21st Ave S, Nashville, TN 37232 USA.	chin.chiang@ccmail.vanderbilt.edu						ALESCIO T, 1962, J EXP ZOOL, V150, P83, DOI 10.1002/jez.1401500202; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bellusci S, 1997, DEVELOPMENT, V124, P53; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brigid H, 1994, MANIPULATING MOUSE E; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; HAFFEN K, 1987, J PEDIATR GASTR NUTR, V6, P14, DOI 10.1097/00005176-198701000-00005; Hogan BLM, 1997, COLD SPRING HARB SYM, V62, P249; ISHIZUYAOKA A, 1984, J EMBRYOL EXP MORPH, V82, P163; Kos L, 1998, MECH DEVELOP, V70, P25, DOI 10.1016/S0925-4773(97)00168-8; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SCHROEDER HW, 1986, CLIN GENET, V30, P285; SHANNON JM, 1994, DEV BIOL, V166, P600, DOI 10.1006/dbio.1994.1340; Skandalakis JE., 1994, EMBRYOLOGY SURG; SPOONER BS, 1970, J EXP ZOOL, V175, P445, DOI 10.1002/jez.1401750404; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; Urase K, 1996, BIOCHEM BIOPH RES CO, V225, P161, DOI 10.1006/bbrc.1996.1147; VERLOES A, 1995, CLIN DYSMORPHOL, V4, P208; WESSELLS NK, 1970, J EXP ZOOL, V175, P455, DOI 10.1002/jez.1401750405	21	526	550	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					58	61		10.1038/1717	http://dx.doi.org/10.1038/1717			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731532				2022-12-27	WOS:000075671400020
J	Letts, VA; Felix, R; Biddlecome, GH; Arikkath, J; Mahaffey, CL; Valenzuela, A; Bartlett, FS; Mori, Y; Campbell, KP; Frankel, WN				Letts, VA; Felix, R; Biddlecome, GH; Arikkath, J; Mahaffey, CL; Valenzuela, A; Bartlett, FS; Mori, Y; Campbell, KP; Frankel, WN			The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit	NATURE GENETICS			English	Article							CALCIUM-CHANNEL; SKELETAL-MUSCLE; CA2+ CHANNELS; MUTANT MOUSE; BETA-SUBUNIT; MICE; BRAIN; EXPRESSION; EPILEPSY; SEIZURES	Stargazer mice have spike-wave seizures characteristic of absence epilepsy, with accompanying defects in the cerebellum and inner ear. We describe here a novel gene, Cacng2, whose expression is disrupted in two stargazer alleles. It encodes a 36-kD protein (stargazin) with structural similarity to the gamma-subunit of skeletal muscle voltage-gated calcium (Ca2+) channels. Stargazin is brain-specific and, like other neuronal Ca2+-channel subunits, is enriched in synaptic plasma membranes. In vitro, stargazin increases steady-state inactivation of alpha(1) class A Ca2+ channels. The anticipated effect in stargazer mutants, inappropriate Ca2+ entry, may contribute to their more pronounced seizure phenotype compared with other mouse absence models with Ca2+-channel defects. The discovery that the stargazer gene encodes a gamma-subunit completes the identification of the major subunit types for neuronal Ca2+ channels, namely alpha(1) alpha(2)delta,beta and gamma, providing a new opportunity to understand how these channels function in the mammalian brain and how they may be targeted in the treatment of neuroexcitability disorders.	Jackson Lab, Bar Harbor, ME 04609 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA; Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan	Jackson Laboratory; Howard Hughes Medical Institute; University of Iowa; University of Iowa; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Frankel, WN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	val@jax.org; wnf@jax.org	Felix, Ricardo/A-6989-2008	Felix, Ricardo/0000-0002-5383-7176; Campbell, Kevin/0000-0003-2066-5889	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032801, R01NS032801] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32801] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COX GA, 1997, CELL, V91, P1; De Waard M, 1996, Ion Channels, V4, P41; DiPasquale E, 1997, J NEUROPHYSIOL, V77, P621, DOI 10.1152/jn.1997.77.2.621; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Eberst R, 1997, PFLUG ARCH EUR J PHY, V433, P633, DOI 10.1007/s004240050324; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harlow E., 1988, ANTIBODIES LAB MANUA; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; KINGSTON RE, 1997, CURRENT PROTOCOLS MO; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert RC, 1997, J NEUROSCI, V17, P6621; Lerche H, 1996, PFLUG ARCH EUR J PHY, V431, P461, DOI 10.1007/s004240050021; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; LEVEQUE C, 1994, J BIOL CHEM, V271, P13804; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; Ludwig A, 1997, J NEUROSCI, V17, P1339; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Noebels J L, 1986, Adv Neurol, V44, P97; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Nooney JM, 1997, TRENDS PHARMACOL SCI, V18, P363, DOI 10.1016/S0165-6147(97)01110-3; Ottman R, 1997, AM J HUM GENET, V60, P667; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; QIAO X, 1998, IN PRESS J NEUROSCI; Qiao XO, 1996, J NEUROSCI, V16, P640; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Scott VES, 1998, J NEUROSCI, V18, P641; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; SWEET HO, 1991, MOUSE GENOME, V89, P552; TAYLOR BA, 1993, GENOMICS, V16, P380, DOI 10.1006/geno.1993.1201; VARADI G, 1995, TRENDS PHARMACOL SCI, V16, P43, DOI 10.1016/S0165-6147(00)88977-4; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; WEI XY, 1991, J BIOL CHEM, V266, P21943; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Wissenbach U, 1998, BIOL CHEM, V379, P45, DOI 10.1515/bchm.1998.379.1.45; WITCHER DR, 1994, METHOD ENZYMOL, V238, P335; [No title captured]	59	448	469	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1998	19	4					340	347		10.1038/1228	http://dx.doi.org/10.1038/1228			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697694				2022-12-27	WOS:000075107600016
J	Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Pearce, WG; Koop, B; Fishman, GA; Mets, M; Musarella, MA; Boycott, KM				Bech-Hansen, NT; Naylor, MJ; Maybaum, TA; Pearce, WG; Koop, B; Fishman, GA; Mets, M; Musarella, MA; Boycott, KM			Loss-of-function mutations in a calcium-channel alpha(1)-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness	NATURE GENETICS			English	Article							B-WAVE; ELECTRORETINOGRAM; EXPRESSION; SUBTYPE; DNA	X-linked congenital stationary night blindness (CSNB) is a recessive non-progressive retinal disorder characterized by night blindness, decreased visual acuity, myopia, nystagmus and strabismus(1-3). Two distinct clinical entities of X-linked CSNB have been proposed(4). Patients with complete CSNB show moderate to severe myopia, undetectable rod function and a normal cone response, whereas patients with incomplete CSNB show moderate myopia to hyperopia and subnormal but measurable rod and cone function. The electrophysiological and psychophysical features of these clinical entities suggest a defect in retinal neurotransmission. The apparent clinical heterogeneity in X-linked CSNB reflects the recently described genetic heterogeneity in which the locus for complete CSNB (CSNB1) was mapped to Xp11.4, and the locus for incomplete CSNB (CSNB2) was refined within Xp11.23 (ref. 5). A novel retina-specific gene mapping to the CSNB2 minimal region was characterized and found to have similarity to voltage-gated L-type calcium channel alpha(1)-subunit genes. Mutation analysis of this new alpha(1)-subunit gene, CACNA1F, in 20 families with incomplete CSNB revealed six different mutations that are all predicted to cause premature protein truncation. These findings establish that loss-of-function mutations in CACNA1F cause incomplete CSNB, making this disorder an example of a human channelopathy of the retina.	Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2G3, Canada; Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; Univ Illinois, Dept Ophthalmol, Chicago, IL 60612 USA; Childrens Mem Hosp, Dept Ophthalmol, Chicago, IL 60614 USA; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Long Isl Coll Hosp, Dept Ophthalmol, Brooklyn, NY 11201 USA	University of Calgary; University of Alberta; University of Victoria; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Toronto; Long Island College Hospital	Bech-Hansen, NT (corresponding author), Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada.		Koop, Ben F./A-8151-2008	Koop, Ben F./0000-0003-0045-5200				BECHHANSEN NT, 1993, AM J HUM GENET, V52, P71; BECHHANSEN NT, IN PRESS HUMAN GENET; Boycott KM, 1997, CYTOGENET CELL GENET, V76, P223, DOI 10.1159/000134555; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Boycott KM, 1996, GENOMICS, V33, P488, DOI 10.1006/geno.1996.0224; Boycott KM, 1998, GENOMICS, V48, P369, DOI 10.1006/geno.1997.5167; Carr R E, 1974, Trans Am Ophthalmol Soc, V72, P448; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Doyle JL, 1998, TRENDS GENET, V14, P92, DOI 10.1016/S0168-9525(97)01370-X; Epp FH, 1975, MENNONITES CANADA 17; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher SE, 1997, GENOMICS, V45, P340, DOI 10.1006/geno.1997.4941; FISHMAN GA, 1990, ELECTROPHYSIOLOGIC T; Heon E, 1994, MOL GENETICS INHERIT, P277; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; NATHANS J, 1984, P NATL ACAD SCI USA, V81, P193; PEARCE WG, 1990, CAN J OPHTHALMOL, V25, P3; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; Smith LA, 1996, J NEUROSCI, V16, P7868; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; STEA A, 1995, LIGAND VOLTAGE GATED, P113; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656	34	385	400	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					264	267		10.1038/947	http://dx.doi.org/10.1038/947			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662400				2022-12-27	WOS:000074565900023
J	D'Adamo, P; Menegon, A; Lo Nigro, C; Grasso, M; Gulisano, M; Tamanini, F; Bienvenu, T; Gedeon, AK; Oostra, B; Wu, SK; Tandon, A; Valtorta, F; Balch, WE; Chelly, J; Toniolo, D				D'Adamo, P; Menegon, A; Lo Nigro, C; Grasso, M; Gulisano, M; Tamanini, F; Bienvenu, T; Gedeon, AK; Oostra, B; Wu, SK; Tandon, A; Valtorta, F; Balch, WE; Chelly, J; Toniolo, D			Mutations in GDI1 are responsible for X-linked non-specific mental retardation	NATURE GENETICS			English	Article							GDP-DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; RAB PROTEINS; GENE; EXOCYTOSIS; XQ28; IDENTIFICATION; EXPRESSION	Rab GDP-dissociation inhibitors (GDI) are evolutionarily conserved proteins that play an essential role in the recycling of Rab GTPases required for vesicular transport through the secretory pathway We have found mutations in the GDI1 gene (which encodes alpha GDI) in two families affected with X-linked non-specific mental retardation. One of the mutations caused a non-conservative substitution (L92P) which reduced binding and recycling of RAB3A, the second was a null mutation. Our results show that both functional and developmental alterations in the neuron may account for the severe impairment of learning abilities as a consequence of mutations in GDI1, emphasizing its critical role in development of human intellectual and learning abilities.	CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy; Galliera Hosp, Lab Human Genet, Genoa, Italy; HSR, DIBIT, Milan, Italy; Inst Cochin Genet Mol, F-75014 Paris, France; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Scripps Res Inst, Dept Mol & Cell Biol, La Jolla, CA USA; Univ Milan, Dept Med Pharmacol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Ente Ospedaliero Ospedali Galliera; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Womens & Childrens Hospital Australia; Erasmus University Rotterdam; Scripps Research Institute; University of Milan	Toniolo, D (corresponding author), CNR, Inst Genet Biochem & Evolut, I-27100 Pavia, Italy.	Toniola@igbe.pv.cnr.it	D'Adamo, Patrizia/AAN-3919-2020; Gulisano, Massimo/F-6609-2012; Flavia, Valtorta/F-3450-2012; Gedeon, Agi/G-7890-2011; menegon, andrea/AAN-3736-2020; Chelly, Jamel/J-7528-2015; Toniolo, Daniela/AAE-2969-2019; Grasso, Marina/AAC-8722-2019	D'Adamo, Patrizia/0000-0002-0312-5541; Gulisano, Massimo/0000-0001-8654-1745; Flavia, Valtorta/0000-0001-9556-4746; menegon, andrea/0000-0002-2396-756X; Chelly, Jamel/0000-0002-0939-8719; Toniolo, Daniela/0000-0001-9545-6032; s, hema/0000-0002-3440-9475; Grasso, Marina/0000-0001-5682-1789	NATIONAL EYE INSTITUTE [R01EY011606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301] Funding Source: NIH RePORTER; NEI NIH HHS [EY11606] Funding Source: Medline; NIGMS NIH HHS [GM33301] Funding Source: Medline; Telethon [E.0297] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon)		BACHNER D, 1995, HUM MOL GENET, V4, P701, DOI 10.1093/hmg/4.4.701; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BEAN JA, 1997, NEURON, V19, P751; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BURGAYA F, 1995, EUR J NEUROSCI, V7, P1810, DOI 10.1111/j.1460-9568.1995.tb00700.x; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; Claes S, 1997, CLIN GENET, V52, P155; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DEKKER LV, 1991, J NEUROCHEM, V56, P1146, DOI 10.1111/j.1471-4159.1991.tb11404.x; desPortes V, 1997, AM J HUM GENET, V60, P903; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hamel BCJ, 1996, AM J MED GENET, V64, P131, DOI 10.1002/(SICI)1096-8628(19960712)64:1<131::AID-AJMG22>3.0.CO;2-N; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1995, METHOD ENZYMOL, V257, P3; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEDLACEK Z, 1994, MAMM GENOME, V5, P633, DOI 10.1007/BF00411459; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; SUEDHOF TC, 1997, NEURON, V18, P519; Takai Y, 1996, GENES CELLS, V1, P615, DOI 10.1046/j.1365-2443.1996.00257.x; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1	42	266	274	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					134	139		10.1038/487	http://dx.doi.org/10.1038/487			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620768				2022-12-27	WOS:000073865100019
J	Dreyer, SD; Zhou, G; Baldini, A; Winterpacht, A; Zabel, B; Cole, W; Johnson, RL; Lee, B				Dreyer, SD; Zhou, G; Baldini, A; Winterpacht, A; Zabel, B; Cole, W; Johnson, RL; Lee, B			Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome	NATURE GENETICS			English	Article							PROTEIN; DOMAIN; GENE	The LIM-homeodomain protein Lmx1b plays a central role in dorso-ventral patterning of the vertebrate limb(1). Targeted disruption of Lmx1b results in skeletal defects including hypoplastic nails, absent patellae and a unique form of renal dysplasia (see accompanying manuscript by Fl. Chen et al.; ref. 2). These features are reminiscent of the dominantly inherited skeletal malformation nail patella syndrome (NPS). We show that LMX1B maps to the NPS locus and that three independent NPS patients carry de novo heterozygous mutations in this gene. Functional studies show that one of these mutations disrupts sequence-specific DNA binding, while the other two mutations result in premature termination of translation. These data demonstrate a unique role for LMX1B in renal development and in patterning of the skeletal system, and suggest that alteration of Lmx1b/LMX1B function in mice and humans results in similar phenotypes, Furthermore, we provide evidence for the first described mutations in a LIM-homeodomain protein which account for an inherited form of abnormal skeletal patterning and renal failure.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Mainz, Dept Pediat, D-6500 Mainz, Germany; Hosp Sick Children, Dept Orthoped Surg, Toronto, ON M5G 1X8, Canada; Univ Texas, Sch Med, MD Anderson Cancer Ctr, Dept Biochem & Mol Biol, Houston, TX USA	Baylor College of Medicine; Johannes Gutenberg University of Mainz; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; UTMD Anderson Cancer Center	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015	Baldini, Antonio/0000-0002-5330-0256				Ausubel FM, 1994, CURRENT PROTOCOLS MO; BALDINI A, 1994, IN SITU HYBRIDIZATIO, P75; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; CAMPEAU E, 1995, AM J HUM GENET, V56, P243; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; DELPOZO E, 1970, AM J CLIN PATHOL, V54, P845; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gill GN, 1995, STRUCTURE, V3, P1285, DOI 10.1016/S0969-2126(01)00265-9; HOYER JR, 1972, KIDNEY INT, V2, P231, DOI 10.1038/ki.1972.99; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Jones K. L., 1997, SMITHS RECOGNIZABLE; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; MCINTOSH L, 1997, AM J HUM GENET, V60, P133; MORITA T, 1973, ARCH INTERN MED, V131, P271, DOI 10.1001/archinte.131.2.271; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; StJacques B, 1996, CURR OPIN GENET DEV, V6, P439, DOI 10.1016/S0959-437X(96)80065-7; TAIRA M, 1995, TRENDS GENET, V11, P431, DOI 10.1016/S0168-9525(00)89139-8	22	362	375	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					47	50		10.1038/ng0598-47	http://dx.doi.org/10.1038/ng0598-47			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590287				2022-12-27	WOS:000073346700015
J	Minetti, C; Sotgia, F; Bruno, C; Scartezzini, P; Broda, P; Bado, M; Masetti, E; Mazzocco, M; Egeo, A; Donati, MA; Volonte, D; Galbiati, F; Cordone, G; Bricarelli, FD; Lisanti, MP; Zara, F				Minetti, C; Sotgia, F; Bruno, C; Scartezzini, P; Broda, P; Bado, M; Masetti, E; Mazzocco, M; Egeo, A; Donati, MA; Volonte, D; Galbiati, F; Cordone, G; Bricarelli, FD; Lisanti, MP; Zara, F			Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy	NATURE GENETICS			English	Article							HETEROTRIMERIC G-PROTEINS; EXPRESSION; IDENTIFICATION; SEQUENCE; ISOFORMS; CELLS	Limb-girdle muscular dystrophy (LGMD) is a clinically and genetically heterogeneous group of myopathies. including autosomal dominant and recessive forms(1-3). To date, two autosomal dominant forms have been recognized(2,3): LGMD1A, linked to chromosome 5q, and LGMD1B, associated with cardiac defects and linked to chromosome 1q11-21. Here we describe eight patients from two different families with a new form of autosomal dominant LGMD, which we propose to call LGMD1C, associated with a severe deficiency of caveolin-3 in muscle fibres. Caveolin-3 (or M-caveolin) is the muscle-specific form of the caveolin protein family, which also includes caveolin-1 and -2 (refs 4-9). Caveolins are the principal protein components of caveolae (50-100 nm invaginations found in most cell types) which represent appendages or sub-compartments of plasma membranes(10,11). We localized the human caveolin-3 gene (CAV3) to chromosome 3p25 and identified two mutations in the gene: a missense mutation in the membrane-spanning region and a micro-deletion in the scaffolding domain. These mutations may interfere with caveolin-3 oligomerization and disrupt caveolae formation at the muscle cell plasma membrane.	Univ Genoa, Ist Giannina Gaslini, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy; EO Osped Galliera, Lab Genet Umana, Genoa, Italy; Columbia Univ, Dept Neurol, New York, NY USA; EO Osped Galliera, Div Neonatol, Genoa, Italy; Univ Florence, Dipartimento Pediat, Florence, Italy; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	University of Genoa; IRCCS Istituto Giannina Gaslini; Ente Ospedaliero Ospedali Galliera; Columbia University; Ente Ospedaliero Ospedali Galliera; University of Florence; Yeshiva University; Albert Einstein College of Medicine	Minetti, C (corresponding author), Univ Genoa, Ist Giannina Gaslini, Serv Malattie Neuromuscolari, Largo Gaslini 5, I-16147 Genoa, Italy.	minettic@unige.it	Mazzocco, Michela/AFT-6759-2022; Lisanti, Michael P/C-6866-2013; Bruno, Claudio/A-3148-2015; Zara, Federico/U-3477-2017; Galbiati, Ferruccio/AAF-3527-2020; Lisanti, Michael/B-6131-2018; Minetti, Carlo/K-4666-2018	Bruno, Claudio/0000-0002-3426-2901; Zara, Federico/0000-0001-9744-5222; Lisanti, Michael/0000-0003-2034-1382; Minetti, Carlo/0000-0002-0640-1804; Sotgia, Federica/0000-0003-2826-4529; MARIA ALICE, DONATI/0000-0003-4769-5025; Broda, Paolo/0000-0002-4178-1128	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050443] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-50443] Funding Source: Medline; Telethon [641] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon)		Bushby K, 1996, NEUROMUSCULAR DISORD, V6, P439, DOI 10.1016/S0960-8966(96)00392-6; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, TRENDS CARDIOVAS MED, V7, P103, DOI 10.1016/S1050-1738(97)00001-7; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; MINETTI C, 1994, NEUROLOGY, V44, P1149, DOI 10.1212/WNL.44.6.1149; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; OKAMOTO T, IN PRESS J BIOL CHEM; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Scartezzini P, 1997, HUM GENET, V99, P387, DOI 10.1007/s004390050377; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SIMIONESCU N, 1975, J CELL BIOL, V64, P586, DOI 10.1083/jcb.64.3.586; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; SPEER MC, 1992, AM J HUM GENET, V50, P1211; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	30	437	448	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					365	368		10.1038/ng0498-365	http://dx.doi.org/10.1038/ng0498-365			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537420				2022-12-27	WOS:000072755500020
J	Broccoli, D; Smogorzewska, A; Chong, L; deLange, T				Broccoli, D; Smogorzewska, A; Chong, L; deLange, T			Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2	NATURE GENETICS			English	Article							DNA-BINDING DOMAIN; SEQUENCE; COMPLEX; YEAST; RAP1	Human telomeres are composed of long arrays of TTAGGG repeats that form a nucleoprotein complex required for the protection and replication of chromosome ends. One component of human telomeres is the TTAGGG repeat binding factor 1 (TRF1), a ubiquitously expressed protein, related to the protooncogene Myb, that is present at telomeres throughout the cell cycle(1-6). Recent evidence has implicated TRF1 in the control of telomere length(7). TRF1 is proposed to be an inhibitor of telomerase, acting in cis to limit the elongation of individual chromosome ends. Here we report the cloning of TRF2, a distant homologue of TRF1 that carries a very similar Myb-related DNA-binding motif. Like TRF1, TRF2 was ubiquitously expressed, bound specifically to duplex TTAGGG repeats in vitro and localized to all human telomeres in metaphase chromosomes. TRF2 was shown to have an architecture similar to that of TRF1 in that it carries a C-terminal Myb motif and a large TRF1-related dimerization domain near its N terminus. However, the dimerization domain of TRF1 and TRF2 did not interact, suggesting that these proteins exist predominantly as homodimers. While having similar telomere binding activity and domain organization, TRF2 differed from TRF1 in that its N terminus was basic rather than acidic, and TRF2 was much more conserved than TRF1. The results indicate that the TTAGGG repeat arrays at the ends of human and mouse chromosomes bind to two related proteins. Because TRF1 and TRF2 showed significant differences, we suggest that these factors have distinct functions at telomeres.	ROCKEFELLER UNIV,NEW YORK,NY 10021	Rockefeller University			de Lange, Titia/B-8263-2011; Smogorzewska, Agata/B-8891-2011	de Lange, Titia/0000-0002-9267-367X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM07739] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Broccoli D, 1997, HUM MOL GENET, V6, P69, DOI 10.1093/hmg/6.1.69; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	19	733	766	0	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					231	235		10.1038/ng1097-231	http://dx.doi.org/10.1038/ng1097-231			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326950				2022-12-27	WOS:A1997XZ55500036
J	Kruglyak, L				Kruglyak, L			The use of a genetic map of biallelic markers in linkage studies	NATURE GENETICS			English	Article							HUMAN GENOME; HUMAN DNA; POLYMORPHISMS; HETEROZYGOSITY; TRAITS; ASSAY; SETS	Improvements in genetic mapping techniques have driven recent progress in human genetics. The use of single nucleotide polymorphisms (SNPs) as biallelic genetic markers offers the promise of rapid, highly automated genotyping. As maps of SNPs and the techniques for genotyping them are being developed, it is important to consider what properties such maps must have in order for them to be useful for linkage studies. I examine how polymorphic and densely spaced biallelic markers need to be for extraction of most of the inheritance information from human pedigrees, and compare maps of biallelics with today's genome-scanning sets of microsatellite markers. I conclude that a map of 700-900 moderately polymorphic biallelic markers is equivalent-and a map of 1,500-3,000 superior-to the current 300-400 microsatellite marker sets.			Kruglyak, L (corresponding author), WHITEHEAD INST BIOMED RES, 1 KENDALL SQ, BLDG 300, CAMBRIDGE, MA 02139 USA.				NHGRI NIH HHS [HG00017] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN DL, 1994, AM J HUM GENET, V54, P544; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HOFKER MH, 1986, AM J HUM GENET, V39, P438; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; TERWILLIGER JD, 1992, GENOMICS, V13, P951, DOI 10.1016/0888-7543(92)90006-E; Wang D., 1996, American Journal of Human Genetics, V59, pA3; WEBER JL, 1989, AM J HUM GENET, V44, P388; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	28	351	395	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					21	24		10.1038/ng0997-21	http://dx.doi.org/10.1038/ng0997-21			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288093				2022-12-27	WOS:A1997XU72400013
J	Ryan, SG; Chance, PF; Zou, CH; Spinner, NB; Golden, JA; Smietana, S				Ryan, SG; Chance, PF; Zou, CH; Spinner, NB; Golden, JA; Smietana, S			Epilepsy and mental retardation limited to females: An X-linked dominant disorder with male sparing	NATURE GENETICS			English	Letter							CHROMOSOME INACTIVATION; MOLECULAR CHARACTERIZATION; LINKAGE ANALYSIS; HUMAN GENOME; GENE; MAP; REPEAT; FORM	Several X-linked disorders affect females disproportionately or exclusively. These including focal dermal hypoplasia(1,2), oral-facial-digital syndrome type I (ref. 3) and epilepsy with bilateral periventricular heterotopias(4). X-linked dominant inheritance with male lethality is probably responsible for sex-limited expression of these disorders, as affected women have frequent spontaneous abortions and the sex ratio of their live offspring is often skewed(5). The same inheritance pattern has been proposed for Rett syndrome(6), Aicardi syndrome(7) and microphthalmia with linear skin defects(8), but in these sporadic conditions, evidence of male lethality is lacking. We investigated an unusual family with epilepsy and mental retardation limited to females (EFMR, #121250 in ref. 9); this disorder is transmitted both by females and by completely unaffected carrier males. Assignment of the EFMR disease locus (EFMR) to the X chromosome indicates that selective involvement of females in X-linked disease may in some instances result from male sparing rather than male lethality.	CHILDRENS HOSP,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104; WAYNE STATE UNIV,SCH MED,DEPT NEUROL,DETROIT,MI 48201; CHILDRENS HOSP MICHIGAN,DETROIT,MI 48201; CHILDRENS HOSP,DEPT PATHOL,PHILADELPHIA,PA 19104	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Wayne State University; Children's Hospital of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ryan, SG (corresponding author), CHILDRENS HOSP,DEPT NEUROL,34TH ST & CIV CTR BLVD,PHILADELPHIA,PA 19104, USA.		Chance, Phillip/AAX-5826-2020	Golden, Jeffrey/0000-0001-9933-5502				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONNENFELD AE, 1989, AM J MED GENET, V32, P461, DOI 10.1002/ajmg.1320320405; EKSIOGLU YZ, 1992, NEURON, V7, P117; FABISIAK K, 1990, CLIN GENET, V38, P353; GOLTZ RW, 1962, ARCH DERMATOL, V86, P708, DOI 10.1001/archderm.1962.01590120006002; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Harlow E., 1988, ANTIBODIES LAB MANUA; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JANI MM, 1995, GENOMICS, V27, P182, DOI 10.1006/geno.1995.1022; JOHNSON WG, 1980, AM J HUM GENET, V32, P374; JUBERG RC, 1971, J PEDIATR-US, V79, P726, DOI 10.1016/S0022-3476(71)80382-7; KAPUSTA L, 1992, EUR J PEDIATR, V151, P837, DOI 10.1007/BF01957936; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; Mckusick V.A., 1994, MENDELIAN INHERITANC; MELNICK M, 1975, ORAL SURG ORAL MED O, V40, P599, DOI 10.1016/0030-4220(75)90370-9; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; MUMM S, IN PRESS GENOME RES; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; TEMPLE IK, 1990, J MED GENET, V27, P180, DOI 10.1136/jmg.27.3.180; VAILLAUD JC, 1968, REV PEDIATR, V4, P383; WEBER JL, 1989, AM J HUM GENET, V44, P388; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472	29	100	104	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					92	95		10.1038/ng0997-92	http://dx.doi.org/10.1038/ng0997-92			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288105				2022-12-27	WOS:A1997XU72400025
J	Cohen, B; Bashirullah, A; Dagnino, L; Campbell, C; Fisher, WW; Leow, CC; Whiting, E; Ryan, D; Zinyk, D; Boulianne, G; Hui, CC; Gallie, B; Phillips, RA; Lipshitz, HD; Egan, SE				Cohen, B; Bashirullah, A; Dagnino, L; Campbell, C; Fisher, WW; Leow, CC; Whiting, E; Ryan, D; Zinyk, D; Boulianne, G; Hui, CC; Gallie, B; Phillips, RA; Lipshitz, HD; Egan, SE			Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila	NATURE GENETICS			English	Article							GENE SERRATE ENCODES; TRANSMEMBRANE PROTEIN; VERTEBRATE DEVELOPMENT; NEUROGENIC GENE; CELL FATE; DELTA; EXPRESSION; MELANOGASTER; MORPHOGENESIS; COMPLEX		HOSP SICK CHILDREN,DIV IMMUNOL & CANC RES,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,DIV ENDOCRINOL,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,PROGRAM DEV BIOL,TORONTO,ON M5G 1X8,CANADA; HOSP SICK CHILDREN,DIV NEUROL,TORONTO,ON M5G 1X8,CANADA; CALTECH,DIV BIOL,PASADENA,CA 91125; UNIV TORONTO,DEPT MOL & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); California Institute of Technology; University of Toronto; University of Toronto				Lipshitz, Howard/0000-0002-7372-4419; Gallie, Brenda/0000-0002-9697-9211; Dagnino, Lina/0000-0003-1483-5159				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; BRAND AH, 1993, DEVELOPMENT, V118, P401; CONLON RA, 1995, DEVELOPMENT, V121, P1533; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; FLEMING RJ, 1990, GENE DEV, V4, P2188, DOI 10.1101/gad.4.12a.2188; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Lardelli M, 1995, INT J DEV BIOL, V39, P769; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Lawrence P.A., 1986, P229; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; PARODY TR, 1993, GENETICS, V135, P527; PARR BA, 1994, CURR OPIN GENET DEV, V4, P523, DOI 10.1016/0959-437X(94)90067-D; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; THOMAS U, 1991, DEVELOPMENT, V111, P749; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; Wu JY, 1996, SCIENCE, V273, P355, DOI 10.1126/science.273.5273.355; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8	36	128	135	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					283	288		10.1038/ng0797-283	http://dx.doi.org/10.1038/ng0797-283			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207795				2022-12-27	WOS:A1997XG60900025
J	Robbins, WA; Meistrich, ML; Moore, D; Hagemeister, FB; Weier, HU; Cassel, MJ; Wilson, G; Eskenazi, B; Wyrobek, AJ				Robbins, WA; Meistrich, ML; Moore, D; Hagemeister, FB; Weier, HU; Cassel, MJ; Wilson, G; Eskenazi, B; Wyrobek, AJ			Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm	NATURE GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; IN-SITU HYBRIDIZATION; HODGKINS-DISEASE; RADIOTHERAPY; ABERRATIONS; CYCLOPHOSPHAMIDE; NONDISJUNCTION; ABNORMALITIES; VINCRISTINE; PREDNISONE	Each year more than 20,000 children and young persons of reproductive age are exposed to known mutagens in the form of chemo- and/or radiotherapy for cancer in the States(1,2). As more of these treatments are effective there is growing concern that genetic defects are introduced in the germ cells of these young patients, It is well documented for male rodents that treatment with chemo- and radio-therapeutic agents before mating can cause genetic damage in the germ line(3-10), and the magnitude of heritable effects depends on the spermatogenic cell stage treated, Similar germinal effects are suspected to occur in humans but remain unproven(11-15), Hodgkin's disease (HD) is an example of a malignancy which is typically diagnosed during a patient's reproductive years, In our study we observed eight male HD patients who were treated with NOVP (Novanthrone, Oncovin, Vinblastine, Prednisone) chemotherapy, We evaluated sperm aneuploidy using multi-colour fluorescence in situ hybridization (FISH), and found similar to 5-fold increases in sperm with disomies, diploidies and complex genotypes involving chromosome X,Y and 8, Increases in sex chromsome aneuploidies arose from segregation errors at meiosis I as well as meiosis II, The aneuploidy effects were transient, however, declining to pretreatment levels within approximately 100 days after the end of the therapy, When compared with normal men, some HD patients showed higher proportions of certain sperm aneupolidy types even before their first therapy.	LAWRENCE LIVERMORE NATL LAB, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94551 USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, EPIDEMIOL GRP, BERKELEY, CA 94720 USA; UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT EXPT RADIAT ONCOL, HOUSTON, TX 77030 USA; UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT HEMATOL, HOUSTON, TX 77030 USA; LAWRENCE BERKELEY LAB, DIV LIFE SCI, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory				Wyrobek, Andrew/0000-0002-5921-5298				ADLER ID, 1993, MUTAT RES, V287, P131, DOI 10.1016/0027-5107(93)90152-6; *AM COLL OBST GYN, 1993, CERV CYT EV MAN ABN, P1; Bishop JB, 1996, ENVIRON MOL MUTAGEN, V28, P159; BRANDRIFF B, 1990, BIOL MAMMALIAN GERM, V34, P83; BRANDRIFF BF, 1994, HUM GENET, V93, P295, DOI 10.1007/BF00212026; CARSON SA, 1991, HUM REPROD, V6, P992, DOI 10.1093/oxfordjournals.humrep.a137475; CHANDLEY AC, 1979, ENVIRON HEALTH PERSP, V31, P123, DOI 10.2307/3429149; Generoso WM, 1995, MUTAT RES-GENET TOX, V345, P167, DOI 10.1016/0165-1218(95)90052-7; GENESCA A, 1990, HUM GENET, V85, P495; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Hagemeister F B, 1993, Leuk Lymphoma, V10 Suppl, P91, DOI 10.3109/10428199309149119; HAGEMEISTER FB, 1994, SEMIN HEMATOL, V31, P36; HASSOLD T, 1990, HUM GENET, V85, P648; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Jacobs P A, 1992, Oxf Rev Reprod Biol, V14, P47; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; JENDERNY J, 1992, HUM GENET, V90, P151; KELLY SM, 1994, BIOL REPROD, V50, P55, DOI 10.1095/biolreprod50.1.55; LAHDETIE J, 1988, MUTAT RES, V203, P47, DOI 10.1016/0165-1161(88)90007-6; LI FP, 1979, JNCI-J NATL CANCER I, V62, P1193; LIANG JC, 1993, LEUKEMIA LYMPHOMA, V9, P503, DOI 10.3109/10428199309145757; LORDASANCHEZ I, 1992, AM J MED GENET, V42, P487, DOI 10.1002/ajmg.1320420414; MARTIN RH, 1986, MUTAT RES, V174, P219, DOI 10.1016/0165-7992(86)90155-7; MARTIN RH, 1989, MUTAT RES, V226, P21, DOI 10.1016/0165-7992(89)90088-2; MARTIN RH, 1995, CANCER GENET CYTOGEN, V80, P29, DOI 10.1016/0165-4608(94)00162-5; MEISTRICH ML, 1982, CANCER RES, V42, P122; MEISTRICH ML, 1993, HUM REPROD, V8, P8, DOI 10.1093/oxfordjournals.humrep.a137880; MEISTRICH ML, IN PRESS PRINCIPLES; MILLER BA, 1993, SEER CANC STAT REV 1; MULVIHILL JJ, 1990, PROG CLIN BIOL RES, V340, P179; NICHOLSON HS, 1992, MED PEDIATR ONCOL, V20, P6, DOI 10.1002/mpo.2950200103; NYGAARD R, 1991, MED PEDIATR ONCOL, V19, P459, DOI 10.1002/mpo.2950190603; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Robbins WA, 1995, REPROD FERT DEVELOP, V7, P799, DOI 10.1071/RD9950799; RUSSELL LB, 1985, MUTAT RES, V154, P69, DOI 10.1016/0165-1110(85)90020-X; RUSSELL LD, 1991, AM J ANAT, V192, P142, DOI 10.1002/aja.1001920205; SENTURIA YD, 1985, LANCET, V2, P766; VanHummelen P, 1996, HUM GENET, V98, P608; WYROBEK AJ, 1994, AM J MED GENET, V53, P1, DOI 10.1002/ajmg.1320530102; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; WYROBEK AJ, 1993, REPROD TOXICOL, V7, P3, DOI 10.1016/0890-6238(93)90064-E	41	168	172	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					74	78		10.1038/ng0597-74	http://dx.doi.org/10.1038/ng0597-74			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140398				2022-12-27	WOS:A1997WX02400025
J	Veldman, T; Vignon, C; Schrock, E; Rowley, JD; Ried, T				Veldman, T; Vignon, C; Schrock, E; Rowley, JD; Ried, T			Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping	NATURE GENETICS			English	Article							TRANSLOCATION; LEUKEMIA	Cytogenetic analysis provides critical information of diagnostic and prognostic importance for haematological malignancies(1,2). In fact, the identification of recurring chromosomal breakpoints in leukaemias and lymphomas has expedited the cloning of genes whose translocation-induced deregulation causes malignant transformation(3,4). The pillar of karyotype analysis rests on chromosome banding techniques that have the distinct advantage that the entire genome can be analysed in a single experiment. However, poorly spread or contracted metaphase chromosomes and highly rearranged karyotypes with numerous marker chromosomes, common in tumour cell preparations, are often difficult to interpret unambiguously and subtle chromosomal aberrations, in particular the exchange of telomeric chromatin or small insertions remain elusive, Fluorescence in situ hybridization (FISH) overcomes some of these limitations, but is mainly utilized to confirm the presence of previously characterized or suspected aberrations(5). We have developed a novel approach, termed spectral karyotyping or SKY6,7 based on the hybridization of 24 fluorescently labelled chromosome painting probes that allows the simultaneous and differential colour display of all human chromosomes. We have used SKY to complement conventional banding techniques in haematological malignancies by analysing 15 cases with unidentified chromosome aberrations. In all instances SKY provided additional cytogenetic information, including the identification of marker chromosomes, the detection of subtle chromosomal translocations and the clarification of complex chromosomal rearrangements. Thus, SKY in combination with standard chromosome banding allows the characterization of chromosomal aberrations in leukaemia with unprecedented accuracy.	NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV CHICAGO,DEPT MED,HEMATOL ONCOL SECT,CHICAGO,IL 60637	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Chicago					NATIONAL CANCER INSTITUTE [R35CA042557] Funding Source: NIH RePORTER; NCI NIH HHS [CA42557] Funding Source: Medline; PHS HHS [9512-8] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Garini Y., 1996, Bioimaging, V4, P65, DOI 10.1002/1361-6374(199606)4:2<65::AID-BIO4>3.3.CO;2-4; Heim S, 1995, CANC CYTOGENETICS; LeBeau MM, 1996, BLOOD, V88, P1930; LEBEAU MM, 1993, BLOOD, V81, P1979; LEBEAU MM, 1991, ASS CYTOGENETICS TEC, P95; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Malik Z, 1996, J MICROSC-OXFORD, V182, P133, DOI 10.1046/j.1365-2818.1996.131411.x; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROMANA SP, 1994, GENE CHROMOSOME CANC, V9, P186, DOI 10.1002/gcc.2870090307; ROWLEY JD, 1990, CANCER, V65, P2178, DOI 10.1002/1097-0142(19900515)65:10<2178::AID-CNCR2820651004>3.0.CO;2-#; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311	14	285	296	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					406	410		10.1038/ng0497-406	http://dx.doi.org/10.1038/ng0497-406			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090389				2022-12-27	WOS:A1997WQ38900022
J	Flint, J; Thomas, K; Micklem, G; Raynham, H; Clark, K; Doggett, NA; King, A; Higgs, DR				Flint, J; Thomas, K; Micklem, G; Raynham, H; Clark, K; Doggett, NA; King, A; Higgs, DR			The relationship between chromosome structure and function at a human telomeric region	NATURE GENETICS			English	Article							GLOBIN GENE-CLUSTER; HUMAN ZETA-GLOBIN; ALPHA-THALASSEMIA; LENGTH POLYMORPHISM; REGULATORY ELEMENT; HUMAN GENOME; DNA; SEQUENCE; EXPRESSION; CHROMATIN	We have sequenced a contiguous 284,495-bp segment of DNA extending from the terminal (TTAGGC)(n) repeats of the short arm of chromosome 16, providing a full description of the transition from telomeric through subtelomeric DNA to sequences that are unique to the chromosome. To complement and extend analysis of the primary sequence, we have characterized mRNA transcripts, patterns of DNA methylation and DNase I sensitivity. Together with previous data these studies describe in detail the structural and functional organization of a human telomeric region.	JOHN RADCLIFFE HOSP, INST MOL MED, MRC, MOL HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; SANGER CTR, CAMBRIDGE CB10 1RQ, ENGLAND; LOS ALAMOS NATL LAB, DIV LIFE SCI, LOS ALAMOS, NM 87545 USA	University of Oxford; Wellcome Trust Sanger Institute; United States Department of Energy (DOE); Los Alamos National Laboratory				Micklem, Gos/0000-0002-6883-6168; Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS MD, 1995, NATURE, V377, P3; BICKMORE WA, 1989, TRENDS GENET, V5, P144, DOI 10.1016/0168-9525(89)90055-3; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COHENSOLAL MM, 1982, DNA-J MOLEC CELL BIO, V1, P355, DOI 10.1089/dna.1982.1.355; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; FLINT J, 1994, AM J HUM GENET, V55, P505; FOUGEROUSSE F, 1992, NUCLEIC ACIDS RES, V20, P1165, DOI 10.1093/nar/20.5.1165; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; GOURDON G, 1994, NUCLEIC ACIDS RES, V22, P4139, DOI 10.1093/nar/22.20.4139; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HARDISON RC, 1986, NUCLEIC ACIDS RES, V14, P1903, DOI 10.1093/nar/14.4.1903; Harris Peter C., 1993, V5, P107; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Higgs DR, 1993, CHROMOSOMES TODAY, V11, P35; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; HSU SL, 1988, NATURE, V331, P94, DOI 10.1038/331094a0; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JARMAN AP, 1988, AM J HUM GENET, V42, P8; JURKA J, 1988, NUCLEIC ACIDS RES, V16, P766, DOI 10.1093/nar/16.2.766; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; JURKA J, 1992, J MOL EVOL, V35, P286, DOI 10.1007/BF00161166; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; Kitsberg D, 1991, CURR OPIN GENET DEV, V1, P534, DOI 10.1016/S0959-437X(05)80204-7; LAMB J, 1993, AM J HUM GENET, V52, P668; LARSEN F, 1993, HUM MOL GENET, V2, P1589, DOI 10.1093/hmg/2.10.1589; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; LEUNG S, 1987, NATURE, V329, P551, DOI 10.1038/329551a0; NELLIST M, 1993, CELL, V75, P1305; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; PROUDFOOT NJ, 1980, CELL, V21, P537, DOI 10.1016/0092-8674(80)90491-2; Raynham H, 1996, QJM-MON J ASSOC PHYS, V89, P169; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHEDL P, CHROMATIN STRUCTURE; Solovyev V V, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P367; SONNHAMMER E, 1994, P INT SOC MOL BIOL, V94, P363; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VICKERS MA, 1993, P NATL ACAD SCI USA, V90, P3437, DOI 10.1073/pnas.90.8.3437; VYAS P, 1995, GENOMICS, V29, P679, DOI 10.1006/geno.1995.9951; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; WARD CJ, 1994, CELL, V77, P881; WILKIE AOM, 1992, GENOMICS, V13, P81, DOI 10.1016/0888-7543(92)90205-7; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601	56	129	133	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					252	257		10.1038/ng0397-252	http://dx.doi.org/10.1038/ng0397-252			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054936				2022-12-27	WOS:A1997WK38600013
J	Eisenberg, RS				Eisenberg, RS			Structure and function in gene patenting	NATURE GENETICS			English	Editorial Material							OBESE; RNA				Eisenberg, RS (corresponding author), UNIV MICHIGAN,SCH LAW,HUTCHINS HALL,ANN ARBOR,MI 48104, USA.		Eisenberg, Robert/P-6070-2019					BURROUGHS WELLCOME C, 1988, Patent No. 4724232; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cioffi JA, 1996, NAT MED, V2, P585, DOI 10.1038/nm0596-585; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DICKSON D, 1989, SCIENCE, V243, P1002, DOI 10.1126/science.11653832; Dresser Rebecca, 1988, Jurimetrics, V28, P399; GOLDSTEIN J, 1995, J NIH RES, V7, P58; GREER TJ, 1979, WRITING UNDERSTANDIN; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; HAMILTON J, 1995, BUSINESS WEEK   0320; KASS LR, 1981, COMMENTARY       DEC, P56; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LI H, 1996, Patent No. 5504003; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Merges Robert P., 1995, AIPLA Q J, V23, P1; SHERWOOD P, 1996, BIOVENTURE VIEW  JUN, P15; Steffe EK, 1995, BIOTECHNOL LAW REP, V14, P947, DOI 10.1089/blr.1995.14.947; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; VAISSE C, 1996, NAT GENET, V14, P85; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; 1989, Patent No. 4818538; 1996, Patent No. 5506133; 1989, Patent No. 4828838; 1989, Patent No. 4818750; 1996, Patent No. 8510; 1989, Patent No. 4837208; 1989, Patent No. 4833130; 1996, Patent No. 5501969	29	21	23	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					125	130		10.1038/ng0297-125	http://dx.doi.org/10.1038/ng0297-125			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020836				2022-12-27	WOS:A1997WF08700010
J	Basson, CT; Bachinsky, DR; Lin, RC; Levi, T; Elkins, JA; Soults, J; Grayzel, D; Kroumpouzou, E; Traill, TA; LeblancStraceski, J; Renault, B; Kucherlapati, R; Seidman, JG; Seidman, CE				Basson, CT; Bachinsky, DR; Lin, RC; Levi, T; Elkins, JA; Soults, J; Grayzel, D; Kroumpouzou, E; Traill, TA; LeblancStraceski, J; Renault, B; Kucherlapati, R; Seidman, JG; Seidman, CE			Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome	NATURE GENETICS			English	Article							CONSERVED PROTEIN MOTIF; GRAM SYNDROME; GENES; EMBRYOGENESIS; BRACHYURY; DISEASE; HOMOLOG; FAMILY; LOCUS; MAPS	Holt-Gram syndrome is characterized by upper limb malformations and cardiac septation defects, Here, we demonstrate that mutations in the human TBX5 gene underlie this disorder. TBX5 was cloned from the disease locus on human chromosome 12q24.1 and identified as a member of the T-box transcription factor family, A nonsense mutation in TBX5 causes Holt-Gram syndrome in affected members of one family; a TBX5 missense mutation was identified in affected members of another, We conclude that TBX5 is critical for limb and heart development and suggest that haploinsufficiency of TBX5 causes Holt-Gram syndrome.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115; JOHNS HOPKINS UNIV HOSP,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21205; ALBERT EINSTEIN COLL MED,DEPT MOL GENET,BRONX,NY 10461; BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Basson, CT (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOVASC,75 FRANCIS ST,BOSTON,MA 02115, USA.		Kucherlapati, Raju/ABC-8807-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003468] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000965] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00965] Funding Source: Medline; NHLBI NIH HHS [HL03468-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agulnik SI, 1996, GENETICS, V144, P249; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; BASSON CT, 1995, CIRCULATION, V91, P1326, DOI 10.1161/01.CIR.91.5.1326; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; BONNET D, 1994, NAT GENET, V6, P405, DOI 10.1038/ng0494-405; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; DALTON ME, 1993, NEW ENGL J MED, V328, P114; Edwards YH, 1996, GENOME RES, V6, P226, DOI 10.1101/gr.6.3.226; FOOTE S, 1996, CURRENT PROTOCOLS HU; GALL JC, 1966, AM J HUM GENET, V18, P187; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HOLT M, 1960, BRIT HEART J, V22, P236; HUANG JX, 1995, ANN NY ACAD SCI, V752, P217; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KULLMANN F, 1993, DEUT MED WOCHENSCHR, V118, P1455, DOI 10.1055/s-2008-1059473; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LEBLANCSTRACESKI JM, 1994, GENOMICS, V19, P341, DOI 10.1006/geno.1994.1067; LETTS RM, 1976, CLIN ORTHOPAEDICS, V116, P149; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; OTT J, 1976, AM J HUM GENET, V28, P528; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; PRUZNANSKI W, 1964, CARDIOLOGIA, V45, P1; Rossant J, 1996, CIRC RES, V78, P349, DOI 10.1161/01.RES.78.3.349; RUZIC B, 1981, RADIOLOGE, V21, P296; SAHN DJ, 1981, CHEST, V79, P113, DOI 10.1378/chest.79.1.113; SATOH N, 1995, TRENDS GENET, V11, P354, DOI 10.1016/S0168-9525(00)89106-4; SMITH AT, 1979, J PEDIATR-US, V95, P538, DOI 10.1016/S0022-3476(79)80758-1; STARKE H, 1967, AM J CARDIOL, V19, P588, DOI 10.1016/0002-9149(67)90436-5; STERNBERG NL, 1996, CURRENT PROTOCOLS HU; TERRETT JA, 1994, NAT GENET, V6, P401, DOI 10.1038/ng0494-401; Terrett JA, 1996, AM J HUM GENET, V59, P1337; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WESLEY CS, 1993, NUCLEIC ACIDS RES, V22, P538; ZHANG KZ, 1986, AM HEART J, V111, P572, DOI 10.1016/0002-8703(86)90066-9	45	797	816	0	366	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					30	35		10.1038/ng0197-30	http://dx.doi.org/10.1038/ng0197-30			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988165				2022-12-27	WOS:A1997WA37300017
J	Murphy, M; Stinnakre, MG; SenamaudBeaufort, C; Winston, NJ; Sweeney, C; Kubelka, M; Carrington, M; Brechot, C; SobczakThepot, J				Murphy, M; Stinnakre, MG; SenamaudBeaufort, C; Winston, NJ; Sweeney, C; Kubelka, M; Carrington, M; Brechot, C; SobczakThepot, J			Delayed early embryonic lethality following disruption of the murine cyclin A2 gene	NATURE GENETICS			English	Article							S-PHASE; MOUSE EMBRYO; CELL-CYCLE; MICE; OVEREXPRESSION; LINK; D1	In higher eukaryotes, cell cycle progression is controlled by cyclin dependent kinases (Cdks) complexed with cyclins. A-type cyclins are involved at both G1/S and G2/M transitions of the cell cycle. Cyclin A2 activates cdc2 (Cdk1) on passage into mitosis and Cdk2 at the G1/S transition(1). Antisense constructs, or antibodies directed against cyclin AZ block cultured mammalian cells at both of these transitions(2-4). In contrast, overexpression of cyclin A2 appears to advance S phase entry(5,6) and confer anchorage-independent growth(7), and can lead to apoptosis(8). A second A-type cyclin, cyclin A1 has been described recently which, in the mouse, is expressed in germ cells but not somatic tissues(9,10). To address the possible redundancy between different cyclins in vivo and also the control of early embryonic cell cycles, we undertook the targeted deletion of the murine cyclin A2 gene. The homozygous null mutant is embryonically lethal, demonstrating that the cyclin A2 gene is essential. Surprisingly, homozygous null mutant embryos develop normally until postimplantation, around day 5.5 p.c. This observation may be explained by the persistence of a maternal pool of cyclin AZ protein until at least the blastocyst stage, or an unexpected role for cyclin Al during early embryo development.	FAC MED NECKER ENFANTS MALAD,INSERM U370,F-75730 PARIS 15,FRANCE; INRA,BIOCHIM GENET LAB,JOUY EN JOSAS,FRANCE; UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND; BABRAHAM INST,CAMBRIDGE CB2 4AT,ENGLAND; ACAD SCI CZECH REPUBL,INST ANIM PHYSIOL & GENET,DEPT GENET,CR-27721 LIBECHOV,CZECH REPUBLIC	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences			Sobczak, Joelle/HHZ-5610-2022; Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018; Kubelka, Michal/G-7127-2014	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Sobczak, Joelle/0000-0001-7180-2789	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1989, SCIENCE; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; BORTNER DM, 1995, CELL GROWTH DIFFER, V6, P1579; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; Hogan B, 1994, MANIPULATING MOUSE E; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Sweeney C, 1996, DEVELOPMENT, V122, P53; THEILER K, 1989, HOUSE MOUSE; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G	20	198	205	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					83	86		10.1038/ng0197-83	http://dx.doi.org/10.1038/ng0197-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988174				2022-12-27	WOS:A1997WA37300026
J	Coin, F; Marinoni, JC; Rodolfo, C; Fribourg, S; Pedrini, AM; Egly, JM				Coin, F; Marinoni, JC; Rodolfo, C; Fribourg, S; Pedrini, AM; Egly, JM			Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH	NATURE GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR TFIIH; RNA-POLYMERASE-II; DNA HELICASE; XERODERMA-PIGMENTOSUM; SACCHAROMYCES-CEREVISIAE; RAD3 PROTEIN; KINASE; ASSOCIATION; BTF2/TFIIH	In most cases, xeroderma pigmentosum group D (XP-D) and trichothiodystrophy (TTD) patients carry mutations in the carboxy-terminal domain of the evolutionarily conserved helicase XPD, which is one of the subunits of the transcription/repair factor TFIIH (ref 1, 2). In this study, we demonstrate that XPD interacts specifically with p44, another subunit of TFIIH, and that this interaction results in the stimulation of 5' --> 3' helicase activity. Mutations in the XPD C-terminal domain, as found in most patients, prevent the interaction with p44, thus explaining the decrease in XPD helicase activity and the nucleotide excision repair (NER) defect.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Consiglio Nazionale delle Ricerche (CNR)	Egly, JM (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.		Fribourg, Sebastien/M-7418-2014; Coin, Frédéric/F-5925-2013; Rodolfo, Carlo/H-8953-2019	Fribourg, Sebastien/0000-0003-4112-7510; Coin, Frédéric/0000-0002-5620-8519; Rodolfo, Carlo/0000-0001-7087-545X	Telethon [E.0550] Funding Source: Medline	Telethon(Fondazione Telethon)		BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; Burglen L, 1997, AM J HUM GENET, V60, P72; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Evans J, 1997, INTERNET WORLD, V8, P16; GERARD M, 1991, J BIOL CHEM, V266, P20940; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; JOHNSON RT, 1985, J CELL SCI, V76, P115; LEHMANN AR, 1995, TRENDS BIOCHEM SCI, V20, P402, DOI 10.1016/S0968-0004(00)89088-X; MA LB, 1994, NUCLEIC ACIDS RES, V22, P4095, DOI 10.1093/nar/22.20.4095; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, J BIOL CHEM, V269, P9826; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; YOON H, 1992, GENE DEV, V6, P2463, DOI 10.1101/gad.6.12b.2463	27	290	302	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					184	188		10.1038/2491	http://dx.doi.org/10.1038/2491			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771713				2022-12-27	WOS:000076231300022
J	Blouin, JL; Dombroski, BA; Nath, SK; Lasseter, VK; Wolyniec, PS; Nestadt, G; Thornquist, M; Ullrich, G; McGrath, J; Kasch, L; Lamacz, M; Thomas, MG; Gehrig, C; Radhakrishna, U; Snyder, SE; Balk, KG; Neufeld, K; Swartz, KL; DeMarchi, N; Papadimitriou, GN; Dikeos, DG; Stefanis, CN; Chakravarti, A; Childs, B; Housman, DE; Kazazian, HH; Antonarakis, SE; Pulver, AE				Blouin, JL; Dombroski, BA; Nath, SK; Lasseter, VK; Wolyniec, PS; Nestadt, G; Thornquist, M; Ullrich, G; McGrath, J; Kasch, L; Lamacz, M; Thomas, MG; Gehrig, C; Radhakrishna, U; Snyder, SE; Balk, KG; Neufeld, K; Swartz, KL; DeMarchi, N; Papadimitriou, GN; Dikeos, DG; Stefanis, CN; Chakravarti, A; Childs, B; Housman, DE; Kazazian, HH; Antonarakis, SE; Pulver, AE			Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; VULNERABILITY LOCUS; GENETIC-LINKAGE; SUGGESTIVE EVIDENCE; POTENTIAL LINKAGE; FAMILIAL RISK; HUMAN GENOME; HETEROGENEITY; IDENTIFY; SUPPORT	Schizophrenia is a common disorder characterized by psychotic symptoms; diagnostic criteria have been established(1). Family, twin and adoption studies suggest that both genetic and environmental factors influence susceptibility (heritability is approximately 71%; ref. 2), however, little is known about the aetiology of schizophrenia. Clinical and family studies suggest aetiological heterogeneity(3-6). Previously, we reported that regions on chromosomes 22, 3 and 8 may be associated with susceptibility to schizophrenia(7-8), and collaborations provided some support for regions on chromosomes 8 and 22 (refs 9-13). We present here a genome-wide scan for schizophrenia susceptibility loci (SSL) using 452 microsatellite markers on 54 multiplex pedigrees. Non-parametric linkage (NPL) analysis provided significant evidence for an SSL on chromosome 13q32 (NPL score=4.18; P=0.00002), and suggestive evidence for another SSL on chromosome 8p21-22 (NPL=3.64; P=0.0001). Parametric linkage analysis provided additional support for these SSL. Linkage evidence at chromosome 8 is weaker than that at chromosome 13, so it is more probable that chromosome 8 may be a false positive linkage. Additional putative SSL were noted on chromosomes 14q13 (NPL=2.57: P=0.005), 7q11 (NPL=2.50, P=0.007) and 22q11 (NPL=2.42, P=0.009). Verification of suggestive SSL on chromosomes 13q and 8p was attempted in a follow-up sample of 54 multiplex pedigrees. This analysis confirmed the SSL in 13q14-q33 (NPL=2.36, P=0.007) and supported the SSL in 8p22-p21 (NPL=1.95, P=0.023).	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21231 USA; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Naples 2, Inst Psichiatria, I-80138 Naples, Italy; Univ Athens, Eginit Hosp, Mental Hlth Res Inst, GR-11528 Athens, Greece; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Johns Hopkins University; University of Geneva; University of Geneva; University of Pennsylvania; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Universita della Campania Vanvitelli; National & Kapodistrian University of Athens; Massachusetts Institute of Technology (MIT)	Pulver, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21231 USA.	aepulver@welchlink.welch.jhu.edu	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Neufeld, Karin/0000-0002-2395-1883; Swartz, Karen/0000-0003-0420-5823	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045588] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00722] Funding Source: Medline; NIMH NIH HHS [R01 MH-45588] Funding Source: Medline; PHS HHS [1 R01 35712] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; ANTONARAKIS SE, IN PRESS AM J MED GE; BUETOW KH, 1991, AM J HUM GENET, V49, P985; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Kendler KS, 1996, AM J PSYCHIAT, V153, P1534; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LASHER L, 1991, AM J HUM GENET, V49, P369; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; Levinson DF, 1996, AM J MED GENET, V67, P580; Lin MW, 1995, PSYCHIATR GENET, V5, P117, DOI 10.1097/00041444-199505030-00004; Lin MW, 1997, HUM GENET, V99, P417, DOI 10.1007/s004390050382; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MELTON B, 1994, GENET EPIDEMIOL, V11, P311, DOI 10.1002/gepi.1370110402; PULVER AE, 1989, GENET EPIDEMIOL, V6, P671, DOI 10.1002/gepi.1370060604; PULVER AE, 1991, GENET EPIDEMIOL, V8, P339, DOI 10.1002/gepi.1370080506; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Pulver AE, 1996, COLD SPRING HARB SYM, V61, P797; PULVER AE, 1992, BRIT J PSYCHIAT, V160, P65, DOI 10.1192/bjp.160.1.65; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; TSUANG MT, 1995, SCHIZOPHR RES, V17, P161, DOI 10.1016/0920-9964(95)00057-S; Wildenauer DB, 1996, COLD SPRING HARB SYM, V61, P845	30	426	452	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					70	73		10.1038/1734	http://dx.doi.org/10.1038/1734			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731535				2022-12-27	WOS:000075671400023
J	Woodage, T; King, SM; Wacholder, S; Hartge, P; Struewing, JP; McAdams, M; Laken, SJ; Tucker, MA; Brody, LC				Woodage, T; King, SM; Wacholder, S; Hartge, P; Struewing, JP; McAdams, M; Laken, SJ; Tucker, MA; Brody, LC			The APC 11307K allele and cancer risk in a community-based study of Ashkenazi Jews	NATURE GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; BREAST-CANCER; BETA-CATENIN; GENE; CARCINOMAS; MUTATIONS	Mutations in APC are classically associated with familial adenomatous polyposis (FAP), a highly penetrant autosomal dominant disorder characterized by multiple intestinal polyps and, without surgical intervention, the development of colorectal cancer(1) (CRC). APC is a tumour-suppressor gene, and somatic Loss occurs in tumours. The germline T-to-A transversion responsible for the APC I1307K allele converts the wild-type sequence to a homopolymer tract (A,) that is genetically unstable and prone to somatic mutation. The I1307K allele was found in 6.1% of unselected Ashkenazi Jews and higher proportions of Ashkenazim with family or personal histories of CRC (ref. 2). To evaluate the role of I1307K in cancer, we genotyped 5,081 Ashkenazi volunteers in a community survey. Risk of developing colorectal, breast and other cancers were compared between genotyped I1307K carriers and non-carriers and their first-degree relatives.	Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; Informat Management Serv Inc, Silver Spring, MD 20904 USA; Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Johns Hopkins University; Johns Hopkins Medicine	Brody, LC (corresponding author), Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.		Struewing, Jeffery P/C-3221-2008; Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/I-7502-2013	Struewing, Jeffery P/0000-0002-4848-3334				CAPORASO N, 1995, PHARMACOGENETICS, V5, pS129, DOI 10.1097/00008571-199512001-00014; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; FEUER EJ, 1997, DEVCAN PROBABILITY D; GIARDIELLO FM, 1991, J PEDIATR-US, V119, P766, DOI 10.1016/S0022-3476(05)80297-5; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; KASHIWABA M, 1994, J CANCER RES CLIN, V120, P727, DOI 10.1007/BF01194271; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; MEDEIROS AC, 1994, CANCER EPIDEM BIOMAR, V3, P331; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Nugent KP, 1996, BRIT J SURG, V83, P1121, DOI 10.1002/bjs.1800830828; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; PETERSEN GM, 1994, ANN MED, V26, P205, DOI 10.3109/07853899409147891; Petrukhin L, 1997, CANCER RES, V57, P5480; Redston M, 1998, NAT GENET, V20, P13, DOI 10.1038/1666; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; THOMPSON AM, 1993, BRIT J CANCER, V68, P64, DOI 10.1038/bjc.1993.287; WACHOLDER S, 1998, IN PRESS AM J EPIDEM	20	135	138	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					62	65		10.1038/1722	http://dx.doi.org/10.1038/1722			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731533				2022-12-27	WOS:000075671400021
J	Crosby, JR; Seifert, RA; Soriano, P; Bowen-Pope, DF				Crosby, JR; Seifert, RA; Soriano, P; Bowen-Pope, DF			Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages	NATURE GENETICS			English	Article							MOUSE CHIMERAS; DIFFERENTIATION; GROWTH; CELLS; EXPRESSION; MYOBLASTS; MICE; PROLIFERATION; DEFICIENT; FETAL	Blood vessels originate as simple endothelial cell tubes. It has been proposed that platelet-derived growth factor B polypeptide (Pdgfb) secreted by these endothelial cells drives the formation of the surrounding muscular wall by recruiting nearby mesenchymal cells(1,2). However. targetted inactivation of the Pdgfb gene(3) or the Pdgf receptor beta (Pdgfrb) gene(4), by homologous recombination, does not prevent the development of apparently normal large arteries and connective tissue. We have used an in vivo competition assay in which we prepared chimaeric blastocysts, composed of a mixture of wild-type (Pdgfrb(+/+)) and Pdgfrb(+/-) or wild-type and Pdgfrb(-/-) cells, and quantified the relative success of cells of the two component genotypes in competing for representation in different cell lineages as the chimaeric embryos developed. This study revealed that the participation of Pdgfrb(-/-) cells in all muscle lineages (smooth, cardiac, skeletal and pericyte) was reduced by eightfold compared with Pdgfrb(+/+) cells, and that participation of Pdgfrb(+/-) cells was reduced by twofold (eightfold for pericytes). Pdgfrb inactivation did not affect cell contribution to non-muscle mesodermal lineages, including fibroblasts and endothelial cells. Chimaera competition is therefore a sensitive, quantitative method for determining developmental roles of specific genes, even when those roles are not apparent from analysis of purebred mutants; most likely because they are masked by homeostatic mechanisms.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Bowen-Pope, DF (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.		Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X	NHLBI NIH HHS [HL-03174] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barrett TB, 1996, J CELL PHYSIOL, V169, P126, DOI 10.1002/(SICI)1097-4652(199610)169:1<126::AID-JCP13>3.0.CO;2-B; Deng CX, 1997, DEV BIOL, V185, P42, DOI 10.1006/dbio.1997.8553; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; HOLMGREN L, 1991, DEVELOPMENT, V113, P749; JIN P, 1993, DIFFERENTIATION, V54, P47; JIN P, 1991, J BIOL CHEM, V266, P1245; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; LO CW, 1987, DIFFERENTIATION, V35, P37, DOI 10.1111/j.1432-0436.1987.tb00149.x; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; MUSCI TS, 1992, DEV BIOL, V152, P133, DOI 10.1016/0012-1606(92)90163-B; PALMER SJ, 1991, DEVELOPMENT, V112, P265; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Smits A, 1989, GROWTH FACTORS, V2, P1, DOI 10.3109/08977198909069076; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; TERRACIO L, 1988, J CELL BIOL, V107, P1947, DOI 10.1083/jcb.107.5.1947; Topouzis S, 1996, DEV BIOL, V178, P430, DOI 10.1006/dbio.1996.0229; Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0; West JD, 1996, GENET RES, V67, P135, DOI 10.1017/S0016672300033590; WEST JD, 1984, J EMBRYOL EXP MORPH, V84, P309; WILKENS AS, 1986, GENETIC ANAL ANIMAL; YABLONKAREUVENI Z, 1990, J CELL BIOL, V111, P1623, DOI 10.1083/jcb.111.4.1623; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	26	97	98	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					385	388		10.1038/ng0498-385	http://dx.doi.org/10.1038/ng0498-385			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537425				2022-12-27	WOS:000072755500025
J	Jenne, DE; Reimann, H; Nezu, J; Friedel, W; Loff, S; Jeschke, R; Muller, D; Back, W; Zimmer, M				Jenne, DE; Reimann, H; Nezu, J; Friedel, W; Loff, S; Jeschke, R; Muller, D; Back, W; Zimmer, M			Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase	NATURE GENETICS			English	Article							CANCER; GENES; CHROMOSOME-5Q21; IDENTIFICATION; LOCUS; MAP	Peutz-Jeghers (PJ) syndrome is an autosomal-dominant disorder characterized by melanocytic macules of the lips, multiple gastrointestinal hamartomatous polyps and an increased risk for various neoplasms, including gastrointestinal cancer. The PJ gene was recently mapped to chromosome 19p13.3 by linkage analysis, with the highest lod score at marker D19S886. In a distance of 190 kb proximal to D19S886, we identified and characterized a novel human gene encoding the serine threonine kinase STK11. In a three-generation PJ family, we found an STK11 allele with a deletion of exons 4 and 5 and an inversion of exons 6 and 7 segregating with the disease. Sequence analysis of STK11 exons in four unrelated PJ patients has identified three nonsense and one acceptor splice site mutations. All five germline mutations are predicted to disrupt the function of the kinase domain, We conclude that germline mutations in STK11, probably in conjunction with acquired genetic defects of the second allele in somatic cells, cause the manifestations of PJ syndrome.	Max Planck Inst Psychiat, Dept Neuroimmunol, D-82152 Martinsried, Germany; Chugai Res Inst Mol Med, Ibaraki, Osaka 30041, Japan; Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Heidelberg, Mannheim Clin, Dept Pediat Surg, D-68135 Mannheim, Germany; Univ Wurzburg, Childrens Clin & Polyclin, D-97080 Wurzburg, Germany; Max Planck Inst Mol Physiol, Dept Biol Struct, D-44139 Dortmund, Germany; Univ Heidelberg, Mannheim Clin, Dept Pathol, D-68135 Mannheim, Germany; Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97078 Wurzburg, Germany	Max Planck Society; University of Bonn; Ruprecht Karls University Heidelberg; University of Wurzburg; Max Planck Society; Ruprecht Karls University Heidelberg; University of Wurzburg	Jenne, DE (corresponding author), Max Planck Inst Psychiat, Dept Neuroimmunol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Jenne, Dieter Erich/AAP-1414-2020	Loff, Steffan/0000-0003-4788-3181				Amos CI, 1997, CANCER RES, V57, P3653; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LOFF S, 1995, LANGENBECK ARCH CHIR, V380, P43; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; PILAT D, 1994, GENOMICS, V24, P445, DOI 10.1006/geno.1994.1651; RACKWITZ HR, 1985, GENE, V40, P259, DOI 10.1016/0378-1119(85)90048-4; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SPIGELMAN AD, 1989, GUT, V30, P1588, DOI 10.1136/gut.30.11.1588; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	19	836	887	1	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					38	44		10.1038/ng0198-38	http://dx.doi.org/10.1038/ng0198-38			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425897				2022-12-27	WOS:000071259600018
J	Kohlhase, J; Wischermann, A; Reichenbach, H; Froster, U; Engel, W				Kohlhase, J; Wischermann, A; Reichenbach, H; Froster, U; Engel, W			Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome	NATURE GENETICS			English	Article							HOMEOTIC GENE; DROSOPHILA EMBRYO; SPALT; REGION; HOMOLOG; SYSTEM; HEAD; DPP; EYE	Townes-Brocks syndrome (TBS, OMIM #107480) is a rare autosomal-dominant malformation syndrome with a combination of anal, renal, limb and ear anomalies(1), Cytogenetic findings(2) suggested that the gene mutated in TBS maps to chromosome 16q12.1, where SALL1 (previously known as HSAL1), a human homologue of spalt (sal), is located(3). SAL is a developmental regulator in Drosophila melanogaster(4-8) and is conserved throughout evolution(3,9-11). No phenotype has yet been attributed to mutations in vertebrate sal-like genes. The expression patterns of sal-like genes in mouse(9), Xenopus(10) and the fish Medaka(11), and the finding that Medaka sal is regulated by Sonic hedgehog (Shh; ref. 11), prompted us to examine SALL1 as a TBS candidate gene. Here we demonstrate that SALL1 mutations cause TBS in a family with vertical transmission of TBS12 and in an unrelated family with a sporadic case of TBS. Both mutations are predicted to result in a prematurely terminated SALL1 protein lacking all putative DNA binding domains. TBS therefore represents another human developmental disorder caused by mutations in a putative C2H2 zinc-finger transcription factor.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Kinderkrankenhaus, Kinderchirurg Klin, D-50735 Cologne, Germany; Univ Leipzig Klinikum, Inst Human Genet, D-04103 Leipzig, Germany	University of Gottingen; Leipzig University	Kohlhase, J (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-37073 Gottingen, Germany.							CAMERON TH, 1991, AM J MED GENET, V41, P1, DOI 10.1002/ajmg.1320410102; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DEPINANETO JM, 1984, AM J MED GENET, V18, P147, DOI 10.1002/ajmg.1320180118; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; FERRAZ FG, 1989, ANN GENET-PARIS, V32, P120; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Ishikiriyama S, 1996, AM J MED GENET, V61, P191, DOI 10.1002/ajmg.1320610203; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koster R, 1997, DEVELOPMENT, V124, P3147; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Newman WG, 1997, CLIN DYSMORPHOL, V6, P57; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; ROSSMILLER DR, 1994, OTOLARYNG HEAD NECK, V111, P175, DOI 10.1016/S0194-5998(94)70588-7; Serville F., 1993, Genetic Counseling, V4, P109; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tickle C, 1996, DEV GENET, V19, P1, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;1::AID-DVG1&gt;3.0.CO;2-D; TOWNES PL, 1972, J PEDIATR-US, V81, P321, DOI 10.1016/S0022-3476(72)80302-0; Valentini RP, 1997, J BIOL CHEM, V272, P8466, DOI 10.1074/jbc.272.13.8466; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wischermann A, 1997, MONATSSCHR KINDERH, V145, P382, DOI 10.1007/s001120050137	28	317	332	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					81	83		10.1038/ng0198-81	http://dx.doi.org/10.1038/ng0198-81			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425907				2022-12-27	WOS:000071259600028
J	Everett, LA; Glaser, B; Beck, JC; Idol, JR; Buchs, A; Heyman, M; Adawi, F; Hazani, E; Nassir, E; Baxevanis, AD; Sheffield, VC; Green, ED				Everett, LA; Glaser, B; Beck, JC; Idol, JR; Buchs, A; Heyman, M; Adawi, F; Hazani, E; Nassir, E; Baxevanis, AD; Sheffield, VC; Green, ED			Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)	NATURE GENETICS			English	Article							HORMONE RECEPTOR-BETA; CONGENITAL CHLORIDE DIARRHEA; PROTEIN-CODING REGIONS; THYROID-HORMONE; HUMAN GENOME; WAARDENBURG SYNDROME; HEARING-LOSS; SEQUENCE; LINKAGE; MAPS	Pendred syndrome is a recessively inherited disorder with the hallmark features of congenital deafness and thyroid goitre, By some estimates, the disorder may account for upwards of 10% of hereditary deafness, Previous genetic linkage studies localized the gene to a broad interval on human chromosome 7q22-31.1. Using a positional cloning strategy, we have identified the gene (PDS) mutated in Pendred syndrome and found three apparently deleterious mutations, each segregating with the disease in the respective families in which they occur. PDS produces a transcript of approximately 5 kb that was found to be expressed at significant levels only in the thyroid. The predicted protein, pendrin, is closely related to a number of known sulphate transporters. These studies provide compelling evidence that defects in pendrin cause Pendred syndrome thereby launching a new area of investigation into thyroid physiology, the pathogenesis of congenital deafness and the role of altered sulphate transport in human disease.	NATL HUMAN GENOME RES INST, GENOME TECHNOL BRANCH, NIH, BETHESDA, MD 20892 USA; HADASSAH UNIV HOSP, DEPT ENDOCRINOL & METAB, IL-91120 JERUSALEM, ISRAEL; UNIV IOWA, DEPT PEDIAT, DIV MED GENET, IOWA CITY, IA 52242 USA; RIVKA ZEEV HOSP, DEPT ENDOCRINOL, IL-16950 ZAFAD, ISRAEL; WESTERN GALILEE NAHARIYA HOSP, DEPT INTERNAL MED, IL-22100 NAHARIYYA, ISRAEL	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hebrew University of Jerusalem; University of Iowa; Western Galilee Hospital			Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000; Sheffield, Val/0000-0002-6282-0835; Baxevanis, Andy/0000-0002-5370-0014	NHGRI NIH HHS [R01-HG00457] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BATSAKIS JG, 1962, ARCHIV OTOLARYNGOL, V76, P401; BAUMEISTER FAM, 1988, CELL TISSUE RES, V252, P349; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1; Boguski M, 1996, GENOME RES, V6, P771, DOI 10.1101/gr.6.9.771; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Bouffard GG, 1997, GENOME RES, V7, P59, DOI 10.1101/gr.7.1.59; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; Byeon MK, 1996, ONCOGENE, V12, P387; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Coucke P, 1997, GENOMICS, V40, P48, DOI 10.1006/geno.1996.4541; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; DEOL MS, 1973, J MED GENET, V10, P235, DOI 10.1136/jmg.10.3.235; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; FRASER GR, 1965, ANN HUM GENET, V28, P201; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gausden E, 1997, J MED GENET, V34, P126, DOI 10.1136/jmg.34.2.126; George DG, 1997, NUCLEIC ACIDS RES, V25, P24, DOI 10.1093/nar/25.1.24; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GREEN ED, 1995, GENOMICS, V25, P170, DOI 10.1016/0888-7543(95)80123-4; GREEN ED, 1991, GENOMICS, V11, P548, DOI 10.1016/0888-7543(91)90062-J; GREEN ED, 1994, HUM MOL GENET, V3, P489, DOI 10.1093/hmg/3.3.489; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HERZOG V, 1986, EUR J CELL BIOL, V39, P399; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Hoglund P, 1996, GENOME RES, V6, P202, DOI 10.1101/gr.6.3.202; ILLUM P, 1972, ARCHIV OTOLARYNGOL, V96, P297; JOHNSEN T, 1986, ACTA OTO-LARYNGOL, V102, P239, DOI 10.3109/00016488609108673; JOHNSEN T, 1989, CLIN OTOLARYNGOL, V14, P395, DOI 10.1111/j.1365-2273.1989.tb00392.x; JOHNSEN T, 1987, J LARYNGOL OTOL, V101, P1187, DOI 10.1017/S0022215100103470; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; MARRA MA, IN PRESS GENOME RES; Mondini C., 1791, BONONIAE, V7, P419; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; OMALLEY BW, 1995, HEARING RES, V88, P181, DOI 10.1016/0378-5955(95)00111-G; Pendred V, 1896, LANCET, V148, P532, DOI [DOI 10.1016/S0140-6736(01)74403-0, 10.1016/S0140-6736(01)74403-0]; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Reardon W, 1996, J MED GENET, V33, P1037, DOI 10.1136/jmg.33.12.1037; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; ROST B, 1995, PROTEIN SCI, V4, P521; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; Stoesser G, 1997, NUCLEIC ACIDS RES, V25, P7, DOI 10.1093/nar/25.1.7; TAKEDA K, 1991, J CLIN INVEST, V87, P496, DOI 10.1172/JCI115023; TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P49, DOI 10.1210/jc.74.1.49; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TROTTER WR, 1960, BRIT MED BULL, V16, P92, DOI 10.1093/oxfordjournals.bmb.a069828; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; UZIEL A, 1981, ACTA OTO-LARYNGOL, V92, P469, DOI 10.3109/00016488109133286; VanCamp G, 1997, AM J HUM GENET, V60, P758; VANMIDDLESWORTH L, 1980, ENDOCRINOLOGY, V106, P1686, DOI 10.1210/endo-106-6-1686; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Xu Y, 1994, Genet Eng (N Y), V16, P241; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649	74	871	974	2	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1997	17	4					411	422		10.1038/ng1297-411	http://dx.doi.org/10.1038/ng1297-411			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398842	Green Published			2022-12-27	WOS:A1997YJ92400021
J	Jansen, G; Hazendonk, E; Thijssen, KL; Plasterk, RHA				Jansen, G; Hazendonk, E; Thijssen, KL; Plasterk, RHA			Reverse genetics by chemical mutagenesis in Caenorhabditis elegans	NATURE GENETICS			English	Letter							SEQUENCE; GENES	Traditional reverse genetics on yeast, mice and other organisms a uses homologous recombination with transgenic DNA to interrupt a target gene. Here we report that target-selected gene inactivation can be achieved in Caenorhabditis elegans with the use of chemical mutagens, We use PCR to selectively visualize deletions in genes of interest; the method is sensitive enough to permit detection of a single mutant among more than 15,000 wild types. A permanent frozen mutant collection of more than a million mutagenized animals has been established, and deletion mutants of several G-protein genes were isolated from it. The approach is suitable to be scaled up for systematic inactivation of all 17,000 C. elegans genes. Because it requires no transgenesis or cell culturing, it may also be applicable to small organisms usually considered to be outside the realm of reverse genetics (for example, other nematodes and insects), Any sequenced gene in any organism that can be handled in Very large numbers can possibly be targeted in this way.	NETHERLANDS CANC INST,DIV MOL BIOL,NL-1066 CX AMSTERDAM,NETHERLANDS	Netherlands Cancer Institute			Jansen, Gert/HCI-8852-2022	Jansen, Gert/0000-0002-7524-171X	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR010082] Funding Source: NIH RePORTER; NCRR NIH HHS [5R01 RR10082] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anderson P, 1995, METHOD CELL BIOL, V48, P31; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; Sambrook J., 2002, MOL CLONING LAB MANU; SMITH V, 1995, P NATL ACAD SCI USA, V92, P6479, DOI 10.1073/pnas.92.14.6479; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Sulston J., 1988, NEMATODE CAENORHABDI, P587; VANLUENEN HGAM, 1994, NUCLEIC ACIDS RES, V22, P262, DOI 10.1093/nar/22.3.262; WATERSTON R, 1995, P NATL ACAD SCI USA, V92, P10836, DOI 10.1073/pnas.92.24.10836; YANDELL MD, 1994, P NATL ACAD SCI USA, V91, P1381, DOI 10.1073/pnas.91.4.1381; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	10	230	252	2	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					119	121		10.1038/ng0997-119	http://dx.doi.org/10.1038/ng0997-119			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288111				2022-12-27	WOS:A1997XU72400031
J	Laken, SJ; Petersen, GM; Gruber, SB; Oddoux, C; Ostrer, H; Giardiello, FM; Hamilton, SR; Hampel, H; Markowitz, A; Klimstra, D; Jhanwar, S; Winawer, S; Offit, K; Luce, MC; Kinzler, KW; Vogelstein, B				Laken, SJ; Petersen, GM; Gruber, SB; Oddoux, C; Ostrer, H; Giardiello, FM; Hamilton, SR; Hampel, H; Markowitz, A; Klimstra, D; Jhanwar, S; Winawer, S; Offit, K; Luce, MC; Kinzler, KW; Vogelstein, B			Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC	NATURE GENETICS			English	Letter							POLYPOSIS-COLI GENE; ADENOMATOUS POLYPOSIS; MUTATIONS; SUSCEPTIBILITY; LESSONS; RISK	Approximately 130,000 cases of colorectal cancer (CRC) are a diagnosed in the United States each year(1), and about 15% of have a hereditary component(2,3). Two well-defined syndromes, familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC), account for up to 5% of the total new cases of CRC4. Truncating APC mutations are responsible for FAP(5,6), and defective mismatch repair genes cause HNPCC4,7,8. However, the genes responsible for most of the familial cases are unknown. Here we report a mutation (T to A at APC nucleotide 3920) found in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of CRC. Rather than altering the function of the encoded protein, this mutation creates a small hypermutable region of the gene, indirectly causing cancer predisposition.	JOHNS HOPKINS ONCOL CTR, BALTIMORE, MD 21231 USA; JOHNS HOPKINS SCH PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA; NYU, MED CTR, DEPT PEDIAT, HUMAN GENET PROGRAM, NEW YORK, NY 10016 USA; JOHNS HOPKINS UNIV HOSP, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV HOSP, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA; MEM SLOAN KETTERING CANC CTR, DEPT HUMAN GENET, CLIN GENET SERV, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT MED, SERV GASTROENTEROL & NUTR, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT PATHOL, SURG PATHOL SERV, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT HUMAN GENET, CYTOGENET SERV, NEW YORK, NY 10021 USA; LAB CORP AMER, RES TRIANGLE PK, NC 27709 USA; HOWARD HUGHES MED INST, BALTIMORE, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; New York University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute					NCI NIH HHS [CA62924, CA63722, CA43460] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043460, P50CA062924, R37CA043460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAT L, 1986, CANCER-AM CANCER SOC, V58, P1167, DOI 10.1002/1097-0142(19860901)58:5<1167::AID-CNCR2820580532>3.0.CO;2-R; BURT RW, 1996, FAMILIAL COLORECTAL, P171; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; GREENWALD P, 1975, CANCER RES, V35, P3507; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hall NR, 1996, DIS COLON RECTUM, V39, P739, DOI 10.1007/BF02054437; HOULSTON RS, 1992, ANN HUM GENET, V56, P99, DOI 10.1111/j.1469-1809.1992.tb01136.x; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; KUNE S, 1986, INT J EPIDEMIOL, V15, P483, DOI 10.1093/ije/15.4.483; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; Minnick DT, 1996, CANCER SURV, V28, P3; MIYAKI M, 1994, CANCER RES, V54, P3011; MULLER H, 1994, CLIN GENET, V46, P106; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204; 1997, CA CANC J CLIN, V47, P5	25	480	493	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					79	83		10.1038/ng0997-79	http://dx.doi.org/10.1038/ng0997-79			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288102				2022-12-27	WOS:A1997XU72400022
J	Vorechovsky, I; Luo, LP; Dyer, MJS; Catovsky, D; Amlot, PL; Yaxley, JC; Foroni, L; Hammarstrom, L; Webster, ADB; Yuille, MAR				Vorechovsky, I; Luo, LP; Dyer, MJS; Catovsky, D; Amlot, PL; Yaxley, JC; Foroni, L; Hammarstrom, L; Webster, ADB; Yuille, MAR			Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia	NATURE GENETICS			English	Letter							ATM GENE; PROLYMPHOCYTIC LEUKEMIA; CANCER; FAMILIES; PATIENT	Ataxia-telangiectasia (A-T) is a recessive multi-system disorder caused by mutations in the ATM gene(1,2) at 11q22-q23 (ref. 3). The risk of cancer, especially lymphoid neoplasias, is substantially elevated in A-T patients(4) and has long been associated with chromosomal instability(5), By analysing tumour DMA from patients with sporadic T-cell prolymphocytic leukaemia (T-PLL), a rare clonal malignancy with similarities to a mature T-cell leukaemia seen in A-T-6,T-7, We demonstrate a high frequency of ATM mutations in T-PLL. In marked contrast to the ATM mutation pattern in A-T, the most frequent nucleotide changes in this leukaemia were missense mutations. These clustered in the region corresponding to the kinase domain, which is highly conserved in ATM-related proteins in mouse, yeast and Drosophila. The resulting amino-acid substitutions are predicted to interfere with ATP binding or substrate recognition. Two of seventeen mutated T-PLL samples had a previously reported A-T allele. In contrast, no mutations were detected in the p53 gene, suggesting that this tumour suppressor is not frequently altered in this leukaemia. Occasional missense mutations in ATM were also found in tumour DNA from patients with B-cell non-Hodgkin's lymphomas (B-NHL) and a B-NHL cell line. The evidence of a significant proportion of loss-of-function mutations and a complete absence of the normal copy of ATM in the majority of mutated tumours establishes somatic inactivation of this gene in the pathogenesis of sporadic T-PLL and suggests that ATM acts as a tumour suppressor. As constitutional DNA was not available, a putative hereditary predisposition to T-PLL will require further investigation.	UNIV LONDON,ROYAL FREE HOSP,SCH MED,LONDON NW3 2PF,ENGLAND; INST CANC RES,SUTTON SM2 5NG,SURREY,ENGLAND	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; Institute of Cancer Research - UK	Vorechovsky, I (corresponding author), KAROLINSKA INST,NOVUM,DEPT BIOSCI,CTR BIOTECHNOL,S-14157 HUDDINGE,SWEDEN.		Dyer, Martin/F-2691-2014	Dyer, Martin/0000-0002-5033-2236				Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baumer A, 1996, HUM GENET, V98, P246, DOI 10.1007/s004390050202; BRITOBABAPULLE V, 1991, CANCER GENET CYTOGEN, V55, P1, DOI 10.1016/0165-4608(91)90228-M; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HECHT F, 1966, LANCET, V2, P1193; Jadayel DM, 1997, LEUKEMIA, V11, P64, DOI 10.1038/sj.leu.2400555; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lakin ND, 1996, ONCOGENE, V13, P2707; McConville CM, 1996, AM J HUM GENET, V59, P320; RUSSO G, 1989, P NATL ACAD SCI USA, V86, P602, DOI 10.1073/pnas.86.2.602; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1986, INT J CANCER, V37, P511, DOI 10.1002/ijc.2910370407; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Telatar M, 1996, AM J HUM GENET, V59, P40; Vorechovsky I, 1996, CANCER RES, V56, P4130; Vorechovsky I, 1996, EUR J HUM GENET, V4, P352; Vorechovsky I, 1996, CANCER RES, V56, P2726; Wright J, 1996, AM J HUM GENET, V59, P839; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; ZECH L, 1983, INT J CANCER, V32, P431, DOI 10.1002/ijc.2910320406	30	225	228	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					96	99		10.1038/ng0997-96	http://dx.doi.org/10.1038/ng0997-96			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288106				2022-12-27	WOS:A1997XU72400026
J	Smith, DJ; Stevens, ME; Sudanagunta, SP; Bronson, RT; Makhinson, M; Watabe, AM; ODell, TJ; Fung, J; Weier, HUG; Cheng, JF; Rubin, EM				Smith, DJ; Stevens, ME; Sudanagunta, SP; Bronson, RT; Makhinson, M; Watabe, AM; ODell, TJ; Fung, J; Weier, HUG; Cheng, JF; Rubin, EM			Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down's syndrome	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; GAMMA-MUTANT MICE; CGMP-PHOSPHODIESTERASE; BETA-SUBUNIT; RD MOUSE; HIPPOCAMPAL; GENE; GENERATION; DISRUPTION; DEFICITS	Using Down syndrome as a model for complex trait analysis, we sought to identify loci from chromosome 21q22.2 which, when present in an extra dose, contribute to learning abnormalities. We generated low-copy-number transgenic mice, containing four different yeast artificial chromosomes (YACs) that together cover approximately 2 megabases (Mb) of contiguous DNA from 21q22.2. We subjected independent lines derived from each of these YAC transgenes to a series of behavioural and learning assays. Two of the four YACs caused defects in learning and memory in the transgenic animals, while the other two YACs had no effect. The most severe defects were caused by a 570-kb YAC; the interval responsible for these defects was narrowed to a 180-kb critical region as a consequence of YAC fragmentation, This region contains the human homologue of a Drosophila gene, minibrain, and strongly implicates it in learning defects associated with Down syndrome.	UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,CTR HUMAN GENOME,BERKELEY,CA 94720; TUFTS UNIV,SCH MED,USDA,HUMAN NUTR RES CTR AGING,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; JACKSON LAB,BAR HARBOR,ME 04609; UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,BRAIN RES INST,LOS ANGELES,CA 90024	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tufts University; United States Department of Agriculture (USDA); Tufts University; Jackson Laboratory; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				Cheng, Jan-Fang/0000-0001-7315-7613	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018574] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL18574] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; CHENG JF, 1994, GENOMICS, V23, P75, DOI 10.1006/geno.1994.1461; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Epstein C J, 1993, Prog Clin Biol Res, V384, P1; FILIPPI M, 1990, GENOMICS, V7, P453, DOI 10.1016/0888-7543(90)90184-V; GUIREMA J, 1996, HUM MOL GENET, V5, P1305; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; JOHNSTON MV, 1995, NEUROPEDIATRICS, V26, P119, DOI 10.1055/s-2007-979740; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lupski JR, 1996, AM J HUM GENET, V58, P21; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Ohira M, 1997, GENOME RES, V7, P47, DOI 10.1101/gr.7.1.47; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PETERSON A, 1994, HUM MOL GENET, V3, P1735, DOI 10.1093/hmg/3.10.1735; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SMITH DJ, 1995, GENOMICS, V27, P425, DOI 10.1006/geno.1995.1073; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; TONIOLO D, 1988, P NATL ACAD SCI USA, V85, P851, DOI 10.1073/pnas.85.3.851; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WEIER HU, 1994, METHOD MOL CELL BIOL, V4, P231; WEIER HUG, 1995, HUM MOL GENET, V4, P1903	46	248	254	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					28	36		10.1038/ng0597-28	http://dx.doi.org/10.1038/ng0597-28			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140392				2022-12-27	WOS:A1997WX02400019
J	Chang, CC; Lee, WH; Moser, H; Valle, D; Gould, SJ				Chang, CC; Lee, WH; Moser, H; Valle, D; Gould, SJ			Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TARGETING SIGNAL; PROTEIN; MUTATIONS; THIOLASE; MEMBER; IMPORT	The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous diseases lethal in early infancy(1). Although the clinical features of PBD patients may vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins. This cellular phenotype is shared by yeast per mutants, and human orthologues of yeast PEX genes have been shown to be defective in some groups of PBD patients(2,3). We identified a putative human orthologue of ScPEX12 by screening the database of expressed sequence tags for cDNAs capable of encoding a protein similar to yeast Pex12p(4). Although its sequence similarity to yeast Pex12 proteins was limited. PEX12 shared the same subcellular distribution as yeast Pex12p and localized to the peroxisome membrane. PEX12 expression restored peroxisomal protein import in fibroblasts from PBD patients of complement group 3 (CG3) and frameshift mutations in PEX12 were detected in two unrelated CG3 patients. These data demonstrate that mutations in PEX12 are responsible for CG3 of the PBD and that PEX12 plays an essential role in peroxisomal matrix protein import.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ANAT & CELL BIOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University				Chang, Chia-Che/0000-0003-3509-3713	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10981] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Kalish JE, 1996, EMBO J, V15, P3275, DOI 10.1002/j.1460-2075.1996.tb00692.x; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MOTLEY A, 1994, J CELL BIOL, V125, P735; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	19	121	123	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					385	388		10.1038/ng0497-385	http://dx.doi.org/10.1038/ng0497-385			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090384				2022-12-27	WOS:A1997WQ38900017
J	Simon, MP; Pedeutour, F; Sirvent, N; Grosgeorge, J; Minoletti, F; Coindre, JM; TerrierLacombe, MJ; Mandahl, N; Craver, RD; Blin, N; Sozzi, G; TurcCarel, C; OBrien, KP; Kedra, D; Fransson, I; Guilbaud, C; Dumanski, JP				Simon, MP; Pedeutour, F; Sirvent, N; Grosgeorge, J; Minoletti, F; Coindre, JM; TerrierLacombe, MJ; Mandahl, N; Craver, RD; Blin, N; Sozzi, G; TurcCarel, C; OBrien, KP; Kedra, D; Fransson, I; Guilbaud, C; Dumanski, JP			Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma	NATURE GENETICS			English	Article							SIMIAN SARCOMA-VIRUS; SIS; CHROMOSOME-17; TRANSLOCATION; EXPRESSION; SEQUENCES; CONTIG; REGION; LOCUS; RANGE	Dermatofibrosarcoma protuberans (DP), an infiltrative skin tumour of intermediate malignancy(1). presents specific features such as reciprocal translocations t(17;22)(q22;q13) and supernumerary ring chromosomes derived from the t(17;22)(2,3). In this report, the breakpoints from translocations and rings in DP and its juvenile form. giant cell fibroblastoma (GCF)(4.5), were characterised on the genomic and RNA level. These rearrangements fuse the platelet-derived growth factor B-chain (PDGFB, c-sis proto-oncogene) and the collagen type I alpha 1 (COL1A1) genes. PDGFB has transforming activity and is a potent mitogen for a number of cell types. but its role in oncogenic processes is not fully understood(6,7). COL1A1 is a major constituent of the connective tissue matrix(8). Neither PDGFB nor COL1A1 have so far been implicated in any tumour translocations. These gene fusions delete exon 1 of PDGFB, and release this growth factor from its normal regulation.	FAC MED NICE,CNRS URA 1462,LAB GENET CHROMOSOM TUMEURS,F-06107 NICE 02,FRANCE; IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,I-20133 MILAN,ITALY; INST BERGONIE,ANAT PATHOL LAB,F-33076 BORDEAUX,FRANCE; INST GUSTAVE ROUSSY,LAB HISTOPATHOL A,F-94905 VILLEJUIF,FRANCE; UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN; NEW ORLEANS CHILDRENS HOSP,DEPT PATHOL,NEW ORLEANS,LA 70118; UNIV TUBINGEN,ABT MOL GENET,D-72074 TUBINGEN,GERMANY; KAROLINSKA HOSP,CLIN GENET UNIT,DEPT MOL MED,S-17176 STOCKHOLM,SWEDEN	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Fondazione IRCCS Istituto Nazionale Tumori Milan; UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; Lund University; Skane University Hospital; Children's Hospital of New Orleans; Eberhard Karls University of Tubingen; Karolinska Institutet; Karolinska University Hospital			Kedra, Darek/H-7641-2012; SIMON, Marie-Pierre/B-8017-2012; sozzi, gabriella/G-8259-2011	Kedra, Darek/0000-0002-9723-4465; sozzi, gabriella/0000-0001-9360-6914; Dumanski, Jan Piotr/0000-0002-1489-1452				BLIN N, 1993, CANCER GENET CYTOGEN, V70, P108, DOI 10.1016/0165-4608(93)90177-N; CHU ML, 1993, CONNECTIVE TISSUE IT; COLLINS JE, 1995, NATURE, V377, P367; CRAVER RD, 1995, CANCER GENET CYTOGEN, V80, P20, DOI 10.1016/0165-4608(94)00152-2; DalCin P, 1996, GENE CHROMOSOME CANC, V15, P73; DIRKS RPH, 1993, EUR J BIOCHEM, V216, P487, DOI 10.1111/j.1432-1033.1993.tb18167.x; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Enzinger FM, 1995, SOFT TISSUE TUMORS, V3rd; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; JEFFREYS AJ, 1984, NUCLEIC ACIDS RES, V12, P3235, DOI 10.1093/nar/12.7.3235; Kedra D, 1996, HUM MOL GENET, V5, P625, DOI 10.1093/hmg/5.5.625; KIKUCHI K, 1993, BIOCHEM BIOPH RES CO, V196, P409, DOI 10.1006/bbrc.1993.2264; MINOLETTI F, 1995, GENE CHROMOSOME CANC, V13, P62, DOI 10.1002/gcc.2870130110; PDEUTOUR F, 1996, CELL GENET, V72, P171; PEDEUTOUR F, 1995, CANCER RES, V55, P2400; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; RATNER L, 1985, NUCLEIC ACIDS RES, V13, P5007, DOI 10.1093/nar/13.14.5007; RAYNAUD SD, 1993, GENE CHROMOSOME CANC, V8, P80, DOI 10.1002/gcc.2870080204; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; ROYCE PM, 1993, CONNECTIVE TISSUE IT, P1; Sambrook J., 2002, MOL CLONING LAB MANU; SMITS A, 1992, AM J PATHOL, V140, P639; Soenen V, 1996, GENE CHROMOSOME CANC, V15, P191, DOI 10.1002/(SICI)1098-2264(199603)15:3<191::AID-GCC9>3.0.CO;2-Y; Staden R, 1994, Methods Mol Biol, V25, P9; VANDENOUWELAND AMW, 1985, BIOCHIM BIOPHYS ACTA, V825, P140, DOI 10.1016/0167-4781(85)90097-1; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Westermark B, 1993, CYTOKINES, V5, P1; XIE YG, 1993, HUM MOL GENET, V2, P1361; YAN XQ, 1994, ONCOGENE, V9, P163	30	367	387	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					95	98		10.1038/ng0197-95	http://dx.doi.org/10.1038/ng0197-95			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988177				2022-12-27	WOS:A1997WA37300029
J	Liyanage, M; Coleman, A; duManoir, S; Veldman, T; McCormack, S; Dickson, RB; Barlow, C; WynshawBoris, A; Janz, S; Wienberg, J; FergusonSmith, MA; Schrock, E; Ried, T				Liyanage, M; Coleman, A; duManoir, S; Veldman, T; McCormack, S; Dickson, RB; Barlow, C; WynshawBoris, A; Janz, S; Wienberg, J; FergusonSmith, MA; Schrock, E; Ried, T			Multicolour spectral karyotyping of mouse chromosomes	NATURE GENETICS			English	Article							TUMORIGENESIS; MODELS; MICE		NIH,DIAGNOST DEV BRANCH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; NIH,LAB GENET DIS RES,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; NCI,GENET LAB,NIH,BETHESDA,MD 20892; GEORGETOWN UNIV,LOMBARDI CANC CTR,WASHINGTON,DC 20057; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1TN,ENGLAND	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; University of Cambridge			du manoir, stan p/O-8677-2017	du manoir, stan p/0000-0002-2200-2651	NCI NIH HHS [1P50CA58185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058185] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 1996, ONCOGENE, V13, P757; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CARDIFF RD, 1993, CANCER SURV, V16, P97; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; KASTAN MB, 1993, NAT GENET, V5, P207, DOI 10.1038/ng1193-207; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Malik Z, 1996, J MICROSC-OXFORD, V182, P133, DOI 10.1046/j.1365-2818.1996.131411.x; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; RABBITTS P, 1995, NAT GENET, V9, P369, DOI 10.1038/ng0495-369; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Telenius H, 1992, GENE CHROMOSOME CANC, V4, P267	15	236	245	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					312	315		10.1038/ng1196-312	http://dx.doi.org/10.1038/ng1196-312			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896561				2022-12-27	WOS:A1996VQ14600026
J	Liu, J; Aoki, M; Illa, I; Wu, CY; Fardeau, M; Angelini, C; Serrano, C; Urtizberea, JA; Hentati, F; Ben Hamida, M; Bohlega, S; Culper, EJ; Amato, AA; Bossie, K; Oeltjen, T; Bejaoui, K; McKenna-Yasek, D; Hosler, BA; Schurr, E; Arahata, K; de Jong, PJ; Brown, RH				Liu, J; Aoki, M; Illa, I; Wu, CY; Fardeau, M; Angelini, C; Serrano, C; Urtizberea, JA; Hentati, F; Ben Hamida, M; Bohlega, S; Culper, EJ; Amato, AA; Bossie, K; Oeltjen, T; Bejaoui, K; McKenna-Yasek, D; Hosler, BA; Schurr, E; Arahata, K; de Jong, PJ; Brown, RH			Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy	NATURE GENETICS			English	Article							FERTILIZATION-DEFECTIVE MUTANTS; HUMAN GENOME; CAENORHABDITIS-ELEGANS; CHROMOSOME 2P; SPERM; LOCUS; CYTOSKELETON; PROTEINS; DOMAINS; DOC2	Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that we have mapped to human chromosome 2p13. We recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig spanning the MM candidate region. This clarified the order of genetic markers across the MM locus, provided five new polymorphic markers within it and narrowed the locus to approximately 2 Mb. Five skeletal muscle expressed sequence tags (ESTs) map in this region. We report that one of these is located in a novel, full-length 6.9-kb muscle cDNA, and we designate the corresponding protein 'dysferlin'. We describe nine mutations in the dysferlin gene in nine families; five are predicted to prevent dysferlin expression. Identical mutations in the dysferlin gene can produce more than one myopathy phenotype (MM, limb girdle dystrophy, distal myopathy with anterior tibial onset).	Day Neuromuscular Res Lab, Charlestown, MA 02129 USA; UAB, Hosp St Pau, Dept Neurol, Neuromuscular Dis Sect, Barcelona, Spain; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Hop La Pitie Salpetriere, Assoc Francaise Myopathies, Inst Myol, F-75651 Paris 13, France; Univ Padua, Dept Neurol, Neuromuscular Ctr, I-35128 Padua, Italy; Serv Neurol, Tunis, Tunisia; King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; Univ Texas, Hlth Sci Ctr, Dept Med Neurol, San Antonio, TX 78284 USA; Montreal Gen Hosp, Res Inst, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; NCNP, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan	Autonomous University of Barcelona; Roswell Park Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Padua; King Faisal Specialist Hospital & Research Center; University of Texas System; University of Texas Health San Antonio; McGill University; National Center for Neurology & Psychiatry - Japan	Brown, RH (corresponding author), Day Neuromuscular Res Lab, Room 6627,Bldg 149,13th St,Navy Yard, Charlestown, MA 02129 USA.	brown@helix.mgh.harvard.edu	Angelini, Corrado I/J-3655-2019; ILLA, Isabel/AAD-1816-2019	Angelini, Corrado I/0000-0002-9554-8794; Serrano Munuera, Carmen/0000-0003-3551-8240	NIA NIH HHS [5PO1AG12992] Funding Source: Medline; NINDS NIH HHS [5PO1NS31248] Funding Source: Medline; PHS HHS [5RO1N834913A] Funding Source: Medline; Telethon [552] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012992] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Achanzar WE, 1997, J CELL SCI, V110, P1073; Aoki M, 1998, ANN NEUROL, V43, P645, DOI 10.1002/ana.410430514; ARGON Y, 1980, GENETICS, V96, P413; Bashir R, 1996, GENOMICS, V33, P46, DOI 10.1006/geno.1996.0157; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bejaoui K, 1998, NEUROGENETICS, V1, P189, DOI 10.1007/s100480050028; Benes V, 1997, BIOTECHNIQUES, V23, P98, DOI 10.2144/97231bm21; Bonnemann Carsten G., 1996, Current Opinion in Pediatrics, V8, P569; Brown RH, 1997, ANNU REV MED, V48, P457, DOI 10.1146/annurev.med.48.1.457; GASTIER JM, 1995, HUM MOL GENET, V4, P1829, DOI 10.1093/hmg/4.10.1829; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Hoffman EP, 1996, BRAIN PATHOL, V6, P49, DOI 10.1111/j.1750-3639.1996.tb00782.x; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Illarioshkin SN, 1997, GENOMICS, V42, P345, DOI 10.1006/geno.1997.4725; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Liu J, 1998, GENOMICS, V49, P23, DOI 10.1006/geno.1998.5204; MIYOSHI K, 1986, BRAIN, V109, P31, DOI 10.1093/brain/109.1.31; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; SAMBROOK J, 1989, MOL CLONING LIB MANU; SCHON EA, J BIOENEG BIOMEMBR, V29, P131; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; Weiler T, 1996, AM J HUM GENET, V59, P872	35	626	650	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					31	36		10.1038/1682	http://dx.doi.org/10.1038/1682			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731526				2022-12-27	WOS:000075671400014
J	Di Cristofano, A; Pesce, B; Cordon-Cardo, C; Pandolfi, PP				Di Cristofano, A; Pesce, B; Cordon-Cardo, C; Pandolfi, PP			Pten is essential for embryonic development and tumour suppression	NATURE GENETICS			English	Article							STEM-CELL DIFFERENTIATION; LHERMITTE-DUCLOS DISEASE; YOLK-SAC; MOUSE; GENE; MXI1; DISRUPTION; 10Q24-Q25; DEATH; LINES	The PTEN gene encodes a dual-specificity phosphatase mutated in a variety of human cancers. PTEN germline mutations are found in three related human autosomal dominant disorders, Cowden disease (CD), Lhermitte-Duclos disease (LDD) and Bannayan-Zonana syndrome (BZS), characterized by tumour susceptibility and developmental defects. To examine the role of PTEN in ontogenesis and tumour suppression, we disrupted mouse PTEN by homologous recombination. Pten inactivation resulted in early embryonic lethality. Pten(-/-) ES cells formed aberrant embryoid bodies and displayed an altered ability to differentiate into endodermal, ectodermal and mesodermal derivatives. Pten(+/-) mice and chimaeric mice derived from Pten(+/-) ES cells showed hyperplastic-dysplastic changes in the prostate, skin and colon, which are characteristic of to, LDD and BZS. They also spontaneously developed germ cell, gonadostromal, thyroid and colon tumours. In addition, Pten inactivation enhanced the ability of ES cells to generate tumours in nude and syngeneic mice, due to increased anchorage-independent growth and aberrant differentiation. These results support the notion that PTEN haploinsufficiency plays a causal role in Co, LDD and BZS pathogenesis, and demonstrate that Pten is a tumour suppressor essential for embryonic development.	Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		di cristofano, antonio/AAJ-3796-2020; Di Cristofano, Antonio/B-4148-2016	di cristofano, antonio/0000-0003-2537-3228; 	NCI NIH HHS [CA-08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; BANNAYAN GA, 1971, ARCH PATHOL, V92, P1; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Collignon J, 1996, DEVELOPMENT, V122, P509; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EAGLE LR, 1995, NAT GENET, V9, P249, DOI 10.1038/ng0395-249; EDELHOFF S, 1994, ONCOGENE, V9, P665; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; ENG C, 1994, J MED GENET, V31, P458, DOI 10.1136/jmg.31.6.458; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Gerlach C, 1997, LAB INVEST, V77, P697; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; Guldberg P, 1997, CANCER RES, V57, P3660; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Myers MP, 1997, AM J HUM GENET, V61, P1234, DOI 10.1086/301659; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; PADBERG GW, 1991, ANN NEUROL, V29, P517, DOI 10.1002/ana.410290511; Risinger JI, 1997, CANCER RES, V57, P4736; ROACH S, 1994, EXP CELL RES, V215, P189, DOI 10.1006/excr.1994.1331; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Rosti V, 1997, J CLIN INVEST, V100, P1028, DOI 10.1172/JCI119613; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHAPIRO DN, 1994, GENOMICS, V23, P282, DOI 10.1006/geno.1994.1496; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Suzuki H, 1998, CANCER RES, V58, P204; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WECHSLER DS, 1994, GENOMICS, V21, P669, DOI 10.1006/geno.1994.1336; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; WILES MV, 1993, METHOD ENZYMOL, V225, P900; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; ZONANA J, 1976, J PEDIATR-US, V89, P600, DOI 10.1016/S0022-3476(76)80397-6	44	1210	1235	2	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					348	355		10.1038/1235	http://dx.doi.org/10.1038/1235			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697695				2022-12-27	WOS:000075107600017
J	Goldfarb, LG; Park, KY; Cervenakova, L; Gorokhova, S; Lee, HS; Vasconcelos, O; Nagle, JW; Semino-Mora, C; Sivakumar, K; Dalakas, MC				Goldfarb, LG; Park, KY; Cervenakova, L; Gorokhova, S; Lee, HS; Vasconcelos, O; Nagle, JW; Semino-Mora, C; Sivakumar, K; Dalakas, MC			Missense mutations in desmin associated with familial cardiac and skeletal myopathy	NATURE GENETICS			English	Article							ELECTRON-MICROSCOPY; CELLS	Desmin-related myopathy (OMIM 601419) is a familial disorder characterized by skeletal muscle weakness associated with cardiac conduction blocks, arrhythmias and restrictive heart failure, and by intracytoplasmic accumulation of desmin-reactive deposits in cardiac and skeletal muscle cells(1-4). The underlying molecular mechanisms are unknown. Involvement of the desmin gene (DES) has been excluded in three families diagnosed with desmin-related myopathy(5), We report two new families with desmin-related cardioskeletal myopathy associated with mutations in the highly conserved carboxy-terminal end of the desmin rod domain. A heterozygous A337P mutation was identified in a family with an adult-onset skeletal myopathy and mild cardiac involvement. Compound heterozygosity for two other mutations, A360P and N393I, was detected in a second family characterized by childhood-onset aggressive course of cardiac and skeletal myopathy.	NINDS, Med Neurol Branch, NIH, Bethesda, MD 20892 USA; NINDS, Cent Nervous Syst Studies Lab, NIH, Bethesda, MD 20892 USA; Amer Red Cross, Jerome H Holland Lab, Rockville, MD 20855 USA; Barrow Neurol Inst, Phoenix, AZ 85013 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); American Red Cross; Barrow Neurological Institute	Goldfarb, LG (corresponding author), NINDS, Med Neurol Branch, NIH, Bethesda, MD 20892 USA.		Gorokhova, Svetlana/L-9380-2019	Gorokhova, Svetlana/0000-0001-6870-4061				FARDEAU M, 1978, REV NEUROL, V134, P411; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GOEBEL HH, 1978, MUSCLE NERVE, V1, P14, DOI 10.1002/mus.880010104; GOEBEL HH, 1995, MUSCLE NERVE, V18, P1306, DOI 10.1002/mus.880181114; HOROWITZ SH, 1994, MUSCLE NERVE, V17, P151, DOI 10.1002/mus.880170204; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008; RAATS JMH, 1991, EUR J CELL BIOL, V56, P84; Raats JMH, 1996, EUR J CELL BIOL, V71, P221; Vicart P, 1996, HUM GENET, V98, P422, DOI 10.1007/s004390050233; YU KR, 1994, P NATL ACAD SCI USA, V91, P2497, DOI 10.1073/pnas.91.7.2497	11	375	390	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					402	403		10.1038/1300	http://dx.doi.org/10.1038/1300			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697706				2022-12-27	WOS:000075107600028
J	Cucca, F; Goy, JV; Kawaguchi, Y; Esposito, L; Merriman, ME; Wilson, AT; Cordell, HJ; Bain, SC; Todd, JA				Cucca, F; Goy, JV; Kawaguchi, Y; Esposito, L; Merriman, ME; Wilson, AT; Cordell, HJ; Bain, SC; Todd, JA			A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients	NATURE GENETICS			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ISLET-CELL ANTIBODIES; INSULIN AUTOANTIBODIES; HLA; MELLITUS; ASSOCIATION; RISK; SUSCEPTIBILITY; ONSET; IDDM	It is generally assumed that the male:female (M:F) ratio in patients with type 1 (insulin-dependent) diabetes mellitus (IDDM) is 1. A recent survey, however, revealed that high incidence countries (mainly European) have a high M:F ratio and low incidence ones (Asian and African) have a low M:F ratio(1) We have now analysed the M:F ratio according to genotype at the major locus, the major histocompatibility complex (MHC; IDDM1). There are two main IDDM1 susceptibility haplotypes, HLA-DR3 and -DR4, which are present in 95% of Caucasian cases(2-4). We report here that in medium/high incidence Caucasian populations from the United States of America, United Kingdom and Sardinia (1307 cases), the bias in male incidence is largely restricted to the DR3/X category of patients (X not equal DR4) with a M:F ratio of 1.7 (P = 9.3 x 10(-7)), compared with a ratio of 1.0 in the DR4/Y category (Y not equal DR3). This is additional evidence for significant heterogeneity between the aetiology of 'DR4-associated' and 'DR3-associated' diabetes(5-13). We analysed linkage of type 1 diabetes to chromosome X, and as expected, most of the linkage to Xp13-p11 was in the DR3/X affected sib-pair families (n=97; peak multipoint Mts at DXS1068 = 3.5, P = 2.7 x 10(-4); single point MLS = 4.5, P = 2.7 x 10(-5)). This is evidence for aetiological heterogeneity at the IDDM1/MHC locus and, therefore, in the search for non-MHC loci in type 1 diabetes, conditioning of linkage data by HLA type is advised.	Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Cagliari, Ist Clin & Biol Eta Evolut, I-09100 Cagliari, Italy; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; Univ Birmingham, Birmingham Heartlands Hosp, Dept Med, Birmingham B9 5SS, W Midlands, England	University of Oxford; Wellcome Centre for Human Genetics; University of Cagliari; Case Western Reserve University; Heart of England NHS Foundation Trust; University of Birmingham	Todd, JA (corresponding author), Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; CUCCA, Francesco/0000-0002-7414-1995; Cordell, Heather/0000-0002-1879-5572; Wilson, Amanda/0000-0001-5681-9611	Telethon [E.0604] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; CORDELL HJ, 1995, ANN HUM GENET, V59, P435, DOI 10.1111/j.1469-1809.1995.tb00761.x; CUCCA F, 1993, HUM IMMUNOL, V37, P85, DOI 10.1016/0198-8859(93)90146-R; CUCCA F, 1996, HLA MHC GENES MOL FU, P383; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Genovese S, 1996, DIABETOLOGIA, V39, P1223, DOI 10.1007/BF02658510; HARRISON LC, 1993, LANCET, V341, P1365, DOI 10.1016/0140-6736(93)90940-I; Ilonen J, 1996, DIABETES CARE, V19, P795, DOI 10.2337/diacare.19.8.795; Jackerott M, 1997, J AUTOIMMUN, V10, P35, DOI 10.1006/jaut.1996.0105; Karvonen M, 1997, DIABETES METAB REV, V13, P275, DOI 10.1002/(SICI)1099-0895(199712)13:4<275::AID-DMR197>3.0.CO;2-V; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Roep BO, 1996, EUR J IMMUNOL, V26, P1285, DOI 10.1002/eji.1830260616; Sanjeevi CB, 1996, DIABETIC MED, V13, P209, DOI 10.1002/(SICI)1096-9136(199603)13:3<209::AID-DIA39>3.0.CO;2-2; SERJEANTSON SW, 1992, DIABETOLOGIA, V35, P996, DOI 10.1007/BF00401432; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; THOMSON G, 1988, AM J HUM GENET, V43, P799; Thorsby E, 1996, J PEDIATR ENDOCR MET, V9, P75; VANDEWALLE CL, 1993, DIABETOLOGIA, V36, P1155, DOI 10.1007/BF00401060; WORDSWORTH BP, 1990, IMMUNOGENETICS, V32, P413; ZIEGLER R, 1991, DIABETES, V40, P709, DOI 10.2337/diabetes.40.6.709	23	112	112	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					301	302		10.1038/995	http://dx.doi.org/10.1038/995			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662410				2022-12-27	WOS:000074565900033
J	LaBranche, H; Dupuis, S; Ben-David, Y; Bani, MR; Wellinger, RJ; Chabot, B				LaBranche, H; Dupuis, S; Ben-David, Y; Bani, MR; Wellinger, RJ; Chabot, B			Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase	NATURE GENETICS			English	Article							DNA-BINDING-PROTEINS; IMMORTAL CELLS; LENGTH; SENESCENCE; EXPRESSION; YEAST; GENE; RAP1	Telomeric DNA of mammalian chromosomes consists of several kilobase-pairs of tandemly repeated sequences with a terminal 3' overhang in single-stranded form. Maintaining the integrity of these repeats is essential for cell survival; telomere attrition is associated with chromosome instability and cell senescence, whereas stabilization of telomere length correlates with the immortalization of somatic cells(1), Telomere elongation is carried out by telomerase, an RNA-dependent DNA polymerase which adds single-stranded TAGGGT repeats to the 3' ends of chromosomes'. While proteins that associate with single-stranded telomeric repeats can influence tract lengths in yeast(2,3), equivalent factors have not yet been identified in vertebrates. Here, it is shown that the heterogeneous nuclear ribonucleoprotein Al participates in telomere biogenesis. A mouse cell line deficient in Al expression harbours telomeres that are shorter than those of a related cell line expressing normal levels of Al, Restoring Al expression in Al-deficient cells increases telomere length. Telomere elongation is also observed upon introduction of exogenous UP1, the amino-terminal fragment of A1. While both Al and UP1 bind to vertebrate single-stranded telomeric repeats directly and with specificity in vitro, only UP1 can recover telomerase activity from a cell lysate. These findings establish A1/UP1 as the first single-stranded DNA binding protein involved in mammalian telomere biogenesis and suggest possible mechanisms by which UP1 may modulate telomere length.	Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada	University of Sherbrooke; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med, Dept Microbiol & Infectiol, Sherbrooke, PQ J1H 5N4, Canada.	b.chabot@courrier.usherb.ca	Bani, Maria Rosa/AAB-3397-2020; Wellinger, Raymund/K-3207-2019; Chabot, Benoit/A-8943-2008	Bani, Maria Rosa/0000-0001-8178-1432; Wellinger, Raymund/0000-0001-6670-2759; Chabot, Benoit/0000-0003-0994-0042				AbdulMana N, 1996, BIOCHEMISTRY-US, V35, P3545, DOI 10.1021/bi952298p; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; BENDAVID Y, 1992, MOL CELL BIOL, V12, P4449, DOI 10.1128/MCB.12.10.4449; Blackburn EH, 1995, TELOMERES; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; HUBBARD K, 1995, EXP CELL RES, V218, P241, DOI 10.1006/excr.1995.1152; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; KAMMA H, 1995, EXP CELL RES, V221, P187, DOI 10.1006/excr.1995.1366; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; LESTOURGEON WM, 1977, COLD SPRING HARB SYM, V42, P885, DOI 10.1101/SQB.1978.042.01.090; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; PANDOLFO M, 1985, NUCLEIC ACIDS RES, V13, P6577, DOI 10.1093/nar/13.18.6577; RIVA S, 1986, EMBO J, V5, P2267, DOI 10.1002/j.1460-2075.1986.tb04494.x; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Strahl C, 1996, MOL CELL BIOL, V16, P53; VALENTINI O, 1985, NUCLEIC ACIDS RES, V13, P337, DOI 10.1093/nar/13.2.337; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; VirtaPearlman V, 1996, GENE DEV, V10, P3094, DOI 10.1101/gad.10.24.3094; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	33	246	252	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					199	202		10.1038/575	http://dx.doi.org/10.1038/575			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620782				2022-12-27	WOS:000073865100033
J	Larsson, NG; Wang, JM; Wilhelmsson, H; Oldfors, A; Rustin, P; Lewandoski, M; Barsh, GS; Clayton, DA				Larsson, NG; Wang, JM; Wilhelmsson, H; Oldfors, A; Rustin, P; Lewandoski, M; Barsh, GS; Clayton, DA			Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice	NATURE GENETICS			English	Article							DNA; PROTEIN	The regulation of mitochondrial DNA (mtDNA) expression is crucial for mitochondrial biogenesis during development and differentiation. We have disrupted the mouse gene for mitochondrial transcription factor A (Tfam; formerly known as m-mtTFA) by gene targettimg of loxP-sites followed by cre-mediated excision in vivo. Heterozygous knockout mice exhibit reduced mtDNA copy number and respiratory chain deficiency in heart. Homozygous knockout embryos exhibit a severe mtDNA depletion with abolished oxidative phosphorylation. Mutant embryos proceed through implantation and gastrulation, but die prior to embryonic day (E)10.5. Thus, Tfam is the first mammalian protein demonstrated to regulate mtDNA copy number in vivo and is essential for mitochondrial biogenesis and embryonic development.	Dept Mol Med, Ctr Mol Med L8 02, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; Sahlgrenska Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Hop Necker Enfants Malad, INSERM, U393, F-75015 Paris, France; Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute	Larsson, NG (corresponding author), Dept Mol Med, Ctr Mol Med L8 02, S-17176 Stockholm, Sweden.	nils-goran.larsson@cmm.ki.se	Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Lewandoski, Mark/0000-0002-1066-3735; Oldfors, Anders/0000-0002-5758-7397	NIGMS NIH HHS [R37-GM33088-27] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033088] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTARDI G, 1982, MITOCHONDRIAL GENES, P51; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; EBERT KM, 1988, J REPROD FERTIL, V82, P145, DOI 10.1530/jrf.0.0820145; ENGLAND JM, 1978, J MOL BIOL, V119, P455, DOI 10.1016/0022-2836(78)90226-7; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HOGAN B, 1994, LAB MANUAL; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; LANSMAN RA, 1975, J MOL BIOL, V99, P761, DOI 10.1016/S0022-2836(75)80183-5; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Larsson NG, 1997, MAMM GENOME, V8, P139, DOI 10.1007/s003359900373; Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWANDOSKI M, IN PRESS COLD SPRING; MICHAEL NL, 1984, EMBO J, V3, P3165, DOI 10.1002/j.1460-2075.1984.tb02275.x; Ostronoff LK, 1995, BIOCHEM BIOPH RES CO, V217, P1094, DOI 10.1006/bbrc.1995.2881; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; PIKO L, 1973, J CELL BIOL, V58, P357, DOI 10.1083/jcb.58.2.357; POLOSA PL, 1991, J BIOL CHEM, V266, P10011; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SCHON EA, 1994, J BIOENERG BIOMEMBR, V26, P291, DOI 10.1007/BF00763100; STUART ET, 1994, ANNU REV GENET, V28, P219, DOI 10.1146/annurev.ge.28.120194.001251; Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0	29	1141	1187	2	67	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					231	236		10.1038/ng0398-231	http://dx.doi.org/10.1038/ng0398-231			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500544				2022-12-27	WOS:000072325000020
J	Dolphin, CT; Janmohamed, A; Smith, RL; Shephard, EA; Phillips, IR				Dolphin, CT; Janmohamed, A; Smith, RL; Shephard, EA; Phillips, IR			Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome	NATURE GENETICS			English	Article							FLAVOPROTEIN DISULFIDE OXIDOREDUCTASES; POLYMERASE CHAIN-REACTION; CONTAINING MONOOXYGENASE; SUBSTRATE-SPECIFICITY; GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; SEQUENCE; EXPRESSION; TRIMETHYLAMINURIA; CLONING	Individuals with primary trimethylaminuria exhibit a body odour reminiscent of rotting fish, due to excessive excretion of trimethylamine (TMA; refs 1-3). The disorder, colloquially known as fish-odour syndrome, is inherited recessively as a defect in hepatic N-oxidation of dietary-derived TMA(4-6) and cannot be considered benign, as sufferers may display a variety of psychosocial reactions, ranging from social isolation to clinical depression and attempted suicide(6). TMA oxidation is catalyzed by flavin-containing mono-oxygenase (FMO; refs 7,8), and tissue localization(9,10) and functional studies(11) have established FMO3 as the form most likely to be defective in fish-odour syndrome. Direct sequencing of the coding exons of FMO3 amplified from a patient with fish-odour syndrome identified two missense mutations. Although one of these represented a common polymorphism, the other, a C-->T transition in exon 4, was found only in an affected pedigree, in which it segregated with the disorder. The latter mutation predicts a proline-->leucine substitution at residue 153 and abolishes FMO3 catalytic activity. Our results indicate that defects in FMO3 underlie fish-odour syndrome and that the Pro153-->Leu153 mutation described here is a cause of this distressing condition.	UNIV LONDON QUEEN MARY & WESTFIELD COLL,DEPT BIOCHEM,MOL BIOL LAB,LONDON E1 4NS,ENGLAND; UNIV LONDON UNIV COLL,DEPT BIOCHEM & MOL BIOL,LONDON WC1E 6BT,ENGLAND; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,SCH MED,LONDON W2 1PG,ENGLAND	University of London; Queen Mary University London; University of London; University College London; Imperial College London			Phillips, Ian R/A-7337-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABOAGYEKWARTENG T, 1992, MOL MICROBIOL, V6, P3089, DOI 10.1111/j.1365-2958.1992.tb01766.x; ALWAIZ M, 1987, CLIN PHARMACOL THER, V42, P608, DOI 10.1038/clpt.1987.207; ALWAIZ M, 1987, LANCET, V1, P634; ALWAIZ M, 1988, CLIN SCI, V74, P231, DOI 10.1042/cs0740231; AYESH R, 1988, BRIT J CLIN PHARMACO, V25, pP664; AYESH R, 1993, BRIT MED J, V307, P655, DOI 10.1136/bmj.307.6905.655; CHEN YCJ, 1988, J BACTERIOL, V170, P781, DOI 10.1128/jb.170.2.781-789.1988; DIXIT A, 1984, ARCH BIOCHEM BIOPHYS, V233, P50, DOI 10.1016/0003-9861(84)90600-3; Dolphin CT, 1996, EUR J BIOCHEM, V235, P683, DOI 10.1111/j.1432-1033.1996.00683.x; DOLPHIN CT, IN PRESS GENOMICS; GREER S, 1986, BIOCHEMISTRY-US, V25, P2736, DOI 10.1021/bi00357a069; GUT I, 1993, BIOCHEM PHARMACOL, V46, P239, DOI 10.1016/0006-2952(93)90409-P; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; Itagaki K, 1996, J BIOL CHEM, V271, P20102, DOI 10.1074/jbc.271.33.20102; LADDAGA RA, 1987, P NATL ACAD SCI USA, V84, P5106, DOI 10.1073/pnas.84.15.5106; Lake BG, 1987, BIOCH TOXICOLOGY PRA, P183; LAWTON MP, 1994, ARCH BIOCHEM BIOPHYS, V308, P254, DOI 10.1006/abbi.1994.1035; LOMRI N, 1993, CHEM RES TOXICOL, V6, P425, DOI 10.1021/tx00034a006; Mitchell SC, 1996, PERSPECT BIOL MED, V39, P514; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; OVERBY LH, 1995, ARCH BIOCHEM BIOPHYS, V317, P275, DOI 10.1006/abbi.1995.1163; PARK SB, 1993, CHEM RES TOXICOL, V6, P880, DOI 10.1021/tx00036a019; PHILLIPS IR, 1995, CHEM-BIOL INTERACT, V96, P17, DOI 10.1016/0009-2797(94)03580-2; SHELLEY ED, 1984, JAMA-J AM MED ASSOC, V251, P253, DOI 10.1001/jama.251.2.253; SHEPHARD EA, 1993, GENOMICS, V16, P85, DOI 10.1006/geno.1993.1144; Spellacy E, 1980, J Inherit Metab Dis, V2, P85; Suh JK, 1996, ARCH BIOCHEM BIOPHYS, V336, P268, DOI 10.1006/abbi.1996.0557; TUTIC M, 1990, EUR J BIOCHEM, V188, P523, DOI 10.1111/j.1432-1033.1990.tb15431.x; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; ZIEGLER DM, 1990, TRENDS PHARMACOL SCI, V11, P321, DOI 10.1016/0165-6147(90)90235-Z	30	203	235	1	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					491	494		10.1038/ng1297-491	http://dx.doi.org/10.1038/ng1297-491			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398858				2022-12-27	WOS:A1997YJ92400037
J	Kupfer, GM; Naf, D; Suliman, A; Pulsipher, M; DAndrea, AD				Kupfer, GM; Naf, D; Suliman, A; Pulsipher, M; DAndrea, AD			The Fanconi anaemia proteins, FAA and FAG, interact to form a nuclear complex	NATURE GENETICS			English	Article							GROUP-C; ANEMIA; COMPLEMENTATION; GENE; POLYPEPTIDE; CLONING; FACC; PHOSPHORYLATION; EXPRESSION; CYTOPLASM	Fanconi anaemia (FA) is an autosomal-recessive disorder characterized by genomic instability, developmental defects, DNA crosslinking agent hypersensitivity and cancer susceptibility(1-3). Somatic-cell hybrid studies have revealed five FA complementation groups (A-E; refs 4-6) displaying similar phenotypes, suggesting that FA genes are functionally related(7). The two cloned FA genes, FAA and FAG, encode proteins that are unrelated to each other or to other proteins in GenBank(8-10). In the current study, we demonstrate that FAA and FAC bind each other and form a complex. Protein binding correlates with the functional activity of FAA and FAG, as patient-derived mutant FAC (L554P) fails to bind FAA. Although unbound FAA and FAC localize predominantly to the cytoplasm, the FAA-FAC complex is found in similar abundance in both cytoplasm and nucleus. Our results confirm the interrelatedness of the FA genes in a pathway, suggesting the cooperation of FAA and FAC in a nuclear function.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,DIV CELLULAR & MOL BIOL,BOSTON,MA 02115; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Kupfer, GM (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,DIV PEDIAT ONCOL,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [P01CA039542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003420] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA39542] Funding Source: Medline; NHLBI NIH HHS [R01-HL5725, K08-HL03420] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER BP, 1993, HEMATOLOGY INFANCY C, V1, P216; Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; DAndrea AD, 1996, NAT GENET, V14, P240, DOI 10.1038/ng1196-240; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GAVISH H, 1993, HUM MOL GENET, V2, P123, DOI 10.1093/hmg/2.2.123; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Kupfer GM, 1997, BLOOD, V90, P1047, DOI 10.1182/blood.V90.3.1047.1047_1047_1054; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PAPAVASSILIOU AG, 1992, SCIENCE, V258, P1941, DOI 10.1126/science.1470918; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Yamashita T, 1996, BLOOD, V87, P4424, DOI 10.1182/blood.V87.10.4424.bloodjournal87104424; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975; Youssoufian H, 1996, J CLIN INVEST, V97, P957, DOI 10.1172/JCI118519	23	156	157	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					487	490		10.1038/ng1297-487	http://dx.doi.org/10.1038/ng1297-487			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398857				2022-12-27	WOS:A1997YJ92400036
J	Quaderi, NA; Schweiger, S; Gaudenz, K; Franco, B; Rugarli, EI; Berger, W; Feldman, GJ; Volta, M; Andolfi, G; Gilgenkrantz, S; Marion, RW; Hennekam, RCM; Opitz, JM; Muenke, M; Ropers, HH; Ballabio, A				Quaderi, NA; Schweiger, S; Gaudenz, K; Franco, B; Rugarli, EI; Berger, W; Feldman, GJ; Volta, M; Andolfi, G; Gilgenkrantz, S; Marion, RW; Hennekam, RCM; Opitz, JM; Muenke, M; Ropers, HH; Ballabio, A			Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22	NATURE GENETICS			English	Article							LINEAR SKIN DEFECTS; ACUTE PROMYELOCYTIC LEUKEMIA; XENOPUS NUCLEAR FACTOR-7; FAT GLOBULE-MEMBRANE; SONIC-HEDGEHOG; PROTEIN; MICROPHTHALMIA; ANOMALIES; DOMAIN; XNF7	Opitz syndrome (OS) is an inherited disorder characterized by midline defects including hypertelorism, hypospadias, lip-palate-laryngotracheal clefts and imperforate anus. We have identified a new gene on Xp22, MIDI (Midline 1), which is disrupted in an OS patient carrying an X-chromosome inversion and is also mutated in several OS families. MID 1 encodes a member of the B-box family of proteins, which contain protein-protein interaction domains, including a RING finger, and are implicated in fundamental processes such as body axis patterning and control of cell proliferation. The association of MIDI with OS suggests an important role for this gene in midline development.	TELETHON INST GENET & MED,I-20132 MILAN,ITALY; MAX PLANCK INST MOL GENET,D-14195 BERLIN,GERMANY; UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOL BIOL,PHILADELPHIA,PA 19104; MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DEPT PEDIAT,BRONX,NY 10467; UNIV AMSTERDAM,INST HUMAN GENET,NL-1105 AZ AMSTERDAM,NETHERLANDS; UNIV UTAH,DEPT PEDIAT HUMAN GENET & OBSTET & GYNECOL,SALT LAKE CITY,UT 84132; CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NL-6500 HB NIJMEGEN,NETHERLANDS; UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Max Planck Society; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Amsterdam; Utah System of Higher Education; University of Utah; Radboud University Nijmegen; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia			Quaderi, Nandita/V-8708-2019; Volta, Manuela/D-2147-2012; BALLABIO, Andrea/AAL-2672-2020; FRANCO, Brunella/S-2882-2018	Volta, Manuela/0000-0001-8468-0346; BALLABIO, Andrea/0000-0003-1381-4604; Muenke, Maximilian/0000-0002-7719-6545; FRANCO, Brunella/0000-0001-5588-4569; Rugarli, Elena/0000-0002-5782-1067	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028732, R01HD029862] Funding Source: NIH RePORTER; NICHD NIH HHS [R29HD28732, R01HD29862] Funding Source: Medline; Telethon [TGM97000, TGM06S01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		ALGAZALI LI, 1990, J MED GENET, V27, P59, DOI 10.1136/jmg.27.1.59; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BELLINI M, 1993, EMBO J, V12, P107, DOI 10.1002/j.1460-2075.1993.tb05636.x; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BERSHOF JF, 1992, J CRANIO MAXILL SURG, V20, P24, DOI 10.1016/S1010-5182(05)80192-1; BIRD LM, 1994, AM J MED GENET, V53, P141, DOI 10.1002/ajmg.1320530205; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; CAPPA M, 1987, AM J MED GENET, V28, P303, DOI 10.1002/ajmg.1320280207; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; CORDERO JF, 1978, AM J MED GENET, V2, P145, DOI 10.1002/ajmg.1320020205; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; FARNDON PA, 1983, CLIN GENET, V23, P446; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; FRYNS JP, 1992, CLIN GENET, V42, P314; GRIGNANI F, 1994, BLOOD, V83, P10; GUIONALMEIDA ML, 1992, AM J MED GENET, V43, P918, DOI 10.1002/ajmg.1320430603; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HOWELL L, 1989, ANN OTO RHINOL LARYN, V98, P185, DOI 10.1177/000348948909800304; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Ishii T, 1995, BBA-GEN SUBJECTS, V1245, P285, DOI 10.1016/0304-4165(95)00102-6; JOHNSTON K, 1987, AM J MED GENET, V27, P603, DOI 10.1002/ajmg.1320270313; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LI XX, 1993, J CELL SCI, V105, P389; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACDONALD MR, 1993, AM J MED GENET, V46, P706, DOI 10.1002/ajmg.1320460622; Maniatis T., 1982, MOL CLONING; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MATHER IH, 1993, J DAIRY SCI, V76, P3832, DOI 10.3168/jds.S0022-0302(93)77726-7; May M, 1997, AM J MED GENET, V68, P244, DOI 10.1002/(SICI)1096-8628(19970120)68:2<244::AID-AJMG27>3.0.CO;2-T; MILLER M, 1991, DEVELOPMENT, V113, P569; Opitz, 1969, BIRTH DEFECTS OAS, VV, P95; Opitz J. M., 1969, BIRTH DEFECTS AOS, VV, P86; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; REDDY BA, 1991, DEV BIOL, V148, P107, DOI 10.1016/0012-1606(91)90321-S; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robin NH, 1996, AM J MED GENET, V62, P305, DOI 10.1002/(SICI)1096-8628(19960329)62:3<305::AID-AJMG20>3.0.CO;2-N; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SEDANO HO, 1988, AM J MED GENET, V30, P847, DOI 10.1002/ajmg.1320300322; Shou WN, 1996, MOL CELL BIOL, V16, P990; STEVENS CA, 1988, J MED GENET, V25, P536, DOI 10.1136/jmg.25.8.536; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TEMPLE IK, 1990, J MED GENET, V27, P56, DOI 10.1136/jmg.27.1.56; TOLMIE JL, 1987, J MED GENET, V24, P688, DOI 10.1136/jmg.24.11.688; VERLOES A, 1995, AM J MED GENET, V59, P123, DOI 10.1002/ajmg.1320590124; VERLOES A, 1989, AM J MED GENET, V34, P313, DOI 10.1002/ajmg.1320340303; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947	60	295	302	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					285	291		10.1038/ng1197-285	http://dx.doi.org/10.1038/ng1197-285			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354791	Green Submitted			2022-12-27	WOS:A1997YD66700021
J	Lu, WN; Peissel, B; Babakhanlou, H; Pavlova, A; Geng, L; Fan, XH; Larson, C; Brent, G; Zhou, J				Lu, WN; Peissel, B; Babakhanlou, H; Pavlova, A; Geng, L; Fan, XH; Larson, C; Brent, G; Zhou, J			Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY; DISEASE; GENE; CELLS; PROTEIN; PRODUCT; FETAL; ADULT	PKD1 is the most common site for mutations in human autosomal dominant polycystic kidney disease (ADPKD). ADPKD is characterized by progressive replacement of kidney tissue by epithelial cysts and eventual renal failure. Hepatic and pancreatic cysts are also common(1). The PKD1 protein, polycystin, is a cell-surface protein(2,3) of unknown function that is widely expressed in epithelia and in vascular smooth muscle and myocardium(4-9). None of the genetic forms of murine polycystic disease map to the murine Pkd1 locus. We introduced into mice by homologous recombination a Pkd1 truncation mutation, Pkd1(-), that mimics a mutation found in ADPKD. Pkd1(-) heterozygotes have no discernible phenotype, whereas homozygotes die during the perinatal period with massively enlarged cystic kidneys, pancreatic ductal cysts and pulmonary hypoplasia. Renal cyst formation begins at embryonic day 15.5 (E15.5) in proximal tubules and progresses rapidly to replace the entire renal parenchyma. The timing of cyst formation indicates that full-length polycystin is required for normal morphogenesis during elongation and maturation of tubular structures in the kidney and pancreas.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV RENAL, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, DIV THYROID, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School			Peissel, Bernard/E-8187-2017	Peissel, Bernard/0000-0001-9233-3571; Lu, Weining/0000-0002-6570-3044	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051050] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK51050] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Geng L, 1997, AM J PHYSIOL-RENAL, V272, pF451, DOI 10.1152/ajprenal.1997.272.4.F451; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; GENG L, 1994, J AM SOC NEPHROL, V5, P622; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Griffin MD, 1996, P ASSOC AM PHYSICIAN, V108, P185; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Madsen OD, 1996, EUR J BIOCHEM, V242, P435, DOI 10.1111/j.1432-1033.1996.435rr.x; Palsson R, 1996, MOL MED, V2, P702, DOI 10.1007/BF03401654; Peral B, 1996, AM J HUM GENET, V58, P86; Peters DJM, 1996, LAB INVEST, V75, P221; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524	16	358	362	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1997	17	2					179	181		10.1038/ng1097-179	http://dx.doi.org/10.1038/ng1097-179			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326937				2022-12-27	WOS:A1997XZ55500023
J	Kimura, A; Harada, H; Park, JE; Nishi, H; Satoh, M; Takahashi, M; Hiroi, S; Sasaoka, T; Ohbuchi, N; Nakamura, T; Koyanagi, T; Hwang, TH; Choo, TA; Chung, KS; Hasegawa, A; Nagai, R; Okazaki, O; Nakamura, H; Matsuzaki, M; Sakamoto, T; Toshima, H; Koga, Y; Imaizumi, T; Sasazuki, T				Kimura, A; Harada, H; Park, JE; Nishi, H; Satoh, M; Takahashi, M; Hiroi, S; Sasaoka, T; Ohbuchi, N; Nakamura, T; Koyanagi, T; Hwang, TH; Choo, TA; Chung, KS; Hasegawa, A; Nagai, R; Okazaki, O; Nakamura, H; Matsuzaki, M; Sakamoto, T; Toshima, H; Koga, Y; Imaizumi, T; Sasazuki, T			Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy	NATURE GENETICS			English	Article							HEAVY-CHAIN GENE; PROTEIN-C GENE; SKELETAL-MUSCLE; BIOLOGICAL-ACTIVITY; MISSENSE MUTATION; ALPHA-TROPOMYOSIN; MOLECULAR-BASIS; SEQUENCE; LOCUS; MAPS	Hypertrophic cardiomyopathy (HCM), the most common cause of sudden death in the young, is an autosomal dominant disease characterized by ventricular hypertrophy accompanied by myofibrillar disarrays(1). Linkage studies and candidate-gene approaches have demonstrated that about half of the patients have mutations in one of six disease genes: cardiac beta-myosin heavy chain (c beta MHC)(2,3), cardiac troponin T (cTnT)(4,5), alpha-tropomyosin (alpha TM)(5,6), cardiac myosin binding protein C (cMBP-C)(7-9), ventricular myosin essential light chain (vMLC1)(10) and ventricular myosin regulatory light chain (vMLC2)(10) genes. Other disease genes remain unknown. Because all the known disease genes encode major contractile elements in cardiac muscle(11), we have systematically characterized the cardiac sarcomere genes, including cardiac troponin I (cTnI), cardiac actin (cACT) and cardiac troponin C (cTnC)(12) in 184 unrelated patients with HCM and found mutations in the cTnI gene in several patients(13).	KURUME UNIV,SCH MED,DEPT INTERNAL MED 3,KURUME,FUKUOKA 830,JAPAN; SAMSUNG MED CTR,DIV CARDIOL,SEOUL 135230,SOUTH KOREA; KURUME UNIV,INST CARDIOVASC RES,KURUME,FUKUOKA 830,JAPAN; GUNMA UNIV,SCH MED,DEPT INTERNAL MED 2,MAEBASHI,GUMMA 371,JAPAN; INT MED CTR,DEPT CARDIOL,TOKYO 162,JAPAN; YAMAGUCHI UNIV,SCH MED,DEPT INTERNAL MED 2,YAMAGUCHI 755,JAPAN; HANZOMON HOSP,TOKYO 102,JAPAN; KURUME UNIV,KURUME MED CTR,DEPT CARDIOL,KURUME,FUKUOKA 835,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,DEPT GENET,FUKUOKA 812,JAPAN	Kurume University; Sungkyunkwan University (SKKU); Samsung Medical Center; Kurume University; Gunma University; Yamaguchi University; Kurume University; Kyushu University	Kimura, A (corresponding author), TOKYO MED & DENT UNIV,MED RES INST,DEPT TISSUE PSYCHOL,DIV ADULT DIS,TOKYO 101,JAPAN.		nishi, Hiroaki/X-7736-2019; Kimura, Akinori/I-5989-2018	nishi, Hiroaki/0000-0002-6331-2947; Kimura, Akinori/0000-0002-4933-2132				BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Bermingham N, 1995, GENOMICS, V30, P620, DOI 10.1006/geno.1995.1288; Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FODOR WL, 1989, J BIOL CHEM, V264, P2143; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P5901, DOI 10.1073/pnas.79.19.5901; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; Ko YL, 1996, HUM GENET, V97, P457; LIEW CC, 1990, NUCLEIC ACIDS RES, V18, P3647, DOI 10.1093/nar/18.12.3647; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; MACRAE CA, 1995, J CLIN INVEST, V96, P1216, DOI 10.1172/JCI118154; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; NISHI H, 1995, CIRCULATION, V91, P2911, DOI 10.1161/01.CIR.91.12.2911; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; SCHREIER T, 1990, J BIOL CHEM, V265, P21247; SCHWARTZ K, 1995, CIRCULATION, V91, P532, DOI 10.1161/01.CIR.91.2.532; SOLARO RJ, 1995, ADV EXP MED BIOL, V382, P109; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; TAO T, 1989, BIOCHEMISTRY-US, V28, P5902, DOI 10.1021/bi00440a029; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434	29	431	450	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					379	382		10.1038/ng0897-379	http://dx.doi.org/10.1038/ng0897-379			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241277				2022-12-27	WOS:A1997XM90900022
J	Oda, T; Elkahloun, AG; Pike, BL; Okajima, K; Krantz, ID; Genin, A; Piccoli, DA; Meltzer, PS; Spinner, NB; Collins, FS; Chandrasekharappa, SC				Oda, T; Elkahloun, AG; Pike, BL; Okajima, K; Krantz, ID; Genin, A; Piccoli, DA; Meltzer, PS; Spinner, NB; Collins, FS; Chandrasekharappa, SC			Mutations in the human Jagged1 gene are responsible for Alagille syndrome	NATURE GENETICS			English	Article							ARTERIOHEPATIC DYSPLASIA; DELETION; FAMILY; NOTCH; MICRODELETIONS; CHROMOSOME-20; DROSOPHILA; REGION; 20P	Alagille syndrome (AGS) is an autosomal-dominant disorder characterized by intrahepatic cholestasis and abnormalities of heart, eye and vertebrae, as well as a characteristic facial appearance. Identification of rare AGS patients with cytogenetic deletions has allowed mapping of the gene to 20p12. We have generated a cloned contig of the critical region and used fluorescent in situ hybridization on cells from patients with submicroscopic deletions to narrow the candidate region to only 250 kb. Within this region we identified JAG1, the human homologue of rat Jagged1, which encodes a ligand for the Notch receptor. Cell-cell Jagged/Notch interactions are known to be critical for determination of cell fates in early development, making this an attractive candidate gene for a developmental disorder in humans. Determining the complete exon-intron structure of JAG1 allowed detailed mutational analysis of DNA samples from non-deletion ACS patients, revealing three frame-shift mutations, two splice donor mutations and one mutation abolishing RNA expression from the altered allele. We conclude that AGS is caused by haploinsufficiency of JAG1.	NATL HUMAN GENOME RES INST,LAB GENE TRANSFER,NIH,BETHESDA,MD 20892; NATL HUMAN GENOME RES INST,CANC GENET LAB,NIH,BETHESDA,MD 20892; NAGOYA CITY UNIV,SCH MED,DEPT PEDIAT,NAGOYA,AICHI 467,JAPAN; CHILDRENS HOSP,PHILADELPHIA,PA 19104; RES GENET INC,HUNTSVILLE,AL 35801	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Nagoya City University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia								ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; ANAD F, 1990, J MED GENET, V27, P729, DOI 10.1136/jmg.27.12.729; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bao ZZ, 1997, J NEUROSCI, V17, P1425; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BYRNE JLB, 1986, AM J MED GENET, V24, P673, DOI 10.1002/ajmg.1320240411; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; Deleuze Jean-Francois, 1994, European Journal of Human Genetics, V2, P185; DELEUZE JF, 1994, MAMM GENOME, V5, P663, DOI 10.1007/BF00426072; DESMAZE C, 1992, J MED GENET, V29, P233, DOI 10.1136/jmg.29.4.233; DHOMEPOLLET S, 1994, J MED GENET, V31, P453; Elkahloun AG, 1996, GENE CHROMOSOME CANC, V17, P205, DOI 10.1002/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.3.CO;2-#; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; ELMSLIE FV, 1995, J MED GENET, V32, P264, DOI 10.1136/jmg.32.4.264; Garrod A, 1928, LANCET, V1, P1055; HATTORI M, 1995, NIPPON SHONIKA GAKKA, V99, P1984; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HOL FA, 1995, HUM GENET, V95, P687; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Krantz I. D., 1996, American Journal of Human Genetics, V59, pA224; Krantz ID, 1996, CYTOGENET CELL GENET, V74, P304; LEGIUS E, 1990, AM J MED GENET, V35, P532, DOI 10.1002/ajmg.1320350419; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; NYE JS, 1995, CURR BIOL, V5, P966, DOI 10.1016/S0960-9822(95)00189-8; ODA T, IN PRESS GENOMCIS; POLLET N, 1995, GENOMICS, V27, P467, DOI 10.1006/geno.1995.1078; RAND EB, 1995, AM J HUM GENET, V57, P1068; SCHNITTGER S, 1989, HUM GENET, V83, P239, DOI 10.1007/BF00285164; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Spinner N. B., 1995, American Journal of Human Genetics, V57, pA35; SPINNER NB, 1994, AM J HUM GENET, V55, P238; SPINNER NB, IN PRESS CYTOGENET C; TEEBI AS, 1992, AM J MED GENET, V42, P35, DOI 10.1002/ajmg.1320420109	37	783	825	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					235	242		10.1038/ng0797-235	http://dx.doi.org/10.1038/ng0797-235			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207787	Green Published			2022-12-27	WOS:A1997XG60900017
J	Srivastava, D; Thomas, T; Lin, Q; Kirby, ML; Brown, D; Olson, EN				Srivastava, D; Thomas, T; Lin, Q; Kirby, ML; Brown, D; Olson, EN			Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND	NATURE GENETICS			English	Article							MORPHOGENESIS; EXPRESSION; PROTEINS; LINEAGES; HEART; EMBRYOGENESIS; LACKING; EMBRYO; MICE	dHAND and eHAND are related basic helix-loop-helix (bHLH) transcription factors that are expressed in mesodermal and neural crest-derived structures of the developing heart. In contrast to their homogeneous expression during avian cardiogenesis, during mouse heart development we show that dHAND and eHAND are expressed in a complementary fashion and are restricted to segments of the heart tube fated to form the right and left ventricles, respectively. dHAND and eHAND represent the earliest cardiac chamber-specific transcription factors yet identified. Targeted gene deletion of dHAND in mouse embryos resulted in embryonic lethality at embryonic day 10.5 from heart failure. Our description of the cardiac phenotype of dHAND mutant embryos is the first demonstration of a single gene controlling the formation of the mesodermally derived right ventricle and the neural crest-derived aortic arches and reveals a novel cardiogenic subprogramme for right ventricular development.	UNIV TEXAS,SW MED CTR,DEPT MOL BIOL & ONCOL,DALLAS,TX 75235; MED COLL GEORGIA,DEPT ANAT & CELLULAR BIOL,AUGUSTA,GA 30912	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University System of Georgia; Augusta University	Srivastava, D (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PEDIAT,DIV CARDIOL,5323 HARRY HINES BLVD,DALLAS,TX 75235, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057181] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL57181-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; DEHAAN RL, 1964, ORGANOGENESIS, P377; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; LIN Q, 1997, IN PRESS SCIENCE; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PEXIEDER T, 1984, CONGENITAL HEART DIS, P423; Ross RS, 1996, DEVELOPMENT, V122, P1799; Rossant J, 1996, CIRC RES, V78, P349, DOI 10.1161/01.RES.78.3.349; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; STANIER DYR, 1992, DEV BIOL, V153, P91; YUTZEY KE, 1995, CIRC RES, V77, P216, DOI 10.1161/01.RES.77.2.216	32	537	552	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					154	160		10.1038/ng0697-154	http://dx.doi.org/10.1038/ng0697-154			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171826				2022-12-27	WOS:A1997XB54300015
J	Sassaman, DM; Dombroski, BA; Moran, JV; Kimberland, ML; Naas, TP; DeBerardinis, RJ; Gabriel, A; Swergold, GD; Kazazian, HH				Sassaman, DM; Dombroski, BA; Moran, JV; Kimberland, ML; Naas, TP; DeBerardinis, RJ; Gabriel, A; Swergold, GD; Kazazian, HH			Many human L1 elements are capable of retrotransposition	NATURE GENETICS			English	Article							HUMAN TRANSPOSABLE ELEMENT; REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCES; INSERTION; LINE-1; MUTAGENESIS; GENE; IDENTIFICATION; FAMILY	Using a selective screening strategy to enrich for active L1 elements, we isolated 13 full-length elements from a human genomic library. We tested these and two previously-isolated L1s (L1.3 and L1.4) for reverse transcriptase (RT) activity and the ability to retrotranspose in HeLa cells, Of the 13 newly-isolated L1s, eight had RT activity and three were able to retrotranspose. L1.3 and L1.4 possessed RT activity and retrotransposed at remarkably high frequencies. These studies bring the number of characterized active human L1 elements to seven. Based on these and other data, we estimate that 30-60 active L1 elements reside in the average diploid genome.	UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; RUTGERS STATE UNIV, DEPT MOL BIOL & BIOCHEM, PISCATAWAY, NJ 08855 USA; US FDA, BETHESDA, MD 20892 USA	University of Pennsylvania; Rutgers State University New Brunswick; US Food & Drug Administration (FDA)			Naas, Thierry/O-3999-2018	Naas, Thierry/0000-0001-9937-9572				ADAMS JW, 1980, NUCLEIC ACIDS RES, V8, P6113, DOI 10.1093/nar/8.24.6113; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; BRAITERMAN LT, 1994, GENE, V139, P19, DOI 10.1016/0378-1119(94)90518-5; BURTON FH, 1986, J MOL BIOL, V187, P291, DOI 10.1016/0022-2836(86)90235-4; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; DOMBROSKI BA, 1994, MOL CELL BIOL, V14, P4485, DOI 10.1128/MCB.14.7.4485; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P47; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; HOLMES SE, 1992, J BIOL CHEM, V267, P19765; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; MIKI Y, 1992, CANCER RES, V52, P643; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Rose MD., 1990, METHODS YEAST GENETI; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SASSAMAN DM, 1996, THESIS J HOPKINS U B; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; [No title captured]	39	362	368	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					37	43		10.1038/ng0597-37	http://dx.doi.org/10.1038/ng0597-37			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140393				2022-12-27	WOS:A1997WX02400020
J	Decottignies, A; Goffeau, A				Decottignies, A; Goffeau, A			Complete inventory of the yeast ABC proteins	NATURE GENETICS			English	Article							BINDING CASSETTE TRANSPORTER; ATP-DEPENDENT PERMEASES; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; ADRENOLEUKODYSTROPHY GENE; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; MEMBRANE-PROTEINS; CANDIDA-ALBICANS	The complete sequence of the yeast genome predicts the existence of 29 proteins belonging to the ubiquitous ATP-binding cassette (ABC) superfamily. Using binary comparison, phylogenetic classification and detection of conserved amino acid residues, the yeast ABC proteins have been classified in a total of six clusters, including ten subclusters of distinct predicted topology and presumed distinct function. Study of the yeast ABC proteins provides insight into the physiological function and biochemical mechanisms of their human homologues, such as those involved in cystic fibrosis, adrenoleukodystrophy, Zellweger syndrome, multidrug resistance and the antiviral activity of interferons.	UNIV CATHOLIQUE LOUVAIN,UNITE BIOCHIM PHYSIOL,B-1348 LOUVAIN,BELGIUM	Universite Catholique Louvain								ALLIGNET J, 1992, GENE, V117, P45, DOI 10.1016/0378-1119(92)90488-B; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; BOSSIER P, 1994, YEAST, V10, P1; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; CUCCA F, 1994, TISSUE ANTIGENS, V44, P234, DOI 10.1111/j.1399-0039.1994.tb02388.x; CUI Z, IN PRESS J BIOL CHEM; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; DREESEN TD, 1988, MOL CELL BIOL, V8, P5206, DOI 10.1128/MCB.8.12.5206; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; DUJON B, 1994, NATURE, V369, P371, DOI 10.1038/369371a0; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GOFFEAU A, 1994, NATURE, V369, P101, DOI 10.1038/369101a0; GOFFEAU A, 1993, FEBS LETT, V325, P112, DOI 10.1016/0014-5793(93)81425-Y; GOFFEAU A, 1993, YEAST, V9, P691, DOI 10.1002/yea.320090703; GONZALEZESCRIBANO MF, 1995, ANN RHEUM DIS, V54, P386, DOI 10.1136/ard.54.5.386; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; HAASE E, 1992, CURR GENET, V21, P319, DOI 10.1007/BF00351689; HETTEMA EH, IN PRESS EMBO J; Hieter P, 1996, NAT GENET, V13, P253, DOI 10.1038/ng0796-253; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; JOHNSTON M, 1994, SCIENCE, V265, P2077, DOI 10.1126/science.8091229; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; KOLACZKOWSKI M, 1996, IN PRESS J BIOL CHEM; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; LEPPERT G, 1990, GENETICS, V125, P13; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; Michaelis S, 1995, COLD SPRING HARB SYM, V60, P291, DOI 10.1101/SQB.1995.060.01.034; MIDDLETON D, 1994, HUM IMMUNOL, V40, P131, DOI 10.1016/0198-8859(94)90057-4; MIOSGA T, IN PRESS YEAST; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MURAKAMI Y, 1995, NAT GENET, V10, P261, DOI 10.1038/ng0795-261; NAGAO K, 1995, J BACTERIOL, V177, P1536, DOI 10.1128/jb.177.6.1536-1543.1995; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; OROZCO E, 1995, PARASITOL TODAY, V11, P473, DOI 10.1016/0169-4758(95)80067-0; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PARLE AG, IN PRESS YEAST; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; PURNELLE B, 1991, YEAST, V7, P867, DOI 10.1002/yea.320070813; QIN SL, 1990, J BIOL CHEM, V265, P1903; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; SANDBAKEN MG, 1990, J BIOL CHEM, V265, P15838; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; SAPTARSHI P, 1996, P NATL ACAD SCI USA, V93, P6929; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; SAVARY S, IN PRESS MAMMAL GENO; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; Shan N, 1996, J BIOL CHEM, V271, P8725, DOI 10.1074/jbc.271.15.8725; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Smart CC, 1996, J BIOL CHEM, V271, P19351, DOI 10.1074/jbc.271.32.19351; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; TABAK HF, 1995, TRANSPORT PROTEINS M, P649; TAULER A, 1990, J BIOL CHEM, V265, P15617; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; WEMMIE JA, 1994, J BIOL CHEM, V269, P35592; XIE JX, 1995, J BIOL CHEM, V270, P28084; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	78	387	405	1	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					137	145		10.1038/ng0297-137	http://dx.doi.org/10.1038/ng0297-137			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020838				2022-12-27	WOS:A1997WF08700012
J	Angrist, M; Bolk, S; Halushka, M; Lapchak, PA; Chakravarti, A				Angrist, M; Bolk, S; Halushka, M; Lapchak, PA; Chakravarti, A			Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a hirschsprung disease patient	NATURE GENETICS			English	Article							TYROSINE KINASE; SURVIVAL FACTOR; RECEPTOR GENE; MOTOR-NEURONS; PROTOONCOGENE; MAPS; CHROMOSOME-10; MOTONEURONS		CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106; AMGEN INC,DEPT NEUROSCI,THOUSAND OAKS,CA 91320	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Amgen			Lapchak, Paul/P-1845-2019	Lapchak, Paul/0000-0003-4413-7554; Halushka, Marc/0000-0002-7112-7389	NICHD NIH HHS [HD28088] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028088] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; BADNER JA, 1990, AM J HUM GENET, V46, P568; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; BERMINGHAM N, 1995, HUM GENET, V96, P671, DOI 10.1007/BF00210297; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRESSLER GR, 1994, CURR BIOL, V4, P354, DOI 10.1016/S0960-9822(00)00078-6; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Durbec PL, 1996, DEVELOPMENT, V122, P349; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; EZOE K, 1995, AM J HUM GENET, V56, P58; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOLSCHNEIDER AM, 1982, HIRSCHSPRUNGS DIS; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LAPCHAK PA, IN PRESS REV NEUROSC; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHINDELHAUER D, 1995, GENOMICS, V28, P605, DOI 10.1006/geno.1995.1202; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Yin Luo, 1994, European Journal of Human Genetics, V2, P272; ZURN AD, 1994, NEUROREPORT, V6, P113, DOI 10.1097/00001756-199412300-00030	43	213	219	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					341	344		10.1038/ng1196-341	http://dx.doi.org/10.1038/ng1196-341			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896568				2022-12-27	WOS:A1996VQ14600033
J	Apostolou, S; Whitmore, SA; Crawford, J; Lennon, G; Sutherland, GR; Callen, DF; Ianzano, L; Savino, M; DApolito, M; Notarangelo, A; Memeo, E; Piemontese, MR; Zelante, L; Savoia, A; Gibson, RA; Tipping, AJ; Morgan, NV; Hassock, S; Jansen, S; deRavel, TJ; VanBerkel, C; Pronk, JC; Easton, DF; Mathew, CG; Levran, O; Verlander, PC; Batish, SD; Erlich, T; Auerbach, AD; CletonJansen, AM; Moerland, EW; Cornelisse, CJ; Doggett, NA; Deaven, LL; Moyzis, RK				Apostolou, S; Whitmore, SA; Crawford, J; Lennon, G; Sutherland, GR; Callen, DF; Ianzano, L; Savino, M; DApolito, M; Notarangelo, A; Memeo, E; Piemontese, MR; Zelante, L; Savoia, A; Gibson, RA; Tipping, AJ; Morgan, NV; Hassock, S; Jansen, S; deRavel, TJ; VanBerkel, C; Pronk, JC; Easton, DF; Mathew, CG; Levran, O; Verlander, PC; Batish, SD; Erlich, T; Auerbach, AD; CletonJansen, AM; Moerland, EW; Cornelisse, CJ; Doggett, NA; Deaven, LL; Moyzis, RK			Positional cloning of the Fanconi anaemia group A gene	NATURE GENETICS			English	Article							EXON AMPLIFICATION; PHYSICAL MAP; ANEMIA; COMPLEMENTATION; LOCALIZATION; STRATEGIES; MUTATION; FACC		UMDS, GUYS HOSP, DIV MED & MOL GENET, LONDON SE1 9RT, ENGLAND; ADELAIDE WOMENS & CHILDRENS HOSP, DEPT CYTOGENET & MOL GENET, ADELAIDE, SA 5006, AUSTRALIA; LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME, LIVERMORE, CA 94550 USA; UNIV ORANGE FREE STATE, DEPT HUMAN GENET, ZA-9301 BLOEMFONTEIN, SOUTH AFRICA; UNIV WITWATERSRAND, S AFRICAN INST MED RES, DEPT HUMAN GENET, ZA-2050 WITWATERSRAND, SOUTH AFRICA; FREE UNIV AMSTERDAM, DEPT HUMAN GENET, AMSTERDAM, NETHERLANDS; UNIV CAMBRIDGE, INST PUBL HLTH, GENET EPIDEMIOL UNIT, CAMBRIDGE CB2 1TN, ENGLAND; ROCKEFELLER UNIV, LAB HUMAN GENET & HEMATOL, NEW YORK, NY 10021 USA; LEIDEN UNIV, DEPT PATHOL, LEIDEN, NETHERLANDS; LOS ALAMOS NATL LAB, CTR HUMAN GENOME STUDIES, LOS ALAMOS, NM 87545 USA; OSPED CASA SOLLIEVO SOFFERENZA, I-71013 SAN GIOVANNI ROTONDO, FOGGIA, ITALY	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Womens & Childrens Hospital Australia; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of the Free State; University of Witwatersrand; Vrije Universiteit Amsterdam; University of Cambridge; Rockefeller University; Leiden University; Leiden University - Excl LUMC; United States Department of Energy (DOE); Los Alamos National Laboratory; IRCCS Casa Sollievo Della Sofferenza			Savoia, Anna/B-6463-2014; Sutherland, Grant Robert/D-2606-2012; Savoia, Anna/AIC-4560-2022; Crawford, Joanna/F-9135-2013; Callen, David F/G-1975-2012; d'Apolito, Maria/G-5793-2012; d'Apolito, Maria/AAQ-9290-2021; Levran, Orna/H-2772-2019; Lennon, Greg/T-4717-2019; Morgan, Neil V/A-5475-2009	Savoia, Anna/0000-0002-2407-2696; Savoia, Anna/0000-0002-2407-2696; Crawford, Joanna/0000-0003-0786-6889; Morgan, Neil V/0000-0001-6433-5692; Gibson, Rachel/0000-0002-1338-1290; Notarangelo, Angelantonio/0000-0002-1540-8530	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032987, R37HL032987] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom; NHLBI NIH HHS [HL32987] Funding Source: Medline; Telethon [E.0364] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondazione Telethon(Fondazione Telethon); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Altherr MR, 1996, CYTOGENET CELL GENET, V72, P271; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CLETONJANSEN AM, 1994, GENE CHROMOSOME CANC, V9, P101, DOI 10.1002/gcc.2870090205; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOGGETT NA, 1995, NATURE, V377, P335; Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; Gschwend M, 1996, AM J HUM GENET, V59, P377; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Savoia A, 1996, HUM GENET, V97, P599; SIDERAS P, 1992, J IMMUNOL, V149, P244; STALLINGS RL, 1992, GENOMICS, V13, P1031, DOI 10.1016/0888-7543(92)90016-L; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; TAGLE DA, 1993, NATURE, V361, P751, DOI 10.1038/361751a0; TRUMPP A, 1992, GENE DEV, V6, P14, DOI 10.1101/gad.6.1.14; VERLANDER PC, 1994, AM J HUM GENET, V54, P595	29	245	246	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					324	328		10.1038/ng1196-324	http://dx.doi.org/10.1038/ng1196-324			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896564				2022-12-27	WOS:A1996VQ14600029
J	Hulander, M; Wurst, W; Carlsson, P; Enerback, S				Hulander, M; Wurst, W; Carlsson, P; Enerback, S			The winged helix transcription factor Fkh10 is required for normal development of the inner ear	NATURE GENETICS			English	Article							SEGMENTATION MUTANT; GENE-EXPRESSION; 2 RHOMBOMERES; MOUSE EMBRYO; DNA-BINDING; HNF-3-BETA; PAX-3; MICE; KR	Fkh10 is a member of the forkhead family of winged helix transcriptional regulators. Genes encoding forkhead proteins are instrumental during embryogenesis in mammals, in particular during development of the nervous system(1-5). Here we report that mice with a targeted disruption of the Fkh10 locus exhibit circling behaviour, poor swimming ability and abnormal reaching response-all common findings in mice with vestibular dysfunction(6). These animals also fail to elicit a Preyer reflex in response to a suprathreshold auditory stimulation, as seen in mice with profound hearing impairment(7,8). Histological examination of the inner ear reveals a gross structural malformation of the vestibulum as well as the cochlea. These structures have been replaced by a single irregular cavity in which neither proper semicircular ducts nor cochlea can be identified. We also show that at 9.5 days post coitum (dpc), Fkh10 is exclusively expressed in the otic vesicle. These findings implicate Fkh10 as an early regulator necessary for development of both cochlea and vestibulum and identify its human homologue FKHL10 as a previously unknown candidate deafness gene at 5q34.	Univ Gothenburg, Lundberg Lab, Dept Biol Mol, SE-40530 Gothenburg, Sweden; Max Planck Inst Psychiat, D-80804 Munich, Germany; Chalmers Univ Technol, Dept Chem Phys, Unit Biotechnol, SE-41296 Gothenburg, Sweden	University of Gothenburg; Max Planck Society; Chalmers University of Technology	Enerback, S (corresponding author), Univ Gothenburg, Lundberg Lab, Dept Biol Mol, Box 462, SE-40530 Gothenburg, Sweden.	sven.enerback@molbio.gu.se	Carlsson, Peter/B-5551-2008	Carlsson, Peter/0000-0001-6535-5927; Wurst, Wolfgang/0000-0003-4422-7410				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; DEOL MS, 1964, J EMBRYOL EXP MORPH, V12, P475; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; FROHMAN MA, 1993, DEVELOPMENT, V117, P925; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hadrys T, 1998, DEVELOPMENT, V125, P33; Labosky PA, 1997, DEVELOPMENT, V124, P1263; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; LYON MF, 1996, GENETIC VARIANTS STR; MARK M, 1993, DEVELOPMENT, V119, P319; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; Overdier DG, 1997, J BIOL CHEM, V272, P13725, DOI 10.1074/jbc.272.21.13725; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1983, BEHAV NEUROSCI, V97, P381, DOI 10.1037/0735-7044.97.3.381; STEEL KP, 1992, DEV AUDITORY VESTIBU, V2, P221; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang WD, 1998, DEVELOPMENT, V125, P621; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7	30	70	70	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					374	376		10.1038/3850	http://dx.doi.org/10.1038/3850			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843211				2022-12-27	WOS:000077199600026
J	Seielstad, MT; Minch, E; Cavalli-Sforza, LL				Seielstad, MT; Minch, E; Cavalli-Sforza, LL			Genetic evidence for a higher female migration rate in humans	NATURE GENETICS			English	Article							DNA; HAPLOTYPES; TRANSITION; LINEAGES; MARKERS; NUCLEAR	Mitochondrial DNA and the Y chromosome have been used extensively in the study of modern human origins and other phylogenetic questions, but not in the context of their sex-specific modes of transmission, mtDNA is transmitted exclusively by females, whereas the Y chromosome is passed only among males. As a result, differences in the reproductive output or migration rate of males and females will influence the geographic patterns and relative level of genetic diversity on the Y chromosome, autosomes and mtDNA (ref. 1). We have found that Y chromosome variants tend to be more localized geographically than those of mtDNA and the autosomes(2-5). The fraction of variation within human populations for Y chromosome single nucleotide polymorphisms (SNPs) is 35.5%, versus 80-85% for the autosomes and mtDNA (refs 6-8). A higher female than male migration rate (via patrilocality, the tendency for a wife to move into her husband's natal household) explains most of this discrepancy, because diverse Y chromosomes would enter a population at a lower rate than mtDNA or the autosomes. Polygyny may also contribute, but the reduction of variation within populations that we measure for the Y chromosome, relative to the autosomes and mitochondrial DNA, is of such magnitude that differences in the effective population sizes of the sexes alone are insufficient to produce the observation.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; Stanford University	Seielstad, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, 665 Huntington Ave, Boston, MA 02115 USA.	mark@ppg.harvard.edu	Seielstad, Mark/T-7841-2019	Seielstad, Mark/0000-0001-5783-1401	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BURTON GJ, 1987, PLACENTA, V8, P37, DOI 10.1016/0143-4004(87)90038-5; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; DORJAHN DR, 1959, CONTINUITY CHANGE AF, P87; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; EXCOFFIER L, 1992, GENETICS, V131, P479; FELDMAN MW, IN PRESS MICROSATELL; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HEWLETT B, 1982, MAN, V17, P418, DOI 10.2307/2801706; Hrdlicka A, 1931, AM J PHYS ANTHROPOL, V16, P81, DOI 10.1002/ajpa.1330160118; ISAAC BL, 1980, ETHNOLOGY, V19, P297, DOI 10.2307/3773334; Keane B, 1997, MOL ECOL, V6, P267, DOI 10.1046/j.1365-294X.1997.00178.x; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIYATA T, 1982, J MOL EVOL, V19, P28, DOI 10.1007/BF02100221; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Richards M, 1996, AM J HUM GENET, V59, P185; Salem AH, 1996, AM J HUM GENET, V59, P741; SCHNEIDER S, 1997, ARLEQUIN VER 1 1; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; SLATKIN M, 1995, GENETICS, V139, P457; THOMAS JMC, 1963, NGBAKA LOBAYE; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WHITE DR, 1988, CURR ANTHROPOL, V29, P529, DOI 10.1086/203674; WIJSMAN EM, 1984, ANNU REV ECOL SYST, V15, P279	30	425	437	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					278	280		10.1038/3088	http://dx.doi.org/10.1038/3088			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	133QW	9806547				2022-12-27	WOS:000076698100022
J	Chen, ZF; Paquette, AJ; Anderson, DJ				Chen, ZF; Paquette, AJ; Anderson, DJ			NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis	NATURE GENETICS			English	Article							RESTRICTIVE SILENCER ELEMENT; CELL-ADHESION MOLECULE; SODIUM-CHANNEL GENE; CHICK-EMBRYO; SYNAPSIN-I; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; PROTEIN; VECTORS	The neuron-restrictive silencer factor NRSF (also known as REST and XBR) can silence transcription from neuronal promoters in non-neuronal cell lines, but its function during normal development is unknown. In mice, a targeted mutation of Rest, the gene encoding NRSF, caused derepression of neuron-specific tubulin in a subset of non-neural tissues and embryonic lethality. Mosaic inhibition of NRSF in chicken embryos, using a dominant-negative form of NRSF, also caused derepression of neuronal tubulin, as well as of several other neuronal target genes, in both non-neural tissues and central nervous system neuronal progenitors. These results indicate that NRSF is required to repress neuronal gene expression in vivo, in both extra-neural and undifferentiated neural tissue.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.							Arnone MI, 1997, DEVELOPMENT, V124, P1851; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Homburger SA, 1996, DEV DYNAM, V206, P112, DOI 10.1002/(SICI)1097-0177(199605)206:1<112::AID-AJA10>3.0.CO;2-7; Hunter E, 1979, Methods Enzymol, V58, P379; KALLUNKI P, 1995, J BIOL CHEM, V270, P21291, DOI 10.1074/jbc.270.36.21291; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; KALLUNKI P, IN PRESS P NATL ACAD; Kaufman M. H, 1990, POSTIMPLANTATION MAM, P81; Kohler J, 1996, NUCLEIC ACIDS RES, V24, P2543, DOI 10.1093/nar/24.13.2543; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MANDEL G, 1993, ANNU REV NEUROSCI, V16, P323, DOI 10.1146/annurev.ne.16.030193.001543; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; MORGAN BA, 1996, METHODS AVIAN EMBRYO, P185; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Palm K, 1998, J NEUROSCI, V18, P1280; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Scholl T, 1996, J IMMUNOL, V156, P1448; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; VANDENBERGH DJ, 1989, NEURON, V3, P507, DOI 10.1016/0896-6273(89)90209-2; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	36	381	387	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					136	142		10.1038/2431	http://dx.doi.org/10.1038/2431			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771705				2022-12-27	WOS:000076231300014
J	Van Laer, L; Huizing, EH; Verstreken, M; van Zuijlen, D; Wauters, JG; Bossuyt, PJ; Van de Heyning, P; McGuirt, WT; Smith, RJH; Willems, PJ; Legan, PK; Richardson, GP; Van Camp, G				Van Laer, L; Huizing, EH; Verstreken, M; van Zuijlen, D; Wauters, JG; Bossuyt, PJ; Van de Heyning, P; McGuirt, WT; Smith, RJH; Willems, PJ; Legan, PK; Richardson, GP; Van Camp, G			Nonsyndromic hearing impairment is associated with a mutation in DFNA5	NATURE GENETICS			English	Article							PRE-MESSENGER-RNA; FAMILY; GENE; INTRON	Nonsyndromic hearing impairment is one of the most heterogeneous hereditary conditions, with more than 40 loci mapped on the human genome(1), however, only a limited number of genes implicated in hearing loss have been identified. We previously reported linkage to chromosome 7p15 for autosomal dominant hearing impairment segregating in an extended Dutch family(2,3) (DFNA5). Here. we report a further refinement of the DFNA5 candidate region and the isolation of a gene from this region that is expressed in the cochlea. In intron 7 of this gene. we identified an insertion/deletion mutation that does not affect intron-exon boundaries, but deletes five G-triplets at the 3' end of the intron. The mutation co-segregated with deafness in the family and causes skipping of exon 8. resulting in premature termination of the open reading frame. As no physiological function could be assigned, the gene was designated DFNA5.	Univ Instelling Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Univ Utrecht Hosp, Dept Otorhinolaryngol, NL-3584 CX Utrecht, Netherlands; Univ Instelling Antwerp, Dept Otorhinolaryngol, B-2610 Antwerp, Belgium; Univ Iowa Hosp & Clin, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Antwerp; Utrecht University; Utrecht University Medical Center; University of Antwerp; University of Iowa; University of Sussex	Van Camp, G (corresponding author), Univ Instelling Antwerp, Dept Med Genet, Univ Plein 1, B-2610 Antwerp, Belgium.	gvcamp@uia.ua.ac.be	Heyning, Paul H Vande/I-8278-2017; Van Camp, Guy/F-3386-2013	Heyning, Paul H Vande/0000-0002-8424-3717; Van Camp, Guy/0000-0001-5105-9000; Legan, P. Kevin/0000-0002-7403-6415; Smith, Richard/0000-0003-1201-6731	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003544] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 03544] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; Huizing E H, 1966, Acta Otolaryngol, V61, P161, DOI 10.3109/00016486609127053; Huizing E H, 1966, Acta Otolaryngol, V61, P35, DOI 10.3109/00016486609127040; HUIZING EH, 1983, ACTA OTO-LARYNGOL, V95, P620, DOI 10.3109/00016488309139453; HUIZING EH, 1972, AUDIOLOGY, V11, P261; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; Thompson DA, 1998, EUR J BIOCHEM, V252, P169, DOI 10.1046/j.1432-1327.1998.2520169.x; Van Laer L, 1997, EUR J HUM GENET, V5, P397, DOI 10.1159/000484798; VanCamp G, 1997, AM J HUM GENET, V60, P758; VANCAMP G, 1995, HUM MOL GENET, V4, P2159; VANDENWIJNGAART WSIM, 1985, AUDIOLOGY, V24, P336; VANDENWIJNGAART WSIM, 1985, AUDIOLOGY, V24, P233; WAUTERS JG, 1992, CYTOGENET CELL GENET, V60, P194, DOI 10.1159/000133334; Xu Y, 1994, Genet Eng (N Y), V16, P241; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565	21	234	243	2	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					194	197						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771715				2022-12-27	WOS:000076231300024
J	Magnaghi, P; Roberts, C; Lorain, S; Lipinski, M; Scambler, PJ				Magnaghi, P; Roberts, C; Lorain, S; Lipinski, M; Scambler, PJ			HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; DIGEORGE-SYNDROME; NEURAL CREST; WAARDENBURG-SYNDROME; VELOCARDIOFACIAL SYNDROMES; CRITICAL REGION; CANDIDATE GENE; MOUSE; 22Q11; MUTANT	HIRA maps to the DiGeorge/velocardiofacial syndrome critical region (DGCR) at 22q11 (refs 1,2) and encodes a WD40 repeat protein similar to yeast Hir1p and Hir2p. These transcriptional co-repressors regulate cell cycle-dependent histone gene transcription(3), possibly by remodelling local chromatin structure. We report an interaction between HIRA and the transcription factor Pax3. Pax3 haploinsufficiency results in the mouse splotch and human Waardenburg syndrome (WSI and WSIII) phenotypes. Mice homozygous for Pax3 mutations die in utero with a phenocopy of DCS, or neonatally with neural tube defects. HIRA was also found to interact with core histones. Thus, altered stoichiometry of complexes containing HIRA may be important for the development of structures affected in WS and DCS.	Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Gustave Roussy, CNRS UMR1598, Lab Biol Tumeurs Humaines, F-94805 Villejuif, France	University of London; University College London; UNICANCER; Gustave Roussy	Scambler, PJ (corresponding author), Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.		Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Lorain, Stephanie/0000-0001-5266-9994				BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Conway SJ, 1997, DEVELOPMENT, V124, P505; Dallapiccola B, 1996, AM J HUM GENET, V59, P7; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; EDMUNDSON DG, 1996, GENE DEV, V10, P1247; FRANZ T, 1989, ANAT EMBRYOL, V180, P457, DOI 10.1007/BF00305120; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; Harlow E., 1988, ANTIBODIES LAB MANUA; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JOSTES B, 1991, MECH DEVELOP, V33, P27; KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; LORAIN S, 1998, IN PRESS MOL CELL BI; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Mansouri A, 1996, DEVELOPMENT, V122, P831; MOASE CE, 1990, TERATOLOGY, V42, P171, DOI 10.1002/tera.1420420208; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Rizzu P, 1996, MAMM GENOME, V7, P639, DOI 10.1007/s003359900197; Roberts C, 1997, HUM MOL GENET, V6, P237, DOI 10.1093/hmg/6.2.237; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247; ZAPPAVIGNA V, 1996, EMBO J, V15, P5981; ZLOTOGORA J, 1995, AM J HUM GENET, V56, P1173	30	104	108	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					74	77		10.1038/1739	http://dx.doi.org/10.1038/1739			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731536				2022-12-27	WOS:000075671400024
J	Motoyama, J; Liu, J; Mo, R; Ding, Q; Post, M; Hui, CC				Motoyama, J; Liu, J; Mo, R; Ding, Q; Post, M; Hui, CC			Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus	NATURE GENETICS			English	Article							PALLISTER-HALL SYNDROME; SONIC-HEDGEHOG; PATCHED GENE; MOUSE; MORPHOGENESIS; INVOLVEMENT; EXPRESSION; INDUCTION; POLARITY; MESODERM	Foregut malformations (oesophageal atresia. tracheo-oesophageal fistula, lung anomalies and congenital stenosis of the oesophagus and trachea) are relatively common anomalies occurring in 1 in 2,000-5,000 live births, although their aetiology is poorly understood(1). The secreted glycoprotein Sonic hedgehog (Shh) has been suggested to act as an endodermal signal that controls hindgut patterning(2) and lung growth(3). In mice, three zinc-finger transcription factors, Gli1, Gli2 and Gli3, have been implicated in the transduction of Shh signal(4-10). We report here that mutant mice lacking Gli2 function exhibit Foregut defects, including stenosis of the oesophagus and trachea, as well as hypoplasia and lobulation defects of the lung. A reduction of 50% in the gene dosage of Gli3 in a Gli2(-/-) background resulted in oesophageal atresia with tracheo-oesophageal fistula and a severe lung phenotype. Mutant mice lacking both Gli2 and Gli3 function did not form oesophagus, trachea and lung. These results indicate that Gli2 and Gli3 possess specific and overlapping functions in Shh signalling during foregut development, and suggest that mutations in GLI genes may be involved in human foregut malformations.	Hosp Sick Children, Res Inst, Programs Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Program Lung Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Program Canc & Blood, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Physiol, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Hui, CC (corresponding author), Hosp Sick Children, Res Inst, Programs Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cchui@sickkids.on.ca						Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Ding Q, 1998, DEVELOPMENT, V125, P2533; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; Mo R, 1997, DEVELOPMENT, V124, P113; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Skandalakis JE., 1994, EMBRYOLOGY SURG; SPOONER BS, 1970, J EXP ZOOL, V175, P445, DOI 10.1002/jez.1401750404; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; VERLOES A, 1995, J MED GENET, V32, P605, DOI 10.1136/jmg.32.8.605; WESSELLS NK, 1970, J EXP ZOOL, V175, P455, DOI 10.1002/jez.1401750405	27	412	431	2	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					54	57		10.1038/1711	http://dx.doi.org/10.1038/1711			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731531				2022-12-27	WOS:000075671400019
J	Geller, DS; Rodriguez-Soriano, J; Boado, AV; Schifter, S; Bayer, M; Chang, SS; Lifton, RP				Geller, DS; Rodriguez-Soriano, J; Boado, AV; Schifter, S; Bayer, M; Chang, SS; Lifton, RP			Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I	NATURE GENETICS			English	Article							EPITHELIAL SODIUM-CHANNEL; RNA SPLICE JUNCTIONS; BETA-SUBUNIT; ALDOSTERONE; SALT; CORTICOSTERONE; HYPERTENSION	Pseudohypoaldosteronism type I (PHA1) is characterized by neonatal renal salt wasting with dehydration, hypotension, hyperkalaemia and metabolic acidosis, despite elevated aldosterone levels. Two forms of PHA1 exist. An autosomal recessive form features severe disease with manifestations persisting into adulthood(1). This form is caused by toss-of-function mutations in genes encoding subunits of the amiloride-sensitive epithelial sodium channel (ENaC; refs 2,3). Autosomal dominant or sporadic PHA1 is a milder disease that remits with age. Among six dominant and seven sporadic PHA1 kindreds, we have found no ENaC gene mutations, implicating mutations in other genes. As ENaC activity in the kidney is regulated by the steroid hormone aldosterone acting through the mineralocorticoid receptor(4), we have screened the mineralocorticoid receptor gene (MLR) for variants and have identified heterozygous mutations in one sporadic and four dominant kindreds. These include two frameshift mutations tone a de novo mutation), two premature termination codons and one splice donor mutation. These mutations segregate with PHA1 and are not found in unaffected subjects. These findings demonstrate that heterozygous MLR mutations cause PHA1, underscore the important role of mineralocorticoid receptor function in regulation of salt and blood pressure homeostasis in humans and motivate further study of this gene for a potential role in blood pressure variation.	Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06510 USA; Hosp Cruces, Dept Pediat, E-48903 Barakaldo, Spain; Glostrup Cty Hosp, Dept Clin Physiol & Nucl Med, DK-2600 Glostrup, Denmark; Charles Univ, Fac Med 1, Dept Pediat, Prague, Czech Republic	Howard Hughes Medical Institute; Yale University; Yale University; Hospital Universitario Cruces; University of Copenhagen; Charles University Prague	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.							ARAI K, 1995, J CLIN ENDOCR METAB, V80, P814, DOI 10.1210/jc.80.3.814; BAYER M, 1993, ACTA PAEDIATR, V82, P504, DOI 10.1111/j.1651-2227.1993.tb12736.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Berger S, 1996, ENDOCR RES, V22, P641, DOI 10.1080/07435809609043758; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; EPPLE HJ, 1995, AM J PHYSIOL-GASTR L, V269, pG42, DOI 10.1152/ajpgi.1995.269.1.G42; GomezSanchez EP, 1996, STEROIDS, V61, P184, DOI 10.1016/0039-128X(96)00010-4; Grunder S, 1997, CURR OPIN NEPHROL HY, V6, P35; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; KOMESAROFF PA, 1994, J CLIN ENDOCR METAB, V79, P27, DOI 10.1210/jc.79.1.27; KOO WWK, 1982, ARCH DIS CHILD, V57, P500, DOI 10.1136/adc.57.7.500; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kuhnle U, 1997, MOL CELL ENDOCRINOL, V133, P77, DOI 10.1016/S0303-7207(97)00149-4; LimTio SS, 1997, ENDOCRINOLOGY, V138, P2537, DOI 10.1210/en.138.6.2537; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; PETERSEN S, 1978, ACTA PAEDIATR SCAND, V67, P255, DOI 10.1111/j.1651-2227.1978.tb16314.x; RODRIGUEZSORIANO J, 1990, PEDIATR NEPHROL, V4, P105, DOI 10.1007/BF00858819; ROSLER A, 1984, J CLIN ENDOCR METAB, V59, P689; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SIPPELL WG, 1980, PEDIATR RES, V14, P39, DOI 10.1203/00006450-198014010-00010; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; ZENNARO MC, 1995, J BIOL CHEM, V270, P21016, DOI 10.1074/jbc.270.36.21016; ZENNARO MC, 1994, J CLIN ENDOCR METAB, V79, P32, DOI 10.1210/jc.79.1.32	24	253	259	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					279	281		10.1038/966	http://dx.doi.org/10.1038/966			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662404				2022-12-27	WOS:000074565900027
J	Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K				Hayashi, YK; Chou, FL; Engvall, E; Ogawa, M; Matsuda, C; Hirabayashi, S; Yokochi, K; Ziober, BL; Kramer, RH; Kaufman, SJ; Ozawa, E; Goto, Y; Nonaka, I; Tsukahara, T; Wang, JZ; Hoffman, EP; Arahata, K			Mutations in the integrin alpha 7 gene cause congenital myopathy	NATURE GENETICS			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CYTOPLASMIC DOMAINS; NERVOUS-SYSTEM; CHAIN GENE; EXPRESSION; LAMININ; MEROSIN; DEFICIENCY	The basal lamina of muscle fibers plays a crucial role in the of development and function of skeletal muscle. An important laminin receptor in muscle is integrin alpha 7 beta 1D. Integrin beta 1 is expressed throughout the body, while integrin alpha 7 is more muscle-specific(1-5). To address the role of integrin alpha 7 in human muscle disease, we determined alpha 7 protein expression in muscle biopsies from 117 patients with unclassified congenital myopathy and congenital muscular dystrophy by immunocytochemistry. We found three unrelated patients with integrin alpha 7 deficiency and normal laminin alpha 2 chain expression. To determine nine if any of these three patients had mutations of the integrin alpha 7 gene, ITGA7, we cloned and sequenced the full-length human ITGA7 cDNA, and screened the patients for mutations. One patient had splice mutations on both alleles; one causing a 21-bp insertion in the conserved cysteine-rich region, and the other causing a 98-bp deletion, A second patient was a compound heterozygote for the same 98-bp deletion, and had a l-bp frame-shift deletion on the other allele. A third showed marked deficiency of ITGA7 mRNA, Clinically, these patients showed congenital myopathy with delayed motor milestones, Our results demonstrate that mutations in ITGA7 are involved in a form of congenital myopathy.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Cell Biol, Kodaira, Tokyo 187, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 187, Japan; Univ Pittsburgh, Sch Med, Dept Human Genet, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; La Jolla Canc Res Ctr, Burnham Inst, La Jolla, CA 92037 USA; Agcy Ind Sci & Technol, Natl Inst Biosci & Human Technol, Dept Biomol Engn, Oho, Ibaraki 305, Japan; Nagano Childrens Hosp, Dept Pediat, Nagano 399, Japan; Seirei Mikatabara Hosp, Dept Neuropediat, Shizuoka 433, Japan; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sanford Burnham Prebys Medical Discovery Institute; National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign	Arahata, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 187, Japan.	arahata@ncnaxp.ncnp.go.jp		Hoffman, Eric/0000-0001-6470-5139	NIA NIH HHS [AG 14632] Funding Source: Medline; PHS HHS [R01 29525] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014632] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BANKER BQ, 1994, MYOLOGY, P1275; COLLO G, 1993, J BIOL CHEM, V268, P19019; DUBOWITZ V, 1989, COLOR ATLAS MUSCLE D, P52; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Guicheney P, 1997, NEUROMUSCULAR DISORD, V7, P180, DOI 10.1016/S0960-8966(97)00460-4; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hodges BL, 1997, J CELL SCI, V110, P2873; Kil SH, 1996, INT J DEV NEUROSCI, V14, P181, DOI 10.1016/0736-5748(96)00006-8; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Nagano A, 1996, NAT GENET, V12, P254, DOI 10.1038/ng0396-254; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; VACHON P, 1997, J CLIN INVEST, V100, P170; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VIDAL F, 1995, GENOMICS, V30, P273, DOI 10.1006/geno.1995.9877; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; WANG W, 1995, GENOMICS, V26, P56; YOSHIDA M, 1993, J BIOCHEM-TOKYO, V114, P634, DOI 10.1093/oxfordjournals.jbchem.a124229; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773; [No title captured]	30	275	282	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					94	97		10.1038/ng0598-94	http://dx.doi.org/10.1038/ng0598-94			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590299				2022-12-27	WOS:000073346700027
J	Shan, XY; Kruger, WD				Shan, XY; Kruger, WD			Correction of disease-causing CBS mutations in yeast	NATURE GENETICS			English	Article							CYSTATHIONINE BETA-SYNTHASE; EXPRESSION; GENES	Mutations in cystathionine beta-synthase (CBS) are known to cause homocystinuria, a recessive disorder characterized by excessive levels of total homocysteine (tHcy) in plasma(1). The primary cause of mortality is thromboembolism induced by the excessive tHcy levels. Mild increases in tHcy levels are a significant risk factor in the development of vascular disease in the general population(2). This can result from heterozygosity at the CB5 locus or polymorphic variation in other enzymes involved in homocysteine re-methylation. We report here that a mutation which deletes the carboxy-terminal 145 amino acids of CBS can functionally suppress the phenotype of several CBS mutant alleles found in homocystinurics when expressed in yeast. This C-terminal domain of CB5 acts to inhibit enzymatic activity and is in turn regulated by S-adenosylmethionine (AdoMet), a positive effector of CBS. Our results indicate that most mutations found in homocystinurics do not cause dysfunction of the catalytic domain, but rather interfere with the activation of the enzyme. These findings suggest a new drug target to treat homocystinuria and homocysteine-related vascular disease.	Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	wd_kruger@fccc.edu	kruger, warren/A-6407-2008; Kruger, Warren/Y-2541-2018	kruger, warren/0000-0002-4990-3695; 	NHLBI NIH HHS [HL57299-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057299, R29HL057299] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; GALLAGHER PM, 1995, HUM MUTAT, V6, P177, DOI 10.1002/humu.1380060211; Harlow E., 1988, ANTIBODIES LABORATOR, P511; Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213; Kluijtmans LAJ, 1996, J CLIN INVEST, V98, P285, DOI 10.1172/JCI118791; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155; MUDD SH, 1995, METABOLIC BASIS INHE, P693; ROPER MD, 1992, ARCH BIOCHEM BIOPHYS, V298, P514, DOI 10.1016/0003-9861(92)90443-Z; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3	12	103	107	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					91	93		10.1038/ng0598-91	http://dx.doi.org/10.1038/ng0598-91			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590298				2022-12-27	WOS:000073346700026
J	Odorisio, T; Rodriguez, TA; Evans, EP; Clarke, AR; Burgoyne, PS				Odorisio, T; Rodriguez, TA; Evans, EP; Clarke, AR; Burgoyne, PS			The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis	NATURE GENETICS			English	Article							P53 PROTEIN; MICE; SPERMATOGENESIS; CHROMOSOME; FERTILITY	Evidence is accumulating that meiosis is subject to 'checkpoints' that monitor the quality of this complex process. In yeast, unresolved double strand breaks (DSBs) in DNA are thought to trigger a 'recombination checkpoint' that leads to pachytene arrest(1). In higher eukaryotes, there is evidence for a checkpoint that monitors chromosome synapsis and in mammals the most compelling evidence relates to the sex chromosomes(2). In normal male mice, there is synapsis between the X and Y pseudoautosomal regions; in XSxr(a)O mice, with a single asynaptic sex chromosome, there is arrest at the first meiotic metaphase(3), the arrested cells being eliminated by apoptosis (our unpublished data). Satisfying the requirement for pseudoautosomal synapsis by providing a pairing partner for the XSxr(a) chromosome avoids this arrest(4). We have considered that this 'synapsis checkpoint' may be a modification of the yeast 'recombination checkpoint', with unresolved DSBs (a corollary of asynapsis) providing the trigger for apoptosis. DSBs induced by irradiation are known to trigger apoptosis in a number of cell types via a p53-dependent pathway(5,6), and we now show that irradiation-induced spermatogonial apoptosis is also p53-dependent. In contrast, the apoptotic elimination of spermatocytes with synaptic errors proved to be p53-independent.	Natl Inst Med Res, Lab Dev Genet, London NW7 1AA, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Univ Edinburgh, Sch Med, Dept Pathol, Edinburgh EH8 9AG, Midlothian, Scotland	MRC National Institute for Medical Research; MRC Harwell; University of Edinburgh	Burgoyne, PS (corresponding author), Natl Inst Med Res, Lab Dev Genet, Ridgeway,Mill Hill, London NW7 1AA, England.		clarke, alan r/P-2820-2014; Clarke, Alan R/A-6256-2008	Clarke, Alan/0000-0002-4281-426X; ODORISIO, Teresa/0000-0001-8851-3502; Rodriguez, Tristan/0000-0002-3415-8493				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Allan D.J., 1987, P229; Barlow C, 1997, NAT GENET, V17, P462, DOI 10.1038/ng1297-462; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Beumer TL, 1997, MOL REPROD DEV, V47, P240, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;240::AID-MRD2&gt;3.0.CO;2-L; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; Burgoyne PS, 1993, CHROMOSOMES TODAY, V11, P243; BURGOYNE PS, 1984, CONTROLLING EVENTS M, P349; CLARKE AR, 1994, ONCOGENE, V9, P1767; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; EICHER EM, 1991, CYTOGENET CELL GENET, V57, P221, DOI 10.1159/000133152; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; EVANS EP, 1975, NATURE, V256, P40, DOI 10.1038/256040a0; FORD CE, 1964, CYTOGENETICS, V3, P295, DOI 10.1159/000129819; Hendry JH, 1996, INT J RADIAT BIOL, V70, P677, DOI 10.1080/095530096144563; HENRIKSEN K, 1996, J ANDROL, V17, P939; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; MAHADEVAIAH S, 1986, CYTOGENET CELL GENET, V41, P169, DOI 10.1159/000132222; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; Plug AW, 1997, NAT GENET, V17, P457, DOI 10.1038/ng1297-457; READER CR, 1969, ACTA PHYSIOL LAT AM, V19, P249; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSL F, 1992, NUCLEIC ACIDS RES, V20, P5243, DOI 10.1093/nar/20.19.5243; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; SCHWARTZ D, 1993, ONCOGENE, V8, P1487; SUTCLIFFE MJ, 1991, MOL REPROD DEV, V30, P81, DOI 10.1002/mrd.1080300202; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	31	230	242	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					257	261		10.1038/ng0398-257	http://dx.doi.org/10.1038/ng0398-257			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500548				2022-12-27	WOS:000072325000024
J	Banerjee, P; Kleyn, PW; Knowles, JA; Lewis, CA; Ross, BM; Parano, E; Kovats, SG; Lee, JJ; Penchaszadeh, GK; Ott, J; Jacobson, SG; Gilliam, TC				Banerjee, P; Kleyn, PW; Knowles, JA; Lewis, CA; Ross, BM; Parano, E; Kovats, SG; Lee, JJ; Penchaszadeh, GK; Ott, J; Jacobson, SG; Gilliam, TC			TULP1 mutation in two extended Dominican kindreds with autosomal recessive Retinitis pigmentosa	NATURE GENETICS			English	Article							SPLICE-SITE; GENE; TUBBY; MOUSE; IDENTIFICATION; FAMILY	The RP14 autosomal recessive Retinitis pigmentosa (arRP) locus has been mapped to a 2cM region of chromosome 6p21.3 (refs 1-3). TULP1 (the gene encoding tubby-like protein 1) is a candidate target for the disease mutation because it maps to the RP14 minimum genetic region and because a mutation in the highly homologous mouse tub gene leads to obesity, deafness and early progressive retinal degeneration(4-6). Here we report a splice-site mutation (IVS14+1, G-->A) that is homozygous in all affected individuals (N=33) and heterozygous in all obligate carriers (N=50) from two RP14-linked kindreds. The mutation was not observed in 210 unrelated controls. The data indicate that impairment of TULP1 protein function is a rare cause of arRP and that the normal protein plays an essential role in the physiology of the retina.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; New York State Psychiat Inst, New York, NY 10032 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Med Ctr, Carrabelle, FL 32322 USA; Univ Catania, Pediat Clin, Catania, Italy; CNR, IBFSNC, Catania, Italy; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Rockefeller University; University of Pennsylvania; Pennsylvania Medicine	Gilliam, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.			Jacobson, Samuel/0000-0003-2122-169X; PARANO, ENRICO/0000-0002-0713-7339				BANERJEE P, IN PRESS GENOMICS; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; JACOBSON SG, 1994, INVEST OPHTH VIS SCI, V35, P2521; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; KNOWLES JA, 1994, HUM MOL GENET, V3, P1401, DOI 10.1093/hmg/3.8.1401; KRAWCZAK M, 1992, HUM GENET, V90, P41; LINCOLN AL, 1991, PRIMER COMPUTER PROG; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Reig C, 1996, HUM MUTAT, V8, P93, DOI 10.1002/(SICI)1098-1004(1996)8:1<93::AID-HUMU17>3.0.CO;2-M; SHUGART YY, 1995, AM J HUM GENET, V57, P499; SINGH RK, 1993, HUM MOL GENET, V2, P875	15	120	123	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					177	179		10.1038/ng0298-177	http://dx.doi.org/10.1038/ng0298-177			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462751				2022-12-27	WOS:000071779500030
J	Williams, BC; Murphy, TD; Goldberg, ML; Karpen, GH				Williams, BC; Murphy, TD; Goldberg, ML; Karpen, GH			Neocentromere activity of structurally acentric mini-chromosomes in Drosophila	NATURE GENETICS			English	Article							POSITION-EFFECT VARIEGATION; KINESIN-LIKE PROTEIN; ALPHA-SATELLITE DNA; CENP-C; CENTROMERE PROTEIN; DICENTRIC CHROMOSOME; FISSION YEAST; P-ELEMENTS; CHROMATIN; HETEROCHROMATIN	Chromosome fragments that lack centromeric DNA (structurally acentric chromosomes) are usually not inherited in mitosis and meiosis. We previously described the isolation, after irradiation of a Drosophila melanogaster minichromosome, of structurally acentric mini-chromosomes that display efficient mitotic and meiotic transmission despite their small size (under 300 kb) and lack of centromeric DNA. Here we report that these acentric minichromosomes bind the centromere-specific protein ZW10 and associate with the spindle poles in anaphase. The sequences in these acentric mini-chromosomes were derived from the tip of the X chromosome, which does not display centromere activity or localize ZW10, even when separated from the rest of the X. We conclude that the normally non-centromeric DNAs present in these acentric mini-chromosomes have acquired centromere function, and suggest that this example of 'neocentromere' formation involves appropriation of a self-propagating centromeric chromatin structure. The potential relevance of these observations to the identity, propagation and function of normal centromeres is discussed.	Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA; Cornell Univ, Genet & Dev Sect, Ithaca, NY 14853 USA	Salk Institute; Cornell University	Karpen, GH (corresponding author), Salk Inst Biol Studies, Mol Biol & Virol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			WILLIAMS, BYRON/0000-0002-1517-931X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048430] Funding Source: NIH RePORTER; NIGMS NIH HHS [5R01GM48430] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; AJIRO K, 1985, J BIOL CHEM, V260, P5379; Albertson D, 1997, NEMATODE C ELEGANS, P47; ALFENITO MR, 1993, GENETICS, V135, P589; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; AULT JG, 1988, CHROMOSOMA, V97, P71, DOI 10.1007/BF00331796; BONNER JJ, 1984, CELL, V37, P979; BROWN MT, 1995, GENE, V160, P111, DOI 10.1016/0378-1119(95)00163-Z; BROWN W, 1995, TRENDS GENET, V11, P337, DOI 10.1016/S0168-9525(00)89100-3; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; CLARKE L, 1993, COLD SPRING HARB SYM, V58, P687, DOI 10.1101/SQB.1993.058.01.076; Cook KR, 1997, GENETICS, V145, P737; Dawe RK, 1996, P NATL ACAD SCI USA, V93, P8512, DOI 10.1073/pnas.93.16.8512; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; GOLDSTEIN LS, 1991, BIOESSAYS, V13, P675; GOLIC KG, 1994, GENETICS, V137, P551; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; KARPEN GH, 1992, GENETICS, V132, P737; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; KARPEN GH, 1990, CELL, V63, P97; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; LE MH, 1995, GENETICS, V141, P283; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOHE AR, 1995, CURR OPIN GENET DEV, V5, P746, DOI 10.1016/0959-437X(95)80007-R; MARSCHALL LG, 1995, J CELL BIOL, V128, P445, DOI 10.1083/jcb.128.4.445; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; Mather K, 1933, J GENET, V28, P1, DOI 10.1007/BF02981766; MCKEE BD, 1990, CELL, V61, P61, DOI 10.1016/0092-8674(90)90215-Z; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; MERRY DE, 1985, AM J HUM GENET, V37, P425; MURPHY TD, 1995, CELL, V81, P139, DOI 10.1016/0092-8674(95)90378-X; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; Ngan VK, 1997, MOL CELL BIOL, V17, P3305, DOI 10.1128/MCB.17.6.3305; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; Rhoades M. M., 1952, Heterosis., P66; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Starr DA, 1997, J CELL BIOL, V138, P1289, DOI 10.1083/jcb.138.6.1289; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; SUN X, 1997, CELL, V91; Taylor SS, 1996, CHROMOSOMA, V105, P70, DOI 10.1007/BF02509516; THERMAN E, 1974, AM J HUM GENET, V26, P83; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; TOWER J, 1993, GENETICS, V133, P347; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; Warburton PE, 1997, CHROMOSOMA, V106, P149, DOI 10.1007/s004120050234; WEVRICK R, 1992, GENOMICS, V14, P912, DOI 10.1016/S0888-7543(05)80112-0; WILLIAMS BC, 1992, J CELL BIOL, V118, P759, DOI 10.1083/jcb.118.4.759; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Williams BC, 1996, J CELL BIOL, V134, P1127, DOI 10.1083/jcb.134.5.1127; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4	65	167	172	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					30	37		10.1038/ng0198-30	http://dx.doi.org/10.1038/ng0198-30			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425896				2022-12-27	WOS:000071259600017
J	Chen, KS; Manian, P; Koeuth, T; Potocki, L; Zhao, Q; Chinault, AC; Lee, CC; Lupski, JR				Chen, KS; Manian, P; Koeuth, T; Potocki, L; Zhao, Q; Chinault, AC; Lee, CC; Lupski, JR			Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome	NATURE GENETICS			English	Article							SMITH-MAGENIS SYNDROME; YEAST ARTIFICIAL CHROMOSOMES; POLYMERASE CHAIN-REACTION; IN-SITU HYBRIDIZATION; SPINAL MUSCULAR-ATROPHY; PRADER-WILLI-SYNDROME; SOMATIC-CELL HYBRIDS; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; HUMAN GENOME	Smith-Magenis syndrome (SMS), caused by del(17)p11.2, represents one of the most frequently observed human microdeletion syndromes. We have identified three copies of a low-copy-number repeat (SMS-REPs) located within and flanking the SMS common deletion region and show that SMS-REP represents a repeated gene cluster. We have isolated a corresponding cDNA clone that identifies a novel junction fragment from 29 unrelated SMS patients and a different-sized junction fragment from a patient with dup(17)p11.2. Our results suggest that homologous recombination of a flanking repeat gene cluster is a mechanism for this common microdeletion syndrome.	BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; TEXAS CHILDRENS HOSP,BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Chen, Ken-Shiung/A-2204-2011		NCRR NIH HHS [M01 RR-00188] Funding Source: Medline; NHGRI NIH HHS [HG00210] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BOTTO M, 1992, P NATL ACAD SCI USA, V89, P4957, DOI 10.1073/pnas.89.11.4957; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; Buetow K H, 1994, Science, V265, P2055, DOI 10.1126/science.8091228; Campbell HD, 1997, GENOMICS, V42, P46, DOI 10.1006/geno.1997.4709; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; CHEN KS, 1995, AM J HUM GENET, V56, P175; CHEVILLARD C, 1993, HUM MOL GENET, V2, P1235, DOI 10.1093/hmg/2.8.1235; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; DeLaurenzi V, 1996, NAT GENET, V12, P52; ELDER FFB, 1985, AM J MED GENET, V20, P519, DOI 10.1002/ajmg.1320200312; ELSEA SH, 1995, AM J HUM GENET, V57, P1342; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; GUZZETTA V, 1991, GENOMICS, V9, P31, DOI 10.1016/0888-7543(91)90217-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HERZ J, 1990, FEBS LETT, V276, P103, DOI 10.1016/0014-5793(90)80518-N; HIRAOKA LR, 1995, GENOMICS, V25, P323, DOI 10.1016/0888-7543(95)80150-K; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; JI Y, 1996, AM J HUM GENET, V59, pA158; JONES C, 1995, NATURE, V376, P145, DOI 10.1038/376145a0; Jurado LAP, 1996, AM J HUM GENET, V59, P781; JUYAL RC, 1995, AM J MED GENET, V58, P286, DOI 10.1002/ajmg.1320580317; JUYAL RC, 1995, AM J MED GENET, V59, P406, DOI 10.1002/ajmg.1320590332; Juyal RC, 1996, AM J HUM GENET, V58, P998; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; Kimura T, 1997, AM J MED GENET, V69, P320; KMIEC EB, 1985, CELL, V40, P139, DOI 10.1016/0092-8674(85)90317-4; Koyama K, 1996, CYTOGENET CELL GENET, V72, P78, DOI 10.1159/000134167; KRAWCZAK M, 1991, HUM GENET, V86, P425; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEDBETTER DH, 1995, METABOLIC MOL BASES, V1, P811; LEE CC, 1995, HUM MOL GENET, V4, P1373, DOI 10.1093/hmg/4.8.1373; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LeGuern E, 1996, HUM MOL GENET, V5, P103, DOI 10.1093/hmg/5.1.103; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Matsuda Y, 1996, GENOMICS, V33, P325, DOI 10.1006/geno.1996.0203; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAKAMURA T, 1992, ONCOGENE, V7, P733; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; OCHMAN H, 1988, GENETICS, V120, P621; PEETERS BPH, 1988, MOL GEN GENET, V212, P450, DOI 10.1007/BF00330849; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; ROA BB, 1994, ADV HUM GENET, V22, P117; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Roa BB, 1996, HUM GENET, V97, P642; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Scheurlen WG, 1997, GENE CHROMOSOME CANC, V18, P50, DOI 10.1002/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0; Shaffer LG, 1997, AM J MED GENET, V69, P325, DOI 10.1002/(SICI)1096-8628(19970331)69:3<325::AID-AJMG20>3.0.CO;2-S; SILVERMAN GA, 1991, GENOMICS, V9, P219, DOI 10.1016/0888-7543(91)90245-A; SINGER BS, 1988, J MOL BIOL, V202, P233, DOI 10.1016/0022-2836(88)90454-8; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; TOWNSENDNICHOLSON A, 1995, GENOMICS, V25, P605, DOI 10.1016/0888-7543(95)80074-V; Trask BJ, 1996, HUM GENET, V98, P710, DOI 10.1007/s004390050291; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHORISKEY SK, 1991, GENETICS, V127, P21; Wilgenbus KK, 1997, GENOMICS, V42, P1, DOI 10.1006/geno.1997.4707; WU CL, 1993, BIOCHIM BIOPHYS ACTA, V1174, P241, DOI 10.1016/0167-4781(93)90193-H; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589; ZORI RT, 1993, AM J MED GENET, V47, P504, DOI 10.1002/ajmg.1320470414	83	293	297	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					154	163		10.1038/ng1097-154	http://dx.doi.org/10.1038/ng1097-154			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326934				2022-12-27	WOS:A1997XZ55500020
J	Brennan, TJ; Seeley, WW; Kilgard, M; Schreiner, CE; Tecott, LH				Brennan, TJ; Seeley, WW; Kilgard, M; Schreiner, CE; Tecott, LH			Sound-induced seizures in serotonin 5-HT2C receptor mutant mice	NATURE GENETICS			English	Article							INFERIOR COLLICULUS NEURONS; CENTRAL-NERVOUS-SYSTEM; EPILEPSY-PRONE RATS; AUDIOGENIC-SEIZURES; C-FOS; HEARING-LOSS; SUSCEPTIBILITY; MOUSE; 5-HYDROXYTRYPTAMINE; RESOLUTION	The epilepsies are a heterogeneous collection of seizure disorders with a lifetime expectancy risk rate of 2-4%(1). A convergence of evidence indicates that heritable factors contribute significantly to seizure susceptibility(2,3). Genetically epilepsy-prone rodent strains have been frequently used to examine the effect of genetic factors on seizure susceptibility. The most extensively studied of these have been strains that are susceptible to sound-induced convulsions (audiogenic seizures, or AGSs). Early observations of the ACS phenomenon were made in the laboratory of Dr. Ivan Pavlov; in the course of appetite-conditioning experiments in mice, the loud bell used to signal food presentation unexpectedly produced seizures in some animals(4). In 1947, DBA/2 (D2) mice were found to exhibit a genetic susceptibility to AGSs stimulated by a doorbell mounted in an iron tub(5). Since this discovery, AGSs have been among the most intensively studied phenotypes in behavioural genetics(6,7). Although several genetic loci confer susceptibility to AGSs, the corresponding genes have not been cloned. We report that null mutant mice lacking serotonin 5-HT2C receptors are extremely susceptible to AGSs. The onset of susceptibility is between two and three months of age, with complete penetrance in adult animals. ACS-induced immediate early gene expression indicates that AGSs are subcortical phenomena in auditory circuits. This AGS syndrome is the first produced by a known genetic defect; it provides a robust model for the examination of serotoninergic mechanisms in epilepsy.	UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT OTOLARYNGOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Schreiner, Christoph/0000-0002-4571-4328; Kilgard, Michael/0000-0002-6699-1818	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002260] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERMANN E, 1982, GENETIC BASIS EPILEP, P355; ANDERSON VE, 1982, GENETIC BASIS EPILEP, P103; BEVAN W, 1955, PSYCHOL BULL, V52, P473, DOI 10.1037/h0044568; Browning R A, 1978, Ann N Y Acad Sci, V305, P437, DOI 10.1111/j.1749-6632.1978.tb31540.x; BUTERBAUGH GG, 1978, LIFE SCI, V23, P2393, DOI 10.1016/0024-3205(78)90297-7; COLLINS RL, 1968, SCIENCE, V162, P1137, DOI 10.1126/science.162.3858.1137; COLLINS RL, 1972, EXPT MODELS EPILEPSY, P347; DAILEY JW, 1992, LIFE SCI, V50, P319, DOI 10.1016/0024-3205(92)90340-U; DAILEY JW, 1992, J PHARMACOL EXP THER, V260, P533; DECKARD BS, 1976, DEV PSYCHOBIOL, V9, P17, DOI 10.1002/dev.420090104; DELGADOESCUETA AV, 1986, ADV NEUROL, P3; FULLER JL, 1967, J HERED, V58, P135, DOI 10.1093/oxfordjournals.jhered.a107565; Hall Calvin S., 1947, JOUR HEREDITY, V38, P3; HENRY KR, 1980, AUDIOLOGY, V19, P369; HENRY KR, 1967, SCIENCE, V158, P938, DOI 10.1126/science.158.3803.938-a; HIRAMATSU M, 1987, EPILEPSY RES, V1, P40, DOI 10.1016/0920-1211(87)90049-0; JOBE PC, 1973, LIFE SCI, V13, P1, DOI 10.1016/0024-3205(73)90271-3; Krushinsky L., 1970, PHYSIOLOGICAL EFFECT, P159; LANGNER G, 1987, HEARING RES, V31, P197, DOI 10.1016/0378-5955(87)90127-4; LASALLE GL, 1990, BRAIN RES, V518, P308, DOI 10.1016/0006-8993(90)90988-N; LAZAROVA M, 1983, N-S ARCH PHARMACOL, V322, P147, DOI 10.1007/BF00512388; Milatovich Athena, 1992, Human Molecular Genetics, V1, P681, DOI 10.1093/hmg/1.9.681; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; PIERSON M, 1992, EPILEPSY RES, V13, P35, DOI 10.1016/0920-1211(92)90005-E; RIGEL CE, 1989, EPILEPSY RES, V4, P63; SCHLESINGER K, 1968, LIFE SCI PT 1 PHYSI, V7, P437, DOI 10.1016/0024-3205(68)90015-5; SCHREIBER RA, 1971, PHYSIOL BEHAV, V6, P635, DOI 10.1016/0031-9384(71)90247-2; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SEYFRIED TN, 1983, BRAIN RES, V271, P325, DOI 10.1016/0006-8993(83)90294-9; SEYFRIED TN, 1981, GENETICS, V99, P117; SHARP FR, 1993, CRIT REV NEUROBIOL, V7, P205; SNYDERKELLER AM, 1992, NEUROSCI LETT, V135, P108, DOI 10.1016/0304-3940(92)90147-Y; SPARKS DL, 1985, PHARMACOL BIOCHEM BE, V23, P753, DOI 10.1016/0091-3057(85)90067-X; SPROTT RL, 1975, BEHV STUDIES USING G, P27; Statnick M. A., 1992, Society for Neuroscience Abstracts, V18, P907; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vicari EM, 1951, J PSYCHOL, V32, P79, DOI 10.1080/00223980.1951.9916086; WADA JA, 1972, ELECTROEN CLIN NEURO, V33, P520, DOI 10.1016/0013-4694(72)90216-7; WILLOTT JF, 1981, J NEUROPHYSIOL, V45, P35, DOI 10.1152/jn.1981.45.1.35; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391	41	123	125	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					387	390		10.1038/ng0897-387	http://dx.doi.org/10.1038/ng0897-387			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241279				2022-12-27	WOS:A1997XM90900024
J	Blumenthal, D; Causino, N; Campbell, EG				Blumenthal, D; Causino, N; Campbell, EG			Academic industry research relationships in genetics: A field apart	NATURE GENETICS			English	Article								Academic-industry research relationships (AIRRS) have become widely accepted and increasingly common in the life sciences. Using nationwide surveys from the United States, we found significant differences between the AIRRs of genetics firms and faculty and those of other firms and faculty, Significantly more genetics than nongenetics firms funded AIRRs, and genetics firms' AIRRs were larger and longer, Genetics faculty with AIRRs were significantly more likely than non-genetics faculty to report that patents, licenses, new companies and trade secrets had resulted from their university research; and that they had refused to share research results or biomaterials with colleagues.			Blumenthal, D (corresponding author), MASSACHUSETTS GEN HOSP,HLTH POLICY RES & DEV UNIT,50 STANIFORD ST,BOSTON,MA 02114, USA.				NHGRI NIH HHS [HG00724-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R55HG000724, R01HG000724] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; BLUMENTHAL D, 1986, SCIENCE, V232, P1361, DOI 10.1126/science.3715452; BLUMENTHAL D, 1996, NEW ENGL J MED, V335, P1735; BLUMENTHAL D, IN PRESS JAMA; COHEN J, 1995, SCIENCE, V268, P1715, DOI 10.1126/science.7792594; PINSKI G, 1976, INFORM PROCESS MANAG, V12, P297, DOI 10.1016/0306-4573(76)90048-0	6	23	24	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					104	108		10.1038/ng0597-104	http://dx.doi.org/10.1038/ng0597-104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140405				2022-12-27	WOS:A1997WX02400032
J	Mortlock, DP; Innis, JW				Mortlock, DP; Innis, JW			Mutation of HOXA13 in hand-foot-genital syndrome	NATURE GENETICS			English	Article							URINARY-TRACT ABNORMALITIES; HOMEO DOMAIN; ANOMALIES; PROTEIN; FAMILY; UPDATE; DNA	There are several human syndromes which involve defects of the limbs and the Mullerian ducts or its derivatives. The hand-foot-genital (HFG) syndrome is an autosomal dominant, fully penetrant disorder that was originally described by Stern et al. Additional reports describing other affected families have also been published. Limb anomalies include short first metacarpals of normal thickness, small distal phalanges of the thumbs, short middle phalanges of the fifth fingers, and fusion or delayed ossification of wrist bones. In the feet, the great toe is shorter due to a short first metatarsal and a small, pointed distal phalanx. Uterine anomalies are common in females with HFG, and typically involve a partially divided (bicornuate) or completely divided (didelphic) uterus, representing defects of Mullerian duct fusion. Urinary tract malformations in affected HFG females include a displaced urethral opening and malposition of ureteral orifices in the bladder wall; affected males may have hypospadias (ventrally misplaced urethral opening) of variable severity. We report the identification of a HOXA13 nonsense mutation in a family with hand-foot-genital syndrome. The mutation converts a highly conserved tryptophan residue in the homeodomain to a stop codon, which truncates 20 amino acids from the protein and likely eliminates or greatly reduces the ability of the protein to bind to DNA.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Mortlock, Douglas P/C-9981-2010; Morlock, Doug/C-3482-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER; NIAMS NIH HHS [5 P60 AR20557] Funding Source: Medline; NICHD NIH HHS [HD34059] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACIEN P, 1992, HUM REPROD, V7, P437, DOI 10.1093/oxfordjournals.humrep.a137666; Blum V, 1986, VERTEBRATE REPRODUCT; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; CLEVELAND RH, 1990, PEDIATR RADIOL, V20, P339, DOI 10.1007/BF02013170; Copeland JWR, 1996, NATURE, V379, P162, DOI 10.1038/379162a0; DONNENFELD AE, 1992, AM J MED GENET, V44, P482, DOI 10.1002/ajmg.1320440419; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; FRYNS JP, 1993, CLIN GENET, V43, P232; Giedion A, 1976, Pediatr Radiol, V4, P96, DOI 10.1007/BF00973951; Gruenwald P, 1941, ANAT REC, V81, P1, DOI 10.1002/ar.1090810102; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALAL F, 1988, AM J MED GENET, V30, P793, DOI 10.1002/ajmg.1320300312; HALAL F, 1986, AM J MED GENET, V24, P119, DOI 10.1002/ajmg.1320240114; HUMMEL KP, 1970, J HERED, V61, P219, DOI 10.1093/oxfordjournals.jhered.a108088; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; PINSKY L, 1973, TERATOLOGY, V9, P65; POZNANSKI AK, 1970, RADIOLOGY, V95, P129, DOI 10.1148/95.1.129; Schnabel CA, 1996, MOL CELL BIOL, V16, P2678; SHARMAN G B, 1970, Science (Washington D C), V167, P1221, DOI 10.1126/science.167.3922.1221; STERN AM, 1970, J PEDIATR-US, V77, P109, DOI 10.1016/S0022-3476(70)80052-X; VERP MS, 1983, FERTIL STERIL, V40, P80; VERP MS, 1989, AM J MED GENET, V32, P555, DOI 10.1002/ajmg.1320320429; VERSHON AK, 1995, GENE DEV, V9, P182, DOI 10.1101/gad.9.2.182; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732	25	397	420	1	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					179	180		10.1038/ng0297-179	http://dx.doi.org/10.1038/ng0297-179			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020844				2022-12-27	WOS:A1997WF08700018
J	Kishino, T; Lalande, M; Wagstaff, J				Kishino, T; Lalande, M; Wagstaff, J			UBE3A/E6-AP mutations cause Angelman syndrome	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; FACTOR-II GENE; LINKAGE ANALYSIS; PROTEIN; REGION; MOUSE; SNRPN; IDENTIFICATION; EXPRESSION; DEFINE	Angelman syndrome (AS), characterized by mental retardation, seizures, frequent smiling and laughter, and abnormal gait, is one of the best examples of human disease in which genetic imprinting plays a role(1). In about 70% of cases, AS is caused by de novo maternal deletions at 15q11-q13 (ref, 2), Approximately 2% of AS cases are caused by paternal uniparental disomy (UPD) of chromosome 15 (ref, 3) and 2-3% are caused by imprinting mutations'(4). In the remaining 25% of AS cases, no deletion, uniparental disomy (UPD), or methylation abnormality is detectable, and these cases, unlike deletions or UPD, can be familial(5-7). These cases are likely to result from mutations in a gene that is expressed either exclusively or preferentially from the maternal chromosome 15. We have found that a 15q inversion inherited by an AS child from her normal mother disrupts the 5' end of the UBE3A (E6-AP) gene, the product of which functions in protein ubiquitination(15). We have looked for novel UBE2A mutations in nondeletion/non-UPD/non-imprinting mutation (NDUI) AS patients and have found one patient who is heterozygous for a 5-bp de novo tandem duplication, We have also found in two brothers a heterozygous mutation, an A to G transition that creates a new 3' splice junction 7 bp upstream from the normal splice junction. Both mutations are predicted to cause a frameshift and premature termination of translation. Our results demonstrate that UBE3A mutations are one cause of AS and indicate a possible abnormality in ubiquitin-mediated protein degradation during brain development in this disease.	CHILDRENS HOSP,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030628] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS30628] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burke LW, 1996, AM J HUM GENET, V58, P777; Chung WY, 1996, HUM MOL GENET, V5, P1101, DOI 10.1093/hmg/5.8.1101; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; COOPER DN, 1991, HUM GENET, V87, P409; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GREGER V, 1994, AM J MED GENET, V53, P396, DOI 10.1002/ajmg.1320530425; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; MALCOLMM S, 1992, LANCET, V337, P694; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NING Y, 1996, GENOME RES, V6, P735; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pearsall RS, 1996, BIOCHEM BIOPH RES CO, V222, P171, DOI 10.1006/bbrc.1996.0716; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; Riesewijk AM, 1996, GENOMICS, V35, P380, DOI 10.1006/geno.1996.0372; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; WOODAGE T, 1994, GENOMICS, V19, P170, DOI 10.1006/geno.1994.1031	33	942	979	3	86	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					70	73		10.1038/ng0197-70	http://dx.doi.org/10.1038/ng0197-70			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988171				2022-12-27	WOS:A1997WA37300023
J	Liu, D; Matzuk, MM; Sung, WK; Guo, QX; Wang, P; Wolgemuth, DJ				Liu, D; Matzuk, MM; Sung, WK; Guo, QX; Wang, P; Wolgemuth, DJ			Cyclin A1 is required for meiosis in the male mouse	NATURE GENETICS			English	Article							MALE GERM-CELL; DIFFERENTIAL EXPRESSION; PROMOTING FACTOR; MESSENGER-RNA; GENE; SPECIFICITY; ONCOGENESIS; COMPLEXES; DISTINCT; TESTIS	The mammalian A-type cyclin family consists of two members. cyclin Al (encoded by Ccna1) and cyclin AZ (encoded by Ccna2). Cyclin AZ promotes both G1/S and G2/M transitions(1,2), and targeted deletion of Ccna2 in mouse is embryonic lethal(3). Cyclin Al is expressed in mice exclusively in the germ cell lineage(4) and is expressed in humans at highest levels in the testis and certain myeloid leukaemia cells(5,6). To investigate the role of cyclin Al and possible redundancy among the cyclins in vivo, we generated mice bearing a null mutation of Ccna1. Ccna1(-/-) males were sterile due to a block of spermatogenesis before the first meiotic division, whereas females were normal. Meiosis arrest in Ccna1(-/-) males was associated with increased germ cell apoptosis, desynapsis abnormalities and reduction of Cdc2 kinase activation at the end of meiotic prophase. Cyclin Al is therefore essential for spermatocyte passage into the first meiotic division in mate mice, a function that cannot be complemented by the concurrently expressed B-type cyclins.	Columbia Univ Coll Phys & Surg, Ctr Reprod Sci, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Irving Comprehens Canc Ctr, New York, NY 10032 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wolgemuth, DJ (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Reprod Sci, 630 W 168th St, New York, NY 10032 USA.	djw3@columbia.edu		Wang, Pei/0000-0003-2373-7315				ANDERSEN B, 1993, P NATL ACAD SCI USA, V90, P11084, DOI 10.1073/pnas.90.23.11084; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; CHAPMAN DL, 1994, DEV BIOL, V165, P500, DOI 10.1006/dbio.1994.1270; Dix DJ, 1997, DEVELOPMENT, V124, P4595; DRESSER ME, 1979, EXP CELL RES, V121, P416, DOI 10.1016/0014-4827(79)90023-5; DUGGAL RN, 1987, ANN NY ACAD SCI, V513, P112, DOI 10.1111/j.1749-6632.1987.tb25002.x; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOETZ P, 1984, J CELL SCI, V65, P249; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; Kramer A, 1998, LEUKEMIA, V12, P893, DOI 10.1038/sj.leu.2401051; KREMER EJ, 1991, EXP CELL RES, V197, P330, DOI 10.1016/0014-4827(91)90442-W; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Russell L. D., 1990, HISTOLOGICAL HISTOPA; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sweeney C, 1996, DEVELOPMENT, V122, P53; WOLGEMUTH DJ, 1987, P NATL ACAD SCI USA, V84, P5813, DOI 10.1073/pnas.84.16.5813; WU S, 1995, DEV BIOL, V170, P195, DOI 10.1006/dbio.1995.1207; Yang R, 1997, CANCER RES, V57, P913	25	287	300	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					377	380		10.1038/3855	http://dx.doi.org/10.1038/3855			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843212				2022-12-27	WOS:000077199600027
J	Coffey, AJ; Brooksbank, RA; Brandau, O; Oohashi, T; Howell, GR; Bye, JM; Cahn, AP; Durham, J; Heath, P; Wray, P; Pavitt, R; Wilkinson, J; Leversha, M; Huckle, E; Shaw-Smith, CJ; Dunham, A; Rhodes, S; Schuster, V; Porta, G; Yin, L; Serafini, P; Sylla, B; Zollo, M; Franco, B; Bolino, A; Seri, M; Lanyi, A; Davis, JR; Webster, D; Harris, A; Lenoir, G; St Basile, GD; Jones, A; Behloradsky, BH; Achatz, H; Murken, J; Fassler, R; Sumegi, J; Romeo, G; Vaudin, M; Ross, MT; Meindl, A; Bentley, DR				Coffey, AJ; Brooksbank, RA; Brandau, O; Oohashi, T; Howell, GR; Bye, JM; Cahn, AP; Durham, J; Heath, P; Wray, P; Pavitt, R; Wilkinson, J; Leversha, M; Huckle, E; Shaw-Smith, CJ; Dunham, A; Rhodes, S; Schuster, V; Porta, G; Yin, L; Serafini, P; Sylla, B; Zollo, M; Franco, B; Bolino, A; Seri, M; Lanyi, A; Davis, JR; Webster, D; Harris, A; Lenoir, G; St Basile, GD; Jones, A; Behloradsky, BH; Achatz, H; Murken, J; Fassler, R; Sumegi, J; Romeo, G; Vaudin, M; Ross, MT; Meindl, A; Bentley, DR			Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; ARTIFICIAL CHROMOSOME LIBRARIES; BONE-MARROW TRANSPLANTATION; HUMAN DYSTROPHIN GENE; XLP LOCUS; LARGE INSERTS; SH3 DOMAINS; HUMAN DNA; PROTEIN; DELETION	X-linked lymphoproliferative syndrome (XLP or Duncan disease) is characterized by extreme sensitivity to Epstein-Barr virus (EBV), resulting in a complex phenotype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia and malignant lymphoma. We have identified a gene, SH2D1A, that is mutated in XLP patients and encodes a novel protein composed of a single SH2 domain. SH2D1A is expressed in many tissues involved in the immune system. The identification of SH2D1A will allow the determination of its mechanism of action as a possible regulator of the EBV-induced immune response.	Sanger Ctr, Hinxton CB10 1SA, Cambs, England; LMU, Abt Med Genet, D-80336 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Addenbrookes Hosp, Dept Resp Med, Cambridge CB2 2QQ, England; Univ Wurzburg, Kinderklin, D-97080 Wurzburg, Germany; Osped San Paolo, Ist Sci Biomed, Cattedra Gen Umana, Milan, Italy; Univ Pavia, Fac Med 2, Dip Patol Umana & Ereditaria, I-27100 Pavia, Italy; Int Agcy Res Canc, Genet Canc Susceptibil Unit, F-69372 Lyon, France; TIGEM, I-20132 Milan, Italy; Inst Gaslini, Mol Genet Lab, Genoa, Italy; Univ Nebraska, Dept Microbiol & Pathol, Omaha, NE 68182 USA; Royal Free Hosp, Sch Med, Dept Clin Immunol, London, England; Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Int Agcy Res Canc, Programme Viral & Hereditary Factors Carcinogenes, F-69372 Lyon, France; Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; LMU, Haunersche Immundefektambulanz, D-80336 Munich, Germany	Wellcome Trust Sanger Institute; University of Munich; Max Planck Society; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Wurzburg; San Paolo-Polo Universitaria Hospital; University of Pavia; World Health Organization; International Agency for Research on Cancer (IARC); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Nebraska System; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Oxford; World Health Organization; International Agency for Research on Cancer (IARC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Munich	Coffey, AJ (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	ajc@sanger.ac.uk	Bolino, Alessandra/O-2933-2013; Oohashi, Toshitaka/B-1599-2011; Bolino, Alessandra/AAN-5442-2020; FRANCO, Brunella/S-2882-2018; Seri, Marco/A-4339-2014	Bolino, Alessandra/0000-0002-8980-4878; FRANCO, Brunella/0000-0001-5588-4569; porta, giovanni/0000-0001-5260-2415; Oohashi, Toshitaka/0000-0002-9302-1913; Seri, Marco/0000-0003-2425-2176	NIAID NIH HHS [1 R01 AI33532-OIA3] Funding Source: Medline; Telethon [TGM06S01, E.0440] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033532] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; ARKWRIGHT PD, IN PRESS ARCH DIS CH; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BOLINO A, IN PRESS EUR J HUM G; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; FAINSTEIN E, 1989, ONCOGENE, V4, P1477; FILIPOVICH AH, 1986, TRANSPLANTATION, V42, P222; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gregory SG, 1997, GENOME RES, V7, P1162, DOI 10.1101/gr.7.12.1162; HARRINGTON DS, 1987, CANCER-AM CANCER SOC, V59, P1419, DOI 10.1002/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO;2-P; HUANG SH, 1993, METHODS MOL BIOL PCR, P357; IMAI S, 1994, P NATL ACAD SCI USA, V91, P9131, DOI 10.1073/pnas.91.19.9131; KLEIN G, 1975, NEW ENGL J MED, V293, P1353, DOI 10.1056/NEJM197512252932607; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KURIYAN J, 1993, CURR OPIN STRUC BIOL, V3, P828, DOI 10.1016/0959-440X(93)90145-B; Lamartine J, 1996, EUR J HUM GENET, V4, P342; Lanyi A, 1997, GENOMICS, V39, P55, DOI 10.1006/geno.1996.4466; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MCCLAIN KL, 1995, NEW ENGL J MED, V332, P12, DOI 10.1056/NEJM199501053320103; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; PURTILO D T, 1991, Pediatric Pathology, V11, P685; PURTILO DT, 1975, LANCET, V1, P936; Rickinson AB, 1996, CURR OPIN IMMUNOL, V8, P492, DOI 10.1016/S0952-7915(96)80036-7; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; SANGER WG, 1990, CANCER GENET CYTOGEN, V47, P163, DOI 10.1016/0165-4608(90)90026-7; SCHUSTER V, 1994, EUR J PEDIATR, V153, P432; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SKARE J, 1993, GENOMICS, V16, P254, DOI 10.1006/geno.1993.1169; SKARE JC, 1989, HUM GENET, V82, P354; Soderlund C, 1995, COMPUT APPL BIOSCI, V11, P645; SOLOVYEV VV, 1995, INTELLIGENT SYSTEMS, V3, P367; Thompson AD, 1996, ONCOGENE, V13, P2649; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VOWELS MR, 1993, NEW ENGL J MED, V329, P1623, DOI 10.1056/NEJM199311253292205; Ware JE, 1996, BEHAV HEALTHC TOM, V5, P88; WEISENBURGER DD, 1986, EPSTEINBARR VIRUS RE, P129; WILLIAMS LL, 1993, LANCET, V342, P587, DOI 10.1016/0140-6736(93)91413-G; WU BL, 1993, GENOMICS, V17, P163, DOI 10.1006/geno.1993.1298; WYANDT HE, 1989, AM J MED GENET, V33, P426, DOI 10.1002/ajmg.1320330331; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	53	589	610	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					129	135		10.1038/2424	http://dx.doi.org/10.1038/2424			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771704				2022-12-27	WOS:000076231300013
J	Wallace, RH; Wang, DW; Singh, R; Scheffer, IE; George, AL; Phillips, HA; Saar, K; Reis, A; Johnson, EW; Sutherland, GR; Berkovic, SF; Mulley, JC				Wallace, RH; Wang, DW; Singh, R; Scheffer, IE; George, AL; Phillips, HA; Saar, K; Reis, A; Johnson, EW; Sutherland, GR; Berkovic, SF; Mulley, JC			Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta 1 subunit gene SCN1B	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; SODIUM-CHANNEL; BRAIN; CONVULSIONS	Febrile seizures affect approximately 3% of all children under six years of age and are by far the most common seizure disorder(1). A small proportion of children with febrile seizures later develop ongoing epilepsy with afebrile seizures(2). Segregation analysis suggests the majority of cases have complex inheritance(3) but rare families show apparent autosomal dominant: inheritance. Two putative loci have been mapped (FEB1 and FEB2), but specific genes have not yet been identified(4,5). We recently described a clinical subset, termed generalized epilepsy with febrile seizures plus (GEFS(+)), in which many family members have seizures with fever that may persist beyond six years of age or be associated with afebrile generalized seizures(6). We now report linkage, in another large GEFS(+) family, to chromosome region 19q13.1 and identification of a mutation in the voltage-gated sodium (Na+)-channel beta 1 subunit gene (SCN1B). The mutation changes a conserved cysteine residue disrupting a putative disulfide bridge which normally maintains an extracellular immunoglobulin-like fold. Go-expression of the mutant pr subunit with a brain Na+-channel alpha subunit in Xenopus laevis oocytes demonstrates that the mutation interferes with the ability of the subunit to modulate channel-gating kinetics consistent with a loss-of-function allele. This observation develops the theme that idiopathic epilepsies are a family of channelopathies and raises the possibility of involvement of other Na+-channel subunit genes in febrile seizures and generalized epilepsies with complex inheritance patterns.	Womens & Childrens Hosp, Ctr Genet Med, Dept Cytogenet & Mol Genet, N Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Dept Pharmacol, Nashville, TN 37232 USA; Univ Melbourne, Dept Med Neurol, Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; Monash Med Ctr, Melbourne, Vic, Australia; Max Delbruck Zentrum, Mikrosatellitenzentrum, D-14059 Berlin, Germany; Humboldt Univ, Inst Human Genet, Berlin, Germany; Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Univ Adelaide, Dept Genet, Adelaide, SA, Australia	University of Adelaide; Vanderbilt University; Vanderbilt University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; Monash University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; University of Adelaide	Mulley, JC (corresponding author), Womens & Childrens Hosp, Ctr Genet Med, Dept Cytogenet & Mol Genet, N Adelaide, SA 5006, Australia.		Sutherland, Grant Robert/D-2606-2012; Reis, André/D-2309-2009; Scheffer, Ingrid E/G-1668-2013; jiang, yu/HGU-0029-2022	Reis, André/0000-0002-6301-6363; Scheffer, Ingrid E/0000-0002-2311-2174; Wallace, Robyn/0000-0001-6141-3317; Berkovic, Samuel/0000-0003-4580-841X; Saar, Kathrin/0000-0002-4483-1557	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032387, R37NS032387] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32387] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERKOVIC SF, 1997, EPILEPSY COMPREHENSI, P217; BLERVERT C, 1998, SCIENCE, V279, P403; Bulman DE, 1997, HUM MOL GENET, V6, P1679, DOI 10.1093/hmg/6.10.1679; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONOHUE NV, 1992, EPILEPTIC SYNDROMES, P45; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Johnson WG, 1996, AM J MED GENET, V61, P345; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MACDONALD RL, 1994, EPILEPSIA, V35, P541; MAKITA N, 1994, GENOMICS, V23, P628, DOI 10.1006/geno.1994.1551; Makita N, 1996, J NEUROSCI, V16, P7117; MAKITA N, 1994, J BIOL CHEM, V269, P7571; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; NELSON KB, 1981, FEBRILE SEIZURES, P360; RICH SS, 1987, AM J HUM GENET, V41, P249; RYAN SG, 1995, NAT GENET, V10, P4, DOI 10.1038/ng0595-4; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308	30	821	874	0	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					366	370		10.1038/1252	http://dx.doi.org/10.1038/1252			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697698				2022-12-27	WOS:000075107600020
J	Belin, V; Cusin, V; Viot, G; Girlich, D; Toutain, A; Moncla, A; Vekemans, M; Le Merrer, M; Munnich, A; Cormier-Daire, V				Belin, V; Cusin, V; Viot, G; Girlich, D; Toutain, A; Moncla, A; Vekemans, M; Le Merrer, M; Munnich, A; Cormier-Daire, V			SHOX mutations in dyschondrosteosis (Leri-Weill syndrome)	NATURE GENETICS			English	Article							LOCI; MAP	Dyschondrosteosis(1) (DCS) is an autosomal dominant(2) form of mesomelic dysplasia with deformity of the forearm (Madelung deformity; ref. 3). Based on the observation of XY translocations (p22,q12; refs 4-6) in DCS patients, we tested the pseudoautosomal region in eight families with DCS and showed linkage of the DCS gene to a microsatellite DNA marker at the DXYS233 locus (Zmax=6.26 at theta=0). The short stature homeobox-containing gene(7,8) (SHOX), involved in idiopathic growth retardation and possibly Turner short stature, maps to this region and was therefore regarded as a strong candidate gene in DCS. Here, we report large-scale deletions tin seven families) and a nonsense mutation tin one family) of SHOX in patients with DCS and show that Langer mesomelic dwarfism(9) results from homozygous mutations at the DCS locus.	Hop Enfants Malad, INSERM U393, Dept Genet, Paris, France; Hop Enfants Malad, INSERM U393, Unite Rech Handicaps Genet Enfant, Paris, France; Hop Clocheville, Serv Genet, Tours, France; Hop Enfants La Timone, Dept Genet, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Munnich, A (corresponding author), Hop Enfants Malad, INSERM U393, Dept Genet, Paris, France.		; cormier-daire, valerie/H-6520-2017	Girlich, Delphine/0000-0002-7698-2798; cormier-daire, valerie/0000-0002-2839-9856; Toutain, Annick/0000-0002-5999-5300				BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; CASTILLO S, 1985, CYTOGENET CELL GENET, V40, P601; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; ESPERITU C, 1975, AM J DIS CHILD, V129, P375; Guichet A, 1997, CLIN DYSMORPHOL, V6, P341, DOI 10.1097/00019605-199710000-00007; LERI A, 1929, B MEM SOC MED HOP P, V35, P1491; LICHTENSTEIN JR, 1980, J MED GENET, V17, P41, DOI 10.1136/jmg.17.1.41; Madelung V, 1878, ARCH KLIN CHIR, V23, P395; OGATA T, 1992, J MED GENET, V29, P624, DOI 10.1136/jmg.29.9.624; PFEIFFER RA, 1980, CYTOGENET CELL GENET, V26, P150, DOI 10.1159/000131436; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; TOUTAIN A, 1991, ANN PEDIATR-PARIS, V38, P37	14	260	267	2	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					67	69		10.1038/ng0198-67	http://dx.doi.org/10.1038/ng0198-67			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590292				2022-12-27	WOS:000073346700020
J	Pajukanta, P; Nuotio, I; Terwilliger, JD; Porkka, KVK; Ylitalo, K; Pihlajamaki, J; Suomalainen, AJ; Syvanen, AC; Lehtimaki, T; Viikari, JSA; Laakso, M; Taskinen, MR; Ehnholm, C; Peltonen, L				Pajukanta, P; Nuotio, I; Terwilliger, JD; Porkka, KVK; Ylitalo, K; Pihlajamaki, J; Suomalainen, AJ; Syvanen, AC; Lehtimaki, T; Viikari, JSA; Laakso, M; Taskinen, MR; Ehnholm, C; Peltonen, L			Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23	NATURE GENETICS			English	Article							CORONARY HEART-DISEASE; LOCUS; STRATEGIES; PHENOTYPE; FINLAND; RISK	More than half of the patients with angiographically confirmed premature coronary heart disease (CHD) have a familiar lipoprotein disorder(1). Familial combined hyperlipidaemia (FCHL) represents the most common genetic dyslipidemia with a prevalence of 1.0-2.0% (refs 2,3). FCHL is estimated to cause 10-20% of premature CHD (ref. 1) and is characterized by elevated levels of cholesterol, triglycerides, or both(3,4). Attempts to characterize genes predisposing to FCHL have been hampered by its equivocal phenotype definition, unknown mode of inheritance and genetic heterogeneity. In order to minimize genetic heterogeneity, we chose 31 extended FCHL families from the isolated Finnish population(5) that fulfilled strictly defined criteria for the phenotype status. We performed linkage analyses with markers from ten chromosomal regions that contain lipid-metabolism candidate genes. One marker, D1S104. adjacent to the apolipoprotein A-II (APOA2) gene on chromosome 1, revealed a lod score of Z=3.50 assuming a dominant mode of inheritance. Multipoint analysis combining information from D1S104 and the neighbouring marker D1S1677 resulted in a lod score of 5.93. Physical positioning of known genes in the area (APOA2 and three selectin genes) outside the linked region suggests a novel locus for FCHL on 1q21-q23. A second paper in this issue (Castellani et al.) reports the identification of a mouse combined hyperlipidaemia locus in the syntenic region of the mouse genome(6), thus further implicating a gene in this region in the aetiology of FCHL.	Univ Helsinki, Natl Inst Publ Hlth, Dept Human Mol Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; Univ Turku, Dept Med, Turku, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Genome Ctr, New York, NY USA; Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland; Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland; Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; Tampere Univ Hosp, Tampere, Finland	University of Helsinki; University of Helsinki; University of Turku; Columbia University; Columbia University; Finland National Institute for Health & Welfare; University of Helsinki; University of Eastern Finland; Tampere University; Tampere University Hospital	Peltonen, L (corresponding author), Univ Helsinki, Natl Inst Publ Hlth, Dept Human Mol Genet, FIN-00014 Helsinki, Finland.	leena.peltonen@ktl.fi	Lehtimäki, Terho/AAD-1094-2022; Taskinen, Marja-Riitta/AAN-5432-2020	Lehtimäki, Terho/0000-0002-2555-4427; Taskinen, Marja-Riitta/0000-0002-6229-3588; Pihlajamaki, Jussi/0000-0002-6241-6859				AUSTIN MA, 1989, ARTERIOSCLEROSIS, V9, P335; CASTELLANI, 1998, NATURE GENET, V18, P372; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; CUTHBERT JA, 1986, NEW ENGL J MED, V314, P879, DOI 10.1056/NEJM198604033141404; DallingaThie GM, 1997, J CLIN INVEST, V99, P953, DOI 10.1172/JCI119260; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DURNER M, 1992, AM J HUM GENET, V51, P859; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; JARVIK GP, 1994, ARTERIOSCLER THROMB, V14, P1687, DOI 10.1161/01.ATV.14.11.1687; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; Kwiterovich Peter O. Jr., 1993, Current Opinion in Lipidology, V4, P133, DOI 10.1097/00041433-199304000-00009; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Marcil M, 1996, J LIPID RES, V37, P309; NIKKILA EA, 1973, LANCET, V1, P954; NISHINA PM, 1992, P NATL ACAD SCI USA, V89, P708, DOI 10.1073/pnas.89.2.708; Ott J., 1991, ANAL HUMAN GENETIC L; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; Pajukanta P, 1997, ARTERIOSCL THROM VAS, V17, P841, DOI 10.1161/01.ATV.17.5.841; PORKKA KVK, 1994, ACTA PAEDIATR, V83, P838, DOI 10.1111/j.1651-2227.1994.tb13155.x; REYMER PWA, 1995, HUM MOL GENET, V4, P1543, DOI 10.1093/hmg/4.9.1543; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; TERWILLIGER JD, IN PRESS ENCY BIOSTA; TERWILLIGER JD, IN PRESS HUM HERED; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Weiss KM., 1995, GENETIC VARIATION HU; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0	33	215	221	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					369	373		10.1038/ng0498-369	http://dx.doi.org/10.1038/ng0498-369			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537421				2022-12-27	WOS:000072755500021
J	Barila, D; Superti-Furga, G				Barila, D; Superti-Furga, G			An intramolecular SH3-domain interaction regulates c-Abl activity	NATURE GENETICS			English	Article							PROTEIN-TYROSINE KINASES; SH3 DOMAINS; ACTIVATION; BINDING; SRC; ONCOGENE; STRESS; GROWTH; FORMS	The ABL1 proto-oncogene encodes a cytoplasmic and nuclear protein tyrosine kinase (c-Abl) that has been implicated in processes of cell differentiation, cell division, cell adhesion and stress response(1-4). Alterations of ABL1 by chromosomal rearrangement or viral transduction can lead to malignant transformation(5,6). Activity of the c-Abl protein is negatively regulated by its SH3 domain through an unknown mechanism, and deletion of the SH3 domain turns ABL1 into an oncogene(7-10). We present evidence for an intramolecular inhibitory interaction of the SH3 domain with the catalytic domain and with the linker between the SH2 and catalytic domain (SH2-CD linker). Site-directed mutations in each of these three elements activate c-Abl. Mutations in the linker cause a conformational change of the molecule and increase binding of the SH3 domain to peptide ligands. Individual mutation of two charged residues in the SH3 and catalytic domain activates c-Abl, while inhibition is restored in the double reciprocal mutant. We propose that regulators of c-Abl will have opposite effects on its activity depending on their ability to favour or disrupt these intramolecular interactions.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Superti-Furga, G (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	superti@embl-heidelberg.de	Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015; Barilà, Daniela/K-8506-2016	Superti-Furga, Giulio/0000-0002-0570-1768; Barilà, Daniela/0000-0002-6192-1562				Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; MACAULEY A, 1989, MOL CELL BIOL, V9, P2648, DOI 10.1128/MCB.9.6.2648; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; RENSHAW MW, 1992, EMBO J, V11, P3941, DOI 10.1002/j.1460-2075.1992.tb05488.x; REYNOLDS CH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P122, DOI 10.1016/0925-4439(93)90100-F; ROSENBERG N, 1988, ADV VIRUS RES, V35, P39; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; UAUSUBEL FM, 1987, CURRENT PROTOCOLS MO; Walkenhorst J, 1996, ONCOGENE, V12, P1513; WANG JYJ, 1993, CURR OPIN GENET DEV, V3, P35, DOI 10.1016/S0959-437X(05)80338-7; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhu JY, 1996, MOL CELL BIOL, V16, P7054	30	174	178	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					280	282		10.1038/ng0398-280	http://dx.doi.org/10.1038/ng0398-280			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500553				2022-12-27	WOS:000072325000029
J	Prolla, TA; Baker, SM; Harris, AC; Tsao, EL; Yao, X; Bronner, CE; Zheng, BH; Gordon, M; Reneker, J; Arnheim, N; Shibata, D; Bradley, A; Liskay, RM				Prolla, TA; Baker, SM; Harris, AC; Tsao, EL; Yao, X; Bronner, CE; Zheng, BH; Gordon, M; Reneker, J; Arnheim, N; Shibata, D; Bradley, A; Liskay, RM			Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; COLON-CANCER; MICROSATELLITE INSTABILITY; HEREDITARY; HOMOLOG; CELLS; MSH2	Germline mutations in the human MSH2, MLH1, PMS2 and PMS1 DNA mismatch repair (MMR) gene homologues appear to be responsible for most cases of hereditary non-polyposis colorectal cancer (HNPCC; refs 1-5). An important role for DNA replication errors in colorectal tumorigenesis has been suggested by the finding of frequent alterations in the length of specific mononucleotide tracts within genes controlling cell growth, including TGF-beta receptor type II (ref. 6), BAX (ref. 7) and APC (ref. 8). A broader role for MMR deficiency in human tumorigenesis is implicated by microsatellite instability in a fraction of sporadic tumours, including gastric, endometrial and colorectal malignancies(9). To better define the role of individual MMR genes in cancer susceptibility and MMR functions, we have generated mice deficient for the murine homologues of the human genes MLH1, PMS1 and PMS2. Surprisingly, we find that these mice show different tumour susceptibilities, most notably, to intestinal adenomas and adenocarcinomas, and different mutational spectra. Our results suggest that a general increase in replication errors may not be sufficient for intestinal tumour formation and that these genes share overlapping, but not identical functions.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Oregon Hlth Sci Univ, Dept Pathol, Portland, OR 97201 USA; Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Dept Mol Biol, Los Angeles, CA 90089 USA	Oregon Health & Science University; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Oregon Health & Science University; University of Southern California; University of Southern California	Liskay, RM (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, L103,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	liskay@ohsu.edu		Bradley, Allan/0000-0002-2349-8839; Arnheim, Norman/0000-0003-1247-1347				Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BOOTSMA D, 1994, MUTAT RES, V307, P15, DOI 10.1016/0027-5107(94)90273-9; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GUPTA RS, 1980, MUTAT RES, V69, P113, DOI 10.1016/0027-5107(80)90181-5; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Karran P, 1996, SEMIN CANCER BIOL, V7, P15, DOI 10.1006/scbi.1996.0003; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Luria SE, 1943, GENETICS, V28, P491; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Narayanan L, 1997, P NATL ACAD SCI USA, V94, P3122, DOI 10.1073/pnas.94.7.3122; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Reitmair AH, 1996, CANCER RES, V56, P3842; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676; Tsao JL, 1997, AM J PATHOL, V151, P573; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#	24	298	304	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					276	279		10.1038/ng0398-276	http://dx.doi.org/10.1038/ng0398-276			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500552				2022-12-27	WOS:000072325000028
J	Wehner, JM; Radcliffe, RA; Rosmann, ST; Christensen, SC; Rasmussen, DL; Fulker, DW; Wiles, M				Wehner, JM; Radcliffe, RA; Rosmann, ST; Christensen, SC; Rasmussen, DL; Fulker, DW; Wiles, M			Quantitative trait locus analysis of contextual fear conditioning in mice	NATURE GENETICS			English	Article							MUTANT MICE; AMYGDALA; HIPPOCAMPUS; DEFICIENT; EMOTION; HUMANS; MEMORY; BRAIN	Family, twin and adoption studies provide evidence for a Table I Mean scores for measures of learning substantial genetic component underlying individual Altered Auditory differences in general intelligence(1), specific cognitive abilities(2) and susceptibility to psychopathologies related to fear-inducing events(3). Contextual fear conditioning, which is highly conserved across species, can serve as a model for elucidating genes that regulate individual differences in learning and emotion(4-8). In fear conditioning, an initially neutral stimulus, such as shock. Two neural circuits have been implicated in fear conditioning. The fear component is regulated by amyhdaloid pathways, while the contextual component is, at least in part, dependent on the hippocampus(9-14). C57BL/6J (B6) and DBA/2J (D2) mice differ in several types of complex learning(15,16), including contextual fear conditioning(17). A quantitative trait locus (QTL) analysis of contextual fear conditioning was performed in a B6/D2 FZ intercross population. Two QTLs for contextual conditioning (led score>4.3) were identified on chromosomes 10 and 16. QTLs for conditioning to the auditory cue (led score>4.3) were localized to chromosomes 1 and 10. Suggestive QTLs (led score=2.8-4.1) for contextual conditioning were detected on chromosomes 1, 2 and 3.	UNIV COLORADO,SCH PHARM,BOULDER,CO 80309; UNIV COLORADO,DEPT PSYCHOL,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Wehner, JM (corresponding author), UNIV COLORADO,INST BEHAV GENET,BOULDER,CO 80309, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016880, R01MH053668] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-00141] Funding Source: Medline; NIMH NIH HHS [MH-53668, MH-16880] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BUCK KJ, 1997, J NEUROSCI, V17, P3945; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; DEFRIES JC, 1979, BEHAV GENET, V9, P23; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Falconer D. S., 1989, Introduction to quantitative genetics.; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Ferraro TN, 1997, MAMM GENOME, V8, P200, DOI 10.1007/s003359900389; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; FRANKEL WN, 1995, MAMM GENOME, V6, P830, DOI 10.1007/BF00292431; GERSHENFIELD HK, BEHAV GENET, V27, P201; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LABAR KS, 1995, J NEUROSCI, V15, P6846; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; LU Y, IN PRESS BRAIN RES; Markel PD, 1997, GENOME RES, V7, P92, DOI 10.1101/gr.7.2.92; Owen EH, 1997, BEHAV NEUROSCI, V111, P292, DOI 10.1037/0735-7044.111.2.292; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PAYLOR R, 1993, PSYCHOBIOLOGY, V21, P11; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Sambrook J., 2002, MOL CLONING LAB MANU; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075	36	133	135	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					331	334		10.1038/ng1197-331	http://dx.doi.org/10.1038/ng1197-331			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YD667	9354800				2022-12-27	WOS:A1997YD66700030
J	Ozelius, LJ; Hewett, JW; Page, CE; Bressman, SB; Kramer, PL; Shalish, C; deLeon, D; Brin, MF; Raymond, D; Corey, DP; Fahn, S; Risch, NJ; Buckler, AJ; Gusella, JF; Breakefield, XO				Ozelius, LJ; Hewett, JW; Page, CE; Bressman, SB; Kramer, PL; Shalish, C; deLeon, D; Brin, MF; Raymond, D; Corey, DP; Fahn, S; Risch, NJ; Buckler, AJ; Gusella, JF; Breakefield, XO			The early-onset torsion dystonia gene (DYT1) encodes an ATP binding protein	NATURE GENETICS			English	Article							AUTOSOMAL DOMINANT INHERITANCE; TYROSINE-HYDROXYLASE GENE; ASHKENAZI JEWS; EXON AMPLIFICATION; RECEPTOR-BINDING; HUMAN-CHROMOSOME; MESSENGER-RNAS; POINT MUTATION; PARKINSONISM; CONSTRUCTION	Early-onset torsion dystonia is a movement disorder, characterized by twisting muscle contractures, that begins in childhood. Symptoms are believed to result from altered neuronal communication in the basal ganglia, This study identifies the DMI gene on human chromosome 9q34 as being responsible for this dominant disease. Almost all cases of early-onset dystonia have a unique 3-bp deletion that appears to have arisen independently in different ethnic populations. This deletion results in loss of one of a pair of glutamic-acid residues in a conserved region of a novel ATP-binding protein, termed torsinA. This protein has homologues in nematode, rat, mouse and humans, with some resemblance to the family of heat-shock proteins and Clp proteases.	HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02114; COLUMBIA PRESBYTERIAN MED CTR,DEPT NEUROL,DYSTONIA CLIN RES CTR,NEW YORK,NY 10032; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; MASSACHUSETTS GEN HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; MT SINAI HOSP,MOVEMENT DISORDERS CTR,NEW YORK,NY 10029; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital; Oregon Health & Science University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Stanford University	Ozelius, LJ (corresponding author), MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,BOSTON,MA 02114, USA.			Corey, David/0000-0003-4497-6016	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028384, R01NS026656, P01NS024279] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28384, NS24279, NS26656] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIYAMA Y, 1994, J BIOL CHEM, V269, P5225; ALMASY L, IN PRESS NEUROLOGY; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; APTE AN, 1993, BIOTECHNIQUES, V15, P890; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; Brashear A, 1996, MOVEMENT DISORD, V11, P151, DOI 10.1002/mds.870110206; BRESSMAN SB, 1994, NEUROLOGY, V44, P283, DOI 10.1212/WNL.44.2.283; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURKE RE, 1982, NEUROLOGY, V32, P1335, DOI 10.1212/WNL.32.12.1335; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTIAN CD, 1958, NEW ENGL J MED, V259, P828, DOI 10.1056/NEJM195810232591708; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CHUTORIAN AH, 1996, ACTA NEUROPEDIATR, V2, P33; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; DOOLING EC, 1975, BRAIN, V98, P29, DOI 10.1093/brain/98.1.29; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; Endo Kotaro, 1995, V14, P120; Fahn S, 1988, Adv Neurol, V50, P1; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Fink JK, 1996, AM J HUM GENET, V59, P140; FONTAINE B, 1994, NAT GENET, V6, P267, DOI 10.1038/ng0394-267; Fouad GT, 1996, AM J HUM GENET, V59, P135; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FURUKAWA Y, 1996, ADV NUROL, V69, P37; Gasser T, 1996, MOVEMENT DISORD, V11, P163, DOI 10.1002/mds.870110208; GRAEBER MB, 1992, P NATL ACAD SCI USA, V89, P8245, DOI 10.1073/pnas.89.17.8245; GREENE P, 1995, MOVEMENT DISORD, V10, P143, DOI 10.1002/mds.870100204; GROSSON CL, 1995, NEUROL DISORD, V6, P27; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; Gusella JF, 1997, MOL MED, V3, P238, DOI 10.1007/BF03401677; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; Hedreen J C, 1988, Adv Neurol, V50, P123; KNAPPSKOG PM, 1995, HUM MOL GENET, V4, P1209, DOI 10.1093/hmg/4.7.1209; KORCZYN AD, 1980, ANN NEUROL, V8, P387, DOI 10.1002/ana.410080409; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KRAMER PL, 1994, AM J HUM GENET, V55, P468; KULISEVSKY J, 1993, MOVEMENT DISORD, V8, P239, DOI 10.1002/mds.870080230; LEDOUX MS, 1995, BRAIN RES, V697, P91, DOI 10.1016/0006-8993(95)00792-O; LUDECKE B, 1995, HUM GENET, V95, P123; LUEBE B, 1996, HUM MOL GENET, V5, P1673; MCCORMICK MK, 1993, GENOMICS, V18, P553, DOI 10.1016/S0888-7543(05)80355-6; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; MURRELL J, 1995, GENOMICS, V25, P59, DOI 10.1016/0888-7543(95)80109-Y; NEWMAN PJ, 1988, J CLIN INVEST, V22, P739; NOBREGA JN, 1995, NEUROSCIENCE, V64, P229, DOI 10.1016/0306-4522(94)00334-2; Nobrega JN, 1996, NEUROSCIENCE, V71, P927, DOI 10.1016/0306-4522(95)00511-0; NUTT JG, 1988, MOVEMENT DISORD, V3, P188, DOI 10.1002/mds.870030302; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; Ozelius LJ, 1997, GENOME RES, V7, P483, DOI 10.1101/gr.7.5.483; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; PERIER F, 1995, GENE, V152, P157, DOI 10.1016/0378-1119(94)00697-Q; PRATT GD, 1995, J NEUROCHEM, V64, P2153; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RISCH NJ, 1990, AM J HUM GENET, V46, P533; Sambrook J., 2002, MOL CLONING LAB MANU; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; TABADDOR K, 1978, NEUROLOGY, V28, P1249, DOI 10.1212/WNL.28.12.1249; VANDILLA MA, 1990, CYTOMETRY, V11, P208, DOI 10.1002/cyto.990110124; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WATKINS H, 1993, AM J HUM GENET, V53, P1180; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203; Wolfson L I, 1988, Adv Neurol, V50, P177; Zeman W, 1967, Psychiatr Neurol Neurochir, V70, P77	74	781	811	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					40	48		10.1038/ng0997-40	http://dx.doi.org/10.1038/ng0997-40			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288096				2022-12-27	WOS:A1997XU72400016
J	Hakem, R; delaPompa, JL; Eli, A; Potter, J; Mak, TW				Hakem, R; delaPompa, JL; Eli, A; Potter, J; Mak, TW			Partial rescue of Brca1(5-6) early embryonic lethality by p53 or p21 null mutation	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN; ARREST; INHIBITION; KINASES		AMGEN INST,TORONTO,ON M5G 2C1,CANADA; UNIV TORONTO,ONTARIO CANC INST,TORONTO,ON M5G 2C1,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO,ON M5G 2C1,CANADA; UNIV TORONTO,DEPT IMMUNOL,TORONTO,ON M5G 2C1,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto			De La Pompa, José Luis/F-9719-2014	De La Pompa, José Luis/0000-0001-6761-7265; Hakem, Razqallah/0000-0001-5948-7931				ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUDOS CJ, 1996, GENE DEV, V10, P2038; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; HARPER JW, 1993, CELL, V75, P805; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaufman M. H, 1990, POSTIMPLANTATION MAM, P81; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; RADDING CM, 1991, J BIOL CHEM, V266, P5355; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SELIVANOVA G, 1995, ADV CANCER RES, V66, P143, DOI 10.1016/S0065-230X(08)60253-5; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; TSUZUKI T, 1996, P NATL ACAD SCI USA, V93, P6336; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	26	216	223	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					298	302		10.1038/ng0797-298	http://dx.doi.org/10.1038/ng0797-298			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207798				2022-12-27	WOS:A1997XG60900028
J	Kemp, SJ; Iraqi, F; Darvasi, A; Soller, M; Teale, AJ				Kemp, SJ; Iraqi, F; Darvasi, A; Soller, M; Teale, AJ			Localization of genes controlling resistance to trypanosomiasis in mice	NATURE GENETICS			English	Article							CONGOLENSE; MOUSEPOX	Tsetse fly-transmitted trypanosomes (Trypanosoma spp,) cause 'sleeping sickness' in man and have a serious impact on livestock-based agriculture in large areas of Africa(1). Multigene control of variation in susceptibility to trypanosomiasis is known to occur in mice, where the C57BI/6 (B6) strain is relatively resistant and the A/J (A) and Balb/c (B) strains are susceptible(2,3). Such resistance is also well described among several types of west African cattle(4). We report here the results of genome-wide scans for genes controlling this trait in the B6 mouse using crosses with two different susceptible strains. Regions on mouse chromosomes 5 and 17 were found to be important in determining resistance in both crosses while an additional region on chromosome 1 showed evidence of involvement in only one cross, We confirmed the size of the effect due to chromosome 17 in F3 intercross populations fixed for alternative parental chromosomes, The three loci are of large effect and account for most of the genetic variation in both F2 populations. We propose that they be designated Tir1, Tir2 and Tir3.	INT LIVESTOCK RES INST,NAIROBI,KENYA; JACKSON LAB,BAR HARBOR,ME 04609; HEBREW UNIV JERUSALEM,DEPT GENET,IL-91904 JERUSALEM,ISRAEL	CGIAR; International Livestock Research Institute (ILRI); Jackson Laboratory; Hebrew University of Jerusalem								ALBRIGHT JW, 1981, INFECT IMMUN, V33, P364, DOI 10.1128/IAI.33.2.364-371.1981; Bakhiet M, 1996, J IMMUNOL, V157, P3518; BROWNSTEIN DG, 1995, J VIROL, V69, P6958, DOI 10.1128/JVI.69.11.6958-6964.1995; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; DARVASI A, 1995, GENETICS, V141, P1199; DEGEE ALW, 1988, J IMMUNOL, V140, P283; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DOEBLEY J, 1995, GENETICS, V141, P333; Eshed Y, 1996, GENETICS, V143, P1807; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LARK KG, 1995, P NATL ACAD SCI USA, V92, P4656, DOI 10.1073/pnas.92.10.4656; LEVINE RF, 1981, INFECT IMMUN, V34, P513, DOI 10.1128/IAI.34.2.513-518.1981; LINCOLN S, 1994, WHITEHEAD I TECHNICA, V2; MORRISON WI, 1979, EXP PARASITOL, V48, P364, DOI 10.1016/0014-4894(79)90121-8; MORRISON WI, 1978, CLIN EXP IMMUNOL, V32, P25; MURRAY M, 1984, PREV VET MED, V2, P541, DOI 10.1016/0167-5877(84)90100-4; NANTULYA VM, 1984, INFECT IMMUN, V43, P735, DOI 10.1128/IAI.43.2.735-738.1984; PATERSON E, 1994, NATURE, V335, P721; RIFKIN MR, 1978, P NATL ACAD SCI USA, V75, P3450, DOI 10.1073/pnas.75.7.3450; Sambrook J., 2002, MOL CLONING LAB MANU; WALLACE GD, 1985, J VIROL, V55, P890, DOI 10.1128/JVI.55.3.890-891.1985; *WHIT I MIT CTR GE, 1996, GEN MAP MOUS DAT REL; *WINR INT, 1992, ASS AN AGR SUBS AFR	23	106	107	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					194	196		10.1038/ng0697-194	http://dx.doi.org/10.1038/ng0697-194			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171834				2022-12-27	WOS:A1997XB54300023
J	Abdelhak, S; Kalatzis, V; Heilig, R; Compain, S; Samson, D; Vincent, C; Weil, D; Cruaud, C; Sahly, I; Leibovici, M; BitnerGlindzicz, M; Francis, M; Lacombe, D; Vigneron, J; Charachon, R; Boven, K; Bedbeder, P; VanRegemorter, N; Weissenbach, J; Petit, C				Abdelhak, S; Kalatzis, V; Heilig, R; Compain, S; Samson, D; Vincent, C; Weil, D; Cruaud, C; Sahly, I; Leibovici, M; BitnerGlindzicz, M; Francis, M; Lacombe, D; Vigneron, J; Charachon, R; Boven, K; Bedbeder, P; VanRegemorter, N; Weissenbach, J; Petit, C			A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family	NATURE GENETICS			English	Article							KIDNEY DEVELOPMENT; VARIABLE EXPRESSIVITY; APPLE MACINTOSH; HEARING-LOSS; PAX6 GENE; PROTEIN; DYSPLASIA; MUTATIONS; DEFECTS; SYSTEM	A candidate gene for Branchio-Oto-Renal (BOR) syndrome was identified at chromosome 8q13.3 by positional cloning and shown to underlie the disease. This gene is a human homologue of the Drosophila eyes absent gene (eya), and was therefore called EYA1. A highly conserved 271-amino acid C-terminal region was also found in the products of two other human genes (EYA2 and EYA3), demonstrating the existence of a novel gene family. The expression pattern of the murine EYA1 orthologue, Eya1, suggests a role in the development of all components of the inner ear, from the emergence of the otic placode. In the developing kidney, the expression pattern is indicative of a role for Eya1 in the metanephric cells surrounding the 'just-divided' ureteric branches.	INST PASTEUR, URA CNRS 1968, UNITE GENET MOL HUMAINE, F-75724 PARIS 15, FRANCE; GENET HUMAN RES CTR, F-91000 EVRY, FRANCE; UNIV LONDON, INST CHILD HLTH, LONDON WC1N 1EH, ENGLAND; UNIV WALES HOSP, WELSH HEARING INST, CARDIFF CF4 4XW, S GLAM, WALES; CHRU, GRP HOSP PELLEGRIN ENFANTS, CLIN PEDIAT & GENET MED, F-33076 BORDEAUX, FRANCE; SERV NEONATAL GENET, F-54042 NANCY, FRANCE; HOP NORD ALBERT MICHALLON, CTR HOSP UNIV, OTORHINOLARYNGOL CLIN, F-38043 GRENOBLE 09, FRANCE; UNIV ANTWERP HOSP, B-2650 EDEGEM, BELGIUM; CTR HOSP INTERCOMMUNAL, SERV OTORHINOLARYNGOL & CHIRURG CERVICO FACIALE, F-94010 CRETEIL, FRANCE; FREE UNIV BRUSSELS, HOP ERASME, CTR GENET, B-1070 BRUSSELS, BELGIUM	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Cardiff University; CHU Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Antwerp; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Libre de Bruxelles; Vrije Universiteit Brussel			Kalatzis, Vasiliki/F-6170-2019; Leibovici, Michel/ABB-6745-2020; Vincent, Christophe/F-6261-2016; Bitner-Glindzicz, Maria/A-4231-2009; Abdelhak, Sonia/L-2831-2013	Kalatzis, Vasiliki/0000-0002-9626-8807; Vincent, Christophe/0000-0003-3201-7213; Petit, Christine/0000-0002-9069-002X; Abdelhak, Sonia/0000-0001-8466-5525; Cruaud, Corinne/0000-0002-4752-7278; Lacombe, Didier/0000-0002-8956-2207; Steinbach, Delphine/0000-0001-7144-7908				Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; BRYDEN MM, 1972, J MORPHOL, V138, P187, DOI 10.1002/jmor.1051380205; CHEN A, 1995, AM J MED GENET, V58, P365, DOI 10.1002/ajmg.1320580413; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CLAPP WL, 1994, RENAL PATHOLOGY CLIN, P3; COREY DP, 1994, P NATL ACAD SCI USA, V91, P433, DOI 10.1073/pnas.91.2.433; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dressler G R, 1995, Curr Opin Nephrol Hypertens, V4, P253, DOI 10.1097/00041552-199505000-00010; FRASER FC, 1983, AM J MED GENET, V14, P473, DOI 10.1002/ajmg.1320140311; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; FUCHS R, 1994, COMPUT APPL BIOSCI, V10, P171; FUCHS R, 1991, COMPUT APPL BIOSCI, V7, P105; GIMSING S, 1986, ANN OTO RHINOL LARYN, V95, P421, DOI 10.1177/000348948609500419; GREENBERG CR, 1988, PRENATAL DIAG, V8, P103, DOI 10.1002/pd.1970080204; Gu JZ, 1996, GENOMICS, V31, P201, DOI 10.1006/geno.1996.0032; HAAN EA, 1989, AM J MED GENET, V32, P490, DOI 10.1002/ajmg.1320320412; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; HEIMLER A, 1986, AM J MED GENET, V25, P15, DOI 10.1002/ajmg.1320250104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HURST HC, 1995, PROTEIN PROFILE, V2, P105; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kalatzis V, 1996, GENOMICS, V34, P422, DOI 10.1006/geno.1996.0307; KONIG R, 1994, EUR J PEDIATR, V153, P446, DOI 10.1007/s004310050171; KOSEKI C, 1992, J CELL BIOL, V119, P1327, DOI 10.1083/jcb.119.5.1327; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MELNICK M, 1976, CLIN GENET, V9, P25; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; NI L, 1994, AM J MED GENET, V51, P176, DOI 10.1002/ajmg.1320510222; PATTERSON LT, 1994, CURR OPIN GENET DEV, V4, P696, DOI 10.1016/0959-437X(94)90136-Q; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SPENCE SE, 1992, GENOMICS, V12, P403, DOI 10.1016/0888-7543(92)90392-6; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; SULK KK, 1995, HEREDITARY HEARING L, P22; Torres M, 1995, DEVELOPMENT, V121, P4057; VANDEWATER TR, 1992, DEV AUDITORY VESTIBU, V2, P1; VINCENT C, 1994, HUM MOL GENET, V3, P1859, DOI 10.1093/hmg/3.10.1859; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	58	460	496	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1997	15	2					157	164		10.1038/ng0297-157	http://dx.doi.org/10.1038/ng0297-157			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020840				2022-12-27	WOS:A1997WF08700014
J	Taylor, RW; Chinnery, PF; Turnbull, DM; Lightowlers, RN				Taylor, RW; Chinnery, PF; Turnbull, DM; Lightowlers, RN			Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids	NATURE GENETICS			English	Article							BINDING PROTEIN; MYOCLONIC EPILEPSY; ESCHERICHIA-COLI; RNALYS MUTATION; GENE-THERAPY; TRANSCRIPTION; DEFECTS; MERRF; MTDNA; PNA	Mitochondrial DNA (mtDNA) is the only extrachromosomal DNA in humans. It is a small (16.5 kb) genome which encodes 13 essential peptides of the respiratory chain, two rRNAs and 22 tRNAs. Defects of this genome are now recognized as important causes of disease and may take the form of point mutations or rearrangements(1-3). There is no effective treatment for patients with mtDNA mutations(4). In the majority of patients with mtDNA defects, both mutant and wild-type molecules are present in the same cell - a phenomenon known as intracellular heteroplasmy. In addition, in the presence of heteroplasmy there is a threshold whereby a certain level of mutant mtDNA is necessary before the disease becomes biochemically and clinically apparent(5-7) Based on the presence of heteroplasmy and the recessive nature of these mutations, we believe it will be possible to treat patients by selectively inhibiting the replication of the mutant mtDNA, thereby allowing propagation of only the wild-type molecule. To confirm the validity of such an approach we synthesised peptide nucleic acids (PNAs) complementary to human mtDNA templates containing a deletion breakpoint or single base mutation, both mutations well documented to cause disease. Using an in vitro replication run-off assay under physiological conditions, the antigenomic PNAs specifically inhibited replication of mutant but not wild-type mtDNA templates. Furthermore, we have shown uptake of these PNAs into cultured human myoblasts. We believe that we have therefore established the potential value of antigenomic PNA therapy for patients with heteroplasmic mtDNA disorders.	UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT NEUROL,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND	Newcastle University - UK				Chinnery, Patrick/0000-0002-7065-6617				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BOULET L, 1992, AM J HUM GENET, V51, P1187; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; CHRZANOWSKALIGHTOWLERS ZMA, 1995, GENE THER, V2, P311; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062; GENUARIO R, 1993, CELL MOL BIOL RES, V39, P625; HOKE GD, 1990, ARCH BIOCHEM BIOPHYS, V282, P116, DOI 10.1016/0003-9861(90)90094-F; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200; TORRONI A, 1995, AM J HUM GENET, V57, P507; VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860; WONG TW, 1985, J BIOL CHEM, V260, P1530	30	196	208	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					212	215		10.1038/ng0297-212	http://dx.doi.org/10.1038/ng0297-212			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020853				2022-12-27	WOS:A1997WF08700027
J	Petit, C				Petit, C			Genes responsible for human hereditary deafness: Symphony of a thousand	NATURE GENETICS			English	Article							SYNDROMIC HEARING-LOSS; ENDOTHELIN-B RECEPTOR; RECESSIVE DEAFNESS; WAARDENBURG SYNDROME; ALPORT SYNDROME; HAIR-CELLS; PERICENTROMERIC REGION; THYROID-HORMONE; GROWTH-FACTOR; MUTATIONS	Hearing loss is the most frequent sensory defect in humans. Dozens of genes may be responsible for the early onset forms of isolated deafness and several hundreds of syndromes with hearing loss have been described. Both the difficulties encountered by linkage analysis in families affected by isolated deafness and the paucity of data concerning the molecular components specifically involved in the peripheral auditory process, have long hampered the identification of genes responsible for hereditary hearing loss. Rapid progress is now being made in both fields. This should allow completion of major pieces of the jigsaw for understanding the development and function of the ear.			Petit, C (corresponding author), INST PASTEUR, UNIT GENET MOL HUMAINE, URA 1968 CNRS, 25 RUE DR ROUX, F-75724 PARIS, FRANCE.			Petit, Christine/0000-0002-9069-002X				AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BACH I, 1992, AM J HUM GENET, V51, P38; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BALLABIO A, 1993, NAT GENET, V3, P277, DOI 10.1038/ng0493-277; BARGMANN CI, 1994, CELL, V78, P729; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bernex F, 1996, DEVELOPMENT, V122, P3023; BonneTamir B, 1996, AM J HUM GENET, V58, P1254; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; Chaib H, 1996, HUM MOL GENET, V5, P155, DOI 10.1093/hmg/5.1.155; CHAIB H, 1994, HUM MOL GENET, V3, P2219, DOI 10.1093/hmg/3.12.2219; CHEN AH, 1995, HUM MOL GENET, V4, P1073, DOI 10.1093/hmg/4.6.1073; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; COREY DP, 1994, P NATL ACAD SCI USA, V91, P433, DOI 10.1073/pnas.91.2.433; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; DEESCOBAR GM, 1987, HORM RES, V26, P12, DOI 10.1159/000180681; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; delCastillo I, 1996, HUM MOL GENET, V5, P1383, DOI 10.1093/hmg/5.9.1383; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Fagerheim T, 1996, HUM MOL GENET, V5, P1187, DOI 10.1093/hmg/5.8.1187; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; FUKUSHIMA K, 1995, HUM MOL GENET, V4, P1643, DOI 10.1093/hmg/4.9.1643; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gorlin RJ, 1995, HEREDITARY HEARING L; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; GUYER MS, 1995, P NATL ACAD SCI USA, V92, P10841, DOI 10.1073/pnas.92.24.10841; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; HUYGEN PLM, 1993, INT J PEDIATR OTORHI, V25, P39, DOI 10.1016/0165-5876(93)90008-Q; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; JELAMRAOUI A, 1996, HUM MOL GENET, V5, P1171; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; KEATS BJB, 1995, MAMM GENOME, V6, P8, DOI 10.1007/BF00350886; KIRSHHOFER K, 1995, MOL BIOL HEARING DEA; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; LALWANI AK, 1994, AM J HUM GENET, V55, P685; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEON PE, 1992, P NATL ACAD SCI USA, V89, P5181, DOI 10.1073/pnas.89.11.5181; LESPERANCE MM, 1995, HUM MOL GENET, V4, P1967, DOI 10.1093/hmg/4.10.1967; Manolis EN, 1996, HUM MOL GENET, V5, P1047, DOI 10.1093/hmg/5.7.1047; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MARKIN VS, 1995, ANNU REV BIOPH BIOM, V24, P59, DOI 10.1146/annurev.bb.24.060195.000423; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; MOTOHASHI H, 1994, HEARING RES, V80, P10, DOI 10.1016/0378-5955(94)90003-5; NADEAU JH, 1991, ANN NY ACAD SCI, V630, P49, DOI 10.1111/j.1749-6632.1991.tb19575.x; OMALLEY BW, 1995, HEARING RES, V88, P181, DOI 10.1016/0378-5955(95)00111-G; ONeill ME, 1996, HUM MOL GENET, V5, P853, DOI 10.1093/hmg/5.6.853; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; PREZANT TR, 1992, AM J MED GENET, V44, P465, DOI 10.1002/ajmg.1320440416; REARDON W, 1991, GENOMICS, V11, P885, DOI 10.1016/0888-7543(91)90011-3; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; Scott DA, 1996, AM J HUM GENET, V59, P385; SCOTT HS, 1991, P NATL ACAD SCI USA, V88, P9695, DOI 10.1073/pnas.88.21.9695; Sheffield VC, 1996, NAT GENET, V12, P424, DOI 10.1038/ng0496-424; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; Steel KP, 1995, ANNU REV GENET, V29, P675; TAKEDA K, 1991, J CLIN INVEST, V87, P496, DOI 10.1172/JCI115023; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; TREMBLAY P, 1995, DEV BIOL, V171, P317, DOI 10.1006/dbio.1995.1284; VANCAMP G, 1995, HUM MOL GENET, V4, P2159; VANMIDDLESWORTH L, 1980, ENDOCRINOLOGY, V106, P1686, DOI 10.1210/endo-106-6-1686; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; YAMASHITA H, 1995, P NATL ACAD SCI USA, V92, P3152, DOI 10.1073/pnas.92.8.3152	94	213	227	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					385	391		10.1038/ng1296-385	http://dx.doi.org/10.1038/ng1296-385			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944017				2022-12-27	WOS:A1996VV73000013
J	Rouault, JP; Falette, N; Guehenneux, F; Guillot, C; Rimokh, R; Wang, Q; Berthet, C; MoyretLalle, C; Savatier, P; Pain, B; Shaw, P; Berger, R; Samarut, J; Magaud, JP; Ozturk, M; Samarut, C; Puisieux, A				Rouault, JP; Falette, N; Guehenneux, F; Guillot, C; Rimokh, R; Wang, Q; Berthet, C; MoyretLalle, C; Savatier, P; Pain, B; Shaw, P; Berger, R; Samarut, J; Magaud, JP; Ozturk, M; Samarut, C; Puisieux, A			Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway	NATURE GENETICS			English	Article							WILD-TYPE P53; HUMAN-BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; GENE; EXPRESSION; PROTEIN; GROWTH; CELLS; ARREST; LINE	Cell cycle regulation is critical for maintenance of genome integrity. A prominent factor that guarantees genomic stability of cells is p53 (ref. 1). The P53 gene encodes a transcription factor that has a role as a tumour suppressor(2). identification of p53-target genes should provide greater insight into the molecular mechanisms that mediate the tumour suppressor activities of p53. The rodent Pc3/Tis21 gene was initially described as an immediate early gene induced by tumour promoters and growth factors in PC12 and Swiss 3T3 cells(3,4). It is expressed in a variety of cell and tissue types and encodes a remarkably labile protein(4,5). Pc3/Tis21 has a strong sequence similarity to the human antiproliferative BTG1 gene cloned from a chromosomal translocation of a B-cell chronic lymphocytic leukaemia(6). This similarity led us to speculate that BTG1 and the putative human homologue of Pc3/Tis21 (named BTG2) were members of a new family of genes involved in growth control and/or differentiation. This hypothesis was recently strengthened by the identification of a new antiproliferative protein, named TOE, which shares sequence similarity with BTG1 and PC3/TIS21 (ref. 7). Here, we cloned and localized the human BTG2 gene. We show that BTG2 expression is induced through a p53-dependent mechanism and that BTG2 function may be relevant to cell cycle control and cellular response to DNA damage.	CTR LEON BERARD,INSERM U453,CNRS,F-69373 LYON 08,FRANCE; HOP EDOUARD HERRIOT,LAB CYTOGENET MOL,F-69437 LYON 03,FRANCE; ECOLE NORMALE SUPER LYON,LAB BIOL MOL & CELLULAIRE,CNRS UMR49,INRA,F-69373 LYON 08,FRANCE; INST PATHOL,DIV EXPT ONCOL,CH-1011 LAUSANNE,SWITZERLAND; INST GENET MOL,INSERM,U301,F-75010 PARIS,FRANCE; BILKENT UNIV,DEPT MOL BIOL & GENET,TR-06533 BILKENT,ANKARA,TURKEY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Ihsan Dogramaci Bilkent University			Samarut, Jacques/AAD-2587-2019; ozturk, mehmet/G-3330-2014; berthet, cyril/T-4842-2017; Moyret-Lalle, Caroline/G-2742-2013; SAVATIER, Pierre/J-4663-2014; Rimokh, Ruth/G-7506-2014; OZTURK, MEHMET/AAS-7241-2021; Pain, Bertrand/A-7686-2015	berthet, cyril/0000-0003-3166-3141; Moyret-Lalle, Caroline/0000-0002-8359-2018; OZTURK, MEHMET/0000-0002-6092-9706; PUISIEUX, Alain/0000-0002-9938-3798; Pain, Bertrand/0000-0002-1210-8444				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARTEK J, 1990, ONCOGENE, V5, P893; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CASEY G, 1991, ONCOGENE, V6, P1791; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; CHERIFF D, 1990, P NATL ACAD SCI USA, V87, P8639; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FREBOURG T, 1992, CANCER RES, V52, P6976; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HENSLER PJ, 1994, MOL CELL BIOL, V14, P2291, DOI 10.1128/MCB.14.4.2291; KASTAN MB, 1991, CANCER RES, V51, P6304; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; MATHEWS CG, 1987, NATURE, V325, P524; MATSUDA A, 1996, ONCOGENE, V12, P705; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MIYASHITA T, 1994, CANCER RES, V54, P3131; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PARASKEVA C, 1988, INT J CANCER, V41, P908; POWELL SN, 1995, CANCER RES, V55, P1643; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; RAO PN, 1979, EFFECTS DRUGS CELL N, P475; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; SAVATIER P, 1994, ONCOGENE, V9, P809; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; STEWART N, 1995, ONCOGENE, V10, P109; TAKAHASHI K, 1993, MOL CARCINOGEN, V8, P58, DOI 10.1002/mc.2940080112; VARNUM BC, 1994, J CELL PHYSIOL, V158, P205, DOI 10.1002/jcp.1041580125; VIKHANSKAYA F, 1994, NUCLEIC ACIDS RES, V22, P1012, DOI 10.1093/nar/22.6.1012; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WALDMAN T, 1995, CANCER RES, V55, P5187; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	44	345	360	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					482	486		10.1038/ng1296-482	http://dx.doi.org/10.1038/ng1296-482			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944033	Green Published			2022-12-27	WOS:A1996VV73000029
J	Ross, AJ; Ruiz-Perez, V; Wang, YM; Hagan, DM; Scherer, S; Lynch, SA; Lindsay, S; Custard, E; Belloni, E; Wilson, DI; Wadey, R; Goodman, F; Orstavik, KH; Monclair, T; Robson, S; Reardon, W; Burn, J; Scambler, P; Strachan, T				Ross, AJ; Ruiz-Perez, V; Wang, YM; Hagan, DM; Scherer, S; Lynch, SA; Lindsay, S; Custard, E; Belloni, E; Wilson, DI; Wadey, R; Goodman, F; Orstavik, KH; Monclair, T; Robson, S; Reardon, W; Burn, J; Scambler, P; Strachan, T			A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis	NATURE GENETICS			English	Article							SONIC HEDGEHOG; CURRARINO TRIAD; MALFORMATIONS; EMBRYOGENESIS; MUTATIONS; DISEASE; REGION; MOUSE; MAPS; 7Q36	Partial absence of the sacrum is a rare congenital defect which also occurs as an autosomal dominant trait; association with anterior meningocoele. presacral teratoma and anorectal abnormalities constitutes the Currarino triad(1) (MIM 176450). Malformation at the caudal end of the developing notochord at approximately Carnegie stage 7 (16 post-ovulatory days). which results in aberrant secondary neurulation. can explain the observed pattern of anomalies(2,4). We previously reported linkage to 7q36 markers in two dominantly inherited sacral agenesis families(2). We now present data refining the initial subchromosomal localization in several additional hereditary sacral agenesis (HSA) families. We excluded several candidate genes before identifying patient-specific mutations in a homeobox gene, HLXB9 which was previously reported to map to 1q41-q42.1 and to be expressed in lymphoid and pancreatic tissues(5,6).	Univ Newcastle Upon Tyne, Sch Biochem & Genet, Human Genet Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ London, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Oslo, Ulleval Hosp, Dept Med Genet, N-0315 Oslo, Norway; Natl Hosp Norway, Dept Pediat Surg, N-0027 Oslo, Norway; Univ Newcastle Upon Tyne, Dept Obstet & Gynaecol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ London, Inst Child Hlth, Clin Genet Unit, London WC1N 1EH, England	Newcastle University - UK; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; University College London; University of Oslo; University of Oslo; National Hospital Norway; Newcastle University - UK; University of London; University College London	Strachan, T (corresponding author), Univ Newcastle Upon Tyne, Sch Biochem & Genet, Human Genet Unit, Ridley Bldg,Claremont Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	tom.strachan@ncl.ac.uk	Scherer, Stephen W./B-3785-2013; belloni, elena/H-9909-2013; Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020; Ruiz-Perez, Victor L/K-6066-2014; Wilson, David/A-6264-2010	Scherer, Stephen W./0000-0002-8326-1999; Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Ruiz-Perez, Victor L/0000-0003-0635-3619; Wilson, David/0000-0001-8779-2060; Lindsay, Susan/0000-0003-2980-4582; Belloni, Elena/0000-0003-3214-0780; Reardon, Willie/0000-0001-7329-9179; Lynch, Sally Ann/0000-0003-3540-1333; Burn, John/0000-0002-9823-2322				Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bullen P, 1997, MOL GENETICS EARLY H; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; COPP AJ, 1989, J MED GENET, V26, P160, DOI 10.1136/jmg.26.3.160; CURRARINO G, 1981, AM J ROENTGENOL, V137, P395, DOI 10.2214/ajr.137.2.395; HARDWICK RJ, 1992, J PAEDIATR CHILD H, V28, P328, DOI 10.1111/j.1440-1754.1992.tb02680.x; HARLOW CL, 1995, PEDIATR NEUROSURG, V23, P140, DOI 10.1159/000120951; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KALTER H, 1993, CLIN GENET, V43, P174, DOI 10.1111/j.1399-0004.1993.tb04443.x; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Lanoue L, 1997, AM J MED GENET, V73, P24; LYNCH SA, 1995, NAT GENET, V11, P93, DOI 10.1038/ng0995-93; Mackay M, 1996, GENOMICS, V37, P345, DOI 10.1006/geno.1996.0569; Masuno M, 1996, J MED GENET, V33, P877, DOI 10.1136/jmg.33.10.877; MORICHONDELVALLEZ N, 1993, J MED GENET, V30, P521, DOI 10.1136/jmg.30.6.521; NAJFELD V, 1992, GENE CHROMOSOME CANC, V5, P343, DOI 10.1002/gcc.2870050410; ORIORDAIN DS, 1991, BRIT J SURG, V78, P536, DOI 10.1002/bjs.1800780507; PANG D, 1993, NEUROSURGERY, V32, P755, DOI 10.1227/00006123-199305000-00009; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; Savage NM, 1997, J MED GENET, V34, P866, DOI 10.1136/jmg.34.10.866; TSUKUROV O, 1994, NAT GENET, V6, P282, DOI 10.1038/ng0394-282; VARGAS EC, 1992, PEDIATRIE, V47, P273; Vargas FR, 1998, HUM GENET, V102, P387, DOI 10.1007/s004390050709; 1998, CLIN GENET, V53, P333	28	209	221	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					358	361		10.1038/3828	http://dx.doi.org/10.1038/3828			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843207				2022-12-27	WOS:000077199600022
J	de Winter, JP; Waisfisz, Q; Rooimans, MA; van Berkel, CGM; Bosnoyan-Collins, L; Alon, N; Carreau, M; Bender, O; Demuth, I; Schindler, D; Pronk, JC; Arwert, F; Hoehn, H; Digweed, M; Buchwald, M; Joenje, H				de Winter, JP; Waisfisz, Q; Rooimans, MA; van Berkel, CGM; Bosnoyan-Collins, L; Alon, N; Carreau, M; Bender, O; Demuth, I; Schindler, D; Pronk, JC; Arwert, F; Hoehn, H; Digweed, M; Buchwald, M; Joenje, H			The Fanconi anaemia group G gene FANCG is identical with XRCC9	NATURE GENETICS			English	Article							CHROMOSOMAL INSTABILITY; ANEMIA GENES; COMPLEMENTATION; SUSCEPTIBILITY; SENSITIVITY; UV40; MICE; FAA	Fanconi anemia (FA) is an autosomal recessive disease with diverse clinical symptoms including developmental anomalies, bone marrow failure and early occurrence of malignancies'. In addition to spontaneous chromosome instability, FA cells exhibit cell cycle disturbances and hypersensitivity to crosslinking agents(1). Eight complementation groups (A-H) have been distinguished(2), each group possibly representing a distinct FA gene(3). The genes mutated in patients of complementation groups A (FANCA; refs 4,5) and C (FANCC; ref. 6) have been identified, and FANCD has been mapped to chromosome band 3p22-26 (ref. 7). An additional FA gene has recently been mapped to chromosome 9p (ref. 8). Here we report the identification of the gene mutated in group G, FANCG, on the basis of complementation of an FA-G cell line and the presence of pathogenic mutations in four FA-C patients. We identified the gene as human XRCC9, a gene which has been shown to complement the MMC-sensitive Chinese hamster mutant UV40, and is suspected to be involved in DNA post-replication repair or cell cycle checkpoint control(9,10). The gene is localized to chromosome band 9p13 (ref. 9), corresponding with a known localization of an FA gene.	Free Univ Amsterdam, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands; Hosp Sick Children, Program Genet & Genomic Biol, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Humboldt Univ, Inst Human Genet, D-13353 Berlin, Germany; Univ Wurzburg, Inst Human Genet, D-8700 Wurzburg, Germany	Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Humboldt University of Berlin; University of Wurzburg	Joenje, H (corresponding author), Free Univ Amsterdam, Dept Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	h.joenje.humgen@med.vu.nl	Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523; Carreau, Madeleine/0000-0002-0582-6114; Waisfisz, Quinten/0000-0002-7384-9182	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050131] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50131] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; Auerbach Arleen D., 1997, Current Opinion in Pediatrics, V9, P600, DOI 10.1097/00008480-199712000-00010; BUCHWALD M, 1995, NAT GENET, V11, P228, DOI 10.1038/ng1195-228; Busch DB, 1996, MUTAT RES-DNA REPAIR, V363, P209, DOI 10.1016/0921-8777(96)00014-6; Carreau M, 1998, MOL MED TODAY, V4, P201, DOI 10.1016/S1357-4310(98)01243-X; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kupfer GM, 1997, NAT GENET, V17, P487, DOI 10.1038/ng1297-487; Levran O, 1997, P NATL ACAD SCI USA, V94, P13051, DOI 10.1073/pnas.94.24.13051; Liu N, 1997, P NATL ACAD SCI USA, V94, P9232, DOI 10.1073/pnas.94.17.9232; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; MOSHELL AN, 1981, IN VITRO CELL DEV B, V17, P299; Saar K, 1998, EUR J HUM GENET, V6, P501, DOI 10.1038/sj.ejhg.5200241; SAVOV A, 1992, NUCLEIC ACIDS RES, V20, P6741, DOI 10.1093/nar/20.24.6741; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Whitney MA, 1996, BLOOD, V88, P49	25	260	265	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					281	283		10.1038/3093	http://dx.doi.org/10.1038/3093			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806548				2022-12-27	WOS:000076698100023
J	Inoue, H; Tanizawa, Y; Wasson, J; Behn, P; Kalidas, K; Bernal-Mizrachi, E; Mueckler, M; Marshall, H; Donis-Keller, H; Crock, P; Rogers, D; Mikuni, M; Kumashiro, H; Higashi, K; Sobue, G; Oka, Y; Permutt, MA				Inoue, H; Tanizawa, Y; Wasson, J; Behn, P; Kalidas, K; Bernal-Mizrachi, E; Mueckler, M; Marshall, H; Donis-Keller, H; Crock, P; Rogers, D; Mikuni, M; Kumashiro, H; Higashi, K; Sobue, G; Oka, Y; Permutt, MA			A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)	NATURE GENETICS			English	Article							BETA-CELL; DIDMOAD SYNDROME; LINKAGE	Wolfram syndrome (WFS; OMIM 222300) is an autosomal recessive neurodegenerative disorder defined by young-onset non-immune insulin-dependent diabetes mellitus and progressive optic atrophy. Linkage to markers on chromosome 4p was confirmed in five families. On the basis of meiotic recombinants and disease-associated haplotypes, the WFS gene was localized to a BAC/P1 contig of less than 250 kb. Mutations in a novel gene (WFS1) encoding a putative transmembrane protein were found in all affected individuals in six WFS families, and these mutations were associated with the disease phenotype. WFS1 appears to function in survival of islet beta-cells and neurons.	Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Surg, Div Human Mol Genet, St Louis, MO 63110 USA; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Ube, Yamaguchi 755, Japan; John Hunter Hosp, Newcastle, NSW, Australia; Cleveland Clin Fdn, Div Pediat, Cleveland, OH 44195 USA; Gunma Univ, Sch Med, Dept Neuropsychiat, Gunma, Japan; Fukushima Med Coll, Dept Neuropsychiat, Fukushima, Japan; Fujiwara Mem Hosp, Akita, Japan; Nagoya Univ, Sch Med, Dept Neurol, Nagoya, Aichi 466, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Yamaguchi University; John Hunter Hospital; Cleveland Clinic Foundation; Gunma University; Fukushima Medical University; Nagoya University	Permutt, MA (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA.		Mueckler, Mike M/F-6115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016746, T32DK007120, P60DK020579, R37DK016746] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20579, DK07120, DK16746] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; Barrientos A, 1996, AM J HUM GENET, V58, P963; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Chadwick RB, 1996, BIOTECHNIQUES, V20, P676; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collier DA, 1996, AM J HUM GENET, V59, P855; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Ferrer J, 1997, DIABETES, V46, P386, DOI 10.2337/diabetes.46.3.386; FRASER FC, 1977, J MED GENET, V14, P190, DOI 10.1136/jmg.14.3.190; Groop LC, 1997, ANN MED, V29, P37, DOI 10.3109/07853899708998742; Hanis CL, 1998, SCIENTIST, V12, P11; HIGASHI K, 1991, AM J OTOL, V12, P57; HOFFMANN S, 1997, GENOMICS, V39, P8; Inoue H, 1996, DIABETES, V45, P789, DOI 10.2337/diabetes.45.6.789; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; KARASIK A, 1989, DIABETES CARE, V12, P135, DOI 10.2337/diacare.12.2.135; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MARUYAMA A, 1987, MAKROMOL CHEM-RAPID, V8, P27; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; NANKO S, 1992, BRIT J PSYCHIAT, V161, P282, DOI 10.1192/bjp.161.2.282; Nestorowicz A, 1998, HUM MOL GENET, V7, P1119, DOI 10.1093/hmg/7.7.1119; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; Pratley RE, 1998, J CLIN INVEST, V101, P1757, DOI 10.1172/JCI1850; RAITI S, 1963, Br Med J, V2, P1625; RANDO TA, 1992, NEUROLOGY, V42, P1220, DOI 10.1212/WNL.42.6.1220; Ries S, 1998, HUM MUTAT, V12, P44, DOI 10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O; ROTTER JI, 1990, DIABETES MELLITUS TH, P378; Swift RG, 1998, MOL PSYCHIATR, V3, P86, DOI 10.1038/sj.mp.4000344; WILSON RK, GENOME ANAL LAB MANU; Wolfram DJ, 1938, P MAYO CLIN, V13, P715	33	514	540	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					143	148		10.1038/2441	http://dx.doi.org/10.1038/2441			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771706				2022-12-27	WOS:000076231300015
J	Zhuang, ZP; Park, WS; Pack, S; Schmidt, L; Vortmeyer, AO; Pak, E; Pham, T; Weil, RJ; Candidus, S; Lubensky, IA; Linehan, WM; Zbar, B; Weirich, G				Zhuang, ZP; Park, WS; Pack, S; Schmidt, L; Vortmeyer, AO; Pak, E; Pham, T; Weil, RJ; Candidus, S; Lubensky, IA; Linehan, WM; Zbar, B; Weirich, G			Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas	NATURE GENETICS			English	Article							HUMAN CANCER; MUTATIONS; LYMPHOMA; TUMORS	The gene defect for hereditary papillary renal carcinoma(1) (HPRC) has recently been mapped to chromosome 7q, and germline mutations of MET (also known as c-met) at 7q31 have been detected in patients with HPRC (ref, 2). Tumours from these patients commonly show trisomy of chromosome 7 when analysed by cytogenetic studies and comparative genomic hybridization(3) (CGH), However, the relationship between trisomy 7 and MET germline mutations is not clear. We studied 16 renal tumours from two patients with documented germline mutations in exon 16 of MET. Flourescent in situ hybridization (FISH) analysis showed trisomy 7 in all tumours, To determine whether the chromosome bearing the mutant or wild-type MET gene was duplicated, we performed duplex PCR and phosphoimage densitometry using polymorphic microsatellite markers D7S1801 and D7S1822, which were linked to the disease gene locus, and D1S1646 as an internal control. We determined the parental origin of chromosome alleles by genotyping parental DNA, In ail 16 tumours there was an increased signal intensity (2:1 ratio) of the microsatellite allele from the chromosome bearing the mutant MET compared with the allele from the chromosome bearing the wild-type MET. Our study demonstrates a non-random duplication of the chromosome bearing the mutated MET in HPRC and implicates this event in tumorigenesis.	NCI, Pathol Lab, Bethesda, MD 20892 USA; Sci Applicat Int Corp, Intramural Res Support Program, Frederick, MD USA; Tech Univ Munich, Inst Pathol, D-8000 Munich, Germany; NCI, Urol Oncol Branch, Bethesda, MD 20892 USA; NCI, Immunobiol Lab, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Technical University of Munich; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Zhuang, ZP (corresponding author), NCI, Pathol Lab, Bldg 10, Bethesda, MD 20892 USA.		Pack, Svetlana D./C-2020-2014	Pack, Svetlana D./0000-0003-3256-6626				BIANCHI AB, 1990, P NATL ACAD SCI USA, V87, P6902, DOI 10.1073/pnas.87.17.6902; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KOVACS G, 1993, ADV CANCER RES, V62, P89, DOI 10.1016/S0065-230X(08)60316-4; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; ROWLEY JD, 1984, CANCER RES, V44, P3159; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt L, 1998, CANCER RES, V58, P1719; WIRSCHUBSKY Z, 1984, INT J CANCER, V33, P477, DOI 10.1002/ijc.2910330410; ZBAR B, 1995, J UROLOGY, V153, P907, DOI 10.1016/S0022-5347(01)67601-8	11	224	234	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					66	69		10.1038/1727	http://dx.doi.org/10.1038/1727			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731534				2022-12-27	WOS:000075671400022
J	Street, VA; McKee-Johnson, JW; Fonseca, RC; Tempel, BL; Noben-Trauth, K				Street, VA; McKee-Johnson, JW; Fonseca, RC; Tempel, BL; Noben-Trauth, K			Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice	NATURE GENETICS			English	Article							HAIR-CELLS; GERBIL COCHLEA; CA-ATPASE; TRANSDUCTION; EXPRESSION	Hearing loss is the most common sensory deficit in humans. Because the auditory systems of mice and humans are conserved, studies on mouse models have predicted several human deafness genes and identified new genes involved in hearing(1,2). The deafwaddler (dfw) mouse mutant is deaf and displays vestibular/motor imbalance. Here we report that the gene encoding a plasma membrane Ca2+-ATPase type 2 pump (Atp2b2, also known as Pmca2) is mutated in dfw. An A-->G nucleotide transition in dfw DNA causes a glycine-to-serine substitution at a highly conserved amino-acid position, whereas in a second allele, dfw(2J), a 2-base-pair deletion causes a frameshift that predicts a truncated protein. In the cochlea, the protein Atp2b2 is localized to stereocilia and the basolateral wall of hair cells in wild-type mice, but is not detected in dfw(2J) mice. This indicates that mutation of Atp2b2 may cause deafness and imbalance by affecting sensory transduction in stereocilia(3) as well as neurotransmitter release from the basolateral membrane(4). These mutations affecting Atp2b2 in dfw and dfw(2J) are the first to be found in a mammalian plasma membrane calcium pump and define a new class of deafness genes that directly affect hair-cell physiology.	Univ Washington, Sch Med, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; Natl Inst Deafness & Commun Disorders, Sect Murine Genet, NIH, Rockville, MD 20850 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Tempel, BL (corresponding author), Univ Washington, Sch Med, Virginia Merrill Bloedel Hearing Res Ctr, Box 357923, Seattle, WA 98195 USA.							ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; Apicella S, 1997, NEUROSCIENCE, V79, P1145, DOI 10.1016/S0306-4522(97)00035-3; CARAFOLI E, 1994, J NEUROBIOL, V25, P312, DOI 10.1002/neu.480250311; Crouch JJ, 1996, HEARING RES, V101, P55, DOI 10.1016/S0378-5955(96)00132-3; Crouch JJ, 1995, HEARING RES, V92, P112, DOI 10.1016/0378-5955(95)00201-4; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; EATOCK RA, 1987, J NEUROSCI, V7, P2821; GAO JZ, 1995, CANCER RES, V55, P743; GHISLAIN M, 1987, J BIOL CHEM, V262, P17549; KUZMIN I, 1994, CANCER RES, V54, P2486; Lane PW, 1987, MOUSE NEWS LETT, V77, P129; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; McKee-Johnson JW, 1998, GENOMICS, V49, P371, DOI 10.1006/geno.1998.5274; MCKEEJOHNSON J, 1996, PROTOCOLS YEAST ARTI, P167; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; NORTON SJ, 1996, ASS RES OT ABSTR, V19, P82; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; STAHL WL, 1992, MOL BRIN RES, V16, P222; Steel KP, 1996, CURR OPIN NEUROBIOL, V6, P520, DOI 10.1016/S0959-4388(96)80059-6; STREET VA, 1995, GENOMICS, V29, P123, DOI 10.1006/geno.1995.1222; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Yamoah EN, 1998, J NEUROSCI, V18, P610	23	222	233	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					390	394		10.1038/1284	http://dx.doi.org/10.1038/1284			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697703				2022-12-27	WOS:000075107600025
J	Krude, H; Biebermann, H; Luck, W; Horn, R; Brabant, G; Gruters, A				Krude, H; Biebermann, H; Luck, W; Horn, R; Brabant, G; Gruters, A			Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans	NATURE GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; SCANNING MODEL; COAT COLOR; GENE; TRANSLATION; CODON; DELETION	Sequential cleavage of the precursor protein pre-pro-opiomelanocortin (POMC) generates the melanocortin peptides adrenocorticotrophin (ACTH), melanocyte-stimulating hormones (MSH) alpha, beta and gamma as well as the opioid-receptor ligand beta-endorphin(1) While a few cases of isolated ACTH deficiency have been reported (OMIM 201400), an inherited POMC defect has not been described so far(2). Recent studies in animal models elucidated a central role of alpha-MSH in the regulation of food intake by activation of the brain melanocortin-4-receptor (MC4-R; refs 3-5) and the linkage of human obesity to chromosome 2 in close proximity to the POMC locus(6), led to the proposal of an association of POMC with human obesity(7). The dual role of alpha-MSH in regulating food intake and influencing hair pigmentation predicts that the phenotype associated with a defect in POMC function would include obesity, alteration in pigmentation and ACTH deficiency. The observation of these symptoms in two probands prompted us to search for mutations within their POMC genes. Patient 1 was found to be a compound heterozygote for two mutations in exon 3 (G7013T. C7133 Delta) which interfere with appropriate synthesis of ACTH and alpha-MSH. Patient 2 was homozygous for a mutation in exon 2 (C3804A) which abolishes POMC translation. These findings represent the first examples of a genetic defect within the POMC gene and define a new monogenic endocrine disorder resulting in early-onset obesity, adrenal insufficiency and red hair pigmentation.	Humboldt Univ, Dept Pediat, Berlin, Germany; Med Hsch Hannover, Dept Clin Endocrinol, Hannover, Germany	Humboldt University of Berlin; Hannover Medical School	Gruters, A (corresponding author), Humboldt Univ, Dept Pediat, Campus Virchow, Berlin, Germany.	grueters@ukrv.de		Biebermann, Heike/0000-0002-2024-7778				BERGENHEM NCH, 1992, P NATL ACAD SCI USA, V89, P8798, DOI 10.1073/pnas.89.18.8798; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Joerg H, 1996, MAMM GENOME, V7, P317, DOI 10.1007/s003359900090; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; MORLE F, 1985, EMBO J, V4, P1245, DOI 10.1002/j.1460-2075.1985.tb03767.x; NUSSEY SS, 1993, CLIN ENDOCRINOL, V39, P381, DOI 10.1111/j.1365-2265.1993.tb02381.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Rutishauser J, 1996, J CLIN ENDOCR METAB, V81, P192, DOI 10.1210/jc.81.1.192; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; TAKAHASHI H, 1983, NUCLEIC ACIDS RES, V11, P6847, DOI 10.1093/nar/11.19.6847; TAKAHASHI H, 1981, FEBS LETT, V135, P97, DOI 10.1016/0014-5793(81)80952-0; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328	26	1180	1228	3	84	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					155	157		10.1038/509	http://dx.doi.org/10.1038/509			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620771				2022-12-27	WOS:000073865100022
J	Mansouri, A; Chowdhury, K; Gruss, P				Mansouri, A; Chowdhury, K; Gruss, P			Follicular cells of the thyroid gland require Pax8 gene function	NATURE GENETICS			English	Article							DEVELOPING EXCRETORY SYSTEM; MOUSE; DIFFERENTIATION; EXPRESSION; MIDBRAIN; LUNG	The thyroid gland develops from two distinct embryonic lineages: follicular cells (which produce thyroxine) and parafollicular C-cells (which produce calcitonin) are of endodermal and neural crest origin, respectively, Little is known about the molecular mechanisms governing the generation of these different cell types, Mice lacking the transcription factor Ttf1 lack both cell types and thus are unable to develop a thyroid gland. By analysis of Pax8(-/-) mice, we demonstrate that Pax8 is required for the formation of the follicular cells in the thyroid. We present evidence that Pax8 is necessary for providing cues for the differentiation of competent endoderm primordia into thyroxin-producing follicular cells.	MPI Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Max Planck Society	Gruss, P (corresponding author), MPI Biophys Chem, Dept Mol Cell Biol, Am Fassberg, D-37077 Gottingen, Germany.	pgruss@gwdg.de						ASANO M, 1992, MECH DEVELOP, V39, P29, DOI 10.1016/0925-4773(92)90023-D; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; FONTAINE J, 1979, GEN COMP ENDOCR, V37, P81, DOI 10.1016/0016-6480(79)90049-2; HILFER SR, 1968, EPITHELIAL MESENCHYM, P177; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Nagy A., 1993, Gene targeting: a practical approach., P147; PEARSE AGE, 1967, NATURE, V214, P929, DOI 10.1038/214929a0; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POHL V, 1990, J CELL BIOL, V111, P663, DOI 10.1083/jcb.111.2.663; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; TORRES M, 1994, CELL BIOL LAB HDB, P112; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WILKINSON DG, 1992, IN SITU HYBRIDISATIO	20	454	473	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					87	90		10.1038/ng0598-87	http://dx.doi.org/10.1038/ng0598-87			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590297				2022-12-27	WOS:000073346700025
J	Riley, P; Anson-Cartwright, L; Cross, JC				Riley, P; Anson-Cartwright, L; Cross, JC			The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis	NATURE GENETICS			English	Article							MOUSE; GENE; EXPRESSION; HEART; CLONING; CELLS; IMPLANTATION; PROTEINS; ENCODES; SYSTEM	The placenta and cardiovascular system are the first organ systems to form during mammalian embryogenesis. We show here that a single gene is critical for development of both. The Hand1 gene, previously called Hxt, eHAND and Thing1, encodes a basic helix-loop-helix (bHLH) transcription factor that starts to be expressed during pre-implantation development. After implantation, Hand1 expression is restricted to placental trophoblast cells and later to embryonic cardiac and neural crest cells(1-3). We generated Hand1-null mutant mice by gene targetting. Homozygous mutant embryos arrested by embryonic day (E) 7.5 of gestation with defects in trophoblast giant cell differentiation. This early mortality could be rescued by aggregation of mutant embryos with wild-type tetraploid embryos, which contribute wild-type cells to the trophoblast, but not the embryo. By E10.5, however, the Hand1-null fetuses derived from tetraploid chimaeras died due to cardiac failure. Their heart tubes showed abnormal looping and ventricular myocardial differentiation. Therefore, Hand1 is essential for differentiation of both trophoblast and cardiomyocytes, which are embryologically distinct cell lineages.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Cross, JC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				Alexander CM, 1996, DEVELOPMENT, V122, P1723; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; CHENG AK, 1995, MECH DEVELOP, V52, P187, DOI 10.1016/0925-4773(95)00400-U; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HOGAN B, 1986, MANIPULATING MOUSE E; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; ILGREN EB, 1983, PLACENTA, V4, P307, DOI 10.1016/S0143-4004(83)80010-1; JACKSON LL, 1986, P NATL ACAD SCI USA, V83, P8496, DOI 10.1073/pnas.83.22.8496; KNUDSEN TB, 1991, BIOL REPROD, V44, P171, DOI 10.1095/biolreprod44.1.171; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Millen Kathleen J., 1996, P339; Nagy A., 1993, Gene targeting: a practical approach., P147; NIETO MA, 1992, DEVELOPMENT, V116, P227; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SMITH DE, 1992, DEVELOPMENT, V116, P1033; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Wurst W., 1993, Gene targeting: a practical approach., P33	31	402	414	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					271	275		10.1038/ng0398-271	http://dx.doi.org/10.1038/ng0398-271			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500551				2022-12-27	WOS:000072325000027
J	Fisher, SE; Vargha-Khadem, F; Watkins, KE; Monaco, AP; Pembrey, ME				Fisher, SE; Vargha-Khadem, F; Watkins, KE; Monaco, AP; Pembrey, ME			Localisation of a gene implicated in a severe speech and language disorder	NATURE GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HUMAN GENOME; DEFECTS; MAP	Between 2 and 5% of children who are otherwise unimpaired have significant difficulties in acquiring expressive and/or receptive language, despite adequate intelligence and opportunity(1,2) While twin studies indicate a significant role for genetic factors in developmental disorders of speech and language(1), the majority of families segregating such disorders show complex patterns of inheritance, and are thus not amenable for conventional linkage analysis(2). A rare exception is the KE family, a large three-generation pedigree in which approximately half of the members are affected with a severe speech and language disorder which appears to be transmitted as an autosomal dominant monogenic trait(3). This family has been widely publicised as suffering primarily from a defect in the use of grammatical suffixation rules(4-7), thus supposedly supporting the existence of genes specific to grammar. The phenotype, however, is broader in nature, with virtually every aspect of grammar and of language affected(8-10). in addition, affected members have a severe orofacial dyspraxia, and their speech is largely incomprehensible to the naive listener(10). We initiated a genome-wide search for linkage in the KE family and have identified a region on chromosome 7 which co-segregates with the speech and language disorder (maximum lod score = 6.62 at theta = 0.0), confirming autosomal dominant inheritance with full penetrance. Further analysis of microsatellites from within the region enabled us to fine map the locus responsible (designated SPCH1) to a 5.6-cM interval in 7q31, thus providing an important step towards its identification. Isolation of SPCH1 may offer the first insight into the molecular genetics of the developmental process that culminates in speech and language.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Inst Child Hlth, Wolfson Ctr, Cognit Neurosci Unit, London WC1N 2AP, England; Inst Child Hlth, Mothercare Unit Clin Genet & Fetal Med, London WC1N 1EH, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; University of London; University College London	Pembrey, ME (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Monaco, Anthony P/A-4495-2010; Vargha-Khadem, Faraneh/C-2558-2008; Fisher, Simon E./E-9130-2012; Watkins, Kate E/A-6559-2012	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; Watkins, Kate E/0000-0002-2621-482X; vargha-khadem, faraneh/0000-0003-4890-8379	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FLETCHER P, 1990, NATURE, V346, P226, DOI 10.1038/346226a0; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; *INT MOL GEN STUD, IN PRESS HUM MOL GEN; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Pinker Steven, 1994, LANGUAGE INSTINCT; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SARDA P, 1988, ANN GENET-PARIS, V31, P258; SCHINZEL A, 1997, HUMAN GENETICS DATAB; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SMITH SD, 1996, PRINCIPLES PRACTICE, P1767; Sobel E, 1996, AM J HUM GENET, V58, P1323; Szathmary E, 1995, MAJOR TRANSITIONS EV; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1990, NATURE, V346, P226, DOI 10.1038/346226c0; [No title captured]	21	368	379	0	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					168	170		10.1038/ng0298-168	http://dx.doi.org/10.1038/ng0298-168			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462748	Green Published			2022-12-27	WOS:000071779500027
J	Carmeliet, P; Moons, L; Lijnen, HR; Baes, M; Lemaitre, V; Tipping, P; Drew, A; Eeckhout, Y; Shapiro, S; Lupu, F; Collen, D				Carmeliet, P; Moons, L; Lijnen, HR; Baes, M; Lemaitre, V; Tipping, P; Drew, A; Eeckhout, Y; Shapiro, S; Lupu, F; Collen, D			Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation	NATURE GENETICS			English	Article							ABDOMINAL AORTIC-ANEURYSM; ATHEROSCLEROTIC LESIONS; MICE; MACROPHAGES; DEGRADATION; ELASTIN; PATHOGENESIS; PROTEOGLYCAN; PROTEOLYSIS; EXPRESSION	The molecular mechanisms predisposing to atherosclerotic aneurysm formation remain undefined(1-5). Nevertheless, rupture of aortic aneurysms is a major cause of death in Western societies, with few available treatments and poor long-term prognosis. Indirect evidence suggests that matrix metalloproteinases (MMPs) and plasminogen activators (PAs) are involved in its pathogenesis (1,6-12). MMPs are secreted as inactive zymogens (pro-MMPs), requiring activation in the extracellular compartment(11,13). Plasmin, generated from the zymogen plasminogen by tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA; refs 14,15), has been proposed as a possible activator in vitro, but evidence for such a role in vivo is lacking(16,17) . Analysis of atherosclerotic aorta in mice with a deficiency of apoliprotein E (Apoe(-/-);ref. 18), singly or combined with a deficiency of t-PA (Apoe(-/-):Plat(-/-)) or of u-PA (Apoe(-/-):Plau(-/-); ref. 19), indicated that deficiency of u-PA protected against media destruction and aneurysm formation, probably by means of reduced plasmin-dependent activation of pro-MMPs. This genetic evidence suggests that plasmin is a pathophysiologically significant activator of pro-MMPs in vivo and may have implications for the design of therapeutic strategies to prevent aortic-wall destruction by controlling Plau gene function.	UNIV CATHOLIQUE LOUVAIN VIB, CTR TRANSGENE TECHNOL & GENE THERAPY, B-3000 LOUVAIN LA NEUVE, BELGIUM; KATHOLIEKE UNIV LEUVEN, LAB CLIN CHEM & PHARM, B-3001 LOUVAIN, BELGIUM; UNIV LOUVAIN, SCH MED, INT INST CELLULAR & MOL PATHOL, CELL BIOL UNIT, BRUSSELS, BELGIUM; MONASH UNIV, MONASH MED CTR, DEPT MED, CTR INFLAMMATORY DIS, CLAYTON, VIC 3168, AUSTRALIA; WASHINGTON UNIV, SCH MED, ST LOUIS, MO 63130 USA; THROMBOSIS RES INST, VASC BIOL LAB, LONDON SW3 6LR, ENGLAND	Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Monash University; Washington University (WUSTL); Thrombosis Research Institute			Lijnen, Roger/AAA-4085-2020; Lupu, Florea/C-3162-2009; Carmeliet, Peter/AAQ-5140-2020; Lupu, Florea/AAV-3257-2021	Lupu, Florea/0000-0003-1249-9278; Carmeliet, Peter/0000-0001-7961-1821; Lupu, Florea/0000-0003-1249-9278; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Baes, Myriam/0000-0002-2525-2269				Anidjar S, 1992, Ann Vasc Surg, V6, P298, DOI 10.1007/BF02000279; BRAVERMAN AC, 1994, CURR OPIN CARDIOL, V9, P591, DOI 10.1097/00001573-199409000-00014; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Carmeliet P, 1997, CIRC RES, V81, P829; Carmeliet Peter, 1996, Seminars in Thrombosis and Hemostasis, V22, P525, DOI 10.1055/s-2007-999055; COLLEN D, 1991, BLOOD, V78, P3114; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; DELAISSE JM, 1993, J CELL SCI, V106, P1071; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; EECKHOUT Y, 1977, BIOCHEM J, V166, P21, DOI 10.1042/bj1660021; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Halloran B G, 1995, Semin Vasc Surg, V8, P85; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; LUPU F, 1995, ARTERIOSCL THROM VAS, V15, P1444, DOI 10.1161/01.ATV.15.9.1444; MACSWEENEY STR, 1994, BRIT J SURG, V81, P935, DOI 10.1002/bjs.1800810704; Murphy G, 1995, ACTA ORTHOP SCAND, V66, P55, DOI 10.3109/17453679509157648; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; NEWMAN KM, 1994, J VASC SURG, V20, P814, DOI 10.1016/S0741-5214(94)70169-5; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; PATEL MI, 1995, J AM COLL SURGEONS, V181, P371; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; SCHNEIDERMAN J, 1995, J CLIN INVEST, V96, P639, DOI 10.1172/JCI118079; SENIOR RM, 1989, AM REV RESPIR DIS, V139, P1251, DOI 10.1164/ajrccm/139.5.1251; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; WERB Z, 1980, J EXP MED, V152, P1340, DOI 10.1084/jem.152.5.1340	29	546	559	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1997	17	4					439	444		10.1038/ng1297-439	http://dx.doi.org/10.1038/ng1297-439			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398846				2022-12-27	WOS:A1997YJ92400025
J	Connor, F; Bertwistle, D; Mee, PJ; Ross, GM; Swift, S; Grigorieva, E; Tybulewicz, VLJ; Ashworth, A				Connor, F; Bertwistle, D; Mee, PJ; Ross, GM; Swift, S; Grigorieva, E; Tybulewicz, VLJ; Ashworth, A			Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; EARLY EMBRYONIC LETHALITY; BREAST-CANCER; ATAXIA-TELANGIECTASIA; MDM2-DEFICIENT MICE; TARGETED DISRUPTION; OVARIAN-CANCER; DEFICIENT MICE; P53; DIFFERENTIATION	Germline mutation of the BRCA2 gene carries a high risk of developing breast cancer. To study the function of this gene, we generated a mutation in Brca2 in mice, Unlike other mutations in the Brca2 gene, which are lethal early in embryogenesis when homozygous, some of our homozygous mutant mice survive to adulthood. These animals have a wide range of defects, including small size, improper differentiation of tissues, absence of germ cells and the development of lethal thymic lymphomas. Fibroblasts cultured from Brca2(-/-)embryos have a defect in proliferation that may be mediated by over-expression of p53 and p21(Waf1/CIP1). We show that BrcaZ is required for efficient DNA repair, and our results suggest that loss of the p53 checkpoint may be essential for tumour progression triggered by mutations in BRCA2.	INST CANC RES,CHESTER BEATTY LABS,CRC,CTR CELL & MOL BIOL,LONDON SW3 6JB,ENGLAND; INST CANC RES,CHESTER BEATTY LABS,SECT GENE FUNCT & REGULAT,LONDON SW3 6JB,ENGLAND; NATL INST MED RES,DIV CELLULAR IMMUNOL,LONDON NW7 1AA,ENGLAND; NATL INST MED RES,DIV DEV NEUROBIOL,LONDON NW7 1AA,ENGLAND; INST CANC RES,ACAD UNIT RADIOTHERAPY & ONCOL,SUTTON SM2 5NG,SURREY,ENGLAND; ROYAL MARSDEN HOSP,SUTTON SM2 5NG,SURREY,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust				Tybulewicz, Victor/0000-0003-2439-0798				Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bishop DT, 1997, NAT GENET, V15, P226, DOI 10.1038/ng0397-226; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Connor F, 1997, HUM MOL GENET, V6, P291, DOI 10.1093/hmg/6.2.291; Crook T, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63327-2; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Easton D, 1997, NAT GENET, V16, P210, DOI 10.1038/ng0797-210; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Godley LA, 1996, GENE DEV, V10, P836, DOI 10.1101/gad.10.7.836; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; IVANOV EL, 1997, CURR BIOL, V7, P492; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; LUNA RMD, 1995, NATURE, V378, P203; MEYN MS, 1995, CANCER RES, V55, P5991; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSS GM, 1995, CANCER RES, V55, P1235; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sharan SK, 1997, GENOMICS, V40, P234, DOI 10.1006/geno.1996.4573; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Stratton MR, 1996, CURR OPIN GENET DEV, V6, P93, DOI 10.1016/S0959-437X(96)90017-9; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vaughn JP, 1996, CANCER RES, V56, P4590; Westphal CH, 1997, CANCER RES, V57, P1664; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	54	353	356	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					423	430		10.1038/ng1297-423	http://dx.doi.org/10.1038/ng1297-423			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398843				2022-12-27	WOS:A1997YJ92400022
J	White, JK; Auerbach, W; Duyao, MP; Vonsattel, JP; Gusella, JF; Joyner, AL; MacDonald, ME				White, JK; Auerbach, W; Duyao, MP; Vonsattel, JP; Gusella, JF; Joyner, AL; MacDonald, ME			Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion	NATURE GENETICS			English	Article							ABNORMAL BRAIN-DEVELOPMENT; GENE HOMOLOG HDH; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; PROTEIN; MOUSE; POLYGLUTAMINE; PHENOTYPE; LOCALIZATION	Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder caused by a CAG repeat expansion that lengthens a glutamine segment in the novel huntingtin protein. To elucidate the molecular basis of HD, we extended the polyglutamine tract of the mouse homologue, Hdh, by targetted introduction of an expanded human HD CAG repeat, creating mutant Hdh(neoQ50) and Hdh(Q50) alleles that express reduced and wildtype levels of altered huntingtin, respectively. Mice homozygous for reduced levels displayed characteristic aberrant brain development and perinatal lethality, indicating a critical function for Hdh in neurogenesis. However, mice with normal levels of mutant huntingtin did not display these abnormalities, indicating that the expanded CAG repeat does not eliminate or detectably impair huntingtin's neurogenic function. Thus, the HD defect in man does not mimic complete or partial Hdh inactivation and appears to cause neurodegenerative disease by a gain-of-function mechanism.	MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,CHARLESTOWN,MA 02129; NYU,MED CTR,DEPT CELL BIOL,NEW YORK,NY 10016; NYU,MED CTR,SKIRBALL INST BIOMOL MED,DEV GENET PROGRAM,NEW YORK,NY 10016; MASSACHUSETTS GEN HOSP,MOL NEUROPATHOL LAB,CHARLESTOWN,MA 02129	Harvard University; Massachusetts General Hospital; New York University; New York University; Harvard University; Massachusetts General Hospital					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367, R01NS032765] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32765, NS16367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Gusella JF, 1997, MOL MED, V3, P238, DOI 10.1007/BF03401677; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; *HUNT DIS COLL RES, 1993, CELL, V72, P971; IDE K, 1995, BIOCHEM BIOPH RES CO, V209, P1119, DOI 10.1006/bbrc.1995.1613; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN BY, 1995, GENOMICS, V25, P707, DOI 10.1016/0888-7543(95)80014-D; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; MACDONALD ME, 1996, HDB COLD SPRING HARB, V61, P627; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; McNeil SM, 1997, HUM MOL GENET, V6, P775, DOI 10.1093/hmg/6.5.775; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MYERS RH, 1989, AM J HUM GENET, V45, P615; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; PERSICHETTI F, 1995, NEUROBIOL DIS, V1, P159; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SHAH V, 1995, NAT GENET, V10, P175; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Wu M, 1996, P NATL ACAD SCI USA, V93, P2110, DOI 10.1073/pnas.93.5.2110; Wurst W., 1993, Gene targeting: a practical approach., P33; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	47	389	403	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					404	410		10.1038/ng1297-404	http://dx.doi.org/10.1038/ng1297-404			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398841				2022-12-27	WOS:A1997YJ92400020
J	Allikmets, R; Singh, N; Sun, H; Shroyer, NE; Hutchinson, A; Chidambaram, A; Gerrard, B; Baird, L; Stauffer, D; Peiffer, A; Rattner, A; Smallwood, P; Li, YX; Anderson, KL; Lewis, RA; Nathans, J; Leppert, M; Dean, M; Lupski, JR				Allikmets, R; Singh, N; Sun, H; Shroyer, NE; Hutchinson, A; Chidambaram, A; Gerrard, B; Baird, L; Stauffer, D; Peiffer, A; Rattner, A; Smallwood, P; Li, YX; Anderson, KL; Lewis, RA; Nathans, J; Leppert, M; Dean, M; Lupski, JR			A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy	NATURE GENETICS			English	Article							FUNDUS-FLAVIMACULATUS; MULTIDRUG-RESISTANCE; RETINAL DEGENERATION; MOLECULAR-GENETICS; CYSTIC-FIBROSIS; POINT MUTATIONS; NORRIE DISEASE; CLONING; SEQUENCE; MAPS	Stargardt disease (STGD, also known as fundus flavimaculatus; FFM) is an autosomal recessive retinal disorder characterized by a juvenile-onset macular dystrophy, alterations of the peripheral retina, and subretinal deposition of lipofuscin-like material. A gene encoding an ATP-binding cassette (ABC) transporter was mapped to the 2-cM (centiMorgan) interval at 1p13-p21 previously shown by linkage analysis to harbour the STGD gene. This gene, ABCR, is expressed exclusively and at high levels in the retina, in rod but not cone photoreceptors, as detected by in situ hybridization. Mutational analysis of ABCR in STGD families revealed a total of 19 different mutations including homozygous mutations in two families with consanguineous parentage. These data indicate that ABCR is the causal gene of STGD/FFM.	NCI, FREDERICK CANC RES & DEV CTR, SAIC FREDERICK, LAB GEN DIVERS, FREDERICK, MD 21702 USA; NCI, FREDERICK CANC RES & DEV CTR, SAIC FREDERICK, INTRAMURAL RES SUPPORT PROGRAM, FREDERICK, MD 21702 USA; UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MOL BIOL & GENET, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT OPHTHALMOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, BALTIMORE, MD 21205 USA; BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT OPHTHALMOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MED, HOUSTON, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Allikmets, Rando/ABD-4533-2021	Dean, Michael C/0000-0003-2234-0631; Shroyer, Noah/0000-0002-5934-2852; Nathans, Jeremy/0000-0001-8106-5460; Rattner, Amir/0000-0001-9542-6212	NCI NIH HHS [5P30CA42014] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLIKMETS R, 1995, MAMM GENOME, V6, P114, DOI 10.1007/BF00303254; ALLIKMETS R, 1993, GENE, V136, P231, DOI 10.1016/0378-1119(93)90470-N; Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON KL, 1995, AM J HUM GENET, V57, P1351; ANDERSON KL, 1996, THESIS BAYLOR COLL M; ANDERSON RE, 1972, ARCH BIOCHEM BIOPHYS, V151, P270, DOI 10.1016/0003-9861(72)90497-3; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Blacharski P.A., 1988, RETINAL DYSTROPHY DE, P135; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Childs S, 1994, Important Adv Oncol, P21; CHIU MI, 1994, GENOMICS, V21, P440, DOI 10.1006/geno.1994.1292; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAEMEN FJM, 1973, BIOCHIM BIOPHYS ACTA, V300, P255, DOI 10.1016/0304-4157(73)90006-3; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; FONG SL, 1984, J BIOL CHEM, V259, P6534; Franceschetti A., 1963, ENTWICKLUNG FORTSCHR, P107; GASS JDM, 1987, STEREOSCOPIC ATLAS M, P256; GERBER S, 1995, AM J HUM GENET, V56, P396; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; HAYES KC, 1974, INVEST OPHTH VISUAL, V13, P499; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hoyng CB, 1996, HUM GENET, V98, P500, DOI 10.1007/s004390050247; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; KLIEN BA, 1967, AM J OPHTHALMOL, V64, P3, DOI 10.1016/0002-9394(67)93339-9; Klugbauer N, 1996, FEBS LETT, V391, P61, DOI 10.1016/0014-5793(96)00700-4; KUWANO Y, 1985, J BIOCHEM-TOKYO, V97, P983, DOI 10.1093/oxfordjournals.jbchem.a135175; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LINCOLN AL, 1991, PRIMER COMPUTER PROG; LOPEZ PF, 1990, OPHTHALMOLOGY, V97, P798; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; MCDONNELL PJ, 1986, OPHTHALMOLOGY, V93, P116; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; MEITINGER T, 1993, NAT GENET, V5, P376, DOI 10.1038/ng1293-376; MICHAELIS S, 1995, COLD SPRING HARBOR S, V60; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; *NAT ADV EYE COUNC, 1993, NIH PUBLICATION; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NOBLE KG, 1979, ARCH OPHTHALMOL-CHIC, V97, P1281; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RANDO RR, 1990, ANGEW CHEM INT EDIT, V29, P461, DOI 10.1002/anie.199004611; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roa BB, 1996, HUM MUTAT, V7, P36, DOI 10.1002/(SICI)1098-1004(1996)7:1<36::AID-HUMU5>3.0.CO;2-N; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Sambrook J, 1989, MOL CLONING; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STEINMETZ RL, 1991, OPHTHALMOLOGY, V98, P953; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; THOMAS PM, 1992, SCIENCE, V255, P1132; Valle D, 1995, METABOLIC MOL BASES, V1, P1147; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996; ZINN KM, 1979, RETINAL PIGMENT EPIT, P521	77	1020	1058	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					236	246		10.1038/ng0397-236	http://dx.doi.org/10.1038/ng0397-236			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054934				2022-12-27	WOS:A1997WK38600011
J	Howard, TD; Paznekas, WA; Green, ED; Chiang, LC; Ma, N; DeLuna, RIO; Delgado, CG; GonzalezRamos, M; Kline, AD; Jabs, EW				Howard, TD; Paznekas, WA; Green, ED; Chiang, LC; Ma, N; DeLuna, RIO; Delgado, CG; GonzalezRamos, M; Kline, AD; Jabs, EW			Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-2; JACKSON-WEISS-SYNDROME; CROUZON-SYNDROME; SYNDROME LOCUS; BALANCED TRANSLOCATIONS; DROSOPHILA EMBRYOS; GENE; CRANIOSYNOSTOSIS; HETEROGENEITY; LOCALIZATION	Saethre-Chotzen syndrome is one of the most common autosomal dominant disorders of craniosynostosis in humans and is characterized by craniofacial and limb anomalies. The locus for Saethre-Chotzen syndrome maps to chromosome 7p21-p22, We have evaluated TWIST; a basic helix-loop-helix transcription factor, as a candidate gene for this condition because its expression pattern and mutant phenotypes in Drosophila and mouse are consistent with the Saethre-Chotzen phenotype. We mapped TWIST to human chromosome 7p21-p22 and mutational analysis reveals nonsense, missense, insertion and deletion mutations in patients. These mutations occur within the basic DNA binding, helix I and loop domains, or result in premature termination of the protein, Studies in Drosophila indicate that twist may affect the transcription of fibroblast growth factor receptors (FGFRs), another gene family implicated in human craniosynostosis. The emerging cascade of molecular components involved in craniofacial and limb development now includes TWIST, which may function as an upstream regulator of FGFRs.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,CTR MED GENET,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,CTR MED GENET,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT SURG,CTR MED GENET,BALTIMORE,MD 21287; NIH,GENOME TECHNOL BRANCH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; GENOME THERAPEUT CORP,COLLABORAT RES DIV,WALTHAM,MA 02154; HOSP INFANTIL MEXICO DR FEDERICO GOMEZ,DEPT GENET,MEXICO CITY 06720,DF,MEXICO; SINAI HOSP,DEPT PEDIAT,DIV CLIN GENET,BALTIMORE,MD 21215	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hospital Infantil de Mexico Federico Gomez; Sinai Hospital of Baltimore				Jabs, Ethylin/0000-0001-8983-5466	NCRR NIH HHS [RR00722] Funding Source: Medline; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE11131] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chotzen F., 1932, MSCHR KINDERHEILK, V55, P97; COHEN MM, 1986, CRANIOSYNOSTOSIS DIA, P467; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; DUBOIS BL, 1993, GENOMICS, V16, P315, DOI 10.1006/geno.1993.1191; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; FRANCKE U, 1977, ANN REV BIRTH DEFECT, V13, P241; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Goodman B. K., 1995, American Journal of Human Genetics, V57, pA114; GORLIN RJ, 1990, SYNDROMES HEAD NECK, P799; GREEN ED, 1995, GENOMICS, V25, P170, DOI 10.1016/0888-7543(95)80123-4; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; KREBS I, 1996, M GEN MAPP SEQ, P140; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; LEWANDA AF, 1994, AM J HUM GENET, V55, P1195; MATTEI MG, 1993, MAMM GENOME, V4, P127, DOI 10.1007/BF00290439; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; MURRAY SS, 1992, J BONE MINER RES, V10, P1132; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; ROSE CSP, 1994, HUM MOL GENET, V3, P1405; Saethre H., 1931, DTSCH Z NERVENHEILK, V117, P533, DOI [10.1007/BF01673869, 10.1007/bf01673869]; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; SIMPSON P, 1983, GENETICS, V105, P615; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; STOETZEL C, 1995, MECH DEVELOP, V51, P251, DOI 10.1016/0925-4773(95)00369-X; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; TSUJI K, 1994, AM J MED GENET, V45, P108; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; vonGernet S, 1996, AM J MED GENET, V63, P177; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WANG S, IN PRESS GENE; WILKIE AOM, 1995, J MED GENET, V32, P174, DOI 10.1136/jmg.32.3.174; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I	41	486	499	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					36	41		10.1038/ng0197-36	http://dx.doi.org/10.1038/ng0197-36			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988166				2022-12-27	WOS:A1997WA37300018
J	Matsuura, T; Sutcliffe, JS; Fang, P; Galjaard, RJ; Jiang, YH; Benton, CS; Rommens, JM; Beaudet, AL				Matsuura, T; Sutcliffe, JS; Fang, P; Galjaard, RJ; Jiang, YH; Benton, CS; Rommens, JM; Beaudet, AL			De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome	NATURE GENETICS			English	Article							WILLI-SYNDROME REGION; FACTOR-II GENE; LINKAGE ANALYSIS; EXPRESSED GENE; E6 ONCOPROTEIN; SNRPN GENE; IDENTIFICATION; 15Q11-Q13; DEFINE; P53	Angelman syndrome (AS) is associated with maternal deletions of human chromosome 15q11-q13 and with paternal uniparental disomy for this region indicating that deficiency of an imprinted, maternally expressed gene within the critical interval is the likely cause of the syndrome, Although the gene for EG-AP ubiquitin-protein ligase (UBE3A) was mapped to the critical region for AS, evidence of expression from both parental alleles initially suggested that it was an unlikely candidate gene for this disorder, Because attempts to identify any novel maternally expressed transcripts were unsuccessful and because the UBE3A gene remained within a narrowed AS critical region, we searched for mutations in UBE3A in 11 AS patients without known molecular defects (large deletion, uniparental disomy, or imprinting mutation), This analysis tested the possibility that deficiency of an undefined, maternally expressed transcript or isoform of the UBE3A gene could cause AS, Four mutations were identified including a de novo frameshift mutation and a de novo nonsense mutation in exon 3 and two missense mutations of less certain significance, The de novo truncating mutations indicate that UBE3A is the AS gene and suggest the possibility of a maternally expressed gene product in addition to the biallelically expressed transcript, Intragenic mutation of UBE3A in AS is the first example of a genetic disorder of the ubiquitin-dependent proteolytic pathway in mammals, It may represent an example of a human genetic disorder associated with a locus producing functionally distinct imprinted and biallelically expressed gene products.	BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MED & MOL GENET,TORONTO,ON M5G 1X8,CANADA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto			Sutcliffe, James S/C-1348-2012	Sutcliffe, James S/0000-0001-5200-6007	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 00188] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Burke LW, 1996, AM J HUM GENET, V58, P777; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Clechanover A., 1994, CELL, V79, P13; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Matuschewski K, 1996, J BIOL CHEM, V271, P2789, DOI 10.1074/jbc.271.5.2789; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; OH CE, 1994, J NEUROSCI, V14, P3166; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; WOODAGE T, 1994, GENOMICS, V19, P170, DOI 10.1006/geno.1994.1031	29	635	656	2	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					74	77		10.1038/ng0197-74	http://dx.doi.org/10.1038/ng0197-74			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988172				2022-12-27	WOS:A1997WA37300024
J	Zeng, YX; Somasundaram, K; ElDeiry, WS				Zeng, YX; Somasundaram, K; ElDeiry, WS			AP2 inhibits cancer cell growth and activates p21(WAF1)/(CIP1) expression	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR AP-2; INDUCIBLE ENHANCER; LEUKEMIA-CELLS; GENE; DIFFERENTIATION; INDUCTION; CARCINOMA; CHROMOSOME-6; PATHWAY; KINASES	The 52-kD Activator Protein (AP2) is a DNA-binding transcription factor(1-3) implicated in signalling terminal differentiation(2-4). Profound developmental abnormalities have been recently observed in AP2-null mice(5-6). The molecular events by which AP2 promotes differentiation or development are, however, unknown. Increased expression of the universal cell cycle inhibitor p21(WAF1/CIP1) occurs in growth-arrested terminally differentiating cells(7-12). In a search for cellular factors that could activate p21 during phorbol ester (TPA)-induced differentiation, we identified AP2 as a regulator of p21 expression. Mutagenesis of an AP2 DNA-binding site within a p21 promoter-luciferase reporter inhibited its activation by either AP2 transfection or TPA stimulation. Endogenous p21 protein levels were elevated and DNA synthesis was inhibited in AP2 versus control vector-transfected cells. Overexpression of AP2 in HepG2 human hepatoblastoma and SW480 human colon adenocarcinoma cells inhibited cell division and stable colony formation. These results link the differentiation-associated factor AP2 to negative cell cycle and growth control, possibly through p21 activation.	UNIV PENN,SCH MED,HOWARD HUGHES MED INST,DEPT MED & GENET,LAB MOL ONCOL & CELL CYCLE REGULAT,PHILADELPHIA,PA 19104	Howard Hughes Medical Institute; University of Pennsylvania								BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; DUAN CM, 1995, J BIOL CHEM, V270, P24844, DOI 10.1074/jbc.270.42.24844; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FOULKES WD, 1993, BRIT J CANCER, V67, P551, DOI 10.1038/bjc.1993.101; GAYNOR RB, 1991, GENOMICS, V10, P1100, DOI 10.1016/0888-7543(91)90209-W; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HYMAN SE, 1989, MOL CELL BIOL, V9, P321, DOI 10.1128/MCB.9.1.321; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; MICHIELI P, 1994, CANCER RES, V54, P3391; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NAWROZ H, 1994, CANCER RES, V54, P1152; Robertson GP, 1996, CANCER RES, V56, P1635; SATO EF, 1995, BBA-MOL CELL RES, V1266, P23, DOI 10.1016/0167-4889(94)00238-A; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Somasundaram K, 1996, P NATL ACAD SCI USA, V93, P3088, DOI 10.1073/pnas.93.7.3088; STEINMAN RA, 1994, ONCOGENE, V9, P389; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; WILL, 1991, WILLIAMS T, V5, P671; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	32	263	267	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					78	82		10.1038/ng0197-78	http://dx.doi.org/10.1038/ng0197-78			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988173				2022-12-27	WOS:A1997WA37300025
J	Maichele, AJ; Burwinkel, B; Maire, I; Sovik, O; Kilimann, MW				Maichele, AJ; Burwinkel, B; Maire, I; Sovik, O; Kilimann, MW			Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans	NATURE GENETICS			English	Article							CATALYTIC SUBUNIT; MUSCLE ISOFORM; ALPHA-SUBUNIT; ENZYMATIC ANALYSIS; STORAGE DISEASE; MESSENGER-RNA; DEFICIENCY; DOMAIN; GENES; LOCALIZATION		RUHR UNIV BOCHUM, INST PHYSIOL CHEM, D-44780 BOCHUM, GERMANY; HOP DEBROUSSE, CTR ETUDE MALAD METAB, F-69322 LYON 5, FRANCE; UNIV BERGEN, HAUKELAND HOSP, DEPT PEDIAT, N-5016 BERGEN, NORWAY	Ruhr University Bochum; CHU Lyon; University of Bergen; Haukeland University Hospital								BENDER PK, 1987, J BIOL CHEM, V262, P8799; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Burwinkel B, 1996, HUM MOL GENET, V5, P653, DOI 10.1093/hmg/5.5.653; CALALB MB, 1992, J BIOL CHEM, V267, P1455; CHAMBERLAIN JS, 1987, P NATL ACAD SCI USA, V84, P2886, DOI 10.1073/pnas.84.9.2886; CHEN YT, 1995, METABOLIC MOL BASES, V1, P935; CHRISMAN TD, 1982, J BIOL CHEM, V257, P798; CLARK D, 1988, CURR TOP CELL REGUL, V29, P217; DAVIDSON JJ, 1992, P NATL ACAD SCI USA, V89, P2096, DOI 10.1073/pnas.89.6.2096; FRANCKE U, 1989, AM J HUM GENET, V45, P276; Gray R G, 1983, J Inherit Metab Dis, V6, P107, DOI 10.1007/BF01800737; HANKS SK, 1989, MOL ENDOCRINOL, V3, P110, DOI 10.1210/mend-3-1-110; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HARMANN B, 1990, FEBS LETT, V273, P248, DOI 10.1016/0014-5793(90)81096-7; HARMANN B, 1991, J BIOL CHEM, V266, P15631; Hendrickx J, 1996, HUM MOL GENET, V5, P649, DOI 10.1093/hmg/5.5.649; HUG G, 1966, SCIENCE, V153, P1534, DOI 10.1126/science.153.3743.1534; JONES TA, 1990, BIOCHIM BIOPHYS ACTA, V1048, P24, DOI 10.1016/0167-4781(90)90017-V; KAGALWALLA AF, 1995, J PEDIATR-US, V127, P602, DOI 10.1016/S0022-3476(95)70123-0; KIKUCHI M, 1988, J INHERIT METAB DIS, V11, P315, DOI 10.1007/BF01800383; LEDERER B, 1980, BIOCHEM BIOPH RES CO, V92, P169, DOI 10.1016/0006-291X(80)91535-1; LEDERER B, 1975, BIOCHEM J, V147, P23, DOI 10.1042/bj1470023; LERNER A, 1982, AM J DIS CHILD, V136, P406, DOI 10.1001/archpedi.1982.03970410024004; Liu L, 1996, J BIOL CHEM, V271, P11761, DOI 10.1074/jbc.271.20.11761; MADLOM M, 1989, EUR J PEDIATR, V149, P52, DOI 10.1007/BF02024335; NAGAI T, 1988, ACTA PAEDIATR SCAND, V77, P460, DOI 10.1111/j.1651-2227.1988.tb10681.x; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; SANJAD SA, 1993, AM J DIS CHILD, V147, P957, DOI 10.1001/archpedi.1993.02160330047016; SCHNEIDER A, 1993, NAT GENET, V5, P381, DOI 10.1038/ng1293-381; SOVIK O, 1982, EUR J PEDIATR, V139, P210, DOI 10.1007/BF01377363; TAIRA T, 1982, J BIOCHEM-TOKYO, V91, P883, DOI 10.1093/oxfordjournals.jbchem.a133776; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; WEHNER M, 1995, HUM GENET, V96, P616; WEHNER M, 1994, HUM MOL GENET, V3, P1983, DOI 10.1093/hmg/3.11.1983; WHITMORE SA, 1994, GENOMICS, V20, P169, DOI 10.1006/geno.1994.1150; WILLEMS PJ, 1990, EUR J PEDIATR, V149, P268, DOI 10.1007/BF02106291; WULLRICH A, 1993, J BIOL CHEM, V268, P23208; WullrichSchmoll A, 1996, EUR J BIOCHEM, V238, P374, DOI 10.1111/j.1432-1033.1996.0374z.x	38	53	61	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					337	340		10.1038/ng1196-337	http://dx.doi.org/10.1038/ng1196-337			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896567				2022-12-27	WOS:A1996VQ14600032
J	Robertson, NG; Lu, L; Heller, S; Merchant, SN; Eavey, RD; McKenna, M; Nadol, JB; Miyamoto, RT; Linthicum, FH; Neto, JFL; Hudspeth, AJ; Seidman, CE; Morton, CC; Seidman, JG				Robertson, NG; Lu, L; Heller, S; Merchant, SN; Eavey, RD; McKenna, M; Nadol, JB; Miyamoto, RT; Linthicum, FH; Neto, JFL; Hudspeth, AJ; Seidman, CE; Morton, CC; Seidman, JG			Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction	NATURE GENETICS			English	Article							SENSORINEURAL HEARING-LOSS; MYOSIN-VIIA GENE; SERINE-PROTEASE ZYMOGEN; TEMPORAL BONE FINDINGS; EXTRACELLULAR-MATRIX; FACTOR-C; DOMAINS; HYBRIDIZATION; PROTEINS; LIMULUS	DFNA9 is an autosomal dominant, nonsyndromic, progressive sensorineural hearing loss with vestibular pathology. Here we report three missense mutations in human COCH (previously described as Coch5b2), a novel cochlear gene, in three unrelated kindreds with DFNA9. All three residues mutated in DFNA9 are conserved in mouse and chicken Coch, and are found in a region containing four conserved cysteines with homology to a domain in factor C, a lipopolysaccharide-binding coagulation factor in Limulus polyphemus. COCH message, found at high levels in human cochlear and vestibular organs, occurs in the chicken inner ear in the regions of the auditory and vestibular nerve fibres, the neural and abneural limbs adjacent to the cochlear sensory epithelium and the stroma of the crista ampullaris of the vestibular labyrinth. These areas correspond to human inner ear structures which show histopathological findings of acidophilic ground substance in DFNA9 patients.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; Indiana Univ, Sch Med, Dept Otolaryngol, Indianapolis, IN 46202 USA; House Ear Inst, Dept Histopathol, Los Angeles, CA 90057 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Indiana University System; Indiana University-Purdue University Indianapolis; House Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Morton, CC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003402] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00317, DC03402] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DW, 1996, CIRCULATION, V93, P1791, DOI 10.1161/01.CIR.93.10.1791; Cohen M. M., 1995, HEREDITARY HEARING L, P9; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; COLOMBATTI A, 1991, BLOOD, V77, P2305; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; HALPIN C, 1996, AM J AUDIOL, V5, P105; IWANAGA S, 1992, THROMB RES, V68, P1, DOI 10.1016/0049-3848(92)90124-S; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KHETARPAL U, 1991, ARCH OTOLARYNGOL, V117, P1032; KHETARPAL U, 1993, ARCH OTOLARYNGOL, V119, P106; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Manolis EN, 1996, HUM MOL GENET, V5, P1047, DOI 10.1093/hmg/5.7.1047; MUTA T, 1991, J BIOL CHEM, V266, P6554; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VanCamp G, 1997, AM J HUM GENET, V60, P758; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191	29	251	280	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					299	303		10.1038/3118	http://dx.doi.org/10.1038/3118			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806553				2022-12-27	WOS:000076698100028
J	Xu, JF; Meyers, D; Freije, D; Isaacs, S; Wiley, K; Nusskern, D; Ewing, C; Wilkens, E; Bujnovszky, P; Bova, GS; Walsh, P; Isaacs, W; Schleutker, J; Matikainen, M; Tammela, T; Visakorpi, T; Kallioniemi, OP; Berry, R; Schaid, D; French, A; McDonnell, S; Schroeder, J; Blute, M; Thibodeau, S; Gronberg, H; Emanuelsson, M; Damber, JE; Bergh, A; Jonsson, BA; Smith, J; Bailey-Wilson, J; Carpten, J; Stephan, D; Gillanders, E; Amundson, I; Kainu, T; Freas-Lutz, D; Baffoe-Bonnie, A; Van Aucken, A; Sood, R; Collins, F; Brownstein, M; Trent, J				Xu, JF; Meyers, D; Freije, D; Isaacs, S; Wiley, K; Nusskern, D; Ewing, C; Wilkens, E; Bujnovszky, P; Bova, GS; Walsh, P; Isaacs, W; Schleutker, J; Matikainen, M; Tammela, T; Visakorpi, T; Kallioniemi, OP; Berry, R; Schaid, D; French, A; McDonnell, S; Schroeder, J; Blute, M; Thibodeau, S; Gronberg, H; Emanuelsson, M; Damber, JE; Bergh, A; Jonsson, BA; Smith, J; Bailey-Wilson, J; Carpten, J; Stephan, D; Gillanders, E; Amundson, I; Kainu, T; Freas-Lutz, D; Baffoe-Bonnie, A; Van Aucken, A; Sood, R; Collins, F; Brownstein, M; Trent, J			Evidence for a prostate cancer susceptibility locus on the X chromosome	NATURE GENETICS			English	Article							ANDROGEN-RECEPTOR GENE; LINKAGE ANALYSIS; FAMILY HISTORY; RISK; INHERITANCE; SUPPORT; HUMANS; CAG	Over 200.000 new prostate cancer cases are diagnosed in the United States each year, accounting for more than 35% of all cancer cases affecting men, and resulting in 40,000 deaths annually(1). Attempts to characterize genes predisposing to prostate cancer have been hampered by a high phenocopy rate, the late age of onset of the disease and, in the absence of distinguishing clinical features, the inability to stratify patients into subgroups relative to suspected genetic locus heterogeneity. We previously performed a genome-wide search for hereditary prostate cancer (HPC) genes, finding evidence of a prostate cancer susceptibility locus on chromosome 1 (termed HPC1; ref. 2). Here we present evidence for the location of a second prostate cancer susceptibility gene, which by heterogeneity estimates accounts for approximately 16% of HPC cases. This HPC locus resides on the X chromosome (Xq27-28), a finding consistent with results of previous population-based studies suggesting an X-linked mode of HPC inheritance. Linkage to Xq27-28 was observed in a combined study population of 360 prostate cancer families collected at four independent sites in North America, Finland and Sweden. A maximum two-point lod score of 4.60 was observed at DXS1113, theta=0.26, in the combined data set. Parametric multipoint and non-parametric analyses provided results consistent with the two-point analysis. Significant evidence for genetic locus heterogeneity was observed, with similar estimates of the proportion of linked families in each separate family collection. Genetic mapping of the locus represents an important initial step in the identification of an X-linked gene implicated in the aetiology of HPC.	Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; Univ Maryland, Ctr Genet Asthma & Complex Dis, Baltimore, MD 21201 USA; Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55902 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55902 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55902 USA; Umea Univ, Dept Oncol, Umea, Sweden; Umea Univ, Dept Urol & Androl, Umea, Sweden; Umea Univ, Dept Pathol, Umea, Sweden; Natl Human Genome Res Inst, Canc Invest Grp, NIH, Bethesda, MD 20892 USA; Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19012 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Tampere University; Tampere University; Tampere University Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic; Umea University; Umea University; Umea University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fox Chase Cancer Center	Isaacs, W (corresponding author), Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA.	wisaacs@jhmi.edu	Kallioniemi, Olli P/H-5111-2011; Brownstein, Michael/B-8609-2009; Smith, Jeff/C-3484-2012	Kallioniemi, Olli P/0000-0002-3231-0332; Bailey-Wilson, Joan/0000-0002-9153-2920; Schleutker, Johanna/0000-0002-1863-0305; McDonnell, Shannon/0000-0001-6201-369X; Bova, George/0000-0003-1639-3104; Smith, Jeffrey/0000-0001-8424-910X; Visakorpi, Tapio/0000-0002-5004-0364	NATIONAL CANCER INSTITUTE [P50CA058236, R01CA072818] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG055389] Funding Source: NIH RePORTER; NCI NIH HHS [CA72818, CA58236] Funding Source: Medline; NHGRI NIH HHS [N01-HG-55389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Collins A, 1996, GENOMICS, V36, P157, DOI 10.1006/geno.1996.0436; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Hakimi JM, 1996, WORLD J UROL, V14, P329; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; IRVINE RA, 1995, CANCER RES, V55, P1937; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Ott J., 1991, ANAL HUMAN GENETIC L; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P361	28	357	362	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					175	179		10.1038/2477	http://dx.doi.org/10.1038/2477			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771711				2022-12-27	WOS:000076231300020
J	Bullido, MJ; Artiga, MJ; Recuero, M; Sastre, I; Garcia, MA; Aldudo, J; Lendon, C; Han, SW; Morris, JC; Frank, A; Vazquez, J; Goate, A; Valdivieso, F				Bullido, MJ; Artiga, MJ; Recuero, M; Sastre, I; Garcia, MA; Aldudo, J; Lendon, C; Han, SW; Morris, JC; Frank, A; Vazquez, J; Goate, A; Valdivieso, F			A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; TYPE-4 ALLELE; DISEASE; FREQUENCY; RNA	The epsilon 4 allele of the apolipoprotein E gene (APOE) has been associated with an increased risk of developing Alzheimer's disease (AD; refs 1,2). However, it is apparent that the APOE epsilon 4 allele alone is neither necessary nor sufficient to cause the disease(3-5). We have recently found three new polymorphisms within the APOE transcriptional regulatory region (M.J.A. et al., manuscript submitted) and now establish an association between one of these polymorphisms (-491A/T) and dementia as observed in Cases Alzheimer's disease, in two independent clinical populations. The results suggest that homozygosity of a common variant (-491A) is associated with increased risk for AD, and that this association is independent of APOE epsilon 4 status. In vitro studies suggest that the -491A/T polymorphism may increase risk for AD by altering the level of ApoE protein expression.	Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol & Genet, St Louis, MO 63110 USA; Univ Autonoma Madrid, Hosp La Paz, Serv Neurol, Madrid 28034, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Washington University (WUSTL); Washington University (WUSTL); Autonomous University of Madrid; Hospital Universitario La Paz	Valdivieso, F (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, E-28049 Madrid, Spain.	fvaldivieso@cbm.uam.es	Morris, John C/A-1686-2012; Bullido, maria j/C-8509-2014; Vazquez, Jesus/B-7697-2015; García, Ana Frank/I-5159-2015	Bullido, maria j/0000-0002-6477-1117; Vazquez, Jesus/0000-0003-1461-5092; García, Ana Frank/0000-0003-3858-9116; Aldudo, Jesus/0000-0002-7098-4709; Goate, Alison/0000-0002-0576-2472	NIA NIH HHS [AG00634, AG05681] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENNETT C, 1995, AM J MED GENET, V60, P1, DOI 10.1002/ajmg.1320600102; Berg Leonard, 1994, P9; Blesa R, 1996, ANN NEUROL, V39, P548, DOI 10.1002/ana.410390419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Garcia MA, 1996, J NEUROSCI, V16, P7550; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HIXSON JE, 1990, J LIPID RES, V31, P545; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Muros M, 1996, ATHEROSCLEROSIS, V121, P13, DOI 10.1016/0021-9150(95)06643-8; PAYAMI H, 1993, LANCET, V342, P738; Relkin NR, 1996, LANCET, V347, P1091, DOI 10.1016/S0140-6736(96)90284-6; SANTANA MA, 1996, J NEUROL S2, V243, P591; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taddei K, 1997, NEUROSCI LETT, V223, P29, DOI 10.1016/S0304-3940(97)13394-8; YAMADA T, 1995, J NEUROL SCI, V129, P56, DOI 10.1016/0022-510X(94)00249-N	20	260	268	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1998	18	1					69	71		10.1038/ng0198-69	http://dx.doi.org/10.1038/ng0198-69			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425904				2022-12-27	WOS:000071259600025
J	Plenge, RM; Hendrich, BD; Schwartz, C; Arena, JF; Naumova, A; Sapienza, C; Winter, RM; Willard, HF				Plenge, RM; Hendrich, BD; Schwartz, C; Arena, JF; Naumova, A; Sapienza, C; Winter, RM; Willard, HF			A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation	NATURE GENETICS			English	Article							DISTAL SHORT ARM; MENTAL-RETARDATION; CONSERVATION; METHYLATION; EXPRESSION; DELETIONS; LINKAGE; TISSUE	X-chromosome inactivation is the process by which a cell recognizes the presence of two copies of an X chromosome early in the development of XX embryos and chooses one to be active and one to be inactive(1) Although it is commonly believed that the initiation of X inactivation is random, with an equal probability (50:50) that either X chromosome will be the inactive X in a given cell, significant variation in the proportion of cells with either X inactive is observed both in mice heterozygous for alleles at the Xce locus(2) and among normal human females in the population(3-5). Families in which multiple females demonstrate extremely skewed inactivation patterns that are otherwise quite rare in the general population are thought to reflect possible genetic influences on the X-inactivation process(5-7). Here we report a rare cytosine to guanine mutation in the XIST minimal promoter that underlies both epigenetic and functional differences between the two X chromosomes in nine females from two unrelated families. All females demonstrate preferential inactivation of the X chromosome carrying the mutation, suggesting that there is an association between alterations in the regulation of XIST expression and X-chromosome inactivation.	CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,DEPT GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106; GREENWOOD GENET CTR,JC SELF RES INST,GREENWOOD,SC 29646; UNIV MIAMI,SCH MED,DEPT PEDIAT,DIV GENET,MIAMI,FL; FELS INST CANC RES & MOL BIOL,PHILADELPHIA,PA; INST CHILD HLTH,MOTHERCARE UNIT CLIN GENET & FETAL MED,LONDON WC1N 1EH,ENGLAND	Case Western Reserve University; University Hospitals of Cleveland; Greenwood Genetic Center; University of Miami; University of London; University College London			Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Naumova, Anna K./0000-0001-8481-5765				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Arena JF, 1996, AM J MED GENET, V64, P50, DOI 10.1002/(SICI)1096-8628(19960712)64:1<50::AID-AJMG7>3.3.CO;2-4; Ballabio Andrea, 1992, Human Molecular Genetics, V1, P221, DOI 10.1093/hmg/1.4.221; Belmont JW, 1996, AM J HUM GENET, V58, P1101; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BRUSQUE L, 1994, NUCLEIC ACIDS RES, V22, P697; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Carrel L, 1996, AM J MED GENET, V64, P27, DOI 10.1002/(SICI)1096-8628(19960712)64:1<27::AID-AJMG3>3.0.CO;2-O; CATTANACH BM, 1969, GENET RES, V14, P223, DOI 10.1017/S0016672300002068; GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; HEARD E, 1994, HUM MOL GENET, V3, P1481, DOI 10.1093/hmg/3.suppl_1.1481; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Hendrich BD, 1997, NUCLEIC ACIDS RES, V25, P2661, DOI 10.1093/nar/25.13.2661; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; NANCE WE, 1964, COLD SPRING HARB SYM, V29, P415, DOI 10.1101/SQB.1964.029.01.043; Naumova AK, 1996, AM J HUM GENET, V58, P1111; Orstavik KH, 1996, AM J MED GENET, V64, P31, DOI 10.1002/(SICI)1096-8628(19960712)64:1<31::AID-AJMG4>3.0.CO;2-U; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; Rupert JL, 1995, EUR J HUM GENET, V3, P333; TAYLOR SAM, 1991, P NATL ACAD SCI USA, V88, P39, DOI 10.1073/pnas.88.1.39; Willard H, 1995, METABOLIC MOL BASES, P719; Willard HF, 1996, CELL, V86, P5, DOI 10.1016/S0092-8674(00)80071-9; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	33	221	228	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					353	356		10.1038/ng1197-353	http://dx.doi.org/10.1038/ng1197-353			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354806				2022-12-27	WOS:A1997YD66700036
J	Bell, DM; Leung, KKH; Wheatley, SC; Ng, LJ; Zhou, S; Ling, KW; Sham, MH; Koopman, P; Tam, PPL; Cheah, KSE				Bell, DM; Leung, KKH; Wheatley, SC; Ng, LJ; Zhou, S; Ling, KW; Sham, MH; Koopman, P; Tam, PPL; Cheah, KSE			SOX9 directly regulates the type-II collagen gene	NATURE GENETICS			English	Article							SRY-RELATED GENE; CHONDROCYTE EXPRESSION; ACTIVATION DOMAIN; TRANSGENIC MICE; COL2A1 GENE; BINDING; MOUSE; ENHANCER; MUTATIONS; PROTEIN	Mutations in human SOX9 are associated with campomelic dysplasia (CD), characterised by skeletal malformation and XY sex reversal(1-3). During chondrogenesis in the mouse, Sox9 is coexpressed with Col2a1, the gene encoding type-II collagen, the major cartilage matrix protein(4). Col2a1 is therefore a candidate regulatory target of SOX9. Regulatory sequences required for chondrocyte-specific expression of the type-II collagen gene have been localized to conserved sequences in the first intron in rats, mice and humans(5-8). We show here that SOX9 protein binds specifically to sequences in the first intron of human COL2A1, Mutation of these sequences abolishes SOX9 binding and chondrocyte-specific expression of a COL2A1-driven reporter gene (COL2A1-lacZ) in transgenic mice. Furthermore, ectopic expression of Sox9 trans-activates both a COL2A1-driven reporter gene and the endogenous Col2a1 gene in transgenic mice. These results demonstrate that COL2A1 expression is directly regulated by SOX9 protein in vivo and implicate abnormal regulation of COL2A1 during chondrogenesis as a cause of the skeletal abnormalities associated with campomelic dysplasia.	UNIV HONG KONG,DEPT BIOCHEM,HONG KONG,HONG KONG; UNIV QUEENSLAND,CTR CELLULAR & MOL BIOL,BRISBANE,QLD 4072,AUSTRALIA; UNIV QUEENSLAND,DEPT ANAT SCI,BRISBANE,QLD 4072,AUSTRALIA; CHILDRENS MED RES INST,WENTWORTHVILLE 2145,AUSTRALIA	University of Hong Kong; University of Queensland; University of Queensland; Children's Medical Research Institute - Australia			Sham, Mai Har/C-4387-2009; Sham, Mai Har/AAX-3781-2020; Koopman, Peter A/C-9416-2009; Leung, Keith/C-4491-2009; Cheah, Kathryn/C-4222-2009	Sham, Mai Har/0000-0003-1179-7839; Koopman, Peter A/0000-0001-6939-0914; Bell, Donald/0000-0002-3788-1580				CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HOSKING BM, 1995, NUCLEIC ACIDS RES, V23, P2626, DOI 10.1093/nar/23.14.2626; KAMACHI YS, 1995, EMBO J, V14, P1310; KANAI Y, 1996, J CELL BIOL, V133, P1; Kent J, 1996, DEVELOPMENT, V122, P2813; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; NG LJ, 1993, DEV BIOL, V159, P403, DOI 10.1006/dbio.1993.1251; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nonchev S, 1996, DEVELOPMENT, V122, P543; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; RITVANIEMI P, 1995, ARTHRITIS RHEUM, V38, P999, DOI 10.1002/art.1780380717; SAVAGNER P, 1995, DNA CELL BIOL, V14, P501, DOI 10.1089/dna.1995.14.501; Schafer AJ, 1996, ANN NY ACAD SCI, V785, P137, DOI 10.1111/j.1749-6632.1996.tb56252.x; SEGHATOLESLAMI MR, 1994, MATRIX BIOL, V14, P753; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; WAGNER T, 1994, CELL, V79, P111; WANG LQ, 1991, J BIOL CHEM, V266, P19878; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; ZHOU G, 1995, J CELL SCI, V108, P3677	30	731	764	3	49	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					174	178		10.1038/ng0697-174	http://dx.doi.org/10.1038/ng0697-174			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171829				2022-12-27	WOS:A1997XB54300018
J	Monckton, DG; Coolbaugh, MI; Ashizawa, KT; Siciliano, MJ; Caskey, CT				Monckton, DG; Coolbaugh, MI; Ashizawa, KT; Siciliano, MJ; Caskey, CT			Hypermutable myotonic dystrophy CTG repeats in transgenic mice	NATURE GENETICS			English	Article							UNSTABLE TRIPLET REPEAT; MACHADO-JOSEPH DISEASE; TRINUCLEOTIDE REPEAT; CAG TRINUCLEOTIDE; EXPANSION; GENE; MOUSE; INSTABILITY; MUTATION; GERMLINE	Myotonic dystrophy (DM) is one of a growing number of inherited human disorders associated with the expansion of triplet repeat DNA sequences(1). Expanded alleles are highly unstable in both the germline and soma, accounting in large part for the unusual genetics of this disorder, its phenotypic variability and probably, the progressive nature of the symptoms(2-7) However, the molecular mechanisms and the genetic factors modulating repeat stability in DM and the other human disorders associated with expanded repeats are not well understood. To provide a model system in which the turnover of triplet repeats could be studied throughout mammalian development, we have generated five transgenic mouse lines incorporating expanded CTG/CAG arrays derived from the human DM locus. Transgene analysis has revealed germline hypermutability, including expansions, deletions and parent-of-origin effects, somatic and early embryonic instability and segregation distortion. Mutational differences between lines and sexes demonstrate that stability, as in humans, is modulated by as yet unidentified cis and trans acting genetic elements.	BAYLOR COLL MED, HOWARD HUGHES MED INST, TEXAS MED CTR, HOUSTON, TX 77030 USA; BAYLOR COLL MED, TEXAS MED CTR, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; UNIV TEXAS, MD ANDERSON CANCER CTR, TEXAS MED CTR, DEPT MOL GENET, HOUSTON, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Monckton, DG (corresponding author), UNIV GLASGOW, INST BIOMED & LIFE SCI, ANDERSON COLL, DIV MOL GENET, 56 DUMBARTON RD, GLASGOW G11 6NU, LANARK, SCOTLAND.		Monckton, Darren/B-4943-2013	Monckton, Darren/0000-0002-8298-8264				Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chakraborty R, 1996, AM J HUM GENET, V59, P109; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; COLLICK A, 1994, EMBO J, V13, P5745, DOI 10.1002/j.1460-2075.1994.tb06912.x; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; HENRION AA, 1995, GENOMICS, V25, P36, DOI 10.1016/0888-7543(95)80107-W; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; Ikeuchi T, 1996, AM J HUM GENET, V58, P730; JANSEN G, 1994, AM J HUM GENET, V54, P575; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KELLY R, 1991, P ROY SOC B-BIOL SCI, V245, P235, DOI 10.1098/rspb.1991.0115; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHON KA, 1988, P NATL ACAD SCI USA, V85, P1165, DOI 10.1073/pnas.85.4.1165; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; MONCKTON DG, 1995, CIRCULATION, V91, P513, DOI 10.1161/01.CIR.91.2.513; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PINKERT CA, 1994, TRANSGENIC ANIMAL TE; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; WONG LJC, 1995, AM J HUM GENET, V56, P114; YU YE, IN PRESS MOUSE GENOM	30	108	112	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1997	15	2					193	196		10.1038/ng0297-193	http://dx.doi.org/10.1038/ng0297-193			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020848				2022-12-27	WOS:A1997WF08700022
J	Imbert, G; Saudou, F; Yvert, G; Devys, D; Trottier, Y; Garnier, JM; Weber, C; Mandel, JL; Cancel, G; Abbas, N; Durr, A; Didierjean, O; Stevanin, G; Agid, Y; Brice, A				Imbert, G; Saudou, F; Yvert, G; Devys, D; Trottier, Y; Garnier, JM; Weber, C; Mandel, JL; Cancel, G; Abbas, N; Durr, A; Didierjean, O; Stevanin, G; Agid, Y; Brice, A			Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; TRINUCLEOTIDE CAG REPEAT; MACHADO-JOSEPH DISEASE; AGE-OF-ONSET; HUNTINGTONS-DISEASE; CHROMOSOME 3P12-P21.1; CLINICAL-FEATURES; MUSCULAR-ATROPHY; FMR1 GENE; INSTABILITY	Two forms of the neurodegenerative disorder spinocerebellar ataxia are known to be caused by the expansion of a CAG (polyglutamine) trinucleotide repeat. By screening cDNA expression libraries, using an antibody specific for polyglutamine repeats, we identified six novel genes containing CAG stretches. One of them is mutated in patients with spinocerebellar ataxia linked to chromosome 12q (SCA2). This gene shows ubiquitous expression and encodes a protein of unknown function. Normal SCA2 alleles (17 to 29 CAG repeats) contain one to three CAAs in the repeat. Mutated alleles (37 to 50 repeats) appear particularly unstable, upon both paternal and maternal transmissions. The sequence of three of them revealed pure CAG stretches. The steep inverse correlation between age of onset and CAG number suggests a higher sensitivity to polyglutamine length than in the other polyglutamine expansion diseases.	ULP, INSERM, CNRS, IGBMC, F-67404 ILLKIRCH GRAFFENSTADEN, STRASBOURG, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, FEDERAT NEUROL, F-75651 PARIS 13, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			Stevanin, Giovanni/E-5038-2016; Trottier, Yvon/H-8852-2016; brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; SAUDOU, Frédéric/L-3454-2014	Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; SAUDOU, Frédéric/0000-0001-6107-1046; Trottier, Yvon/0000-0001-7230-4810; Yvert, Gael/0000-0003-1955-4786; Devys, Didier/0000-0001-9655-3512; Cancel-Tassin, Geraldine/0000-0002-9583-6382				ALLOTEY R, 1995, AM J HUM GENET, V57, P185; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BELAL S, 1994, NEUROLOGY, V44, P1423, DOI 10.1212/WNL.44.8.1423; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; BROHOLM J, 1994, NEUROLOGY, V44, P1533; BURK K, IN PRESS BRAIN; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Gastier JM, 1996, GENOMICS, V32, P75, DOI 10.1006/geno.1996.0078; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Gispert S, 1995, Am J Hum Genet, V57, P972; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IHARA T, 1994, JPN J HUM GENET, V39, P305, DOI 10.1007/BF01874049; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; IMBERT G, 1994, GENOMICS, V21, P667, DOI 10.1006/geno.1994.1335; JIANG JX, 1995, GENOMICS, V30, P91, DOI 10.1006/geno.1995.0015; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAUTER K, 1995, NATURE, V377, P321; KREMER B, 1995, AM J HUM GENET, V57, P343; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LESCURE A, 1994, EMBO J, V13, P1166, DOI 10.1002/j.1460-2075.1994.tb06366.x; Lezin A, 1996, HUM GENET, V97, P671; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Neri C, 1996, HUM MOL GENET, V5, P1001, DOI 10.1093/hmg/5.7.1001; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANEN NG, 1995, AM J HUM GENET, V57, P593; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; RIGGINS GJ, 1993, NAT GENET, V3, P273, DOI 10.1038/ng0393-273b; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Zoghbi HY, 1991, CURR NEUROL, V11, P121	62	737	760	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					285	291		10.1038/ng1196-285	http://dx.doi.org/10.1038/ng1196-285			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896557				2022-12-27	WOS:A1996VQ14600022
J	DeBerardinis, RJ; Goodier, JL; Ostertag, EM; Kazazian, HH				DeBerardinis, RJ; Goodier, JL; Ostertag, EM; Kazazian, HH			Rapid amplification of a retrotransposon subfamily is evolving the mouse genome	NATURE GENETICS			English	Article							L1 ELEMENTS; 5' END; SPASTIC MOUSE; SEQUENCE; MICE; EVOLUTION; INSERTION; CELLS; GENE	Retrotransposition affects genome structure by increasing repetition and producing insertional mutations(1,2). Dispersion of the retrotransposon L1 throughout mammalian genomes suggests that L1 activity might be an important evolutionary force(1). Here we report that L1 retrotransposition contributes to rapid genome evolution in the mouse, because a number of L1 sequences from the T-F subfamily are retrotransposition competent. We show that the T-F subfamily is large, young and expanding, containing approximately 4,800 full-length members in strain 129. Eleven randomly isolated, full-length T-F elements averaged 99.8% sequence identity to each other, and seven of these retrotransposed in cultured cells. Thus, we estimate that the mouse genome contains approximately 3,000 active T-F elements, 75 times the estimated number of active human L1s. Moreover, as T-F elements are polymorphic among closely related mice, they have retrotransposed recently, implying rapid amplification of the subfamily to yield genomes with different patterns of interspersed repetition. Our data show that mice and humans differ considerably in the number of active L1s, and probably differ in the contribution of retrotransposition to ongoing sequence evolution.	Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazazian, HH (corresponding author), Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.							ADEY NB, 1994, MOL BIOL EVOL, V11, P778; DEBERARDINIS RJ, 1998, THESIS U PENN; FANNING TG, 1983, NUCLEIC ACIDS RES, V11, P5073, DOI 10.1093/nar/11.15.5073; JUBIERMAURIN V, 1992, MOL BIOL EVOL, V9, P41; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; LUNDRIGAN BL, 1994, MOL BIOL EVOL, V11, P483; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; PADGETT RW, 1988, NUCLEIC ACIDS RES, V16, P739, DOI 10.1093/nar/16.2.739; Sambrook J., 2002, MOL CLONING LAB MANU; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saxton JA, 1998, J MOL BIOL, V280, P611, DOI 10.1006/jmbi.1998.1899; SCHICHMAN SA, 1992, J MOL BIOL, V224, P559, DOI 10.1016/0022-2836(92)90544-T; SHE JX, 1990, BIOL J LINN SOC, V41, P83, DOI 10.1111/j.1095-8312.1990.tb00823.x; SHEHEE WR, 1987, J MOL BIOL, V196, P757, DOI 10.1016/0022-2836(87)90402-5; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; THALER L, 1986, CURR TOP MICROBIOL, V127, P3; WINCKER P, 1987, NUCLEIC ACIDS RES, V15, P8593, DOI 10.1093/nar/15.21.8593; [No title captured]	23	113	118	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					288	290		10.1038/3104	http://dx.doi.org/10.1038/3104			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806550				2022-12-27	WOS:000076698100025
J	Wang, H; Long, QM; Marty, SD; Sassa, S; Lin, S				Wang, H; Long, QM; Marty, SD; Sassa, S; Lin, S			A zebrafish model for hepatoerythropoietic porphyria	NATURE GENETICS			English	Article							HUMAN UROPORPHYRINOGEN DECARBOXYLASE; NUCLEOTIDE-SEQUENCE; POINT MUTATION; GENE SEQUENCE; CUTANEA-TARDA; IDENTIFICATION; DEFECTS; CLONING; CDNA; DNA	Defects in the enzymes involved in the haem biosynthetic pathway can lead to a group of human diseases known as the porphyrias. yquem (yqe(tp61)) is a zebrafish mutant with a photosensitive porphyria syndrome. Here we show that the porphyric phenotype is due to an inherited homozygous mutation in the gene encoding uroporphyrinogen decarboxylase (UROD); a homozygous deficiency of this enzyme causes hepatoerythropoietic porphyria (HEP) in humans. The zebrafish mutant represents the first genetically 'accurate' animal model of HEP, and should be useful for studying the pathogenesis of UROD deficiency and evaluating gene therapy vectors.. We rescued the mutant phenotype by transient and germline expression of the wild-type allele.	Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; Rockefeller Univ, New York, NY 10021 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Rockefeller University	Lin, S (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.		Long, Qiaoming/L-5074-2017; Wang, Han/A-9774-2008	Long, Qiaoming/0000-0001-8243-589X; Wang, Han/0000-0003-2420-3147	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054508, R01DK032890] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-32890, R01 DK54508-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; CHELSTOWSKA A, 1992, BIOCHEM J, V288, P753, DOI 10.1042/bj2880753; CULP P, 1991, P NATL ACAD SCI USA, V88, P7953, DOI 10.1073/pnas.88.18.7953; de Verneuil H, 1978, Hum Genet, V44, P145; DEVERNEUIL H, 1983, BIOCHEM J, V214, P145, DOI 10.1042/bj2140145; DEVERNEUIL H, 1992, HUM GENET, V89, P548; DEVERNEUIL H, 1986, SCIENCE, V234, P732, DOI 10.1126/science.3775362; ELDER GH, 1989, CLIN BIOCHEM, V22, P163, DOI 10.1016/S0009-9120(89)80072-4; Elder GH, 1998, SEMIN LIVER DIS, V18, P67, DOI 10.1055/s-2007-1007142; GAREY JR, 1992, EUR J BIOCHEM, V205, P1011, DOI 10.1111/j.1432-1033.1992.tb16868.x; GAREY JR, 1989, BLOOD, V73, P892; Haffter P, 1996, DEVELOPMENT, V123, P1; Kappas A, 1995, METABOLIC MOL BASES, P2103; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; Long QM, 1997, DEVELOPMENT, V124, P4105; McManus JF, 1996, BLOOD, V88, P3589, DOI 10.1182/blood.V88.9.3589.bloodjournal8893589; MEGURO K, 1994, J INVEST DERMATOL, V102, P681, DOI 10.1111/1523-1747.ep12374134; MoranJimenez MJ, 1996, AM J HUM GENET, V58, P712; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NISHIMURA K, 1993, GENE, V133, P109; NUSSLEINVOLHARD C, 1994, SCIENCE, V266, P572, DOI 10.1126/science.7939708; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Ransom DG, 1996, DEVELOPMENT, V123, P311; ROBERTS AG, 1995, J INVEST DERMATOL, V104, P500, DOI 10.1111/1523-1747.ep12605953; ROMANA M, 1991, EUR J CLIN INVEST, V21, P225, DOI 10.1111/j.1365-2362.1991.tb01814.x; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7343, DOI 10.1093/nar/15.18.7343; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7211, DOI 10.1093/nar/15.17.7211; ROMEO PH, 1986, J BIOL CHEM, V261, P9825; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Westerfield M, 1995, ZEBRAFISH BOOK; Wu C, 1996, MAMM GENOME, V7, P349, DOI 10.1007/s003359900101; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	33	121	131	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					239	243		10.1038/3041	http://dx.doi.org/10.1038/3041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806541				2022-12-27	WOS:000076698100016
J	Timpl, P; Spanagel, R; Sillaber, I; Kresse, A; Reul, JMHM; Stalla, GK; Blanquet, V; Steckler, T; Holsboer, F; Wurst, W				Timpl, P; Spanagel, R; Sillaber, I; Kresse, A; Reul, JMHM; Stalla, GK; Blanquet, V; Steckler, T; Holsboer, F; Wurst, W			Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1	NATURE GENETICS			English	Article							ETHANOL WITHDRAWAL; CENTRAL NUCLEUS; ADRENAL-CORTEX; AMYGDALA; ALCOHOL; CELLS; RAT; PHARMACOLOGY; EXPRESSION; PHYSIOLOGY	Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol(1,2). Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse(3,4). Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase(5,6). Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.	Max Planck Inst Psychiat, D-80804 Munich, Germany; GSF Munich, Res Ctr, Inst Mammalian Genet, D-85764 Munich, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wurst, W (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	Wurst@mpipsykl.mpg.de	Steckler, Thomas/AAF-3975-2020; Reul, Johannes/B-4132-2019	Reul, Johannes/0000-0002-8787-4012; Wurst, Wolfgang/0000-0003-4422-7410				Aguilera G, 1988, Adv Exp Med Biol, V245, P83; BILEZIKJIAN LM, 1983, ENDOCRINOLOGY, V113, P657, DOI 10.1210/endo-113-2-657; BORNSTEIN SR, 1990, ENDOCRINOLOGY, V127, P900, DOI 10.1210/endo-127-2-900; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; CONTI LH, 1994, PHARMACOL BIOCHEM BE, V48, P497, DOI 10.1016/0091-3057(94)90559-2; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; EDWARDS AV, 1987, J PHYSIOL-LONDON, V390, P23, DOI 10.1113/jphysiol.1987.sp016683; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; HOLSBOER F, 1992, PROG BRAIN RES, V93, P385; Karanth S, 1997, ENDOCRINOLOGY, V138, P3476, DOI 10.1210/en.138.8.3476; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; MENZAGHI F, 1994, ANN NY ACAD SCI, V739, P176, DOI 10.1111/j.1749-6632.1994.tb19819.x; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; OWENS MJ, 1991, PHARMACOL REV, V43, P425; PICH EM, 1995, J NEUROSCI, V15, P5439; RASSNICK S, 1993, BRAIN RES, V605, P25, DOI 10.1016/0006-8993(93)91352-S; Spanagel R, 1996, EUR J PHARMACOL, V305, P45, DOI 10.1016/0014-2999(96)00175-6; STALLA GK, 1988, ENDOCRINOLOGY, V122, P618; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; SWANSON LW, 1989, J COMP NEUROL, V285, P413, DOI 10.1002/cne.902850402; Tabakoff B, 1996, NEURON, V16, P909, DOI 10.1016/S0896-6273(00)80113-0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; Wurst W., 1993, Gene targeting: a practical approach., P33	30	749	765	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					162	166		10.1038/520	http://dx.doi.org/10.1038/520			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620773				2022-12-27	WOS:000073865100024
J	Dunger, DB; Ong, KKL; Huxtable, SJ; Sherriff, A; Woods, KA; Ahmed, ML; Golding, J; Pembrey, ME; Ring, S; Bennett, ST; Todd, JA				Dunger, DB; Ong, KKL; Huxtable, SJ; Sherriff, A; Woods, KA; Ahmed, ML; Golding, J; Pembrey, ME; Ring, S; Bennett, ST; Todd, JA		ALSPAC Study Team	Association of the INS VNTR with size at birth	NATURE GENETICS			English	Article							POSTNATAL-GROWTH; INSULIN; FETAL; IDDM2; LOCUS	Size at birth is an important determinant of perinatal survival(1) and has also been associated with the risk for cardiovascular disease and type 2 diabetes in adult life(2). Common genetic variation that regulates fetal growth could therefore influence perinatal survival and predispose to the development of adult disease. We have tested the insulin gene (INS) variable number of tandem repeats (VNTR) locus, which in Caucasians has two main allele sizes (class I and class III; ref. 3), as a functional candidate polymorphism for association with size at birth, as it has been shown to influence transcription of INS (refs 3-5). In a cohort of 758 term singletons (Avon Longitudinal Study of Pregnancy and Childhood; ALSPAC(6)) followed longitudinally from birth to 2 years, we detected significant genetic associations with size at birth: class III homozygotes had larger mean head circumference (P=0.004) than class I homozygotes. These associations were amplified in babies who did not show postnatal realignment of growth (45%), and were also evident for length (P=0.015) and weight (P=0.009) at birth. The INS VNTR III/III genotype might have bestowed a perinatal survival during human history(7) by conferring larger size at birth. Common genetic variation of this kind may contribute to reported associations between birth size and adult disease.	Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England; Inst Child Hlth, Mothercare Unit Clin Genet & Fetal Med, London WC1N 1EH, England; Southmead Gen Hosp, Lewis Labs, Mol Genet Unit, Bristol BS10 5NB, Avon, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Bristol; University of London; University College London; Southmead Hospital	Todd, JA (corresponding author), Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.	david.dunger@paediatrics.ox.ac.uk; john.todd@well.ox.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Dunger, Professor David/0000-0002-2566-9304; sherriff, andrea/0000-0002-1016-037X; Golding, Jean/0000-0003-2826-3307	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERMAN E, 1991, J ROY SOC MED, V84, P257, DOI 10.1177/014107689108400505; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; FOWDEN AL, 1989, J DEV PHYSIOL, V12, P173; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GEORGIEFF MK, 1986, CLIN PERINATOL, V13, P73, DOI 10.1016/S0095-5108(18)30839-X; GOLDING J, 1996, CONT REV OBSTET GYNA, V8, P89; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HILL DJ, 1989, BAILLIERE CLIN ENDOC, V3, P579, DOI 10.1016/S0950-351X(89)80059-X; Morison IM, 1996, NAT MED, V2, P311, DOI 10.1038/nm0396-311; NEEL JV, 1962, AM J HUM GENET, V14, P353; OUNSTED M, 1975, LANCET, V1, P1393, DOI 10.1016/S0140-6736(75)92605-7; SMITH DW, 1976, J PEDIATR-US, V89, P225, DOI 10.1016/S0022-3476(76)80453-2; TANNER J, 1994, WILKINS DIAGNOSIS TR; Tanner J. M., 1994, Acta Medica Auxologica (Milan), V26, P7; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	22	233	236	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					98	100		10.1038/ng0598-98	http://dx.doi.org/10.1038/ng0598-98			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590300				2022-12-27	WOS:000073346700028
J	Smith, L; Liu, SJ; Goodrich, L; Jacobson, D; Degnin, C; Bentley, N; Carr, A; Flaggs, G; Keegan, K; Hoekstra, M; Thayer, MJ				Smith, L; Liu, SJ; Goodrich, L; Jacobson, D; Degnin, C; Bentley, N; Carr, A; Flaggs, G; Keegan, K; Hoekstra, M; Thayer, MJ			Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SQUAMOUS-CELL CARCINOMAS; ALVEOLAR RHABDOMYOSARCOMA; P53; EXPRESSION; PROTEIN; LOOP; GENE; DIFFERENTIATION; TRANSCRIPTION	Chromosome Sq alterations occur frequently in many types of tumours. In a genetic screen for loci present in rhabdomyosarcomas, we identified an isochromosome 3q [i(3q)], which inhibits muscle differentiation when transferred into myoblasts. The i(3q) inhibits MyoD function, resulting in a non-differentiating phenotype. Furthermore, the i(3q) induces a 'cut' phenotype, abnormal centrosome amplification, aneuploidy and loss of G1 arrest following gamma-irradiation, Testing candidate genes within this region reveals that forced expression of ataxia-telangiectasia and rad3-related (ATR) results in a phenocopy of the i(3q). Thus, genetic alteration of ATR leads to loss of differentiation as well as cell-cycle abnormalities.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Med & Mol Genet, Portland, OR 97201 USA; Univ Sussex, MRC, Cell Mutat Unit, Brighton BN1 9RR, E Sussex, England; ICOS Corp, Bothell, WA 98021 USA	Oregon Health & Science University; Oregon Health & Science University; University of Sussex; Icos Corporation	Thayer, MJ (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	thayerm@ohsu.edu		Carr, Antony Michael/0000-0002-2028-2389; Smith, Leslie/0000-0001-6452-6624				BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CAREY TE, 1993, J CELL BIOCHEM, P213; Carr AM, 1997, CURR OPIN GENET DEV, V7, P93, DOI 10.1016/S0959-437X(97)80115-3; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; DAVIS RJ, 1994, CANCER RES, V54, P2869; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DIAS P, 1990, AM J PATHOL, V137, P1283; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Favaloro J, 1980, Methods Enzymol, V65, P718; Fiddler TA, 1996, MOL CELL BIOL, V16, P5048; Forozan F, 1997, TRENDS GENET, V13, P405, DOI 10.1016/S0168-9525(97)01244-4; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; HARDY S, 1993, MOL CELL BIOL, V13, P5943, DOI 10.1128/MCB.13.10.5943; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; JIN YS, 1993, CANCER RES, V53, P2140; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LUGO TG, 1987, MOL CELL BIOL, V7, P2814, DOI 10.1128/MCB.7.8.2814; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MITCHELL CD, 1991, ONCOGENE, V6, P89; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; PETERSON CA, 1990, CELL, V62, P493, DOI 10.1016/0092-8674(90)90014-6; RABBITTS P, 1990, GENE CHROMOSOME CANC, V2, P231, DOI 10.1002/gcc.2870020312; RAO PH, 1994, CANCER GENET CYTOGEN, V77, P60, DOI 10.1016/0165-4608(94)90150-3; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RIED T, 1994, CANCER RES, V54, P1801; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCRABLE HJ, 1990, P NATL ACAD SCI USA, V87, P2182, DOI 10.1073/pnas.87.6.2182; SHAPIRO DN, 1993, CANCER RES, V53, P5108; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; SPEICHER MR, 1995, CANCER RES, V55, P1010; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Trask B, 1990, FLOW CYTOMETRY; WeberHall SR, 1996, CANCER RES, V56, P3220; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yunis J J, 1978, Prog Clin Pathol, V7, P267	51	75	78	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					39	46		10.1038/ng0598-39	http://dx.doi.org/10.1038/ng0598-39			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590286				2022-12-27	WOS:000073346700014
J	Relaix, F; Wei, XJ; Wu, XW; Sassoon, DA				Relaix, F; Wei, XJ; Wu, XW; Sassoon, DA			Peg3/Pw1 is an imprinted gene involved in the TNF-NF kappa B signal transduction pathway	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; DOMAIN-CONTAINING RECEPTOR; RING FINGER PROTEIN; CYTOPLASMIC DOMAIN; DEATH-DOMAIN; CELL-DEATH; ACTIVATION; APOPTOSIS; CD40; CHROMOSOME-7	Tumor necrosis factor (TNF) mediates a variety of biological activities including cell proliferation, differentiation and programmed cell death. The specific response to TNF depends upon cell type and reflects the presence of specific regulatory proteins that participate in the TNF response pathway. TNF signal transduction is mediated by TRAF2 which binds the TNF Receptor2 (TNFR2) and activates NF kappa B. We previously identified a gene Pw1, which encodes a large zinc-finger containing protein(1). We have determined that Pw1 is identical to Peg3, a paternally expressed gene of unknown function(2) (and will therefore be referred to as Peg3 throughout this text). We report here that Peg3 associates specifically with TRAF2 but not with other TRAF family members. Peg3 expression activates NF kappa B via I kappa B-NF kappa B dissociation and acts synergistically with TRAF2. Transfection of a truncated Peg3 containing the TRAF2 interaction site, abolishes NF kappa B activation by TRAF2 and/or TNF. We conclude that Peg3 is a regulator of the TNF response. These data reveal the involvement of an imprinted gene in this pathway.	Mt Sinai Med Ctr, Brookdale Ctr Mol & Dev Biol, New York, NY 10029 USA; Mt Sinai Med Ctr, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sassoon, DA (corresponding author), Mt Sinai Med Ctr, Brookdale Ctr Mol & Dev Biol, 1 Gustave Levy Pl, New York, NY 10029 USA.	dsassoo@smtplink.mssm.edu	SASSOON, David A/G-2502-2013	SASSOON, David A/0000-0001-6074-048X; Relaix, Frederic/0000-0003-1270-1472	PHS HHS [C873678/01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BROWN SDM, 1993, GENOMICS, V18, P459, DOI 10.1006/geno.1993.1502; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; DUYAO MP, 1990, P NATL ACAD SCI USA, V87, P4727, DOI 10.1073/pnas.87.12.4727; HERMEKING H, 1994, SCIENCE, V165, P1091; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; JANSEN G, 1993, HUM MOL GENET, V2, P1221, DOI 10.1093/hmg/2.8.1221; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; RUBIO MP, 1994, CANCER RES, V54, P4760; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SONG HY, 1995, BIOCHEM J, V309, P825, DOI 10.1042/bj3090825; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; YONG WH, 1995, J NEUROPATH EXP NEUR, V54, P622, DOI 10.1097/00005072-199509000-00002	36	128	134	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					287	291		10.1038/ng0398-287	http://dx.doi.org/10.1038/ng0398-287			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500555				2022-12-27	WOS:000072325000031
J	Martindale, D; Hackam, A; Wieczorek, A; Ellerby, L; Wellington, C; McCutcheon, K; Singaraja, R; Kazemi-Esfarjani, P; Devon, R; Kim, SU; Bredesen, DE; Tufaro, F; Hayden, MR				Martindale, D; Hackam, A; Wieczorek, A; Ellerby, L; Wellington, C; McCutcheon, K; Singaraja, R; Kazemi-Esfarjani, P; Devon, R; Kim, SU; Bredesen, DE; Tufaro, F; Hayden, MR			Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates	NATURE GENETICS			English	Article							SIMPLEX VIRUS TYPE-1; COLORIMETRIC ASSAY; TRANSGENIC MICE; CAG REPEAT; PROTEIN; PHENOTYPE; CELLS	It is unclear how polyglutamine expansion is associated with the pathogenesis of Huntington disease (HD). Here. we provide evidence that polyglutamine expansion leads to the formation of large intracellular aggregates in vitro and in vivo. In vitro these huntingtin-containing aggregates disrupt normal cellular architecture and increase in frequency with polyglutamine length. Huntingtin truncated at nucleotide 1955, close to the caspase-3 cleavage site, forms perinuclear aggregates more readily than full-length huntingtin and increases the susceptibility of cells to death following apoptotic stimuli. Further truncation of huntingtin to nucleotide 436 results in both intranuclear and perinuclear aggregates. For a given protein size, increasing polyglutamine length is associated with increased cellular toxicity. Asymptomatic transgenic mice expressing full-length huntingtin with 138 polyglutamines form exclusively perinuclear aggregates in neurons. These data support the hypothesis that proteolytic cleavage of mutant huntingtin leads to the development of aggregates which compromise cell viability, and that their localization is influenced by protein length.	Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z4, Canada; NeuroVir Inc, Vancouver, BC V6T 1Z3, Canada; Burnham Inst, Program Aging, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; Univ Saskatchewan, Coll Dent, Saskatoon, SK S7N 5E4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of Saskatchewan	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada.	mrh@ulam.generes.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012282] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NIA NIH HHS [AG12282] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CARMICHAEL J, 1987, CANCER RES, V47, P936; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; CUNNINGHAM C, 1993, VIROLOGY, V197, P116, DOI 10.1006/viro.1993.1572; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DIFIGLIA M, 1997, SCIENCE, V277, P199; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Johnson PR, 1997, TRENDS CELL BIOL, V7, P408, DOI 10.1016/S0962-8924(97)01132-X; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Perutz MF, 1996, CURR OPIN STRUC BIOL, V6, P848, DOI 10.1016/S0959-440X(96)80016-9; SAPP E, 1997, ANN NEUROL, V23, P2247; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; TELLEZNAGEL I, 1973, ADV NEUROL, V1, P387; VISTICA DT, 1991, CANCER RES, V51, P2515; Wellington CL, 1997, CURR OPIN NEUROL, V10, P291, DOI 10.1097/00019052-199708000-00003	27	393	406	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					150	154		10.1038/ng0298-150	http://dx.doi.org/10.1038/ng0298-150			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462744				2022-12-27	WOS:000071779500023
J	Schiedner, G; Morral, N; Parks, RJ; Wu, Y; Koopmans, SC; Langston, C; Graham, FL; Beaudet, AL; Kochanek, S				Schiedner, G; Morral, N; Parks, RJ; Wu, Y; Koopmans, SC; Langston, C; Graham, FL; Beaudet, AL; Kochanek, S			Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity	NATURE GENETICS			English	Article							HUMAN ALPHA-1-ANTITRYPSIN GENE; FULL-LENGTH DYSTROPHIN; CRE-MEDIATED EXCISION; HUMAN HPRT LOCUS; IN-VIVO; HELPER VIRUS; VIRAL GENES; MOUSE MODEL; THERAPY; MICE	Many applications for human gene therapy would be facilitated by high levels and long duration of physiologic gene expression, Adenoviral vectors are frequently used for gene transfer because of their high cellular transduction efficiency in vitro and in vivo. Expression of viral proteins and the low capacity for foreign DNA limits the clinical application of first-and second-generation adenoviral vectors(1-7). Adenoviral vectors with all viral coding sequences deleted(8-15) offer the prospect of decreased host immune responses to viral proteins, decreased cellular toxicity of viral proteins and increased capacity to accommodate large regulatory DNA regions. Currently most vectors used in vivo for preclinical and clinical studies express cDNAs under the control of heterologous eukaryotic or viral promoters. Using an adenoviral vector with all viral coding sequences deleted and containing the complete human alpha(1)-antitrypsin (PI) locus, we observed tissue-specific transcriptional regulation in cell culture and in vivo; intravenous injection in mice resulted in high levels of very stable expression for more than ten months and decreased acute and chronic toxicity. These results indicate significant advantages of regulated gene expression using genomic DNA for gene transfer and of adenoviral gene transfer vectors devoid of all viral coding sequences.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA; McMaster Univ, Dept Biol & Pathol, Hamilton, ON L8S 4K1, Canada; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; McMaster University; Baylor College of Medicine	Kochanek, S (corresponding author), Univ Cologne, Ctr Mol Med, Kerpenerstr 34, D-50931 Cologne, Germany.		Morral, Nuria/AAC-7149-2020	Morral, Nuria/0000-0002-8932-2887	NHLBI NIH HHS [HL51754] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051754] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARMENTANO D, 1995, HUM GENE THER, V6, P1343, DOI 10.1089/hum.1995.6.10-1343; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Clemens PR, 1996, GENE THER, V3, P965; DYCAICO MJ, 1988, SCIENCE, V242, P1409, DOI 10.1126/science.3264419; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Fisher KJ, 1996, VIROLOGY, V217, P11, DOI 10.1006/viro.1996.0088; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Guo ZS, 1996, GENE THER, V3, P802; HAFEEZ W, 1992, J CLIN INVEST, V89, P1214, DOI 10.1172/JCI115705; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; KAY MA, 1992, HUM GENE THER, V3, P641, DOI 10.1089/hum.1992.3.6-641; Kochanek S, 1996, P NATL ACAD SCI USA, V93, P5731, DOI 10.1073/pnas.93.12.5731; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; Krougliak V, 1995, HUM GENE THER, V6, P1575, DOI 10.1089/hum.1995.6.12-1575; KumarSingh R, 1996, HUM MOL GENET, V5, P913, DOI 10.1093/hmg/5.7.913; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; MITANI K, 1995, P NATL ACAD SCI USA, V92, P3854, DOI 10.1073/pnas.92.9.3854; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morral N, 1997, HUM GENE THER, V8, P1275, DOI 10.1089/hum.1997.8.10-1275; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Parks RJ, 1997, J VIROL, V71, P3293, DOI 10.1128/JVI.71.4.3293-3298.1997; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; SYKES RC, 1988, MOL GEN GENET, V212, P301, DOI 10.1007/BF00334700; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Wang Q, 1995, GENE THER, V2, P775; Yang YP, 1996, HUM MOL GENET, V5, P1703, DOI 10.1093/hmg/5.11.1703; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zhou HS, 1996, J VIROL, V70, P7030, DOI 10.1128/JVI.70.10.7030-7038.1996	30	512	546	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					180	183		10.1038/ng0298-180	http://dx.doi.org/10.1038/ng0298-180			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462752				2022-12-27	WOS:000071779500031
J	Charlier, C; Singh, NA; Ryan, SG; Lewis, TB; Reus, BE; Leach, RJ; Leppert, M				Charlier, C; Singh, NA; Ryan, SG; Lewis, TB; Reus, BE; Leach, RJ; Leppert, M			A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family	NATURE GENETICS			English	Article							NEONATAL CONVULSIONS; GENERALIZED EPILEPSY; HETEROGENEITY; CHROMOSOME-8Q; CONFIRMATION; LOCUS; MAP	Epileptic disorders affect about 20-40 million people worldwide, and 40% of these are idiopathic generalized epilepsies (IGEs: ref. 1). Most of the IGEs that are inherited are complex, multigenic diseases. To address basic mechanisms for epilepsies, we have focused on one well-defined class of IGEs with an autosomal-dominant mode of inheritance: the benign familiar neonatal convulsions (BFNC: refs 2,3). Genetic heterogeneity of BFNC has been observed(4). Two loci, EBN1 and EBN2, have been mapped by linkage analysis to chromosome 20q13 (refs 5,6) and chromosome 8q24 (refs 7,8), respectively. By positional cloning, we recently identified the gene for EBN1 as KCNQ2 (ref. 9). This gene, a voltage-gated potassium channel, based on homology, is a member of the KQT-like family(10). Here we describe an additional member, KCNQ3. We mapped this new gene to chromosome 8, between markers D8S256 and D8S284 on a radiation hybrid map(11). We screened KCNQ3 for mutations in the large BFNC family(4,7) previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype. The same conserved amino acid is also mutated in KVLQT1 (KCNQ1) in an LQT patient(12). KCNQ2, KCNQ3 and undiscovered genes of the same family of K+ channels are strong candidates for other IGEs.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat Neurol, Philadelphia, PA 19104 USA; Indiana Univ, Sch Med, Dept Med Genet, Indianapolis, IN 46902 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio	Leppert, M (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.			Charlier, Carole/0000-0002-9694-094X; Leach, Robin/0000-0002-3201-5579	NCI NIH HHS [5P30CA42014] Funding Source: Medline; NHGRI NIH HHS [P01-HG00470] Funding Source: Medline; NINDS NIH HHS [R01-NS32666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEPPERT M, 1993, BRAIN PATHOL, V3, P357, DOI 10.1111/j.1750-3639.1993.tb00764.x; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; LEWIS TB, 1993, AM J HUM GENET, V53, P670; LEWIS TB, 1995, GENOME RES, V5, P334, DOI 10.1101/gr.5.4.334; MALAFOSSE A, 1992, HUM GENET, V89, P54, DOI 10.1007/BF00207042; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Plouin P., 1994, IDIOPATHIC GEN EPILE, P39; REUTENS DC, 1995, NEUROLOGY, V45, P1469, DOI 10.1212/WNL.45.8.1469; RONEN GM, 1993, NEUROLOGY, V43, P1355, DOI 10.1212/WNL.43.7.1355; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Steinlein O, 1997, AM J MED GENET, V74, P445, DOI 10.1002/(SICI)1096-8628(19970725)74:4<445::AID-AJMG18>3.0.CO;2-I; STEINLEIN O, 1995, HUM GENET, V95, P411; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	25	754	809	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					53	55		10.1038/ng0198-53	http://dx.doi.org/10.1038/ng0198-53			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425900				2022-12-27	WOS:000071259600021
J	Southard-Smith, EM; Kos, L; Pavan, WJ				Southard-Smith, EM; Kos, L; Pavan, WJ			Sox10 mutation disrupts neural crest development in DOM Hirschsprung mouse model	NATURE GENETICS			English	Article							MICE LACKING GDNF; AUTOSOMAL SEX REVERSAL; ENDOTHELIN-B RECEPTOR; SRY-RELATED GENE; ENTERIC NEURONS; MESSENGER-RNA; CAMPOMELIC DYSPLASIA; MEGACOLON; MELANOCYTES; FAMILY	Hirschsprung disease (HSCR, MIM #142623) is a multigenic neurocristopathy (neural crest disorder) characterized by absence of enteric ganglia in a variable portion of the distal colon. Subsets of HSCR individuals also present with neural crest-derived melanocyte deficiencies (Hirschsprung-Waardenburg, HSCR-WS, MIM #277580). Murine models have been instrumental in the identification and analysis of HSCR disease genes. These include mice with deficiencies of endothelin B receptor (Ednrb(s-l); refs 1,2) endothelin 3 (Edn3(ls); refs 1,3) the tyrosine kinase receptor cRet(4) and glial-derived neurotrophic factor(5-7). Another mouse model of HSCR disease, Dom, arose spontaneously at the Jackson Laboratory(8). While Dom/+ heterozygous mice display regional deficiencies of neural crest-derived enteric ganglia in the distal colon, Dom/Dom homozygous animals are embryonic lethal(8). We have determined that premature termination of Sox10, a member of the SRY-like HMG box family of transcription factors, is responsible for absence of the neural crest derivatives in Dom mice. We demonstrate expression of Sox10 in normal neural crest cells, disrupted expression of both Sox10 and the HSCR disease gene Ednrb in Dom mutant embryos, and loss of neural crest derivatives due to apoptosis. Our studies suggest that Sox10 is essential for proper peripheral nervous system development. We propose SOX10 as a candidate disease gene for individuals with HSCR whose disease does not have an identified genetic origin.	Natl Human Genome Res Inst, Mouse Embryol Sect, Lab Genet Dis Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Pavan, WJ (corresponding author), Natl Human Genome Res Inst, Mouse Embryol Sect, Lab Genet Dis Res, NIH, Bldg 49,Room 4A82,49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	bpavan@nhgri.nih.gov	Southard-Smith, Michelle/C-3488-2012	Pavan, William/0000-0001-8281-5120; Southard-Smith, E Michelle/0000-0003-4718-5869				BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GERSHON MD, 1995, CURR BIOL, V5, P601, DOI 10.1016/S0960-9822(95)00120-5; Hashimoto Y, 1996, CANCER RES, V56, P5266; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; KAPUR RP, 1993, DEVELOPMENT, V117, P993; Kapur RP, 1996, DEV BIOL, V174, P360, DOI 10.1006/dbio.1996.0080; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; PAVAN WJ, 1995, GENOME RES, V5, P29, DOI 10.1101/gr.5.1.29; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pringault V, 1997, GENOMICS, V39, P86, DOI 10.1006/geno.1996.4476; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; PULITI A, 1995, MAMM GENOME, V6, P763, DOI 10.1007/BF00539000; Reid K, 1996, DEVELOPMENT, V122, P3911; ROTHMAN TP, 1993, DEV BIOL, V159, P559, DOI 10.1006/dbio.1993.1264; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Stock DW, 1996, GENOMICS, V37, P234, DOI 10.1006/geno.1996.0548; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; SWIFT GH, 1982, P NATL ACAD SCI-BIOL, V79, P7263, DOI 10.1073/pnas.79.23.7263; Tani M, 1997, GENOMICS, V39, P30, DOI 10.1006/geno.1996.4483; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT EM, 1993, NUCLEIC ACIDS RES, V21, P744, DOI 10.1093/nar/21.3.744	36	586	600	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1998	18	1					60	64		10.1038/ng0198-60	http://dx.doi.org/10.1038/ng0198-60			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425902	Green Published			2022-12-27	WOS:000071259600023
J	Xiao, S; Nalabolu, SR; Aster, JC; Ma, JL; Abruzzo, L; Jaffe, ES; Stone, R; Weissman, SM; Hudson, TJ; Fletcher, JA				Xiao, S; Nalabolu, SR; Aster, JC; Ma, JL; Abruzzo, L; Jaffe, ES; Stone, R; Weissman, SM; Hudson, TJ; Fletcher, JA			FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome	NATURE GENETICS			English	Article							FIBROBLAST GROWTH-FACTOR; T-CELL; CHROMOSOMAL TRANSLOCATIONS; LYMPHOBLASTIC LYMPHOMA; RECEPTOR; EOSINOPHILIA; ABERRATIONS; MALIGNANCY; ACTIVATION; MUTATIONS	Various histological subtypes of leukaemia and lymphoma are associated with diagnostic chromosome translocations(1-4), and substantial strides have been made in determining the specific oncogenes targetted by those translocations. We report the cloning of a novel fusion oncogene associated with a unique leukaemia/lymphoma syndrome. Patients afflicted with this syndrome present with lymphoblastic lymphoma and a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow, which generally progress to full-blown acute myelogenous leukaemia within a year of diagnosis(5-9). A specific chromosome translocation, t(8;13)(p11;q11-12), is found in both lymphoma and myeloid leukaemia cells from these patients, supporting bi-lineage differentiation from a transformed stem cell(6-8). We find that the 8p11 translocation breakpoints, in each of four patients, interrupt intron 8 of the fibroblast growth factor receptor 1 gene (FGFR1). These translocations are associated with aberrant transcripts in which four predicted zinc-finger domains, contributed by a novel and widely expressed chromosome-13 gene (ZNF198), are fused to the FGFR1 tyrosine-kinase domain. Transient expression studies show that the ZNF198-FGFR1 fusion transcript directs the synthesis of an approximately 87-kD polypeptide, localizing predominantly to the cytoplasm. Our studies demonstrate an FGFR1 oncogenic role and suggest a tumorigenic mechanism in which ZNF198-FGFR1 activation results from ZNF198 zinc-finger-mediated homodimerization.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Yale Univ, Sch Med, New Haven, CT 06536 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA; Univ Maryland, Med Ctr, Dept Pathol, Baltimore, MD 21201 USA; NCI, Hematopathol Sect, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Yale University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital	Xiao, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Jaffe, Elaine S/G-8984-2014	Jaffe, Elaine S/0000-0003-4632-0301	NATIONAL CANCER INSTITUTE [R01CA072791] Funding Source: NIH RePORTER; NCI NIH HHS [CA72791] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRUZZO LV, 1992, AM J SURG PATHOL, V16, P236, DOI 10.1097/00000478-199203000-00003; Aster JC, 1997, J BIOL CHEM, V272, P11336; AVRAHAM H, 1994, BLOOD, V83, P2126; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; CROCE CM, 1993, SEMIN ONCOL, V20, P31; DIB A, 1995, ONCOGENE, V10, P995; FAGAN K, 1993, CANCER GENET CYTOGEN, V65, P71, DOI 10.1016/0165-4608(93)90062-Q; FLETCHER JA, 1991, NEW ENGL J MED, V324, P436, DOI 10.1056/NEJM199102143240702; GABBIANELLI M, 1990, SCIENCE, V249, P1561, DOI 10.1126/science.2218497; GABRILOVE JL, 1994, BLOOD, V83, P907; INHORN RC, 1995, BLOOD, V85, P1881, DOI 10.1182/blood.V85.7.1881.bloodjournal8571881; ITOH N, 1990, BIOCHEM BIOPH RES CO, V169, P680, DOI 10.1016/0006-291X(90)90384-Y; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MACDONALD D, 1995, LEUKEMIA, V9, P1628; NAEEM R, 1995, GENE CHROMOSOME CANC, V12, P148, DOI 10.1002/gcc.2870120210; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; OFFIT K, 1991, HEMATOL ONCOL CLIN N, V5, P853, DOI 10.1016/S0889-8588(18)30389-7; PARIMOO S, 1993, NUCLEIC ACIDS RES, V21, P4422, DOI 10.1093/nar/21.18.4422; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; ROWLEY JD, 1990, CANCER RES, V50, P3816; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Tong Q, 1997, J BIOL CHEM, V272, P9043; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Verdier AS, 1997, GENOMICS, V40, P151, DOI 10.1006/geno.1996.4492; WILSON EL, 1991, BLOOD, V77, P954; XIAO S, 1995, AM J PATHOL, V147, P896	30	263	279	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					84	87		10.1038/ng0198-84	http://dx.doi.org/10.1038/ng0198-84			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425908				2022-12-27	WOS:000071259600029
J	Caldarone, B; Saavedra, C; Tartaglia, K; Wehner, JM; Dudek, BC; Flaherty, L				Caldarone, B; Saavedra, C; Tartaglia, K; Wehner, JM; Dudek, BC; Flaherty, L			Quantitative trait loci analysis affecting contextual conditioning in mice	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; LENGTH POLYMORPHISMS; MENDELIAN FACTORS; MUTANT MICE; GENETIC-MAP; FEAR; MOUSE	In an extensive backcross of mice between C3H/HeJ (C3H) and C57BL/6J (B6), we sought to map genes that influence learning and memory as measured by performance in a contextual fear-conditioning paradigm. Our results indicate that there are several genetic regions that have a strong influence on performance in this paradigm. The strongest influences map to the proximal and distal ends of chromosome 1 (led scores of 5.14 and 4.76, respectively). Other chromosomal regions (chromosomes 3, 7, 8, 9 and 18) were also identified as candidates for regions containing genes influencing contextual fear conditioning, with rod scores ranging from 1.8 to 2.7.	SUNY ALBANY,DEPT PSYCHOL,ALBANY,NY 12222; SUNY ALBANY,DEPT BIOMED SCI,ALBANY,NY 12222; NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,MOL GENET PROGRAM,ALBANY,NY 12201; UNIV COLORADO,INST BEHAV GENET,BOULDER,CO 80309	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; University of Colorado System; University of Colorado Boulder					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009038] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA00170, AA09038] Funding Source: Medline; NIGMS NIH HHS [GM50283] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SILVA AJ, 1992, COLD SPRING HARB SYM, V57, P527, DOI 10.1101/SQB.1992.057.01.058; TARRICONE BJ, 1995, BEHAV GENET, V25, P489, DOI 10.1007/BF02253378; Wehner JM, 1997, NAT GENET, V17, P331, DOI 10.1038/ng1197-331	16	111	112	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					335	337		10.1038/ng1197-335	http://dx.doi.org/10.1038/ng1197-335			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354801				2022-12-27	WOS:A1997YD66700031
J	Strachan, T; Abitbol, M; Davidson, D; Beckmann, JS				Strachan, T; Abitbol, M; Davidson, D; Beckmann, JS			A new dimension for the human genome project: Towards comprehensive expression maps	NATURE GENETICS			English	Editorial Material							GENE-EXPRESSION; MOUSE; DATABASE	The current Human Genome Project is largely devoted to structural characterisation of our genome. We now need international co-ordination of a second phase of genome analysis, the systematic construction of expression maps using both basic and high-resolution expression assays. Databases recording different types of expression pattern for a variety of human cell types need to be established and co-ordinated. There is a compelling need for a database of gene expression in early human development, but the scarcity of human material for study requires optimisation of research strategies and co-ordination of expression studies in early human and mouse development.	UNIV PARIS 05, LAB EMBRYOL HUMAINE, PARIS, FRANCE; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; CEPH, FDN JEAN DAUSSET, PARIS, FRANCE; GENETHON, EVRY, FRANCE	UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; Foundation Jean Dausset-CEPH	Strachan, T (corresponding author), UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND.		Beckmann, Jacques S/A-9772-2008	Beckmann, Jacques S/0000-0002-9741-1900				ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; Adams MD, 1996, BIOESSAYS, V18, P261, DOI 10.1002/bies.950180402; Anderson NG, 1996, ELECTROPHORESIS, V17, P443, DOI 10.1002/elps.1150170303; Appel RD, 1996, ELECTROPHORESIS, V17, P540, DOI 10.1002/elps.1150170324; Bains W, 1996, NAT BIOTECHNOL, V14, P711, DOI 10.1038/nbt0696-711; BALDOCK R, 1992, BIOESSAYS, V14, P501, DOI 10.1002/bies.950140713; BENNETT R, MOL GENETICS EARLY H; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; BULLEN P, IN PRESS MOL GENETIC; BURN J, 1995, NAT GENET, V11, P3, DOI 10.1038/ng0995-3; Chait BT, 1996, NAT BIOTECHNOL, V14, P1544, DOI 10.1038/nbt1196-1544; DAVIDSON D, IN PRESS SITU HYBRID; DAVIDSON D, IN PRESS MOL GENETIC; DeRisi J, 1996, NAT GENET, V14, P457; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Fields S, 1997, NAT GENET, V15, P325, DOI 10.1038/ng0497-325; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Goffeau A, 1997, NATURE, V385, P202, DOI 10.1038/385202a0; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Kuska B, 1996, J NATL CANCER I, V88, P1801, DOI 10.1093/jnci/88.24.1801; LAING P, 1992, SCIENCE, V257, P274; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Li QY, 1997, NAT GENET, V15, P21; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Machin GA, 1996, INT REV EXP PATHOL, V36, P1; Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Nelson N, 1996, J NATL CANCER I, V88, P1803, DOI 10.1093/jnci/88.24.1803; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; ORahilly R, 1987, DEV STAGES HUMAN EMB; RINGWALD M, 1994, SCIENCE, V265, P2033, DOI 10.1126/science.8091224; Schena M, 1996, BIOESSAYS, V18, P427, DOI 10.1002/bies.950180513; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shiota K, 1993, Birth Defects Orig Artic Ser, V29, P261; STRACHAN T, IN PRESS MOL GENETIC; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; VERBEEK FJ, 1995, MICROSC RES TECHNIQ, V30, P496, DOI 10.1002/jemt.1070300607; Wang DG, 1996, P NATL ACAD SCI USA, V93, P7103, DOI 10.1073/pnas.93.14.7103; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; 1996, NAT GENET, V14, P367	43	63	68	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1997	16	2					126	132		10.1038/ng0697-126	http://dx.doi.org/10.1038/ng0697-126			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171823				2022-12-27	WOS:A1997XB54300012
J	Simpson, EM; Linder, CC; Sargent, EE; Davisson, MT; Mobraaten, LE; Sharp, JJ				Simpson, EM; Linder, CC; Sargent, EE; Davisson, MT; Mobraaten, LE; Sharp, JJ			Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice	NATURE GENETICS			English	Article							GERM-LINE TRANSMISSION; EMBRYONIC STEM-CELLS; TESTICULAR TERATOMAS; EGF RECEPTOR; DISRUPTION; MUTATION; PROTOONCOGENE; ESTABLISHMENT	Targeted mutagenesis in mice, a powerful tool for the analysis of gene function and human disease, makes extensive use of 129 mouse substrains. Although all are named 129, we document that outcrossing of these substrains, both deliberate and accidental, has lead to extensive genetic variability among substrains and embryonic stem cells derived from them. This clearer understanding of 129 substrain variability allows consideration of its negative impact on targeting technology, including: homologous recombination frequencies, preparation of inbred animals, and availability of appropriate controls. Based on these considerations we suggest a number of recommendations for future experimental design.	JACKSON LAB, BAR HARBOR, ME 04609 USA	Jackson Laboratory			Simpson, Elizabeth/H-1183-2012	Simpson, Elizabeth/0000-0002-0654-4303				ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; BAILEY DW, 1970, TRANSPLANT P, V2, P32; BAILEY DW, 1982, IMMUNOL TODAY, V3, P210, DOI 10.1016/0167-5699(82)90093-7; BAILEY DW, 1960, PLAST RECONSTR SURG, V25, P424; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DIETRICH WF, 1993, COMPLETE GENETIC MAP, P1; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; FESTING MFW, 1996, MOUSE GENOME, V94, P523; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; *JACKS LAB, 1996, MOUS GEN DAT MOUS GE; KAWASE E, 1994, INT J DEV BIOL, V38, P385; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Matouk C, 1996, MAMM GENOME, V7, P603, DOI 10.1007/s003359900178; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; McWhir J, 1996, NAT GENET, V14, P223, DOI 10.1038/ng1096-223; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NOMURA T, 1984, ICLAS MANUAL GENETIC, P1; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; SHIROISHI T, 1981, MICROBIOL IMMUNOL, V25, P1327, DOI 10.1111/j.1348-0421.1981.tb00141.x; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Silver L, 1995, MOUSE GENETICS CONCE, P1; Silvers W.K., 1979, COAT COLORS MICE, P1; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; STEVENS LC, 1957, J NATL CANCER I, V18, P719; STEVENS LC, 1979, MOUSE NEWS LETT, V61, P38; STEVENS LC, 1977, MOUSE NEWS LETT, V57, P35; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; WEHNER JM, 1996, MENT RETARD DEV D R, V4, P1; ZUBERL AR, 1996, MOUSE GENOME, V94, P152	42	575	599	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					19	27		10.1038/ng0597-19	http://dx.doi.org/10.1038/ng0597-19			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140391				2022-12-27	WOS:A1997WX02400018
J	Munier, FL; Korvatska, E; Djemai, A; LePaslier, D; Zografos, L; Pescia, G; Schorderet, DF				Munier, FL; Korvatska, E; Djemai, A; LePaslier, D; Zografos, L; Pescia, G; Schorderet, DF			Kerato-epithelin mutations in four 5q31-linked corneal dystrophies	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; SEQUENCE-ANALYSIS; REIS-BUCKLERS; FASCICLIN-I; PROTEIN; BETA-IG-H3; CHROMOSOME-5Q; DEPOSITS; CLONING; CDNA	Granular dystrophy Groenouw type I (CDGG1), Reis-Bucklers (CDL1), lattice type I (CDL1) and Avellino (ACD) are four 5q31-linked human autosomal dominant corneal dystrophies. Clinically, they show progressive opacification of the cornea leading to severe visual handicap. The nature of the deposits remains unknown in spite of amyloid aetiology ascribed to the last two. We generated a YAC contig of the linked region and, following cDNA selection, recovered the beta ig-h3 gene. In six affected families we identified missense mutations. All detected mutations occurred at the CpG dinucleotide of two arginine codons: R555W in one CDGG1, R555Q in one CDRB, R124C in two CDL1 and R124H in two ACD families. This suggests, as the last two diseases are characterized by amyloid deposits, that R124 mutated kerato-epithelin (the product of beta ig-h3) forms amyloidogenic intermediates that precipitate in the cornea. Our data establish a common molecular origin for the 5q31-linked corneal dystrophies.	CHU VAUDOIS, MOL GENET UNIT, CH-1011 LAUSANNE, SWITZERLAND; HOP JULES GONIN, DEPT OPHTHALMOL, CH-1004 LAUSANNE, SWITZERLAND; CTR ETUD POLYMORPHISME HUMAIN, FDN JEAN DAUSSET, F-75010 PARIS, FRANCE; CHU VAUDOIS, DIV MED GENET, CH-1011 LAUSANNE, SWITZERLAND	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Foundation Jean Dausset-CEPH; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)				Le Paslier, Denis/0000-0003-4335-9956				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BLAKE DJ, 1995, TRENDS BIOCHEM SCI, V20, P133, DOI 10.1016/S0968-0004(00)88986-0; BUCHI ER, 1994, CORNEA, V13, P190; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Eiberg Hans, 1994, European Journal of Human Genetics, V2, P132; ESCRIBANO J, 1994, J CELL PHYSIOL, V160, P511, DOI 10.1002/jcp.1041600314; FOLBERG R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1080, DOI 10.1001/archopht.1994.01090200086027; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; GALLO G, 1988, MODERN PATHOL, V1, P453; GREGORY CY, 1995, J MED GENET, V32, P224, DOI 10.1136/jmg.32.3.224; KLINTWOR.GK, 1967, AM J PATHOL, V50, P371; Korvatska E, 1996, EUR J HUM GENET, V4, P214; KUCHLE M, 1995, CORNEA, V14, P333; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANNIS MJ, 1981, ARCH OPHTHALMOL-CHIC, V99, P1217, DOI 10.1001/archopht.1981.03930020091008; MOLLER HU, 1989, ACTA OPHTHALMOL, V67, P669; MOLLER HU, 1989, ACTA OPHTHALMOL, V67, P678; ROSENWASSER GOD, 1993, ARCH OPHTHALMOL-CHIC, V111, P1546, DOI 10.1001/archopht.1993.01090110112035; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Small KW, 1996, AM J OPHTHALMOL, V121, P384, DOI 10.1016/S0002-9394(14)70434-9; STOCK EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P354, DOI 10.1001/archopht.1991.01080030056038; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	27	443	475	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					247	251		10.1038/ng0397-247	http://dx.doi.org/10.1038/ng0397-247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054935				2022-12-27	WOS:A1997WK38600012
J	Nichols, WC; Koller, DL; Slovis, B; Foroud, T; Terry, VH; Arnold, ND; Siemieniak, DR; Wheeler, L; Phillips, JA; Newman, JH; Conneally, PM; Ginsburg, D; Loyd, JE				Nichols, WC; Koller, DL; Slovis, B; Foroud, T; Terry, VH; Arnold, ND; Siemieniak, DR; Wheeler, L; Phillips, JA; Newman, JH; Conneally, PM; Ginsburg, D; Loyd, JE			Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32	NATURE GENETICS			English	Article							HUMAN GENOME; LINKAGE ANALYSIS; MAPS	Primary pulmonary hypertension (PPH), an often fatal disease, is characterized by elevated pulmonary artery pressures in the absence of a secondary cause(1). Endovascular occlusion in the smallest pulmonary arteries occurs by proliferation of cells and matrix, with thrombus and vasospasm(2). Diagnosis is often delayed because the initial symptoms of fatigue and dyspnea on exertion are nonspecific and definitive diagnosis requires invasive procedures. The average life expectancy after diagnosis is two to three years with death usually due to progressive right heart failure(3). The aetiology of the disease is unknown. Although most cases appear to be sporadic, similar to 6% of cases recorded in the NIH Primary Pulmonary Hypertension Registry are inherited in an autosomal dominant manner with reduced penetrance(4-6). Following a genome-wide search using a set of highly polymorphic short tandem repeat (STR) markers and 19 affected individuals from six families, initial evidence for linkage was obtained with two chromosome 2q markers. We subsequently genotyped patients and all available family members for 19 additional markers spanning similar to 40 centiMorgans (cM) on the long arm of chromosome 2. We obtained a maximum two-point lod score of 6.97 at theta=0 with the marker D2S389; multipoint linkage analysis yielded a maximum lod score of 7.86 with the marker D2S311. Haplotype analysis established a minimum candidate interval of similar to 25 cM.	UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MED CTR, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MED CTR, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA; INDIANA UNIV, SCH MED, DEPT MED & MOL GENET, INDIANAPOLIS, IN 46202 USA; VANDERBILT UNIV, MED CTR, DEPT INTERNAL MED, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, DEPT PEDIAT, NASHVILLE, TN 37232 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University				Loyd, James/0000-0002-5042-7390	NHLBI NIH HHS [HL48164] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048164] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRESDALE DT, 1954, B NEW YORK ACAD MED, V30, P195; DRESDALE DT, 1951, AM J MED, V11, P686, DOI 10.1016/0002-9343(51)90020-4; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FERNANDEZRUIZ E, 1993, CYTOGENET CELL GENET, V62, P26, DOI 10.1159/000133437; GIRARD TJ, 1991, J BIOL CHEM, V266, P5036; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOYD JE, 1988, AM REV RESPIR DIS, V138, P952, DOI 10.1164/ajrccm/138.4.952; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; MORSE JH, 1992, AM REV RESPIR DIS, V145, P787, DOI 10.1164/ajrccm/145.4_Pt_1.787; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RUBIN LJ, 1993, CHEST, V104, P236, DOI 10.1378/chest.104.1.236; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SOLOMON E, 1985, P NATL ACAD SCI USA, V82, P3330, DOI 10.1073/pnas.82.10.3330; Terwilliger J., 1994, HDB HUMAN GENETIC LI; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	30	197	213	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					277	280		10.1038/ng0397-277	http://dx.doi.org/10.1038/ng0397-277			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054941				2022-12-27	WOS:A1997WK38600018
J	Mendez, MJ; Green, LL; Corvalan, JRF; Jia, XC; MaynardCurrie, CE; Yang, XD; Gallo, ML; Louie, DM; Lee, DV; Erickson, KL; Luna, J; Roy, CMN; Abderrahim, H; Kirschenbaum, F; Noguchi, M; Smith, DH; Fukushima, A; Hales, JF; Finer, MH; Davis, CG; Zsebo, KM; Jakobovits, A				Mendez, MJ; Green, LL; Corvalan, JRF; Jia, XC; MaynardCurrie, CE; Yang, XD; Gallo, ML; Louie, DM; Lee, DV; Erickson, KL; Luna, J; Roy, CMN; Abderrahim, H; Kirschenbaum, F; Noguchi, M; Smith, DH; Fukushima, A; Hales, JF; Finer, MH; Davis, CG; Zsebo, KM; Jakobovits, A			Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOME; POLYMERASE CHAIN-REACTION; EPIDERMAL GROWTH-FACTOR; TRANSGENIC MICE; MONOCLONAL-ANTIBODIES; HEAVY; CELLS; RECOMBINATION; GENES; REPERTOIRE	We constructed two megabase-sized YACs containing large contiguous fragments of the human heavy and kappa (kappa) light chain immunoglobulin (Ig) loci in nearly germline configuration, including approximately 66 V-H and 32 V-kappa genes. We introduced these YACs into Ig-inactivated mice and observed human antibody production which closely resembled that seen in humans in all respects, including gene rearrangement, assembly, and repertoire. Diverse Ig gene usage together with somatic hypermutation enables the mice to generate high affinity fully human antibodies to multiple antigens, including human proteins. Our results underscore the importance of the large Ig fragments with multiple V genes for restoration of a normal humoral immune response. These mice are likely to be a valuable tool for the generation of therapeutic antibodies.	ABGENIX INC,FREMONT,CA 94555; CELL GENESYS INC,FOSTER CITY,CA 94404	Cell Genesys Inc			Pillay, Nischalan/F-9536-2012	Noguchi, Masato/0000-0002-3092-0946				ABERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BRUGGEMANN M, 1991, EUR J IMMUNOL, V21, P1323, DOI 10.1002/eji.1830210535; Bruggemann M, 1996, IMMUNOL TODAY, V17, P391, DOI 10.1016/0167-5699(96)10025-6; Coligan JE., 1994, CURRENT PROTOCOLS IM; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; COX JPL, 1994, EUR J IMMUNOL, V24, P827, DOI 10.1002/eji.1830240409; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; FEENEY AJ, 1990, J EXP MED, V172, P137; Fishwild DM, 1996, NAT BIOTECHNOL, V14, P845, DOI 10.1038/nbt0796-845; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; Galfre G, 1981, Methods Enzymol, V73, P3; GEMMILL RM, 1991, ADV GENOME BIOL, V1, P217; GILL GN, 1984, J BIOL CHEM, V259, P7755; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; HERMANSON GG, 1991, NUCLEIC ACIDS RES, V19, P4943, DOI 10.1093/nar/19.18.4943; HUBER C, 1993, EUR J IMMUNOL, V23, P2860, DOI 10.1002/eji.1830231120; JAKOBOVITS A, 1994, CURR BIOL, V4, P761, DOI 10.1016/S0960-9822(00)00172-X; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; LUSTINARASIMHAN M, 1995, J BIOL CHEM, V270, P2716, DOI 10.1074/jbc.270.6.2716; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; MATSUDA F, 1993, ADV IMMUNOL, V62, P1; Max Edward E., 1993, P315; MENDEZ M, 1993, GENOME MAPPING SEQUE, V163; MENDEZ MJ, 1995, GENOMICS, V26, P294, DOI 10.1016/0888-7543(95)80214-7; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; Sato J D, 1983, Mol Biol Med, V1, P511; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sherman F, 1986, LAB COURSE MANUAL ME; SILVERMAN GA, 1990, P NATL ACAD SCI USA, V87, P9913, DOI 10.1073/pnas.87.24.9913; TAYLOR LD, 1994, INT IMMUNOL, V6, P579, DOI 10.1093/intimm/6.4.579; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; TUAILLON N, 1993, P NATL ACAD SCI USA, V90, P3720, DOI 10.1073/pnas.90.8.3720; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; WAGNER SD, 1994, EUR J IMMUNOL, V24, P2672, DOI 10.1002/eji.1830241116; WEICHHOLD GM, 1993, GENOMICS, V16, P503, DOI 10.1006/geno.1993.1217; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395	44	287	771	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					146	156		10.1038/ng0297-146	http://dx.doi.org/10.1038/ng0297-146			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020839				2022-12-27	WOS:A1997WF08700013
J	Kunst, CB; Mezey, E; Brownstein, MJ; Patterson, D				Kunst, CB; Mezey, E; Brownstein, MJ; Patterson, D			Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions	NATURE GENETICS			English	Article							SUPEROXIDE-DISMUTASE GENE; TRANSFER-RNA-SYNTHETASE; SACCHAROMYCES-CEREVISIAE; WILD-TYPE; AUTOANTIBODIES; COMPLEX; MODEL; CELLS; YEAST; MICE	A subset of familial and sporadic amyotrophic lateral sclerosis (ALS - a fatal disorder characterised by progressive motor neuron degeneration) cases are due to mutations in the gene encoding Cu,Zn superoxide dismutase (SOD1)(1-4). Two mutations which have been successfully used to generate transgenic mice that develop an ALS-like syndrome are glycine 85 to arginine (G85R) and glycine 93 to alanine (G93A) with the mutant SOD1 allele overexpressed in a normal mouse genetic background(5-7). No ALS-like phenotype is observed in mice overexpressing wild-type SOD1 or mice without any SOD1 activity(6,8,9). These dominant mutations, which do not necessarily decrease SOD1 activity, may confer a gain of function that is selectively lethal to motor neurons(5,10-12). The yeast interaction trap system(13) allowed us to determine whether these mutations in SOD1 caused novel protein interactions not observed with wild-type SOD1 and which might participate in the generation of the ALS phenotype. Two proteins, lysyl-tRNA synthetase and translocon-associated protein delta, interact with mutant forms of SOD1 but not with wild-type SOD1. The specificity of the interactions was confirmed by the coimmunoprecipitation of mutant SOD1 and the expressed proteins. These proteins are expressed in ventral cord, lending support to the relevance of this interaction to motor neuron disease.	UNIV COLORADO,HLTH SCI CTR,ELEANOR ROOSEVELT INST CANC RES,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,HUMAN MED GENET PROGRAM,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80206; NIMH,CELL BIOL LAB,BETHESDA,MD 20892	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Brownstein, Michael/B-8609-2009; Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691	NIA NIH HHS [AG 00029] Funding Source: Medline; NICHD NIH HHS [HD 17449, HD 07197] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD017449] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; CHAN PH, 1990, STROKE, V21; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; FINLEY RL, 1984, GENE PROBES PRACTICA; FREIST W, 1995, BIOL CHEM H-S, V376, P451; FUJII J, 1995, J NEUROCHEM, V64, P1456; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; GELPI C, 1994, J IMMUNOL, V152, P1989; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALLEWELL RA, 1989, J BIOL CHEM, V264, P5260; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; HOLTHUIS JCM, 1995, BIOCHEM J, V312, P205, DOI 10.1042/bj3120205; JONES CT, 1993, LANCET, V342, P1050, DOI 10.1016/0140-6736(93)92905-9; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; REUME AG, 1996, NAT GENET, V13, P43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1994, HUM MOL GENET, V3, P981, DOI 10.1093/hmg/3.6.981; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIKORSKI RS, 1989, GENETICS, V122, P19; SWINGLER RJ, 1995, LANCET, V345, P391, DOI 10.1016/S0140-6736(95)90380-1; TARGOFF IN, 1993, J CLIN INVEST, V91, P2556, DOI 10.1172/JCI116493; TSUDA T, 1994, NEURON, V13, P727, DOI 10.1016/0896-6273(94)90039-6; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	31	107	121	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					91	94		10.1038/ng0197-91	http://dx.doi.org/10.1038/ng0197-91			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988176				2022-12-27	WOS:A1997WA37300028
J	Lyons, LA; Laughlin, TF; Copeland, NG; Jenkins, NA; Womack, JE; OBrien, SJ				Lyons, LA; Laughlin, TF; Copeland, NG; Jenkins, NA; Womack, JE; OBrien, SJ			Comparative anchor tagged sequences (CATS) for integrative mapping of mammalian genomes	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; BOVINE GENOME; POLYMORPHISMS; MOUSE; LOCI	Precise comparisons of mammalian gene maps require common anchor loci as landmarks for conserved chromosomal segments. Using a computer script that automates DNA sequence database alignments. we designed 410 evolutionarily conserved primer pair sequences which are specific for anchor locus gene amplification from any mammalian species' DNA. Primer pairs were designed to span introns for polymorphism ascertainment. and to include sufficient exonic sequence (25-400 bp) to allow for gene identification. A total of 318 primer pairs were optimized for domestic cats, and 86% of the sequenced feline PCR products showed homology to the gene of primer origin. A screen of 20 mammals from 11 orders revealed that 35-52% of the 318 primers yielded a single PCR product without further optimization suggesting that nearly 75% can be optimized for any eutherian mammal.	NCI,FREDERICK CANC RES & DEV CTR,LAB GENOM DIVERS,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,BIOL CARCINOGENESIS & DEV PROGRAM,SAIC FREDERICK,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK,MD 21702; TEXAS A&M UNIV,DEPT VET PATHOBIOL,COLLEGE STN,TX 77843	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Texas A&M University System; Texas A&M University College Station			OBRIEN, STEPHEN/ABD-1346-2020	Lyons, Leslie/0000-0002-1628-7726; OBRIEN, STEPHEN/0000-0001-7857-0757				ADAMS MD, 1995, ANTURE, V377, pS654; BARENDSE W, 1994, NAT GENET, V6, P227, DOI 10.1038/ng0394-227; BENSON DA, 1994, NUCLEIC ACIDS RES, V22, P3441, DOI 10.1093/nar/22.17.3441; BISHOP MD, 1994, GENETICS, V136, P619; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURT DW, 1995, TRENDS GENET, V11, P190, DOI 10.1016/S0168-9525(00)89042-3; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CRAWFORD AM, 1995, GENETICS, V140, P703; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; JOHANSSON M, 1995, GENOMICS, V25, P682, DOI 10.1016/0888-7543(95)80011-A; Lincoln S.E., 1991, PRIMER COMPUTER PROG; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lyons L. A., 1994, Animal Biotechnology, V5, P103, DOI 10.1080/10495399409525811; MAZZARELLA R, 1992, P NATL ACAD SCI USA, V89, P3681, DOI 10.1073/pnas.89.9.3681; NADEAU JH, 1995, NATURE, V373, P363, DOI 10.1038/373363a0; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OBRIEN SJ, 1993, GENETIC MAPS; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; WOMACK JE, 1995, CURR OPIN GENET DEV, V5, P725, DOI 10.1016/0959-437X(95)80004-O; 1996, MAMM GENOME, V7, P717	29	305	313	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					47	56		10.1038/ng0197-47	http://dx.doi.org/10.1038/ng0197-47			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988168				2022-12-27	WOS:A1997WA37300020
J	DeRisi, J; Penland, L; Brown, PO; Bittner, ML; Meltzer, PS; Ray, M; Chen, YD; Su, YA; Trent, JM				DeRisi, J; Penland, L; Brown, PO; Bittner, ML; Meltzer, PS; Ray, M; Chen, YD; Su, YA; Trent, JM			Use of a cDNA microarray to analyse gene expression patterns in human cancer	NATURE GENETICS			English	Article							SUPPRESSION	The development and progression of cancer(1-3) and the experimental reversal of tumorigenicity(4,5) are accompanied by complex changes in patterns of gene expression. Microarrays of cDNA provide a powerful tool for studying these complex phenomena(6-8). The tumorigenic properties of a human melanoma cell line, UACC-903, can be suppressed by introduction of a normal human chromosome 6, resulting in a reduction of growth rate, restoration of contact inhibition, and suppression of both soft agar clonogenicity and tumorigenicity in nude mice(4,5,9). We used a high density microarray of 1,161 DNA elements to search for differences in gene expression associated with tumour suppression in this system. Fluorescent probes for hybridization were derived from two sources of cellular mRNA [UACC-903 and UACC-903(+6)] which were labelled with different fluors to provide a direct and internally controlled comparison of the mRNA levels corresponding to each arrayed gene. The fluorescence signals representing hybridization to each arrayed gene were analysed to determine the relative abundance in the two samples of mRNAs corresponding to each gene. Previously unrecognized alterations in the expression of specific genes provide leads for further investigation of the genetic basis of the tumorigenic phenotype of these cells. DNA microarrays, containing 1,161 total elements.	STANFORD UNIV,MED CTR,DEPT BIOCHEM,STANFORD,CA 94305; STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; NIH,NATL CTR HUMAN GENOME RES,CANC GENET LAB,BETHESDA,MD 20892	Stanford University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)					NHGRI NIH HHS [HG00450] Funding Source: Medline; FDA HHS [2T32BM07276-21] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG000450, R01HG000450] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); FDA HHS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GRAVES DT, 1992, AM J PATHOL, V140, P9; HUANG SY, 1995, J INTERF CYTOK RES, V15, P655, DOI 10.1089/jir.1995.15.655; JIANG HP, 1995, ONCOGENE, V10, P1855; KRISTENSEN MS, 1993, CYTOKINE, V5, P520, DOI 10.1016/1043-4666(93)90044-6; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; Miele ME, 1996, MOL CARCINOGEN, V15, P284, DOI 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G; NAKAO J, 1995, J NEUROCHEM, V6455, P2396; Ray ME, 1996, ONCOGENE, V12, P2527; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHENA M, 1996, P NATL ACAD SCI USA, V93, P10539; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Su YA, 1996, CANCER RES, V56, P3186; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; VIYAYASARADHI S, 1995, J INVEST DERMATOL, V105, P113; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WEINBERG RA, 1995, ANN NY ACAD SCI, V758, P331, DOI 10.1111/j.1749-6632.1995.tb24838.x	22	1604	1890	0	87	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					457	460						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944026				2022-12-27	WOS:A1996VV73000022
J	Lamb, NE; Freeman, SB; SavageAustin, A; Pettay, D; Taft, L; Hersey, J; Gu, YC; Shen, J; Saker, D; May, KM; Avramopoulos, D; Petersen, MB; Hallberg, A; Mikkelsen, M; Hassold, TJ; Sherman, SL				Lamb, NE; Freeman, SB; SavageAustin, A; Pettay, D; Taft, L; Hersey, J; Gu, YC; Shen, J; Saker, D; May, KM; Avramopoulos, D; Petersen, MB; Hallberg, A; Mikkelsen, M; Hassold, TJ; Sherman, SL			Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II	NATURE GENETICS			English	Article							REDUCED RECOMBINATION; DNA POLYMORPHISMS; ABERRANT RECOMBINATION; PARENTAL ORIGIN; MEIOTIC STAGE; NONDISJUNCTION; TRISOMY-21; AGE; MECHANISMS; ETIOLOGY	The cause of non-disjunction of chromosome 21 remains largely unknown. Advanced maternal age is associated with both maternal meiosis I (MI) and meiosis II (MII) non-disjunction events. While reduced genetic recombination has been demonstrated in maternal MI errors, the basis for MII errors remains uncertain. We studied 133 trisomy 21 cases with maternal MII errors to test the hypothesis that segregation at MII may also be influenced by genetic recombination. Our data support a highly significant association: MII non-disjunction involves increased recombination that is largely restricted to proximal 21q. Thus, while absence of a proximal recombination appears to predispose to nondisjunction in MI, the presence of a proximal exchange predisposes to non-disjunction in MII. These findings profoundly affect our understanding of trisomy 21 as they suggest that virtually all maternal non-disjunction results from events occurring in meioisis I.	EMORY UNIV,SCH MED,DEPT GENET & MOL MED,ATLANTA,GA 30322; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH 44106; EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA; INST CHILD HLTH,DEPT GENET,ATHENS,GREECE; JF KENNEDY INST,DANISH CTR HUMAN GENOME RES,GLOSTRUP,DENMARK	Emory University; Case Western Reserve University; Case Western Reserve University; Emory University; Aarhus University			Avramopoulos, Dimitrios/J-4392-2012; Petersen, Michael Bjørn B/D-1483-2017; Shen, Joseph/AAY-5083-2020	Petersen, Michael Bjørn B/0000-0003-0316-8207; Shen, Joseph/0000-0002-5604-7639	NICHD NIH HHS [P01 HD32111] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRUZZO MA, 1995, ENVIRON MOL MUTAGEN, V25, P38, DOI 10.1002/em.2850250608; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; Bridges CB, 1916, GENETICS, V1, P1; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FARNET C, 1989, MECH CONSEQUENCES DN; FISHER JM, 1995, AM J HUM GENET, V56, P669; HASSOLD T, 1990, HUM GENET, V85, P648; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD T, 1985, AM J HUM GENET, V37, P965; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HAWLEY RS, 1993, ANNU REV GENET, V27, P281; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HENDERSON SA, 1968, NATURE, V217, P22; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LORBER BJ, 1992, AM J HUM GENET, V51, P1265; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MALONE RE, 1981, MOL CELL BIOL, V1, P891, DOI 10.1128/MCB.1.10.891; MASCARI MJ, 1993, AM J HUM GENET, V53, pA260; MIKKELSEN M, 1995, DEV BRAIN DYSFUNCT, V8, P4; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1984, GENET RES, V44, P99, DOI 10.1017/S0016672300026276; MORTON NE, 1994, ANN HUM GENET, V54, P39; PETERSEN MB, 1992, AM J HUM GENET, V51, P516; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; ROEDER G, 1989, MOL CYTOGENETIC STUD, P303; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; VANHUL W, 1993, GENOMICS, V15, P626, DOI 10.1006/geno.1993.1117; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Yoon PW, 1996, AM J HUM GENET, V58, P628	37	289	297	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					400	405		10.1038/ng1296-400	http://dx.doi.org/10.1038/ng1296-400			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944019				2022-12-27	WOS:A1996VV73000015
J	Reddy, PH; Williams, M; Charles, V; Garrett, L; Pike-Buchanan, L; Whetsell, WO; Miller, G; Tagle, DA				Reddy, PH; Williams, M; Charles, V; Garrett, L; Pike-Buchanan, L; Whetsell, WO; Miller, G; Tagle, DA			Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA	NATURE GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; INTRANUCLEAR INCLUSIONS; CAG REPEAT; NEUROLOGICAL PHENOTYPE; WIDESPREAD EXPRESSION; TRINUCLEOTIDE REPEAT; PROTEIN; BRAIN; ONSET; AGE	Huntington disease (HD) is an adult-onset, autosomal dominant inherited human neurodegenerative disorder characterized by hyperkinetic involuntary movements, including motor restlessness and chorea, slowing of voluntary movements and cognitive impairment. Selective regional neuron loss and gliosis in striatum. cerebral cortex, thalamus, subthalamus and hippocampus(1-4) are well recognized as neuropathological correlates for the clinical manifestations of HD. The underlying genetic mutation is the expansion of CAG trinucleotide repeats (coding for polyglutamines) to 36-121 copies in exon 1 of the HD gene(5-8). The HD mRNA and protein product (huntingtin) show widespread distribution(9-11), and thus much remains to be understood about the selective and progressive neurodegeneration in HD. To create an experimental animal model for HD, transgenic mice were generated showing widespread expression of full-length human HD cDNA with either 16, 48 or 89 CAG repeats. Only mice with 48 or 89 CAG repeats manifested progressive behavioural and motor dysfunction with neuron loss and gliosis in striatum, cerebral cortex, thalamus and hippocampus. These animals represent clinically relevant models for HD pathogenesis, and may provide insights into the underlying pathophysiological mechanisms of other triplet repeat disorders.	Natl Human Genome Res Inst, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Lab Genet Dis Res, Bethesda, MD 20892 USA; NIH, Off Res Serv, Vet Resources Program, Bethesda, MD 20892 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; Vanderbilt University	Tagle, DA (corresponding author), Natl Human Genome Res Inst, Genet & Mol Biol Branch, Bldg 49,Room 3A26,49 Convent Dr MSC 4442, Bethesda, MD 20892 USA.	datagle@helix.nih.gov			NINDS NIH HHS [NS-28236] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028236] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Folstein S.E., 1990, HUNTINGTONS DIS; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; Kosinski CM, 1997, EXP NEUROL, V144, P239, DOI 10.1006/exnr.1997.6441; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SPARGO E, 1993, J NEUROL NEUROSUR PS, V56, P487, DOI 10.1136/jnnp.56.5.487; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wood JD, 1996, HUM MOL GENET, V5, P481, DOI 10.1093/hmg/5.4.481	30	322	328	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					198	202		10.1038/2510	http://dx.doi.org/10.1038/2510			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771716				2022-12-27	WOS:000076231300025
J	Ul Haque, MF; King, LM; Krakow, D; Cantor, RM; Rusiniak, ME; Swank, RT; Superti-Furga, A; Haque, S; Abbas, H; Ahmad, W; Ahmad, M; Cohn, DH				Ul Haque, MF; King, LM; Krakow, D; Cantor, RM; Rusiniak, ME; Swank, RT; Superti-Furga, A; Haque, S; Abbas, H; Ahmad, W; Ahmad, M; Cohn, DH			Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse	NATURE GENETICS			English	Article							SULFATE-TRANSPORTER GENE; ADENOSINE 5'-PHOSPHOSULFATE KINASE; ATP-SULFURYLASE; EXPRESSION CLONING; RAT CHONDROSARCOMA; FIBROBLAST GROWTH; BLEEDING-TIME; MICE; PROTEOGLYCANS; CARTILAGE	The osteochondrodysplasias are a genetically heterogeneous group of disorders affecting skeletal development, linear growth and the maintenance of cartilage and bone. We have studied a large inbred Pakistani family with a distinct form of recessively inherited spondyloepimetaphyseal dysplasia (SEMD) and mapped a gene associated with this dwarfing condition to chromosome 10q23-24, a region syntenic with the locus for the brachymorphic mutation on mouse chromosome 19. We identified two orthologous genes, ATPSK2 and Atpsk2, encoding novel ATP sulfurylase/APS kinase orthologues in the respective regions of the human and mouse genomes, We characterized a nonsense mutation in ATPSK2 in the SEMD family and a missense mutation in the region of Atpsk2 encoding the APS kinase activity in the brachymorphic mouse. ATP sulfurylase/APS kinase catalyses the metabolic activation of inorganic sulfate to PAPS, the universal donor for post-translational protein sulfation in all cell types. The cartilage-specificity of the human and mouse phenotypes provides further evidence of the critical role of sulfate activation in the maturation of cartilage extracellular matrix molecules and the effect of defects in this process on the architecture of cartilage and skeletogenesis.	Cedars Sinai Res Inst, Stephen Spielberg Pediat Res Ctr, Ahmanson Dept Pediat, Los Angeles, CA 90048 USA; Cedars Sinai Res Inst, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Zurich, Childrens Hosp, Dept Pediat, Div Metab & Mol Dis, CH-8032 Zurich, Switzerland; Quaid I Azam Univ, Dept Biol Sci, Islamabad, Pakistan; Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Roswell Park Cancer Institute; University Children's Hospital Zurich; University of Zurich; Quaid I Azam University; Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cohn, DH (corresponding author), Cedars Sinai Res Inst, Stephen Spielberg Pediat Res Ctr, Ahmanson Dept Pediat, Los Angeles, CA 90048 USA.		Ahmad, Wasim/GSD-8904-2022; superti-furga, andrea/E-9162-2015; Ahmad, Wasim/E-9713-2015	superti-furga, andrea/0000-0002-3543-7531; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051480] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL51480] Funding Source: Medline; NIAMS NIH HHS [AR02038] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahmad M, 1998, AM J MED GENET, V78, P468; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BISSIG M, 1994, J BIOL CHEM, V269, P3017; Blache D, 1995, BBA-LIPID LIPID MET, V1259, P291, DOI 10.1016/0005-2760(95)00177-8; BOBERG EW, 1983, CANCER RES, V43, P5163; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; ELGAVISH A, 1985, J CELL PHYSIOL, V125, P243, DOI 10.1002/jcp.1041250211; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; GELLER DH, 1987, J BIOL CHEM, V262, P7374; Gray IC, 1997, GENOMICS, V43, P85, DOI 10.1006/geno.1997.4809; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hastbacka J, 1996, AM J HUM GENET, V58, P255; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAI CC, 1987, CARCINOGENESIS, V8, P471, DOI 10.1093/carcin/8.3.471; LANE PW, 1968, J HERED, V59, P300, DOI 10.1093/oxfordjournals.jhered.a107725; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; LIPMANN F, 1958, SCIENCE, V128, P575, DOI 10.1126/science.128.3324.575; LYLE S, 1994, BIOCHEMISTRY-US, V33, P5920, DOI 10.1021/bi00185a032; LYLE S, 1995, BIOCHEMISTRY-US, V34, P940, DOI 10.1021/bi00003a028; LYMAN SD, 1983, BIOCHEM PHARMACOL, V32, P3345, DOI 10.1016/0006-2952(83)90360-X; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; MANENTI G, 1994, GENOMICS, V23, P118, DOI 10.1006/geno.1994.1466; MARKOVICH D, 1993, P NATL ACAD SCI USA, V90, P8073, DOI 10.1073/pnas.90.17.8073; MILLER WA, 1976, J COMP PATHOL, V86, P349, DOI 10.1016/0021-9975(76)90002-5; OBRIEN EP, 1994, MAMM GENOME, V5, P356, DOI 10.1007/BF00356554; ORKIN RW, 1977, J CELL BIOL, V73, P287, DOI 10.1083/jcb.73.2.287; ORKIN RW, 1976, DEV BIOL, V50, P82, DOI 10.1016/0012-1606(76)90069-5; Ozeran JD, 1996, BIOCHEMISTRY-US, V35, P3685, DOI 10.1021/bi951302u; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rossi A, 1997, EUR J BIOCHEM, V248, P741, DOI 10.1111/j.1432-1033.1997.t01-1-00741.x; Rossi A, 1996, J BIOL CHEM, V271, P18456, DOI 10.1074/jbc.271.31.18456; ROSSI A, IN PRESS MATRIX BIOL; Rusiniak ME, 1996, MAMM GENOME, V7, P98, DOI 10.1007/s003359900027; Schlicht W, 1995, ANXIETY STRESS COPIN, V8, P357, DOI 10.1080/10615809508249385; SCHWARTZ NB, 1978, BIOCHEM BIOPH RES CO, V82, P173, DOI 10.1016/0006-291X(78)90592-2; SUGAHARA K, 1982, ARCH BIOCHEM BIOPHYS, V214, P602, DOI 10.1016/0003-9861(82)90065-0; SUGAHARA K, 1979, P NATL ACAD SCI USA, V76, P6615, DOI 10.1073/pnas.76.12.6615; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; SupertiFurga A, 1996, ANN NY ACAD SCI, V785, P195, DOI 10.1111/j.1749-6632.1996.tb56259.x; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Willing MC, 1996, AM J HUM GENET, V59, P799; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	42	156	160	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					157	162		10.1038/2458	http://dx.doi.org/10.1038/2458			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771708				2022-12-27	WOS:000076231300017
J	Scharf, JM; Endrizzi, MG; Wetter, A; Huang, S; Thompson, TG; Zerres, K; Dietrich, WF; Wirth, B; Kunkel, LM				Scharf, JM; Endrizzi, MG; Wetter, A; Huang, S; Thompson, TG; Zerres, K; Dietrich, WF; Wirth, B; Kunkel, LM			Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics	NATURE GENETICS			English	Article							WERDNIG-HOFFMANN DISEASE; LARGE-SCALE DELETIONS; MOTOR-NEURON GENE; 5Q13 REGION; PROTEIN; SEVERITY; SMN; COPIES; ASSOCIATION; (C)BCD541	Spinal muscular atrophy (SMA) is a common recessive disorder characterized by the loss of lower motor neurons in the spinal cord. The disease has been classified into three types based on age of onset and severity(1). SMA I-III all map to chromosome 5q13 (refs 2,3), and nearly all patients display deletions or gene conversions of the survival motor neuron (SMN1) gene(4-7). Some correlation has been established between SMN protein levels and disease course(8-10): nevertheless, the genetic basis for SMA phenotypic variability remains unclear, and it has been postulated that the loss of an additional modifying factor contributes to the severity of type I SMA. Using comparative genomics to screen for such a factor among evolutionarily conserved sequences between mouse and human, we have identified a novel transcript, H4F5, which lies closer to SMN? than any previously identified gene in the region. A multi-copy microsatellite marker that is deleted in more than 90% of type I SMA chromosomes is embedded in an intron of this gene, indicating that H4F5 is also highly deleted in type I SMA chromosomes, and thus is a candidate phenotypic modifier for SMA.	Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Childrens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Bonn; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Kunkel, LM (corresponding author), Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA.		Wirth, Brunhilde/H-3192-2019	Huang, Sidong/0000-0002-2838-4726; Wirth, Brunhilde/0000-0003-4051-5191	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 23740] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Burglen L, 1997, AM J HUM GENET, V60, P72; Burlet P, 1996, J MED GENET, V33, P281, DOI 10.1136/jmg.33.4.281; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; Chen QF, 1998, GENOMICS, V48, P121, DOI 10.1006/geno.1997.5141; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Mortillaro MJ, 1998, J BIOL CHEM, V273, P8183, DOI 10.1074/jbc.273.14.8183; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Nishio H, 1997, NEUROLOGY, V48, P1266, DOI 10.1212/WNL.48.5.1266; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Scharf JM, 1996, GENOMICS, V38, P405, DOI 10.1006/geno.1996.0644; Schwartz M, 1997, HUM MOL GENET, V6, P99, DOI 10.1093/hmg/6.1.99; SELIG S, 1995, P NATL ACAD SCI USA, V92, P3702, DOI 10.1073/pnas.92.9.3702; THOMPSON TG, 1996, THESIS U CALIFORNIA; vanderSteege G, 1996, AM J HUM GENET, V59, P834; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273	30	92	102	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					83	86		10.1038/1753	http://dx.doi.org/10.1038/1753			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731538				2022-12-27	WOS:000075671400026
J	Korinek, V; Barker, N; Moerer, P; van Donselaar, E; Huls, G; Peters, PJ; Clevers, H				Korinek, V; Barker, N; Moerer, P; van Donselaar, E; Huls, G; Peters, PJ; Clevers, H			Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR LEF-1; MOUSE SMALL-INTESTINE; BETA-CATENIN; APC GENE; DIFFERENTIATION; MUTATION; NEOPLASIA; RENEWAL	Mutations of the genes encoding APC or beta-catenin in colon carcinoma induce the constitutive formation of nuclear beta-catenin/Tcf-4 complexes, resulting in activated transcription of Tcf target genes(1,2). To study the physiological role of Tcf-4 (which is encoded by the Tcf712 gene), we disrupted Tcf712 by homologous recombination. Tcf712(-/-) mice die shortly after birth. A single histopathological abnormality was observed. An apparently normal transition of intestinal endoderm into epithelium occurred at approximately embryonic day (E) 14.5. However, no proliferative compartments were maintained in the prospective crypt regions between the villi. As a consequence, the neonatal epithelium was composed entirely of differentiated, non-dividing villus cells. We conclude that the genetic program controlled by Tcf-4 maintains the crypt stem cells of the small intestine. The constitutive activity of Tcf-4 in APC-deficient human epithelial cells may contribute to their malignant transformation by maintaining stem-cell characteristics.	Univ Utrecht Hosp, Dept Immunol, NL-3508 GA Utrecht, Netherlands; Univ Utrecht Hosp, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Univ Utrecht Hosp, Dept Immunol, POB 85500, NL-3508 GA Utrecht, Netherlands.		Barker, Nick/AAS-2774-2020; Korinek, Vladimir/G-6348-2014; Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011	Korinek, Vladimir/0000-0002-9777-4664; Barker, Nick/0000-0003-3566-4475; 				Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALVERT R, 1990, ANAT REC, V227, P199, DOI 10.1002/ar.1092270208; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Hermiston Michelle L., 1994, P521; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; LOUVARD D, 1992, ANNU REV CELL BIOL, V8, P157, DOI 10.1146/annurev.cb.08.110192.001105; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0	30	1252	1331	1	60	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					379	383		10.1038/1270	http://dx.doi.org/10.1038/1270			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697701				2022-12-27	WOS:000075107600023
J	Clerc, P; Avner, P				Clerc, P; Avner, P			Role of the region 3 ' to Xist exon 6 in the counting process of X-chromosome inactivation	NATURE GENETICS			English	Article							GENE; EXPRESSION; INTERPHASE; NUCLEUS; MICE; RNA	During early embryogenesis of female mammals, one of the two X chromosomes is randomly chosen to be inactivated in each cell(1), leading to the transcriptional silencing of thousands of genes on this chromosome. This random X-inactivation process also occurs during in vitro differentiation of female embryonic stem (ES) cells(2-4). A locus on the X chromosome, the X inactivation centre (Xic) is initially 'counted', given that at least two copies of Xic must be present per diploid genome in order for inactivation to occur(2). The counting process ensures that one X chromosome remains active in diploid cells, In the mouse, the essential functions of Xic can be assured by a 450-kb region(5,6) containing the Xist gene. Xist maps within Xic (refs 7-10) and is necessary in cis for inactivation(11,12), The Xist transcript is a 15-kb RNA which is confined within the nucleus and coats the inactive X chromosome(13). In order to characterize functional elements within Xic and the Xist gene, we created a 65-kb cre/loxP deletion extending 3' to Xist exon 6, In undifferentiated ES cells, Xist expression from the deleted X chromosome was markedly reduced. in differentiated XX ES cells containing one deleted X chromosome, the X inactivation process still occurred but was never initiated from the unmutated X chromosome, In differentiated ES cells that were essentially XO, the mutated Xic was capable of initiating X inactivation, even in the absence of another Xic, These results demonstrate a role for the region 3' to Xist exon 6 in the counting process and suggest that counting is mediated by a repressive mechanism which prevents inactivation of a single X chromosome in diploid cells.	Inst Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Clerc, P (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.							BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CATTANACH BM, 1970, GENET RES, V15, P189; CATTANACH BM, 1975, ANNU REV GENET, V75, P1; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; HEARD E, 1993, GENOMICS, V15, P559, DOI 10.1006/geno.1993.1108; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; PLENGE MR, 1997, NAT GENET, V17, P353; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Robertson E. J., 1987, TERATOCARCINOMAS EMB; ROUGEULLE C, 1994, MAMM GENOME, V5, P416, DOI 10.1007/BF00357001; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Simmler MC, 1996, HUM MOL GENET, V5, P1713, DOI 10.1093/hmg/5.11.1713; Simmler MC, 1997, MAMM GENOME, V8, P760, DOI 10.1007/s003359900561	30	149	153	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					249	253		10.1038/924	http://dx.doi.org/10.1038/924			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662396				2022-12-27	WOS:000074565900019
J	Ivanova, AV; Bonaduce, MJ; Ivanov, SV; Klar, AJS				Ivanova, AV; Bonaduce, MJ; Ivanov, SV; Klar, AJS			The chromo and SET domains of the Clr4 protein are essential for silencing in fission yeast	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; SCHIZOSACCHAROMYCES-POMBE; DROSOPHILA; GENE; MUTATIONS; DISRUPT; REGION	Heritable inactivation of specific regions of the genome is a widespread, possibly universal phenomenon for gene regulation in eukaryotes. Self-perpetuating, clonally inherited chromatin structure has been proposed as the explanation for such phenomena as position-effect variegation(1,2) (PEV) and control of segment determination and differentiation in flies(3), X-chromosome inactivation and parental imprinting in mammals(4,5), gene silencing by paramutation in maize(6) and silencing of the mating-type loci in yeasts(7,8). We have now found that the clr4 gene, which is essential for silencing of centromeres(9) and the mating-type loci in Schizosaccharomyces pombe(8,10), encodes a protein with high homology to the product of Su(var)3-9, a gene affecting PEV in Drosophila(1). Like Su(var)3-9p, Clr4p contains SET and chrome domains, motifs found in proteins that modulate chromatin structure. Site-directed mutations in the conserved residues of the chrome domain confirm that it is required for proper silencing and directional switching of the mating type, like SET domain. Surprisingly, RNA differential display experiments demonstrated that clr4(+) can mediate transcriptional activation of certain other loci. These results show that clr4 plays a critical role in silencing at mating-type loci and centromeres through the organization of repressive chromatin structure and demonstrate a new, activator function for Clr4p.	NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Klar, AJS (corresponding author), NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA.	klar@ncifcrf.gov		Ivanov, Sergey/0000-0001-9770-7237				Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; ALLSHIRE RC, 1996, EPIGENETIC MECH GENE, P443; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ekwall K, 1996, J CELL SCI, V109, P2637; ENGELKE U, 1987, CURR GENET, V12, P535, DOI 10.1007/BF00419563; Grewal SIS, 1997, GENETICS, V146, P1221; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; HOLLICK JB, 1995, GENETICS, V141, P709; JIANG YW, 1992, MOL CELL BIOL, V12, P4503, DOI 10.1128/MCB.12.10.4503; Klar AJS, 1998, CIBA F SYMP, V214, P87; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LYON MF, 1986, J EMBRYOL EXP MORPH, V97, P75; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Sawin KE, 1996, P NATL ACAD SCI USA, V93, P15146, DOI 10.1073/pnas.93.26.15146; SINGH PB, 1994, J CELL SCI, V107, P2653; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x	30	139	142	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					192	195		10.1038/566	http://dx.doi.org/10.1038/566			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620780				2022-12-27	WOS:000073865100031
J	Knapik, EW; Goodman, A; Ekker, M; Chevrette, M; Delgado, J; Neuhauss, S; Shimoda, N; Driever, W; Fishman, MC; Jacob, HJ				Knapik, EW; Goodman, A; Ekker, M; Chevrette, M; Delgado, J; Neuhauss, S; Shimoda, N; Driever, W; Fishman, MC; Jacob, HJ			A microsatellite genetic linkage map for zebrafish (Danio rerio)	NATURE GENETICS			English	Article							HUMAN GENOME; MOUSE; EMBRYOS	We have constructed a zebrafish genetic linkage map consisting of 705 simple sequence-length polymorphism markers (SSLPs). The map covers 2350 centimorgans (cM) of the zebrafish genome with an average resolution of 3.3 cM. It is a complete map in genetic mapping terms (there is one linkage group for each of the 25 chromosomes), and it has been confirmed by somatic-cell hybrids and centromere-mapping using half-tetrad analysis. The markers are highly polymorphic in the zebrafish strains used for genetic crosses and provide a means to compare genetic segregation of developmental mutations between laboratories. These markers will provide an initial infrastructure for the positional cloning of the nearly 600 zebrafish genes identified as crucial to vertebrate development,and will become the anchor for the physical map of the zebrafish genome.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Univ Ottawa, Ottawa Civic Hosp, Loeb Inst Med Res, Ottawa, ON K1Y 4E9, Canada; McGill Univ, Dept Surg, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada	Harvard University; Massachusetts General Hospital; University of Ottawa; Ottawa Hospital Research Institute; McGill University; McGill University	Knapik, EW (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, D-85758 Neuherberg, Germany.	fishman@cvrc-taco.mgh.harvard.edu	Knapik, Ela W./J-6172-2014; Neuhauss, Stephan/AAX-9915-2020	Knapik, Ela W./0000-0002-2977-3619; Neuhauss, Stephan/0000-0002-9615-480X; Driever, Wolfgang/0000-0002-9551-9141	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR008888] Funding Source: NIH RePORTER; NCRR NIH HHS [RR08888] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BISHOP MD, 1994, GENETICS, V136, P619; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; CHIN AJ, 1997, DEV GENES EVOL, V207, P104; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; CRAWFORD AM, 1995, GENETICS, V140, P703; Daga RR, 1996, CHROMOSOME RES, V4, P29, DOI 10.1007/BF02254941; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Driever W, 1996, J CLIN INVEST, V97, P1788, DOI 10.1172/JCI118608; Driever W, 1996, DEVELOPMENT, V123, P37; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; Ekker M, 1996, GENOMICS, V33, P57, DOI 10.1006/geno.1996.0159; Fisher S, 1997, DEVELOPMENT, V124, P1301; GOFF DJ, 1992, GENOMICS, V14, P200, DOI 10.1016/S0888-7543(05)80309-X; Haffter P, 1996, DEVELOPMENT, V123, P1; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Johnson SL, 1996, GENETICS, V142, P1277; Knapik EW, 1996, DEVELOPMENT, V123, P451; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MARTINEZBARBERA JP, 1997, GENE, V198, P653; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Phillips RB, 1996, CAN J ZOOL, V74, P323, DOI 10.1139/z96-040; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; Sambrooke J., 1989, MOL CLONING LAB MANU; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; STACHEL SE, 1993, DEVELOPMENT, V117, P1261	33	288	302	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					338	343		10.1038/ng0498-338	http://dx.doi.org/10.1038/ng0498-338			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537415				2022-12-27	WOS:000072755500015
J	Bull, LN; van Eijk, MJT; Pawlikowska, L; DeYoung, JA; Juijn, JA; Liao, M; Klomp, LWJ; Lomri, N; Berger, R; Scharschmidt, BF; Knisely, AS; Houwen, RHJ; Freimer, NB				Bull, LN; van Eijk, MJT; Pawlikowska, L; DeYoung, JA; Juijn, JA; Liao, M; Klomp, LWJ; Lomri, N; Berger, R; Scharschmidt, BF; Knisely, AS; Houwen, RHJ; Freimer, NB			A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis	NATURE GENETICS			English	Article							RECURRENT INTRAHEPATIC CHOLESTASIS; BYLER DISEASE; BILE; PHOSPHATIDYLCHOLINE; GLYCOPROTEIN; TRANSLOCASE; ABSENCE; VECTOR	Cholestasis, or impaired bile flow, is an important but poorly understood manifestation of liver disease. Two clinically distinct forms of inherited cholestasis, benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis type 1 (PFIC1), were previously mapped to 18q21. Haplotype analysis narrowed the candidate region for both diseases to the same interval of less than 1 cM, in which we identified a gene mutated in BRIC and PFIC1 patients. This gene (called FIC1) is the first identified human member of a recently described subfamily of P-type ATPases; ATP-dependent aminophospholipid transport is the previously described function of members of this subfamily. NCI is expressed in several epithelial tissues and, surprisingly, more strongly in small intestine than in liver. Its protein product is likely to play an essential role in enterohepatic circulation of bile acids; further characterization of FIC1 will facilitate understanding of normal bile formation and cholestasis.	Univ Calif San Francisco, Dept Psychiat, Neurogenet Lab, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Wilhelmina Childrens Hosp, Dept Pediat Gastroenterol, Utrecht, Netherlands; Wilhelmina Childrens Hosp, Lab Metab Disorders, Utrecht, Netherlands; Chiron Corp, Emeryville, CA 94608 USA; UniPath LLC, Denver, CO 80218 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wilhelmina Kinderziekenhuis; Wilhelmina Kinderziekenhuis; Novartis	Freimer, NB (corresponding author), Univ Calif San Francisco, Dept Psychiat, Neurogenet Lab, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA.	nelson@ngl.ucsf.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050697, R01DK026270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001375] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK26270, DK50697] Funding Source: Medline; NIMH NIH HHS [MH01375] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BIJLEVELD CMA, 1989, GASTROENTEROLOGY, V97, P427, DOI 10.1016/0016-5085(89)90079-6; BIJLEVELD CMA, 1989, HEPATOLOGY, V9, P532, DOI 10.1002/hep.1840090404; Bourke B, 1996, ARCH DIS CHILD, V75, P223, DOI 10.1136/adc.75.3.223; Bull LN, 1997, HEPATOLOGY, V26, P155; CARLTON VEH, 1995, HUM MOL GENET, V4, P1049, DOI 10.1093/hmg/4.6.1049; CLAYTON RJ, 1969, AM J DIS CHILD, V117, P112, DOI 10.1001/archpedi.1969.02100030114014; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; DEKONING TJ, 1995, AM J MED GENET, V57, P479, DOI 10.1002/ajmg.1320570324; FAGAN MJ, 1994, J MOL EVOL, V38, P57; HOFMAN F, 1997, SLEISENGER FORDTRANS, P937; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JACQUEMIN E, 1994, EUR J PEDIATR, V153, P424; Knisely AS, 1997, ARCH DIS CHILD, V77, P276, DOI 10.1136/adc.77.3.276; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIDOFSKY SD, 1997, SLEISENGER FORDTRANS, P220; LINARELLI LG, 1972, J PEDIATR-US, V81, P484, DOI 10.1016/S0022-3476(72)80174-4; LLOYDSTILL JD, 1981, J PEDIATR-US, V99, P580, DOI 10.1016/S0022-3476(81)80261-2; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; Sinke RJ, 1997, HUM GENET, V100, P382, DOI 10.1007/s004390050520; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; SUMMERSKILL WH, 1965, AM J MED, V38, P298, DOI 10.1016/0002-9343(65)90184-1; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; TAZAWA Y, 1985, J PEDIATR GASTR NUTR, V4, P32, DOI 10.1097/00005176-198502000-00007; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vlahcevic ZR, 1996, HEPATOLOGY TXB LIVER, V1, P376; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; Wu CY, 1996, NUCLEIC ACIDS RES, V24, P2614, DOI 10.1093/nar/24.13.2614; Zhao J, 1997, BBA-MOL CELL RES, V1357, P57, DOI 10.1016/S0167-4889(97)00014-1	33	563	581	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					219	224		10.1038/ng0398-219	http://dx.doi.org/10.1038/ng0398-219			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500542				2022-12-27	WOS:000072325000018
J	Melov, S; Schneider, JA; Day, BJ; Hinerfeld, D; Coskun, P; Mirra, SS; Crapo, JD; Wallace, DC				Melov, S; Schneider, JA; Day, BJ; Hinerfeld, D; Coskun, P; Mirra, SS; Crapo, JD; Wallace, DC			A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase	NATURE GENETICS			English	Article							CENTRAL-NERVOUS-SYSTEM; HEART-MITOCHONDRIA; ALZHEIMERS-DISEASE; MIMETIC PROTECTS; NITRIC-OXIDE; INJURY; MUTANT; ENERGY	Reactive oxygen species (ROS) have been implicated in a wide range of degenerative processes including amyotrophic lateral sclerosis, ischemic heart disease, Alzheimer disease, Parkinson disease and aging(1-5). ROS are generated by mitochondria as the toxic by-products of oxidative phosphorylation, their energy generating pathway(6,7). Genetic inactivation of the mitochondrial form of superoxide dismutase in mice results in dilated cardiomyopathy, hepatic lipid accumulation and early neonatal deaths. We report that treatment with the superoxide dismutase (SOD) mimetic Manganese 5, 10, 15, 20-tetrakis (4-benzoic acid) porphyrin (MnTBAP) rescues these Sod2(tm1Cje)(-/-) mutant mice from this systemic pathology and dramatically prolongs their survival. The animals instead develop a pronounced movement disorder progressing to total debilitation by three weeks of age. Neuropathologic evaluation reveals a striking spongiform degeneration of the cortex and specific brain stem nuclei associated with gliosis and intramyelinic vacuolization similar to that observed in cytotoxic edema and disorders associated with mitochondrial abnormalities such as Leighs disease and Canavans disease. We believe that due to the failure of MnTBAP to cross the blood brain barrier progressive neuropathology is caused by excessive mitochondrial production of ROS. Consequently, MnTBAP-treated Sod2(tm1Cje)(-/-) mice may provide an excellent model for examining the relationship between free radicals and neurodegenerative diseases and for screening new drugs to treat these disorders.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Rush Presbyterian St Lukes Med Ctr, Rush Inst Aging, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; Emory Univ, Sch Med, Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30033 USA	Emory University; Rush University; Rush University; Duke University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University	Wallace, DC (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA.		Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45572] Funding Source: Medline; NIA NIH HHS [AG13154] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI M, 1967, J NEUROPATH EXP NEUR, V26, P164; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HENSLEY K, 1995, P W PHARMACOL SOC, V38, P113; HIRANO A, 1968, J NEUROPATH EXP NEUR, V27, P571; KIMURA S, 1991, PEDIATR NEUROL, V7, P56, DOI 10.1016/0887-8994(91)90108-W; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Schulz JB, 1995, ANN NY ACAD SCI, V765, P100, DOI 10.1111/j.1749-6632.1995.tb16565.x; SIMONIAN NA, 1996, ANN REV PHARM TOXICO, V36, P83106; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Wallace D., 1996, MOL GENETIC BASIS NE, P237; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	23	418	429	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					159	163		10.1038/ng0298-159	http://dx.doi.org/10.1038/ng0298-159			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462746				2022-12-27	WOS:000071779500025
J	Martens, UM; Zijlmans, JMJM; Poon, SSS; Dragowska, W; Yui, J; Chavez, EA; Ward, RK; Lansdorp, PM				Martens, UM; Zijlmans, JMJM; Poon, SSS; Dragowska, W; Yui, J; Chavez, EA; Ward, RK; Lansdorp, PM			Short telomeres on human chromosome 17p	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; GENE; CARCINOMAS; (TTAGGG)N; MUTATIONS; SEQUENCE; 17P13.3; FUSION; CELLS; DNA	Human chromosomes terminate in a series of T(2)AG(3), repeats(1), which, together with associated proteins, are essential for chromosome stability(2,3). In somatic cells, these sequences are known to be gradually lost through successive cells divisions(4,5); however, information about changes on specific chromosomes is not available. Individual telomeres could mediate important biological effects as was shown in yeast, in which loss of a single telomere results in cell-cycle arrest and chromosome loss(6). We now demonstrate by quantitative fluorescence in situ hybridization (Q-FISH; ref. 7) that the number of T(2)AG(3) repeats on specific chromosome arms is very similar in different tissues from the same donor and varies only to some extent between donors. In all sixteen individuals studied, telomeres on chromosome 17p were shorter than the median telomere length-a finding confirmed by analysis of terminal restriction fragments from sorted chromosomes. These observations provide evidence of chromosome-specific factors regulating the number of T(2)AG(3) repeats in individual telomeres and raise the possibility that the relatively short telomeres on chromosome 17p contribute to the frequent loss of 17p alleles in human cancers.	British Columbia Canc Res Ctr, Terry Fox Lab Hematol Oncol, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Elect Engn, Ctr Integrated Comp Syst Res, Vancouver, BC, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Lansdorp, PM (corresponding author), British Columbia Canc Res Ctr, Terry Fox Lab Hematol Oncol, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.			Lansdorp, Peter/0000-0001-7435-1071	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI029524, R01AI029524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056162] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29524] Funding Source: Medline; NIGMS NIH HHS [GM56162] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Blackburn EH, 1995, TELOMERES; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; CORNELIS RS, 1994, CANCER RES, V54, P4200; DELANGE T, 1995, TELOMERES, P265; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LANSDORP PM, 1992, J EXP MED, V175, P1501, DOI 10.1084/jem.175.6.1501; MELTZER PS, 1993, NAT GENET, V4, P252, DOI 10.1038/ng0793-252; MONARD SP, 1995, HUMAN CHROMOSOMES PR, V2, P172; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; SALTMAN D, 1993, CHROMOSOMA, V102, P121, DOI 10.1007/BF00356029; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; White GRM, 1996, BRIT J CANCER, V74, P863, DOI 10.1038/bjc.1996.449; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	30	297	305	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					76	80		10.1038/ng0198-018	http://dx.doi.org/10.1038/ng0198-018			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425906				2022-12-27	WOS:000071259600027
J	Siffert, W; Rosskopf, D; Siffert, G; Busch, S; Moritz, A; Erbel, R; Sharma, AM; Ritz, E; Wichmann, HE; Jakobs, KH; Horsthemke, B				Siffert, W; Rosskopf, D; Siffert, G; Busch, S; Moritz, A; Erbel, R; Sharma, AM; Ritz, E; Wichmann, HE; Jakobs, KH; Horsthemke, B			Association of a human G-protein beta 3 subunit variant with hypertension	NATURE GENETICS			English	Article							SODIUM-PROTON EXCHANGE; IMMORTALIZED LYMPHOBLASTS	Hypertension is a common disorder of multifactorial origin that constitutes a major risk factor for cardiovascular events such as stroke and myocardial infarction. Previous studies demonstrated an enhanced signal transduction via pertussis toxin-sensitive G proteins in lymphoblasts and fibroblasts from selected patients with essential hypertension. We have detected a novel polymorphism (C825T) in exon 10 of the gene encoding the beta 3 subunit of heterotrimeric G proteins (GNB3). The T allele is associated with the occurrence of a splice variant, GNB3-s (encoding G beta 3-s), in which the nucleotides 498-620 of exon 9 are deleted. This in-frame deletion causes the loss of 41 amino acids and one WD repeat domain of the G beta subunit. By western-blot analysis, G beta 3-s appears to be predominantly expressed in cells from individuals carrying the T allele. Significant enhancement of stimulated GTP gamma S binding to Sf9 insect cells expressing G beta 3-s together with G alpha(i)2 and G gamma 5 indicates that this splice variant is biologically active. Genotype analysis of 427 normotensive and 426 hypertensive subjects suggests a significant association of the T allele with essential hypertension.	Univ Essen Gesamthsch Klinikum, Inst Pharmakol, D-45122 Essen, Germany; Univ Essen Gesamthsch Klinikum, Abt Kardiol, D-45122 Essen, Germany; Free Univ Berlin, Klinikum Benjamin Franklin, Abt Endokrinol & Nephrol, D-12200 Berlin, Germany; Klinikum Univ Heidelberg, Sekt Nephrol, D-69115 Heidelberg, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, D-85764 Neuherberg, Germany; Univ Essen Gesamthsch Klinikum, Inst Human Genet, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Duisburg Essen	Siffert, W (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Pharmakol, Hufelandstr 55, D-45122 Essen, Germany.		Wichmann, Heinz Erich/AAA-5695-2022					AALKJAER C, 1989, J HYPERTENS, V7, P305; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Gruska S, 1997, J HYPERTENS, V15, P29, DOI 10.1097/00004872-199715010-00003; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; KALKBRENNER RF, 1996, BIOCHIM BIOPHYS ACTA, V1314, P125; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; MacrezLepretre N, 1997, J BIOL CHEM, V272, P10095; MacrezLepretre N, 1997, J BIOL CHEM, V272, P5261, DOI 10.1074/jbc.272.8.5261; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Pietruck F, 1996, CIRC RES, V79, P974, DOI 10.1161/01.RES.79.5.974; ROSSKOPF D, 1993, J CLIN INVEST, V92, P2553, DOI 10.1172/JCI116865; ROSSKOPF D, 1993, HYPERTENSION, V21, P607, DOI 10.1161/01.HYP.21.5.607; ROSSKOPF D, 1992, J HYPERTENS, V10, P839; SIFFERT W, 1995, HYPERTENSION, V26, P649, DOI 10.1161/01.HYP.26.4.649; SIFFERT W, 1995, J CLIN INVEST, V96, P759, DOI 10.1172/JCI118120; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; StallingsMann ML, 1996, P NATL ACAD SCI USA, V93, P12394, DOI 10.1073/pnas.93.22.12394	25	687	762	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					45	48		10.1038/ng0198-45	http://dx.doi.org/10.1038/ng0198-45			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425898				2022-12-27	WOS:000071259600019
J	Wiestner, A; Schlemper, RJ; van der Maas, APC; Skoda, RC				Wiestner, A; Schlemper, RJ; van der Maas, APC; Skoda, RC			An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia	NATURE GENETICS			English	Article							FAMILIAL ESSENTIAL THROMBOCYTHEMIA; MOLECULAR-CLONING; DIFFERENTIATION; GROWTH; MICE	Essential thrombocythaemia (ET) is a chronic myeloproliferative syndrome due to sustained proliferation of megakaryocytes, which results in elevated numbers of circulating platelets, thrombotic or haemorrhagic episodes and occasional leukaemic transformation(1). The cause of ET is unknown. Hereditary thrombocythaemia (HT) with autosomal-dominant transmission has been described with manifestations similar to those of sporadic ET2-8. As the thrombopoietin gene (THPO) encodes a lineage-restricted growth factor with profound stimulatory effects on megakaryopoiesis and platelet production(9,10), we tested the hypothesis that HT results from a mutation in the human THPO gene. In a Dutch family with eleven affected individuals(7), the thrombopoietin protein (TPO) concentrations in serum were consistently elevated in individuals with HT. We derived an intragenic CA marker for the human THPO gene and performed linkage analysis in fourteen informative meioses in this family. This resulted in a lod score of 3.5 at theta=0, A G-->C transversion was found in the splice donor site of intron 3 of the THPO gene in all affected family members. This mutation leads to THPO mRNAs with shortened 5'-untranslated regions (UTR) that are more efficiently translated than the normal THPO transcripts. We conclude that a splice donor mutation in THPO leads to systemic overproduction of TPO and causes thrombocythaemia.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Fukuoka Univ, Sch Med, Dept Anat, Fukuoka 81480, Japan; Westeinde Hosp, Dept Internal Med, NL-2512 VA The Hague, Netherlands	University of Basel; Fukuoka University	Skoda, RC (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.							BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; CHANG MS, 1995, J BIOL CHEM, V270, P511, DOI 10.1074/jbc.270.2.511; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DANDREA AD, 1994, NEW ENGL J MED, V330, P839; Eaton DL, 1997, EXP HEMATOL, V25, P1; EYSTER ME, 1986, AM J MED, V80, P497, DOI 10.1016/0002-9343(86)90727-8; FERNANDEZROBLES E, 1990, PEDIATR HEMAT ONCOL, V7, P373, DOI 10.3109/08880019009033414; FICKERS M, 1974, ACTA HAEMATOL-BASEL, V51, P257, DOI 10.1159/000208303; Jackson RJ, 1997, CURR OPIN GENET DEV, V7, P233, DOI 10.1016/S0959-437X(97)80133-5; Kamura T, 1997, J BIOL CHEM, V272, P11361; Kaushansky K, 1997, ANNU REV MED, V48, P1; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KIKUCHI M, 1995, BRIT J HAEMATOL, V89, P900; KRAWCZAK M, 1992, HUM GENET, V90, P41; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OTT J, 1976, AM J HUM GENET, V28, P528; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SCHLEMPER RJ, 1994, ANN HEMATOL, V68, P153, DOI 10.1007/BF01727421; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SLEE PHTJ, 1981, ACTA MED SCAND, V210, P321; SOHMA Y, 1994, FEBS LETT, V353, P57, DOI 10.1016/0014-5793(94)01008-0; Stoffel R, 1996, BLOOD, V87, P567, DOI 10.1182/blood.V87.2.567.bloodjournal872567; Tahara T, 1996, BRIT J HAEMATOL, V93, P783, DOI 10.1046/j.1365-2141.1996.d01-1741.x; vanDijken PJ, 1996, ACTA PAEDIATR, V85, P1132, DOI 10.1111/j.1651-2227.1996.tb14234.x; WILLIAMS EC, 1991, AM J HEMATOL, V37, P124, DOI 10.1002/ajh.2830370211; YAN XQ, 1995, BLOOD, V86, P4025, DOI 10.1182/blood.V86.11.4025.bloodjournal86114025; Zhou W, 1997, BLOOD, V89, P1551, DOI 10.1182/blood.V89.5.1551.1551_1551_1559	28	226	230	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					49	52		10.1038/ng0198-49	http://dx.doi.org/10.1038/ng0198-49			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425899				2022-12-27	WOS:000071259600020
J	Barbaux, S; Niaudet, P; Gubler, MC; Grunfeld, JP; Jaubert, F; Kuttenn, F; Fekete, CN; SouleyreauTherville, N; Thibaud, E; Fellous, M; McElreavey, K				Barbaux, S; Niaudet, P; Gubler, MC; Grunfeld, JP; Jaubert, F; Kuttenn, F; Fekete, CN; SouleyreauTherville, N; Thibaud, E; Fellous, M; McElreavey, K			Donor splice-site mutations in WT1 are responsible for Frasier syndrome	NATURE GENETICS			English	Article							DENYS-DRASH SYNDROME; TUMOR-SUPPRESSOR GENE; DNA-BINDING SPECIFICITY; WILMS-TUMOR; GONADAL-DYSGENESIS; UROGENITAL DEVELOPMENT; RENAL-FAILURE; NEPHROPATHY; PSEUDOHERMAPHRODITISM; TRANSCRIPTION	Frasier syndrome (FS) is a rare disease defined by male pseudo-hermaphroditism and progressive glomerulopathy(1-3) Patients present with normal female external genitalia, streak gonads and XY karyotype(4) and frequently develop gonadoblastoma(1,2,5,6). Glomerular symptoms consist of childhood proteinuria and nephrotic syndrome, characterized by unspecific focal and segmental glomerular sclerosis, progressing to end-stage renal failure in adolescence or early adulthood(4). No case of Wilms' tumour has been reported, even in patients with extended follow-up(1-5). In contrast with FS patients, most individuals with Denys-Drash syndrome (DDS; refs 6,7) have ambiguous genitalia or a female phenotype, an XY karyotype and dysgenetic gonads. Renal symptoms are characterized by diffuse mesangial sclerosis, usually before the age of one year, and patients frequently develop Wilms' tumour(8,9). Mutations of the Wilms'-tumour gene, WT1, cause different pathologies of the urogenital system, including DDS10-12. WT1 is composed of ten exons and encodes a protein with four zinc-finger motifs and transcriptional and tumour-suppressor activities(13-15). Alternative splicing generates four isoforms: the fifth exon may or may not be present, and an alternative splice site in intron 9 allows the addition of three amino acids (KTS) between the third and fourth zinc fingers of WT1 (ref. 17). Here we demonstrate that FS is caused by mutations in the donor splice site in intron 9 of WT1, with the predicted loss of the +KTS isoform. Examination of WT1 transcripts indeed showed a diminution of the +KTS/-KTS isoform ratio in patients with FS.	HOP NECKER ENFANTS MALAD, INSERM U423, PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Barbaux, S (corresponding author), INST PASTEUR, INSERM U276, PARIS, FRANCE.		Barbaux, Sandrine C/B-2878-2019; Therville, Nicole/P-2371-2014	Barbaux, Sandrine C/0000-0002-8204-1855; Gubler, Marie-Claire/0000-0002-3526-5661; Therville, Nicole/0000-0002-7068-1361				BARDEESY N, 1994, GENOMICS, V21, P663, DOI 10.1006/geno.1994.1333; BERTA P, 1992, HORM RES, V37, P103, DOI 10.1159/000182291; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BLANCHET P, 1977, AM J OBSTET GYNECOL, V129, P221, DOI 10.1016/0002-9378(77)90751-7; BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; Bruening Wendy, 1994, Seminars in Developmental Biology, V5, P333, DOI 10.1006/sedb.1994.1042; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; COPPES MJ, 1993, J PEDIATR-US, V123, P673, DOI 10.1016/S0022-3476(05)80839-X; DENYS P, 1967, ARCH FR PEDIATR, V24, P729; DRASH A, 1970, J PEDIATR-US, V76, P585, DOI 10.1016/S0022-3476(70)80409-7; FRASIER SD, 1964, J PEDIATR-US, V64, P740, DOI 10.1016/S0022-3476(64)80622-3; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HABIB R, 1985, CLIN NEPHROL, V24, P269; HANING RV, 1985, AM J KIDNEY DIS, V6, P40, DOI 10.1016/S0272-6386(85)80036-6; Hastie Nicholas D., 1992, Human Molecular Genetics, V1, P293; Hewitt SM, 1996, J BIOL CHEM, V271, P8588, DOI 10.1074/jbc.271.15.8588; JADRESIC L, 1990, J PEDIATR-US, V117, P717, DOI 10.1016/S0022-3476(05)83327-X; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; KINBERG JA, 1987, AM J KIDNEY DIS, V9, P507, DOI 10.1016/S0272-6386(87)80078-1; KONIG A, 1993, HUM MOL GENET, V2, P1967; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Moorthy A V, 1987, Am J Med Genet Suppl, V3, P297; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; POULAT F, 1993, HUM GENET, V91, P285; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; SCHMITT K, 1995, EUR J PEDIATR, V154, P577, DOI 10.1007/s004310050346; WANG ZY, 1995, ONCOGENE, V10, P415	32	493	516	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1997	17	4					467	470		10.1038/ng1297-467	http://dx.doi.org/10.1038/ng1297-467			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398852				2022-12-27	WOS:A1997YJ92400031
J	Akimaru, H; Hou, DX; Ishii, S				Akimaru, H; Hou, DX; Ishii, S			Drosophila CBP is required for dorsal-dependent twist gene expression	NATURE GENETICS			English	Article							NUCLEAR-PROTEIN CBP; DNA-BINDING SUBUNIT; NF-KAPPA-B; TRANSCRIPTIONAL COACTIVATOR; DORSOVENTRAL PATTERN; LOCALIZATION; GRADIENT; EMBRYOS; REL; MUTATIONS	Although CREB-binding protein (CBP) functions as a co-activator of many transcription factors(1-3), relatively little is known about the physiological role of CBP. Mutations in the human CBP gene are associated with Rubinstein-Taybi syndrome, a haplo-insufficiency disorder characterized by abnormal pattern formation(4). Recently we isolated a Drosophila CBP (dCBP) mutant(5), and found dCBP to be maternally expressed, suggesting that it plays a role in early embryogenesis. Mesoderm formation is one of the most important events during early embryogenesis. To initiate the differentiation of the mesoderm in Drosophila, multiple zygotic genes such as twist (twi) and snail (sna), which encode a basic-helix-loop-helix and a zinc finger transcription factor, respectively, are required(6,7). The transcription of these genes is induced by maternal dorsal (dl) protein (Dl; refs 8-10), a transcription factor that is homologous to the NF-kappa B family of proteins(11-13). The activity of dl is negatively regulated by cactus (cact), a Drosophila homologue of I kappa B-14. Here, we show that dCBP mutants fail to express twi and generate twisted embryos. This is explained by results showing the dCBP is necessary for dl-mediated activation of the twi promoter.	RIKEN,TSUKUBA LIFE SCI CTR,MOL GENET LAB,TSUKUBA,IBARAKI 305,JAPAN	RIKEN			Hou, De-Xing/C-9296-2011; Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478				Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; CHOU TB, 1992, GENETICS, V131, P643; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; ElGhouzzi V, 1997, NAT GENET, V15, P42; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GOVIND S, 1993, DEVELOPMENT, V117, P135; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEPTIN M, 1990, DEVELOPMENT, V110, P73; NOCERA PPD, 1983, P NATL ACAD SCI USA, V82, P1025; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; PAN DJ, 1991, GENE DEV, V5, P1892, DOI 10.1101/gad.5.10.1892; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; THISSE C, 1991, CELL, V65, P1191, DOI 10.1016/0092-8674(91)90014-P; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; WORTKAMP A, 1991, NATURE, V352, P539; ZALOKAR M, 1977, STAIN TECHNOL, V52, P89, DOI 10.3109/10520297709116753	31	96	97	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					211	214		10.1038/ng1097-211	http://dx.doi.org/10.1038/ng1097-211			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326945				2022-12-27	WOS:A1997XZ55500031
J	Jansen, GA; Ferdinandusse, S; Ijlst, L; Muijsers, AO; Skjeldal, OH; Stokke, O; Jakobs, C; Besley, GTN; Wraith, JE; Wanders, RJA				Jansen, GA; Ferdinandusse, S; Ijlst, L; Muijsers, AO; Skjeldal, OH; Stokke, O; Jakobs, C; Besley, GTN; Wraith, JE; Wanders, RJA			Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene	NATURE GENETICS			English	Article							ACID ALPHA-OXIDATION; 3-KETOACYL-COA THIOLASE; RAT-LIVER; PEROXISOMES; SIGNAL	Refsum disease is an autosomal-recessively inherited disorder characterized clinically by a tetrad of abnormalities: retinitis pigmentosa, peripheral neuropathy, cerebellar ataxia and elevated protein levels in the cerebrospinal fluid (CSF) without an increase in the number of cells in the CSF. All patients exhibit accumulation of an unusual branched-chain fatty acid, phytanic acid (3,7,11,15-tetramethylhexadecanoic acid), in blood and tissues. Biochemically, the disease is caused by the deficiency of phytanoyl-CoA hydroxylase (PhyH), a peroxisomal protein catalyzing the first step in the alpha-oxidation of phytanic acid. We have purified PhyH from rat-liver peroxisomes and determined the N-terminal amino-acid sequence, as well as an additional internal amino-acid sequence obtained after Lys-C digestion of the purified protein. A search of the EST database with these partial amino-acid sequences led to the identification of the full-length human cDNA sequence encoding PhyH: the open reading frame encodes a 41.2-kD protein of 338 amino acids, which contains a cleavable peroxisomal targeting signal type 2 (PTS2). Sequence analysis of PHYH fibroblast cDNA from five patients with Refsum disease revealed distinct mutations, including a one-nucleotide deletion, a 111-nucleotide deletion and a point mutation. This analysis confirms our finding that Refsum disease is caused by a deficiency of PhyH.	UNIV AMSTERDAM,ACAD MED CTR,DEPT CLIN BIOCHEM,NL-1100 DE AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT PEDIAT,NL-1100 DE AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EC SLATER INST,NL-1018 TV AMSTERDAM,NETHERLANDS; UNIV OSLO,RIKSHOSP,INST CLIN BIOCHEM,DEPT PEDIAT,N-0027 OSLO 1,NORWAY; FREE UNIV AMSTERDAM HOSP,DEPT CLIN CHEM,METAB UNIT,NL-1081 HV AMSTERDAM,NETHERLANDS; ROYAL MANCHESTER CHILDRENS HOSP,WILLINK BIOCHEM GENET UNIT,MANCHESTER M27 4HA,LANCS,ENGLAND	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Oslo; National Hospital Norway; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Manchester Children's Hospital				Ferdinandusse, Sacha/0000-0002-7738-5709				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Croes K, 1996, EUR J BIOCHEM, V240, P674, DOI 10.1111/j.1432-1033.1996.0674h.x; deVet ECJM, 1997, J BIOL CHEM, V272, P798, DOI 10.1074/jbc.272.2.798; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Jansen GA, 1997, J INHERIT METAB DIS, V20, P444, DOI 10.1023/A:1005379406639; Jansen GA, 1997, NEW ENGL J MED, V337, P133, DOI 10.1056/NEJM199707103370215; Jansen GA, 1996, BIOCHEM BIOPH RES CO, V229, P205, DOI 10.1006/bbrc.1996.1781; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MIHALIK SJ, 1995, EUR J BIOCHEM, V232, P545, DOI 10.1111/j.1432-1033.1995.tb20842.x; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; REFSUM S, 1946, ACTA PSYCHIAT SCAND, V38, P9; SKJELDAL OH, 1987, J NEUROL SCI, V77, P87, DOI 10.1016/0022-510X(87)90209-7; Steinberg D., 1995, METABOLIC MOL BASES, P2351; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Waterham HR, 1997, BIOESSAYS, V19, P57, DOI 10.1002/bies.950190110	22	213	219	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					190	193		10.1038/ng1097-190	http://dx.doi.org/10.1038/ng1097-190			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326940				2022-12-27	WOS:A1997XZ55500026
J	Thomas, JT; Kilpatrick, MW; Lin, K; Erlacher, L; Lembessis, P; Costa, T; Tsipouras, P; Luyten, FP				Thomas, JT; Kilpatrick, MW; Lin, K; Erlacher, L; Lembessis, P; Costa, T; Tsipouras, P; Luyten, FP			Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1	NATURE GENETICS			English	Article							FACTOR-BETA SUPERFAMILY; PROTEINS; MEMBER; CHONDRODYSPLASIA; REGULATORS; MOUSE; BMP-7	Chondrodysplasia Grebe type (CGT) is an autosomal recessive disorder characterized by severe limb shortening and dysmorphogenesis. We have identified a causative point mutation in the gene encoding the bone morphogenetic protein (BMP)-like molecule, cartilage-derived morphogenetic protein-1 (CDMP-1). The mutation substitutes a tyrosine for the first of seven highly conserved cysteine residues in the mature active domain of the protein, We demonstrate that the mutation results in a protein that is not secreted and is inactive in vitro. It produces a dominant negative effect by preventing the secretion of other, related BMP family members. We present evidence that this may occur through the formation of heterodimers. The mutation and its proposed mechanism of action provide the first human genetic indication that composite expression patterns of different BMPs dictate limb and digit morphogenesis.	UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06030; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA	University of Connecticut; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Thomas, JT (corresponding author), NIDR,CRANIOFACIAL & SKELETAL DIS BRANCH,NIH,BETHESDA,MD 20892, USA.		Luyten, Frank/GPS-7793-2022	Lembessis, Panagiotis/0000-0001-8972-3499	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022610] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-22610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bell J., 1951, TREASURY HUMAN INHER, P1; CHANG SC, 1994, J BIOL CHEM, V269, P28227; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Dudley AT, 1997, DEV DYNAM, V208, P349; FENG B, 1985, ACTA GENET SIN, V12, P378; FITCH N, 1978, J MED GENET, V16, P36; GARCIACASTRO JM, 1975, J PEDIATR-US, V87, P948, DOI 10.1016/S0022-3476(75)80915-2; GRAY DJ, 1957, AM J ANAT, V101, P169, DOI 10.1002/aja.1001010202; GREBE H, 1952, FOLIA HERED PATHOL, V2, P23; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Hall B., 1994, BONE, V8, P137; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; JONES CM, 1991, DEVELOPMENT, V111, P531; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KUMAR D, 1984, CLIN GENET, V25, P68; Lin KM, 1996, GENOMICS, V34, P150, DOI 10.1006/geno.1996.0257; LOPEZ AR, 1992, MOL CELL BIOL, V12, P1674, DOI 10.1128/MCB.12.4.1674; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MASTROBATTISTA JM, 1995, J MED GENET, V32, P851, DOI 10.1136/jmg.32.11.851; QUELCE-SALGADO A., 1964, ACTA GENET STATIST MED [BASEL], V14, P63; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; VENKATARAMAN G, 1995, P NATL ACAD SCI USA, V92, P5406, DOI 10.1073/pnas.92.12.5406; VUKKEVIC S, 1994, J HISTOCHEM CYTOCHEM, V42, P869; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	36	255	274	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					58	64		10.1038/ng0997-58	http://dx.doi.org/10.1038/ng0997-58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288098				2022-12-27	WOS:A1997XU72400018
J	FromontRacine, M; Rain, JC; Legrain, P				FromontRacine, M; Rain, JC; Legrain, P			Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; SPLICING FACTORS; 2-HYBRID SYSTEM; IDENTIFICATION; COMPLEX; IDENTIFY; PRP11; SM; U6; U2		INST PASTEUR,CNRS URA 1300,LAB METAB,ARN,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris				RAIN, Jean-Christophe/0000-0001-8110-0641; Fromont-Racine, Micheline/0000-0001-9906-0334				ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Arning S, 1996, RNA, V2, P794; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; Bordonne R, 1996, GENE, V176, P111, DOI 10.1016/0378-1119(96)00230-2; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; GARRELS, 1996, YEAST PROTEOME HDB; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; He F, 1996, RNA, V2, P153; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LEGRAIN P, 1993, GENE DEV, V7, P1390, DOI 10.1101/gad.7.7b.1390; Racevskis J, 1996, CELL GROWTH DIFFER, V7, P271; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; RIAN JC, 1996, RNA, V2, P535; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Sourdive DJD, 1997, NUCLEIC ACIDS RES, V25, P1476, DOI 10.1093/nar/25.8.1476; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; STUTZ F, 1995, CELL, V82, P495, DOI 10.1016/0092-8674(95)90438-7; vanVenrooij WJ, 1995, CURR OPIN IMMUNOL, V7, P819, DOI 10.1016/0952-7915(95)80054-9; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wells SE, 1996, GENE DEV, V10, P220, DOI 10.1101/gad.10.2.220	32	674	725	0	32	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					277	282		10.1038/ng0797-277	http://dx.doi.org/10.1038/ng0797-277			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207794				2022-12-27	WOS:A1997XG60900024
J	Bassett, DE; Boguski, MS; Spencer, F; Reeves, R; Kim, SH; Weaver, T; Hieter, P				Bassett, DE; Boguski, MS; Spencer, F; Reeves, R; Kim, SH; Weaver, T; Hieter, P			Genome cross-referencing and XREFdb: Implications for the identification and analysis of genes mutated in human disease	NATURE GENETICS			English	Article							HOMOLOG; ENCODES; CANCER	Comparative genomics approaches and multi-organismal biology are valuable tools for genetic analysis. Cross-species connections between genes mutated in human disease states and homologues in model organisms can be particularly powerful, as model-organism gene function data and experimental approaches can shed light an the molecular mechanisms defective in the disease. We describe a project that is systematically identifying novel expressed sequence tag (EST) sequences that are highly related to genes in model organisms and mapping them to positions on the mouse and human maps. This process effectively cross-references model organism genes with mapped mammalian phenotypes, facilitating the identification of genes mutated in human disease states via the positional candidate approach. A public database, XREFdb (http://www.ncbi.nlm.nih.gov/XREFdb/), disseminates similarity search, mapping and mammalian phenotype information and increases the rate at which these cross-species connections are established.	JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR GENET MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205; NATL LIB MED,NATL CTR BIOTECHNOL INFORMAT,NIH,BETHESDA,MD 20894	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)				Bassett, Douglas/0000-0002-1619-4618	NCI NIH HHS [CA16519] Funding Source: Medline; NHGRI NIH HHS [HG00971-01] Funding Source: Medline; NIGMS NIH HHS [P32GM07814] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000971] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BASSET DE, 1995, TRENDS GENET, V11, P372, DOI 10.1016/S0168-9525(00)89109-X; BLATTNER F, 1996, MICROB COMP GENOME, V1, P357; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FUNABIKI H, 1991, J MOL BIOL, V217, P23; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hieter P, 1996, NAT GENET, V13, P253, DOI 10.1038/ng0796-253; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Mckusick V.A., 1994, MENDELIAN INHERITANC; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540	21	68	72	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					339	344		10.1038/ng0497-339	http://dx.doi.org/10.1038/ng0497-339			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090377				2022-12-27	WOS:A1997WQ38900010
J	Kang, S; Graham, JM; Olney, AH; Biesecker, LG				Kang, S; Graham, JM; Olney, AH; Biesecker, LG			GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome	NATURE GENETICS			English	Article							CONGENITAL HYPOTHALAMIC HAMARTOBLASTOMA; GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; IMPERFORATE ANUS; GENE; HYPOPITUITARISM; LOCALIZATION; DELETION; 7P13	Pallister-Hail syndrome (PHS, M146510) was first described in 1980 in six newborns. It is a pleiotropic disorder of human development that comprises hypothalamic hamartoma, central polydactyly, and other malformations(1,2). This disorder is inherited as an autosomal dominant trait and has been mapped to 7p13 (S. Kang et al. Autosomal dominant Pallister-Hail syndrome maps to 7p13. Am. J. Hum. Genet. 59, A81 (1996)). colocalizing the PHS locus and the GLI3 zinc finger transcription factor gene(3). Large deletions or translocations resulting in haploinsufficiency of the GLI3 gene have been associated with Greig cephalopolysyndactyly syndrome (GCPS; M175700)(4-6) although no mutations have been identified in GCPS patients with normal karyotypes. Both PHS and GCPS have polysyndactyly, abnormal craniofacial features and are inherited in an autosomal dominant pattern, but they are clinically distinct(7,8). The polydactyly of CCPS is commonly preaxial and that of PHS is typically central or postaxial. No reported cases of CCPS have hypothalamic hamartoma and PHS does not cause hypertelorism or broadening of the nasal root or forehead. The co-localization of the loci for PHS and GCPS led us to investigate GLI3 as a candidate gene for PHS. Herein we report two PHS families with frameshift mutations in GLI3 that are 3' of the zinc finger-encoding domains, including one family with a de novo mutation. These data implicate mutations in GLI3 as the cause of autosomal dominant PHS, and suggest that frameshift mutations of the GLI3 transcription factor gene can alter the development of multiple organ systems in vertebrates.	NIH, NATL HUMAN GENOME RES INST, LAB GENET DIS RES, BETHESDA, MD 20892 USA; CEDARS SINAI MED CTR, DEPT PEDIAT, CTR MED GENET BIRTH DEFECTS, LOS ANGELES, CA 90048 USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90048 USA; UNIV NEBRASKA, SCH MED, CTR HUMAN GENET, OMAHA, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Nebraska System			Graham, John M./J-1429-2019					Biesecker LG, 1996, J MED GENET, V33, P585, DOI 10.1136/jmg.33.7.585; Biesecker LG, 1996, AM J MED GENET, V65, P76, DOI 10.1002/(SICI)1096-8628(19961002)65:1<76::AID-AJMG12>3.0.CO;2-O; Biesecker LG, 1996, J MED GENET, V33, P947, DOI 10.1136/jmg.33.11.947; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; BRUETON LA, 1992, J MED GENET, V29, P635, DOI 10.1136/jmg.29.9.635; CLARREN SK, 1980, AM J MED GENET, V7, P75, DOI 10.1002/ajmg.1320070111; COHN DH, 1990, AM J HUM GENET, V46, P591; Dracopoli NC, 1994, CURRENT PROTOCOLS HU; DUNCAN PA, 1979, AM J DIS CHILD, V133, P818, DOI 10.1001/archpedi.1979.02130080058010; Grebe TA, 1996, AM J MED GENET, V66, P129, DOI 10.1002/(SICI)1096-8628(19961211)66:2<129::AID-AJMG2>3.0.CO;2-M; HALL JG, 1980, AM J MED GENET, V7, P47, DOI 10.1002/ajmg.1320070110; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; PETTIGREW AL, 1991, HUM GENET, V87, P452; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; TOPF KF, 1993, J PEDIATR-US, V123, P943, DOI 10.1016/S0022-3476(05)80392-0; VERLOES A, 1995, J MED GENET, V32, P605, DOI 10.1136/jmg.32.8.605; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; [No title captured]	18	367	376	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					266	268		10.1038/ng0397-266	http://dx.doi.org/10.1038/ng0397-266			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054938				2022-12-27	WOS:A1997WK38600015
J	Yamamoto, S; Sippel, KC; Berson, EL; Dryja, TP				Yamamoto, S; Sippel, KC; Berson, EL; Dryja, TP			Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness	NATURE GENETICS			English	Article							HETEROZYGOUS MISSENSE MUTATION; PROTEIN; ISOPRENYLATION; TRANSDUCTION; PHOTOCURRENT; RODS	Oguchi disease is a recessively inherited form of stationary night blindness due to malfunction of the rod photoreceptor mechanism. Patients with this disease show a distinctive golden-brown colour of the fundus that occurs as the retina adapts to light, called the Mizuo phenomenon. Recently a defect in arrestin, a member of the rod phototransduction pathway, was found to cause this disease in some Japanese patients(1). As rhodopsin kinase works with arrestin in shutting off rhodopsin after it has been activated by a photon of light, it is reasonable to propose that some cases of Oguchi disease might be caused by defects in rhodopsin kinase. This report describes an analysis of the arrestin and rhodopsin kinase genes in three unrelated cases of Oguchi disease. No defects in arrestin were detected, but all three cases had mutations in the rhodopsin kinase gene. Two cases were found to be homozygous for a deletion encompassing exon 5, predicted to lead to a nonfunctional protein. The third case was a compound heterozygote with two allelic mutations, a missense mutation (Val380Asp) affecting a residue in the catalytic domain, and a frameshift mutation (Ser536(4-bp del)) resulting in truncation of the carboxy terminus. Our results indicate that null mutations in the rhodopsin kinase gene are a cause of Oguchi disease and extend the known genetic heterogeneity in congenital stationary night blindness.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,OCULAR MOL GENET INST,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary					NEI NIH HHS [EY08683, EY00169] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000169, R37EY000169, R01EY008683] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BERSON EL, 1994, PRINCIPLES PRACTICE, P1214; CARR R E, 1967, Investigative Ophthalmology, V6, P426; CARR RE, 1965, ARCH OPHTHALMOL-CHIC, V73, P646; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; FULTON AB, 1990, CURR EYE RES, V9, P1211, DOI 10.3109/02713689009003477; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Khani SC, 1996, GENOMICS, V35, P571, DOI 10.1006/geno.1996.0399; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PENN RD, 1972, BIOPHYS J, V12, P1073, DOI 10.1016/S0006-3495(72)86145-9; RUSHTON WA, 1961, J PHYSIOL-LONDON, V156, P166, DOI 10.1113/jphysiol.1961.sp006666; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; VANKUIJK FJGM, 1991, INVEST OPHTH VIS SCI, V32, P1962	21	201	207	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					175	178		10.1038/ng0297-175	http://dx.doi.org/10.1038/ng0297-175			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020843				2022-12-27	WOS:A1997WF08700017
J	ElGhouzzi, V; LeMerrer, M; PerrinSchmitt, F; Lajeunie, E; Benit, P; Renier, D; Bourgeois, P; BolcatoBellemin, AL; Munnich, A; Bonaventure, J				ElGhouzzi, V; LeMerrer, M; PerrinSchmitt, F; Lajeunie, E; Benit, P; Renier, D; Bourgeois, P; BolcatoBellemin, AL; Munnich, A; Bonaventure, J			Mutations of the TWIST gene in the Saethre-Chotzen syndrome	NATURE GENETICS			English	Article							SYNDROME LOCUS; PFEIFFER-SYNDROME; JACKSON-WEISS; DNA-BINDING; CRANIOSYNOSTOSIS; LOCALIZATION; DROSOPHILA; EMBRYOS; GROWTH; TRANSLOCATIONS	Saethre-Chotzen syndrome (acrocephalo-syndactyly type III, ACS III) is an autosomal dominant craniosynostosis with brachydactyly, soft tissue syndactyly and facial dysmorphism including ptosis, facial asymmetry and prominent ear crura. ACS III has been mapped to chromosome 7p21-22. Of interest, TWIST, the human counterpart of the murine Twist gene, has been localized on chromosome 7p21 as well, The Twist gene product is a transcription factor containing a basic helix-loop-helix (b-HLH) domain, required in head mesenchyme for cranial neural tube morphogenesis in mice, The co-localisation of ACS III and TWIST prompted us to screen ACS III patients for TWIST gene mutations especially as mice heterozygous for Twist null mutations displayed skull defects and duplication of hind leg digits. Here, we report 21-bp insertions and nonsense mutations of the TWIST gene (S127X, E130X) in seven ACS III probands and describe impairment of head mesenchyme induction by TWIST as a novel pathophysiological mechanism in human craniosynostoses.	INST NECKER,UNITE RECH HANDICAPS GENET ENFANT,INSERM U393,F-75743 PARIS 15,FRANCE; LGME,CNRS,INSERM U184,F-67085 STRASBOURG,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			EL GHOUZZI, Vincent/X-4364-2018	EL GHOUZZI, Vincent/0000-0001-5894-8978; Bourgeois, Patrice/0000-0001-6055-7108				AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOURGEOIS P, MAMM GENOME, V7, P915; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; INOUYE M, 1976, Congenital Anomalies, V16, P171; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; LEWANDA AF, 1994, AM J HUM GENET, V55, P1195; Ma HW, 1996, HUM GENET, V98, P228, DOI 10.1007/s004390050197; Meyers GA, 1996, AM J HUM GENET, V58, P491; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, J MED GENET, V31, P393, DOI 10.1136/jmg.31.5.393; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; ROSE CSP, 1994, HUM MOL GENET, V3, P1405; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; STOETZEL C, 1995, MECH DEVELOP, V51, P251, DOI 10.1016/0925-4773(95)00369-X; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; TSUJI K, 1994, AM J MED GENET, V49, P98, DOI 10.1002/ajmg.1320490119; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	29	468	476	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					42	46						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988167				2022-12-27	WOS:A1997WA37300019
J	McWhir, J; Schnieke, AE; Ansell, R; Wallace, H; Colman, A; Scott, AR; Kind, AJ				McWhir, J; Schnieke, AE; Ansell, R; Wallace, H; Colman, A; Scott, AR; Kind, AJ			Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background	NATURE GENETICS			English	Letter							TRANSCRIPTION FACTOR; ESTABLISHMENT; TRANSMISSION; EXPRESSION; REGION		PPL THERAPEUT,ROSLIN EH25 9PP,MIDLOTHIAN,SCOTLAND		McWhir, J (corresponding author), ROSLIN INST,DEPT MOL BIOL,ROSLIN EH25 9PS,MIDLOTHIAN,SCOTLAND.			Schnieke, Angelika/0000-0002-5761-9635				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; COWARD P, 1994, NAT GENET, V6, P245, DOI 10.1038/ng0394-245; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; HOGAN B, 1986, MANIPULATING MOUSE E; HOOPER ML, 1990, EMBRYONAL STEM CELLS, P147; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; KAWASE E, 1994, INT J DEV BIOL, V38, P385; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SUEMORI H, 1987, DEV GROWTH DIFFER, V29, P133; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; THOMSEN DR, 1984, P NATL ACAD SCI-BIOL, V81, P659, DOI 10.1073/pnas.81.3.659; WHEELER MB, 1994, REPROD FERT DEVELOP, V6, P563, DOI 10.1071/RD9940563; Yeom YI, 1996, DEVELOPMENT, V122, P881	23	93	115	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					223	226		10.1038/ng1096-223	http://dx.doi.org/10.1038/ng1096-223			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841201				2022-12-27	WOS:A1996VL44600035
J	Minassian, BA; Lee, JR; Herbrick, JA; Huizenga, J; Soder, S; Mungall, AJ; Dunham, I; Gardner, R; Fong, CG; Carpenter, S; Jardim, L; Satishchandra, P; Andermann, E; Snead, OC; Lopes-Cendes, I; Tsui, LC; Delgado-Escueta, AV; Rouleau, GA; Scherer, SW				Minassian, BA; Lee, JR; Herbrick, JA; Huizenga, J; Soder, S; Mungall, AJ; Dunham, I; Gardner, R; Fong, CG; Carpenter, S; Jardim, L; Satishchandra, P; Andermann, E; Snead, OC; Lopes-Cendes, I; Tsui, LC; Delgado-Escueta, AV; Rouleau, GA; Scherer, SW			Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy	NATURE GENETICS			English	Article							LAFORAS-DISEASE; FORM; DIAGNOSIS	Lafora's disease (LD; OMIM 254780) is an autosomal recessive form of progressive myoclonus epilepsy characterized by seizures and cumulative neurological deterioration. Onset occurs during late childhood and usually results in death within ten years of the first symptoms(1,2). With few exceptions, patients follow a homogeneous clinical course despite the existence of genetic heterogeneity(3). Biopsy of various tissues, including brain, revealed characteristic polyglucosan inclusions called Lafora bodies(4-8), which suggested LD might be a generalized storage disease(6,9). Using a positional cloning approach, we have identified at chromosome 6q24 a novel gene, EPM2A. that encodes a protein with consensus amino acid sequence indicative of a protein tyrosine phosphatase (PTP). mRNA transcripts representing alternatively spliced forms of EPM2A were found in every tissue examined, including brain. Six distinct DNA sequence variations in EPM2A in nine families, and one homozygous microdeletion in another family have been found to cosegregate with LD. These mutations are predicted to cause deleterious effects in the putative protein product, named laforin, resulting in LD.	Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; Sanger Ctr, Hinxton CB10 1SA, Cambs, England; Salisbury Dist Hosp, Salisbury Hlth Care NHS Trust, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Univ Calif Los Angeles, Sch Med, Calif Comprehens Epilepsy Program, Los Angeles, CA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; Univ Toronto, Toronto Hosp, Dept Pathol, Toronto, ON M5T 2S8, Canada; Hosp Clin Porto Alegre, Med Genet Serv, BR-90035003 Porto Alegre, RS, Brazil; Deemed Univ, Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wellcome Trust Sanger Institute; Salisbury District Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institute of Mental Health & Neurosciences - India; McGill University; McGill University; University of Toronto	Scherer, SW (corresponding author), Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada.		Mungall, Andrew J./U-7067-2018; Scherer, Stephen W./B-3785-2013; Jardim, Laura B/B-6149-2013; Tsui, Lap-chee/A-1081-2010; Lopes-Cendes, Iscia/B-9416-2013	Mungall, Andrew J./0000-0002-0905-2742; Scherer, Stephen W./0000-0002-8326-1999; Lopes-Cendes, Iscia/0000-0002-6221-6822; Dunham, Ian/0000-0003-2525-5598; Delgado-Escueta, Antonio V./0000-0002-1581-6999	NINDS NIH HHS [5P01-NS21908] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021908] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; CARPENTER S, 1981, NEUROLOGY, V31, P1564, DOI 10.1212/WNL.31.12.1564; CARPENTER S, 1974, NEUROLOGY, V24, P531, DOI 10.1212/WNL.24.6.531; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; FONG CG, 1998, EPILEPSIA, V39, P4; Gurd JW, 1997, J NEUROCHEM, V69, P623; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Llinas R, 1997, P NATL ACAD SCI USA, V94, P1990, DOI 10.1073/pnas.94.5.1990; LOPESCENDES I, 1995, EPILEPSIA, V36, P6; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; Minassian Berge A., 1996, Epilepsia, V37, P126; Sainz J, 1997, AM J HUM GENET, V61, P1205, DOI 10.1086/301596; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V12, P172, DOI 10.1001/archneur.1965.00460260062008; SERRATOSA JM, 1995, HUM MOL GENET, V9, P1657; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Van Heycop Ten Ham MW., 1974, HDB CLIN NEUROLOGY, V15, P382; WANG QM, 1994, J BIOL CHEM, V269, P14566; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	24	356	369	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					171	174		10.1038/2470	http://dx.doi.org/10.1038/2470			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771710				2022-12-27	WOS:000076231300019
J	Scoles, DR; Huynh, DP; Morcos, PA; Coulsell, ER; Robinson, NGG; Tamanoi, F; Pulst, SM				Scoles, DR; Huynh, DP; Morcos, PA; Coulsell, ER; Robinson, NGG; Tamanoi, F; Pulst, SM			Neurofibromatosis 2 tumour suppressor schwannomin interacts with beta II-spectrin	NATURE GENETICS			English	Article							RETINAL-PIGMENT EPITHELIUM; NF2 GENE; ACTIN-BINDING; VESTIBULAR SCHWANNOMAS; CELL-ADHESION; TYPE-2; MEMBRANE; PRODUCT; MUTATIONS; PROTEIN	NF2 is the most commonly mutated gene in benign tumours of the human nervous system. The NF2 protein, called schwannomin or merlin, is absent in virtually all schwannomas, and many meningiomas and ependymomas(1-3). Using the yeast two-hybrid system, we identified beta II-spectrin (also known as fodrin) as a schwannomin-binding protein. Interaction occurred between the carboxy-terminal domain of schwannomin isoform 2 and the ankyrin-binding region of beta II-spectrin. Isoform 1 of schwannomin, in contrast, interacted weakly with beta II-spectrin, presumably because of its strong self-interaction. Thus, alternative splicing of NF2 may regulate beta II-spectrin binding. Schwannomin co-immunoprecipitated with beta II-spectrin at physiological concentrations. The two proteins interacted in vitro and co-localized in several target tissues and in STS26T cells. Three naturally occurring NF2 missense mutations showed reduced, but not absent, beta II-spectrin binding, suggesting an explanation for the milder phenotypes seen in patients with missense mutations. STS26T cells treated with NF2 antisense oligonucleotides showed alterations of the actin cytoskeleton. Schwannomin itself lacks the actin binding sites found in ezrin, radixin and moesin, suggesting that signalling to the actin cytoskeleton occurs via actin-binding sites on beta II-spectrin. Thus, schwannomin is a tumour suppressor directly involved in actin-cytoskeleton organization, which suggests that alterations in the cytoskeleton are an early event in the pathogenesis of some tumour types.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, CSMC Burns & Allen Res Inst,Neurogenet Lab, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, CSMC Burns & Allen Res Inst,Div Neurol, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Pulst, SM (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, CSMC Burns & Allen Res Inst,Neurogenet Lab, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.				NINDS NIH HHS [NS01428-01A1, NS10524-01] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENNETT V, 1991, J CLIN INVEST, V87, P1483, DOI 10.1172/JCI115157; Bretscher A, 1995, BIOCHEMISTRY-US, V34, P16830, DOI 10.1021/bi00051a034; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Claudio JO, 1997, NEUROREPORT, V8, P2025, DOI 10.1097/00001756-199705260-00044; Deguen B, 1998, HUM MOL GENET, V7, P217, DOI 10.1093/hmg/7.2.217; DENBAKKER MA, 1995, ONCOGENE, V10, P757; DEPREZ RHL, 1994, AM J HUM GENET, V54, P1022; DISCHER D, 1993, J BIOL CHEM, V268, P7186; EVANS DGR, 1995, J MED GENET, V32, P470, DOI 10.1136/jmg.32.6.470; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; GUNDERSEN D, 1991, J CELL BIOL, V112, P863, DOI 10.1083/jcb.112.5.863; HU RJ, 1992, J BIOL CHEM, V267, P18715; Huynh DP, 1996, ONCOGENE, V13, P73; Huynh DP, 1997, J NEUROPATH EXP NEUR, V56, P382, DOI 10.1097/00005072-199704000-00007; HUYNH DP, 1994, HUM MOL GENET, V3, P1075, DOI 10.1093/hmg/3.7.1075; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; Kluwe L, 1996, HUM GENET, V97, P224, DOI 10.1007/BF02265270; MARRS JA, 1995, J CELL BIOL, V129, P507, DOI 10.1083/jcb.129.2.507; Mautner VF, 1996, NEUROSURGERY, V38, P880, DOI 10.1097/00006123-199605000-00004; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; Morcos P, 1996, MOL CELL BIOL, V16, P2496; POULLET P, 1995, METHOD ENZYMOL, V255, P488; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SAINZ J, 1994, HUM MOL GENET, V3, P885, DOI 10.1093/hmg/3.6.885; Sanderson J, 1996, BIOCHEM BIOPH RES CO, V218, P893, DOI 10.1006/bbrc.1996.0159; SANTOS A, 1994, RETINA-J RET VIT DIS, V14, P6, DOI 10.1097/00006982-199401000-00002; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; SIANO M, 1997, J CELL SCI, V110, P2249; TAKESHIMA H, 1994, ONCOGENE, V9, P2135; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; VYBIRAL T, 1992, CELL MOTIL CYTOSKEL, V21, P293, DOI 10.1002/cm.970210405; WINKELMANN JC, 1993, BLOOD, V81, P3173	34	126	128	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					354	359		10.1038/ng0498-354	http://dx.doi.org/10.1038/ng0498-354			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537418				2022-12-27	WOS:000072755500018
J	Hildebrandt, F; Otto, E; Rensing, C; Nothwang, HG; Vollmer, M; Adolphs, J; Hanusch, H; Brandis, M				Hildebrandt, F; Otto, E; Rensing, C; Nothwang, HG; Vollmer, M; Adolphs, J; Hanusch, H; Brandis, M			A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1	NATURE GENETICS			English	Article							FAMILIAL JUVENILE NEPHRONOPHTHISIS; MESSENGER-RNA; NPH1; REGION; MARKERS; CONTIG; 2Q13; MB	Juvenile nephronophthisis (NPH), an autosomal recessive cystic kidney disease, is the primary genetic cause of chronic renal failure in children. About two thirds of patients with NPH carry a large homozygous deletion at the gene locus NPH1 on 2q13. We here identify a novel gene, NPHP1, which extends over most of this common deletion. The 4.5-kb transcript encodes a protein with an SH3 domain, which is highly conserved throughout evolution. The 11-kb interval between the 3' end of NPHP1 and an inverted repeat containing the distal deletion breakpoint was found to contain the first exon of a second gene, MALL. In patients with a hemizygous deletion of the NPH1 region, additional point mutations were found in NPHP1 but not in MALL.	MAX PLANCK INST MOL GENET, BERLIN, GERMANY	Max Planck Society	Hildebrandt, F (corresponding author), UNIV FREIBURG, CHILDRENS HOSP, HUGSTETTER STR 55, FREIBURG, GERMANY.		Rensing, Christopher/D-3947-2011; Nothwang, Hans G/C-5847-2011	Rensing, Christopher/0000-0002-5012-7953; Otto, Edgar/0000-0002-2387-9973; Nothwang, Hans Gerd/0000-0001-7695-6437				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; CHOWDHURY K, 1991, NUCLEIC ACIDS RES, V19, P2792, DOI 10.1093/nar/19.10.2792; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Hildebrandt F, 1996, CYTOGENET CELL GENET, V73, P235, DOI 10.1159/000134346; HILDEBRANDT F, 1995, GENOMICS, V25, P360, DOI 10.1016/0888-7543(95)80034-J; HILDEBRANDT F, 1993, AM J HUM GENET, V53, P1256; Hildebrandt F, 1997, KIDNEY INT, V51, P261, DOI 10.1038/ki.1997.31; HILDEBRANDT F, 1996, DIS KIDNEY, P499; Karolyi L, 1997, HUM MOL GENET, V6, P17; KLEINKNECHT C, 1992, TXB CLIN NEPHROLOGY, P2188; Konrad M, 1995, GENOMICS, V30, P514, DOI 10.1006/geno.1995.1272; Konrad M, 1996, HUM MOL GENET, V5, P367, DOI 10.1093/hmg/5.3.367; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; MARX J, 1993, SCIENCE, V260, P1588, DOI 10.1126/science.8503004; MEDHIOUB M, 1994, GENOMICS, V22, P296, DOI 10.1006/geno.1994.1387; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; NOTHWANG HG, IN PRESS GENOMICS; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; RANCANO C, 1994, GENOMICS, V21, P447, DOI 10.1006/geno.1994.1294; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SMITH CH, 1945, AM J DIS CHILD, V69, P369; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668	22	250	255	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1997	17	2					149	153		10.1038/ng1097-149	http://dx.doi.org/10.1038/ng1097-149			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326933				2022-12-27	WOS:A1997XZ55500019
J	McGrath, JA; McMillan, JR; Shemanko, CS; Runswick, SK; Leight, IM; Lane, EB; Garrod, DR; Eady, RAJ				McGrath, JA; McMillan, JR; Shemanko, CS; Runswick, SK; Leight, IM; Lane, EB; Garrod, DR; Eady, RAJ			Mutations in the plakophilin 1 gene result in ectodermal dysplasia skin fragility syndrome	NATURE GENETICS			English	Article							DESMOSOMAL PLAQUE PROTEIN; BETA-CATENIN; STRATIFIED EPITHELIA; MONOCLONAL-ANTIBODY; MULTIGENE FAMILY; BAND-6 PROTEIN; PLAKOGLOBIN; DIFFERENTIATION; DESMOPLAKIN; COMPONENTS	Members of the armadillo protein gene family, which includes plakoglobin and beta-catenin, have important functions in cytoskeleton/cell membrane interactions(1,2). These proteins may act as linker molecules at adherens junctions and desmosomes at the plasma membrane(3); in addition, they may have pivotal roles in signal transduction pathways and significant effects on cell behaviour during development(4-7). Here, we describe the first human mutations in one of these dual function proteins, plakophilin 1 (band-6 protein; refs 8-10). The affected individual has a complete absence of immunostaining for plakophilin 1 in the skin and is a compound heterozygote for autosomal-recessively inherited premature termination codons of translation on both alleles of the plakophilin 1 gene (PKP1). Clinically, there are features of both cutaneous fragility and congenital ectodermal dysplasia affecting skin, hair and nails. There is no evidence of significant abnormalities in other epithelia or tissues. Desmosomes in the skin are small and poorly formed with widening of keratinocyte intercellular spaces and perturbed desmosome/keratin intermediate filament interactions. The molecular findings and clinical observations in this patient attest to the dual importance of plakophilin 1 in both cutaneous cell-cell adhesion and epidermal morphogenesis.	UNIV DUNDEE,DEPT PHYSIOL & ANAT,CANC RES CAMPAIGN LABS,CELL STRUCT RES GRP,DUNDEE DD1 4HN,SCOTLAND; UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV LONDON QUEEN MARY & WESTFIELD COLL,ST BARTHOLOMEWS & ROYAL LONDON SCH MED & DENT,LONDON E1 2AT,ENGLAND	University of Dundee; University of Manchester; University of London; Queen Mary University London	McGrath, JA (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,ST JOHNS INST DERMATOL,LONDON SE1 7EH,ENGLAND.		McGrath, John/N-3529-2019; McMillan, James R/C-6657-2009; McGrath, John/D-6824-2012	Shemanko, Carrie/0000-0002-5260-6210; McGrath, John/0000-0002-3708-9964	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; BUXTON RS, 1993, J CELL BIOL, V121, P481, DOI 10.1083/jcb.121.3.481; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4; FOISNER R, 1994, ACTA HISTOCHEM, V96, P421, DOI 10.1016/S0065-1281(11)80029-2; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; Garrod DR, 1996, J ROY COLL PHYS LOND, V30, P366; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HASHIMOTO T, 1993, J CELL SCI, V105, P275; HATZFELD M, 1994, J CELL SCI, V107, P2259; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; HEID HW, 1994, DIFFERENTIATION, V58, P113; KAPPRELL HP, 1988, J CELL BIOL, V106, P1679, DOI 10.1083/jcb.106.5.1679; KARNOVSKY A, 1995, P NATL ACAD SCI USA, V92, P4522, DOI 10.1073/pnas.92.10.4522; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; KOWALCZYK AP, 1994, BIOPHYS CHEM, V50, P97, DOI 10.1016/0301-4622(94)85023-2; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Moll I, 1997, J INVEST DERMATOL, V108, P139, DOI 10.1111/1523-1747.ep12332388; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229; STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VILELA MJ, 1987, J PATHOL, V153, P365, DOI 10.1002/path.1711530410	30	282	290	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					240	244		10.1038/ng1097-240	http://dx.doi.org/10.1038/ng1097-240			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326952				2022-12-27	WOS:A1997XZ55500038
J	Mollenhauer, J; Wiemann, S; Scheurlen, W; Korn, B; Hayashi, Y; Wilgenbus, KK; vonDeimling, A; Poustka, A				Mollenhauer, J; Wiemann, S; Scheurlen, W; Korn, B; Hayashi, Y; Wilgenbus, KK; vonDeimling, A; Poustka, A			DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours	NATURE GENETICS			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; CENTRAL-NERVOUS-SYSTEM; LONG ARM; RECEPTOR; HETEROZYGOSITY; SEQUENCES; DOMAIN; HYBRIDIZATION; PROGRESSION; MELANOMA	Loss of sequences from human chromosome 10q has been associated with the progression of human cancer. Medulloblastoma and glioblastoma multiforme ave the most common malignant brain tumours in children and adults, respectively. In glioblastoma multiforme, the most aggressive form, 80% of the tumours show loss of 10q. We have used representational difference analysis to identify a homozygous deletion at 10q25.3-26.1 in a medulloblastoma cell line and have cloned a novel gene, DMBT1, spanning this deletion. DMBT1 shows homology to the scavenger receptor cysteine-rich (SRCR) superfamily. Intragenic homozygous deletions have been detected in 2/20 medulloblastomas and in 9/39 glioblastomas mutliformes. Lack of DMBT1 expression has been demonstrated in 4/5 brain-tumour cell lines. We suggest that DMBT1 is a putative tumour-suppressor gene implicated in the carcinogenesis of medulloblastoma and glioblastoma multiforme.	DEUTSCH KREBSFORSCHUNGSZENTRUM, DIV MOL GENOME ANAL, D-69120 HEIDELBERG, GERMANY; CHILDRENS HOSP, D-68167 MANNHEIM, GERMANY; UNIV BONN, MED CTR, DEPT NEUROPATHOL, D-53105 BONN, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Bonn			Abrams, William R/A-5782-2008; Mollenhauer, Jan/G-4452-2012; von Deimling, Andreas/F-7774-2013; Wiemann, Stefan/E-4424-2013	von Deimling, Andreas/0000-0002-5863-540X; Wiemann, Stefan/0000-0003-4683-3174				AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; Albarosa R, 1996, AM J HUM GENET, V58, P1260; ALBRECHT S, 1994, NEUROPATH APPL NEURO, V20, P74, DOI 10.1111/j.1365-2990.1994.tb00959.x; AZIZI E, 1995, CANCER, V76, P1571, DOI 10.1002/1097-0142(19951101)76:9<1571::AID-CNCR2820760912>3.0.CO;2-6; BIEGEL JA, 1995, GENE CHROMOSOME CANC, V14, P85, DOI 10.1002/gcc.2870140202; BIEGEL JA, 1989, GENE CHROMOSOME CANC, V1, P139, DOI 10.1002/gcc.2870010206; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Cheng H, 1996, ANAT REC, V244, P327; CHUMAKOV IM, 1995, NATURE, V377, P175; COGEN PH, 1990, GENOMICS, V8, P279, DOI 10.1016/0888-7543(90)90283-Z; FUJII YJ, 1994, GENE CHROMOSOME CANC, V11, P205, DOI 10.1002/gcc.2870110402; GRAY IC, 1995, CANCER RES, V55, P4800; HAHN SA, 1995, CANCER RES, V55, P4670; HERBST RA, 1994, CANCER RES, V54, P3111; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KELSELL DP, 1995, ANN HUM GENET, V59, P233, DOI 10.1111/j.1469-1809.1995.tb00743.x; Kleihues P, 1993, HISTOLOGICAL TYPING; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUHL J, 1993, AM J PEDIAT HEMAT SA, V15, P567; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NEUMANN E, 1993, CANCER GENET CYTOGEN, V71, P40, DOI 10.1016/0165-4608(93)90200-6; NUNES DP, 1995, BIOCHEM J, V310, P41, DOI 10.1042/bj3100041; PEIFFER SL, 1995, CANCER RES, V55, P1922; Petersen I, 1997, BRIT J CANCER, V75, P79, DOI 10.1038/bjc.1997.13; POUSTKA A, 1990, Methods (Orlando), V1, P204, DOI 10.1016/S1046-2023(05)80136-7; RASHEED BKA, 1995, ONCOGENE, V10, P2243; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Scheurlen WG, 1997, GENE CHROMOSOME CANC, V18, P50, DOI 10.1002/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0; Schutz BR, 1996, GENE CHROMOSOME CANC, V16, P196; Starling GC, 1996, EUR J IMMUNOL, V26, P738, DOI 10.1002/eji.1830260403; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; THOMAS GA, 1991, CANCER RES, V51, P639; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; WHITNEY GS, 1995, J BIOL CHEM, V270, P18187, DOI 10.1074/jbc.270.31.18187; Zedenius J, 1996, HUM GENET, V97, P299, DOI 10.1007/BF02185758	41	403	416	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					32	39		10.1038/ng0997-32	http://dx.doi.org/10.1038/ng0997-32			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288095				2022-12-27	WOS:A1997XU72400015
J	Cross, SH; Meehan, RR; Nan, XS; Bird, A				Cross, SH; Meehan, RR; Nan, XS; Bird, A			A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins	NATURE GENETICS			English	Article							CPG BINDING-PROTEIN; DROSOPHILA-TRITHORAX; CHROMOSOMAL PROTEIN; ACUTE LEUKEMIAS; METHYLATED DNA; ALL-1 GENE; SEQUENCE; DOMAIN; PURIFICATION; INVOLVEMENT				Cross, SH (corresponding author), UNIV EDINBURGH,INST CELL & MOL BIOL,KINGS BLDG,MAYFIELD RD,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND.			Cross, Sally/0000-0001-6518-6449; Meehan, Richard/0000-0001-6471-6882; Nan, Xinsheng/0000-0002-0865-7934; Bird, Adrian/0000-0002-8600-0372	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; BASSET DE, 1995, TRENDS GENET, V11, P372, DOI 10.1016/S0168-9525(00)89109-X; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; CHINWALLA V, 1995, EMBO J, V14, P2056, DOI 10.1002/j.1460-2075.1995.tb07197.x; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HAMMARBACK JA, 1990, J BIOL CHEM, V265, P12763; Harlow E., 1988, ANTIBODIES LAB MANUA; HEIERMANN R, 1985, NUCLEIC ACIDS RES, V13, P2709, DOI 10.1093/nar/13.8.2709; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HU CH, 1994, MOL CELL BIOL, V14, P2871, DOI 10.1128/MCB.14.5.2871; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MA Q, 1993, P NATL ACAD SCI USA, V90, P6350, DOI 10.1073/pnas.90.13.6350; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Prasad R, 1995, P NATL ACAD SCI USA, V92, P12160, DOI 10.1073/pnas.92.26.12160; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610	31	205	213	1	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					256	259		10.1038/ng0797-256	http://dx.doi.org/10.1038/ng0797-256			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207790				2022-12-27	WOS:A1997XG60900020
J	Marsh, DG; Maestri, NE; Freidhoff, LR; Barnes, KC; Togias, A; Ehrlich, E; Beaty, T; Duffy, D; Rosenthal, R; Imani, F; Dunston, G; FurbertHarris, P; Malveaux, F; Ober, C; Cox, NJ; Lester, LA; Peterson, R; Gidley, H; Pluzhnikov, A; Anderson, J; Solway, J; Leff, A; Wolf, R; Wylam, M; Kurtz, B; Richardson, A; Parry, R; Blumenthal, MN; King, RA; Oetting, W; Drury, D; Rosenberg, A; Daniels, L; McEvoy, C; Lou, J; Hamra, M; Brott, M; Rich, SS; Spray, BJ; Weber, JL; Yuan, B; Wang, ZY; Bleecker, ER; Amelung, P; Rechstiner, B; Meyers, DA; Samet, J; Wiesch, D; Xu, JF; Murphy, S; BanksSchlegel, S				Marsh, DG; Maestri, NE; Freidhoff, LR; Barnes, KC; Togias, A; Ehrlich, E; Beaty, T; Duffy, D; Rosenthal, R; Imani, F; Dunston, G; FurbertHarris, P; Malveaux, F; Ober, C; Cox, NJ; Lester, LA; Peterson, R; Gidley, H; Pluzhnikov, A; Anderson, J; Solway, J; Leff, A; Wolf, R; Wylam, M; Kurtz, B; Richardson, A; Parry, R; Blumenthal, MN; King, RA; Oetting, W; Drury, D; Rosenberg, A; Daniels, L; McEvoy, C; Lou, J; Hamra, M; Brott, M; Rich, SS; Spray, BJ; Weber, JL; Yuan, B; Wang, ZY; Bleecker, ER; Amelung, P; Rechstiner, B; Meyers, DA; Samet, J; Wiesch, D; Xu, JF; Murphy, S; BanksSchlegel, S			A genome-wide search for asthma susceptibility loci in ethnically diverse populations	NATURE GENETICS			English	Article							RESPONSES UNDERLYING ASTHMA; IMMUNOGLOBULIN-E RESPONSES; INHALATION CHALLENGE; LINKAGE; RHINITIS; ATOPY; CHROMOSOME-11Q; REACTIVITY; ALLERGY	Asthma is an inflammatory airways disease associated with intermittent respiratory symptoms, bronchial hyperresponsiveness (BHR) and reversible airflow obstruction and is phenotypically heterogeneous(1,2). Patterns of clustering and segregation analyses in asthma families have suggested a genetic component to asthma(3-6). Previous studies reported linkage of BHR and atopy to chromosomes 5q (refs 7-9), 6p (refs 10-12), 11q (refs 13-15), 14q (ref. 16), and 12q (ref. 17) using candidate gene approaches. However, the relative roles of these genes in the pathogenesis of asthma or atopy are difficult to assess outside of the context of a genome-wide search. One genome-wide search in atopic sib pairs has been reported(18), however, only 12% of their subjects had asthma. We conducted a genome-wide search in 140 families with greater than or equal to 2 asthmatic sibs, from three racial groups and report evidence for linkage to six novel regions: 5p15 (P = 0.0008) and 17p11.1-q11.2 (P = 0.0015) in African Americans; 11p15 (P = 0.0089) and 19q13 (P = 0.0013) in Caucasians; 2q33 (P = 0.0005) and 21q21 (P = 0.0040) in Hispanics. Evidence for linkage was also detected in five regions previously reported to be linked to asthma-associated phenotypes: 5q23-31 (P = 0.0187), 6p21.3-23 (P = 0.0129), 12q14-24.2 (P = 0.0042), 13q21.3-qter (P = 0.0014), and 14q11.2-13 (P = 0.0062) in Caucasians and 12q14-24.2 (P = 0.0260) in Hispanics.	UNIV CHICAGO, CTR MED GENET, CHICAGO, IL 60637 USA; JOHNS HOPKINS UNIV, BALTIMORE, MD USA; HOWARD UNIV, WASHINGTON, DC 20059 USA; UNIV S DAKOTA, SIOUX FALLS, SD USA; UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA; WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC USA; MARSHFIELD CLIN FDN MED RES & EDUC, MARSHFIELD, WI 54449 USA; UNIV MARYLAND, BALTIMORE, MD 21201 USA; UNIV NEW MEXICO, ALBUQUERQUE, NM 87131 USA; NIH, BETHESDA, MD 20892 USA	University of Chicago; Johns Hopkins University; Howard University; University of South Dakota; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; Marshfield Clinic; University System of Maryland; University of Maryland Baltimore; University of New Mexico; National Institutes of Health (NIH) - USA			Solway, Julian/B-1116-2008; Duffy, David L/B-7392-2013	Solway, Julian/0000-0002-0898-8530; Duffy, David L/0000-0001-7227-632X; Rich, Stephen/0000-0003-3872-7793	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049596, R01HL049609, U01HL049612, U01HL049609] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL/AI-49612, HL/AI-49609, HL/AI-49596] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ATS, 1987, AM J RESP CRIT CARE, V153, P1285; Barnes KC, 1996, GENOMICS, V37, P41, DOI 10.1006/geno.1996.0518; BLUMENTHAL M, 1992, J IMMUNOL, V148, P411; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; CHATHAM M, 1982, CHEST, V82, P15, DOI 10.1378/chest.82.1.15; COOKSON WOCM, 1989, LANCET, V1, P1292; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; EDFORSLUBS ML, 1971, ACTA ALLERGOL, V26, P249, DOI 10.1111/j.1398-9995.1971.tb01300.x; HOPP RJ, 1988, ANN ALLERGY, V61, P184; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LAPP NL, 1974, THORAX, V29, P185, DOI 10.1136/thx.29.2.185; MARSH D, 1990, GENETIC ENV FACTORS; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; *NHLBI, 1992, NAT HEART LUNG BLOOD; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; SHEFFER AL, 1991, J ALLERGY CLIN IMMUN, V87, P468, DOI 10.1016/0091-6749(91)90002-6; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; SHIRAKAWA T, 1991, CYTOGENET CELL GENET, V58, P1970; SIBBALD B, 1979, THORAX, V34, P332, DOI 10.1136/thx.34.3.332; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; WEISS ST, 1984, AM REV RESPIR DIS, V129, P898; YOUNG RP, 1994, CLIN EXP ALLERGY, V24, P431, DOI 10.1111/j.1365-2222.1994.tb00931.x	26	599	606	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					389	392						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090385				2022-12-27	WOS:A1997WQ38900018
J	Virtaneva, K; DAmato, E; Miao, IM; Koskiniemi, M; Norio, R; Avanzini, G; Franceschetti, S; Michelucci, R; Tassinari, CA; Omer, S; Pennacchio, LA; Myers, RM; DieguezLucena, JL; Krahe, R; delaChapelle, A; Lehesjoki, AE				Virtaneva, K; DAmato, E; Miao, IM; Koskiniemi, M; Norio, R; Avanzini, G; Franceschetti, S; Michelucci, R; Tassinari, CA; Omer, S; Pennacchio, LA; Myers, RM; DieguezLucena, JL; Krahe, R; delaChapelle, A; Lehesjoki, AE			Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1	NATURE GENETICS			English	Article							DIABETES SUSCEPTIBILITY LOCUS; HUMAN INSULIN GENE; UNVERRICHT-LUNDBORG; LOCALIZATION; LINKAGE; REGION; MUTATION; IDDM2	Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1; MIM 254800) is an autosomal recessive disorder that occurs with a low frequency in many populations but is more common in Finland and the Mediterranean region(1,2). It is characterized by stimulus-sensitive myoclonus and tonic-clonic seizures with onset at age 6-15 years, typical electroencephalographic abnormalities and a variable rate of progression between and within families(3-5). Following the initial mapping of the EPM1 gene to chromosome 21 (ref. 6) and the refinement of the critical region to a small interval(7-9), positional cloning identified the gene encoding cystatin B (CST6), a cysteine protease inhibitor, as the gene underlying EPM1 (ref. 10). Levels of messenger RNA encoded by CST6 were dramatically decreased in patients. A 3' splice site and a stop codon mutation were identified in three families, leaving most mutations uncharacterized(10). In this study, we report a novel type of disease-causing mutation, an unstable 15- to 18-mer minisatellite repeat expansion in the putative promoter region of the CST6 gene. The mutation accounts for the majority of EPM1 patients worldwide. Haplotype data are compatible with a single ancestral founder mutation. The length of the repeat array differs between chromosomes and families, but changes in repeat number seem to be comparatively rare events.	UNIV HELSINKI, DEPT MED GENET, HAARTMAN INST, FIN-00014 HELSINKI, FINLAND; UNIV HELSINKI, DEPT VIROL, HAARTMAN INST, FIN-00014 HELSINKI, FINLAND; FAMILY FEDERAT FINLAND, DEPT MED GENET, HELSINKI 00100, FINLAND; IST NEUROCHIRURG C BESTA, DEPT NEUROPHYSIOL, I-20133 MILAN, ITALY; UNIV BOLOGNA, BELLARIA HOSP, DEPT NEUROL, I-40139 BOLOGNA, ITALY; KING KHALID HOSP, JEDDAH 21423, SAUDI ARABIA; STANFORD UNIV, DEPT GENET, SCH MED, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA; UNIV MALAGA, FAC MED, DEPT BIOCHEM & MOL BIOL, MALAGA 29080, SPAIN	University of Helsinki; University of Helsinki; Family Federation of Finland; AUSL di Bologna; University of Bologna; King Khalid Hospital; Stanford University; Stanford University; Universidad de Malaga			Michelucci, Roberto/AAB-9074-2020; Franceschetti, Silvana/K-3438-2016	Franceschetti, Silvana/0000-0002-1921-6755; Michelucci, Roberto/0000-0002-9655-7940; Pennacchio, Len/0000-0002-8748-3732; Tassinari, Carlo Alberto/0000-0002-4183-5165	Fondazione Telethon Funding Source: Custom; Telethon [E.0444] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		ANDERMANN, 1990, ANN NEUROL, V28, P113; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; Cooper DN, 1995, METABOLIC MOL BASES, P259; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GACY AM, 1995, CELL, V81, P533; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P333; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P307; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LEHESJOKI AE, 1992, NEUROLOGY, V42, P1545, DOI 10.1212/WNL.42.8.1545; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEHESJOKI AE, 1994, HUM GENET, V93, P668, DOI 10.1007/BF00201568; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; NORIO R, 1979, CLIN GENET, V15, P382; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Stone NE, 1996, GENOME RES, V6, P218, DOI 10.1101/gr.6.3.218; Virtaneva K, 1996, AM J HUM GENET, V58, P1247; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374	29	158	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					393	396		10.1038/ng0497-393	http://dx.doi.org/10.1038/ng0497-393			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090386				2022-12-27	WOS:A1997WQ38900019
J	Lafreniere, RG; Rochefort, DL; Chretien, N; Rommens, JM; Cochius, JI; Kalviainen, R; Nousiainen, U; Patry, G; Farrell, K; Soderfeldt, B; Federico, A; Hale, BR; Cossio, OH; Sorensen, T; Pouliot, MA; Kmiec, T; Uldall, P; Janszky, J; Pranzatelli, MR; Andermann, F; Andermann, E; Rouleau, GA				Lafreniere, RG; Rochefort, DL; Chretien, N; Rommens, JM; Cochius, JI; Kalviainen, R; Nousiainen, U; Patry, G; Farrell, K; Soderfeldt, B; Federico, A; Hale, BR; Cossio, OH; Sorensen, T; Pouliot, MA; Kmiec, T; Uldall, P; Janszky, J; Pranzatelli, MR; Andermann, F; Andermann, E; Rouleau, GA			Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1	NATURE GENETICS			English	Article							RAMSAY-HUNT-SYNDROME; FRAGILE-X-SYNDROME; DINUCLEOTIDE REPEAT; HUMAN CHROMOSOME-21; RESTRICTION MAP; CGG REPEAT; LONG ARM; INSTABILITY; HUMAN-CHROMOSOME-21; POLYMORPHISM	Progressive myoclonus epilepsy type 1 (EPM1, also known as Unverricht-Lundborg disease) is an autosomal recessive disorder characterized by progressively worsening myoclonic jerks, frequent generalized tonic-clonic seizures, and a slowly progressive decline in cognition(1). Recently, two mutations in the cystatin B gene (also known as stefin B, STFB) mapping to 21q22.3 have been implicated in the EPM1 phenotype: a G-->C substitution in the last nucleotide of intron 1 that was predicted to cause a splicing defect in one family, and a C-->T substitution that would change an Arg codon (CGA) to a stop codon (TCA) at amino acid position 68, resulting in a truncated cystatin B protein in two other families(2). A fourth family showed undetectable amounts of STFB mRNA by northern blot analysis in an affected individual. We present haplotype and mutational analyses of our collection of 20 unrelated EPM1 patients and families from different ethnic groups. We identify four different mutations, the most common of which consists of an unstable similar to 600-900 bp insertion which is resistant to PCR amplification. This insertion maps to a 12-bp polymorphic tandem repeat located in the 5' flanking region of the STFB gene, in the region of the promoter. The size of the insertion varies between different EPM1 chromosomes sharing a common haplotype and a common origin, suggesting some level of meiotic instability over the course of many generations. This dynamic mutation, which appears distinct from conventional trinucleotide repeat expansions, may arise via a novel mechanism related to the instability of tandemly repeated sequences.	MONTREAL GEN HOSP, RES INST, DEPT NEUROL, MONTREAL, PQ H3G 1A4, CANADA; UNIV TORONTO, HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5S 1A1, CANADA; NORFOLK & NORWICH HOSP, DEPT NEUROL, NORWICH, NORFOLK, ENGLAND; KUOPIO UNIV HOSP, DEPT NEUROL, SF-70210 KUOPIO, FINLAND; UNIV KUOPIO, VAAJASALO HOSP, DEPT CLIN NEUROPHYSIOL, FIN-70211 KUOPIO, FINLAND; UNIV LAVAL, DEPT NEUROL, QUEBEC CITY, PQ, CANADA; UNIV BRITISH COLUMBIA, DEPT PAEDIAT, VANCOUVER, BC V5Z 1M9, CANADA; LINKOPING UNIV HOSP, DEPT NEUROL, S-58185 LINKOPING, SWEDEN; UNIV SIENA, INST NEUROL SCI, DEPT NEUROL, I-53100 SIENA, ITALY; DEPT PEDIAT NEUROL, INDIANAPOLIS, IN USA; HOSP SANTA CASA MISERICORDIA, CTR NEUROL & NEUROCIRUGIA, CURITIBA, PARANA, BRAZIL; UNIV COPENHAGEN, HVIDOVRE HOSP, DEPT NEUROL, DK-2650 HVIDOVRE, DENMARK; CHILDRENS MEM HLTH INST, DEPT NEUROL, WARSAW, POLAND; DIANALUND EPILEPSY HOSP, CHILD DEPT, DIANALUND, DENMARK; ORSZAGOS NEUROL & PSICHIAT INTEZET, DEPT NEUROL, BUDAPEST, HUNGARY; GEORGE WASHINGTON UNIV, DEPT NEUROL, WASHINGTON, DC 20052 USA; GEORGE WASHINGTON UNIV, DEPT PAEDIAT, WASHINGTON, DC 20052 USA; GEORGE WASHINGTON UNIV, DEPT PHARMACOL, WASHINGTON, DC 20052 USA; MCGILL UNIV, DEPT NEUROL & NEUROSURG, MONTREAL, PQ H3A 2T5, CANADA; MCGILL UNIV, DEPT PEDIAT, MONTREAL, PQ H3A 2T5, CANADA; MONTREAL NEUROL HOSP & INST, EPILEPSY SERV, MONTREAL, PQ H3A 2B4, CANADA; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ, CANADA; MONTREAL NEUROL HOSP & INST, NEUROGENET UNIT, MONTREAL, PQ H3A 2B4, CANADA	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Laval University; University of British Columbia; Linkoping University; University of Siena; University of Copenhagen; Children's Memorial Health Institute; George Washington University; George Washington University; George Washington University; McGill University; McGill University; McGill University; McGill University; McGill University	Lafreniere, RG (corresponding author), MCGILL UNIV, CTR RES NEUROSCI, ROOM L12-144, 1650 CEDAR AVE, MONTREAL, PQ H3G 1A4, CANADA.			Kmiec, Tomasz/0000-0001-6958-6239; federico, antonio/0000-0002-5246-1621				ANDERMANN F, 1989, MOVEMENT DISORD, V4, P13, DOI 10.1002/mds.870040104; [Anonymous], 1990, Ann Neurol, V28, P113; AVRAMOPOULOS D, 1993, HUM GENET, V90, P566; CHENG JF, 1994, GENOMICS, V23, P75, DOI 10.1006/geno.1994.1461; COCHIUS JI, 1993, ANN NEUROL, V34, P739, DOI 10.1002/ana.410340519; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GENTON P, 1990, ACTA NEUROL SCAND, V81, P8; ICHIKAWA H, 1993, NAT GENET, V4, P361, DOI 10.1038/ng0893-361; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAFRENIERE RG, 1995, GENOMICS, V29, P288, DOI 10.1006/geno.1995.1248; MUNKE M, 1988, AM J HUM GENET, V42, P542; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEDERSEN E, 1982, J NEUROL SCI, V53, P305, DOI 10.1016/0022-510X(82)90015-6; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; PETERSEN MB, 1991, HUM GENET, V87, P401; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P2517, DOI 10.1093/nar/19.9.2517; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291	20	148	151	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					298	302		10.1038/ng0397-298	http://dx.doi.org/10.1038/ng0397-298			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054946				2022-12-27	WOS:A1997WK38600023
J	You, Y; Bergstrom, R; Klemm, M; Lederman, B; Nelson, H; Ticknor, C; Jaenisch, R; Schimenti, J				You, Y; Bergstrom, R; Klemm, M; Lederman, B; Nelson, H; Ticknor, C; Jaenisch, R; Schimenti, J			Chromosomal deletion complexes in mice by radiation of embryonic stem cells	NATURE GENETICS			English	Article							SEX-DETERMINING REGION; MOUSE CHROMOSOME-7; LETHAL MUTATIONS; GENE; LOCUS; INVERSIONS; ECTODERM; ENCODES; PROTEIN; DEFINE	Chromosomal deletions ('deficiencies') are powerful tools in the genetic analysis of complex genomes. They have been exploited extensively in Drosophila melanogaster, an organism in which deficiencies can be efficiently induced and selected(1). Spontaneous deletions in humans have facilitated the dissection of phenotypes in contiguous gene syndromes(2,3) and led to the positional cloning of critical genes(4,5). In mice, deletion complexes created by whole animal irradiation experiments have enabled a systematic characterization of functional units along defined chromosomal regions(6,7). However, classical mutagenesis in mice is logistically impractical for generating deletion sets on a genome-wide scale. Here, we report a high-throughput method for generating radiation-induced deletion complexes at defined regions in the genome using ES cells. Dozens of deletions of up to several centiMorgans, encompassing a specific locus, can be created in a single experiment and transmitted through the germline. The ability to rapidly create deletion complexes along chromosomes will facilitate systematic functional analyses of the mammalian genome.	JACKSON LAB, BAR HARBOR, ME 04609 USA; MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE CTR 9, CAMBRIDGE, MA 02142 USA; SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND	Jackson Laboratory; Massachusetts Institute of Technology (MIT); Whitehead Institute; Novartis; Sandoz								ASHBURNER M, 1989, DROSOPHILA LAB MAN; ASKEW GR, 1993, MOL CELL BIOL, V13, P4115, DOI 10.1128/MCB.13.7.4115; BELL JA, 1995, MAMM GENOME, V6, P389, DOI 10.1007/BF00355638; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Gregorova S, 1996, MAMM GENOME, V7, P107, DOI 10.1007/s003359900029; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; Hamvas R, 1996, MAMM GENOME, V6, pS281; HOLDENER BC, 1995, GENOMICS, V27, P447, DOI 10.1006/geno.1995.1076; HOLDENERKENNY B, 1992, BIOESSAYS, V14, P831, DOI 10.1002/bies.950141208; JOHNSON DR, 1974, GENETICS, V76, P795; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; RINCHIK EM, 1993, MAMM GENOME, V4, P349, DOI 10.1007/BF00360583; RINCHIK EM, 1993, GENETICS, V135, P1117; RUSSELL LB, 1982, GENETICS, V100, P427; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHARAN SK, 1991, GENETICS, V129, P825; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; URLAUB G, 1986, SOMAT CELL MOLEC GEN, V12, P555, DOI 10.1007/BF01671941	24	89	92	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					285	288		10.1038/ng0397-285	http://dx.doi.org/10.1038/ng0397-285			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054943				2022-12-27	WOS:A1997WK38600020
J	Tapanainen, JS; Aittomaki, K; Min, J; Vaskivuo, T; Huhtaniemi, IT				Tapanainen, JS; Aittomaki, K; Min, J; Vaskivuo, T; Huhtaniemi, IT			Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility	NATURE GENETICS			English	Article							SERTOLI; NUMBERS; CLONING; CELLS	Gonadal function is controlled by the two pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). While LH mainly regulates gonadal steroidogenesis, FSH is considered essential for folliculogenesis in the female and spermatogenesis in the male. We recently discovered that an inactivating point mutation in the FSH receptor (R) gene causes a recessively inherited form of hypergonadotropic ovarian failure in homozygous females(1). This 566C-->T mutation, predicting an alanine to valine substitution, is located in exon 7 of the FSHR gene, in the region encoding the extracellular domain of the receptor molecule. Functional testing showed a clear-cut reduction in ligand binding and signal transduction by the mutated receptor. Hence, lack of FSH function is incompatible with ovarian follicular maturation and female fertility. In the male, FSH is generally considered essential for the pubertal initiation of spermatogenesis and maintenance of quantitatively normal sperm production in adults(2-5). We report here the first characterization of males homozygous for an inactivating FSHR mutation. They have variable degrees of spermatogenic failure. but, surprisingly, do not show azoospermia or absolute infertility. These results question the essential role of FSH for the initiation of spermatogenesis, and demonstrate that FSH is more important for female than for male fertility.	UNIV HELSINKI,DEPT MED GENET,FIN-00290 HELSINKI,FINLAND; UNIV HELSINKI,CENT HOSP,DEPT CLIN GENET,FIN-00290 HELSINKI,FINLAND; UNIV TURKU,INST BIOMED,DEPT PHYSIOL,FIN-20520 TURKU,FINLAND	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku	Tapanainen, JS (corresponding author), OULU UNIV HOSP,DEPT OBSTET & GYNECOL,FIN-90220 OULU,FINLAND.							AITTOMAKI K, 1994, AM J HUM GENET, V54, P844; Aittomaki K, 1996, J CLIN ENDOCR METAB, V81, P3722, DOI 10.1210/jc.81.10.3722; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; BREMNER WJ, 1981, J CLIN INVEST, V68, P1044, DOI 10.1172/JCI110327; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; KELTON CA, 1992, MOL CELL ENDOCRINOL, V89, P141, DOI 10.1016/0303-7207(92)90220-Z; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; MATSUMOTO AM, 1986, J CLIN ENDOCR METAB, V62, P1184, DOI 10.1210/jcem-62-6-1184; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Sharpe Richard M., 1994, P1363; STEIN LJ, 1991, PHYSIOL BEHAV, V51, P1; WEINBAUER GF, 1991, ENDOCRINOLOGY, V129, P1831, DOI 10.1210/endo-129-4-1831; World Health Organization, 1992, LAB MAN EX HUM SEM S; ZELEZNIK AJ, 1993, OVARY, P41; ZIRKIN BR, 1994, J ANDROL, V15, P273	17	381	390	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					205	206		10.1038/ng0297-205	http://dx.doi.org/10.1038/ng0297-205			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020851				2022-12-27	WOS:A1997WF08700025
J	Unseld, M; Marienfeld, JR; Brandt, P; Brennicke, A				Unseld, M; Marienfeld, JR; Brandt, P; Brennicke, A			The mitochondrial genome of Arabidopsis thaliana contains 57 genes in 366,924 nucleotides	NATURE GENETICS			English	Article							II INTRON SEQUENCES; PLANT-MITOCHONDRIA; CHLAMYDOMONAS-REINHARDTII; WHEAT MITOCHONDRIA; DNA; RNA; EXON; TRANSCRIPTION; ORGANIZATION; NUCLEUS	We have determined the complete sequence of the mitochondrial DNA in the model plant species Arabidopsis thaliana, affording access to the first of its three genomes. The 366,924 nucleotides code for 57 identified genes, which cover only 10% of the genome. Introns in these genes add about 8%, open reading frames larger than 100 amino acids represent 10% of the genome, duplications account for 7%, remnants of retrotransposons of nuclear origin contribute 4% and integrated plastid sequences amount to 1% - leaving 60% of the genome unaccounted for. With the significant contribution of duplications, imported foreign DNA and the extensive background of apparently functionless sequences, the mosaic structure of the Arabidopsis thaliana mitochondrial genome features many aspects of size-relaxed nuclear genomes.	INST GENBIOL FORSCH,D-14195 BERLIN,GERMANY; UNIV ULM,D-89069 ULM,GERMANY	Ulm University								BENDICH AJ, 1993, CURR GENET, V24, P279, DOI 10.1007/BF00336777; BINDER S, 1993, J BIOL CHEM, V268, P7849; BLACKBOURN H, 1986, TRENDS PLANT SCI, V1, P291; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310; BRANDT P, 1992, MOL GEN GENET, V236, P33, DOI 10.1007/BF00279640; BRENNER SE, 1995, NATURE, V378, P140, DOI 10.1038/378140a0; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; FOX TD, 1981, CELL, V26, P315, DOI 10.1016/0092-8674(81)90200-2; GOODMAN HM, 1995, P NATL ACAD SCI USA, V92, P10831, DOI 10.1073/pnas.92.24.10831; GRAY MW, 1988, PHILOS T R SOC B, V319, P135, DOI 10.1098/rstb.1988.0038; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P5461, DOI 10.1093/nar/17.14.5461; KLEIN M, 1994, PLANT J, V6, P447, DOI 10.1046/j.1365-313X.1994.06030447.x; Knoop V, 1996, GENETICS, V142, P579; KNOOP V, 1994, J MOL BIOL, V242, P389, DOI 10.1006/jmbi.1994.1589; KNOOP V, 1991, EMBO J, V10, P3483, DOI 10.1002/j.1460-2075.1991.tb04912.x; KNOOP V, 1994, J MOL EVOL, V39, P144; Knoop Volker, 1993, P221; Lang BF, 1996, J MOL BIOL, V261, P607, DOI 10.1006/jmbi.1996.0486; LEVINGS CS, 1990, SCIENCE, V250, P942, DOI 10.1126/science.250.4983.942; LIPPOK B, 1996, BIOL CHEM, V337, P251; MARECHALDROUARD L, 1993, ANNU REV PLANT PHYS, V44, P13, DOI 10.1146/annurev.pp.44.060193.000305; MEYEROWITZ EM, 1994, ARAQBIDOPSIS; MICHAELIS G, 1990, MOL GEN GENET, V223, P211, DOI 10.1007/BF00265056; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; OHTA E, 1993, NUCLEIC ACIDS RES, V21, P1297, DOI 10.1093/nar/21.5.1297; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1984, NATURE, V307, P411; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B	34	705	856	5	60	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					57	61		10.1038/ng0197-57	http://dx.doi.org/10.1038/ng0197-57			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988169				2022-12-27	WOS:A1997WA37300021
J	Taylor, TD; Litt, M; Kramer, P; Pandolfo, M; Angelini, L; Nardocci, N; Davis, S; Pineda, M; Hattori, H; Flett, PJ; Cilio, MR; Bertini, E; Hayflick, SJ				Taylor, TD; Litt, M; Kramer, P; Pandolfo, M; Angelini, L; Nardocci, N; Davis, S; Pineda, M; Hattori, H; Flett, PJ; Cilio, MR; Bertini, E; Hayflick, SJ			Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13	NATURE GENETICS			English	Article							REGIONAL DISTRIBUTION; ALZHEIMERS-DISEASE; SUBSTANTIA NIGRA; HUMAN GENOME; IRON; LINKAGE; BRAIN; GENE; MAP; LOCALIZATION	Hallervorden-Spatz syndrome (HSS) (OMIM #234200) is a rare, autosomal recessive neurodegenerative disorder with brain iron accumulation as a prominent finding. Clinical features include extrapyramidal dysfunction, onset in childhood, and a relentlessly progressive course(1). Histologic study reveals massive iron deposits in the basal ganglia. Systemic and cerebrospinal fluid iron levels are normal, as are plasma levels of ferritin, transferrin and ceruloplasmin. Conversely, in disorders of systemic iron overload, such as haemochromatosis, brain iron is not increased, which suggests that fundamental differences exist between brain and systemic iron metabolism and transport. In normal brain, non-haem iron accumulates regionally and is highest in basal ganglia(2). Pathologic brain iron accumulation is seen in common disorders, including Parkinson's disease(3,4), Alzheimer's disease(5,6) and Huntington disease(7). In order to gain insight into normal and abnormal brain iron transport, metabolism and function, our approach was to map the gene for HSS. A primary genome scan was performed using samples from a large, consanguineous family (HS1) (see Fig. 1). While this family was immensely powerful for mapping, the region demonstrating homozygosity in all affected members spans only 4 cM, requiring very close markers in order to detect linkage. The HSS gene maps to an interval flanked by D20S906 and D20S116 on chromosome 20p12.3-p13. Linkage was confirmed in nine additional families of diverse ethnic backgrounds.	OREGON HLTH SCI UNIV, DEPT MOL & MED GENET, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT NEUROL, PORTLAND, OR 97201 USA; BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; IST NAZL NEUROL CARLO BESTA, DEPT CHILD NEUROL, I-20133 MILAN, ITALY; AUCKLAND HOSP, NEUROSERV UNIT, AUCKLAND 1, NEW ZEALAND; HOSP SAN JUAN DIOS, DEPT NEUROPEDIAT, BARCELONA 08034, SPAIN; KYOTO UNIV, SCH MED, DEPT PEDIAT, KYOTO 606, JAPAN; ADELAIDE CHILDRENS HOSP INC, DEPT PEDIAT, ADELAIDE, SA 5006, AUSTRALIA; BAMBINO GESU PEDIAT HOSP, NEUROPHYSIOL UNIT, I-00165 ROME, ITALY	Oregon Health & Science University; Oregon Health & Science University; Baylor College of Medicine; IRCCS Istituto Neurologico Besta; Auckland City Hospital; University of Barcelona; Kyoto University; IRCCS Bambino Gesu			Bertini, Enrico/A-2284-2014; Cilio, Maria Roberta/AAY-6197-2021; Nardocci, Nardo/AAB-9903-2019; Bertini, Enrico/ABG-1278-2020; Davis, Sean/AAD-1801-2021; Pandolfo, Massimo/B-2853-2010; Taylor, Todd/A-7121-2009	Bertini, Enrico/0000-0001-9276-4590; Cilio, Maria Roberta/0000-0003-2481-8053; Nardocci, Nardo/0000-0001-5863-5592; Davis, Sean/0000-0002-8991-6458; Taylor, Todd/0000-0003-4247-6253	NATIONAL EYE INSTITUTE [K11EY000348] Funding Source: NIH RePORTER; NEI NIH HHS [1 K11 EY00348-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P451; ALVAREZ RA, 1995, GENOMICS, V29, P53, DOI 10.1006/geno.1995.1214; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; CHUMAKOV IM, 1995, NATURE, V377, P175; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEDMAN DJ, 1992, BIOCHEM J, V287, P509, DOI 10.1042/bj2870509; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOOLING EC, 1974, ARCH NEUROL-CHICAGO, V30, P70, DOI 10.1001/archneur.1974.00490310072012; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; HILL JM, 1985, BRAIN RES, V342, P18, DOI 10.1016/0006-8993(85)91348-4; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KUZNIECKY RI, 1993, NEUROLOGY, V43, P1452, DOI 10.1212/WNL.43.7.1452-a; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1988, AM J HUM GENET, V42, P327; LITT M, 1989, AM J HUM GENET, V44, P397; LITT M, 1993, BIOTECHNIQUES, V15, P280; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHEVELL M, 1992, NEUROLOGY, V42, P2214, DOI 10.1212/WNL.42.11.2214; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029; Terwilliger J., 1994, HDB HUMAN GENETIC LI; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wunderle V, 1994, Eur J Hum Genet, V2, P242; YANGFENG TL, 1994, CYTOGENET CELL GENET, V66, P170, DOI 10.1159/000133693	35	113	119	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					479	481		10.1038/ng1296-479	http://dx.doi.org/10.1038/ng1296-479			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944032				2022-12-27	WOS:A1996VV73000028
J	Acampora, D; Mazan, S; Avantaggiato, V; Barone, P; Tuorto, F; Lallemand, Y; Brulet, P; Simeone, A				Acampora, D; Mazan, S; Avantaggiato, V; Barone, P; Tuorto, F; Lallemand, Y; Brulet, P; Simeone, A			Epilepsy and brain abnormalities in mice lacking the Otx1 gene	NATURE GENETICS			English	Letter							ANTERIOR NEUROECTODERM; HOMEOBOX GENES; ORTHODENTICLE; LOCALIZATION; DROSOPHILA; FOREBRAIN; REGIONS; EN-2		CNR,INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY; INST PASTEUR,UNITE EMBRYOL MOL,CNRS,URA 1947,F-75724 PARIS,FRANCE; UNIV NAPLES FEDERICO II,DEPT NEUROL SCI,I-80131 NAPLES,ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Naples Federico II			Tuorto, Francesca/AAJ-2760-2021; Simeone, Antonio/ABG-5269-2020; Acampora, Dario/C-2156-2013	Tuorto, Francesca/0000-0003-1625-1181; Simeone, Antonio/0000-0003-2693-9836; 	Telethon [D.037] Funding Source: Medline	Telethon(Fondazione Telethon)		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DICHTER MA, 1991, HARRISONS PRINCIPLES, P1968; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HADDON CM, 1991, DEVELOPMENT, V112, P541; HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8; Hogan B, 1994, MANIPULATING MOUSE E; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KELLY JP, 1985, PRINCIPLES NEURAL SC, P584; Kuhlenbeck H., 1973, CENTRAL NERVOUS SYST; LEMOUELLIC H, 1990, P NATL ACAD SCI USA, V87, P4712, DOI 10.1073/pnas.87.12.4712; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MEENCKE HJ, 1984, EPILEPSIA, V25, P8, DOI 10.1111/j.1528-1157.1984.tb04149.x; Noebels JL, 1996, NEURON, V16, P241, DOI 10.1016/S0896-6273(00)80042-2; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; RAYMOND AA, 1995, BRAIN, V118, P629, DOI 10.1093/brain/118.3.629; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROYET J, 1995, DEVELOPMENT, V121, P3561; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; 1989, EPILEPSIA, V30, P391	28	218	222	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					218	222		10.1038/ng1096-218	http://dx.doi.org/10.1038/ng1096-218			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841200				2022-12-27	WOS:A1996VL44600034
J	De Felice, M; Ovitt, C; Biffali, E; Rodriguez-Mallon, A; Arra, C; Anastassiadis, K; Macchia, PE; Mattei, MG; Mariano, A; Scholer, H; Macchia, V; Di Lauro, R				De Felice, M; Ovitt, C; Biffali, E; Rodriguez-Mallon, A; Arra, C; Anastassiadis, K; Macchia, PE; Mattei, MG; Mariano, A; Scholer, H; Macchia, V; Di Lauro, R			A mouse model for hereditary thyroid dysgenesis and cleft palate	NATURE GENETICS			English	Article							CONGENITAL HYPOTHYROIDISM; LUNG; FUSION; HAIR	Alteration of thyroid gland morphogenesis (thyroid dysgenesis) is a frequent human malformation. Among the one in three to four thousand newborns in which congenital hypothyroidism is detected, 80% have either an ectopic, small and sublingual thyroid, or have no thyroid tissue(1). Most of these cases appear sporadically, although a few cases of recurring familial thyroid dysgenesis have been described(2). The lack of evidence for hereditary thyroid dysgenesis may be due to the severity of the hypothyroid phenotype. Neonatal screening and early thyroid hormone therapy have eliminated most of the clinical consequences of hypothyroidism such that the heritability of this condition may become apparent in the near future. We have recently cloned cDNA encoding a forkhead domain-containing transcription factor, TTF-2, and have located the position of the gene, designated Titf2, to mouse chromosome 4 (ref. 3). Titf2 is expressed in the developing thyroid, in most of the foregut endoderm and in craniopharyngeal ectoderm, including Rathke's pouch(3). Expression of Titf2 in thyroid cell precursors is down-regulated as they cease migration, suggesting that this factor is involved in the process of thyroid gland morphogenesis. Here we show that Titf2-null mutant mice exhibit cleft palate and either a sublingual or completely absent thyroid gland. Thus, mutation of Titf2(-/-) results in neonatal hypothyroidism that shows similarity to thyroid dysgenesis in humans.	Stn Zool A Dohrn, I-80121 Napoli, Italy; European Mol Biol Lab, Heidelberg, Germany; Ist Nazl Tumori Fdn Senatore Pascale, Naples, Italy; Fac Med Timone, Marseille, France; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Napoli, Italy	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Naples Federico II	Di Lauro, R (corresponding author), Stn Zool A Dohrn, I-80121 Napoli, Italy.	rdilauro@unina.it	Rodriguez Mallon, Alina/GVU-0924-2022; Macchia, Paolo Emidio/B-7391-2012; Macchia, Paolo Emidio/AGZ-2839-2022; Anastassiadis, Konstantinos/A-8944-2010; Di Lauro, Roberto/A-2746-2012	Macchia, Paolo Emidio/0000-0001-6503-6942; Macchia, Paolo Emidio/0000-0001-6503-6942; Anastassiadis, Konstantinos/0000-0002-9814-0559; Di Lauro, Roberto/0000-0001-9493-3036; Scholer, Hans/0000-0003-2643-5136; Arra, Claudio/0000-0003-3162-2091	Telethon [D.067] Funding Source: Medline	Telethon(Fondazione Telethon)		Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; Acampora D, 1998, DEVELOPMENT, V125, P1229; BAMFORTH JS, 1989, J MED GENET, V26, P49, DOI 10.1136/jmg.26.1.49; BUNTINCX IM, 1993, J MED GENET, V30, P427, DOI 10.1136/jmg.30.5.427; CARETTE MJM, 1992, DEVELOPMENT, V114, P379; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; DAMANTE G, 1994, BBA-GENE STRUCT EXPR, V1218, P255, DOI 10.1016/0167-4781(94)90176-7; FISHER DA, 1981, NEW ENGL J MED, V304, P702, DOI 10.1056/NEJM198103193041205; Gentile F., 1995, ENDOCRINOLOGY, P517; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MCKUSICK VA, 1994, MENDELIAN INHERTANCE; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; RAMIREZSOLIS R, 1993, GUIDE TECHNIQUES MOU, P855; TOUBLANC JE, 1992, HORM RES, V38, P230, DOI 10.1159/000182549; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185	21	230	235	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					395	398		10.1038/1289	http://dx.doi.org/10.1038/1289			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697704				2022-12-27	WOS:000075107600026
J	Hattersley, AT; Beards, F; Ballantyne, E; Appleton, M; Harvey, R; Ellard, S				Hattersley, AT; Beards, F; Ballantyne, E; Appleton, M; Harvey, R; Ellard, S			Mutations in the glucokinase gene of the fetus result in reduced birth weight	NATURE GENETICS			English	Article							DEPENDENT DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; FETAL GROWTH; INSULIN; HYPERGLYCEMIA; CHILDREN; LINKAGE; DEFECT; YOUNG; SIZE	Low birth weight and fetal thinness have been associated with non-insulin dependent diabetes mellitus (NIDDM) and insulin resistance in childhood and adulthood(1-6). It has been proposed that this association results from fetal programming in response to the intrauterine environment(7,8). An alternative explanation is that the same genetic influences alter both intrauterine growth and adult glucose tolerance. Fetal insulin secretion in response to maternal glycaemia plays a key role in fetal growth, and adult insulin secretion is a primary determinant of glucose tolerance. We hypothesized that a defect in the sensing of glucose by the pancreas, caused by a heterozygous mutation in the glucokinase gene(9), could reduce fetal growth and birth weight in addition to causing hyperglycaemia after birth. In 58 offspring, where one parent has a glucokinase mutation, the inheritance of a glucokinase mutation by the fetus resulted in a mean reduction of birth weight of 533 g (P=0.002). In 19 of 21 sibpairs discordant for the presence of a glucokinase mutation, the child with the mutation had a lower birth weight, with a mean difference of 521 g (P=0.0002). Maternal hyperglycaemia due to a glucokinase mutation resulted in a mean increase in birth weight of 601 g (P=0.001). The effects of maternal and fetal glucokinase mutations on birth weight were additive. We propose that these changes in birth weight reflect changes in fetal insulin secretion which are influenced directly by the fetal genotype and indirectly, through maternal hyperglycaemia, by the maternal genotype. This observation suggests that variation in fetal growth could be used in the assessment of the role of genes which modify either insulin secretion or insulin action.	Univ Exeter, Postgrad Med Sch, Dept Vasc Med & Diabet Res, Exeter EX2 5AX, Devon, England; Dr Grays Hosp, Elgin IV30 1SN, Moray, Scotland	University of Exeter	Hattersley, AT (corresponding author), Univ Exeter, Postgrad Med Sch, Dept Vasc Med & Diabet Res, Barrack Rd, Exeter EX2 5AX, Devon, England.			Hattersley, Andrew/0000-0001-5620-473X; Ellard, Sian/0000-0002-7620-5526				Barker D J, 1992, Paediatr Perinat Epidemiol, V6, P35, DOI 10.1111/j.1365-3016.1992.tb00741.x; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; BEARDS FE, 1998, DIABETIC MED; BYRNE MM, 1994, J CLIN INVEST, V93, P1120, DOI 10.1172/JCI117064; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; DONOHUE WL, 1954, J PEDIATR-US, V45, P505, DOI 10.1016/S0022-3476(54)80113-2; ELSAS LJ, 1985, AM J HUM GENET, V37, P73; Frayling TM, 1997, DIABETES, V46, P720, DOI 10.2337/diabetes.46.4.720; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALES CN, 1994, DIABETOLOGIA, V37, pS162, DOI 10.1007/BF00400840; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; LAW CM, 1995, DIABETIC MED, V12, P24, DOI 10.1111/j.1464-5491.1995.tb02057.x; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; PEDERSON J, 1977, PREGNANT DIABETIC HE; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; RANDLE PJ, 1993, DIABETOLOGIA, V36, P269, DOI 10.1007/BF00400227; STOFFEL M, 1992, NAT GENET, V2, P153, DOI 10.1038/ng1092-153; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; TANNER JM, 1970, ARCH DIS CHILD, V45, P566, DOI 10.1136/adc.45.242.566; VELHO G, 1992, LANCET, V340, P444, DOI 10.1016/0140-6736(92)91768-4; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; WRIGHT NM, 1993, AM J DIS CHILD, V147, P607; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x	27	421	429	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					268	270		10.1038/953	http://dx.doi.org/10.1038/953			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662401				2022-12-27	WOS:000074565900024
J	Barr, FG				Barr, FG			Translocations, cancer and the puzzle of specificity	NATURE GENETICS			English	Article							HUMAN LEUKEMIA; FUSION GENE; ABL; PROTEIN; HEMATOPOIESIS; RECOMBINATION; FIBROBLASTS; ONCOGENES; SEQUENCE; CELLS	The finding of acquired chromosomal translocations that are consistently associated with specific tumour types supports the premise of lineage-specific mechanisms of tumorigenesis. We review the evidence indicating that the specificity of these translocations and the corresponding gene fusions is related to biological constraints at the level of recombination, expression, and protein function. A dynamic relationship between the gene fusion and the cellular environment is proposed in which the environment influences the selection of oncogenic fusions and the oncogenic fusion in turn influences the cellular environment.	Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Barr, FG (corresponding author), Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA.	barrfg@mail.med.upenn.edu						Aplan PD, 1996, BLOOD, V87, P2649, DOI 10.1182/blood.V87.7.2649.bloodjournal8772649; Barr FG, 1997, J PEDIAT HEMATOL ONC, V19, P483, DOI 10.1097/00043426-199711000-00001; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Castellanos A, 1997, BLOOD, V90, P2168, DOI 10.1182/blood.V90.6.2168.2168_2168_2174; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DALEY GQ, 1987, SCIENCE, V237, P532, DOI 10.1126/science.2440107; DALEY GQ, 1991, ADV CANCER RES, V57, P151; David G, 1997, ONCOGENE, V14, P1547, DOI 10.1038/sj.onc.1200989; DeiTos AP, 1997, VIRCHOWS ARCH, V431, P83; Early E, 1996, P NATL ACAD SCI USA, V93, P7900, DOI 10.1073/pnas.93.15.7900; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrucci PF, 1997, P NATL ACAD SCI USA, V94, P10901, DOI 10.1073/pnas.94.20.10901; Fu XY, 1997, MOL CELL BIOL, V17, P1503, DOI 10.1128/MCB.17.3.1503; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; HALUSKA FG, 1990, MOL GENETICS CANC DI, P143; HLSTERKAMP N, 1991, TRANSGENIC RES, V1, P45; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kuroda M, 1997, AM J PATHOL, V151, P735; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; NUCIFORA G, 1995, BLOOD, V86, P1; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHORE SK, 1994, J BIOL CHEM, V269, P5413; VONCKEN JW, 1995, BLOOD, V86, P4603, DOI 10.1182/blood.V86.12.4603.bloodjournal86124603; Wang P, 1997, P NATL ACAD SCI USA, V94, P12018, DOI 10.1073/pnas.94.22.12018; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	36	83	88	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					121	124		10.1038/475	http://dx.doi.org/10.1038/475			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620766				2022-12-27	WOS:000073865100017
J	Nishimura, DY; Swiderski, RE; Alward, WLM; Searby, CC; Patil, SR; Bennet, SR; Kanis, AB; Gastier, JM; Stone, EM; Sheffield, VC				Nishimura, DY; Swiderski, RE; Alward, WLM; Searby, CC; Patil, SR; Bennet, SR; Kanis, AB; Gastier, JM; Stone, EM; Sheffield, VC			The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25	NATURE GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; PROTEIN-CODING REGIONS; HUMAN PAX6 GENE; RIEGER SYNDROME; 2ND LOCUS; DNA; ANIRIDIA; POLYSACCHARIDE; LOCALIZATION; TRANSLATION	A number of different eye disorders with the presence of early-onset glaucoma as a component of the phenotype have been mapped to human chromosome 6p25. These disorders have been postulated to be either allelic to each other or associated with a cluster of tightly linked genes. We have identified two primary congenital glaucoma (PCC) patients with chromosomal anomalies involving 6p25. In order to identify a gene involved in PCG, the chromosomal breakpoints in a patient with a balanced translocation between 6p25 and 13q22 were cloned. Cloning of the 6p25 breakpoint led to the identification of two candidate genes based on proximity to the breakpoint. One of these, FKHL7, encoding a forkhead transcription factor, is in close proximity to the breakpoint in the balanced translocation patient and is deleted in a second PCC patient with partial 6p monosomy. Furthermore, FKHL7 was found to harbour mutations in patients diagnosed with Rieger anomaly (RA), Axenfeld anomaly (AA) and iris hypoplasia (IH). This study demonstrates that mutations in FKHL7 cause a spectrum of glaucoma phenotypes.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; VitreoRetinal Surg, Minneapolis, MN 55435 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; Stanford University	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835	NEI NIH HHS [R01-EY-10564] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; ALTSCHUL SF, 1990, J MOL BIOL, V215, P40; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Alward WLM, 1996, J GLAUCOMA, V5, P276; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CURRIE HL, 1995, CLIN DIAGN LAB IMMUN, V2, P554, DOI 10.1128/CDLI.2.5.554-562.1995; DORIN JR, 1992, HUM MOL GENET, V1, P53, DOI 10.1093/hmg/1.1.53; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Gould DB, 1997, AM J HUM GENET, V61, P765; Graff C, 1997, HUM GENET, V101, P130, DOI 10.1007/s004390050601; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LI Y, 1995, VIROLOGY, V212, P134, DOI 10.1006/viro.1995.1462; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; Phillips JC, 1996, AM J HUM GENET, V59, P613; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Wirtz MK, 1997, AM J HUM GENET, V60, P296; Xu Y, 1994, Genet Eng (N Y), V16, P241	43	343	363	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					140	147		10.1038/493	http://dx.doi.org/10.1038/493			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620769				2022-12-27	WOS:000073865100020
J	Waterman, MJF; Stavridi, ES; Waterman, JLF; Halazonetis, TD				Waterman, MJF; Stavridi, ES; Waterman, JLF; Halazonetis, TD			ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins	NATURE GENETICS			English	Article							WILD-TYPE P53; ATAXIA-TELANGIECTASIA; TETRAMERIZATION DOMAIN; CANCER-THERAPY; DNA-BINDING; CHECKPOINT; APOPTOSIS; PATHWAYS; IRRADIATION; FIBROBLASTS	The p53 tumour-suppressor protein is a sequence-specific DNA-binding transcription factor that induces cell cycle arrest or apoptosis in response to genotoxic stress(1-6). Activation of p53 by DNA-damaging agents is critical for eliminating cells with damaged genomic DNA and underlies the apoptotic response of human cancers treated with ionizing radiation (IR) and radiomimetic drugs(7-8). The molecular mechanisms by which DNA damage activates p53 have not been elucidated. Both the levels of p53 protein and its affinity for specific DNA sequences increase in response to genotoxic stress(6,9-10). In vitro, the affinity of p53 for DNA is regulated by its carboxy-terminus(11-13). We therefore examined whether this region of p53 is targeted by DNA-damage signalling pathways in vivo. In nonirradiated cells, serines 376 and 378 of p53 were phosphorylated. IR led to dephosphorylation of Ser376, creating a consensus binding site for 14-3-3 proteins and leading to association of p53 with 14-3-3. In turn, this increased the affinity of p53 for sequence-specific DNA. Consistent with the lack of p53 activation by IR in ataxia telangiectasia (AT; refs 14, 15), neither Ser376 dephosphorylation, nor the interaction of p53 with 14-3-3 proteins occurred in AT cells.	Wistar Inst, Dept Mol Genet, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Program Mol Biol & Genet, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Halazonetis, TD (corresponding author), Wistar Inst, Dept Mol Genet, 3601 Spruce St, Philadelphia, PA 19104 USA.		Halazonetis, Thanos/D-7923-2011					Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Chernov MV, 1997, ONCOGENE, V14, P2503, DOI 10.1038/sj.onc.1201104; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DELPHIN C, 1994, J BIOL CHEM, V269, P29579; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Haapajarvi T, 1997, MOL CELL BIOL, V17, P3074, DOI 10.1128/MCB.17.6.3074; HALAZONETIS TD, 1993, EMBO J, V12, P1021, DOI 10.1002/j.1460-2075.1993.tb05743.x; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KHANNA KK, 1993, ONCOGENE, V8, P3307; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soussi T, 1996, J MOL BIOL, V260, P623, DOI 10.1006/jmbi.1996.0425; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; Waterman MJF, 1996, CANCER RES, V56, P158; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	30	394	403	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					175	178		10.1038/542	http://dx.doi.org/10.1038/542			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620776				2022-12-27	WOS:000073865100027
J	Shears, DJ; Vassal, HJ; Goodman, FR; Palmer, RW; Reardon, W; Superti-Furga, A; Scambler, PJ; Winter, RM				Shears, DJ; Vassal, HJ; Goodman, FR; Palmer, RW; Reardon, W; Superti-Furga, A; Scambler, PJ; Winter, RM			Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis	NATURE GENETICS			English	Article							TRANSLOCATION; WOMAN	Leri-Weill Dyschondrosteosis (LWD; OMIM 127300) is a dominantly inherited skeletal dysplasia characterized by disproportionate short stature with predominantly mesomelic limb shortening(9). Expression is variable and consistently more severe in females(2), who frequently display the Madelung deformity of the forearm (shortening and bowing of the radius with dorsal subluxation of the distal ulna). The rare Langer Mesomelic Dysplasia(3) (LD; OMIM 249700), characterized by severe short stature with hypoplasia/aplasia of the ulna and fibula, has been postulated to be the homozygous form of LWD (refs 4-6). In a six-generation pedigree with LWD, we established linkage to the marker DXYS6814 in the pseudoautosomal region (PAR1) of the X and Y chromosomes (Z max= 6.28; theta=0). Linkage analysis of three smaller pedigrees increased the lod score to 8.68 (theta=0). We identified submicroscopic PAR1 deletions encompassing the recently described short stature homeobox-containing gene SHOX (refs 7,8) segregating with the LWD phenotype in 5 families. A point mutation leading to a premature stop in exon 4 of SHOX was identified in one LWD family.	Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Child Hlth, Dept Clin Genet, London WC1N 1EH, England; Inst Neurol, N Thames E Reg Cytogenet Unit, London WC1N 3BG, England; Univ Zurich, Childrens Hosp, Div Metab & Mol Dis, CH-8032 Zurich, Switzerland	University of London; University College London; University of London; University College London; University of London; University College London; University Children's Hospital Zurich; University of Zurich	Scambler, PJ (corresponding author), Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.		Scambler, Peter J/C-4998-2008; Scambler, Peter/AAZ-6026-2020; superti-furga, andrea/E-9162-2015	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; superti-furga, andrea/0000-0002-3543-7531; Reardon, Willie/0000-0001-7329-9179	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; ESPIRITU C, 1975, AM J DIS CHILD, V129, P375, DOI 10.1001/archpedi.1975.02120400075020; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; FRANCISCO RJL, 1997, AN ESP PEDIAT, V47, P167; FRYNS JP, 1979, HUM GENET, V46, P21, DOI 10.1007/BF00278898; Guichet A, 1997, CLIN DYSMORPHOL, V6, P341, DOI 10.1097/00019605-199710000-00007; KHUDR G, 1973, JAMA-J AM MED ASSOC, V226, P544, DOI 10.1001/jama.226.5.544; KUNZE J, 1980, EUR J PEDIATR, V134, P269, DOI 10.1007/BF00441485; KUZNETZOVA T, 1994, J MED GENET, V31, P649, DOI 10.1136/jmg.31.8.649; LANGER LO, 1967, RADIOLOGY, V89, P654, DOI 10.1148/89.4.654; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LERI A, 1929, B MEM SOC MED HOP P, V35, P1491; LICHTENSTEIN JR, 1980, J MED GENET, V17, P41, DOI 10.1136/jmg.17.1.41; OGATA T, 1995, J MED GENET, V32, P572, DOI 10.1136/jmg.32.7.572; Ogata T, 1997, J MED GENET, V34, P323, DOI 10.1136/jmg.34.4.323; OGATA T, 1995, HUM GENET, V95, P627; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; YOULTON R, 1985, REV MED CHILE, V113, P228	19	237	249	2	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					70	73		10.1038/ng0198-70	http://dx.doi.org/10.1038/ng0198-70			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590293				2022-12-27	WOS:000073346700021
J	Verhoeven, K; Van Laer, L; Kirschhofer, K; Legan, PK; Hughes, DC; Schatteman, I; Verstreken, M; Van Hauwe, P; Coucke, P; Chen, A; Smith, RJH; Somers, T; Offeciers, FE; Van de Heyning, P; Richardson, GP; Wachtler, F; Kimberling, WT; Willems, PJ; Govaerts, PJ; Van Camp, G				Verhoeven, K; Van Laer, L; Kirschhofer, K; Legan, PK; Hughes, DC; Schatteman, I; Verstreken, M; Van Hauwe, P; Coucke, P; Chen, A; Smith, RJH; Somers, T; Offeciers, FE; Van de Heyning, P; Richardson, GP; Wachtler, F; Kimberling, WT; Willems, PJ; Govaerts, PJ; Van Camp, G			Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment	NATURE GENETICS			English	Article							TAMM-HORSFALL PROTEIN; MEMBRANE-PROTEIN; SEQUENCE; GRANULE; GP-2; GLYCOPROTEIN; HOMOLOGY; RECEPTOR; PANCREAS	The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. alpha-tectorin is one of the major non-collagenous components of the tectorial membrane(1,2). Recently, the gene encoding mouse alpha-tectorin (Tecta) was mapped to a region of mouse chromosome 9, which shows evolutionary conservation with human chromosome 11q (ref. 3), where linkage was found in two families, one Belgian (DFNA12; ref. 4) and the other, Austrian (DFNA8; unpublished data), with autosomal dominant non-syndromic hearing impairment. We determined the complete sequence and the intron-exon structure of the human TECTA gene. In both families, mutation analysis revealed missense mutations which replace conserved amino-acid residues within the zona pellucida domain of TECTA. These findings indicate that mutations in TECTA are responsible for hearing impairment in these families, and implicate a new type of protein in the pathogenesis of hearing impairment.	Univ Instelling Antwerp, Dept Med Genet, B-2610 Wilrijk, Belgium; Univ Instelling Antwerp, Dept Otorhinolaryngol, B-2610 Wilrijk, Belgium; Univ Hosp Vienna, Clin Otorhinol, A-1090 Vienna, Austria; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; St Augustinus Hosp, Dept Otolaryngol, B-2610 Wilrijk, Belgium; Univ Iowa Hosp & Clin, Dept Otolaryngol, Iowa City, IA 52242 USA; Univ Vienna, Inst Histol & Embryol, A-1090 Vienna, Austria; Boys Town Natl Res Hosp, Omaha, NE 68131 USA	University of Antwerp; University of Antwerp; University Hospital Vienna; University of Sussex; University of Nottingham; University of Iowa; University of Vienna; Boys Town National Research Hospital	Van Camp, G (corresponding author), Univ Instelling Antwerp, Dept Med Genet, Universiteitsplein 1, B-2610 Wilrijk, Belgium.	gvcamp@uia.ua.ac.be	Hughes, David/AAB-9237-2019; Coucke, Paul J/AAO-2954-2020; Heyning, Paul H Vande/I-8278-2017; Van Camp, Guy/F-3386-2013	Hughes, David/0000-0002-4539-3093; Coucke, Paul J/0000-0001-7119-586X; Heyning, Paul H Vande/0000-0002-8424-3717; Van Camp, Guy/0000-0001-5105-9000; Smith, Richard/0000-0003-1201-6731; Legan, P. Kevin/0000-0002-7403-6415				BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; DURKIN ME, 1988, J CELL BIOL, V107, P2749, DOI 10.1083/jcb.107.6.2749; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; GOVAERTS PJ, IN PRESS AM J OTOL; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Hughes DC, 1998, GENOMICS, V48, P46, DOI 10.1006/geno.1997.5159; KRAWCZAK M, 1992, HUM GENET, V90, P41; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LERACH H, 1990, GENOME ANAL, V1, P39; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PRASADAN K, 1995, BBA-GENE STRUCT EXPR, V1260, P328, DOI 10.1016/0167-4781(94)00240-4; RICHARDSON GP, 1987, HEARING RES, V25, P45, DOI 10.1016/0378-5955(87)90078-5; SULIK KK, 1995, HEREDITARY HEARING L, pCH4; Verhoeven K, 1997, AM J HUM GENET, V60, P1168; Wong SME, 1996, GENE, V171, P311, DOI 10.1016/0378-1119(96)00065-0; Yu Heron, 1994, Gene Expression, V4, P63	20	259	277	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					60	62		10.1038/ng0598-60	http://dx.doi.org/10.1038/ng0598-60			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590290				2022-12-27	WOS:000073346700018
J	Barlow, C; Liyanage, M; Moens, PB; Deng, CX; Ried, T; WynshawBoris, A				Barlow, C; Liyanage, M; Moens, PB; Deng, CX; Ried, T; WynshawBoris, A			Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA; PARADIGM	Patients with the human disorder ataxia-telangiectasia (A-T; refs 1,2) and Atm-deficient mice(3-5) have a pleiotropic phenotype that includes infertility, Here we demonstrate that male gametogenesis is severely disrupted in Atm-deficient mice in the earliest stages of meiotic prophase I, resulting in apoptotic degeneration. Atm is required for proper assembly of Rad51 onto the chromosomal axial elements during meiosis. In addition, p53, p21 and Bar are elevated in testes from Atm-deficient mice. To determine whether these elevated protein levels are important factors in the meiotic disruption of Atm-deficient mice, we analysed the meiotic phenotype of Atm/p53 or Atm/p21 double mutants. In these double mutants, meiosis progressed to later stages but was only partly rescued. Assembly of Rad51 foci on axial elements remained defective, and gametogenesis proceeded only to pachytene of prophase I. Previous results demonstrated that mice homozygous for a null mutation in Rad51 (ref. 6) display an early embryonic lethal phenotype that can be partly rescued by removing p53 and/or p21. Because Atm-deficient mice are viable but completely infertile, our studies suggest that the Rad51 assembly defects and elevated levels of p53, p21 and Bar represent tissue-specific responses to the absence of Atm.	NIDDKD,LAB GENET DIS RES,NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892; NIDDKD,GENOME TECHNOL BRANCH,NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892; NIDDKD,BIOCHEM & METAB LAB,NIH,BETHESDA,MD 20892; YORK UNIV,DEPT BIOL,DOWNSVIEW,ON M3J 1P3,CANADA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); York University - Canada			deng, chuxia/N-6713-2016					Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Boder E, 1975, Birth Defects Orig Artic Ser, V11, P255; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DOBSON MJ, 1994, J CELL SCI, V107, P2749; DRESSER ME, 1979, EXP CELL RES, V121, P416, DOI 10.1016/0014-4827(79)90023-5; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Harlow E., 1988, ANTIBODIES LAB MANUA; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Luna L.G., 1992, HISTOPATHOLOGICAL ME; MIYASHITA T, 1995, CELL, V80, P293; MOENS PB, 1995, CHROMOSOMA, V104, P169, DOI 10.1007/BF00352181; MOENS PB, IN PRESS CHROMOSOMA; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SEDGWICK RP, 1991, HEREDITARY NEUROPATH, P347; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	23	104	105	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					462	466		10.1038/ng1297-462	http://dx.doi.org/10.1038/ng1297-462			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398851				2022-12-27	WOS:A1997YJ92400030
J	Risch, N				Risch, N			Haemochromatosis, HFE and genetic complexity	NATURE GENETICS			English	Letter							HEREDITARY HEMOCHROMATOSIS; MUTATION ANALYSIS				Risch, N (corresponding author), STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.							Ajioka RS, 1997, AM J HUM GENET, V60, P1439, DOI 10.1086/515466; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Calandro L, 1996, BLOOD CELL MOL DIS, V22, pA194; Carella M, 1997, AM J HUM GENET, V60, P828; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1997, HUM GENET, V100, P544, DOI 10.1007/s004390050549; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251	8	73	74	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					375	376		10.1038/ng1297-375	http://dx.doi.org/10.1038/ng1297-375			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398831				2022-12-27	WOS:A1997YJ92400010
J	Lewandoski, M; Martin, GR				Lewandoski, M; Martin, GR			Cre-mediated chromosome loss in mice	NATURE GENETICS			English	Article							DNA; EXPRESSION; MOUSE; YEAST; CELLS; GENE	Chromosome loss in early human embryos is thought to cause a large proportion of spontaneous abortions(1); when it occurs in specific cell lineages in older embryos or adults, it can result in neoplasia(2). Although early embryonic chromosome loss can be modelled by breeding mice carrying robertsonian translocation chromosomes(3), there is currently no method for producing mice with tissue-specific monosomies. Here we demonstrate that DNA recombination mediated by the site-specific recombinase Cre(4) causes loss of a chromosome carrying loxP sites (Cre recognition sites) in an inverted orientation. Thus, when male mice carrying a Y-linked transgene containing inverted loxP sites are mated with females carrying a cre gene that is ubiquitously expressed in the early embryo, almost all their XY progeny lose the Y chromosome early in embryogenesis and develop as XO females. Because inverted loxP sites can be targetted to any mouse chromosome and mice can be produced that express cre in specific cell lineages, these data suggest a method for engineering tissue-specific loss of particular chromosomes to provide mouse models for human diseases caused by or associated with specific monosomies.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT ANAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,PROGRAM DEV BIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco				Lewandoski, Mark/0000-0002-1066-3735	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025331] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD25331] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREASON GL, 1988, BIOTECHNIQUES, V6, P650; Bouffler SD, 1996, MUTAT RES-REV GENET, V366, P129, DOI 10.1016/S0165-1110(96)90033-0; CATTANACH BM, 1962, GENET RES, V3, P487, DOI 10.1017/S0016672300003335; Epstein C.J, 1986, CONSEQUENCES CHROMOS; EPSTEIN CJ, 1985, TRENDS GENET, V1, P129, DOI 10.1016/0168-9525(85)90054-X; FALCO SC, 1982, CELL, V29, P573, DOI 10.1016/0092-8674(82)90173-8; GOLIC KG, 1994, GENETICS, V137, P551; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Heim S, 1995, CANC CYTOGENETICS; HOGAN B, 1994, MANIPULATING MOUSE E, P226; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWANDOSKI M, IN PRESS COLD SPRING; LUNAFINEMAN S, 1995, BLOOD, V85, P1985, DOI 10.1182/blood.V85.8.1985.bloodjournal8581985; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; NAGAMINE CM, 1987, NUCLEIC ACIDS RES, V15, P9227, DOI 10.1093/nar/15.22.9227; Nagy A., 1993, Gene targeting: a practical approach., P147; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M	22	129	136	2	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					223	225		10.1038/ng1097-223	http://dx.doi.org/10.1038/ng1097-223			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326948				2022-12-27	WOS:A1997XZ55500034
J	Fleming, MD; Trenor, CC; Su, MA; Foernzler, D; Beier, DR; Dietrich, WF; Andrews, NC				Fleming, MD; Trenor, CC; Su, MA; Foernzler, D; Beier, DR; Dietrich, WF; Andrews, NC			Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; INTRACELLULAR PARASITES; NATURAL-RESISTANCE; SYSTEM; INFECTION; PROTEINS; DNA; BCG	Although disorders of iron metabolism are prevalent, iron transport remains poorly understood. To address this problem, we undertook a positional cloning strategy to identify the causative mutation in mice with microcytic anaemia (mk). Homozygous mk/mk mice have microcytic, hypochromic anaemia due to severe defects in intestinal iron absorption and erythroid iron utilization(1-4). We report the identification of a strong candidate gene for mk, and suggest that the phenotype is a consequence of a missense mutation in Nramp2 (ref. 5), a previously identified gene of unknown function. Nramp2 is homologous to Nramp1, a gene active in host defense. If Nramp2 is mk, as the cumulative evidence suggests, our findings have broad implications for the understanding of iron transport and resistance to intracellular pathogens.	CHILDRENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School				Andrews, Nancy/0000-0003-0243-4462; johnson, keith/0000-0002-8578-5921; Su, Maureen/0000-0002-3680-9982; Fleming, Mark/0000-0003-0948-4024	NHLBI NIH HHS [K08 HL03600] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003600] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Cellier M, 1996, TRENDS GENET, V12, P201, DOI 10.1016/0168-9525(96)30042-5; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; EDWARDS JA, 1975, BLOOD, V46, P381; EDWARDS JA, 1972, P SOC EXP BIOL MED, V141, P81; GRUNHEID S, 1995, GENOMICS, V25, P514; GRUNHEID S, 1997, J EXP MED, V185, P717; HANDA S, 1987, GENET RES, V51, P42; HARRISON DE, 1972, BLOOD-J HEMATOL, V40, P893, DOI 10.1182/blood.V40.6.893.893; HOGAN B, 1986, MANIPULATING MOUSE E; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MCFARLAND EC, 1975, MOUSE NEWS LETT, V53, P35; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; RUSSELL ES, 1970, BLOOD-J HEMATOL, V35, P838, DOI 10.1182/blood.V35.6.838.838; RUSSELL ES, 1970, TRANSPLANT P, V2, P144; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; THOMSON ABR, 1971, J LAB CLIN MED, V78, P642; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; WEINBERG ED, 1993, ASM NEWS, V59, P559; WEST AH, 1992, J BIOL CHEM, V267, P24625	25	971	1002	2	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					383	386		10.1038/ng0897-383	http://dx.doi.org/10.1038/ng0897-383			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241278				2022-12-27	WOS:A1997XM90900023
J	Heppner, C; Kester, MB; Agarwal, SK; Debelenko, LV; EmmertBuck, MR; Guru, SC; Manickam, P; Olufemi, SE; Skarulis, MC; Doppman, JL; Alexander, RH; Kim, YS; Saggar, SK; Lubensky, IA; Zhuang, ZP; Liotta, LA; Chandrasekharappa, SC; Collins, FS; Spiegel, AM; Burns, AL; Marx, SJ				Heppner, C; Kester, MB; Agarwal, SK; Debelenko, LV; EmmertBuck, MR; Guru, SC; Manickam, P; Olufemi, SE; Skarulis, MC; Doppman, JL; Alexander, RH; Kim, YS; Saggar, SK; Lubensky, IA; Zhuang, ZP; Liotta, LA; Chandrasekharappa, SC; Collins, FS; Spiegel, AM; Burns, AL; Marx, SJ			Somatic mutation of the MEN1 gene in parathyroid tumours	NATURE GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-1; SUPPRESSOR GENE; TUMORS; CHROMOSOME-11; CARCINOMA; RETINOBLASTOMA; METHYLATION	Primary hyperparathyroidism is a common disorder with an annual incidence of approximately 0.5 in 1,000 (ref. 1), In more than 95% of cases, the disease is caused by sporadic parathyroid adenoma or sporadic hyperplasia. Some cases are caused by inherited syndromes, such as multiple endocrine neoplasia type 1 (MEN1; ref. 2), In most cases, the molecular basis of parathyroid neoplasia is unknown. Parathyroid adenomas are usually monoclonal(3,4), suggesting that one important step in tumour development is a mutation in a progenitor cell, Approximately 30% of sporadic parathyroid tumours show loss of heterozygosity (LOH) for polymorphic markers on 11q13, the site of the MEN1 tumour suppressor gene(4-8). This raises the question of whether such sporadic parathyroid tumours are caused by sequential inactivation of both alleles of the MEN1 gene(9). We recently cloned the MEN1 gene and identified MEN1 germline mutations in fourteen of fifteen kindreds with familial MEN1 (ref. 10). We have studied parathyroid tumours not associated with MEN1 to determine whether somatic mutations in the MEN1 gene are present, Among 33 tumours we found somatic MEN1 gene mutation in 7, while the corresponding MEN1 germline sequence was normal in each patient. All tumours with MEN1 gene mutation showed LOH on 11q13, making the tumour cells hemi- or homozygous for the mutant allele. Thus, somatic MEN1 gene mutation contributes to tumorigenesis in a substantial number of parathyroid tumours not associated with the MEN1 syndrome.	NIDDKD, METAB DIS BRANCH, NIH, BETHESDA, MD 20892 USA; NCI, PATHOL LAB, NIH, BETHESDA, MD 20892 USA; NHGRI, LAB GENE TRANSFER, NIH, BETHESDA, MD 20892 USA; NIH, CTR CLIN, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA; NCI, SURG BRANCH, NIH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Agarwal, Sunita K/D-1428-2016	Agarwal, Sunita K/0000-0002-7557-3191				Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; ARNOLD A, 1994, ENDOCRIN METAB CLIN, V23, P93, DOI 10.1016/S0889-8529(18)30118-X; Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Bright RK, 1997, CANCER RES, V57, P995; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; CRYNS VL, 1994, J CLIN ENDOCR METAB, V78, P1320, DOI 10.1210/jc.78.6.1320; Debelenko LV, 1997, CANCER RES, V57, P2238; Dotzenrath C, 1996, J CLIN ENDOCR METAB, V81, P3194, DOI 10.1210/jc.81.9.3194; EmmertBuck MR, 1997, CANCER RES, V57, P1855; Fain PR, 1996, HUM MOL GENET, V5, P1631, DOI 10.1093/hmg/5.10.1631; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; FRIEDMAN E, 1992, CANCER RES, V52, P6804; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hsi ED, 1996, J CLIN ENDOCR METAB, V81, P1736, DOI 10.1210/jc.81.5.1736; Jakobovitz G, 1996, J CLIN ENDOCR METAB, V81, P3164; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LIDA A, 1995, GENE CHROMOSOME CANC, V12, P73, DOI 10.1002/gcc.2870120114; Lubensky IA, 1996, CANCER RES, V56, P5272; MANICKAM P, IN PRESS HUM GENET; MATSUO K, 1991, MOL ENDOCRINOL, V5, P1873, DOI 10.1210/mend-5-12-1873; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Metz David C., 1994, P591; Pausova Z, 1996, J CLIN ENDOCR METAB, V81, P2711, DOI 10.1210/jc.81.7.2711; Pearce SHS, 1996, CLIN ENDOCRINOL, V45, P195, DOI 10.1046/j.1365-2265.1996.d01-1561.x; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; Tahara H, 1996, J CLIN ENDOCR METAB, V81, P3663, DOI 10.1210/jc.81.10.3663; Tahara H, 1996, CANCER RES, V56, P599; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403	35	338	341	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					375	378		10.1038/ng0897-375	http://dx.doi.org/10.1038/ng0897-375			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241276				2022-12-27	WOS:A1997XM90900021
J	FitzGerald, MG; Bean, JM; Hegde, SR; Unsal, H; MacDonald, DJ; Harkin, DP; Finkelstein, DM; Isselbacher, KJ; Haber, DA				FitzGerald, MG; Bean, JM; Hegde, SR; Unsal, H; MacDonald, DJ; Harkin, DP; Finkelstein, DM; Isselbacher, KJ; Haber, DA			Heterozygous ATM mutations do not contribute to early onset of breast cancer	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA GENE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; NORMAL DONORS; RADIOSENSITIVITY; FAMILIES; LYMPHOCYTES; PRODUCT; PROTEIN; HOMOLOG	Ataxia telangiectasia (AT) is a recessive syndrome, including cerebellar degeneration, immunologic defects and cancer predisposition(1,2), attributed to mutations in the recently isolated ATM (ataxia telangiectasia, mutated) gene(3). AT is diagnosed in 1/40,000 to 1/100,000 live births, with carriers calculated to comprise similar to 1% of the population. Studies of AT families have suggested that female relatives presumed to be carriers have a 5 to 8-fold increased risk for developing breast cancer(4,5), raising the possibility that germline ATM mutations may account for similar to 5% of all breast cancer cases. The increased risk for breast cancer reported for AT family members has been most evident among younger women, leading to an age-specific relative risk model predicting that 8% of breast cancer in women under age 40 arises in AT carriers, compared with 2% of cases between 40-59 years(6). To test this hypothesis, we undertook a germ-line mutational analysis of the ATM gene in a population of women with early onset of breast cancer, using a protein truncation (PTT) assay to detect chain-terminating mutations, which account for 90% of mutations identified in children with AT(7-11). We detected a heterozygous ATM mutation in 2/202 (1%) controls, consistent with the frequency of AT carriers predicted from epidemiologic studies. ATM mutations were present in only 2/401 (0.5%) women with early onset of breast cancer (P = 0.6). We conclude that heterozygous ATM mutations do not confer genetic predisposition to early onset of breast cancer.	MASSACHUSETTS GEN HOSP, CTR CANC, CTR CANC RISK ANAL, CHARLESTOWN, MA 02129 USA; MASSACHUSETTS GEN HOSP, CTR CANC, DEPT BIOSTAT, CHARLESTOWN, MA 02129 USA; HARVARD UNIV, SCH MED, CHARLESTOWN, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University				Bean, James/0000-0001-6733-5794				Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baumer A, 1996, HUM GENET, V98, P246, DOI 10.1007/s004390050202; BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; Byrd PJ, 1996, HUM MOL GENET, V5, P145, DOI 10.1093/hmg/5.1.145; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; EASTON DF, 1994, INT J RADIAT BIOL, V66, pS177, DOI 10.1080/09553009414552011; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Jorgensen TJ, 1996, INT J RADIAT BIOL, V69, P527, DOI 10.1080/095530096145535; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1993, ONCOGENE, V8, P3307; MORRELL D, 1986, J NATL CANCER I, V77, P89; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PIPPARD EC, 1988, CANCER RES, V48, P2929; Ramsay J, 1996, LANCET, V347, P1627, DOI 10.1016/S0140-6736(96)91114-9; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; STINE GJ, 1989, NEW HUMAN GENETICS, P393; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Telatar M, 1996, AM J HUM GENET, V59, P40; Thacker J, 1994, INT J RADIAT BIOL, V66, P587; Vorechovsky I, 1996, CANCER RES, V56, P4130; Vorechovsky I, 1996, CANCER RES, V56, P2726; WEST CML, 1995, INT J RADIAT BIOL, V68, P197, DOI 10.1080/09553009514551101; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	39	271	276	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					307	310		10.1038/ng0397-307	http://dx.doi.org/10.1038/ng0397-307			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054948				2022-12-27	WOS:A1997WK38600025
J	Fleury, C; Neverova, M; Collins, S; Raimbault, S; Champigny, O; LeviMeyrueis, C; Bouillaud, F; Seldin, MF; Surwit, RS; Ricquier, D; Warden, CH				Fleury, C; Neverova, M; Collins, S; Raimbault, S; Champigny, O; LeviMeyrueis, C; Bouillaud, F; Seldin, MF; Surwit, RS; Ricquier, D; Warden, CH			Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia	NATURE GENETICS			English	Article							BROWN ADIPOSE-TISSUE; MOUSE MODEL; LOCI; MITOCHONDRIA; C57BL/6J; WEIGHT; MICE; FAT; THERMOGENESIS; TRANSPORT	A mitochondrial protein called uncoupling protein (UCP1) plays an important role in generating heat and burning calories by creating a pathway that allows dissipation of the proton electrochemical gradient across the inner mitochondrial membrane in brown adipose tissue, without coupling to any other energy-consuming process(1). This pathway has been implicated in the regulation of body temperature, body composition and glucose metabolism(2). However, UCP1-containing brown adipose tissue is unlikely to be involved in weight regulation in adult large-size animals and humans living in a thermoneutral environment (one where an animal does not have to increase expenditure to lose temperature), as there is little brown adipose tissue present(3). We now report the discovery of a gene that codes for a novel uncoupling protein, designated UCP2, which has 59% aminoacid identity to UCP1, and describe properties consistent with a role in diabetes and obesity. In comparison with UCP1, UCP2 has a greater effect on mitochondrial membrane potential when expressed in yeast. Compared to UCP1, the gene is widely expressed in adult human tissues, including tissues rich in macrophages, and it is upregulated in white fat in response to fat feeding. Finally, UCP2 maps to regions of human chromosome 11 and mouse chromosome 7 that have been linked to hyperinsulinaemia and obesity. Our findings suggest that UCP2 has a unique role in energy balance, body weight regulation and thermoregulation and their responses to inflammatory stimuli.	UNIV CALIF DAVIS, DEPT PEDIAT, ROWE PROGRAM GENET, DAVIS, CA 95616 USA; UNIV CALIF DAVIS, DEPT BIOL CHEM, DAVIS, CA 95616 USA; UNIV CALIF DAVIS, DEPT MED, DAVIS, CA 95616 USA; CNRS, CEREMOD, F-92190 MEUDON, FRANCE; DUKE UNIV, MED CTR, DEPT PSYCHIAT & BEHAV SCI, SARAH STEDMAN NUTR CTR, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT PHARMACOL, DURHAM, NC 27710 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); Duke University; Duke University			Bouillaud, Frédéric R/L-3238-2017	Bouillaud, Frédéric R/0000-0002-7518-9237	NHGRI NIH HHS [HG00734] Funding Source: Medline; NIDDK NIH HHS [DK 35747, DK 52581] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052581, P30DK035747] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOUILLAUD F, 1994, EMBO J, V13, P1990, DOI 10.1002/j.1460-2075.1994.tb06468.x; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Brownlow BS, 1996, PHYSIOL BEHAV, V60, P37, DOI 10.1016/0031-9384(95)02210-4; BRUSTOVETSKY N, 1994, J BIOL CHEM, V269, P27329; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; COLLINS AC, 1993, MAMM GENOME, V4, P454, DOI 10.1007/BF00296821; DESSRY RW, 1996, GENOMICS, V33, P337; DIOLEZ P, 1994, 8 EUR BIOEN C VAL SP; DRAGANI TA, 1995, MAMM GENOME, V6, P778, DOI 10.1007/BF00539002; GARRUTI G, 1992, INT J OBESITY, V16, P383; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; HORVAT S, 1995, GENETICS, V139, P1737; NEDERGAARD J, 1992, NEW COMPREHENSIVE BI, V23, P385; NEEL JV, 1962, AM J HUM GENET, V14, P353; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; OPPERT JM, 1994, INT J OBESITY, V18, P526; PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; PRIETO S, 1992, EUR J BIOCHEM, V208, P487, DOI 10.1111/j.1432-1033.1992.tb17212.x; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; SELDIN MF, 1994, J CLIN INVEST, V94, P269, DOI 10.1172/JCI117317; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; VERCESI AE, 1995, NATURE, V375, P24, DOI 10.1038/375024a0; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; WATSON ML, 1992, MAMM GENOME, V2, P158, DOI 10.1007/BF00302874; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477	29	1458	1536	1	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					269	272		10.1038/ng0397-269	http://dx.doi.org/10.1038/ng0397-269			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054939				2022-12-27	WOS:A1997WK38600016
J	Gayther, SA; Mangion, J; Russell, P; Seal, S; Barfoot, R; Ponder, BAJ; Stratton, MR; Easton, D				Gayther, SA; Mangion, J; Russell, P; Seal, S; Barfoot, R; Ponder, BAJ; Stratton, MR; Easton, D			Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENE; APC GENE; POLYPOSIS; PHENOTYPE	The breast cancer susceptibility gene BRCA2 on chromosome 13q12-13 has recently been identified(1). Germline mutations of BRCA2 are predicted to account for approximately 35% of families with multiple case, early onset female breast cancer, and they are also associated with an increased risk of male breast cancer, ovarian cancer, prostate cancer and pancreatic cancer(2-4). Germline mutations of a second cancer susceptibility gene BRCA1 (ref. 5), are associated with a strong predisposition to ovarian cancer as well as female breast cancer(6). Recent studies have suggested that the phenotype in BRCA1 families with respect to the ratio of breast to ovarian cancer varies with the location of the BRCA1 mutation(7,8). To determine whether germline mutations in BRCA2 are associated with a similar variation in phenotypic risk, we have analysed the distribution of mutations in 25 families with multiple cases of breast and/or ovarian cancer ascertained in the United Kingdom and fire. These mutations all lead to premature truncation of BRCA2 as a result of frameshift deletions/insertions or nonsense mutations. Analysis of the mutation distribution along the length of the gene indicates a significant genotype-phenotype correlation. Truncating mutations in families with the highest risk of ovarian cancer relative to breast cancer are clustered in a region of approximately 3.3 kb in exon 11 (P=0.0004). Published data on mutations in 45 other BRCA2-linked families provide support for this correlation.	INST CANC RES,HADDOW LABS,SECT MOL CARCINOGENESIS,SUTTON SM2 5NG,SURREY,ENGLAND; UNIV FORVIE SITE,INST PUBL HLTH,CRC,GENET EPIDEMIOL GRP,CAMBRIDGE CB2 2SR,ENGLAND	University of London; Institute of Cancer Research - UK; University of Cambridge	Gayther, SA (corresponding author), ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,HILLS RD,BOX 238,CAMBRIDGE CB2 2QQ,ENGLAND.							Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P718; GAYTHER SA, 1994, HUM MOL GENET, V3, P53, DOI 10.1093/hmg/3.1.53; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAGASE H, 1992, CANCER RES, V52, P4055; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	16	352	358	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					103	105		10.1038/ng0197-103	http://dx.doi.org/10.1038/ng0197-103			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988179				2022-12-27	WOS:A1997WA37300031
J	Cheung, MC; Goldberg, JD; Kan, YW				Cheung, MC; Goldberg, JD; Kan, YW			Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood	NATURE GENETICS			English	Article							BETA-THALASSEMIA MUTATIONS; ALPHA-THALASSEMIA; ENZYMATIC AMPLIFICATION; NUCLEATED ERYTHROCYTES; GENE DELETION; DNA; HEMOGLOBIN; SAMPLES; SEQUENCES; ANEMIA	Currently, amniocentesis, chorionic villus sampling (CVS) and fetal blood sampling are used to obtain fetal cells for genetic diagnosis. These invasive procedures pose a small but not negligible risk for the fetus. Efforts have been directed towards the enrichment of fetal cells, such as erythroblasts, from maternal blood and progress has been made in the diagnosis of some chromosomal disorders and in sex determinations. We now report the detection of point mutations in single gene disorders using this method of prenatal diagnosis by enriching fetal cells from maternal blood by magnetic cell sorting followed by isolation of pure fetal cells by microdissection. In two pregnancies at risk for sickle cell anaemia and beta-thalassaemia, we successfully identified the fetal genotypes. Thus, prenatal diagnosis of single gene disorders by recovering fetal cells from maternal circulation appears to be a feasible approach.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET & GYNAECOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIDDK NIH HHS [DK16666] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016666, R01DK016666] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADINOLFI M, 1995, PRENATAL DIAG, V15, P889, DOI 10.1002/pd.1970151003; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BIANCHI DW, 1993, PRENATAL DIAG, V13, P293, DOI 10.1002/pd.1970130408; Bianchi DW, 1996, PRENATAL DIAG, V16, P289, DOI 10.1002/(SICI)1097-0223(199604)16:4<289::AID-PD843>3.3.CO;2-K; BIANCHI DW, 1995, J PEDIATR-US, V127, P847, DOI 10.1016/S0022-3476(95)70018-8; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; BUSCH J, 1994, PRENATAL DIAG, V14, P1129, DOI 10.1002/pd.1970141206; CAI SP, 1994, HUM MUTAT, V3, P59, DOI 10.1002/humu.1380030110; CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHEHAB FF, 1995, PCR STRATEGIES, P30; DELHANTY J, 1995, PRENATAL DIAG, V15, P943, DOI 10.1002/pd.1970151009; DOZY AM, 1979, JAMA-J AM MED ASSOC, V241, P1610, DOI 10.1001/jama.241.15.1610; EVANS MI, 1989, AM J OBSTET GYNECOL, V160, P1332, DOI 10.1016/0002-9378(89)90852-1; GANSHIRTAHLERT D, 1992, AM J OBSTET GYNECOL, V166, P1350; GANSHIRTAHLERT D, 1993, AM J REPROD IMMUNOL, V30, P194; GEIFMANHOLTZMAN O, 1995, PRENATAL DIAG, V15, P261, DOI 10.1002/pd.1970150309; HAWES C, 1994, ANN NY ACAD SCI, V731, P217; HERZENBERG LA, 1979, P NATL ACAD SCI USA, V76, P1453, DOI 10.1073/pnas.76.3.1453; KAN YW, 1976, NEW ENGL J MED, V295, P1165, DOI 10.1056/NEJM197611182952104; KAN YW, 1976, NEW ENGL J MED, V294, P1039, DOI 10.1056/NEJM197605062941905; KAN YW, 1975, NEW ENGL J MED, V292, P1096, DOI 10.1056/NEJM197505222922104; MAGGIO A, 1993, BLOOD, V81, P239; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; OTTOLENGHI S, 1974, NATURE, V251, P389, DOI 10.1038/251389a0; PIRASTU M, 1983, NEW ENGL J MED, V309, P284, DOI 10.1056/NEJM198308043090506; PRICE JO, 1991, AM J OBSTET GYNECOL, V165, P1731, DOI 10.1016/0002-9378(91)90024-L; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHRODER J, 1974, TRANSPLANTATION, V17, P346, DOI 10.1097/00007890-197404000-00003; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; TAYLOR JM, 1974, NATURE, V251, P392, DOI 10.1038/251392a0; THOMAS MR, 1995, PRENATAL DIAG, V15, P641, DOI 10.1002/pd.1970150709; TUTSCHEK B, 1995, PRENATAL DIAG, V15, P951, DOI 10.1002/pd.1970151010; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; ZHENG YL, 1995, PRENATAL DIAG, V15, P897, DOI 10.1002/pd.1970151004; ZHENG YL, 1993, J MED GENET, V30, P1051, DOI 10.1136/jmg.30.12.1051	36	200	232	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					264	268		10.1038/ng1196-264	http://dx.doi.org/10.1038/ng1196-264			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896554				2022-12-27	WOS:A1996VQ14600019
J	Roessler, E; Belloni, E; Gaudenz, K; Jay, P; Berta, P; Scherer, SW; Tsui, LC; Muenke, M				Roessler, E; Belloni, E; Gaudenz, K; Jay, P; Berta, P; Scherer, SW; Tsui, LC; Muenke, M			Mutations in the human Sonic hedgehog gene cause holoprosencephaly	NATURE GENETICS			English	Article							TERMINAL CLEAVAGE PRODUCT; CENTRAL-NERVOUS-SYSTEM; CRITICAL REGION; FLOOR PLATE; POLARIZING ACTIVITY; DROSOPHILA; INDUCTION; PERSPECTIVES; EXPRESSION; DIFFERENTIATION		UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DIV HUMAN GENET & MOL BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; CTR RECH BIOCHIM MACROMOL,CNRS ERS 155,INSERM,U249,F-34033 MONTPELLIER,FRANCE	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier			belloni, elena/H-9909-2013; Tsui, Lap-chee/A-1081-2010; Scherer, Stephen W./B-3785-2013; Jay, Philippe/I-7116-2016; Jay, Philippe/ABD-9223-2020	Scherer, Stephen W./0000-0002-8326-1999; Jay, Philippe/0000-0003-0156-5700; Jay, Philippe/0000-0003-0156-5700; Muenke, Maximilian/0000-0002-7719-6545; Belloni, Elena/0000-0003-3214-0780	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029862, R29HD028732, T32HD007107] Funding Source: NIH RePORTER; NICHD NIH HHS [R01HD29862, 5T32HD07107, R29HD28732] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARDINGER HH, 1988, J CRAN GENET DEV BIO, V8, P53; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; COHEN MM, 1992, J CRAN GENET DEV BIO, V12, P196; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; COHEN MM, 1989, AM J MED GENET, V34, P271, DOI 10.1002/ajmg.1320340232; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EKKER SC, 1995, DEVELOPMENT, V121, P2337; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; FIETZ MJ, 1995, CURR BIOL, V5, P643, DOI 10.1016/S0960-9822(95)00129-1; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; JOHNSON VP, 1989, AM J MED GENET, V34, P258, DOI 10.1002/ajmg.1320340228; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LYNCH SA, 1995, NAT GENET, V11, P93, DOI 10.1038/ng0995-93; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; MUENKE M, 1995, AM J HUM GENET, V57, P1074; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Muenke Maximilian, 1994, Seminars in Developmental Biology, V5, P293, DOI 10.1006/sedb.1994.1038; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Schell U, 1996, HUM MOL GENET, V5, P223, DOI 10.1093/hmg/5.2.223; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8	37	873	897	0	63	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					357	360		10.1038/ng1196-357	http://dx.doi.org/10.1038/ng1196-357			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896572				2022-12-27	WOS:A1996VQ14600037
J	Vrana, PB; Guan, XJ; Ingram, RS; Tilghman, SM				Vrana, PB; Guan, XJ; Ingram, RS; Tilghman, SM			Genomic imprinting is disrupted in interspecific Peromyscus hybrids	NATURE GENETICS			English	Article							GENE; LOCUS; REGION	Genomic imprinting, the unequal expression of gene alleles on the basis of parent of origin, is a major exception to mendelian laws of inheritance(1). By maintaining one allele of a gene in a silent state, imprinted genes discard the advantages of diploidy. and for this reason the rationale for the evolution of imprinting has been debated(2). One explanation is the parent-offspring conflict model, which proposes that imprinting arose in polyandrous mammals as the result of a parental conflict over the allocation of maternal resources to embryos(3). This theory predicts that there should be no selection for imprinting in a monogamous species. Crosses between the monogamous rodent species Peromyscus polionotus and the polyandrous Peromyscus maniculatus yield progeny with parent-of-origin growth defects that could be explained if imprinting was absent in the monogamous species(4). We find. however, that imprinting is maintained in P. polionotus, but there is widespread disruption of imprinting in the hybrids. We suggest that the signals governing genomic imprinting are rapidly evolving and that disruptions in the process may contribute to mammalian speciation.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Tilghman, SM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.				NIGMS NIH HHS [GM51460] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051460] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BIRDSALL DA, 1973, EVOLUTION, V27, P106, DOI 10.1111/j.1558-5646.1973.tb05922.x; BLAIR WF, 1950, EVOLUTION, V4, P253, DOI 10.2307/2405335; DAWSON WD, 1965, EVOLUTION, V19, P44, DOI 10.2307/2406294; DAWSON WD, 1993, GROWTH DEVELOP AGING, V57, P121; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FOLTZ DW, 1981, AM NAT, V117, P665, DOI 10.1086/283751; Gray A. P., 1972, MAMMALIAN HYBRIDS; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HAIG D, 1992, SEMIN DEV BIOL, V3, P153; Hu JF, 1998, MOL ENDOCRINOL, V12, P220, DOI 10.1210/me.12.2.220; Hurst L. D., 1997, GENOMIC IMPRINTING, P211; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Miyoshi N, 1998, P NATL ACAD SCI USA, V95, P1102, DOI 10.1073/pnas.95.3.1102; Mochizuki A, 1996, GENETICS, V144, P1283; SMRZKA OW, 1995, HUM MOL GENET, V4, P1945, DOI 10.1093/hmg/4.10.1945; THORVALDSON JL, IN PRESS GENES DEV; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Zechner U, 1996, NAT GENET, V12, P398, DOI 10.1038/ng0496-398	28	154	155	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					362	365		10.1038/3833	http://dx.doi.org/10.1038/3833			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843208				2022-12-27	WOS:000077199600023
J	Zhang, YM; Buchholz, F; Muyrers, JPP; Stewart, AF				Zhang, YM; Buchholz, F; Muyrers, JPP; Stewart, AF			A new logic for DNA engineering using recombination in Escherichia coli	NATURE GENETICS			English	Article							SITE-SPECIFIC RECOMBINATION; STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION; IN-VIVO; BACTERIOPHAGE-LAMBDA; RECT PROTEIN; GENE; CONSTRUCTION; FRAGMENTS; CLONING	A straightforward way to engineer DNA in E. coli using homologous recombination is described. The homologous recombination reaction uses RecE and RecT and is transferable between E. coli strains. Several target molecules were manipulated, including high copy plasmids, a large episome and the E. coli chromosome. Sequential steps of homologous or site-specific recombination were used to demonstrate a new logic for engineering DNA, unlimited by the disposition of restriction endonuclease cleavage sites or the size of the target DNA.	European Mol Biol Lab, Gene Express Program, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Stewart, AF (corresponding author), European Mol Biol Lab, Gene Express Program, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Buchholz, Frank/B-4700-2017; Stewart, A. Francis/E-7789-2010	Buchholz, Frank/0000-0002-4577-3344; 				BARBOUR SD, 1970, P NATL ACAD SCI USA, V67, P128, DOI 10.1073/pnas.67.1.128; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CLARK AJ, 1984, COLD SPRING HARB SYM, V49, P453, DOI 10.1101/SQB.1984.049.01.051; CLARK AJ, 1994, J BACTERIOL, V176, P7024, DOI 10.1128/JB.176.22.7024-7031.1994; CLARK AJ, 1974, GENETICS, V78, P259; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; COLLINS J, 1978, P NATL ACAD SCI USA, V75, P4242, DOI 10.1073/pnas.75.9.4242; Crouzet J, 1997, P NATL ACAD SCI USA, V94, P1414, DOI 10.1073/pnas.94.4.1414; Dabert P, 1997, GENETICS, V145, P877; Degryse E, 1996, GENE, V170, P45, DOI 10.1016/0378-1119(95)00858-6; HALL SD, 1994, P NATL ACAD SCI USA, V91, P3205, DOI 10.1073/pnas.91.8.3205; HALL SD, 1993, J BACTERIOL, V175, P277, DOI 10.1128/JB.175.1.277-287.1993; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HASHIMOTOGOTOH T, 1977, J BACTERIOL, V131, P405, DOI 10.1128/JB.131.2.405-412.1977; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JASIN M, 1984, J BACTERIOL, V159, P783, DOI 10.1128/JB.159.2.783-786.1984; Jessen JR, 1998, P NATL ACAD SCI USA, V95, P5121, DOI 10.1073/pnas.95.9.5121; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; KOLODNER R, 1994, MOL MICROBIOL, V11, P23, DOI 10.1111/j.1365-2958.1994.tb00286.x; KUSANO K, 1994, GENE, V138, P17; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; LUISIDELUCA C, 1992, J MOL BIOL, V227, P72, DOI 10.1016/0022-2836(92)90682-A; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; MUNIYAPPA K, 1986, J BIOL CHEM, V261, P7472; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Newton C.R., 1997, PCR; Noirot P, 1998, J BIOL CHEM, V273, P12274, DOI 10.1074/jbc.273.20.12274; OCONNOR M, 1989, SCIENCE, V244, P1307, DOI 10.1126/science.2660262; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; RESNICK MA, 1976, J THEOR BIOL, V59, P97, DOI 10.1016/S0022-5193(76)80025-2; RUSSELL CB, 1989, J BACTERIOL, V171, P2609, DOI 10.1128/jb.171.5.2609-2613.1989; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	49	884	1090	18	215	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					123	128		10.1038/2417	http://dx.doi.org/10.1038/2417			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771703				2022-12-27	WOS:000076231300012
J	Reiss, J; Cohen, N; Dorche, C; Mandel, H; Mendel, RR; Stallmeyer, B; Zabot, MT; Dierks, T				Reiss, J; Cohen, N; Dorche, C; Mandel, H; Mendel, RR; Stallmeyer, B; Zabot, MT; Dierks, T			Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; EARLY STEPS; BIOSYNTHESIS; MOLYBDOPTERIN; COMPLEMENTATION; REINITIATION; PROTEIN; LENGTH	All molybdoenzymes other than nitrogenase require molyb-dopterin as a metal-binding cofactor(1). Several genes necessary for the synthesis of the molybdenum cofactor (MoCo) have been characterized in bacteria(2,3) and plants(4). The proteins encoded by the Escherichia coli genes moaA and moaC catalyse the first steps in MoCo synthesis. The human homologues of these genes are therefore candidate genes for molybdenum cofactor deficiency, a rare and fatal disease(5). Using oligonucleotides complementary to a conserved region in the moaA gene, we have isolated a human cDNA derived from liver mRNA. This transcript contains an open reading frame (ORF) encoding the human moaA homologue and a second ORF encoding a human moaC homologue. Mutations can be found in the majority of MoCo-deficient patients that confirm the functional role of both ORFs in the corresponding gene MOCS1 (for 'molybdenum cofactor synthesis-step 1'). Northern-blot analysis detected only full-length transcripts containing both consecutive ORFs in various human tissues. The mRNA structure suggests a translation reinitiation mechanism for the second ORF, These data indicate the existence of a eukaryotic mRNA, which as a single and uniform transcript guides the synthesis of two different enzymatic polypeptides with disease-causing potential.	Univ Gottingen, Inst Humangenet, D-37073 Gottingen, Germany; Univ Gottingen, Biochem Abt 2, D-37073 Gottingen, Germany; Technion Israel Inst Technol, Dept Genet, Tamkin Human Mol Genet Res Facil, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Rambam Med Ctr, Dept Pediat, IL-31096 Haifa, Israel; Hop Debrousse, Serv Biochim, F-69322 Lyon 05, France; Tech Univ Braunschweig, Inst Bot, D-38106 Braunschweig, Germany	University of Gottingen; University of Gottingen; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; CHU Lyon; Braunschweig University of Technology	Reiss, J (corresponding author), Univ Gottingen, Inst Humangenet, Gosslerstr 12D, D-37073 Gottingen, Germany.		Dierks, Thomas/A-3596-2012; Stallmeyer, Birgit/AAE-3020-2020	Dierks, Thomas/0000-0001-6426-1339; 				BOUHIDEL K, 1994, NUCLEIC ACIDS RES, V22, P2370, DOI 10.1093/nar/22.12.2370; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; HOFF T, 1995, J BIOL CHEM, V270, P6100, DOI 10.1074/jbc.270.11.6100; IRBY RB, 1994, J BIOL CHEM, V269, P23981; Johnson J.L, 1995, METABOLIC MOL BASES, V7th edition., P2271, DOI [10.1016/0168-9525(96)81407-7, DOI 10.1016/0168-9525(96)81407-7]; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Menendez C, 1996, FEBS LETT, V391, P101, DOI 10.1016/0014-5793(96)00712-0; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; REISS J, 1987, MOL GEN GENET, V206, P352, DOI 10.1007/BF00333594; RIVERS SL, 1993, MOL MICROBIOL, V8, P1071, DOI 10.1111/j.1365-2958.1993.tb01652.x; Shalata A, 1998, AM J HUM GENET, V63, P148, DOI 10.1086/301916; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082	17	94	95	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					51	53		10.1038/1706	http://dx.doi.org/10.1038/1706			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731530				2022-12-27	WOS:000075671400018
J	Honda, H; Oda, H; Nakamoto, T; Honda, Z; Sakai, R; Suzuki, T; Saito, T; Nakamura, K; Nakao, K; Ishikawa, T; Katsuki, M; Yazaki, Y; Hirai, H				Honda, H; Oda, H; Nakamoto, T; Honda, Z; Sakai, R; Suzuki, T; Saito, T; Nakamura, K; Nakao, K; Ishikawa, T; Katsuki, M; Yazaki, Y; Hirai, H			Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130(Cas)	NATURE GENETICS			English	Article							CRK-ASSOCIATED SUBSTRATE; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODIES; CELL-TRANSFORMATION; STABLE ASSOCIATION; PROTEINS; GROWTH; MOLECULE; P130; DISRUPTION	p130(Cas) (Cas), the protein encoded by the Crkas gene (also known as Gas), is an adaptor molecule with a unique structure that contains a Src homology (SH)-3 domain followed by multiple YXXP motifs and a proline-rich region(1). Cas was originally cloned as a highly tyrosine-phosphorylated protein in cells transformed by v-Src (refs 2,3) or v-Crk (ref, 4) and has subsequently been implicated in a variety of biological processes including cell adhesion(5), cell migration(6), growth factor stimulation(7-9), cytokine receptor engagement(10,11) and bacterial infection(12,13). To determine its role in vivo, we generated mice lacking Gas. Cas-deficient embryos died in utero showing marked systemic congestion and growth retardation. Histologically, the heart was poorly developed and blood vessels were prominently dilated. Electron microscopic analysis of the heart revealed disorganization of myofibrils and disruption of Z-disks. In addition, actin stress fiber formation was severely impaired in Cas-deficient primary fibroblasts. Moreover, expression of activated Src in Cas-deficient primary fibroblasts did not induce a fully transformed phenotype, possibly owing to insufficient accumulation of actin cytoskeleton in podosomes. These findings have defined Cas function in cardiovascular development, actin filament assembly and Src-induced transformation.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Internal Med & Phys Therapy, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Inst Med Sci, Dept DNA Embryol, Minato Ku, Tokyo 108, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Hirai, H (corresponding author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.			Sakai, Ryuichi/0000-0001-6833-1103; zhong wei, he gui/0000-0002-3066-3564				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Casamassima A, 1997, J BIOL CHEM, V272, P9363; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ingham RJ, 1996, J BIOL CHEM, V271, P32306, DOI 10.1074/jbc.271.50.32306; Ishino M, 1995, ONCOGENE, V11, P2331; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; KWEE L, 1995, DEVELOPMENT, V121, P489; Law SF, 1996, MOL CELL BIOL, V16, P3327; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Ojaniemi M, 1997, J BIOL CHEM, V272, P25993, DOI 10.1074/jbc.272.41.25993; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SANGER JW, 1984, J CELL BIOL, V98, P825, DOI 10.1083/jcb.98.3.825; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	30	303	304	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					361	365		10.1038/1246	http://dx.doi.org/10.1038/1246			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697697				2022-12-27	WOS:000075107600019
J	Petrukhin, K; Koisti, MJ; Bakall, B; Li, W; Xie, GC; Marknell, T; Sandgren, O; Forsman, K; Holmgren, G; Andreasson, S; Vujic, M; Bergen, AAB; McGarty-Dugan, V; Figueroa, D; Austin, CP; Metzker, ML; Caskey, CT; Wadelius, C				Petrukhin, K; Koisti, MJ; Bakall, B; Li, W; Xie, GC; Marknell, T; Sandgren, O; Forsman, K; Holmgren, G; Andreasson, S; Vujic, M; Bergen, AAB; McGarty-Dugan, V; Figueroa, D; Austin, CP; Metzker, ML; Caskey, CT; Wadelius, C			Identification of the gene responsible for Best macular dystrophy	NATURE GENETICS			English	Article							RETINAL-PIGMENT EPITHELIUM; FIBROBLAST GROWTH-FACTOR; MESSENGER-RNA; ANTISENSE; LIPOFUSCIN; DEGENERATION; LINKAGE; OOCYTES; CELLS	Best macular dystrophy (BMD). also known as vitelliform macular dystrophy (VMD2; OMIM 153700), is an autosomal dominant form of macular degeneration characterized by an abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. In pursuit of the disease gene, we limited the minimum genetic region by recombination breakpoint analysis and mapped to this region a novel retina-specific gene (VMD2). Genetic mapping data, identification of five independent disease-specific mutations and expression studies provide evidence that mutations within the candidate gene are a cause of BMD. The 3' UTR of the candidate gene contains a region of antisense complementarity to the 3' UTR of the ferritin heavy-chain gene (FTH1), indicating the possibility of antisense interaction between VMD2 and FTH1 transcripts.	Merck Res Labs, Dept Human Genet, West Point, PA 19486 USA; Merck Res Labs, Dept Bioinformat, West Point, PA 19486 USA; Univ Uppsala Hosp, Dept Genet & Pathol, Clin Genet Unit, S-75185 Uppsala, Sweden; Umea Univ Hosp, Dept Clin Genet, S-90185 Umea, Sweden; Umea Univ Hosp, Dept Ophthalmol, S-90185 Umea, Sweden; Univ Lund Hosp, Dept Ophthalmol, S-22185 Lund, Sweden; East Hosp, Dept Clin Genet, S-41685 Gothenburg, Sweden; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands	Merck & Company; Merck & Company; Uppsala University; Uppsala University Hospital; Umea University; Umea University; Lund University; Skane University Hospital; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Petrukhin, K (corresponding author), Merck Res Labs, Dept Human Genet, West Point, PA 19486 USA.	konstantin_petrukhin@merck.com; Claes.Wadelius@klingen.uu.se	Bergen, Arthur/J-3637-2013	Petrukhin, Konstantin/0000-0002-5545-6924; Bergen, Arthur/0000-0002-6333-9576				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Batshake B, 1996, BIOCHEM BIOPH RES CO, V227, P70, DOI 10.1006/bbrc.1996.1469; BAZAN NG, 1994, WORLD REV NUTR DIET, V75, P120; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Cooper PR, 1997, GENOMICS, V41, P185, DOI 10.1006/geno.1997.4660; CROSS HE, 1974, AM J OPHTHALMOL, V77, P46, DOI 10.1016/0002-9394(74)90603-5; DHAR M, 1993, GENE, V126, P275, DOI 10.1016/0378-1119(93)90380-L; Dryja T. P., 1998, SCIENCE, V279; Eldred GE, 1995, GERONTOLOGY, V41, P15; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FORSMAN K, 1992, CLIN GENET, V42, P156; GODEL V, 1986, Acta Ophthalmologica Supplementum, V175, P1; GRAFF C, 1994, GENOMICS, V24, P425, DOI 10.1006/geno.1994.1648; Graff C, 1997, HUM GENET, V101, P263, DOI 10.1007/s004390050627; HILDEBRANDT M, 1992, CELL, V69, P197, DOI 10.1016/0092-8674(92)90130-5; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; KATZ ML, 1993, INVEST OPHTH VIS SCI, V34, P3161; KATZ ML, 1994, INVEST OPHTH VIS SCI, V35, P3613; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; KIMELMAN D, 1989, CELL, V59, P687, DOI 10.1016/0092-8674(89)90015-9; KNEE RS, 1994, BIOCHEM BIOPH RES CO, V205, P577, DOI 10.1006/bbrc.1994.2704; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LEIBOWITZ HM, 1980, SURV OPHTHALMOL S, V24, P428; NORDSTROM S, 1976, HEREDITAS, V84, P163; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; Swalla BJ, 1996, DEV BIOL, V178, P23, DOI 10.1006/dbio.1996.0195	32	518	543	3	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					241	247		10.1038/915	http://dx.doi.org/10.1038/915			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662395				2022-12-27	WOS:000074565900018
J	Phylactou, LA; Darrah, C; Wood, MJA				Phylactou, LA; Darrah, C; Wood, MJA			Ribozyme-mediated trans-splicing of a trinucleotide repeat	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; MESSENGER-RNA; CTG REPEAT; EXPANSION; TETRAHYMENA; EXPRESSION; SEQUENCE; MYOPATHY; DISEASE; INVITRO	Trinucleotide repeat expansions (TREs) are a recently described class of mutations characterized by a change in the size of the genomic fragment due to amplification of the repeated unit. A number of diseases have been attributed to TRE, including Huntington disease and myotonic dystrophy (DM; refs 1-3), but attempts at genetic therapy have yet to prove successful. A potential therapeutic approach would be to repair the expanded repeat using the trans-splicing ability of group I intron ribozymes(4). We have used DM as a model to test this hypothesis. A group I intron ribozyme (DMPK-RZ1) was designed to modify the TRE at the 3' end of the human myotonic dystrophy protein kinase (DMPK) transcript(5-8). DMPK-RZ1 was shown to ligate a small DMPK mRNA fragment, contained within the ribozyme, to a simple DMPK-target RNA in vitro. It also modified a larger target transcript, leading to replacement of twelve repeats with five repeats, both in vitro and in mammalian cells. Finally, this ribozyme successfully replaced the 3' end of endogenous DMPK mRNA in fibroblasts with a different 3' region. Ribozyme-mediated RNA repair may thus form a novel therapeutic strategy for diseases associated with repeat expansions.	Univ Oxford, Dept Human Anat, Oxford OX1 3QX, England	University of Oxford	Phylactou, LA (corresponding author), Univ Oxford, Dept Human Anat, S Parks Rd, Oxford OX1 3QX, England.	leonidas.phylactou@anat.ox.ac.uk	Wood, Matthew/HDN-1469-2022	Wood, Matthew/0000-0002-5436-6011				Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; DAVIES KE, 1983, J MED GENET, V20, P259, DOI 10.1136/jmg.20.4.259; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; Hamshere MG, 1996, TRENDS GENET, V12, P332, DOI 10.1016/S0168-9525(96)80002-3; Harper P.S., 1989, MYOTONIC DYSTROPHY; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; JOHNSON KJ, 1996, BIOCHEM SOC T, V54, P510; Jones JT, 1996, NAT MED, V2, P643, DOI 10.1038/nm0696-643; KIEHNTOPF M, 1995, LANCET, V345, P1027, DOI 10.1016/S0140-6736(95)90762-9; Kilpatrick MW, 1996, HUM MOL GENET, V5, P1939, DOI 10.1093/hmg/5.12.1939; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Ohta Y, 1996, NUCLEIC ACIDS RES, V24, P938, DOI 10.1093/nar/24.5.938; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; ROSSI JJ, 1995, TRENDS BIOTECHNOL, V13, P301, DOI 10.1016/S0167-7799(00)88969-6; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; Shelbourne Peggy, 1992, Human Mutation, V1, P183, DOI 10.1002/humu.1380010302; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; Timchenko LT, 1996, FASEB J, V10, P1589, DOI 10.1096/fasebj.10.14.9002550; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; YOUNG B, 1991, CELL, V67, P1007, DOI 10.1016/0092-8674(91)90373-7	30	115	126	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					378	381		10.1038/ng0498-378	http://dx.doi.org/10.1038/ng0498-378			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537423				2022-12-27	WOS:000072755500023
J	Firulli, AB; McFadden, DG; Lin, Q; Srivastava, D; Olson, EN				Firulli, AB; McFadden, DG; Lin, Q; Srivastava, D; Olson, EN			Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1	NATURE GENETICS			English	Article							NEURAL CREST DERIVATIVES; GENE; EXPRESSION; PROTEINS	The basic helix-loop-helix (bHLH) transcription factors, Hand1 and Hand2 (refs 1,2), also called eHand/Hxt/Thing1 and dHand/Hed/Thing2 (refs 3,4), respectively, are expressed in the heart and certain neural-crest derivatives during embryogenesis. In addition, Hand1 is expressed in extraembryonic membranes, whereas Hand2 is expressed in the deciduum. Previous studies have demonstrated that Hand2 is required for formation of the right ventricle of the heart and the aortic arch arteries(5). We have generated a germline mutation in the mouse Hand1 gene by replacing the first coding exon with a beta-galactosidase reporter gene. Embryos homozygous for the Hand1 null allele died between embryonic days 8.5 and 9.5 and exhibited yolk sac abnormalities due to a deficiency in extraembryonic mesoderm, Heart development was also perturbed and did not progress beyond the cardiac-looping stage. Our results demonstrate important roles for Hand1 in extraembryonic mesodermal and heart development.	Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.			/0000-0001-6687-8949	NHLBI NIH HHS [R01 HL061677, R01 HL061677-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061677] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; BARTH J, 1994, BIOTECHNIQUES, V17, P326; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; NG YK, 1994, DEVELOPMENT, V120, P3257; OBRIEN TX, 1993, P NATL ACAD SCI USA, V90, P5157, DOI 10.1073/pnas.90.11.5157; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154	16	292	301	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					266	270		10.1038/ng0398-266	http://dx.doi.org/10.1038/ng0398-266			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500550				2022-12-27	WOS:000072325000026
J	Peters, JM; Barnes, R; Bennett, L; Gitomer, WM; Bowcock, AM; Garg, A				Peters, JM; Barnes, R; Bennett, L; Gitomer, WM; Bowcock, AM; Garg, A			Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; EXTREMITIES; RECEPTOR; HUMANS; ARNT	Obesity is strongly implicated in the pathophysiology of insulin resistance, diabetes mellitus and dyslipidemia(1-3). The mechanisms, however, by which obesity causes these complications are not known, The study of single-gene disorders affecting adipose tissue may elucidate some of the mechanisms involved in these processes. Familial partial lipodystrophy, Dunnigan variety, (FPLD, OMIM 308980) is an autosomal-dominant condition characterized by marked loss of subcutaneous adipose tissue affecting the trunk and extremities but with excess fat deposition in the head and neck areas(4-14). Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus, dyslipidemia and acanthosis nigricans(4-14). The genetic basis of FPLD is unknown. We carried out a genome-wide scan with a set of highly polymorphic short tandem-repeats (STR) in individuals from five well-characterized pedigrees and mapped the FPLD locus to chromosome 1q21-22. The maximum two-point lod score obtained with a highly polymorphic microsatellite at D1S2624 at theta(max) = 0 was 5.84. Multipoint-linkage analysis yielded a peak lod score of 8.25 between D1S305 and D1S1600. There was no evidence for genetic heterogeneity (alpha=1) in the pedigrees.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Mineral Metab, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garg, A (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA.			Bennett, Lynda/0000-0001-7491-5797; Bowcock, Anne/0000-0001-8691-9090	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00633] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BURN J, 1986, J MED GENET, V23, P128, DOI 10.1136/jmg.23.2.128; DAVIDSON MB, 1975, DIABETOLOGIA, V11, P561, DOI 10.1007/BF01222107; DeFronzo RA, 1997, NETH J MED, V50, P191, DOI 10.1016/S0300-2977(97)00012-0; DUNNIGAN MG, 1974, Q J MED, V49, P33; FEDER J, 1985, AM J HUM GENET, V37, P635; Flagiello D, 1997, CYTOGENET CELL GENET, V76, P17, DOI 10.1159/000134502; HOOK B, 1984, HAUTARZT, V35, P530; Jackson SNJ, 1997, QJM-INT J MED, V90, P27; JOHNSON B, 1993, GENOMICS, V17, P592, DOI 10.1006/geno.1993.1377; KOBBERLING J, 1975, HUMANGENETIK, V29, P111, DOI 10.1007/BF00430347; KOBBERLING J, 1986, J MED GENET, V23, P120, DOI 10.1136/jmg.23.2.120; Kobberling J, 1981, VERH DTSCH GES INN M, V87, P958; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Landsberg L, 1996, Hypertens Res, V19 Suppl 1, pS51, DOI 10.1291/hypres.19.SupplementI_S51; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LILLYSTONE D, 1975, ARCH DIS CHILD, V50, P737, DOI 10.1136/adc.50.9.737; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; OZER FL, 1973, CLIN RES, V21, P533; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROBBINS DC, 1982, METABOLISM, V31, P445, DOI 10.1016/0026-0495(82)90232-3; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Wanner R, 1996, BBA-MOL BASIS DIS, V1317, P105, DOI 10.1016/S0925-4439(96)00038-5	23	126	128	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					292	295		10.1038/ng0398-292	http://dx.doi.org/10.1038/ng0398-292			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500556				2022-12-27	WOS:000072325000032
J	Gulcher, JR; Jonsson, P; Kong, A; Kristjansson, K; Frigge, ML; Karason, A; Einarsdottir, IE; Stefansson, H; Einarsdottir, AS; Sigurdardottir, S; Baldursson, S; Bjornsdottir, S; Hrafnkelsdottir, SM; Jakobsson, F; Benedickz, J; Stefansson, K				Gulcher, JR; Jonsson, P; Kong, A; Kristjansson, K; Frigge, ML; Karason, A; Einarsdottir, IE; Stefansson, H; Einarsdottir, AS; Sigurdardottir, S; Baldursson, S; Bjornsdottir, S; Hrafnkelsdottir, SM; Jakobsson, F; Benedickz, J; Stefansson, K			Mapping of a familial essential tremor gene, FET1, to chromosome 3q13	NATURE GENETICS			English	Letter							POSITRON EMISSION TOMOGRAPHY; HEREDITARY ESSENTIAL TREMOR; LINKAGE ANALYSIS; PREVALENCE; CEREBELLAR; PRIMIDONE	Essential tremor (ET), the most common movement disorder in humans, appears to be inherited as an autosomal dominant trait in many families(1,2). The familial form is called familial essential tremor (FET), which seems similar to sporadic essential tremor. ET is a cause of substantial disability, particularly in the elderly(1). The prevalence of Parkinson's disease and dystonia may be increased in families with ET, but other movement disorders are seldom encountered in these families(3,4). Here we report the results of a genome-wide scan for FET genes in 16 Icelandic families with 75 affected individuals, in whom FET was apparently inherited as a dominant trait. The scan, which was performed with a 10-cM framework map, revealed one locus on chromosome 3q13 to which FET mapped with a genome-wide significance when the data were analysed either parametrically, assuming an autosomal dominant model (Iod score = 3.71), or non-parametrically (NPL Z score = 4.70. P < 6.4 x 10(6)).	DECODE GENET, IS-110 REYKJAVIK, ICELAND; UNIV CHICAGO, DEPT STAT, CHICAGO, IL 60637 USA; REYKJAVIK HOSP, DEPT NEUROL, IS-108 REYKJAVIK, ICELAND; NATL HOSP ICELAND, DEPT NEUROL, IS-101 REYKJAVIK, ICELAND	University of Chicago; Landspitali National University Hospital; Landspitali National University Hospital			Stefansson, Kari/AAE-7187-2019	Stefansson, Hreinn/0000-0002-9331-6666				BAIN PG, 1993, J NEUROL, V241, P54, DOI 10.1007/BF00870673; BAIN PG, 1993, J NEUROL NEUROSUR PS, V56, P868, DOI 10.1136/jnnp.56.8.868; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Baloh RW, 1996, NEUROLOGY, V46, P458, DOI 10.1212/WNL.46.2.458; Boecker H, 1996, ANN NEUROL, V39, P650, DOI 10.1002/ana.410390515; BRITTON TC, 1994, BRAIN, V117, P39, DOI 10.1093/brain/117.1.39; BUSENBARK KL, 1991, NEUROLOGY, V41, P1982, DOI 10.1212/WNL.41.12.1982; CONWAY D, 1993, MOVEMENT DISORD, V8, P374, DOI 10.1002/mds.870080324; CRITCHLEY M, 1949, BRAIN, V72, P113, DOI 10.1093/brain/72.2.113; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURR A, 1993, NEUROLOGY, V43, P2212, DOI 10.1212/WNL.43.11.2212; FINDLEY LJ, 1994, HDB TREMOR DISORDERS, P1; HERSKOVI.E, 1969, J NEUROL NEUROSUR PS, V32, P509, DOI 10.1136/jnnp.32.6.509; Im JH, 1996, CLIN NEUROL NEUROSUR, V98, P40, DOI 10.1016/0303-8467(95)00080-1; Jankovic J, 1997, ARCH NEUROL-CHICAGO, V54, P289, DOI 10.1001/archneur.1997.00550150047015; JANKOVIC J, 1995, NEUROLOGY, V45, P645, DOI 10.1212/WNL.45.4.645; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; KOLLER WC, 1992, CLIN NEUROPHARMACOL, V15, P81, DOI 10.1097/00002826-199204000-00001; KOLLER WC, 1994, ANN NEUROL, V35, P717, DOI 10.1002/ana.410350613; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LOU JS, 1991, NEUROLOGY, V41, P234, DOI 10.1212/WNL.41.2_Part_1.234; Louis ED, 1996, NEUROLOGY, V46, P1200, DOI 10.1212/WNL.46.5.1200; LOUIS ED, 1995, ARCH NEUROL-CHICAGO, V52, P1201, DOI 10.1001/archneur.1995.00540360079019; RAJPUT AH, 1984, J NEUROL NEUROSUR PS, V47, P466, DOI 10.1136/jnnp.47.5.466; SALEMI G, 1994, NEUROLOGY, V44, P61, DOI 10.1212/WNL.44.1.61; SASSO E, 1990, CLIN NEUROPHARMACOL, V13, P67, DOI 10.1097/00002826-199002000-00007; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WILLS AJ, 1994, ANN NEUROL, V36, P636, DOI 10.1002/ana.410360413	30	192	206	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					84	87		10.1038/ng0997-84	http://dx.doi.org/10.1038/ng0997-84			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288103				2022-12-27	WOS:A1997XU72400023
J	Westphal, CH; Rowan, S; Schmaltz, C; Elson, A; Fisher, DE; Leder, P				Westphal, CH; Rowan, S; Schmaltz, C; Elson, A; Fisher, DE; Leder, P			atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity	NATURE GENETICS			English	Article							CYCLE CHECKPOINT PATHWAY; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSES; CANCER-THERAPY; DNA-DAMAGE; MICE; INSTABILITY; GENE	Mutations in atm and p53 cause the human cancer-associated diseases ataxia-telangiectasia(1) and Li-Fraumeni syndrome(2,3), respectively. The two genes are believed to interact in a number of pathways(4-6), including regulation of DNA damage-induced cell-cycle checkpoints(7), apoptosis and radiation sensitivity(8), and cellular proliferation(9). Atm-null mice(10-12), as well as those null for p53(13,14), develop mainly T-cell lymphomas, supporting the view that these genes have similar roles in thymocyte development. To study the interactions of these two genes on an organismal level, we bred mice heterozygous for null alleles of both atm and p53 to produce all genotypic combinations. Mice doubly null for atm and p53 exhibited a dramatic acceleration of tumour formation relative to singly null mice, indicating that both genes collaborate in a significant manner to prevent tumorigenesis. With respect to their roles in apoptosis, loss of atm rendered thymocytes only partly resistant to irradiation-induced apoptosis, whereas additional loss of p53 engendered complete resistance. This implies that the irradiation-induced atm and p53 apoptotic pathways are not completely congruent. Finally-and in contrast to prior predictions(4,6)-atm and p53 do not appear to interact in acute radiation toxicity, suggesting a separate atm effector pathway for this DNA damage response and having implications for the prognosis and treatment of human tumours.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT HEMATOL ONCOL,BOSTON,MA 02115; CHILDRENS HOSP BOSTON,BOSTON,MA 02115; WEIZMANN INST SCI,DEPT MOL GENET,IL-76100 REHOVOT,ISRAEL	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Weizmann Institute of Science			Rowan, Sheldon/AAA-3271-2019	Rowan, Sheldon/0000-0002-1123-6743; Elson, Ari/0000-0001-9808-9135	NATIONAL CANCER INSTITUTE [R01CA069531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NCI NIH HHS [CA69531] Funding Source: Medline; NIAMS NIH HHS [AR43369] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; CANMAN CE, 1994, CANCER RES, V54, P5054; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; GOTOFF SP, 1967, AM J DIS CHILD, V114, P617, DOI 10.1001/archpedi.1967.02090270073006; Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MEYN MS, 1995, CANCER RES, V55, P5991; MEYN MS, 1994, INT J RADIAT BIOL, V66, pS141; MORGAN JL, 1968, AM J DIS CHILD, V116, P557, DOI 10.1001/archpedi.1968.02100020561022; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Westphal CH, 1997, CANCER RES, V57, P1664; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	28	194	198	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					397	401		10.1038/ng0897-397	http://dx.doi.org/10.1038/ng0897-397			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241281				2022-12-27	WOS:A1997XM90900026
J	Small, K; Iber, J; Warren, ST				Small, K; Iber, J; Warren, ST			Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats	NATURE GENETICS			English	Article							FACTOR-VIII GENE; DREIFUSS MUSCULAR-DYSTROPHY; SEVERE HEMOPHILIA-A; NONHOMOLOGOUS RECOMBINATION; PERICENTRIC-INVERSION; COLOR-VISION; HUMAN GENOME; XQ28; IDENTIFICATION; CELLS	Emery-Dreifuss muscular dystrophy (EMD) is an X-linked disorder characterized by contractures, progressive muscle weakness and cardiomyopathy(1-3). The emerin gene, located in human Xq28, is approximately 2 kb in length, is composed of 6 exons and falls within a 219-kb region that has been completely sequenced(4-6). Immediately centromeric to emerin is the 26-kb filamin gene (FLN1), composed of 48 exons and encoding the actin-binding protein 280 (refs 7,8). Flanking this 48-kb FLN1/emerin region are two large inverted repeats, each 11.3 kb, that exhibit >99% sequence identity(6). The high level of genomic detail in this region allowed us to characterize the first complete emerin gene deletion mutation that also involved a partial duplication of the nearby FLN1 gene, This rearrangement could be explained by mispairing of the large inverted repeats, followed by double recombination among one set of mispaired repeats and internal sequences. Furthermore, our characterization of this rare DNA rearrangement revealed a more common result of the mispairing of these large inverted repeats - recombination contained within the inverted repeats leading to the maintenance of repeat sequence homogeneity and inversion of the 48-kb FLN1/emerin region. The presence of this frequent inversion, found in the heterozygous state in 33% of females, helps to explain the discrepancies observed between the genetic and physical map distances in this region of the X chromosome. It also illustrates the biological insights which can be gleaned by sequencing the human genome.	HOWARD HUGHES MED INST,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT GENET,ATLANTA,GA 30322	Howard Hughes Medical Institute; Emory University; Emory University; Emory University			Warren, Stephen T/A-2498-2012					ASHLEY T, 1993, CHROMOSOMA, V102, P112, DOI 10.1007/BF00356028; BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; COYNE JA, 1991, GENETICS, V129, P791; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DRESSER ME, 1994, GENETICS, V138, P633; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; FILOSA S, 1993, GENOMICS, V17, P6, DOI 10.1006/geno.1993.1276; GORLIN JB, 1993, GENOMICS, V17, P496, DOI 10.1006/geno.1993.1354; HOPKINS LC, 1993, HDB CLIN NEUROBIOLOG, P145; KING M, 1992, HEREDITY, V68, P437, DOI 10.1038/hdy.1992.63; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Mckusick V.A., 1994, MENDELIAN INHERITANC; NAYLOR JA, 1995, HUM MOL GENET, V4, P1217, DOI 10.1093/hmg/4.7.1217; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; PATROSSO MC, 1994, GENOMICS, V21, P71, DOI 10.1006/geno.1994.1226; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; ROGNER UC, 1994, HUM MOL GENET, V3, P2137, DOI 10.1093/hmg/3.12.2137; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; SASHI V, 1996, AM J HUM GENET, V58, P1231; WANG LH, 1994, GENOMICS, V22, P590, DOI 10.1006/geno.1994.1432; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; WOODSSAMUELS P, 1991, GENOMICS, V10, P94, DOI 10.1016/0888-7543(91)90489-2; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; ZETKA MC, 1992, GENETICS, V131, P321	28	110	114	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					96	99		10.1038/ng0597-96	http://dx.doi.org/10.1038/ng0597-96			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140403				2022-12-27	WOS:A1997WX02400030
J	Pugliese, A; Zeller, M; Fernandez, A; Zalcberg, LJ; Bartlett, RJ; Ricordi, C; Pietropaolo, M; Eisenbarth, GS; Bennett, ST; Patel, DD				Pugliese, A; Zeller, M; Fernandez, A; Zalcberg, LJ; Bartlett, RJ; Ricordi, C; Pietropaolo, M; Eisenbarth, GS; Bennett, ST; Patel, DD			The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes	NATURE GENETICS			English	Article							MOLECULAR-CLONING; II GENE; REGION; AUTOANTIBODIES; EXPRESSION; PROINSULIN; MELLITUS; IDDM; MINISATELLITE; AUTOANTIGEN	Type 1, or insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease associated with loss of tolerance to several pancreatic islet cell molecules, including insulin, glutamic acid decarboxylase (CAD), ICA69 and the tyrosine phosphatase IA-2 (refs 1-3). Among several predisposing loci, IDDM2 maps to the insulin gene (INS) VNTR (variable number of tandem repeats) minisatellite on chromosome 11p15 (refs 4-9). Allelic variation at this VNTR locus correlates with steady-state levels of INS mRNA in pancreas(8,10,11) and transfected rodent cell lines(12-14), but it is difficult to reconcile the association of lower INS mRNA levels in the pancreas with class III VNTRs that are dominantly protective from IDDM(8,15). We show that during fetal development and childhood, mRNAs for insulin and other islet cell autoantigens (GAD, ICA69, IA-2) are expressed at low levels in the human thymus. Critically, we also detect proinsulin and insulin protein. VNTR alleles correlate with differential INS mRNA expression in the thymus where, in contrast to the pancreas, protective class III VNTRs are associated with higher steady-state levels of INS mRNA expression. This finding provides a plausible explanation for the dominant protective effect of class III VNTRs, and suggests that diabetes susceptibility and resistance associated with IDDM2 may derive from the VNTR influence on INS transcription in the thymus. Higher levels of (pro)insulin in the thymus may promote negative selection (deletion) of insulin-specific T-lymphocytes which play a critical role in the pathogenesis of type-1 diabetes.	UNIV PITTSBURGH, CHILDRENS HOSP, DIV IMMUNOGENET, PITTSBURGH, PA 15260 USA; UNIV COLORADO, HLTH SCI CTR, BARBARA DAVIS CTR CHILDHOOD DIABET, DENVER, CO 80262 USA; UNIV OXFORD, NUFFIELD DEPT SURG, WELLCOME TRUST CTR HUMAN GENET, OXFORD, ENGLAND; DUKE UNIV, MED CTR, DEPT MED & IMMUNOL, DURHAM, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oxford; Wellcome Centre for Human Genetics; Duke University	Pugliese, A (corresponding author), UNIV MIAMI, SCH MED, DIABET RES INST, MIAMI, FL USA.		RICORDI, CAMILLO/AAA-4740-2019	Ricordi, Camillo/0000-0001-8092-7153	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U24HD033199] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-3-3199] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; CASTANO L, 1993, DIABETES, V42, P1202, DOI 10.2337/diabetes.42.8.1202; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; French MB, 1997, DIABETES, V46, P34, DOI 10.2337/diabetes.46.1.34; GRIFFIN AC, 1995, AM J PATHOL, V147, P845; Hoffman A.R., 1996, SCI AM, V1, P52; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KEILACKER H, 1995, HORM METAB RES, V27, P90, DOI 10.1055/s-2007-979915; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KUGLIN B, 1988, DIABETES, V37, P130, DOI 10.2337/diabetes.37.1.130; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; Mally MI, 1996, DIABETOLOGIA, V39, P474, DOI 10.1007/s001250050468; OEHEN SU, 1994, CELL IMMUNOL, V158, P342, DOI 10.1006/cimm.1994.1281; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; Owerbach D, 1996, DIABETES, V45, P544, DOI 10.2337/diabetes.45.5.544; PIETROPAOLO M, 1993, J CLIN INVEST, V92, P359, DOI 10.1172/JCI116574; POLYCHRONAKOS C, 1995, DIABETOLOGIA, V38, P715, DOI 10.1007/s001250050343; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; RABIN DU, 1994, J IMMUNOL, V152, P3183; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; UNDLIEN DE, 1995, DIABETES, V44, P620, DOI 10.2337/diabetes.44.6.620; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542	34	725	744	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					293	297		10.1038/ng0397-293	http://dx.doi.org/10.1038/ng0397-293			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054945				2022-12-27	WOS:A1997WK38600022
J	Humphries, MM; Rancourt, D; Farrar, GJ; Kenna, P; Hazel, M; Bush, RA; Sieving, PA; Sheils, DM; McNally, N; Creighton, P; Erven, A; Boros, A; Gulya, K; Capecchi, MR; Humphries, P				Humphries, MM; Rancourt, D; Farrar, GJ; Kenna, P; Hazel, M; Bush, RA; Sieving, PA; Sheils, DM; McNally, N; Creighton, P; Erven, A; Boros, A; Gulya, K; Capecchi, MR; Humphries, P			Retinopathy induced in mice by targeted disruption of the rhodopsin gene	NATURE GENETICS			English	Article							SCOTOPIC THRESHOLD RESPONSE; RETINITIS-PIGMENTOSA; B-WAVE; ELECTRORETINOGRAM; ROD; MUTATIONS; SUBUNIT; LIGHT; CELLS; CAT	Retinitis pigmentosa (RP) represents the most common mendelian degenerative retinopathy of man, involving death of rod photoreceptors, cone cell degeneration, retinal vessel attenuation and pigmentary deposits(1,2). The patient experiences night blindness, usually followed by progressive loss of visual field. Genetic linkage between an autosomal dominant RP locus and rhodopsin(3), the photoreactive pigment of the rod cells, led to the identification of mutations within the rhodopsin gene in both dominant and recessive forms of Rp(3-7). To better understand the functional and structural role of rhodopsin in the normal retina and in the pathogenesis of retinal disease, we generated mice carrying a targeted disruption of the rhodopsin gene. Rho(-/-) mice do not elaborate rod outer segments, losing their photoreceptors over 3 months. There is no rod ERG response in 8-week-old animals. Rho(+/-) animals retain the majority of their photoreceptors although the inner and outer segments of these cells display some structural disorganization, the outer segments becoming shorter in older mice. These animals should provide a useful genetic background on which to express other mutant opsin transgenes, as well as a model to assess the therapeutic potential of re-introducing functional rhodopsin genes into degenerating retinal tissues.	UNIV DUBLIN TRINITY COLL,DEPT GENET,WELLCOME OCULAR GENET UNIT,DUBLIN 2,IRELAND; ROYAL VICTORIAN EYE & EAR HOSP,RES FDN,DUBLIN 2,IRELAND; UNIV UTAH,MED CTR,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV MICHIGAN,KELLOGG EYE CTR,ANN ARBOR,MI 48109; ATTILA JOZSEF UNIV,DEPT ZOOL & CELL BIOL,H-6722 SZEGED,HUNGARY	Trinity College Dublin; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Szeged University			Bateson, Jane Farrar/AAO-6147-2020; Gulya, Karoly/M-7629-2018; Farrar, G Jane/B-9832-2011	Gulya, Karoly/0000-0001-6864-4150; 				Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; BROWN KT, 1968, VISION RES, V8, P633, DOI 10.1016/0042-6989(68)90041-2; BUSH RA, 1995, INVEST OPHTH VIS SCI, V36, P2054; BUSH RA, 1992, CLIN VISION SCI, V7, P393; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DENG CX, 1993, MOL CELL BIOL, V13, P2134, DOI 10.1128/MCB.13.4.2134; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; GREEN DG, 1994, VISUAL NEUROSCI, V11, P919, DOI 10.1017/S0952523800003874; Heckenlively JR, 1988, RETINITIS PIGMENTOSA, P125; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Sambrook J., 1989, MOL CLONING; SIEVING PA, 1986, J NEUROPHYSIOL, V56, P1049, DOI 10.1152/jn.1986.56.4.1049; SIEVING PA, 1988, INVEST OPHTH VIS SCI, V29, P1608; SIEVING PA, 1991, CLIN VISION SCI, V6, P171; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; STEINBERG RH, 1991, PROGR RETINAL RES, V10; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0	27	441	452	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					216	219		10.1038/ng0297-216	http://dx.doi.org/10.1038/ng0297-216			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020854				2022-12-27	WOS:A1997WF08700028
J	Malter, HE; Iber, JC; Willemsen, R; deGraaff, E; Tarleton, JC; Leisti, J; Warren, ST; Oostra, BA				Malter, HE; Iber, JC; Willemsen, R; deGraaff, E; Tarleton, JC; Leisti, J; Warren, ST; Oostra, BA			Characterization of the full fragile X syndrome mutation in fetal gametes	NATURE GENETICS			English	Article							CAG REPEAT LENGTH; MENTAL-RETARDATION; DNA METHYLATION; TRINUCLEOTIDE REPEAT; CGG REPEAT; ABNORMAL METHYLATION; HUNTINGTONS-DISEASE; FMR-1 GENE; GERM-CELLS; INSTABILITY	Fragile X syndrome results from the expansion of the CGG repeat in the FMR1 gene. Expansion has been suggested to be a postzygotic event with the germline protected. From an analysis of intact ovaries of full mutation fetuses, we now show that only full expansion alleles can be detected in oocytes (but in the unmethylated state). Similarly, the testes of a 13-week full mutation fetus show no evidence of premutations while a 17-week full mutation fetus exhibits some germ cells with attributes of premutations. These data discount the hypothesis that the germline is protected from full expansion and suggest full mutation contraction in the immature testis. Thus, full expansion may already exist in the maternal oocyte, or postzygotic expansion, if it occurs, arises quite early in development prior to germline segregation.	EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,NL-3000 DR ROTTERDAM,NETHERLANDS; GREENWOOD GENET CTR,GREENWOOD,SC 29646; UNIV OULU,OULU,FINLAND	Emory University; Howard Hughes Medical Institute; Emory University; Emory University; Erasmus University Rotterdam; Greenwood Genetic Center; University of Oulu			de Graaff, Esther/D-3287-2011; Warren, Stephen T/A-2498-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521] Funding Source: NIH RePORTER; NICHD NIH HHS [R37HD20521] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASHLEY AE, 1995, AM J HUM GENET, V57, P1414; BACHNER D, 1993, NAT GENET, V4, P115, DOI 10.1038/ng0693-115; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BAKKER CE, 1994, CELL, V78, P23; BEAUMONT HM, 1963, J EMBRYOL EXP MORPH, V11, P715; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Byskov A. G., 1982, GERM CELLS FERTILIZA, P1; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DEGRAAFF E, 1995, AM J HUM GENET, V57, P609; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; FISCH GS, 1995, AM J HUM GENET, V56, P1147; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1995, NAT GENET, V6, P9; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAIRD CD, 1987, GENETICS, V117, P587; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LUO SY, 1993, SOMAT CELL MOLEC GEN, V19, P393, DOI 10.1007/BF01232750; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; MIGEON BR, 1991, SOMAT CELL MOLEC GEN, V17, P159, DOI 10.1007/BF01232973; MONK M, 1987, DEVELOPMENT, V99, P371; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1994, HUM MOL GENET, V3, P927, DOI 10.1093/hmg/3.6.927; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SNOW K, 1993, AM J HUM GENET, V53, P1217; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1995, ANNU REV NEUROSCI, V18, P77, DOI 10.1146/annurev.neuro.18.1.77; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140	42	147	149	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					165	169		10.1038/ng0297-165	http://dx.doi.org/10.1038/ng0297-165			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020841				2022-12-27	WOS:A1997WF08700015
J	Perrault, I; Rozet, JM; Calvas, P; Gerber, S; Camuzat, A; Dollfus, H; Chatelin, S; Souied, E; Ghazi, I; Leowski, C; Bonnemaison, M; LePaslier, D; Frezal, J; Dufier, JL; Pittler, S; Munnich, A; Kaplan, J				Perrault, I; Rozet, JM; Calvas, P; Gerber, S; Camuzat, A; Dollfus, H; Chatelin, S; Souied, E; Ghazi, I; Leowski, C; Bonnemaison, M; LePaslier, D; Frezal, J; Dufier, JL; Pittler, S; Munnich, A; Kaplan, J			Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis	NATURE GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; CHROMOSOME 17P13.1; ALPHA-SUBUNIT; PHOSPHODIESTERASE; LOCALIZATION; RECEPTORS; MAPS	Leber's congenital amaurosis (LCA, MIM 204000(1)), the earliest and most severe form of inherited retinopathy, accounts for at least 5% of all inherited retinal dystrophies(2,3). This autosomal recessive condition is usually recognized at birth or during the first months of life in an infant with total blindness or greatly impaired vision, normal fundus and extinguished electroretinogram (ERG(4)). Nystagmus (pendular type) and characteristic eye poking are frequently observed in the first months of life (digito-ocular sign of Franceschetti(5)). Hypermetropia and keratoconus frequently develop in the course of the disease(6,7). The observation by Waardenburg(8) of nor mal children born to affected parents supports the genetic heterogeneity of LCA. Until now, however, little was known about the pathophysiology of the disease, but LCA is usually regarded as the consequence of either impaired development of photoreceptors or extremely early degeneration of cells that have developed normally(9). We have recently mapped a gene for LCA to chromosome 1.7p13.1 (LCA1) by homozygosity mapping in consanguineous families of North African origin and provided evidence of genetic heterogeneity in our sample, as LCA I accounted for 8/15 LCA families in our series(10,11). Here, we report two missense mutations (F589S) and two frameshift mutations (nt 460 del C, nt 693 del C) of the retinal guanylate cyclase (RETGC, GDB symbol GUC2D) gene in four unrelated LCA1 probands of North African ancestry and ascribe LCA1 to an impaired production of cGMP in the retina, with permanent closure of cGMP-gated cation channels.	HOP NECKER ENFANTS MALAD,UNITE RECH HANDICAPS GENET ENFANT,INSERM U393,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,SERV OPHTALMOL,PARIS,FRANCE; INST NATL JEUNES AVEUGLES,PARIS,FRANCE; CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; DEPT BIOCHEM & MOL BIOL,MOBILE,AL; DEPT OPHTHALMOL,MOBILE,AL	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite			ROZET, Jean-Michel/E-5737-2016; Pittler, Steven/J-7091-2013; perrault, isabelle/H-3047-2017	ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769; Le Paslier, Denis/0000-0003-4335-9956; Dollfus, Helene/0000-0002-2249-895X; Pittler, Steven/0000-0002-8464-9303; perrault, isabelle/0000-0002-8560-1379	NEI NIH HHS [EY 09924] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009924] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CALABRESE G, 1994, GENOMICS, V23, P286, DOI 10.1006/geno.1994.1497; Camuzat A, 1996, HUM GENET, V97, P798; CAMUZAT A, 1995, HUM MOL GENET, V4, P1447, DOI 10.1093/hmg/4.8.1447; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FITZGIBBON J, 1994, CYTOGENET CELL GENET, V67, P205, DOI 10.1159/000133823; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; FRANCESCHETTI A, 1958, Ophthalmologica, V135, P610; FRANCESCHETTI A, 1954, Confin Neurol, V14, P184; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; KAPLAN J, 1990, HUM GENET, V85, P635; KAREL I, 1968, OPHTHALMOLOGICA, V155, P8, DOI 10.1159/000305329; Leber T., 1869, GRAEFES ARCH KLIN EX, V15, P13, DOI 10.1007/BF0272121318; LEE N R, 1987, Investigative Ophthalmology and Visual Science, V28, P344; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; LOLLEY RN, 1990, FASEB J, V4, P3001, DOI 10.1096/fasebj.4.12.1697545; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MIZUNO K, 1977, AM J OPHTHALMOL, V83, P32, DOI 10.1016/0002-9394(77)90188-X; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; OLIVEIRA L, 1994, GENOMICS, V22, P478, DOI 10.1006/geno.1994.1415; ROZET JM, IN PRESS GENOMICS; SempleRowland SL, 1996, INVEST OPHTH VIS SCI, V37, P3729; SHASTRY BS, 1994, AM J MED GENET, V52, P467, DOI 10.1002/ajmg.1320520413; TOMBRANTINK J, 1994, GENOMICS, V19, P266, DOI 10.1006/geno.1994.1057; WAARDENBURG PJ, 1963, ACTA OPHTHALMOL, V41, P317; WAGNER RS, 1985, ARCH OPHTHALMOL-CHIC, V103, P1507; Yang RB, 1996, GENOMICS, V31, P367, DOI 10.1006/geno.1996.0060; YUEN PST, 1992, ANNU REV NEUROSCI, V15, P193	30	362	369	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					461	464		10.1038/ng1296-461	http://dx.doi.org/10.1038/ng1296-461			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944027				2022-12-27	WOS:A1996VV73000023
J	Xia, JH; Liu, CY; Tang, BS; Pan, Q; Huang, L; Dai, HP; Zhang, BR; Xie, W; Hu, DX; Zheng, D; Shi, XL; Wang, DA; Xia, K; Yu, KP; Liao, XD; Feng, Y; Yang, YF; Xiao, JY; Xie, DH; Huang, JZ				Xia, JH; Liu, CY; Tang, BS; Pan, Q; Huang, L; Dai, HP; Zhang, BR; Xie, W; Hu, DX; Zheng, D; Shi, XL; Wang, DA; Xia, K; Yu, KP; Liao, XD; Feng, Y; Yang, YF; Xiao, JY; Xie, DH; Huang, JZ			Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant healing impairment	NATURE GENETICS			English	Article							MARIE-TOOTH DISEASE; HEARING IMPAIRMENT; DEAFNESS; HETEROGENEITY; FAMILIES; LINKAGE; REGION; MAPS	Hearing impairment is the most commonly occurring condition that affects the ability of humans to communicate(1). More than 50% of the cases of profound early-onset deafness are caused by genetic factors(2,3). Over 40 loci for non-syndromic deafness have been genetically mapped, and mutations in several genes have been shown to cause hearing loss(4). Mutations in the gene encoding connexin 26 (GJB2) cause both autosomal recessive and dominant forms of hearing impairment(5,6). To study the possible involvement of other members of the connexin family in hereditary hearing impairment, we cloned the gene (GJB3) encoding human gap junction protein beta-3 using homologous EST searching and nested PCR. GJB3 was mapped to human chromosome 1p33-p35. Mutation analysis revealed that a missense mutation and a nonsense mutation of GJB3 were associated with high-frequency hearing loss in two families. Moreover. expression of Gjb3 was identified in rat inner ear tissue by RT-PCR. These findings suggest that mutations in GJB3 may be responsible for bilateral high-frequency hearing impairment.	Affiliated Xiangya Hosp, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; Affiliated Xiangya Hosp, Dept Neurol, Changsha 410078, Hunan, Peoples R China; Affiliated Xiangya Hosp, Dept Otorhinol, Changsha 410078, Hunan, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Otorhinol, Changsha 410078, Hunan, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Changsha 410078, Hunan, Peoples R China; Zhejiang Med Univ, Affiliated Hosp 2, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China	Central South University; Central South University; Zhejiang University	Xia, JH (corresponding author), Affiliated Xiangya Hosp, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China.	nlmglcy@public.cs.hn.cn	Liu, Chunyu/G-7561-2012; XIA, KUN/AAO-3525-2020; Liu, chunyu/Q-3901-2017	Liu, Chunyu/0000-0002-5986-4415; Shi, Xiaoliu/0000-0002-9759-2254				AYIMU D, 1997, J AUDIOL SPEECH PATH, V5, P144; BENOTHMANE K, 1993, GENOMICS, V17, P370; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Engle EC, 1997, AM J HUM GENET, V60, P1150; FAIN PR, 1994, AM J HUM GENET, V54, P229; HULL R, 1978, HDB CLIN AUDIOLOGY, P426; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; VanCamp G, 1997, AM J HUM GENET, V60, P758; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202	19	345	428	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					370	373		10.1038/3845	http://dx.doi.org/10.1038/3845			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843210				2022-12-27	WOS:000077199600025
J	Brown, SA; Warburton, D; Brown, LY; Yu, CY; Roeder, ER; Stengel-Rutkowski, S; Hennekam, RCM; Muenke, M				Brown, SA; Warburton, D; Brown, LY; Yu, CY; Roeder, ER; Stengel-Rutkowski, S; Hennekam, RCM; Muenke, M			Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired	NATURE GENETICS			English	Article							SONIC-HEDGEHOG GENE; PROTEIN; DEFINITION; EXPRESSION; REGION; DOMAIN	Holoprosencephaly (HPE) is the most common structural anomaly of the human brain and is one of the anomalies seen in patients with deletions and duplications of chromosome 13. On the basis of molecular analysis of a series of patients with hemizygous deletions of the long arm of chromosome 13. we have defined a discrete region in band 13q32 where deletion leads to major developmental anomalies (the 13q32 deletion syndrome). This approximately 1-Mb region(1) lies between markers D13S136 and D13S147. Patients in which this region is deleted usually have major congenital malformations, including brain anomalies such as HPE or exencephaly, and digital anomalies such as absent thumbs(2). We now report that human ZIC2 maps to this critical deletion region and that heterozygous mutations in ZIC2 are associated with HPE. Haploinsufficiency for ZIC2 is likely to cause the brain malformations seen in 13q deletion patients.	Columbia Univ, Dept Obstet & Gynecol, New York, NY 10027 USA; Columbia Univ, Dept Pediat, New York, NY 10027 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Presbyterian Hosp, New York, NY 10032 USA; Valley Childrens Hosp, Fresno, CA 93703 USA; Kinderzentrum Munchen, Munich, Germany; Univ Amsterdam, Inst Human Genet, NL-1012 WX Amsterdam, Netherlands; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA	Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; University of Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brown, SA (corresponding author), Columbia Univ, Dept Obstet & Gynecol, New York, NY 10027 USA.	brown@cuccfa.ccc.columbia.edu		Muenke, Maximilian/0000-0002-7719-6545	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029862, R29HD028732, R29HD032467] Funding Source: NIH RePORTER; NICHD NIH HHS [HD28732, HD32467, HD29862] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Aruga J, 1996, GENE, V172, P291, DOI 10.1016/0378-1119(96)00111-4; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; BONALDO MD, 1994, HUM MOL GENET, V3, P1663; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; BROWN S, 1995, AM J HUM GENET, V57, P859; CIMBORA DM, 1995, DEV BIOL, V169, P580, DOI 10.1006/dbio.1995.1171; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; Johnson KR, 1998, HUM MOL GENET, V7, P1033, DOI 10.1093/hmg/7.6.1033; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; Ming JE, 1998, MOL MED TODAY, V4, P343, DOI 10.1016/S1357-4310(98)01299-4; Muenke Maximilian, 1994, Seminars in Developmental Biology, V5, P293, DOI 10.1006/sedb.1994.1038; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Roessler E, 1998, J INHERIT METAB DIS, V21, P481, DOI 10.1023/A:1005406719292; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 1997, HUM GENET, V100, P172, DOI 10.1007/s004390050486; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; TAN DP, 1992, P NATL ACAD SCI USA, V89, P6280, DOI 10.1073/pnas.89.14.6280	28	365	372	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					180	183		10.1038/2484	http://dx.doi.org/10.1038/2484			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771712				2022-12-27	WOS:000076231300021
J	Morgan, D; Turnpenny, L; Goodship, J; Dai, WL; Majumder, K; Matthews, L; Gardner, A; Schuster, G; Vien, L; Harrison, W; Elder, FEB; Penman-Splitt, M; Overbeek, P; Strachan, T				Morgan, D; Turnpenny, L; Goodship, J; Dai, WL; Majumder, K; Matthews, L; Gardner, A; Schuster, G; Vien, L; Harrison, W; Elder, FEB; Penman-Splitt, M; Overbeek, P; Strachan, T			Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; SITUS-INVERSUS; EMBRYOGENESIS; LIBRARIES; SEQUENCES; MUTATION; EMBRYOS; LINKAGE; XENOPUS	Visceral left-right asymmetry occurs in all vertebrates, but the inversion of embryo turning (inv) mouse, which resulted following a random transgene insertion, is the only model in which these asymmetries are consistently reversed(1). We report positional cloning of the gene underlying this recessive phenotype. Although transgene insertion was accompanied by neighbouring deletion and duplication events(1,2), our YAC phenotype rescue studies indicate that the mutant phenotype results from the deletion. After extensively characterizing the 47-kb deleted region and flanking sequences from the wild-type mouse genome, we found evidence for only one gene sequence in the deleted region. We determined the full-length 5.5-kb cDNA sequence and identified 16 exons, of which exons 3-11 were eliminated by the deletion, causing a frameshift. The novel gene specifies a 1062-aa product with tandem ankyrin-like repeat sequences. Characterization of complementing and non-complementing YAC transgenic families revealed that correction of the inv mutant phenotype was concordant with integration and intact expression of this novel gene, which we have named inversin (Invs).	Newcastle Univ, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Sanger Ctr, Cambridge CB10 1RQ, England; Univ Texas, Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	Newcastle University - UK; Baylor College of Medicine; Baylor College of Medicine; Wellcome Trust Sanger Institute; University of Texas System; University of Texas Health Science Center Houston	Goodship, J (corresponding author), Newcastle Univ, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.a.goodship@ncl.ac.uk; tom.strachan@ncl.ac.uk		Overbeek, Paul/0000-0001-9784-2084	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; EWING B, IN PRESS GENOME RES; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; GNIRKE A, 1993, GENOMICS, V15, P659, DOI 10.1006/geno.1993.1121; HARRISON SM, 1995, DEVELOPMENT, V121, P2479; Harvey RP, 1998, CELL, V94, P273, DOI 10.1016/S0092-8674(00)81468-3; Hogan B, 1994, MANIPULATING MOUSE E; Huxley C, 1994, Genet Eng (N Y), V16, P65; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Innis MA, 1990, PCR PROTOCOLS GUIDE; Kaufman MH, 1995, ATLAS MOUSE DEV; KLAR AJS, 1994, TRENDS GENET, V10, P392, DOI 10.1016/0168-9525(94)90055-8; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; Levin M, 1998, SEMIN CELL DEV BIOL, V9, P67, DOI 10.1006/scdb.1997.0192; Levin M, 1997, BIOESSAYS, V19, P287, DOI 10.1002/bies.950190406; Levin M, 1998, GENE DEV, V12, P763, DOI 10.1101/gad.12.6.763; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nascone N, 1997, DEV BIOL, V189, P68, DOI 10.1006/dbio.1997.8635; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; PENMANSPLITT M, 1996, J MED GENET, V33, P498; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; ROBINSON TJ, 1987, CHROMOSOMA, V96, P45, DOI 10.1007/BF00285882; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SILVERMAN GA, 1991, GENOMICS, V9, P219, DOI 10.1016/0888-7543(91)90245-A; SMITH DJ, 1995, GENOMICS, V27, P425, DOI 10.1006/geno.1995.1073; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; VALDES JM, 1994, P NATL ACAD SCI USA, V91, P5377, DOI 10.1073/pnas.91.12.5377; Varlet I, 1997, CURR OPIN GENET DEV, V7, P519, DOI 10.1016/S0959-437X(97)80080-9; Wood WB, 1997, ANNU REV CELL DEV BI, V13, P53; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; YOKOYAMA T, 1995, DEV MECH HEART DIS; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	42	192	194	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					149	156		10.1038/2450	http://dx.doi.org/10.1038/2450			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771707				2022-12-27	WOS:000076231300016
J	Abdel-Majid, RM; Leong, WL; Schalkwyk, LC; Smallman, DS; Wong, ST; Storm, DR; Fine, A; Dobson, MJ; Guernsey, DL; Neumann, PE				Abdel-Majid, RM; Leong, WL; Schalkwyk, LC; Smallman, DS; Wong, ST; Storm, DR; Fine, A; Dobson, MJ; Guernsey, DL; Neumann, PE			Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex	NATURE GENETICS			English	Article							ARTIFICIAL CHROMOSOME LIBRARY; DEVELOPING RAT; MUTANT MICE; SEROTONIN; GENOME; RECEPTORS; CONSTRUCTION; ACTIVATION; INSERTION; BEHAVIOR	The somatosensory (SI) cortex of mice displays a patterned, nonuniform distribution of neurons in layer IV called the "barrelfield' (ref. 1). Thalamocortical afferents (TCAs) that terminate in layer IV are segregated such that each barrel, a readily visible cylindrical array of neurons surrounding a cell-sparse center, represents a distinct receptive field. TCA arbors are confined to the barrel hollow and synapse on barrel-wail neurons whose dendrites are oriented toward the center of the barrel(2). Mice homozygous for the barrelless (brl) mutation, which occurred spontaneously in ICR stock at Universitd de Lausanne (Switzerland), fail to develop this patterned distribution of neurons, but still display normal topological organization of the SI cortex(3). Despite the absence of barrels and the overlapping zones of TCA arborization, the size of individual whisker representations, as judged by 2-deoxyglucose uptake, is similar to that of wild-type mice. We identified adenylyl cyclase type I(Adcy1) as the gene disrupted in brl mutant mice by fine mapping of proximal chromosome 11, enzyme assay, mutation analysis and examination of mice homozygous for a targeted disruption of Adcy1. These results provide the first evidence for involvement of cAMP signalling pathways in pattern formation of the brain.	Dalhousie Univ, Fac Med, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Surg, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Phys & Biophys, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Fac Med, Dept Biochem, Halifax, NS B3H 4H7, Canada; Max Planck Inst Mol Genet, Abt Lehrach, Berlin, Germany; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Max Planck Society; University of Washington; University of Washington Seattle	Neumann, PE (corresponding author), Dalhousie Univ, Fac Med, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada.	neumannp@tupdean1.med.dal.ca	Schalkwyk, Leonard C/A-2150-2010	Schalkwyk, Leonard C/0000-0001-7030-5756; Neumann, Paul/0000-0002-8480-4799; Dobson, Melanie/0000-0001-9291-7200				BENNETTCLARKE CA, 1993, P NATL ACAD SCI USA, V90, P153, DOI 10.1073/pnas.90.1.153; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; BOUHELAL R, 1988, EUR J PHARMACOL, V151, P189, DOI 10.1016/0014-2999(88)90799-6; BYRNE JH, 1991, ANN NY ACAD SCI, V627, P124, DOI DOI 10.1111/J.1749-6632.1991.TB25918.X; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CLAUDIO JO, 1994, GENOMICS, V21, P437, DOI 10.1006/geno.1994.1291; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; EDELHOFF S, 1995, MAMM GENOME, V6, P111, DOI 10.1007/BF00303253; Haldi ML, 1996, MAMM GENOME, V7, P767, DOI 10.1007/s003359900228; JOHNSON RA, 1973, J BIOL CHEM, V248, P5114; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LARIN Z, 1993, METHOD ENZYMOL, V225, P623; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; MITREITER K, 1994, VIROLOGY, V200, P837, DOI 10.1006/viro.1994.1253; Mitrovic N, 1996, EUR J NEUROSCI, V8, P1793, DOI 10.1111/j.1460-9568.1996.tb01323.x; RHOADES RW, 1994, J NEUROPHYSIOL, V72, P2438, DOI 10.1152/jn.1994.72.5.2438; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; WU ZL, 1993, J BIOL CHEM, V268, P23766; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526	30	128	132	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					289	291		10.1038/980	http://dx.doi.org/10.1038/980			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662407				2022-12-27	WOS:000074565900030
J	Anderson, SE; Schlegel, BP; Nakajima, T; Wolpin, ES; Parvin, JD				Anderson, SE; Schlegel, BP; Nakajima, T; Wolpin, ES; Parvin, JD			BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; OVARIAN-CANCER; BREAST; DROSOPHILA	The breast cancer specific tumour suppressor protein, BRCA1 (refs 1,2), activates transcription when linked with a DNA-binding domain(3,4) and is a component of the RNA polymerase II (Pol II) holoenzyme(5,6). We show here that RNA helicase A (RHA) protein(7,8) links BRCA1 to the holoenzyme complex. The region of BRCA1 which interacts with RHA and, thus, the holoenzyme complex, corresponds to subregions of the BRCT domain of BRCA1 (ref. 9). This interaction was shown to occur in yeast nuclei, and expression in human cells of a truncated RHA molecule which retains binding to BRCA1 inhibited transcriptional activation mediated by the BRCA1 carboxy terminus. These data are the first to identify a specific protein interaction with the BRCA1 C-terminal domain and are consistent with the model that BRCA1 functions as a transcriptional coactivator.	Brigham & Womens Hosp, Dept Pathol, Div Mol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Tsukuba, Inst Appl Biochem, Ibaraki, Osaka 3058572, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tsukuba	Parvin, JD (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Mol Oncol, 75 Francis St, Boston, MA 02115 USA.		Parvin, Jeffrey D/C-8955-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053504] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18829, GM53504] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASPENSTROM P, 1995, METHOD ENZYMOL, V256, P228; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LEE CG, 1993, J BIOL CHEM, V268, P16822; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Zhang SS, 1997, J BIOL CHEM, V272, P11487	17	324	342	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					254	256		10.1038/930	http://dx.doi.org/10.1038/930			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662397				2022-12-27	WOS:000074565900020
J	Matsuno, K; Eastman, D; Mitsiades, T; Quinn, AM; Carcanciu, ML; Ordentlich, P; Kadesch, T; Artavanis-Tsakonas, S				Matsuno, K; Eastman, D; Mitsiades, T; Quinn, AM; Carcanciu, ML; Ordentlich, P; Kadesch, T; Artavanis-Tsakonas, S			Human deltex is a conserved regulator of Notch signalling	NATURE GENETICS			English	Article							SIGNALING PATHWAY; ANKYRIN REPEATS; DNA-BINDING; DROSOPHILA; PROTEIN; GENE; ENHANCER; SPLIT; HAIRLESS; SUPPRESSOR	A fundamental cell-fate control mechanism regulating multicellular development is defined by the Notch-signalling pathway(1). Developmental and genetic studies of wild type and activated Notch-receptor expression in diverse organisms suggest that Notch plays a general role in development by governing the ability of undifferentiated precursor cells to respond to specific signals(1,2). Notch signalling has been conserved throughout evolution and controls the differentiation of a broad spectrum of cell types during development(1-3). Genetic studies in Drosophila have led to the identification of several components of the Notch pathway(1). Two of the positive regulators of the pathway are encoded by the suppressor of hairless [Su(H)] and deltex (dx) genes(5-8). Drosophila dr encodes a ubiquitous, novel cytoplasmic protein of unknown biochemical function(9). We have cloned a human deltex homologue and characterized it in parallel with its Drosophila counterpart in biochemical assays to assess deltex function. Both human and Drosophila deltex bind to Notch across species and carry putative Shy-binding domains. Using the yeast interaction trap system, we find that Drosophila and human deltex bind to the human SH3-domain containing protein Grb2 (ref. 10). Results from two different reporter assays allow us for the first time to associate deltex with Notch-dependent transcriptional events. We present evidence linking deltex to the modulation of basic helix-loop-helix (bHLH) transcription factor activity.	Yale Univ, Dept Cell Biol & Biol, Howard Hughes Med Inst, New Haven, CT 06536 USA; Yale Univ, Dept Pathol, New Haven, CT 06511 USA; Univ Penn, Sch Med, Dept Genet, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; University of Pennsylvania	Artavanis-Tsakonas, S (corresponding author), Osaka Univ, Sch Med, Dept Neuroanat, Osaka, Japan.	spyros.artavnis@yale.edu	Mitsiadis, Thimios A/B-9249-2008; Mitsiadis, Thimios/B-5564-2016	Mitsiadis, Thimios/0000-0002-9812-9982				ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Blaumueller CM, 1997, PERSPECT DEV NEUROBI, V4, P325; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BUSSEAU I, 1994, GENETICS, V136, P585; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; EASTMAN DS, IN PRESS MOL CELL BI; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; NICOLAIDES NC, 1995, GENOMICS, V30, P195, DOI 10.1006/geno.1995.9885; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; XU T, 1990, GENETICS, V126, P665; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	30	162	167	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					74	78		10.1038/ng0598-74	http://dx.doi.org/10.1038/ng0598-74			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590294				2022-12-27	WOS:000073346700022
J	Gebbia, M; Ferrero, GB; Pilia, G; Bassi, MT; Aylsworth, AS; PenmanSplitt, M; Bird, LM; Bamforth, JS; Burn, J; Schlessinger, D; Nelson, DL; Casey, B				Gebbia, M; Ferrero, GB; Pilia, G; Bassi, MT; Aylsworth, AS; PenmanSplitt, M; Bird, LM; Bamforth, JS; Burn, J; Schlessinger, D; Nelson, DL; Casey, B			X-linked situs abnormalities result from mutations in ZIC3	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; GENE FAMILY; LATERALITY; DEFECTS; EMBRYOS; XENOPUS; MEMBER; DNA	Vertebrates position unpaired organs of the chest and abdomen asymmetrically along the left-right (LR) body axis. Each structure comes to lie non-randomly with respect to the midline in an overall position designated sites solitus, exemplified in humans by placement of the heart, stomach and spleen consistently to the left. Aberrant LR axis development can lead to randomization of individual organ position (sites ambiguus) or to mirror-image reversal of all lateralized structures (sites inversus)(1). Previously we mapped a locus for sites abnormalities in humans, HTX1, to Xq26.2 by linkage analysis in a single family (LR1) and by detection of a deletion in an unrelated sites ambiguus male (Family LR2; refs 2,3). From this chromosomal region we have positionally cloned ZIC3, a gene encoding a putative zinc-finger transcription factor. One frameshift, two missense and two nonsense mutations have been identified in familial and sporadic sites ambiguus. The frameshift allele is also associated with sites inverses among some heterozygous females, suggesting that ZIC3 functions in the earliest stages of LR-axis formation. ZIC3, which has not been previously implicated in vertebrate LR-axis development, is the first gene unequivocally associated with human sites abnormalities.	BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; WASHINGTON UNIV, DEPT MOL MICROBIOL, ST LOUIS, MO 63130 USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CTR NEUROSCI, CHAPEL HILL, NC 27599 USA; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; CHILDRENS HOSP & HLTH CTR, SAN DIEGO, CA 92123 USA; UNIV ALBERTA HOSP, DEPT MED GENET, EDMONTON, AB T6G 2B7, CANADA	Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK; University of Alberta			Bird, Lynne/AAG-9533-2021; Ferrero, Giovanni Battista/K-5265-2018; Bassi, Maria Teresa T/A-3517-2014	Ferrero, Giovanni Battista/0000-0002-3793-5788; Bassi, Maria Teresa T/0000-0002-8236-1197; Bird, Lynne/0000-0003-4833-3747	NHGRI NIH HHS [HG00201] Funding Source: Medline; NICHD NIH HHS [5K08 HD01078, P30 HD24064] Funding Source: Medline; Telethon [E.0110, TGM06S01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001078] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aruga J, 1996, GENE, V172, P291, DOI 10.1016/0378-1119(96)00111-4; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Casey B, 1996, AM J MED GENET, V61, P325, DOI 10.1002/(SICI)1096-8628(19960202)61:4<325::AID-AJMG5>3.0.CO;2-T; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; CIMBORA DM, 1995, DEV BIOL, V169, P580, DOI 10.1006/dbio.1995.1171; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Danos MC, 1996, DEV BIOL, V177, P96, DOI 10.1006/dbio.1996.0148; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gebbia M, 1996, CIRCULATION, V94, P1909, DOI 10.1161/01.CIR.94.8.1909; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; KOSAKI K, IN PRESS SEMIN CELL; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Larsen WJ, 1993, HUMAN EMBRYOLOGY; Levin M, 1997, BIOESSAYS, V19, P287, DOI 10.1002/bies.950190406; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lohr JL, 1997, DEVELOPMENT, V124, P1465; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pilia G, 1996, GENOMICS, V34, P55, DOI 10.1006/geno.1996.0240; Splitt MP, 1997, HEART, V77, P369, DOI 10.1136/hrt.77.4.369; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155	28	320	329	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1997	17	3					305	308		10.1038/ng1197-305	http://dx.doi.org/10.1038/ng1197-305			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354794				2022-12-27	WOS:A1997YD66700024
J	Kafri, T; Blomer, U; Peterson, DA; Gage, FH; Verma, IM				Kafri, T; Blomer, U; Peterson, DA; Gage, FH; Verma, IM			Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors	NATURE GENETICS			English	Article							LONG-TERM EXPRESSION; RECOMBINANT ADENOVIRUSES; SYSTEMIC DELIVERY; THERAPY; MYOBLASTS; CELLS; TRANSPLANTATION; PROTEIN; INVIVO	Successful gene therapy approaches will require efficient gene delivery and sustained expression of the transgene in recipients. A variety of methods, ranging from direct DNA delivery to infection with recombinant viruses containing foreign genes, have been developed, but they all have some major limitations that restrict their utility(1-4). We have described a human lentiviral (HIV)-based vector that can transduce non-dividing cells in vitro and deliver genes in vivo(5,6). With this vector, expression of transgenes in the brain has been detected for more than six months-the longest period tested so far(7). Because lentiviral vectors are pseudotyped with vesicular stomatitis virus G glycoprotein (VSVG; ref, 8), they can transduce a broad range of tissues and cell types. We now describe the ability of lentiviral vectors to introduce genes directly into liver and muscle. Sustained expression of green fluorescent protein (GFP), used as a surrogate for therapeutic protein, can be observed for more than 22 weeks in the liver. Similar long-term expression (more than eight weeks) was observed in transduced muscle. in contrast, little or no GFP could be detected in liver or muscle transduced with the Moloney murine leukaemia virus (M-MLV), a prototypic retroviral based vector. At a minimum, 3-4% of the total liver tissue was transduced by a single injection of 1-3x10(7) infectious units (I.U.) of recombinant HIV vector. Furthermore, no inflammation or recruitment of lymphocytes could be detected at the site of injection. Animals previously transduced with a lentiviral vector can be efficiently re-infected with lentiviral vectors. Additionally, we show that the requirement for lentiviral accessory proteins to establish efficient transduction in vivo is tissue dependent.	SALK INST BIOL STUDIES,GENET LAB,LA JOLLA,CA 92037	Salk Institute					NIA NIH HHS [AG08514] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG008514, R37AG008514] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; Blomer U, 1997, J VIROL, V71, P6641; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; CRYSTAL RG, 1995, SCIENCE, V270, P404, DOI 10.1126/science.270.5235.404; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; HATTORI N, 1990, P NATL ACAD SCI USA, V87, P8080, DOI 10.1073/pnas.87.20.8080; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; LEIDEN JM, 1995, NEW ENGL J MED, V333, P871, DOI 10.1056/NEJM199509283331310; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; PETERSON DA, 1994, J NEUROSCI, V14, P6872; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	21	493	566	2	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					314	317		10.1038/ng1197-314	http://dx.doi.org/10.1038/ng1197-314			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354796				2022-12-27	WOS:A1997YD66700026
J	Geller, DH; Auchus, RJ; Mendonca, BB; Miller, WL				Geller, DH; Auchus, RJ; Mendonca, BB; Miller, WL			The genetic and functional basis of isolated 17,20-lyase deficiency	NATURE GENETICS			English	Article							SMALL GEOGRAPHIC AREA; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; MULTIPLE MUTATIONS; HUMAN P450C17; CYTOCHROME-P-450; PROTEIN; MUTAGENESIS; REDUCTASE; SEQUENCE; CLONING	Human male sexual differentiation requires production of fetal testicular testosterone, whose biosynthesis requires steroid 17,20-lyase activity(1,2). Patients with putative isolated 17,20-lyase deficiency have been reported(3,4). The existence of true isolated 17,20-lyase deficiency, however, has been questioned because 17 alpha-hydroxylase and 17,20-lyase activities are catalyzed by a single enzyme(5-8), microsomal cytochrome P450c17, and because the index case of apparent isolated 17,20-lyase deficiency had combined deficiencies of both activities(9,10). We studied two patients with clinical and hormonal findings suggestive of isolated 17,20-lyase deficiency. We found two patients homozygous for substitution mutations in CYP17, the gene encoding P450c17. When expressed in COS-1 cells, the mutants retained 17 alpha-hydroxylase activity but had minimal 17,20-lyase activity. Substrate competition experiments suggested that the mutations did not alter the enzyme's substrate-binding capacity, but co-transfection of cells with P450 oxidoreductase, the electron donor used by P450c17, indicated that the mutants had a diminished ability to interact with redox partners. Computer-graphic modelling of P450c17 suggests that both mutations lie in or near the redox-partner binding site, on the opposite side of the haem from the substrate-binding pocket. These mutations alter electrostatic charge distribution in the redox-partner binding site, so that electron transfer for the 17,20-lyase reaction is selectively lost or diverted to uncoupling reactions. These are the first proven cases of isolated 17,20-lyase deficiency, and they demonstrate a novel mechanism for loss of enzymatic activity.	UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, METAB RES UNIT, SAN FRANCISCO, CA 94143 USA; UNIV SAO PAULO, HOSP CLIN, DEPT ENDOCRINOL, SAO PAULO, BRAZIL	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Sao Paulo			Miller, Walter L/J-3696-2012; Mendonca, Berenice B/J-6917-2015; Mendonca, Berenice/AAS-3742-2021; Mendonca, Berenice B/C-2827-2012	Mendonca, Berenice B/0000-0003-1762-1084; Mendonca, Berenice/0000-0003-1762-1084; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922, K08DK002387] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK02387, DK0716, DK37922] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACH G, 1993, AM J HUM GENET, V53, P330; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; FAN YS, 1992, GENOMICS, V14, P1110, DOI 10.1016/S0888-7543(05)80140-5; FARDELLA CE, 1994, J CLIN ENDOCR METAB, V79, P160, DOI 10.1210/jc.79.1.160; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; GrahamLorence SE, 1996, METHOD ENZYMOL, V272, P315, DOI 10.1016/S0076-6879(96)72037-2; Grumbach M. M., 1992, WILLIAMS TXB ENDOCRI, P853; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; HEINISCH U, 1995, AM J HUM GENET, V56, P51; KITAMURA M, 1991, MOL ENDOCRINOL, V5, P1373, DOI 10.1210/mend-5-10-1373; LIN D, 1991, J BIOL CHEM, V266, P15992; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; LIN D, 1994, MOL ENDOCRINOL, V8, P392, DOI 10.1210/me.8.3.392; Miller WL., 1995, ENDOCRINOL METAB, P555; NAKAJIN S, 1981, BIOCHEMISTRY-US, V20, P4037, DOI 10.1021/bi00517a014; NAKAJIN S, 1984, J BIOL CHEM, V259, P3971; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; PICADOLEONARD J, 1988, MOL ENDOCRINOL, V2, P1145, DOI 10.1210/mend-2-11-1145; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SPARKES RS, 1991, DNA CELL BIOL, V10, P359, DOI 10.1089/dna.1991.10.359; YANASE T, 1995, J STEROID BIOCHEM, V53, P153, DOI 10.1016/0960-0760(95)00029-Y; YANASE T, 1992, BIOCHIM BIOPHYS ACTA, V1139, P275, DOI 10.1016/0925-4439(92)90100-2; YANASE T, 1991, ENDOCR REV, V12, P91, DOI 10.1210/edrv-12-1-91; ZACHMANN M, 1992, ACTA ENDOCRINOL-COP, V127, P97, DOI 10.1530/acta.0.1270097; ZACHMANN M, 1972, Clinical Endocrinology, V1, P369, DOI 10.1111/j.1365-2265.1972.tb00407.x; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; Zlotogora J, 1996, AM J HUM GENET, V58, P241; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	31	218	222	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1997	17	2					201	205		10.1038/ng1097-201	http://dx.doi.org/10.1038/ng1097-201			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326943				2022-12-27	WOS:A1997XZ55500029
J	Knudson, CM; Korsmeyer, SJ				Knudson, CM; Korsmeyer, SJ			Bcl-2 and Bax function independently to regulate cell death	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY; DEFICIENT MICE; APOPTOSIS; SURVIVAL; PROTEIN; THYMOCYTES; HAIR; SELECTION; BCL-X(L); BH1	The BCL-2 family has Various pairs of antagonist and agonist proteins that regulate apoptosis, Whether their function is interdependent is uncertain. Using a genetic approach to address this question, we utilized gain- and loss-of-function models of Bcl-2 and Bax and found that apoptosis and thymic hypoplasia characteristic of Bcl-2-deficient mice are largely absent in mice also deficient in Bax. A single copy of Bax promoted apoptosis in the absence of Bcl-2. In contrast, overexpression of Bcl-2 still repressed apoptosis in the absence of Bax. While an in vivo competition exists between Bax and Bcl-2, each is able to regulate apoptosis independently.	WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, DIV MOL ONCOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, DIV MOL ONCOL, ST LOUIS, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)				Knudson, Charles Michael/0000-0003-3964-5466	NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NCI NIH HHS [CA49712] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Boulakia CA, 1996, ONCOGENE, V12, P529; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Farrow SN, 1996, CURR OPIN GENET DEV, V6, P45, DOI 10.1016/S0959-437X(96)90009-X; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KAMADA S, 1995, CANCER RES, V55, P354; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shimizu S, 1996, ONCOGENE, V12, P2251; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Uhlmann EJ, 1996, CANCER RES, V56, P2506; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VEISNOVACK D, 1994, AM J PATHOL, V145, P61; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	40	335	342	3	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					358	363		10.1038/ng0897-358	http://dx.doi.org/10.1038/ng0897-358			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241272				2022-12-27	WOS:A1997XM90900017
J	Lyko, F; Brenton, JD; Surani, MA; Paro, R				Lyko, F; Brenton, JD; Surani, MA; Paro, R			An imprinting element from the mouse H19 locus functions as a silencer in Drosophila	NATURE GENETICS			English	Article							MELANOGASTER; GENE; DNA; METHYLATION	Genomic imprinting as originally described in Sciara(1) is displayed by many organisms. In mammals, X-inactivation and the parent-of-origin-specific silencing of imprinted genes are examples of this phenomenon(2,3). A heritable chromatin structural modification may be the critical mechanism in such instances of chromosome condensation and preferential gene inactivation. H19 is an imprinted gene(4) in which the repressed paternal allele is hypermethylated and the compacted chromatin is relatively resistant to digestion by nucleases(5-7). In order to uncover underlying conserved epigenetic mechanisms we have introduced a mouse H19 transgene into Drosophila. We show here that a 1.2-kb H19 upstream sequence functions in cis as a parent-of-origin independent silencing element in Drosophila. Strikingly, this cis-acting element is located within an upstream region that is necessary for H19 imprinting in mice(8). These results suggest involvement of an evolutionary conserved mechanism in both gene silencing in Drosophila and imprinting in mice.	UNIV HEIDELBERG,ZMBH,D-69120 HEIDELBERG,GERMANY; WELLCOME CRC INST CANC & DEV BIOL,CAMBRIDGE CB2 1QP,ENGLAND; UNIV CAMBRIDGE,PHYSIOL LAB,CAMBRIDGE CB2 3EG,ENGLAND	Ruprecht Karls University Heidelberg; University of Cambridge			Brenton, James D/B-3174-2008	Brenton, James D/0000-0002-5738-6683; Surani, Azim/0000-0002-8640-4318	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; CROUSE HV, 1960, GENETICS, V45, P1429; DANIELS SB, 1985, GENETICS, V109, P95; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; Elson DA, 1997, MOL CELL BIOL, V17, P309, DOI 10.1128/MCB.17.1.309; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; John RM, 1996, CURR OPIN CELL BIOL, V8, P348, DOI 10.1016/S0955-0674(96)80008-1; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; REUTER G, 1981, MOL GEN GENET, V182, P516, DOI 10.1007/BF00293947; ROBERTSON HM, 1988, GENETICS, V118, P461; Sambrook J., 2002, MOL CLONING LAB MANU; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; URIELISHOVAL S, 1982, FEBS LETT, V146, P148, DOI 10.1016/0014-5793(82)80723-0; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	21	99	101	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					171	173		10.1038/ng0697-171	http://dx.doi.org/10.1038/ng0697-171			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171828				2022-12-27	WOS:A1997XB54300017
J	Yergeau, DA; Hetherington, CJ; Wang, Q; Zhang, P; Sharpe, AH; Binder, M; MarinPadilla, M; Tenen, DG; Speck, NA; Zhang, DE				Yergeau, DA; Hetherington, CJ; Wang, Q; Zhang, P; Sharpe, AH; Binder, M; MarinPadilla, M; Tenen, DG; Speck, NA; Zhang, DE			Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; MURINE MYELOPEROXIDASE; NUCLEAR FACTOR; IDENTIFICATION; ENHANCER; PROMOTER; CELLS; BINDS; DNA	Acute myeloid leukaemia (AML) is a major haematopoietic malignancy characterized by the proliferation of a malignant clone of myeloid progenitor cells(1,2). A reciprocal translocation, t(8;21)(q22;q22), observed in the leukaemic cells of approximately 40% of patients with the M2 subtype of AML disrupts both the AML1 (CBFA2) gene on chromosome 21 and the ETO (MTG8) gene on chromosome 8 (refs 3-5). A chimaeric protein is synthesized from one of the derivative chromosomes that contains the N terminus of the AML1 transcription factor, including its DNA-binding domain, fused to most of ETO, a protein of unknown function. We generated mice that mimic human t(8;21) with a 'knock-in' strategy. Mice heterozygous for an AML I-ETO allele (AML1-ETO/+) die in midgestation from haemorrhaging in the central nervous system and exhibit a severe block in fetal liver haematopoiesis. This phenotype is very similar to that resulting from homozygous disruption of the AML1 (Cbfa2) or Cbfb genes(6-8), indicating that AML1-ETO blocks normal AML1 function. However, yolk sac cells from AML1-ETO/+ mice differentiated into macrophages in haematopoietic colony forming unit (CFU) assays, unlike Cbfa2-/- or Cbfb-/- cells, which form no colonies in vitro(6-8). This indicates that AML1-ETO may have other functions besides blocking wild-type AML1, a property that may be important in leukaemogenesis.	HARVARD UNIV, INST MED, SCH MED, BOSTON, MA 02115 USA; BETH ISRAEL DEACONESS MED CTR, DIV HEMATOL ONCOL, BOSTON, MA USA; DARTMOUTH COLL SCH MED, DEPT BIOCHEM, HANOVER, NH 03755 USA; DARTMOUTH COLL SCH MED, DEPT ANAT, HANOVER, NH 03755 USA; DARTMOUTH COLL SCH MED, DEPT PATHOL, HANOVER, NH 03755 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Dartmouth College; Dartmouth College; Dartmouth College; Harvard University; Brigham & Women's Hospital				Tenen, Daniel/0000-0002-6423-3888	NCI NIH HHS [CA41456] Funding Source: Medline; NIAMS NIH HHS [P030AR42689] Funding Source: Medline; NINDS NIH HHS [NS22897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armesilla AL, 1996, J BIOL CHEM, V271, P7781, DOI 10.1074/jbc.271.13.7781; BITTER MA, 1987, HUM PATHOL, V18, P211, DOI 10.1016/S0046-8177(87)80002-3; CAMERON S, 1994, BLOOD, V83, P2851, DOI 10.1182/blood.V83.10.2851.2851; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; ERICKSON P, 1992, BLOOD, V80, P1825; Erickson PF, 1996, BLOOD, V88, P1813; Frank R, 1995, ONCOGENE, V11, P2667; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; HAAS JG, 1992, J IMMUNOL, V149, P237; HSIANG YHH, 1993, J IMMUNOL, V150, P3905; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Meyers S, 1996, ONCOGENE, V13, P303; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; NISSON PE, 1992, CANCER GENET CYTOGEN, V63, P81, DOI 10.1016/0165-4608(92)90384-K; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rhoades KL, 1996, P NATL ACAD SCI USA, V93, P11895, DOI 10.1073/pnas.93.21.11895; ROWLEY JD, 1984, CANCER RES, V44, P3159; SUZOW J, 1993, MOL CELL BIOL, V13, P2141, DOI 10.1128/MCB.13.4.2141; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	30	291	301	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					303	306		10.1038/ng0397-303	http://dx.doi.org/10.1038/ng0397-303			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054947				2022-12-27	WOS:A1997WK38600024
J	Mangiarini, L; Sathasivam, K; Mahal, A; Mott, R; Seller, M; Bates, GP				Mangiarini, L; Sathasivam, K; Mahal, A; Mott, R; Seller, M; Bates, GP			Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; PALLIDOLUYSIAN ATROPHY DRPLA; ANDROGEN RECEPTOR GENE; TRINUCLEOTIDE REPEAT; ONSET; AGE; EXPANSION; LENGTH; MOSAICISM	Six inherited neurodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar muscular atrophy (SBMA)(1), Huntington's disease (HD)(2), spinocerebellar ataxia type 1 (SCA1)(3), dentatorubral pallidoluysian atrophy (DRPLA)(4,5) Machado-Joseph disease (MJD or SCA3)(6) and SCA2(7-9). Normal and expanded HD allele sizes of 6-39 and 35-121 repeats have been reported(10-13), and the allele distributions for the other diseases are comparable. Intergenerational instability has been described in all cases, and repeats tend to be more unstable on paternal transmission. This may present as larger increases on paternal inheritance as in HD14, or as a tendency to increase on male and decrease on female transmission as in SCA1 (ref.15). Stomatic repeat instability is also appears most pronounced in the CNS16,17. The major exception is the cerebellum, which in HD, DRPLA, SCA1 and MJD has a smaller repeat relative to the other brain regions tested(16-21). Of non-CNS tissues, instability was observed in blood, liver, kidney and colon(16,20,21). A mouse model of CAG repeat instability would be helpful in unravelling its molecular basis although an absence of CAG repeat instability in transgenic mice has so far been reported. These studies include (CAG)(45) in the androgen receptor cDNA(22), (CAG)(44), in the HD cDNA(23), (CAG)(82) in the SCA1 cDNA(24), (CAG)(79) in the SCA3 cDNA and as an isolated (CAC)(79) tract(25).	GUYS HOSP,DIV MED & MOL GENET,LONDON SE1 9RT,ENGLAND; SANGER CTR,HINXTON CB10 1RO,CAMBS,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Wellcome Trust Sanger Institute			Bates, Gillian P/E-1146-2012; Longo, Kenneth A/A-5631-2010	Bates, Gillian P/0000-0002-4041-6305; Mott, Richard/0000-0002-1022-9330				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1992, AM J HUM GENET, V50, P528; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; *HDCRG, 1993, CELL, V72, P971; Hogan B, 1994, MANIPULATING MOUSE E; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KRAWCZAK M, 1991, AM J HUM GENET, V49, P735; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MANGIARINI L, 1996, CELL, V87, P497; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; SAMPEI K, 1996, NAT GENET, V14, P277; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Takano H, 1996, AM J HUM GENET, V58, P1212; Tanaka F, 1996, J NEUROL SCI, V135, P43, DOI 10.1016/0022-510X(95)00249-2; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663	30	254	264	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					197	200		10.1038/ng0297-197	http://dx.doi.org/10.1038/ng0297-197			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020849				2022-12-27	WOS:A1997WF08700023
J	Reilly, PR; Boshar, MF; Holtzman, SH				Reilly, PR; Boshar, MF; Holtzman, SH			Ethical issues in genetic research: Disclosure and informed consent	NATURE GENETICS			English	Editorial Material							SAMPLES	As research to correlate genetic status with predisposition to disease has accelerated, so has the concern that participation in such studies creates the risk of genetic discrimination and emotional distress. There is a need to broaden disclosure during the consent process to ensure that potential subjects understand these risks and other issues and to address them in the consent form. We describe the broad approach that we have taken in regard to disclosure and consent in gene mapping studies.	MILLENNIUM PHARMACEUT INC,CAMBRIDGE,MA 02139	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Reilly, PR (corresponding author), EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC,WALTHAM,MA 02154, USA.							*AAAS DIR SCI POL, 1993, C ETH LEG ASP PED RE; *AM SOC HUM GEN, 1994, AM J HUM GENET, V55, pR1; *AM SOC HUM GEN, 1996, AM J HUM GENET, V59, P471; *AM SOC HUM GEN BO, 1995, AM J HUM GENET, V57, P1233; Bernstein T, 1994, RADON RENTAL HOUSING; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BLATT R, 1993, GENET RESOUR, V7, P32; BLOCH M, 1990, AM J HUM GENET, V46, P1; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; EARLEY CL, 1995, AM J HUM GENET, V57, P727; *HOUS COMM, 1995, HUM GEN SCI ITS CONS; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Juengst Eric T, 1995, Genome Sci Technol, V1, P21, DOI 10.1089/gst.1995.1.21; KNOPPERS BM, 1995, JAMA-J AM MED ASSOC, V274, P1806, DOI 10.1001/jama.274.22.1806; *NAT ACT PLAN BREA, 1996, POS PAP HER SUSC TES; *NIH DOE WORK GROU, 1990, 933686 NIH NAT CTR H; *NIH OFF PROT RES, 1993, HUM GEN RES PROT HUM; *PRES COMM STUD ET, 1981, PROT HUM SUBJ	18	74	74	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					16	20		10.1038/ng0197-16	http://dx.doi.org/10.1038/ng0197-16			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988163				2022-12-27	WOS:A1997WA37300015
J	Leister, D; Ballvora, A; Salamini, F; Gebhardt, C				Leister, D; Ballvora, A; Salamini, F; Gebhardt, C			A PCR-based approach for isolating pathogen resistance genes from potato with potential for wide application in plants	NATURE GENETICS			English	Article							F SP LYCOPERSICI; NEMATODE GLOBODERA-ROSTOCHIENSIS; RACE-SPECIFIC RESISTANCE; DISEASE RESISTANCE; PHYTOPHTHORA-INFESTANS; CONFERRING RESISTANCE; CLADOSPORIUM-FULVUM; SOLANUM-TUBEROSUM; VIRUS-RESISTANCE; LINKAGE MAPS	Plant genes for pathogen resistance can be used to engineer disease resistant crops. Oligonucleotides were designed from sequence motifs conserved between resistance genes of tobacco and Arabidopsis thaliana and used as PCR primers in potato DNA. Amplification products were obtained that were homologous to known resistance genes and linked without recombination with the nematode resistance locus Gro1 and the Phytophthora infestans resistance locus R7 of potato. Map positions of PCR-derived potato gene fragments were also correlated with resistance loci of the related tomato and tobacco genomes. Our results indicate that plant resistance genes that are effective against nematodes, fungi,viruses and bacteria may be isolated based on common sequence motifs and PCR methodology.	MAX PLANCK INST ZUCHTUNGSFORSCH, D-50829 COLOGNE, GERMANY	Max Planck Society			Gebhardt, Chris/HGD-6090-2022; Leister, Dario/D-5587-2009	Leister, Dario/0000-0003-1897-8421				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALINTKURTI PJ, 1994, THEOR APPL GENET, V88, P691, DOI 10.1007/BF01253972; BALLVORA A, 1995, MOL GEN GENET, V249, P82, DOI 10.1007/BF00290239; BARONE A, 1990, MOL GEN GENET, V224, P177, DOI 10.1007/BF00271550; BEHARE J, 1991, MOL PLANT MICROBE IN, V4, P489, DOI 10.1094/MPMI-4-489; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BONIERBALE MW, 1988, GENETICS, V120, P1095; BOURNIVAL BL, 1989, THEOR APPL GENET, V78, P489, DOI 10.1007/BF00290832; CHUNWONGSE J, 1994, THEOR APPL GENET, V89, P76, DOI 10.1007/BF00226986; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; ELKHARBOTLY A, 1994, MOL GEN GENET, V242, P749, DOI 10.1007/BF00283432; ELKHARBOTLY A, IN PRESS THEOR APPL; ELLIS JG, 1995, P NATL ACAD SCI USA, V92, P4185, DOI 10.1073/pnas.92.10.4185; Ganal MW, 1995, MOL PLANT MICROBE IN, V8, P886, DOI 10.1094/MPMI-8-0886; GEBHARDT C, 1995, GENET RES, V65, P1, DOI 10.1017/S001667230003295X; GEBHARDT C, 1993, THEOR APPL GENET, V85, P541, DOI 10.1007/BF00220911; GEBHARDT C, 1991, THEOR APPL GENET, V83, P49, DOI 10.1007/BF00229225; GEBHARDT C, 1989, THEOR APPL GENET, V78, P65, DOI 10.1007/BF00299755; GEBHARDT C, 1994, DNA BASED MARKERS PL; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; HAMALAINEN JH, IN PRESS THEOR APPL; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; JONES DA, 1992, TOMATO GENET COOP RE, V42, P19; KALOSHIAN I, 1995, P NATL ACAD SCI USA, V92, P622, DOI 10.1073/pnas.92.2.622; KREIKE CM, 1993, THEOR APPL GENET, V87, P464, DOI 10.1007/BF00215092; LAWRENCE GJ, 1995, PLANT CELL, V7, P1195, DOI 10.1105/tpc.7.8.1195; LEONARDSSCHIPPERS C, 1992, MOL GEN GENET, V233, P278, DOI 10.1007/BF00587589; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; LEVESQUE H, 1990, THEOR APPL GENET, V80, P602, DOI 10.1007/BF00224218; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; MESSEGUER R, 1991, THEOR APPL GENET, V82, P529, DOI 10.1007/BF00226787; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; RITTER E, 1990, GENETICS, V125, P645; RITTER E, 1991, MOL GEN GENET, V227, P81, DOI 10.1007/BF00260710; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SARFATTI M, 1991, THEOR APPL GENET, V82, P22, DOI 10.1007/BF00231273; SARFATTI M, 1989, THEOR APPL GENET, V78, P755, DOI 10.1007/BF00262574; SEGAL G, 1992, MOL GEN GENET, V231, P179, DOI 10.1007/BF00279789; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; STEVENS MR, 1995, THEOR APPL GENET, V90, P451, DOI 10.1007/BF00221989; TANKSLEY SD, 1992, GENETICS, V132, P1141; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; VANBERKEL J, 1994, PLANT PHYSIOL, V104, P445, DOI 10.1104/pp.104.2.445; VANDERBEEK JG, 1994, THEOR APPL GENET, V89, P467, DOI 10.1007/BF00225382; VANDERBIEZEN EA, 1995, MOL GEN GENET, V247, P453, DOI 10.1007/BF00293147; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; YAGHOOBI J, 1995, THEOR APPL GENET, V91, P457, DOI 10.1007/BF00222973; YOUNG ND, 1988, GENETICS, V120, P579; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; ZAMIR D, 1995, TOMATO GENET COOP RE, V43, P51	56	435	513	1	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					421	429		10.1038/ng1296-421	http://dx.doi.org/10.1038/ng1296-421			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944022				2022-12-27	WOS:A1996VV73000018
J	Hoglund, P; Haila, S; Socha, J; Tomaszewski, L; SaarialhoKere, U; KarjalainenLindsberg, ML; Airola, K; Holmberg, C; delaChapelle, A; Kere, J				Hoglund, P; Haila, S; Socha, J; Tomaszewski, L; SaarialhoKere, U; KarjalainenLindsberg, ML; Airola, K; Holmberg, C; delaChapelle, A; Kere, J			Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; EXPRESSION; HYBRIDIZATION; LOCALIZATION; POPULATIONS; TRANSPORT; ENCODES; FINLAND		CHILD HLTH CTR,DEPT GASTROENTEROL & NUTR,WARSAW,POLAND; UNIV HELSINKI,DEPT DERMATOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,HAARTMAN INST,DEPT PATHOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,FIN-00014 HELSINKI,FINLAND	Children's Memorial Health Institute; University of Helsinki; University of Helsinki; University of Helsinki	Hoglund, P (corresponding author), UNIV HELSINKI,HAARTMAN INST,DEPT MED GENET,HAARTMANINKATU 3,FIN-00014 HELSINKI,FINLAND.		Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271				BIEBERDO.FA, 1972, J CLIN INVEST, V51, P1958, DOI 10.1172/JCI107002; BUCHAN AMJ, 1989, TXB PHYSL, P1438; Byeon MK, 1996, ONCOGENE, V12, P387; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Hoglund P, 1996, GENOME RES, V6, P202, DOI 10.1101/gr.6.3.202; HOLMBERG C, 1975, J CLIN INVEST, V56, P302, DOI 10.1172/JCI108094; KERE J, 1993, P NATL ACAD SCI USA, V90, P10686, DOI 10.1073/pnas.90.22.10686; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; NORIO R, 1971, Clinical Genetics, V2, P182; PEARSON AJG, 1973, Q J MED, V167, P453; PROSSER IW, 1989, AM J PATHOL, V135, P1073; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; TOMASZEWSKI L, 1987, MAT MED POL, V4, P271; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; TURNBERG LA, 1971, GUT, V12, P544, DOI 10.1136/gut.12.7.544	22	316	321	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					316	319		10.1038/ng1196-316	http://dx.doi.org/10.1038/ng1196-316			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896562				2022-12-27	WOS:A1996VQ14600027
J	Pennacchio, LA; Bouley, DM; Higgins, KM; Scott, MP; Noebels, JL; Myers, RM				Pennacchio, LA; Bouley, DM; Higgins, KM; Scott, MP; Noebels, JL; Myers, RM			Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice	NATURE GENETICS			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; TEAR FLUID; CATHEPSIN-B; DISEASE; GENE; MUTATIONS; PROTEOLYSIS; PROTEINS; STORAGE; IDENTIFICATION	Loss-of-function mutations in the gene (CSTB) encoding human cystatin B, a widely expressed cysteine protease inhibitor, are responsible for a severe neurological disorder known as Unverricht-Lundborg disease (EPM1). The primary cellular events and mechanisms underlying the disease are unknown. We found that mice lacking cystatin B develop myoclonic seizures and ataxia, similar to symptoms seen in the human disease. The principal cytopathology appears to be a loss of cerebellar granule cells, which frequently display condensed nuclei, fragmented DNA and other cellular changes characteristic of apoptosis. This mouse model of EPM1 provides evidence that cystatin B, a non-caspase cysteine protease inhibitor, has a role in preventing cerebellar apoptosis.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Baylor College of Medicine; Baylor College of Medicine	Myers, RM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	myers@shgc.stanford.edu		Pennacchio, Len/0000-0002-8748-3732; Noebels, Jeffrey/0000-0002-2887-0839	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS29709] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKA T, 1991, CURR EYE RES, V10, P25, DOI 10.3109/02713689109007608; BARRETT AJ, 1986, BIOCHEM J, V236, P312, DOI 10.1042/bj2360312; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; BOHLEY P, 1992, EXPERIENTIA, V48, P151, DOI 10.1007/BF01923508; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CARPENTER S, 1974, NEUROLOGY, V24, P531, DOI 10.1212/WNL.24.6.531; CEJKOVA J, 1989, HISTOCHEMISTRY, V92, P441, DOI 10.1007/BF00492502; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; ELDRIDGE R, 1983, LANCET, V2, P838, DOI 10.1016/s0140-6736(83)90749-3; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HALTIA M, 1969, ACTA NEUROL SCAND, V45, P63; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P333; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P307; KOSKINIEMI M, 1990, PAEDIATRIC EPILEPSY, P137; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KYLLERMAN M, 1991, EPILEPSIA, V32, P900, DOI 10.1111/j.1528-1157.1991.tb05549.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Lane SC, 1996, J NEUROCHEM, V67, P677; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARKS N, 1986, ARCH BIOCHEM BIOPHYS, V249, P489, DOI 10.1016/0003-9861(86)90026-3; NORIO R, 1979, CLIN GENET, V15, P382; OBRIEN JS, 1978, CLIN GENET, V14, P55; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Pennacchio LA, 1996, GENOME RES, V6, P1103, DOI 10.1101/gr.6.11.1103; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; SALONEN EM, 1987, ACTA OPHTHALMOL, V65, P3; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; SAX DS, 1968, NEUROLOGY, V18, P1093, DOI 10.1212/WNL.18.11.1093; SCHOFFNER JM, 1990, CELL, V61, P931; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; TERVO T, 1989, GRAEF ARCH CLIN EXP, V227, P42, DOI 10.1007/BF02169824; TSUNG PK, 1981, CURR EYE RES, V1, P351, DOI 10.3109/02713688108998361; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WILLIAMS MS, 1994, J IMMUNOL, V153, P4247; ZEMAN W, 1963, Ann Histochim, V8, P255; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361	50	231	237	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					251	258		10.1038/3059	http://dx.doi.org/10.1038/3059			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806543				2022-12-27	WOS:000076698100018
J	Clifton-Bligh, RJ; Wentworth, JM; Heinz, P; Crisp, MS; John, R; Lazarus, JH; Ludgate, M; Chatterjee, VK				Clifton-Bligh, RJ; Wentworth, JM; Heinz, P; Crisp, MS; John, R; Lazarus, JH; Ludgate, M; Chatterjee, VK			Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia	NATURE GENETICS			English	Article							ENHANCER-BINDING PROTEIN; CONGENITAL HYPOTHYROIDISM; IDENTIFICATION; PROMOTER; HORMONE; MOUSE; TRANSCRIPTION; HOMEODOMAIN; PITUITARY; RECEPTOR	Congenital hypothyroidism occurs in one of every three to four thousand newborns, owing to complete or partial failure of thyroid gland development(1). Although thyroid hypoplasia has recently been associated with mutations in the thyrotropin (TSH) receptor(2,3), the cause of thyroid agenesis is unknown. Proteins including thyroid transcription factors 1 (TTF-l; refs 4,5) and 2 (TTF-2; refs 6,7) and Pax8 (refs 8,9) are abundant in the developing mouse thyroid and are known to regulate genes expressed during its differentiation (for example, thyroid peroxidase and thyroglobulin genes). TTF-2 is a member of the forkhead/winged-helix domain transcription factor family, many of which are key regulators of embryogenesis(10). Here we report that the transcription factor FKHL15 (ref. 11) is the human homologue of mouse TTF-2 (encoded by the Titf2 gene) and that two siblings with thyroid agenesis, cleft palate and choanal atresia(12) are homozygous for a missense mutation (Ala65Val) within its forkhead domain. The mutant protein exhibits impaired DNA binding and loss of transcriptional function. Our observations represent the first description of a genetic cause for thyroid agenesis.	Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Neath Gen Hosp, Dept Paediat, Neath SA11 2LQ, Wales; Univ Wales Hosp, Dept Pathol, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Hosp, Dept Med, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Hosp, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University; Cardiff University; Cardiff University	Chatterjee, VK (corresponding author), Addenbrookes Hosp, Dept Med, Level 5, Cambridge CB2 2QQ, England.	kkc1@mole.bio.cam.ac.uk	Lazarus, John H/H-5108-2017	Lazarus, John H/0000-0001-8852-704X; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Ludgate, Marian/0000-0002-7436-0821; Wentworth, John/0000-0002-5197-3529; Clifton-Bligh, Roderick/0000-0002-1545-0368	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; ADAMS M, 1994, J CLIN INVEST, V94, P506, DOI 10.1172/JCI117362; Ahlbom BE, 1997, HUM GENET, V99, P186, DOI 10.1007/s004390050335; AZABLANC P, 1993, MOL ENDOCRINOL, V7, P1297, DOI 10.1210/me.7.10.1297; BAMFORTH JS, 1989, J MED GENET, V26, P49, DOI 10.1136/jmg.26.1.49; Biebermann H, 1997, NEW ENGL J MED, V336, P1390, DOI 10.1056/NEJM199705083361914; Chadwick BP, 1997, GENOMICS, V41, P390, DOI 10.1006/geno.1997.4692; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEFELICE M, 1998, NATURE GENET; Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; GRANT DB, 1992, ARCH DIS CHILD, V67, P87, DOI 10.1136/adc.67.1.87; GRANT DB, 1988, BRIT MED J, V296, P1355, DOI 10.1136/bmj.296.6633.1355; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Lapi P, 1997, THYROID, V7, P383, DOI 10.1089/thy.1997.7.383; LAZARUS JH, 1988, LANCET, V2, P52; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; MIZUNO K, 1991, MOL CELL BIOL, V11, P4927, DOI 10.1128/MCB.11.10.4927; Perna MG, 1997, THYROID, V7, P377, DOI 10.1089/thy.1997.7.377; PLACHOV D, 1990, DEVELOPMENT, V110, P643; Roberts HE, 1997, AM J MED GENET, V71, P29, DOI 10.1002/(SICI)1096-8628(19970711)71:1<29::AID-AJMG5>3.0.CO;2-L; SAMUELS HH, 1974, J CLIN INVEST, V54, P853, DOI 10.1172/JCI107825; STEIN SA, 1994, MOL ENDOCRINOL, V8, P129, DOI 10.1210/me.8.2.129; WOOD WM, 1989, J BIOL CHEM, V264, P14840; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	29	284	301	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1998	19	4					399	401		10.1038/1294	http://dx.doi.org/10.1038/1294			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697705				2022-12-27	WOS:000075107600027
J	Schultheis, PJ; Clarke, LL; Meneton, P; Miller, ML; Soleimani, M; Gawenis, LR; Riddle, TM; Duffy, JJ; Doetschman, T; Wang, T; Giebisch, G; Aronson, PS; Lorenz, JN; Shull, GE				Schultheis, PJ; Clarke, LL; Meneton, P; Miller, ML; Soleimani, M; Gawenis, LR; Riddle, TM; Duffy, JJ; Doetschman, T; Wang, T; Giebisch, G; Aronson, PS; Lorenz, JN; Shull, GE			Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger	NATURE GENETICS			English	Article							BLOOD-PRESSURE; BRUSH-BORDER; HYPOKALEMIC ALKALOSIS; BARTTERS-SYNDROME; EXPRESSION; MUTATIONS; ISOFORM; COTRANSPORTER; TRANSPORT; MEMBRANE	NHE3 is one of five plasma membrane Na+/H+ exchangers(1-3) and is encoded by the mouse gene Slc9a3. It is expressed on apical membranes of renal proximal tubule(4,5) and intestinal epithelial cells(6,7) and is thought to play a major role in NaCl and HCO3- absorption(4-10). As the distribution of NHE3 overlaps with that of the NHE2 isoform in kidney(7,11) and intestine(7,12,13), the function and relative importance of NHE3 in vivo is unclear. To analyse its physiological functions, we generated mice lacking NHE3 function. Homozygous mutant (Slc9a3(-/-)) mice survive, but they have slight diarrhoea and blood analysis revealed that they are mildly acidotic. HCO3- and fluid absorption are sharply reduced in proximal convoluted tubules, blood pressure is reduced and there is a severe absorptive defect in the intestine. Thus, compensatory mechanisms must limit gross perturbations of electrolyte and acid-base balance. Plasma aldosterone is increased in NHE3-deficient mice, and expression of both renin and the AE1 (Slc4a1) Cl-/HCO3- exchanger mRNAs are induced in kidney. In the colon, epithelial Na+ channel activity is increased and colonic H+.K+-ATPase mRNA is massively induced. These data show that NHE3 is the major absorptive Na+/H+ exchanger in kidney and intestine, and that lack of the exchanger impairs acid-base balance and Na+-fluid volume homeostasis.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Physiol, Cincinnati, OH 45267 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; Univ Missouri, Dept Vet Biomed Sci, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Yale University; Yale University; University of Missouri System; University of Missouri Columbia	Shull, GE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.		Meneton, Pierre/T-1216-2019; Clarke, Lane L/AAK-2866-2020	Clarke, Lane L/0000-0002-4938-6261	NHLBI NIH HHS [HL41496] Funding Source: Medline; NIDDK NIH HHS [DK48816, R29 DK048816, DK50594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050594, R01DK050594, R56DK048816, R29DK048816, R01DK048816] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Aronson PS, 1997, AM J PHYSIOL-RENAL, V273, pF179, DOI 10.1152/ajprenal.1997.273.2.F179; Azuma KK, 1996, AM J PHYSIOL-CELL PH, V270, pC585, DOI 10.1152/ajpcell.1996.270.2.C585; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Bookstein C, 1997, AM J PHYSIOL-CELL PH, V273, pC1496, DOI 10.1152/ajpcell.1997.273.5.C1496; BOOKSTEIN C, 1994, J CLIN INVEST, V93, P106, DOI 10.1172/JCI116933; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Clarke LL, 1996, AM J PHYSIOL-GASTR L, V270, pG259, DOI 10.1152/ajpgi.1996.270.2.G259; DASILVA JCT, 1991, AM J PHYSIOL, V260, pF204, DOI 10.1152/ajprenal.1991.260.2.F204; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; FELL JM, 1992, J PEDIATR GASTR NUTR, V15, P112, DOI 10.1097/00005176-199208000-00002; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; KAUNITZ JD, 1995, TXB GASTROENTEROLOGY, P326; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; Meneton P, 1998, J CLIN INVEST, V101, P536, DOI 10.1172/JCI1720; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; POWELL DW, 1995, TXB GASTROENTEROLOGY, P813; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; TSE CM, 1992, J BIOL CHEM, V267, P9340; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WANG T, 1990, J PHARMACOL EXP THER, V252, P689; Wu MS, 1996, J BIOL CHEM, V271, P32749, DOI 10.1074/jbc.271.51.32749; YUN CHC, 1993, J BIOL CHEM, V268, P206	30	650	660	4	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					282	285		10.1038/969	http://dx.doi.org/10.1038/969			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662405				2022-12-27	WOS:000074565900028
J	Warner, LE; Mancias, P; Butler, IJ; McDonald, CM; Keppen, L; Koob, KG; Lupski, JR				Warner, LE; Mancias, P; Butler, IJ; McDonald, CM; Keppen, L; Koob, KG; Lupski, JR			Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; ZINC-FINGER PROTEIN; NGFI-A; TRANSCRIPTION FACTORS; BINDING DOMAINS; KROX-20; NEUROPATHY; HINDBRAIN; KROX20	The early growth response 2 gene (EGR2) is part of a multigene family encoding Cys(2)-His(2) type zinc-finger proteins and may play a role in the regulation of cellular proliferation(1,2). Egr2, (also known as Krox20) is the mouse orthologue of human EGR2 and was first identified as an immediate-early response gene, encoding a protein that binds DNA in a sequence-specific manner and acts as a transcription factor(3-6). Stable expression of Egr2 is specifically associated with the onset of myelination in the peripheral nervous system (PNS; ref.7). Egr2(-/-) mice display disrupted hindbrain segmentation and development(8,9). and a block of Schwann-cell differentiation at an early stage(10). We hypothesized that Egr2 may be a transcription factor affecting late myelin genes and that human myelinopathies of the PNS may result from mutations in EGR2. In support of this hypothesis, we have identified one recessive and two dominant missense mutations in EGR2 (within regions encoding conserved functional domains) in patients with congenital hypomyelinating neuropathy (CHN) and a family with Charcot-Marie-Tooth type 1 (CMT1).	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Neurol, Sch Med, Houston, TX 77030 USA; Univ Calif Davis, Med Ctr, Dept Phys Med & Rehabil, Sacramento, CA 95817 USA; Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; Univ S Dakota, Sch Med, Dept Pediat & Adolescent Med, Sioux Falls, SD 57117 USA; Neurol Associates PC, Sioux Falls, SD 57105 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Davis; University of California System; University of California Davis; University of South Dakota; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			McDonald, Craig/0000-0002-8779-3220	NICHD NIH HHS [HD94021] Funding Source: Medline; NIGMS NIH HHS [T32-GM08307] Funding Source: Medline; NINDS NIH HHS [R01 NS27042] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; BROWN RS, 1986, NATURE, V324, P215, DOI 10.1038/324215a0; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; DEJONGHE P, 1997, J PERIPHER NERV SYST, V2, P370; Dyck P.J, 1993, PNP, P1094; GIBSON TJ, 1988, PROTEIN ENG, V2, P209, DOI 10.1093/protein/2.3.209; HARATI Y, 1985, J NEUROL NEUROSUR PS, V48, P1269, DOI 10.1136/jnnp.48.12.1269; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; Lupski JR, 1997, HOSP PRACT, V32, P83, DOI 10.1080/21548331.1997.11443485; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RANGNEKAR VM, 1990, NUCLEIC ACIDS RES, V18, P2749, DOI 10.1093/nar/18.9.2749; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Svaren J, 1996, MOL CELL BIOL, V16, P3545; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; WILSON TE, 1992, J BIOL CHEM, V267, P3718; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	30	372	384	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					382	384		10.1038/ng0498-382	http://dx.doi.org/10.1038/ng0498-382			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537424				2022-12-27	WOS:000072755500024
J	Santer, R; Schneppenheim, R; Dombrowski, A; Gotze, H; Steinmann, B; Schaub, J				Santer, R; Schneppenheim, R; Dombrowski, A; Gotze, H; Steinmann, B; Schaub, J			Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome	NATURE GENETICS			English	Article							AMINO-ACID; JAPANESE SUBJECTS; SEQUENCE; TRYPTOPHAN-412; POLYMORPHISMS; SUBSTITUTION; POLYMERASE; DNA	Fanconi-Bickel syndrome (FBS) is a rare autosomal-recessive inborn error of metabolism characterized by hepatorenal glycogen accumulation, Fanconi nephropathy and impaired utilization of glucose and galactose(1), To date, no underlying enzymatic defect in carbohydrate metabolism has been identified. Therefore, and because of (he impairment of both glucose and galactose metabolism, a primary defect of monosaccharide transport across membranes has been suggested(1-4). Here we report mutations in the gene encoding the facilitative glucose transporter 2 (GLUT2) in three FBS families, including the original patient described in 1949 by Fanconi and Bickel(5) Homozygous mutations were found in affected individuals, whereas all parents tested were heterozygous for the respective mutation. Because all detected mutations (Delta T446-449, C1251T and C1405T) predict truncated translation products that cannot be expected to have functional monosaccharide transport activity, GLUT2 mutations are probably the cause of FBS.	MUNICIPAL CHILDRENS HOSP,ESSLINGEN,GERMANY; UNIV ZURICH,DEPT PAEDIAT,DIV METAB & MOL DIS,CH-8006 ZURICH,SWITZERLAND	University of Zurich	Santer, R (corresponding author), CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PAEDIAT,SCHWANENWEG 20,D-24105 KIEL,GERMANY.							APERIA A, 1981, ACTA PAEDIATR SCAND, V70, P527, DOI 10.1111/j.1651-2227.1981.tb05735.x; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Chen Y-T, 1995, METABOLIC MOL BASES, P935; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; FANCONI G., 1949, HELVETICA PAEDIATR ACTA, V4, P359; FELLERS FX, 1967, PEDIATR RES, V1, P304; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GITZELMANN R, 1957, Helv Paediatr Acta, V12, P425; HOLMAN GD, 1989, BIOCHEM SOC T, V17, P438, DOI 10.1042/bst0170438; ISHIHARA H, 1991, BIOCHEM BIOPH RES CO, V176, P922, DOI 10.1016/S0006-291X(05)80274-8; KATAGIRI H, 1991, J BIOL CHEM, V266, P7769; LOWE T, 1990, NUCLEIC ACIDS RES, V18, P1757, DOI 10.1093/nar/18.7.1757; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; MATSUBARA A, 1995, J CLIN ENDOCR METAB, V80, P3131, DOI 10.1210/jc.80.11.3131; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1994, J BIOL CHEM, V269, P17765; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Muller D, 1997, J INHERIT METAB DIS, V20, P607, DOI 10.1023/A:1005375629820; Odievre M, 1966, Rev Int Hepatol, V16, P1; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PERMUTT MA, 1989, P NATL ACAD SCI USA, V86, P8688, DOI 10.1073/pnas.86.22.8688; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 2002, MOL CLONING LAB MANU; SHIMADA F, 1995, DIABETOLOGIA, V38, P211, DOI 10.1007/s001250050272; TAKEDA J, 1993, DIABETES, V72, P773	28	198	204	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					324	326		10.1038/ng1197-324	http://dx.doi.org/10.1038/ng1197-324			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354798				2022-12-27	WOS:A1997YD66700028
J	Bamshad, M; Lin, RC; Law, DJ; Watkins, WS; Krakowiak, PA; Moore, ME; Franceschini, P; Lala, R; Holmes, LB; Gebuhr, TC; Bruneau, BG; Schinzel, A; Seidman, JG; Seidman, CE; Jorde, LB				Bamshad, M; Lin, RC; Law, DJ; Watkins, WS; Krakowiak, PA; Moore, ME; Franceschini, P; Lala, R; Holmes, LB; Gebuhr, TC; Bruneau, BG; Schinzel, A; Seidman, JG; Seidman, CE; Jorde, LB			Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome	NATURE GENETICS			English	Article							CONSERVED PROTEIN MOTIF; MOUSE BRACHYURY; EEC-SYNDROME; GENE FAMILY; HOMOLOG; DROSOPHILA; EXPRESSION; CLONING; HAND		HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV TURIN,IST DISCIPLINE PEDIAT,SERV GENET CLIN,TURIN,ITALY; OSPED INFANTILE R MARGHERETA,DIV ENDOCRINOL PEDIAT,TURIN,ITALY; MASSACHUSETTS GEN HOSP,GENET & TERATOL UNIT,BOSTON,MA 02114; UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Harvard University; Massachusetts General Hospital; University of Zurich; Harvard University; Brigham & Women's Hospital	Bamshad, M (corresponding author), UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,SALT LAKE CITY,UT 84112, USA.			Bruneau, Benoit/0000-0002-0804-7597	NHGRI NIH HHS [5-P30-HG00199, HG00209] Funding Source: Medline; PHS HHS [M01-00064] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000199] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGUINIK SI, 1996, GENETICS, V144, P249; AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Bamshad M, 1996, AM J MED GENET, V65, P325, DOI 10.1002/(SICI)1096-8628(19961111)65:4<325::AID-AJMG15>3.0.CO;2-W; BAMSHAD M, 1995, HUM MOL GENET, V4, P1973, DOI 10.1093/hmg/4.10.1973; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; BUSS PW, 1995, J MED GENET, V32, P716, DOI 10.1136/jmg.32.9.716; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; FRANCESCHINI P, 1992, AM J MED GENET, V44, P807, DOI 10.1002/ajmg.1320440618; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; GONZALEZ CH, 1976, EUR J PEDIATR, V123, P225, DOI 10.1007/BF00444644; Hamel Ben, 1996, European Journal of Human Genetics, V4, P148; HECHT JT, 1984, CLIN GENET, V25, P63; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HOLT M, 1960, BRIT HEART J, V22, P236; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1994, GENE DEV, V8, P2137, DOI 10.1101/gad.8.18.2137; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; LECK I, 1993, HUMAN MALFORMATIONS, V1, P65; Li QY, 1997, NAT GENET, V15, P21; Morrison K, 1996, HUM MOL GENET, V5, P669, DOI 10.1093/hmg/5.5.669; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nakatani Y, 1996, DEVELOPMENT, V122, P2023; Pallister P D, 1976, Birth Defects Orig Artic Ser, V12, P247; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; RUDIGER RA, 1970, AM J DIS CHILD, V120, P160; SCHINZEL A, 1987, CLIN GENET, V32, P160; SCHINZEL A, 1987, J MED GENET, V24, P778, DOI 10.1136/jmg.24.12.778; SCHINZEL A, 1987, CLIN GENET, V32, P425; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315	40	418	433	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					311	315		10.1038/ng0797-311	http://dx.doi.org/10.1038/ng0797-311			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207801				2022-12-27	WOS:A1997XG60900031
J	Bowers, JE; Meredith, CP				Bowers, JE; Meredith, CP			The parentage of a classic wine grape, Cabernet Sauvignon	NATURE GENETICS			English	Article							CULTIVARS; IDENTIFICATION; POLYMORPHISMS	The world's great wines are produced from a relatively small number of classic European cultivars of Vitis vinifera L. Most are thought to be centuries old and their origins have long been the subject of speculation(1,2). Among the most prominent of these cultivars is Cabernet Sauvignon, described as ''the world's most renowned grape variety for the production of fine red wine''(3). Although now grown in many countries, Cabernet Sauvignon derives its fame from its long association with the Bordeaux region of France, where it has been grown at least since the 17th century(4). We present microsatellite DNA evidence for the hypothesis that Cabernet Sauvignon is the progeny of two other Bordeaux cultivars, Cabernet franc and Sauvignon blanc. Likelihood ratios support this hypothesis to a very high degree of probability. A close relationship between Cabernet Sauvignon and Cabernet franc has been suspected but the genetic contribution of Sauvignon blanc, despite its similar name, is a surprise.	UNIV CALIF DAVIS,DEPT VITICULTURE & ENOL,DAVIS,CA 95616	University of California System; University of California Davis			Bowers, John/B-9245-2009; Bowers, John/AAD-7601-2019	Bowers, John/0000-0001-8984-9796; Bowers, John/0000-0001-5693-2796				Bouquet A., 1982, Progres Agricole et Viticole, V99, P110; BOURQUIN JC, 1993, THEOR APPL GENET, V87, P431, DOI 10.1007/BF00215088; Bowers JE, 1996, GENOME, V39, P628, DOI 10.1139/g96-080; BOWERS JE, 1993, AM J ENOL VITICULT, V44, P266; BOWERS JE, 1993, THESIS U CALIFORNIA; GALET P, 1990, CEPHAGES VIGNOBLES F, V2; HAGELBERG E, 1991, NATURE, V352, P427, DOI 10.1038/352427a0; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; PARFITT DE, 1989, J AM SOC HORTIC SCI, V114, P486; RIVES M., 1961, Annales de l'Amelioration des Plantes, V11, P337; ROBINSON I, 1994, OXFORD COMPANION WIN; Sturtevant Alfred, 1965, HIST GENETICS; THOMAS MR, 1994, PLANT MOL BIOL, V25, P939, DOI 10.1007/BF00014668; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; Viala P., 1901, AMPELOGRAPHIE, V2; Weir BS., 1996, GENETIC DATA ANAL; WOLFE WH, 1976, AM J ENOL VITICULT, V27, P68	18	221	244	2	47	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					84	87		10.1038/ng0597-84	http://dx.doi.org/10.1038/ng0597-84			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140400				2022-12-27	WOS:A1997WX02400027
J	Matthijs, G; Schollen, E; Pardon, E; VeigaDaCunha, M; Jaeken, J; Cassiman, JJ; VanSchaftingen, E				Matthijs, G; Schollen, E; Pardon, E; VeigaDaCunha, M; Jaeken, J; Cassiman, JJ; VanSchaftingen, E			Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)	NATURE GENETICS			English	Article							SERUM TRANSFERRIN	Carbohydrate-deficient glycoprotein syndrome type 1 (CDG1 or Jaeken syndrome) is the prototype of a class of genetic multisystem disorders characterized by defective glycosylation of glycoconjugates(1-4). It is mostly a severe disorder which presents neonatally. There is a severe encephalopathy with axial hypotonia, abnormal eye movements and pronounced psychomotor retardation, as well as a peripheral neuropathy, cerebellar hypoplasia and retinitis pigmentosa. The patients show a peculiar distribution of subcutaneous fat, nipple retraction and hypogonadism. There is a 20% lethality in the first years of life due to severe infections, liver insufficiency or cardiomyopathy(2,3,5). CDG1 shows an autosomal recessive mode of inheritance and has been mapped to chromosome 16p(6,7). Most patients show a deficiency of phosphomannomutase (PMM)(8), an enzyme necessary for the synthesis of GDP-mannose. We have cloned the PMM1 gene, which is on chromosome 22q13 (ref, 9), We now report the identification of a second human PMM gene, PMM2, which is located on 16p13 and which encodes a protein with 66% identity to PMM1. We found eleven different missense mutations in PMM2 in 16 CDG1 patients from different geographical origins and with a documented phosphomannomutase deficiency. Our results give conclusive support to the biochemical finding that the phosphomannomutase deficiency is the basis for CDG1.	INT INST CELLULAR & MOL PATHOL, PHYSIOL CHEM LAB, B-1200 BRUSSELS, BELGIUM; UNIV CATHOLIQUE LOUVAIN, B-1200 BRUSSELS, BELGIUM; KATHOLIEKE UNIV LEUVEN HOSP, DEPT PEDIAT, B-3000 LOUVAIN, BELGIUM	Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Matthijs, G (corresponding author), CATHOLIC UNIV LEUVEN, CTR HUMAN GENET, CAMPUS GASTHUISBERG, B-3000 LOUVAIN, BELGIUM.		Van+Schaftingen, Emile/AAF-5532-2020	Matthijs, Gert/0000-0001-6710-1912; Van Schaftingen, Emile/0000-0002-6199-7647				CHEN ISY, 1983, NATURE, V305, P502, DOI 10.1038/305502a0; DOGGETT NA, 1995, NATURE, V377, P335; JAEKEN J, 1984, CLIN CHIM ACTA, V144, P245, DOI 10.1016/0009-8981(84)90059-7; JAEKEN J, 1980, PEDIATR RES, V14, P179, DOI 10.1203/00006450-198002000-00117; JAEKEN J, 1993, J INHERIT METAB DIS, V16, P813, DOI 10.1007/BF00714272; Jaeken J, 1997, J MED GENET, V34, P73, DOI 10.1136/jmg.34.1.73; JAEKEN J, IN PRESS J INHER MET; JAEKEN J, IN PRESS EUR J PEDIA; KEPES F, 1988, J BIOL CHEM, V263, P9155; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LONGMIRE JL, 1993, GENET ANAL-BIOMOL E, V10, P69, DOI 10.1016/1050-3862(93)90037-J; MARTINSSON T, 1994, HUM MOL GENET, V3, P2037; Matthijs G, 1996, GENOMICS, V35, P597, DOI 10.1006/geno.1996.0404; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Sambrook J., 2002, MOL CLONING LAB MANU; STIBLER H, 1994, J NEUROL NEUROSUR PS, V57, P552, DOI 10.1136/jnnp.57.5.552; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; WADA Y, 1992, BIOCHEM BIOPH RES CO, V189, P832, DOI 10.1016/0006-291X(92)92278-6; YAMASHITA K, 1993, J BIOL CHEM, V268, P5783	19	274	278	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					88	92		10.1038/ng0597-88	http://dx.doi.org/10.1038/ng0597-88			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140401				2022-12-27	WOS:A1997WX02400028
J	Braverman, N; Steel, G; Obie, C; Moser, A; Moser, H; Gould, SJ; Valle, D				Braverman, N; Steel, G; Obie, C; Moser, A; Moser, H; Gould, SJ; Valle, D			Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata	NATURE GENETICS			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; SIGNAL IMPORT RECEPTOR; TARGETING SIGNAL; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; BIOGENESIS DISORDERS; HANSENULA-POLYMORPHA; ZELLWEGER SYNDROME; GENE	Rhizomelic chondrodysplasia punctata (RCDP) is a rare autosomal recessive phenotype that comprises complementation group 11 of the peroxisome biogenesis disorders (PBD). PEX7, a candidate gene for RCDP identified in yeast, encodes the receptor for peroxisomal matrix proteins with the type-2 peroxisome targeting signal (PTS2). By homology probing we identified human and murine PEX7 genes and found that expression of either corrects the PTS2-import defect characteristic of RCDP cells. In a collection of 36 RCDP probands, we found two inactivating PEX7 mutations: one, L292ter, was present in 26 of the probands, all with a severe phenotype; the second, A218V, was present in three probands, including two with a milder phenotype. A third mutation, G217R, whose functional significance is yet to be determined, was present in five probands, all compound heterozygotes with L292ter. We conclude that PEX7 is responsible for RCDP (PBD CG11) and suggest a founder effect may explain the high frequency of L292ter.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University					NCRR NIH HHS [RR00052, RR00722] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barth PG, 1996, AM J MED GENET, V62, P164, DOI 10.1002/(SICI)1096-8628(19960315)62:2<164::AID-AJMG9>3.0.CO;2-W; BRODY LC, 1992, J BIOL CHEM, V267, P3302; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cooper DN, 1995, METABOLIC MOL BASES, P259; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; DODT G, IN PRESS NEW YORK AC; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; ENGELHARDT JF, 1991, J BIOL CHEM, V266, P752; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FABER KN, 1995, FEBS LETT, V357, P115, DOI 10.1016/0014-5793(94)01317-T; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fukuda S, 1996, AM J HUM GENET, V59, P1210; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY RGF, 1992, J INHERIT METAB DIS, V15, P931, DOI 10.1007/BF01800236; HEIKOOP JC, 1990, J CLIN INVEST, V86, P126, DOI 10.1172/JCI114674; HEIKOOP JC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P69; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Hieter P, 1996, NAT GENET, V13, P253, DOI 10.1038/ng0796-253; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; Innis MA, 1990, PCR PROTOCOLS GUIDE; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MAQUAT LE, 1995, RNA, V1, P453; MARYNEN P, 1995, GENOMICS, V30, P366, DOI 10.1006/geno.1995.0032; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1996, BBA-MOL BASIS DIS, V1315, P153, DOI 10.1016/0925-4439(95)00114-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NUOFFER JM, 1994, J INHERIT METAB DIS, V17, P60, DOI 10.1007/BF00735395; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PIKE MG, 1990, J PEDIATR-US, V116, P88, DOI 10.1016/S0022-3476(05)81651-8; POLLTHE BT, 1991, J INHERIT METAB DIS, V14, P361, DOI 10.1007/BF01811703; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Sambrook J., 2002, MOL CLONING LAB MANU; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P11325; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SMEITINK JAM, 1992, J INHERIT METAB DIS, V15, P377, DOI 10.1007/BF02435981; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	69	330	335	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					369	376		10.1038/ng0497-369	http://dx.doi.org/10.1038/ng0497-369			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090381				2022-12-27	WOS:A1997WQ38900014
J	Mitelman, F; Mertens, F; Johansson, B				Mitelman, F; Mertens, F; Johansson, B			A breakpoint map of recurrent chromosomal rearrangements in human neoplasia	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENES; CANCER; TRANSLOCATIONS; ONCOGENES	Cytogenetic studies over the past few decades have revealed clonal chromosomal aberrations in almost 27,000 human neoplasms. Many of these neoplasia-associated chromosomal abnormalities have been characterised at the molecular level, revealing previously unknown genes that are closely associated with the tumorigenic process. Information on chromosome changes in neoplasia is growing rapidly, making it difficult to identify all recurrent chromosomal aberrations. We have developed a computer program to ascertain, for the first time, all recurrent structural abnormalities in all haematological malignancies and solid tumours published up to June 1996. Out of 26,523 cases, a total of 215 balanced and 1,588 unbalanced recurrent aberrations were identified among 75 different neoplastic disorders. Our compilation of all recurrent balanced and unbalanced neoplasia-associated rearrangements should help in directing future efforts aimed at identifying the molecular mechanisms involved in tumorigenesis.			Mitelman, F (corresponding author), UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN.			Mitelman, Felix/0000-0002-3757-7212; Mertens, Fredrik/0000-0002-6278-5232				BAYREUTHER K, 1960, NATURE, V186, P6, DOI 10.1038/186006a0; BERGER R, 1982, CYTOGENET CELL GENET, V32, P205, DOI 10.1159/000131700; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; CASPERSS.T, 1970, EXP CELL RES, V60, P315, DOI 10.1016/0014-4827(70)90523-9; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; Heim S, 1995, CANC CYTOGENETICS; HEUBNER K, 1989, CANCER RES, V49, P4071; KLEIN G, 1989, GENE CHROMOSOME CANC, V1, P3, DOI 10.1002/gcc.2870010103; KNUDSON AG, 1985, CANCER RES, V45, P1437; Knudson AG, 1995, ADV CANCER RES, V67, P1, DOI 10.1016/S0065-230X(08)60708-3; KOLLER PC, 1972, RECENT RESULTS CANC, V38; LEVAN A, 1967, HEREDITAS-GENETISK A, V57, P343; Mitelman F., 1996, P1332; MITELMAN F, 1994, CATALOG CHROMOSOME A; MITELMAN F, IN PRESS CANC GENEN; NOWELL PC, 1960, SCIENCE, V132, P1497; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; ROWLEY JD, 1993, JAMA-J AM MED ASSOC, V270, P2331, DOI 10.1001/jama.270.19.2331; ROWLEY JD, 1990, CANCER, V65, P2178, DOI 10.1002/1097-0142(19900515)65:10<2178::AID-CNCR2820651004>3.0.CO;2-#; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SCHROCK, 1996, SCIENCE, V273, P494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; STANBRIDGE EJ, 1992, CANCER SURV, V12, P5; VONHANSEMANN D, 1890, ARCH PATHOL ANAT PHY, V119, P299; WEINBERG RA, 1994, CA-CANCER J CLIN, V44, P160, DOI 10.3322/canjclin.44.3.160; WINGE O., 1930, ZEITSCHR WISS BIOL ABT B ZEITSCHR ZELL FORSCH U MIKROSK, V10, P683, DOI 10.1007/BF00372971	27	611	631	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15				SI		417	474		10.1038/ng0497supp-417	http://dx.doi.org/10.1038/ng0497supp-417			58	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX845	9140409				2022-12-27	WOS:A1997WX84500003
J	Herault, Y; Rassoulzadegan, M; Cuzin, F; Duboule, D				Herault, Y; Rassoulzadegan, M; Cuzin, F; Duboule, D			Engineering chromosomes in mice through targeted meiotic recombination (TAMERE)	NATURE GENETICS			English	Article							HOXD COMPLEX; GENES; REGIONS	Functional studies of large transcription units, clustered genes and chromosomal loci require the design of novel experimental toots to engineer genomic macro-rearrangements. Here, we present a strategy to produce deficiencies or duplications by crossing mice carrying loxP sites in homologous loci. This trans-allelic targeted meiotic recombination (TAMERE) protocol allows for the combination of various alleles within a particular locus as well as for generation of interchromosomal unequal exchanges. Novel genetic configurations can thus be produced without multiple targeting and selection steps in embryonic stem (ES) cells. A concomitant deletion/duplication event of the Hoxd12 locus shows the potential of this approach. The high frequency of such targeted exchanges in vivo makes TAMERE a powerful genetic tool applicable to research areas in which complex genomic modifications are required.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Nice, INSERM U470, F-06108 Nice, France	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Sci 3,Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	Denis.Duboule@zoo.unige.ch	Herault, Yann/B-5500-2012; Rassoulzadegan, Minoo/O-7939-2016	Herault, Yann/0000-0001-7049-6900; duboule, denis/0000-0001-9961-2960				Beckers J, 1998, DEV DYNAM, V213, P1; Davis AP, 1996, DEVELOPMENT, V122, P1175; Dupe V, 1997, DEVELOPMENT, V124, P399; Gerard M, 1996, GENE DEV, V10, P2326, DOI 10.1101/gad.10.18.2326; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Herault Y, 1998, DEVELOPMENT, V125, P1669; Kondo T, 1996, DEVELOPMENT, V122, P2651; Kondo T, 1998, MOL CELL, V1, P289, DOI 10.1016/S1097-2765(00)80029-5; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; VIDAL F, IN PRESS MOL REPROD; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	18	132	140	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					381	384		10.1038/3861	http://dx.doi.org/10.1038/3861			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843213				2022-12-27	WOS:000077199600028
J	Hager, J; Dina, C; Francke, S; Dubois, S; Houari, M; Vatin, V; Vaillant, E; Lorentz, N; Basdevant, A; Clement, K; Guy-Grand, B; Froguel, P				Hager, J; Dina, C; Francke, S; Dubois, S; Houari, M; Vatin, V; Vaillant, E; Lorentz, N; Basdevant, A; Clement, K; Guy-Grand, B; Froguel, P			A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10	NATURE GENETICS			English	Article							LEPTIN RECEPTOR GENE; HUMAN OB GENE; QUANTITATIVE TRAIT; MARKERS FLANKING; EXTREME OBESITY; PIMA-INDIANS; LINKAGE; MUTATION; ABSENCE; WEIGHT	Obesity, a common multifactorial disorder, is a major risk factor for type 2 diabetes, hypertension and coronary heart disease(1) (CHD). According to the definition of the World Health Organization (WHO), approximately 6-10% of the population in Westernized countries are considered obese(2). Epidemiological studies have shown that 30-70% of the variation in body weight may be attributable to genetic factors. To date, two genome-wide scans using different obesity-related quantitative traits have provided candidate regions for obesity(3,4). We have undertaken a genome-wide scan in affected sibpairs to identify chromosomal regions linked to obesity in a collection of French families. Model-free multipoint linkage analyses revealed evidence for linkage to a region on chromosome 10p (MLS=4.85). Two further loci on chromosomes 5cen-q and 2p showed suggestive evidence for linkage of serum leptin levels in a genome-wide context. The peak on chromosome 2 coincided with the region containing the gene (POMC) encoding pro-opiome-lanocortin, a locus previously linked to leptin levels and fat mass in a Mexican-American population(3) and shown to be mutated in obese humans(5). Our results suggest that there is a major gene on chromosome 10p implicated in the development of human obesity, and the existence of two further loci influencing leptin levels.	Inst Biol, CNRS EP 10, F-59019 Lille, France; Hop Hotel Dieu, Dept Nutr, Paris, France; Univ Bonn, Inst Klin Biochem, D-5300 Bonn, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Bonn	Froguel, P (corresponding author), Inst Biol, CNRS EP 10, 1 Rue Prof Calmette, F-59019 Lille, France.	jorg.hager@xenope.pasteur.lille.fr; froguel@xenope.pasteur-lille.fr	Dina, Christian R/D-3535-2015; FROGUEL, Philippe/O-6799-2017; Clément, karine/R-1120-2017	Dina, Christian R/0000-0002-7722-7348; FROGUEL, Philippe/0000-0003-2972-0784; 				Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Francke S, 1997, HUM GENET, V100, P491, DOI 10.1007/s004390050540; FRAYN KN, 1992, CLIN SCI, V82, P1, DOI 10.1042/cs0820001; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; NAGGERT JK, 1995, NAT GENET, V10, P153; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Norman RA, 1996, DIABETES, V45, P1229, DOI 10.2337/diabetes.45.9.1229; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; TIRET L, 1992, GENET EPIDEMIOL, V9, P389, DOI 10.1002/gepi.1370090603; TRAN LD, 1994, SAGE STAT ANAL GENET; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	27	305	321	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					304	308		10.1038/3123	http://dx.doi.org/10.1038/3123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806554				2022-12-27	WOS:000076698100029
J	Majumdar, A; Khorlin, A; Dyatkina, N; Lin, FLM; Powell, J; Liu, J; Feiz, ZZ; Khripine, Y; Watanabe, KA; George, J; Glazer, PM; Seidman, MM				Majumdar, A; Khorlin, A; Dyatkina, N; Lin, FLM; Powell, J; Liu, J; Feiz, ZZ; Khripine, Y; Watanabe, KA; George, J; Glazer, PM; Seidman, MM			Targeted gene knockout mediated by triple helix forming oligonucleotides	NATURE GENETICS			English	Article							DOUBLE-STRAND BREAKS; ILLEGITIMATE RECOMBINATION; MAMMALIAN CHROMOSOME; BASE-PAIRS; HPRT GENE; DNA; SEQUENCES; BINDING; RECOGNITION; MUTAGENESIS	Triple helix forming oligonucleotides (TFOs) recognize and bind sequences in duplex DNA and have received considerable attention because of their potential for targeting specific genomic sites(1-3). TFOs can deliver DNA reactive reagents to specific sequences in purified chromosomal DNA (ref. 4) and nuclei(5). However, chromosome targeting in viable cells has not been demonstrated, and in vitro experiments indicate that chromatin structure is incompatible with tripler formation(6-8) We have prepared modified TFOs, linked to the DNA-crosslinking reagent psoralen. directed at a site in the Hprt gene. We show that stable Hprt-deficient clones can be recovered following introduction of the TFOs into viable cells and photoactivation of the psoralen. Analysis of 282 clones indicated that 85% contained mutations in the tripler target region. We observed mainly deletions and some insertions. These data indicate that appropriately constructed TFOs can find chromosomal targets, and suggest that the chromatin structure in the target region is more dynamic than predicted by the in vitro experiments.	NIA, NIH, Baltimore, MD 21224 USA; Codon Pharmaceut, Gaithersburg, MD 20877 USA; Yale Univ, Dept Therapeut Radiol, New Haven, CT 06510 USA; Ribozyme Pharmaceut Inc, Boulder, CO USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Yale University	Seidman, MM (corresponding author), NIA, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.		Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560				Agrawal S, 1997, P NATL ACAD SCI USA, V94, P2620, DOI 10.1073/pnas.94.6.2620; Brown PM, 1996, BIOCHEM J, V319, P607, DOI 10.1042/bj3190607; CARIELLO NF, 1993, J MOL BIOL, V231, P41, DOI 10.1006/jmbi.1993.1255; CARIELLO NF, 1994, MUTAT RES, V312, P173, DOI 10.1016/0165-1161(94)90023-X; CHUBB JM, 1992, TRENDS BIOTECHNOL, V10, P132, DOI 10.1016/0167-7799(92)90195-2; ESCUDE C, 1993, NUCLEIC ACIDS RES, V21, P5547, DOI 10.1093/nar/21.24.5547; Espinas ML, 1996, J BIOL CHEM, V271, P31807, DOI 10.1074/jbc.271.50.31807; FOSSELLA JA, 1993, NUCLEIC ACIDS RES, V21, P4511, DOI 10.1093/nar/21.19.4511; Gilar M, 1997, NUCLEIC ACIDS RES, V25, P3615, DOI 10.1093/nar/25.18.3615; Giovannangeli C, 1997, P NATL ACAD SCI USA, V94, P79, DOI 10.1073/pnas.94.1.79; GRIFFIN LC, 1989, SCIENCE, V245, P967, DOI 10.1126/science.2549639; Korshun VA, 1997, NUCLEOS NUCLEOT NUCL, V16, P1461, DOI 10.1080/07328319708006206; KOSHLAP KM, 1993, J AM CHEM SOC, V115, P7908, DOI 10.1021/ja00070a059; Kukreti S, 1997, NUCLEIC ACIDS RES, V25, P4264, DOI 10.1093/nar/25.21.4264; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; LAQUERBE A, 1995, MUTAT RES LETT, V346, P173, DOI 10.1016/0165-7992(95)90050-0; LEE JS, 1984, NUCLEIC ACIDS RES, V12, P6603, DOI 10.1093/nar/12.16.6603; Neidle S, 1997, ANTI-CANCER DRUG DES, V12, P433; ORSON FM, 1994, NUCLEIC ACIDS RES, V22, P479, DOI 10.1093/nar/22.3.479; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; POSVIC TJ, 1989, J AM CHEM SOC, V111, P3059; ROSSITER BJF, 1991, GENOMICS, V9, P247, DOI 10.1016/0888-7543(91)90249-E; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Schneider TD, 1997, NUCLEIC ACIDS RES, V25, P4408, DOI 10.1093/nar/25.21.4408; STROBEL SA, 1991, SCIENCE, V254, P1639, DOI 10.1126/science.1836279; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; THUONG NT, 1993, ANGEW CHEM INT EDIT, V32, P666, DOI 10.1002/anie.199306661; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; WESTIN L, 1995, NUCLEIC ACIDS RES, V23, P2184, DOI 10.1093/nar/23.12.2184	30	154	175	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					212	214		10.1038/2530	http://dx.doi.org/10.1038/2530			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771719				2022-12-27	WOS:000076231300028
J	Wilkie, T				Wilkie, T			Genetics and insurance in Britain: why more than just the Atlantic divides the English-speaking nations	NATURE GENETICS			English	Article								British Government's official advisory committee on genetics has recommended a moratorium on the disclosure of genetic test results for life insurance until predictions based on such tests can be validated as actuarially important. In contrast, the trade association of the British insurance industry believes that genetic tests relating to eight conditions can yield information useful for life insurance. Although the Government has yet to respond, the debate is already moving on to genetic testing and the funding of health care for the elderly.	Wellcome Trust Res Labs, London NW1 2BE, England		Wilkie, T (corresponding author), Wellcome Trust Res Labs, 210 Euston Rd, London NW1 2BE, England.	t.wilkie@wellcome.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*ASS BRIT INS, 1997, GEN TEST ABI COD PRA; HARPER PS, 1993, LANCET, V341, P224, DOI 10.1016/0140-6736(93)90080-Z; *HUM GEN ADV COMM, 1997, IMPL GEN TEST INS; MacDonald AS, 1997, PHILOS T ROY SOC B, V352, P1067, DOI 10.1098/rstb.1997.0087; Nuffield Council on Bioethics, 1993, GEN SCREEN ETH ISS; *SCI TECHN COMM HO, 1995, HUM GEN SCI ITS CONS; WARREN V, COMMUNICATION	7	11	11	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					119	121		10.1038/2416	http://dx.doi.org/10.1038/2416			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771702				2022-12-27	WOS:000076231300011
J	Niida, H; Matsumoto, T; Satoh, H; Shiwa, M; Tokutake, Y; Furuichi, Y; Shinkai, Y				Niida, H; Matsumoto, T; Satoh, H; Shiwa, M; Tokutake, Y; Furuichi, Y; Shinkai, Y			Severe growth defect in mouse cells lacking the telomerase RNA component	NATURE GENETICS			English	Article							ELONGATION; SENESCENCE; CANCER; YEAST; DNA	The ribonucleoprotein enzyme telomerase synthesizes telomeric DNA onto chromosome ends(1). Telomere length is maintained, by the presence of telomerase activity, in the vast majority of primary tumours and stem cells(2,3), suggesting that telomere maintenance is essential for cellular immortalization. Recently, the telomerase RNA component in human(4) and mouse(5) (TERC and Terc, respectively), a telomerase-associated protein TEP1/TLP1 (refs 6,7) and the human catalytic subunit protein TERT (refs 8,9) have been identified. To examine the role of telomerase in telomere maintenance and cellular viability, we established Terc-deficient embryonic stem (ES) cells. It is known that telomerase activity is absent in cells from Terc-knockout mice(10). Although the study showed that telomere shortening was observed in the Terc-deficient cells from first to six generation animals, whether telomerase-dependent telomere maintenance was essential for cellular viability remained to be elucidated. To address this issue, we examined Terc-deficient ES cells under long-term culture conditions. Accompanying the continual telomere shortening, the growth rate of Terc-deficient ES cells was gradually reduced after more than 300 divisions. An impaired growth rate was maintained to approximately 450 divisions, and then cell growth virtually stopped. These data clearly show that telomerase-dependent telomere maintenance is critical for the growth of mammalian cells.	Nippon Roche Res Ctr, Kamakura, Kanagawa 2478530, Japan; Agene Res Inst, Kamakura, Kanagawa 2478530, Japan	Roche Holding	Shinkai, Y (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, 53 Shogoin Kawara Cho, Kyoto 6068397, Japan.		Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484				BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; RADIC MZ, 1987, CELL, V50, P1101, DOI 10.1016/0092-8674(87)90176-0; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	27	137	144	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					203	206		10.1038/580	http://dx.doi.org/10.1038/580			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620783				2022-12-27	WOS:000073865100034
J	Parkes, TL; Elia, AJ; Dickinson, D; Hilliker, AJ; Phillips, JP; Boulianne, GL				Parkes, TL; Elia, AJ; Dickinson, D; Hilliker, AJ; Phillips, JP; Boulianne, GL			Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons	NATURE GENETICS			English	Article							ZINC SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; MELANOGASTER; SPAN; MUTATIONS	Reactive oxygen (RO) has been identified as an important effector in ageing and lifespan determination(1-3). The specific cell types, however, in which oxidative damage acts to limit lifespan of the whole organism have not been explicitly identified. The association between mutations in the gene encoding the oxygen radical metabolizing enzyme CuZn superoxide dismutase (SOD1) and loss of motorneurons in the brain and spinal cord that occurs in the life-shortening paralytic disease, Familial Amyotrophic Lateral Sclerosis (FALS; ref. 4), suggests that chronic and unrepaired oxidative damage occurring specifically in motor neurons could be a critical causative factor in ageing. To test this hypothesis, we generated transgenic Drosophila which express human SOD1 specifically in adult motorneurons. We show that overexpression of a single gene, SOD1, in a single cell type, the motorneuron, extends normal lifespan by up to 40% and rescues the lifespan of a short-lived Sod null mutant. Elevated resistance to oxidative stress suggests that the lifespan extension observed in these flies is due to enhanced RO metabolism. These results show that SOD activity in motorneurons is an important factor in ageing and lifespan determination in Drosophila.	Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada; Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Zool, Toronto, ON, Canada	University of Guelph; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Phillips, JP (corresponding author), Univ Guelph, Dept Mol Biol & Genet, Guelph, ON N1G 2W1, Canada.	jphillip@uoguelph.ca						BRAND AH, 1993, DEVELOPMENT, V118, P401; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; LEE YM, 1981, J BIOL CHEM, V256, P8506; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111; PARKES TL, IN PRESS GENOME; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; STAVELEY BE, 1990, GENOME, V33, P867, DOI 10.1139/g90-130; Tower J, 1996, BIOESSAYS, V18, P799, DOI 10.1002/bies.950181006; Umbreit WW, 1964, MANOMETRIC TECHNIQUE; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	18	672	691	0	56	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					171	174		10.1038/534	http://dx.doi.org/10.1038/534			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620775				2022-12-27	WOS:000073865100026
J	Heiss, NS; Knight, SW; Vulliamy, TJ; Klauck, SM; Wiemann, S; Mason, PJ; Poustka, A; Dokal, I				Heiss, NS; Knight, SW; Vulliamy, TJ; Klauck, SM; Wiemann, S; Mason, PJ; Poustka, A; Dokal, I			X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions	NATURE GENETICS			English	Article							FACTOR-VIII GENE; INCONTINENTIA PIGMENTI; XQ28; REGION; CANDIDATE; PROTEIN; DNA; IDENTIFICATION; AMPLIFICATION; TRANSCRIPTS	X-linked recessive dyskeratosis congenita (DKC) is a rare bone-marrow failure disorder linked to Xq28. Hybridization screening with 28 candidate cDNAs resulted in the detection of a 3' deletion in one DKC patient with a cDNA probe (derived from XAP101). Five different missense mutations in five unrelated patients were subsequently identified in XAP101, indicating that it is the gene responsible for X-linked DKC (DKC1). DKC1 is highly conserved across species barriers and is the orthologue of rat NAP57 and Saccharomyces cerevisiae CBF5. The peptide dyskerin contains two TruB pseudouridine (psi) synthase motifs, multiple phosphorylation sites, and a carboxy-terminal lysine-rich repeat domain. By analogy to the function of the known dyskerin orthologues, involvement in the cell cycle and nucleolar function is predicted for the protein.	Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, D-69120 Heidelberg, Germany; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Haematol, London W12 0NN, England; Hammersmith Hosp, London W12 0NN, England	Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; Imperial College London	Poustka, A (corresponding author), Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.poustka@dkfz-heidelberg.de; i.dokal@rpms.ac.uk	Wiemann, Stefan/E-4424-2013; Mason, Philip J/B-1087-2008	Wiemann, Stefan/0000-0003-4683-3174; Dokal, Inderjeet/0000-0003-4462-4782	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNGRIMSSON R, 1993, J MED GENET, V30, P618, DOI 10.1136/jmg.30.7.618; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Cadwell C, 1997, MOL CELL BIOL, V17, P6175, DOI 10.1128/MCB.17.10.6175; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CONNOR JM, 1986, HUM GENET, V72, P348, DOI 10.1007/BF00290963; COULTHARD S, 1997, BR J HEAMAT, V97, pS1; Coy JF, 1996, GENOMICS, V32, P309, DOI 10.1006/geno.1996.0124; COY JF, 1994, MAMM GENOME, V5, P131, DOI 10.1007/BF00352342; CROSS NCP, 1993, BRIT J HAEMATOL, V84, P67, DOI 10.1111/j.1365-2141.1993.tb03026.x; DAS S, 1994, AM J HUM GENET, V54, P922; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dixon J, 1996, NAT GENET, V12, P130; Dokal I, 1996, BRIT J HAEMATOL, V92, P775, DOI 10.1046/j.1365-2141.1996.355881.x; DOKAL I, 1994, LEUKEMIA LYMPHOMA, V15, P1, DOI 10.3109/10428199409051671; DOKAL I, 1992, BLOOD, V80, P3090; DRACHTMAN RA, 1992, AM J PEDIAT HEMATOL, V14, P297; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Heiss NS, 1997, GENOMICS, V43, P329, DOI 10.1006/geno.1997.4810; Heiss NS, 1996, GENOME RES, V6, P478, DOI 10.1101/gr.6.6.478; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Heiss NS, 1995, METHOD MOL CELL BIOL, V5, P337; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; KENWRICK S, 1992, HUM MOL GENET, V1, P179, DOI 10.1093/hmg/1.3.179; Knight SW, 1996, J MED GENET, V33, P993, DOI 10.1136/jmg.33.12.993; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; MEIER UT, 1994, J CELL BIOL, V127, P1505, DOI 10.1083/jcb.127.6.1505; MEIER UT, 1992, CELL, V70, P127; Metzenberg Aida B., 1992, Human Molecular Genetics, V1, P97, DOI 10.1093/hmg/1.2.97; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; ROGNER UC, 1994, HUM MOL GENET, V3, P2137, DOI 10.1093/hmg/3.12.2137; Rogner UC, 1996, GENOME RES, V6, P922, DOI 10.1101/gr.6.10.922; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; Vulliamy TJ, 1997, BLOOD, V90, P2213; Wilgenbus KK, 1995, METHOD MOL CELL BIOL, V5, P214; WINKLER AA, IN PRESS YEAST	41	674	698	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					32	38		10.1038/ng0598-32	http://dx.doi.org/10.1038/ng0598-32			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590285				2022-12-27	WOS:000073346700013
J	Igarashi, S; Koide, R; Shimohata, T; Yamada, M; Hayashi, Y; Takano, H; Date, H; Oyake, M; Sato, T; Sato, A; Egawa, S; Ikeuchi, T; Tanaka, H; Nakano, R; Tanaka, K; Hozumi, I; Inuzuka, T; Takahashi, H; Tsuji, S				Igarashi, S; Koide, R; Shimohata, T; Yamada, M; Hayashi, Y; Takano, H; Date, H; Oyake, M; Sato, T; Sato, A; Egawa, S; Ikeuchi, T; Tanaka, H; Nakano, R; Tanaka, K; Hozumi, I; Inuzuka, T; Takahashi, H; Tsuji, S			Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch	NATURE GENETICS			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; SPINOCEREBELLAR ATAXIA TYPE-1; TRINUCLEOTIDE CAG REPEAT; CATALYZED CROSS-LINKING; MACHADO-JOSEPH DISEASE; GLUTAMINE REPEATS; NEURODEGENERATIVE DISEASES; HUNTINGTONS-DISEASE; COMPLEMENTARY-DNA; TRANSGENIC MICE	To elucidate the molecular mechanisms whereby expanded polyglutamine stretches elicit a gain of toxic function, we expressed full-length and truncated DRPLA (dentatorubral-pallidoluysian atrophy) cDNAs with or without expanded CAG repeats in COS-7 cells. We found that truncated DRPLA proteins containing an expanded polyglutamine stretch form filamentous peri-and intranuclear aggregates and undergo apoptosis. The apoptotic cell death was partially suppressed by the transglutaminase inhibitors cystamine and monodansyl cadaverine (but not putrescine), suggesting involvement of a transglutaminase reaction and providing a potential basis for the development of therapeutic measures for GAG-repeat expansion diseases.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan	Niigata University; Niigata University	Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1-757 Asahimachi, Niigata 951, Japan.	tsuji@cc.niigata-u.ac.jp		Sato, Toshiya/0000-0001-7844-9930; Hozumi, Isao/0000-0003-0984-6291				BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DICKSON RB, 1981, J BIOL CHEM, V256, P3454; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; JACKSON M, 1995, NEUROPATH APPL NEURO, V21, P18, DOI 10.1111/j.1365-2990.1995.tb01024.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KLEMAN JP, 1995, BIOCHEMISTRY-US, V34, P13768, DOI 10.1021/bi00042a007; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LORAND L, 1979, BIOCHEMISTRY-US, V18, P1756, DOI 10.1021/bi00576a019; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; ONODERA O, 1995, AM J HUM GENET, V57, P1050; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	38	305	317	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					111	117		10.1038/ng0298-111	http://dx.doi.org/10.1038/ng0298-111			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462738				2022-12-27	WOS:000071779500017
J	Choo, KHA				Choo, KHA			Turning on the centromere	NATURE GENETICS			English	Editorial Material							HISTONE		Royal Childrens Hosp, Murdoch Inst Res Birth Defects, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Choo, KHA (corresponding author), Royal Childrens Hosp, Murdoch Inst Res Birth Defects, Flemington Rd, Parkville, Vic 3052, Australia.							AJIRO K, 1985, J BIOL CHEM, V260, P5379; Blackburn EH, 1995, TELOMERES; CANCILLA MR, 1998, IN PRESS GENOMICS; CHOO KHA, 1997, IN PRESS AM J HUM GE; duSart D, 1997, NAT GENET, V16, P144; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Kipling D., 1995, TELOMERE; Rhoades M. M., 1952, Heterosis., P66; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30	12	24	32	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					3	4						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425884				2022-12-27	WOS:000071259600002
J	Dolle, MET; Giese, H; Hopkins, CL; Martus, HJ; Hausdorff, JM; Vijg, J				Dolle, MET; Giese, H; Hopkins, CL; Martus, HJ; Hausdorff, JM; Vijg, J			Rapid accumulation of genome rearrangements in liver but not in brain of old mice	NATURE GENETICS			English	Article							TRANSGENIC MOUSE MODEL; IN-VIVO MUTATIONS; OXIDATIVE DAMAGE; DNA; AGE; 8-HYDROXY-2'-DEOXYGUANOSINE; CELLS	Somatic mutations have long been considered a possible cause of ageing(1,2). To directly study mutational events in organs and tissues of ageing mammals, a transgenic mouse model has been generated that harbours lacZ reporter genes as part of chromosomally integrated plasmids(3-5). Using this model, we determined spontaneous mutant frequencies and spectra in mouse liver and brain as a function of age. In the liver, mutant frequencies increased with age from birth to 34 months; in the brain, an increase was observed only between birth and 4-6 months. Molecular characterization of the mutations showed that a substantial portion involved genome rearrangement events, with one breakpoint in a reporter gene and the other in the mouse flanking sequence. In the liver, these genome rearrangements did not increase with age until after 27 months, when they increased rapidly. In brain, the frequency of genome rearrangements was lower than in liver and did not increase with age.	BETH ISRAEL DEACONESS MED CTR,BOSTON,MA 02115; HARVARD UNIV,SCH MED,INST MED,BOSTON,MA 02115	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School					NATIONAL INSTITUTE ON AGING [P30AG013314] Funding Source: NIH RePORTER; NIA NIH HHS [1 P30 AG13314-01, P01 1801 AG10829-01] Funding Source: Medline; NIEHS NIH HHS [1 RO1 ES/CA 08797-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0; Bronson R.T., 1990, GENETICS AGING, P280; BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169; Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111; FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb54674.x; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GILLE JJP, 1994, CARCINOGENESIS, V15, P2695, DOI 10.1093/carcin/15.12.2695; GOSSEN JA, 1995, MUTAT RES-FUND MOL M, V331, P89, DOI 10.1016/0027-5107(95)00055-N; GOSSEN JA, 1992, NUCLEIC ACIDS RES, V20, P3254, DOI 10.1093/nar/20.12.3254; GOSSEN JA, 1993, MUTAGENESIS, V8, P243, DOI 10.1093/mutage/8.3.243; HARRISON DE, 1983, EXP AGING RES, V9, P245, DOI 10.1080/03610738308258459; HSIE AW, 1986, P NATL ACAD SCI USA, V83, P9616, DOI 10.1073/pnas.83.24.9616; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MARTIN GM, 1994, PRINCIPLES GERIATRIC, P19; MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6; MULLAART E, 1990, MUTAT RES, V237, P9, DOI 10.1016/0921-8734(90)90027-O; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P35; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vijg Jan, 1996, P391; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	24	202	208	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					431	434		10.1038/ng1297-431	http://dx.doi.org/10.1038/ng1297-431			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398844				2022-12-27	WOS:A1997YJ92400023
J	Portsteffen, H; Beyer, A; Becker, E; Epplen, C; Pawlak, A; Kunau, WH; Dodt, G				Portsteffen, H; Beyer, A; Becker, E; Epplen, C; Pawlak, A; Kunau, WH; Dodt, G			Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders	NATURE GENETICS			English	Article							ZELLWEGER SYNDROME; TARGETING SIGNAL; PTS1 RECEPTOR; GENE; MUTATIONS; IDENTIFICATION; HETEROGENEITY; TERMINUS; DEFECTS; ENCODES	Human peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal-recessive diseases caused by mutations in PEX genes that encode peroxins, proteins required for peroxisome biogenesis, These lethal diseases include Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD) and infantile Refsum's disease (IRD)(1), three phenotypes now thought to represent a continuum of clinical features that are most severe in ZS, milder in NALD and least severe in IRD2. At least eleven PBD complementation groups have been identified by somatic-cell hybridization analysis(2-6) compared to the eighteen PEX complementation groups that have been found in yeast, We have cloned the human PEX1 gene encoding a 147-kD member of the AAA protein family ATPases associated with diverse cellular activities)(7), which is the putative orthologue of Saccharomyces cerevisiae Pex1p (ScPex1p). Human PEX1 has been identified by computer-based 'homology probing' using the ScPex1p sequence to screen databases of expressed sequence tags (dbEST) for human cDNA clones. Expression of PEX1 rescued the cells from the biogenesis defect in human fibroblasts of complementation group 1 (CG1), the largest PBD complementation group, We show that PEX1 is mutated in CG1 patients.	HOP HENRI MONDOR,U99 INSERM,F-94010 CRETEIL,FRANCE; RUHR UNIV BOCHUM,INST PHYSIOL CHEM,ABT ZELLBIOCHEM,D-44780 BOCHUM,GERMANY; RUHR UNIV BOCHUM,INST HUMAN GENET,D-44780 BOCHUM,GERMANY	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Ruhr University Bochum; Ruhr University Bochum			Pawlak, André/L-9044-2018; pawlak, andré/Q-2495-2019	Pawlak, André/0000-0002-5486-212X; pawlak, andré/0000-0002-5486-212X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beyer A, 1997, PROTEIN SCI, V6, P2043; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GARTNER J, 1994, J INHERIT METAB DIS, V17, P327, DOI 10.1007/BF00711820; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; HEYMAN JA, 1994, J CELL BIOL, V127, P1259, DOI 10.1083/jcb.127.5.1259; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; LAZAROW PB, 1995, METABOLIC MOL BASES, V2, P2287; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	26	110	112	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					449	452		10.1038/ng1297-449	http://dx.doi.org/10.1038/ng1297-449			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398848				2022-12-27	WOS:A1997YJ92400027
J	Reuber, BE; GermainLee, E; Collins, CS; Morrell, JC; Ameritunga, R; Moser, HW; Valle, D; Gould, SJ				Reuber, BE; GermainLee, E; Collins, CS; Morrell, JC; Ameritunga, R; Moser, HW; Valle, D; Gould, SJ			Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders	NATURE GENETICS			English	Article							TARGETING SIGNAL; PICHIA-PASTORIS; PROTEIN IMPORT; ZELLWEGER SYNDROME; PTS1 RECEPTOR; GENE; ENCODES; MEMBER; FAMILY; THIOLASE	The peroxisome biogenesis disorders (PBDs) are a group of lethal autosomal-recessive diseases caused by defects in peroxisomal matrix protein import, with the concomitant loss of multiple peroxisomal enzyme activities. Ten complementation groups (CGs) have been identified for the PBDs, with CG1 accounting for 51% of all PBD patients. We identified the human orthologue of yeast PEX1, a gene required for peroxisomal matrix protein import. Expression of human PEX1 restored peroxisomal protein import in fibroblasts from 30 CG1 patients, and PEX1 mutations were detected in multiple CG1 probands. A common PEX1 allele, C843D, is present in approximately half of CG1 patients and has a deleterious effect on PEX1 activity. Phenotypic analysis of PEX1-deficient cells revealed severe defects in peroxisomal matrix protein import and destabilization of PEX5, the receptor for the type-1 peroxisomal targetting signal, even though peroxisomes were present in these cells and capable of importing peroxisomal membrane proteins. These data demonstrate an important role for PEX1 in peroxisome biogenesis and suggest that mutations in this gene are the most common cause of the PBDs.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,PREDOCTORAL TRAINING PROGRAM HUMAN GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT GENET & MOL BIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ANAT & CELL BIOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University				Germain-Lee, Emily/0000-0002-5727-610X	NICHD NIH HHS [HD10891, HD00989] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HEYMAN JA, 1994, J CELL BIOL, V127, P1259, DOI 10.1083/jcb.127.5.1259; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SPONG AP, 1993, J CELL BIOL, V123, P535, DOI 10.1083/jcb.123.3.535; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	26	177	181	1	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					445	448		10.1038/ng1297-445	http://dx.doi.org/10.1038/ng1297-445			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398847				2022-12-27	WOS:A1997YJ92400026
J	Bennett, ST; Wilson, AJ; Esposito, L; Bouzekri, N; Undlien, DE; Cucca, F; Nistico, L; Buzzetti, R; Bosi, E; Pociot, F; Nerup, J; CambonThomsen, A; Pugliese, A; Shield, JPH; McKinney, PA; Bain, SC; Polychronakos, C; Todd, JA; Pozzilli, P; Visalli, N; Baroni, M; Fioriti, E; Mesturino, C; Signore, A; Cavallo, M; Lucentini, L; Matteoli, M; Crino, A; Teodonio, C; Amoretti, R; Tombesi, A; Ruggeri, M; Pisano, L; Suraci, C; Pennafina, M; Boscherini, B; Stoduto, S; Fonte, M; Mancabitti, M; Multari, G; Suppa, M; DeMattia, G; Faldetta, MC; Laurenti, O; Marietti, G; Pitocco, D; Ferrazzoli, F; Bizzarri, C; Ghirlanda, G				Bennett, ST; Wilson, AJ; Esposito, L; Bouzekri, N; Undlien, DE; Cucca, F; Nistico, L; Buzzetti, R; Bosi, E; Pociot, F; Nerup, J; CambonThomsen, A; Pugliese, A; Shield, JPH; McKinney, PA; Bain, SC; Polychronakos, C; Todd, JA; Pozzilli, P; Visalli, N; Baroni, M; Fioriti, E; Mesturino, C; Signore, A; Cavallo, M; Lucentini, L; Matteoli, M; Crino, A; Teodonio, C; Amoretti, R; Tombesi, A; Ruggeri, M; Pisano, L; Suraci, C; Pennafina, M; Boscherini, B; Stoduto, S; Fonte, M; Mancabitti, M; Multari, G; Suppa, M; DeMattia, G; Faldetta, MC; Laurenti, O; Marietti, G; Pitocco, D; Ferrazzoli, F; Bizzarri, C; Ghirlanda, G			Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCUS; MINISATELLITE LOCUS; GENE REGION; POLYMORPHISM; ASSOCIATION; PROTECTION; MELLITUS; IDDM2; MAPS	The IDDM2 type 1 diabetes susceptibility locus was mapped to(1-6) and identified as(7) allelic variation at the insulin gene (INS) VNTR regulatory polymorphism. In Caucasians, INS VNTR alleles divide into two discrete size classes'. Class I alleles (26 to 69 repeats) predispose in a recessive way to type 1 diabetes, while class III alleles (140 to more than 200 repeats) ape dominantly protective(8). The protective effect may be explained by higher levels of class III VNTR-associated INS mRNA in thymus such that elevated levels of preproinsulin protein enhance immune tolerance to preproinsulin, a key autoantigen in type 1 diabetes pathogenesis(9,10). The mode of action of IDDM2 is complicated, however, by parent-of-origin effects(2,7,11-14) and possible allelic heterogeneity within the two defined allele classes(7,15). We have now analysed transmission of specific VNTR alleles in 1,316 families and demonstrate that a particular class I allele does not predispose to disease when paternally inherited, suggestive of polymorphic imprinting(16). But this paternal effect is observed only when the father's untransmitted allele is a class III. This allelic interaction is reminiscent of epigenetic phenomena observed in plants (for example, paramutation; ref. 17) and in yeast (for example, trans-inactivation; ref. 18). If untransmitted chromosomes can have functional effects on the biological properties of transmitted chromosomes, the implications for human genetics and disease are potentially considerable.	HOP PURPAN,CTR IMMUNOPATHOL & GENET HUMAINE,CNRS,UPR 8291,F-31300 TOULOUSE,FRANCE; NATL HOSP NORWAY,INST TRANSPLANTAT IMMUNOL,N-0027 OSLO,NORWAY; S MICHELE HOSP,DEPT PAEDIAT,CAGLIARI,SARDINIA,ITALY; UNIV ROMA LA SAPIENZA,INST MED CLIN 2,I-00161 ROME,ITALY; UNIV MILAN,IST SCI SAN RAFFAELE,DEPT INTERNAL MED,I-20122 MILAN,ITALY; STENO DIABET CTR,DK-2820 GENTOFTE,DENMARK; UNIV MIAMI,SCH MED,DIABET RES INST,MIAMI,FL 33136; UNIV BRISTOL,ROYAL HOSP SICK CHILDREN,INST CHILD HLTH,BRISTOL BS2 8BJ,AVON,ENGLAND; UNIV LEEDS,RES SCH MED,PAEDIAT EPIDEMIOL GRP,LEEDS LS2 9LN,W YORKSHIRE,ENGLAND; UNIV BIRMINGHAM,BIRMINGHAM HEARTLANDS HOSP,DEPT MED,BIRMINGHAM B9 5SS,W MIDLANDS,ENGLAND; MONTREAL CHILDRENS HOSP,MONTREAL,PQ H3H 1A4,CANADA	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; University of Oslo; National Hospital Norway; Sapienza University Rome; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Steno Diabetes Center; University of Miami; Bristol Royal Hospital For Children; University of Bristol; University of Leeds; Heart of England NHS Foundation Trust; University of Birmingham; McGill University	Bennett, ST (corresponding author), UNIV OXFORD,NUFFIELD DEPT SURG,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND.		Baroni, Marco Giorgio/AAH-3476-2020; Signore, Alberto/E-5812-2010; Nisticò, Lorenza/AAD-1662-2021; Bizzarri, Carla/AAI-2429-2019; Polychronakos, Constantin/B-8151-2008; Buzzetti, Raffaella/K-3090-2016; Pozzilli, Paolo/A-5235-2010; Nisticò, Lorenza/N-7470-2017; Baroni, Marco/A-1555-2012; Pitocco, Dario/K-4210-2018; Shield, Julian PH/D-6297-2014; Todd, John A/A-3542-2010	Baroni, Marco Giorgio/0000-0002-3224-6078; Signore, Alberto/0000-0001-8923-648X; Nisticò, Lorenza/0000-0003-1805-6240; Bizzarri, Carla/0000-0002-5616-9185; Buzzetti, Raffaella/0000-0003-1490-6041; Nisticò, Lorenza/0000-0003-1805-6240; Shield, Julian PH/0000-0003-2601-7575; Todd, John A/0000-0003-2740-8148; Polychronakos, Constantin/0000-0002-7624-6635; matteoli, maria cristina/0000-0003-1461-6220; Wilson, Amanda/0000-0001-5681-9611; Crino, Antonino/0000-0003-3548-7114; cavallo, maria gisella/0000-0001-6630-8049; Pociot, Flemming/0000-0003-3274-5448; CUCCA, Francesco/0000-0002-7414-1995	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; BENNETT ST, 1995, NAT GENET, V10, P379, DOI 10.1038/ng0895-379; BENNETT ST, 1996, PCR ESSENTIAL TECHNI, P32; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; GIANNOUKAKIS N, IN PRESS J BIOL CHEM; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hollick JB, 1997, TRENDS GENET, V13, P302, DOI 10.1016/S0168-9525(97)01184-0; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; JULIER C, 1994, AM J HUM GENET, V55, P1247; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; POLYCHRONAKOS C, 1995, DIABETOLOGIA, V38, P715, DOI 10.1007/s001250050343; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; SMRZKA OW, 1995, HUM MOL GENET, V4, P1945, DOI 10.1093/hmg/4.10.1945; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560; UNDLIEN DE, 1995, DIABETES, V44, P620, DOI 10.2337/diabetes.44.6.620; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Xu YQ, 1997, ONCOGENE, V14, P1041, DOI 10.1038/sj.onc.1200926	28	153	157	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					350	352		10.1038/ng1197-350	http://dx.doi.org/10.1038/ng1197-350			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354805				2022-12-27	WOS:A1997YD66700035
J	Huang, LP; Gitschier, J				Huang, LP; Gitschier, J			A novel gene involved in zinc transport is deficient in the lethal milk mouse	NATURE GENETICS			English	Article							ACRODERMATITIS-ENTEROPATHICA; SACCHAROMYCES-CEREVISIAE; MUTATION; PROTEIN; RESISTANCE; EXPRESSION; METABOLISM; OTOLITH; DISEASE; SYSTEM	We have identified the gene responsible for the inherited zinc deficiency in the lethal milk (lm) mouse. The gene, here designated Znt4, encodes a 430-amino-acid protein that is homologous to two proteins, ZnT2 and ZnT3, responsible for sequestration of zinc into endosomal/lysosomal compartments and synaptic vesicles, respectively. We show that the Znt4 gene confers zinc resistance to a zinc-sensitive yeast strain and that it is abundantly expressed in the mammary epithelia and brain. The lethal milk mutant: has a nonsense mutation at arginine codon 297 in the Znt4 gene.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; CHAPLIN DD, 1994, CURRENT PROTOCOLS MO; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; DICKIE MM, 1969, MOUSE NEWS LETT, V41, P30; ECKHERT CD, 1977, SCIENCE, V195, P789, DOI 10.1126/science.836589; ERWAY LC, 1984, J HERED, V75, P480, DOI 10.1093/oxfordjournals.jhered.a109990; Glover M T, 1988, Pediatr Dermatol, V5, P10, DOI 10.1111/j.1525-1470.1988.tb00877.x; GREEN MC, 1973, MOUSE NEWS LETT, V49, P32; Gwynn B., 1996, Molecular Biology of the Cell, V7, p550A; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; KURAMOTO Y, 1991, SEMIN DERMATOL, V10, P309; LEE DY, 1992, J NUTR, V122, P2233, DOI 10.1093/jn/122.11.2233; Lyon M., 1989, GENETIC VARIANTS STR; MOYNAHAN EJ, 1974, LANCET, V2, P399; NIES DH, 1989, P NATL ACAD SCI USA, V86, P7351, DOI 10.1073/pnas.86.19.7351; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PALMITER RD, 1995, EMBO J, V14, P633; PILETZ JE, 1978, AM J CLIN NUTR, V31, P560, DOI 10.1093/ajcn/31.4.560; PILETZ JE, 1978, SCIENCE, V199, P181, DOI 10.1126/science.619449; PURICHIA N, 1972, DEV BIOL, V27, P395, DOI 10.1016/0012-1606(72)90178-9; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Roberts E, 1931, SCIENCE, V74, P569, DOI 10.1126/science.74.1927.569; ROBINSON PJ, 1981, IMMUNOGENETICS, V14, P449, DOI 10.1007/BF00373326; Siracusa LD, 1996, MAMM GENOME, V6, pS51; Theophilos MB, 1996, HUM MOL GENET, V5, P1619, DOI 10.1093/hmg/5.10.1619; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VANWOUWE JP, 1989, EUR J PEDIATR, V149, P2, DOI 10.1007/BF02024322; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; ZHAO H, 1996, J BIOL CHEM, V271, P23202	32	284	301	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					292	297		10.1038/ng1197-292	http://dx.doi.org/10.1038/ng1197-292			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354792				2022-12-27	WOS:A1997YD66700022
J	Grimsby, J; Toth, M; Chen, K; Kumazawa, T; Klaidman, L; Adams, JD; Karoum, F; Gal, J; Shih, JC				Grimsby, J; Toth, M; Chen, K; Kumazawa, T; Klaidman, L; Adams, JD; Karoum, F; Gal, J; Shih, JC			Increased stress response and p-phenylethylamine in MAOB-deficient mice	NATURE GENETICS			English	Article							MONOAMINE-OXIDASE-A; NORRIE DISEASE; GENES; ASSOCIATION; INHIBITORS; SEROTONIN; BEHAVIOR; DOPAMINE; CLONING; PATIENT	MAOA and MAOB are key iso-enzymes that degrade biogenic and dietary amines(1-5). MAOA preferentially oxidizes serotonin (5-hydroxytryptamine, or 5-HT) and norepinephrine (NE), whereas MAOB preferentially oxidizes beta-phenylethylamine (PEA). Both forms can oxidize dopamine (DA). A mutation in MAOA results in a clinical phenotype characterized by borderline mental retardation and impaired impulse control(6,7). X-chromosomal deletions which include MAOB were found in patients suffering from atypical Norrie's disease(8,9), which is characterized by blindness and impaired hearing. Reduced MAOB activity has been found in type-II alcoholism and in cigarette smokers(10,11). Because most alcoholics smoke, the effects of alcohol on MAOB activity remain to be determined. Here we show that targetted inactivation of MAOB in mice increases levels of PEA but not those of 5-HT, NE and DA, demonstrating a primary role for MAOB in the metabolism of PEA. PEA has been implicated in modulating mood and affect(12,13). Indeed, MAOB-deficient mice showed an increased reactivity to stress. In addition, mutant mice were resistant to the neurodegenerative effects of MPTP, a toxin that induces a condition reminiscent of Parkinson's disease.	UNIV SO CALIF,SCH PHARM,DEPT MOL PHARMACOL & TOXICOL,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,DEPT CELL & NEUROBIOL,LOS ANGELES,CA 90033; CORNELL UNIV MED COLL,DEPT PHARMACOL,NEW YORK,NY 10021; NIMH,ST ELIZABETHS HOSP,DEPT PSYCHOL & PHARMACOL,WASHINGTON,DC 20032	University of Southern California; University of Southern California; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Toth, Miklos/O-3343-2017		NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039085, R01MH037020, K05MH000796] Funding Source: NIH RePORTER; NIMH NIH HHS [K05 MH00796, R37 MH39085, R01 MH37020] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS JD, 1989, BRAIN RES BULL, V23, P1, DOI 10.1016/0361-9230(89)90157-3; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; BERRY MD, 1994, BRIT J PHARMACOL, V113, P1159, DOI 10.1111/j.1476-5381.1994.tb17119.x; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen K, 1996, J NEUROCHEM, V66, P797; CHEN K, 1994, MOL PHARMACOL, V46, P1226; COLLINS FA, 1992, AM J MED GENET, V42, P127, DOI 10.1002/ajmg.1320420126; DEVOR EJ, 1993, AM J MED GENET, V48, P209, DOI 10.1002/ajmg.1320480407; DIUZEN D, 1992, NEUROPHARMACOLOGY, V31, P1223; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; FOZARD J R, 1984, British Journal of Pharmacology, V82, p309P; Gerlach M, 1996, NEUROLOGY, V47, pS137, DOI 10.1212/WNL.47.6_Suppl_3.137S; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; JUORIO AV, 1988, N-S ARCH PHARMACOL, V338, P644, DOI 10.1007/BF00165628; KUMAZAWA T, 1988, COMP BIOCHEM PHYS C, V91, P571; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; Lenders JWM, 1996, J CLIN INVEST, V97, P1010, DOI 10.1172/JCI118492; LINNOILA M, 1983, BIOL PSYCHIAT, V18, P513; MCFARLAND DJ, 1989, PHARMACOL BIOCHEM BE, V32, P723, DOI 10.1016/0091-3057(89)90024-5; PATERSON IA, 1990, J NEUROCHEM, V55, P1827, DOI 10.1111/j.1471-4159.1990.tb05764.x; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Potkin S G, 1980, Psychopharmacol Bull, V16, P52; SABELLI HC, 1986, J CLIN PSYCHIAT, V47, P66; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SAURA J, 1994, NEUROBIOL AGING, V15, P399, DOI 10.1016/0197-4580(94)90071-X; WU HF, 1993, MOL PHARMACOL, V43, P888	30	199	203	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					206	210		10.1038/ng1097-206	http://dx.doi.org/10.1038/ng1097-206			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326944				2022-12-27	WOS:A1997XZ55500030
J	Gustavsson, P; Willig, TN; vanHaeringen, A; Tchernia, G; Dianzani, I; Donner, M; Elinder, G; Henter, JI; Nilsson, PG; Gordon, L; Skeppner, G; vantVeerKorthof, L; Kreuger, A; Dahl, N				Gustavsson, P; Willig, TN; vanHaeringen, A; Tchernia, G; Dianzani, I; Donner, M; Elinder, G; Henter, JI; Nilsson, PG; Gordon, L; Skeppner, G; vantVeerKorthof, L; Kreuger, A; Dahl, N			Diamond-Blackfan anaemia: Genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb	NATURE GENETICS			English	Article							CONGENITAL HYPOPLASTIC-ANEMIA; HYBRIDIZATION; MUTATIONS	Diamond-Blackfan anaemia (DEA; MIM#205900) is a rare disorder manifested as a pure red-cell aplasia in the neonatal period or in infancy(1-3). The clinical hallmark of DBA is a selective decrease in erythroid precursors and anaemia. Other lineages are usually normal and the peripheral white blood cell count is normal. In approximately one-third of cases, the disease is associated with a wide variety of congenital anomalies and malformations(3-7). Most cases are sporadic, but 10-20% of them follow a recessive or a dominant inheritance pattern(5). A female with DBA and a chromosomal translocation involving chromosome 19q was recently identified(8). We undertook a linkage analysis with chromosome 19 markers in multiplex DBA families of Swedish, French, Dutch, Arabic and Italian origin. Significant linkage to chromosome 19q13 was established for dominant and recessive inherited DBA with a peak rod score at D19S197 (Z(max)=7.08, theta=0.00). Within this region, a submicroscopic de novo deletion of 3.3 Mb was identified in a patient with DBA. The deletion coincides with the translocation break-point and, together with key recombinations, restricts the DBA gene to a 1.8-Mb region. The results suggest that, despite its clinical heterogeneity, DBA is genetically homogeneous for a gene in 19q13.	UNIV UPPSALA,CHILDRENS HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN; HOP BICETRE,DEPT HEMATOL,LE KREMLIN BICETR,FRANCE; HOP BICETRE,DEPT PAEDIAT,LE KREMLIN BICETR,FRANCE; LEIDEN UNIV HOSP,DEPT CLIN GENET,LEIDEN,NETHERLANDS; UNIV TURIN,DEPT PAEDIAT,I-10124 TURIN,ITALY; UNIV TURIN,DEPT GENET,I-10124 TURIN,ITALY; UNIV LUND HOSP,ASTRID LINDGREN CHILD CTR,LUND,SWEDEN; UNIV LUND HOSP,DEPT MED,LUND,SWEDEN; LAWRENCE LIVERMORE NATL LAB,LIVERMORE,CA 94551; OREBRO REG HOSP,DEPT PAEDIAT,OREBRO,SWEDEN; UNIV UPPSALA,CHILDRENS HOSP,DEPT PAEDIAT,S-75185 UPPSALA,SWEDEN	Uppsala University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Leiden University; Leiden University Medical Center (LUMC); University of Turin; University of Turin; Lund University; Skane University Hospital; Lund University; Skane University Hospital; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Uppsala University				Henter, Jan-Inge/0000-0002-0629-2126				ALTER BP, 1980, AM J PEDIAT HEMATOL, V2, P121; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; BAL SE, 1996, BRIT J HAEMATOL, V94, P645; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVANZO M, 1994, PEDIATR HEMAT ONCOL, V11, P189, DOI 10.3109/08880019409141655; Diamond L K, 1976, Adv Pediatr, V22, P349; Diamond L. K., 1938, AM J DIS CHILD, V56, P464; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; GLADER BE, 1988, BRIT J HAEMATOL, V68, P165, DOI 10.1111/j.1365-2141.1988.tb06184.x; GOJIC V, 1994, AM J MED GENET, V50, P87, DOI 10.1002/ajmg.1320500119; GREINIX HT, 1993, BRIT J HAEMATOL, V84, P515, DOI 10.1111/j.1365-2141.1993.tb03109.x; GUSTAVSSON P, IN PRESS J MED GENET; HALPERIN DS, 1989, AM J PEDIAT HEMATOL, V11, P380; Janov AJ, 1996, MEDICINE, V75, P77, DOI 10.1097/00005792-199603000-00004; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LITTLE M, 1995, HUM MOL GENET, V4, P351, DOI 10.1093/hmg/4.3.351; Mohrenweiser Harvey, 1996, Cytogenetics and Cell Genetics, V74, P161, DOI 10.1159/000134408; Ott J., 1991, ANAL HUMAN GENETIC L; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; Young N. S., 1994, APLASTIC ANEMIA ACQU	23	72	72	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					368	371		10.1038/ng0897-368	http://dx.doi.org/10.1038/ng0897-368			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241274				2022-12-27	WOS:A1997XM90900019
J	Yoshizawa, T; Handa, Y; Uematsu, Y; Takeda, S; Sekine, K; Yoshihara, Y; Kawakami, T; Arioka, K; Sato, H; Uchiyama, Y; Masushige, S; Fukamizu, A; Matsumoto, T; Kato, S				Yoshizawa, T; Handa, Y; Uematsu, Y; Takeda, S; Sekine, K; Yoshihara, Y; Kawakami, T; Arioka, K; Sato, H; Uchiyama, Y; Masushige, S; Fukamizu, A; Matsumoto, T; Kato, S			Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning	NATURE GENETICS			English	Article							D ENDOCRINE SYSTEM; GENE-EXPRESSION; SIGNALING PATHWAYS; NUCLEAR RECEPTORS; RESISTANT RICKETS; ESTROGEN-RECEPTOR; 1,25-DIHYDROXYVITAMIN-D3; BINDING; DIFFERENTIATION; RXR	1 alpha,25-Dihydroxyvitamin D-3[1 alpha,25(OH)(2)D-3], an active form of vitamin D, has roles in many biological phenomena such as calcium homeostasis and bone formation(1-3), which are thought to be mediated by the 1 alpha,25(OH)(2)D-3 receptor (VDR), a member of the nuclear hormone receptors superfamily(4-6). However, the molecular basis for the actions of 1 alpha,25(OH)(2)D-3 in bone formation, its role during development and VDR genetic polymorphisms for predicting bone mineral density(7) are uncertain. To investigate the functional role of VDR, we generated mice deficient in VDR by gene targeting. We report here that in VDR null mutant mice, no defects in development and growth were observed before weaning, irrespective of reduced expression of vitamin D target genes. After weaning, however, mutants failed to thrive, with appearance of alopoecia, hypocalcaemia and infertility, and bone formation was severely impaired as a typical feature of vitamin D-dependent rickets type II (refs 8,9). Unlike humans with this disease, most of the null mutant mice died within 15 weeks after birth, and uterine hypoplasia with impaired folliculogenesis was found in female reproductive organs. These defects, such as alopoecia and uterine hypoplasia, were not observed in vitamin D-deficient animals. The findings establish a critical role for VDR in growth, bone formation and female reproduction in the post-weaning stage.	UNIV TOKYO, INST MOL & CELLULAR BIOSCI, BUNKYO KU, TOKYO 113, JAPAN; TOKYO UNIV AGR, DEPT AGR CHEM, SETAGAYA KU, TOKYO 156, JAPAN; CHUGAI PHARMACEUT CO LTD, FUJI GOTENBA RES LABS, SHIZUOKA 412, JAPAN; UNIV TSUKUBA, INST APPL BIOCHEM, TSUKUBA, IBARAKI 305, JAPAN; UNIV TOKUSHIMA, DEPT INTERNAL MED 1, TOKUSHIMA 770, JAPAN	University of Tokyo; Tokyo University of Agriculture; Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Tsukuba; Tokushima University			fukamizu, akiyoshi/J-5350-2012; takeda, shu/B-5195-2012	fukamizu, akiyoshi/0000-0002-8786-6020; Yoshizawa, Tatsuya/0000-0002-5728-1996; Sekine, Keisuke/0000-0001-5133-0876				ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; BERESFORD JN, 1986, ENDOCRINOLOGY, V119, P1776, DOI 10.1210/endo-119-4-1776; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; DELVIN EE, 1987, EUR J BIOCHEM, V163, P659, DOI 10.1111/j.1432-1033.1987.tb10915.x; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; ERICKSON GF, 1986, SEMIN REPROD ENDOCR, V4, P233, DOI 10.1055/s-2007-1022504; Eriebacher Adrian, 1995, Cell, V80, P371; Frohman LA, 1995, ENDOCRINOLOGY METABO, V3rd; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; Hawa NS, 1996, CLIN ENDOCRINOL, V45, P85; HENRY HL, 1984, ANNU REV NUTR, V4, P493, DOI 10.1146/annurev.nu.04.070184.002425; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KATO S, 1995, MOL CELL BIOL, V15, P5858; KAWASHIMA H, 1981, NATURE, V291, P327, DOI 10.1038/291327a0; KOJIMA R, 1994, J BIOL CHEM, V269, P3270; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MALLOY PJ, 1994, J CLIN ENDOCR METAB, V78, P313, DOI 10.1210/jc.78.2.313; MALLOY PJ, 1990, J CLIN INVEST, V86, P2071, DOI 10.1172/JCI114944; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; REEVE L, 1983, J BIOL CHEM, V258, P3615; Studzinski George P., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P279; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459	30	859	895	0	48	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					391	396		10.1038/ng0897-391	http://dx.doi.org/10.1038/ng0897-391			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241280				2022-12-27	WOS:A1997XM90900025
J	duSart, D; Cancilla, MR; Earle, E; Mao, JI; Saffery, R; Tainton, KM; Kalitsis, P; Martyn, J; Barry, AE; Choo, KHA				duSart, D; Cancilla, MR; Earle, E; Mao, JI; Saffery, R; Tainton, KM; Kalitsis, P; Martyn, J; Barry, AE; Choo, KHA			A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA	NATURE GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; PROTEIN CENP-C; ANTICENTROMERE ANTIBODIES; SACCHAROMYCES-CEREVISIAE; KINETOCHORE CENTROMERE; INSITU HYBRIDIZATION; HUMAN AUTOANTIBODIES; MAMMALIAN-CELLS; FISSION YEAST; PHYSICAL MAP	We recently described a human marker chromosome containing a functional neo-centromere that binds anticentromere antibodies, but is devoid of centromeric alpha-satellite repeats and derived from a hitherto non-centromeric: region of chromosome 10q25. Chromosome walking using cloned single-copy DNA from this region enabled us to identify the antibody-binding domain of this centromere. Extensive restriction mapping indicates that this domain has an identical genomic organization to the corresponding normal chromosomal region, suggesting a mechanism for the origin of this centromere through the activation of a latent centromere that exists within 10q25.	ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,PARKVILLE,VIC 3052,AUSTRALIA; GENOME THERAPEUT CORP,COLLABORAT RES DIV,WALTHAM,MA 02154	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne			Saffery, Richard/GLS-1976-2022; Kalitsis, Paul/C-1916-2015	Saffery, Richard/0000-0002-9510-4181; Kalitsis, Paul/0000-0001-5569-0609; Barry, Alyssa/0000-0002-1189-2310				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALEIXANDRE C, 1987, HUM GENET, V77, P46; ARCHIDIACONO N, 1994, SITU HYBRIDIZATION P, P1; BALDINI A, 1993, HUM GENET, V90, P577; BALDINI A, 1991, CYTOGENET CELL GENET, V58, P1868; BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519; BISCHOFF FR, 1990, P NATL ACAD SCI USA, V87, P8617, DOI 10.1073/pnas.87.21.8617; BLENNOW E, 1994, AM J HUM GENET, V54, P877; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; BROWN KE, 1994, HUM MOL GENET, V3, P1227, DOI 10.1093/hmg/3.8.1227; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BROWN MT, 1995, GENE, V160, P111, DOI 10.1016/0378-1119(95)00163-Z; BROWN W, 1995, TRENDS GENET, V11, P337, DOI 10.1016/S0168-9525(00)89100-3; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CHOO KHA, IN PRESS CENTROMERE; CLARKE L, 1985, ANNU REV GENET, V19, P29, DOI 10.1146/annurev.ge.19.120185.000333; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; DASSO M, 1993, TRENDS BIOCHEM SCI, V18, P96, DOI 10.1016/0968-0004(93)90161-F; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; EARNSHAW WC, 1994, FASEB J, V8, P947, DOI 10.1096/fasebj.8.12.8088460; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; FRITZLER MJ, 1980, AM J MED, V69, P520, DOI 10.1016/0002-9343(80)90462-3; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; HAAF T, 1994, HUM MOL GENET, V3, P697, DOI 10.1093/hmg/3.5.697; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HEARTLEIN MW, 1988, MOL CELL BIOL, V8, P3611, DOI 10.1128/MCB.8.9.3611; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KINGWELL B, 1987, CHROMOSOMA, V95, P403, DOI 10.1007/BF00333991; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; MAGNANI I, 1993, CLIN GENET, V43, P180; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; MOIR DT, 1994, GENOMICS, V22, P1, DOI 10.1006/geno.1994.1338; MOROI Y, 1981, J CELL BIOL, V90, P254, DOI 10.1083/jcb.90.1.254; Moschonas N. K., 1996, Cytogenetics and Cell Genetics, V72, P99, DOI 10.1159/000134172; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; NELSON M, 1991, NUCLEIC ACIDS RES, V19, P2045, DOI 10.1093/nar/19.suppl.2045; OHASHI H, 1994, AM J HUM GENET, V55, P1202; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; PLUTA AF, 1990, TRENDS BIOCHEM SCI, V15, P181, DOI 10.1016/0968-0004(90)90158-8; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; RAUCH A, 1992, CLIN GENET, V42, P84; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; VERMA RS, 1992, GENOMICS, V14, P113, DOI 10.1016/S0888-7543(05)80291-5; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Yang CH, 1996, MOL CELL BIOL, V16, P3576; ZHENG CJ, 1994, GENOMICS, V22, P55, DOI 10.1006/geno.1994.1345	65	266	278	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					144	153						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171825				2022-12-27	WOS:A1997XB54300014
J	Purdue, PE; Zhang, JW; Skoneczny, M; Lazarow, PB				Purdue, PE; Zhang, JW; Skoneczny, M; Lazarow, PB			Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor	NATURE GENETICS			English	Article							DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; PEROXISOMAL 3-KETOACYL-COA THIOLASE; SACCHAROMYCES-CEREVISIAE; SKIN FIBROBLASTS; ACYL-COA; PROTEIN; IMPORT; BIOGENESIS; IDENTIFICATION; DISORDERS	The rhizomelic form of chondrodysplasia punctata (RCDP) is an autosomal recessive disease of peroxisome biogenesis characterized by deficiencies in several peroxisomal proteins, including the peroxisomal enzymes of plasmalogen biosynthesis and peroxisomal 3-ketoacyl thiolase(1). In cultured fibroblasts from patients with this disorder, both the peroxisomal targeting and proteolytic removal of the amino-terminal type 2 peroxisomal targeting sequence (PTS2) of thiolase are defective, whereas the biogenesis of proteins targeted by carboxyterminal type 1 peroxisomal targeting sequences (PTS1) is unimpaired. We have previously isolated a Saccharomyces cerevisiae peroxisomal biogenesis mutant, pex7 (formerly peb1/pas7)(2), which demonstrates a striking similarity to the cellular phenotype of RCDP fibroblasts in that PTS1 targeting is functional, but the peroxisomal packaging of PTS2 targeted thiolase is lacking. Complementation of this mutant has led to the identification of the protein ScPex7p(3,4), a PTSZ receptor(5,6). In this paper we report cloning of the human orthologue of ScPEX7, and demonstrate that this is the defective gene in RCDP. We show that expression of human PEX7 in RCDP cells rescues PTSZ targeting and restores some activity of dihydroxyacetone phosphate acyltransferase (DHAP-AT), a peroxisomal enzyme of plasmalogen biosynthesis, and we identify the mutations responsible for loss of function of PEX7 in a compound heterozygote RCDP patient. These results imply that several peroxisomal proteins are targeted by PTSZ signals and that the various biochemical and clinical defects in RCDP result from a defect in the receptor for this class of PTS.	CUNY MT SINAI SCH MED,DEPT CELL BIOL & ANAT,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai			Skoneczny, Marek/S-5390-2019	Skoneczny, Marek/0000-0001-9922-2276	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019394, R37DK019394] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19394] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BALFE A, 1990, PEDIATR RES, V27, P304, DOI 10.1203/00006450-199003000-00023; BASSET DE, 1995, TRENDS GENET, V11, P372, DOI 10.1016/S0168-9525(00)89109-X; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; HEYMANS HSA, 1985, NEW ENGL J MED, V313, P187; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAZAROW PB, 1995, J NEUROPATH EXP NEUR, V54, P720, DOI 10.1097/00005072-199509000-00015; LAZAROW PB, 1995, METABOLIC BASIS INHE, V7, P2287; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; POOLE B, 1971, J BIOL CHEM, V246, P6587; PRICE VE, 1962, J BIOL CHEM, V237, P3468; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; PURDUE PE, 1992, EUR J BIOCHEM, V207, P757, DOI 10.1111/j.1432-1033.1992.tb17106.x; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; SCHUTGENS RBH, 1984, BIOCHEM BIOPH RES CO, V120, P179, DOI 10.1016/0006-291X(84)91430-X; SCHUTGENS RBH, 1986, BIOCHIM BIOPHYS ACTA, V879, P286, DOI 10.1016/0005-2760(86)90217-1; SINGH I, 1991, ARCH BIOCHEM BIOPHYS, V286, P277, DOI 10.1016/0003-9861(91)90041-G; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; WEBBER KO, 1992, METHOD ENZYMOL, V209, P92; ZHANG JW, 1993, J CELL BIOL, V123, P1133, DOI 10.1083/jcb.123.5.1133; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	27	218	219	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					381	384		10.1038/ng0497-381	http://dx.doi.org/10.1038/ng0497-381			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090383				2022-12-27	WOS:A1997WQ38900016
J	Moisan, MP; Courvoisier, H; Bihoreau, MT; Gauguier, D; Hendley, ED; Lathrop, M; James, MR; Mormede, P				Moisan, MP; Courvoisier, H; Bihoreau, MT; Gauguier, D; Hendley, ED; Lathrop, M; James, MR; Mormede, P			A major quantitative trait locus influences hyperactivity in the WKHA rat	NATURE GENETICS			English	Article							ATTENTION-DEFICIT DISORDER; CHILDHOOD HYPERACTIVITY; MICE	The syndrome of hyperactivity describes behavioural disorders existing mainly in children and characterized by increased levels of motor activity, inattention and impulsivity(1,2). Overall the aetiology is poorly understood due to the heterogeneity of the pathology although psychological, biological and social factors acting singly or in concert are generally thought to be involved. In animal studies the observed hyperactivity phenotype results from relative participation of exploration, emotionality and general activity(3). Studies using brain lesions(3), neuropharmacology(4) and gene knock-out strategies(5,6) have shown that specific elements of the brain dopaminergic system can subserve hyperactivity. Evidence of a genetic contribution comes from family(7,8) and twin studies(9) but also from the ability to select divergent animal lines on the basis of their differential activity. The Wistar-Kyoto (WKY) and Wistar-Kyoto hyperactive (WKHA) rats are such strains - distinct for their low and high activity scores in a novel environment, respectively(10). Here, we report the detection of a major hyperactivity-related QTL on chromosome 8, explaining 29% of the variance of an intercross between these strains. This study represents the first behavioural QTL analysis in rat and provides a new starting point for biologically categorizing different forms of hyperactivity.	WELLCOME TRUST CTR HUMAN GENET,OXFORD X3 7BN,ENGLAND; UNIV VERMONT,COLL MED,DEPT PHYSIOL & BIOPHYS,BURLINGTON,VT 05405	University of Oxford; Wellcome Centre for Human Genetics; University of Vermont	Moisan, MP (corresponding author), INST FRANCOIS MAGENDIE,INSERM,INRA,F-33077 BORDEAUX,FRANCE.		Mormede, Pierre/K-5537-2015; Gauguier, Dominique/G-2190-2016; Moisan, Marie-Pierre/AAO-9971-2021; Mormede, Pierre/N-3918-2019	Mormede, Pierre/0000-0003-0345-1432; Gauguier, Dominique/0000-0001-6156-9530; Moisan, Marie-Pierre/0000-0001-7315-5319; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BIHOREAU MT, UNPUB; CASTANON N, 1993, AM J PHYSIOL, V265, pR1304, DOI 10.1152/ajpregu.1993.265.6.R1304; CHURCHILL GA, 1994, GENETICS, V138, P963; COOK EH, 1995, AM J HUM GENET, V56, P993; COURVOISIER H, IN PRESS BRAIN RES; FARAONE SV, 1991, AM J PSYCHIAT, V148, P112; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; GIROS B, 1996, NATURE, V379, P303; HENDLEY ED, 1991, AM J PHYSIOL, V261, pH583, DOI 10.1152/ajpheart.1991.261.2.H583; HENDLEY ED, 1993, BRAIN RES, V586, P44; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; KELLEY AE, 1989, NEUROMETHODS, V13, P95; KNOTT SA, 1992, HEREDITY, V68, P313, DOI 10.1038/hdy.1992.45; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; MOGENSON GJ, 1984, BEHAV NEURAL BIOL, V42, P52, DOI 10.1016/S0163-1047(84)90424-2; NELSON JC, 1995, PLANT GENOME, V4, pA315; SCHACHAR R, 1991, J CHILD PSYCHOL PSYC, V32, P155, DOI 10.1111/j.1469-7610.1991.tb00007.x; THAPAR A, 1995, BEHAV GENET, V25, P537, DOI 10.1007/BF02327577; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V51, P787, DOI 10.1016/0031-9384(92)90117-K; VOELLER KKS, 1991, J CHILD NEUROL, V6, pS2, DOI 10.1177/0883073891006001S01; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4	24	78	80	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					471	473		10.1038/ng1296-471	http://dx.doi.org/10.1038/ng1296-471			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944030				2022-12-27	WOS:A1996VV73000026
J	Belloni, E; Muenke, M; Roessler, E; Traverso, G; SiegelBartelt, J; Frumkin, A; Mitchell, HF; DonisKeller, H; Helms, C; Hing, AV; Heng, HHQ; Koop, B; Martindale, D; Rommens, JM; Tsui, LC; Scherer, SW				Belloni, E; Muenke, M; Roessler, E; Traverso, G; SiegelBartelt, J; Frumkin, A; Mitchell, HF; DonisKeller, H; Helms, C; Hing, AV; Heng, HHQ; Koop, B; Martindale, D; Rommens, JM; Tsui, LC; Scherer, SW			Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; CRITICAL REGION; EXPRESSION; CHROMOSOME-7; 7Q36		HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOL & MED GENET,TORONTO,ON,CANADA; CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104; WASHINGTON UNIV,ST LOUIS,MO; UNIV VICTORIA,CTR ENVIRONM HLTH,VICTORIA,BC,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Washington University (WUSTL); University of Victoria			Koop, Ben F./A-8151-2008; belloni, elena/H-9909-2013; Tsui, Lap-chee/A-1081-2010; Scherer, Stephen W./B-3785-2013	Koop, Ben F./0000-0003-0045-5200; Scherer, Stephen W./0000-0002-8326-1999; Belloni, Elena/0000-0003-3214-0780; Muenke, Maximilian/0000-0002-7719-6545	NHGRI NIH HHS [HG-0100] Funding Source: Medline; NICHD NIH HHS [HD29862, HD28732] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028732, R01HD029862] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BELLONI E, 1995, CYTOGENET CELL GENET, V71, P31; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; HATZIIOANNOU AG, 1991, AM J MED GENET, V40, P201, DOI 10.1002/ajmg.1320400216; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; KRAUSS CM, 1989, AM J MED GENET, V34, P514, DOI 10.1002/ajmg.1320340412; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; MACKAY M, IN PRESS GENOMICS; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; MOHLER J, 1992, DEVELOPMENT, V115, P957; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; PORTER JA, 1996, SCIENCE, V274; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E., 1996, American Journal of Human Genetics, V59, pA233; ROMMENS JM, 1994, IDENTIFICATION OF TRANSCRIBED SEQUENCES, P65; ROWEN L, 1994, AUTOMATED DNA SEQUEN; SCHERER S, 1991, P33; SCHERER SW, 1994, HUM MOL GENET, V3, P1345; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8	30	502	530	0	38	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					353	356		10.1038/ng1196-353	http://dx.doi.org/10.1038/ng1196-353			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896571				2022-12-27	WOS:A1996VQ14600036
J	Nagle, DL; Karim, MA; Woolf, EA; Holmgren, L; Bork, P; Misumi, DJ; McGrail, SH; Dussault, BJ; Perou, CM; Boissy, RE; Duyk, GM; Spritz, RA; Moore, KJ				Nagle, DL; Karim, MA; Woolf, EA; Holmgren, L; Bork, P; Misumi, DJ; McGrail, SH; Dussault, BJ; Perou, CM; Boissy, RE; Duyk, GM; Spritz, RA; Moore, KJ			Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome	NATURE GENETICS			English	Article							PROTEIN-KINASE; FIBROBLASTS; RAPAMYCIN		MILLENNIUM PHARMACEUT INC,CAMBRIDGE,MA 02139; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; EUROPEAN MOL BIOL LABS,HEIDELBERG,GERMANY; MAX DELBRUCK CTR MOL MED,BERLIN,GERMANY; UNIV UTAH,SCH MED,DEPT PATHOL,DIV CELL BIOL & IMMUNOL,SALT LAKE CITY,UT 84132; UNIV CINCINNATI,COLL MED,DEPT DERMATOL,CINCINNATI,OH 45267	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Utah System of Higher Education; University of Utah; University System of Ohio; University of Cincinnati			Bork, Peer/F-1813-2013; Perou, Charles M/H-9934-2014	Bork, Peer/0000-0002-2627-833X; Perou, Charles M/0000-0001-9827-2247				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Barrat FJ, 1996, AM J HUM GENET, V59, P625; Beguez-Cesar AB, 1943, B SOC CUBANA PEDIAT, V15, P900; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; Bork P, 1996, METHOD ENZYMOL, V266, P162; BRANDT EJ, 1975, J CELL BIOL, V67, P774, DOI 10.1083/jcb.67.3.774; BURKHARDT JK, 1993, J EXP MED, V178, P1845, DOI 10.1084/jem.178.6.1845; CHEDIAK M M, 1952, Rev Hematol, V7, P362; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Fukai K, 1996, AM J HUM GENET, V59, P620; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; HIGASHI O, 1954, Tohoku J Exp Med, V59, P315; Holcombe R F, 1994, Immunodeficiency, V5, P131; JONES KL, 1992, CLIN IMMUNOL IMMUNOP, V65, P219, DOI 10.1016/0090-1229(92)90150-M; KLIONSKY DJ, 1990, J BIOL CHEM, V265, P5349; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; LUTZNER MA, 1966, HEREDITY, V58, P299; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NOVAK EK, 1984, BLOOD, V63, P536; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; PENNER JD, 1987, AM J MED GENET, V28, P445, DOI 10.1002/ajmg.1320280222; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; STEIN L, 1995, UNPUB; STEINBRINCK W, 1948, DEUT ARCH KLIN MED, V193, P577; SWANK RT, 1978, AM J PATHOL, V92, P755; WILLINGHAM MC, 1981, EXP CELL RES, V136, P157, DOI 10.1016/0014-4827(81)90047-1; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; ZHAO HQ, 1994, LAB INVEST, V71, P25; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	37	361	374	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					307	311		10.1038/ng1196-307	http://dx.doi.org/10.1038/ng1196-307			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896560	Green Submitted			2022-12-27	WOS:A1996VQ14600025
J	Polyak, K; Li, YB; Zhu, H; Lengauer, C; Willson, JKV; Markowitz, SD; Trush, MA; Kinzler, KW; Vogelstein, B				Polyak, K; Li, YB; Zhu, H; Lengauer, C; Willson, JKV; Markowitz, SD; Trush, MA; Kinzler, KW; Vogelstein, B			Somatic mutations of the mitochondrial genome in human colorectal tumours	NATURE GENETICS			English	Article							DNA; DISEASE; INSTABILITY; CANCER; CELLS; SEGREGATION; SELECTION; NUCLEAR; TUMORS	Alterations of oxidative phosphorylation in tumour cells were originally believed to have a causative role in cancerous growth(1). More recently, mitochondria have again received attention with regards to neoplasia, largely because of their role in apoptosis and other aspects of tumour biology(2-8). The mitochondrial genome is particularly susceptible to mutations because of the high level of reactive oxygen species (ROS) generation in this organelle, coupled with a low level of DNA repair(9-12). However, no detailed analysis of mitochondrial DNA in human tumours has yet been reported. In this study, we analysed the complete mtDNA genome of ten human colorectal cancer cell lines by sequencing and found mutations in seven (70%). The majority of mutations were transitions at purines, consistent with an ROS-related derivation. The mutations were somatic, and those evaluated occurred in the primary tumour from which the cell line was derived. Most of the mutations were homoplasmic, indicating that the mutant genome was dominant at the intracellular and intercellular levels. We showed that mitochondria can rapidly become homogeneous in colorectal cancer cells using cell fusions. These findings provide the first examples of homoplasmic mutations in the mtDNA of tumour cells and have potential implications for the abnormal metabolic and apoptotic processes in cancer.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Ctr Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Environm Hlth Sci, Div Toxicol Sci, Baltimore, MD 21231 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Case Western Reserve University; Case Western Reserve University	Vogelstein, B (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Howard Hughes Med Inst, Baltimore, MD 21231 USA.	vogelbe@welchlink.welch.jhu.edu			NCI NIH HHS [CA 43460, CA 57345, CA 67409] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043460, R01CA067409, R37CA043460, R01CA057345, R37CA057345] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; ATTARDI G, 1995, BBA-MOL BASIS DIS, V1271, P241, DOI 10.1016/0925-4439(95)00034-2; AUGENLICHT LH, 1992, J CELL BIOCHEM, P151; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; BURGART LJ, 1995, AM J PATHOL, V147, P1105; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Cavalli LR, 1998, MUTAT RES-FUND MOL M, V398, P19, DOI 10.1016/S0027-5107(97)00223-6; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; HEERDT BG, 1994, CANCER RES, V54, P3912; HOFHAUS G, 1995, MOL CELL BIOL, V15, P964; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LI Y, 1997, OXYGEN RADICALS DIS, P237; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Parfait B, 1998, BIOCHEM BIOPH RES CO, V247, P57, DOI 10.1006/bbrc.1998.8666; PARSONS R, 1995, CANCER RES, V55, P5548; Rudin CM, 1997, ANNU REV MED, V48, P267; SHAY JW, 1990, ANTICANCER RES, V10, P279; TALLINI G, 1994, CYTOGENET CELL GENET, V66, P253, DOI 10.1159/000133706; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wallace Douglas C., 1998, Biofactors, V7, P187; Wang HG, 1998, HISTOL HISTOPATHOL, V13, P521, DOI 10.14670/HH-13.521; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WELTER C, 1989, GENE CHROMOSOME CANC, V1, P79, DOI 10.1002/gcc.2870010112; YAMAMOTO H, 1992, BIOCHEM BIOPH RES CO, V182, P913, DOI 10.1016/0006-291X(92)91819-C	32	686	732	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					291	293		10.1038/3108	http://dx.doi.org/10.1038/3108			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806551				2022-12-27	WOS:000076698100026
J	Allen, KM; Gleeson, JG; Bagrodia, S; Partington, MW; MacMillan, JC; Cerione, RA; Mulley, JC; Walsh, CA				Allen, KM; Gleeson, JG; Bagrodia, S; Partington, MW; MacMillan, JC; Cerione, RA; Mulley, JC; Walsh, CA			PAK3 mutation in nonsyndromic X-linked mental retardation	NATURE GENETICS			English	Article							P21-ACTIVATED KINASE PAK1; ACTIVATED PROTEIN-KINASE; ADAPTER PROTEIN; FOCAL COMPLEXES; GTPASES; FAMILY; RHO; IDENTIFICATION; LOCALIZATION; CDC42	Nonsyndromic X-linked mental retardation (MRX) syndromes are clinically homogeneous but genetically heterogeneous disorders, whose genetic bases are largely unknown. Affected individuals in a multiplex pedigree with MRX (MRX30), previously mapped to Xq22, show a point mutation in the PAK3 (p21-activated kinase) gene, which encodes a serine-threonine kinase. PAK proteins are crucial effecters linking Rho GTPases to cytoskeletal reorganization and to nuclear signalling. The mutation produces premature termination, disrupting kinase function. MRI analysis showed no gross defects in brain development. Immunofluorescence analysis showed that PAK3 protein is highly expressed in postmitotic neurons of the developing and postnatal cerebral cortex and hippocampus. Signal transduction through Rho GTPases and PAK3 may be critical for human cognitive function.	Harvard Univ, Sch Med, Div Neurogenet, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol Biomed Sci, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Med Ctr, Boston, MA 02115 USA; Cornell Univ, Dept Mol Med, Ithaca, NY USA; Univ Newcastle, Newcastle, NSW 2308, Australia; Royal Brisbane Hosp, Queensland Clin Genet Serv, Brisbane, Qld 4029, Australia; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA, Australia	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Cornell University; University of Newcastle; Royal Brisbane & Women's Hospital; Womens & Childrens Hospital Australia	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, Beth Israel Deaconess Med Ctr, HIM 846,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	MacMillan, John C/C-9591-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001701, R01NS035129] Funding Source: NIH RePORTER; NIMH NIH HHS [MH10691] Funding Source: Medline; NINDS NIH HHS [5K12NS01701, R01 NS 35129] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN K, IN PRESS GENOMICS; Antonarakis SE, 1998, NAT GENET, V19, P106, DOI 10.1038/450; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Donnelly AJ, 1996, AM J MED GENET, V64, P113, DOI 10.1002/(SICI)1096-8628(19960712)64:1<113::AID-AJMG19>3.0.CO;2-Q; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gregg RG, 1996, HUM MOL GENET, V5, P411, DOI 10.1093/hmg/5.3.411; Gu XX, 1996, J MED GENET, V33, P52, DOI 10.1136/jmg.33.1.52; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Illarioshkin SN, 1996, ANN NEUROL, V40, P75, DOI 10.1002/ana.410400113; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; LUO L, 1925, CURR OPIN NEUROBIOL, V7, P8197; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ogilvie D J, 1996, Methods Mol Biol, V54, P131; Osada S, 1997, FEBS LETT, V404, P227, DOI 10.1016/S0014-5793(97)00139-7; Ryan SG, 1997, NAT GENET, V17, P92, DOI 10.1038/ng0997-92; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	36	372	386	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					25	30		10.1038/1675	http://dx.doi.org/10.1038/1675			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731525				2022-12-27	WOS:000075671400013
J	Rust, S; Walter, M; Funke, H; von Eckardstein, A; Cullen, P; Kroes, HY; Hordijk, R; Geisel, J; Kastelein, J; Molhuizen, HOF; Schreiner, M; Mischke, A; Hashmann, HW; Assmann, G				Rust, S; Walter, M; Funke, H; von Eckardstein, A; Cullen, P; Kroes, HY; Hordijk, R; Geisel, J; Kastelein, J; Molhuizen, HOF; Schreiner, M; Mischke, A; Hashmann, HW; Assmann, G			Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy	NATURE GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; CELLULAR CHOLESTEROL; GENETIC DISSECTION; COMPLEX TRAITS; LECITHIN; FIBROBLASTS; DEFICIENCY; EFFLUX	A low level of high density lipoprotein (HDL) cholesterol is a strong predictor of ischaemic heart disease (IHD) and myocardial infarction(1-3). One cause of low HDL-cholesterol is Tangier disease (TD), an autosomal codominant inherited condition first described in 1961 in two siblings on Tangier Island in the United States of America(4). Apart from low HDL-cholesterol levels and an increased incidence of atherosclerosis(5), TD is characterized by reduced total cholesterol, raised triglycerides, peripheral neuropathy and accumulation of cholesteryl esters in macrophages, which causes enlargement of the liver, spleen and tonsils(4,6). In contrast to two other monogenic HDL deficiencies in which defects in the plasma proteins apoA-I and LCAT interfere primarily with the formation of HDL (refs 7-10), TD shows a defect in cell signalling and the mobilization of cellular lipids(11-14). The genetic defect in TD is unknown, and identification of the Tangier gene will contribute to the understanding of this intracellular pathway and of HDL metabolism and its link with IHD. We report here the localization of the genetic defect in TD to chromosome 9q31, using a genome-wide graphical linkage exclusion strategy in one pedigree, complemented by classical rod score calculations at this region in a total of three pedigrees (combined lod 10.05 at D9S1784). We also provide evidence that TD may be due to a loss-of-function defect.	Univ Munster, Inst Arteriosclerosis Res, D-48149 Munster, Germany; Univ Munster, Inst Clin Chem, D-48149 Munster, Germany; Univ Munster, Lab Med, D-48149 Munster, Germany; Univ Groningen, Dept Med Genet, NL-9713 AW Groningen, Netherlands; Univ Saarlandes Kliniken, Klin Chem Zent Labor, D-66421 Homburg, Germany; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Klin Schwabenland, D-88316 Isny Neutrauchburg, Germany	University of Munster; University of Munster; University of Munster; University of Groningen; Universitatsklinikum des Saarlandes; University of Amsterdam; Academic Medical Center Amsterdam	Rust, S (corresponding author), Univ Munster, Inst Arteriosclerosis Res, Domagkstr 3, D-48149 Munster, Germany.	Rusts@uni-muenster.de	Mischke, Andre/D-3614-2011; Kastelein, John/AAF-7950-2020					ASSMANN G, 1977, J CLIN INVEST, V60, P1025, DOI 10.1172/JCI108853; ASSMANN G, 1986, PROCAM TRIAL; ASSMANN G, 1995, METABOLIC MOL BASES, P2053; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; FREDRICKSON D, 1961, ANN INTERN MED, V55, P1016, DOI 10.7326/0003-4819-55-6-1016; FUNKE H, 1991, J CLIN INVEST, V87, P371, DOI 10.1172/JCI114997; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; FUNKE H, 1993, J CLIN INVEST, V91, P677, DOI 10.1172/JCI116248; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; KROES HY, 1994, J MED GENET, V31, P156, DOI 10.1136/jmg.31.2.156; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; NIKALI K, 1995, AM J HUM GENET, V56, P1088; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Walter M, 1996, J CLIN INVEST, V98, P2315, DOI 10.1172/JCI119043; WALTER M, 1994, BIOCHEM BIOPH RES CO, V205, P850, DOI 10.1006/bbrc.1994.2742	25	57	64	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					96	98		10.1038/1770	http://dx.doi.org/10.1038/1770			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731541				2022-12-27	WOS:000075671400029
J	Hirotsune, S; Fleck, MW; Gambello, MJ; Bix, GJ; Chen, A; Clark, GD; Ledbetter, DH; McBain, CJ; Wynshaw-Boris, A				Hirotsune, S; Fleck, MW; Gambello, MJ; Bix, GJ; Chen, A; Clark, GD; Ledbetter, DH; McBain, CJ; Wynshaw-Boris, A			Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality	NATURE GENETICS			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; CYCLIN-DEPENDENT KINASE-5; CORTICAL DEVELOPMENT; ASPERGILLUS-NIDULANS; CELL-MIGRATION; REELER MICE; BRAIN; PROTEIN; SUBUNIT	Heterozygous mutation or deletion of the beta subunit of platelet-activating factor acetylhydrolase (PAFAH1B1, also known as LIS1) in humans is associated with type I lissencephaly, a severe developmental brain disorder thought to result from abnormal neuronal migration. To further understand the function of PAFAH1B1, we produced three different mutant alleles in mouse Pafah1b1. Homozygous null mice die early in embryogenesis soon after implantation. Mice with one inactive allele display cortical, hippocampal and olfactory bulb disorganization resulting from delayed neuronal migration by a cell-autonomous neuronal pathway.. Mice with further reduction of Pafah1b1 activity display more severe brain disorganization as well as cerebellar defects. Our results demonstrate an essential, dosage-sensitive neuronal-specific role for Pafah1b1 in neuronal migration throughout the brain, and an essential role in early embryonic development. The phenotypes observed are distinct from those of other mouse mutants with neuronal migration defects, suggesting that Pafah1b1 participates in a novel pathway for neuronal migration.	NICHHD, Genet Dis Res Branch, Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Baylor Coll Med, Cain Fdn Res Labs, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Cain Fdn Res Labs, Div Neurosci, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Chicago; Baylor College of Medicine; Baylor College of Medicine	Wynshaw-Boris, A (corresponding author), NICHHD, Genet Dis Res Branch, Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA.				NINDS NIH HHS [NS37146] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037146] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; ASOU H, 1992, NEUROSCI LETT, V144, P221, DOI 10.1016/0304-3940(92)90754-U; Barkovich AJ, 1996, NEUROPEDIATRICS, V27, P59, DOI 10.1055/s-2007-973750; Bix GJ, 1998, J NEUROSCI, V18, P307; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Clark GD, 1995, NEUROREPORT, V6, P2569, DOI 10.1097/00001756-199512150-00029; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; DOVER R, 1994, HISTOCHEMISTRY, V102, P383, DOI 10.1007/BF00268909; Garrett W.M., 1998, BIOCHEMICA, V1, P17; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Luna L.G., 1992, HISTOPATHOLOGICAL ME; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; NAGATA I, 1994, INT J DEV NEUROSCI, V12, P387, DOI 10.1016/0736-5748(94)90022-1; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; REINER O, 1995, J NEUROSCI, V15, P3730; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RELD CB, 1996, PROGR BRAIN RES, P17; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; WILLINS DA, 1995, GENETICS, V141, P1287; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297	43	473	481	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					333	339		10.1038/1221	http://dx.doi.org/10.1038/1221			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697693				2022-12-27	WOS:000075107600015
J	Woitach, JT; Zhang, MH; Niu, CH; Thorgeirsson, SS				Woitach, JT; Zhang, MH; Niu, CH; Thorgeirsson, SS			A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability	NATURE GENETICS			English	Article							LIVER EPITHELIAL-CELLS; GENE-PRODUCT; RB GENE; GROWTH FACTOR-BETA-1; TUMOR SUPPRESSOR; CARCINOMA-CELLS; IDENTIFICATION; EXPRESSION	The retinoblastoma (RB) gene is one of the most extensively studied tumour-suppressor genes(1). Deletion or inactivation of both RE alleles is an essential, rate-limiting step in the formation of retinoblastoma and osteosarcoma that arise in families that carry mutant RE (ref. 2). RE inactivation is also found in other human tumours(3-8). Whereas loss of RE function is associated with the loss of cellular proliferative control, introduction of a wild-type RE can suppress cell growth and tumorigenicity(5,9-12). Thus, identification of factors that interfere with and/or control the function of the RE protein is critical for understanding both cell-cycle control and oncogenesis. Here we describe a new gene, Bog (for B5T over-expressed gene), which was identified and shown to be overexpressed in several transformed rat liver epithelial (RLE) cell lines resistant to the growth-inhibitory effect of TGF-beta 1, as well as in primary human liver tumours. The Bog protein shares homology with other retinoblastoma-binding proteins and contains the Rb-binding motif LXCXE. Using the yeast two-hybrid system and co-immunoprecipitation. we demonstrated that Bog binds to Rb. In vivo, Bog/Rb complexes do not contain E2F-1, and Bog can displace E2F-1 from E2F-1/Rb complexes in vitro. Overexpression of Bog in normal RFE cells conferred resistance to the growth-inhibitory effect of TGF-beta 1. Furthermore, normal RLE cells are rapidly transformed when Bog is continuously overexpressed and form hepatoblastoma-like tumours when transplanted into nude mice. These data suggest that Bog may be important in the transformation process, in part due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta 1 through interaction with Rb and the subsequent displacement of E2F-1.	NCI, Expt Carcinogenesis Lab, Div Basic Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Div Basic Sci, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov						Altiok A, 1991, GROWTH FACTORS, V4, P117, DOI 10.3109/08977199109000263; Barrack ER, 1997, PROSTATE, V31, P61; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; Bruno E, 1998, BLOOD, V91, P1917, DOI 10.1182/blood.V91.6.1917.1917_1917_1923; CHENG J, 1990, BLOOD, V75, P730; GARFIELD S, 1988, MOL CARCINOGEN, V1, P189, DOI 10.1002/mc.2940010307; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Gryfe R, 1997, CURR PROB CANCER, V21, P238, DOI 10.1016/S0147-0272(97)80003-7; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; HUGGETT AC, 1991, CANCER RES, V51, P5929; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Namba M, 1996, CRIT REV ONCOGENESIS, V7, P19, DOI 10.1615/CritRevOncog.v7.i1-2.20; Padgett Richard W., 1997, Cytokine and Growth Factor Reviews, V8, P1, DOI 10.1016/S1359-6101(96)00050-0; PIACIBELLO W, 1991, HAEMATOLOGICA, V76, P460; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; TAKAHASHI R, 1991, P NATL ACAD SCI USA, V88, P5257, DOI 10.1073/pnas.88.12.5257; VENTER DJ, 1991, ONCOGENE, V6, P445; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YOKOTA J, 1988, ONCOGENE, V3, P471; ZERFASS K, 1995, J GEN VIROL, V76, P1815, DOI 10.1099/0022-1317-76-7-1815	26	50	54	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1998	19	4					371	374		10.1038/1258	http://dx.doi.org/10.1038/1258			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697699				2022-12-27	WOS:000075107600021
J	Yan, H; Chen, CY; Kobayashi, R; Newport, J				Yan, H; Chen, CY; Kobayashi, R; Newport, J			Replication focus-forming activity 1 and the Werner syndrome gene product	NATURE GENETICS			English	Article							DNA-SYNTHESIS; CENTERS; PROTEIN; ORIGINS; YEAST	The initiation of DNA replication involves a minimum of four factors: a specific DNA sequence (origin), an initiator protein which binds to the origin, a helicase that unwinds the origin and a protein that binds single-stranded DNA that stabilizes the unwound origin(1). In eukaryotic cells, the origin recognition complex(2) (ORC) is the initiator protein and replication protein A (RPA; ref. 3) is the single-stranded DNA-binding protein. However, the helicase has not been identified and the nature of origins remains elusive, except in the case of Saccharomyces cerevisiae. A unique feature of eukaryotic DNA replication is that it occurs at a few-hundred discrete foci(4). It has thus been proposed that a real origin must contain a specific DNA sequence and must be attached to replication foci. Using Xenopus laevis egg extracts, we have identified and purified a 170-kD protein, focus-forming activity 1 (FFA-1), which is required for the formation of replication foci(5). Here we report that FFA-1 has DNA-helicase activity. Moreover, it is a homologue of the human Werner syndrome gene product WRN, a protein associated with premature ageing in humans(6).	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Fox Chase Cancer Center; Cold Spring Harbor Laboratory; University of California System; University of California San Diego	Yan, H (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave,W450, Philadelphia, PA 19111 USA.	hong_yan@fccc.edu						ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUJIWARA Y, 1977, J CELL PHYSIOL, V92, P365, DOI 10.1002/jcp.1040920305; FUKIWARA Y, 1985, WERNERS SYNDROME HUM, P459; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GOBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713; Imamura O, 1997, GENOMICS, V41, P298, DOI 10.1006/geno.1997.4661; Kornberg A., 1992, DNA REPLICATION; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; TAKEUCHI F, 1982, HUM GENET, V60, P365, DOI 10.1007/BF00569220; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; YAN H, 1995, J CELL BIOL, V129, P1, DOI 10.1083/jcb.129.1.1; YAN H, 1995, SCIENCE, V269, P1883, DOI 10.1126/science.7569932; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Yu CE, 1997, AM J HUM GENET, V60, P330; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	25	122	125	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					375	378		10.1038/1263	http://dx.doi.org/10.1038/1263			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697700				2022-12-27	WOS:000075107600022
J	Lizardi, PM; Huang, XH; Zhu, ZR; Bray-Ward, P; Thomas, DC; Ward, DC				Lizardi, PM; Huang, XH; Zhu, ZR; Bray-Ward, P; Thomas, DC; Ward, DC			Mutation detection and single-molecule counting using isothermal rolling-circle amplification	NATURE GENETICS			English	Article							DNA-POLYMERASE; REPLICATION; OLIGONUCLEOTIDES; HYBRIDIZATION; LIGASE	Rolling-circle amplification (RCA) driven by DNA polymerase can replicate circularized oligonucleotide probes with either linear or geometric kinetics under isothermal conditions. In the presence of two primers, one hybridizing to the + strand, and the other, to the - strand of DNA, a complex pattern of DNA strand displacement ensues that generates 10(9) or more copies of each circle in 90 minutes, enabling detection of point mutations in human genomic DNA. Using a single primer, RCA generates hundreds of tandemly linked copies of a covalently closed circle in a few minutes. If matrix-associated, the DNA product remains bound at the site of synthesis, where it may be tagged, condensed and imaged as a point light source. Linear oligonucleotide probes bound covalently on a glass surface can generate RCA signals, the colour of which indicates the allel status of the target, depending on the outcome of specific, target-directed ligation events. As RCA permits millions of individual probe molecules to be counted and sorted using colour codes, it is particularly amenable for the analysis of rare somatic mutations. RCA also shows promise for the detection of padlock probes bound to single-copy genes in cytological preparations.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Oncor Inc, Gaithersburg, MD 20877 USA	Yale University; Yale University	Lizardi, PM (corresponding author), Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.				NHGRI NIH HHS [HG00272] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000272] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABRAVAYA K, 1995, NUCLEIC ACIDS RES, V23, P675, DOI 10.1093/nar/23.4.675; Aliotta JM, 1996, GENET ANAL-BIOMOL E, V12, P185; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; GERDES MG, 1994, J CELL BIOL, V126, P289, DOI 10.1083/jcb.126.2.289; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Heinonen P, 1997, CLIN CHEM, V43, P1142; KONG HM, 1993, J BIOL CHEM, V268, P1965; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; Luo JY, 1996, NUCLEIC ACIDS RES, V24, P3071, DOI 10.1093/nar/24.15.3071; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Nilsson M, 1997, NAT GENET, V16, P252, DOI 10.1038/ng0797-252; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHWARZ K, 1990, NUCLEIC ACIDS RES, V18, P1079, DOI 10.1093/nar/18.4.1079; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7	19	1031	1669	23	581	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					225	232		10.1038/898	http://dx.doi.org/10.1038/898			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662393				2022-12-27	WOS:000074565900016
J	Okawa, A; Nakamura, I; Goto, S; Moriya, H; Nakamura, Y; Ikegawa, S				Okawa, A; Nakamura, I; Goto, S; Moriya, H; Nakamura, Y; Ikegawa, S			Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine	NATURE GENETICS			English	Article							NUCLEOSIDE-TRIPHOSPHATE PYROPHOSPHATASE; MEMBRANE GLYCOPROTEIN PC-1; INORGANIC PYROPHOSPHATE; EPIPHYSEAL CARTILAGE; PARATHYROID-HORMONE; ANTIGEN PC-1; PYROPHOSPHOHYDROLASE; GENERATION; CELLS; BONE	Ossification of the posterior longitudinal ligament of the spine (OPLL) is a common form of human myelopathy caused by a compression of the spinal cord by ectopic ossification of spinal ligaments(1,2). To elucidate the genetic basis for OPLL, we have been studying the ttw (tiptoe walking; previously designated twy) mouse, a naturally occurring mutant which exhibits ossification of the spinal ligaments very similar to human OPLL (refs 3,4). Using a positional candidate-gene approach, we determined the ttw phenotype is caused by a nonsense mutation (glycine 568 to stop) in the Npps gene which encodes nucleotide pyrophosphatase. This enzyme regulates soft-tissue calcification and bone mineralization by producing inorganic pyrophosphate, a major inhibitor of calcification(5-8). The accelerated bone formation characteristic of ttw mice is likely to result from dysfunction of NPPS caused by predicted truncation of the gene product, resulting in the loss of more than one-third of the native protein. Our results may lead to novel insights into the mechanism of ectopic ossification and the aetiology of human OPLL.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 108, Japan; Chiba Univ, Sch Med, Dept Orthopaed Surg, Chyuo Ku, Chiba 260, Japan; Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 390, Japan	University of Tokyo; Chiba University; Shinshu University	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.	yusuke@ims.u-tokyo.ac.jp						ALBINNI U, 1982, CHIR ORG MOVIMENTO, V70, P15; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; CASWELL AM, 1987, BIOCHIM BIOPHYS ACTA, V924, P276, DOI 10.1016/0304-4165(87)90023-7; CASWELL AM, 1988, BIOCHIM BIOPHYS ACTA, V966, P310, DOI 10.1016/0304-4165(88)90080-3; DIETRICH W, 1992, GENETICS, V131, P423; FIROOZNIA H, 1982, NEW YORK STATE J MED, V82, P1193; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; GOTO S, 1997, OSSIFICATION POSTERI, P29; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; HSU HHT, 1983, J BIOL CHEM, V258, P3463; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; OHTSUKA K, 1987, ARCH ORTHOP TRAUM SU, V106, P89, DOI 10.1007/BF00435420; Okawa A, 1998, MAMM GENOME, V9, P155, DOI 10.1007/s003359900707; ONO K, 1977, Spine, V2, P126, DOI 10.1097/00007632-197706000-00005; OYAJOBI BO, 1994, J BONE MINER RES, V9, P1259; REBBE NF, 1991, P NATL ACAD SCI USA, V88, P5192, DOI 10.1073/pnas.88.12.5192; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; SIEGEL SA, 1983, J BIOL CHEM, V258, P8601; TERAKADO A, 1995, CALCIFIED TISSUE INT, V56, P135, DOI 10.1007/BF00296345; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; VANDRIEL IR, 1987, J BIOL CHEM, V262, P4882; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; YAMAZAKI M, 1991, CALCIFIED TISSUE INT, V48, P182, DOI 10.1007/BF02570553	26	314	329	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					271	273		10.1038/956	http://dx.doi.org/10.1038/956			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662402				2022-12-27	WOS:000074565900025
J	Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Martensson, IL; Toresson, H; Fox, M; Wales, JKH; Hindmarsh, PC; Krauss, S; Beddington, RSP; Robinson, ICAF				Dattani, MT; Martinez-Barbera, JP; Thomas, PQ; Brickman, JM; Gupta, R; Martensson, IL; Toresson, H; Fox, M; Wales, JKH; Hindmarsh, PC; Krauss, S; Beddington, RSP; Robinson, ICAF			Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse	NATURE GENETICS			English	Article							ANTERIOR NEURAL PLATE; CRYSTAL-STRUCTURE; CORPUS-CALLOSUM; HOMEODOMAIN; TRANSCRIPTION; AGENESIS; EMBRYO; DNA; ORGANIZATION; EXPRESSION	During early mouse development the homeobox gene Hesx1 is expressed in prospective forebrain tissue, but later becomes restricted to Rathke's pouch, the primordium of the anterior pituitary gland. Mice lacking Hesx1 exhibit variable anterior CNS defects and pituitary dysplasia. Mutants have a reduced prosencephalon, anopthalmia or micropthalmia, defective olfactory development and bifurcations in Rathke's pouch. Neonates exhibit abnormalities in the corpus callosum, the anterior and hippocampal commissures, and the septum pellucidum. A comparable and equally variable phenotype in humans is septo-optic dysplasia (SOD). We have cloned human HESX1 and screened for mutations in affected individuals. Two siblings with SOD were homozygous for an Arg53Cys missense mutation within the HESX1 homeodomain which destroyed its ability to bind target DNA. These data suggest an important role for Hesx1/HESX1 in forebrain, midline and pituitary development in mouse and human.	Natl Inst Med Res, London NW7 1AA, England; Inst Child Hlth, London Ctr Paediat Endocrinol & Metab, London, England; Univ Lund, Dept Mol & Cell Biol, S-22100 Lund, Sweden; Wallenberg Neurosci Ctr, Neurobiol Unit, Lund, Sweden; MRC, Human Biochem Genet Unit, Galton Lab, London, England; Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; Univ Tromso, Dept Mol Genet, Inst Med Biol, N-9037 Breiviklia, Norway	MRC National Institute for Medical Research; University of London; University College London; Lund University; University of London; University College London; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; UiT The Arctic University of Tromso	Robinson, ICAF (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	irobins@nimr.mrc.ac.uk	Thomas, Paul Q/K-4497-2012; DATTANI, MEHUL/C-5401-2008; Hindmarsh, P C/C-4964-2008; Martinez-Barbera, Juan Pedro/AAE-9284-2020; Wales, Jerry/A-6797-2011	Martinez-Barbera, Juan Pedro/0000-0002-5292-7276; Wales, Jerry/0000-0002-8769-648X; Brickman, Joshua/0000-0003-1580-7491; Gupta, Rajeev/0000-0001-9573-0505; Krauss, Stefan/0000-0001-6992-8091; Martensson, Inga-Lill/0000-0003-3415-0560				ARSLANIAN SA, 1984, ACTA ENDOCRINOL-COP, V107, P282, DOI 10.1530/acta.0.1070282; Benassayag C, 1997, MECH DEVELOP, V63, P187, DOI 10.1016/S0925-4773(97)00040-3; BENNER JD, 1990, AM J OPHTHALMOL, V109, P632, DOI 10.1016/S0002-9394(14)72430-4; BLETHEN SL, 1985, AM J MED GENET, V21, P123, DOI 10.1002/ajmg.1320210118; BRNELLI S, 1996, NAURE GENET, V2, P94; BROOK CGD, 1972, BMJ-BRIT MED J, V3, P811, DOI 10.1136/bmj.3.5830.811; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DE MORSIER G, 1956, Schweiz Arch Neurol Psychiatr, V77, P267; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Fortin AS, 1997, HUM MOL GENET, V6, P1781, DOI 10.1093/hmg/6.11.1781; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; GILLETT GT, 1993, GENOMICS, V15, P332, DOI 10.1006/geno.1993.1065; Hermesz E, 1996, DEVELOPMENT, V122, P41; HOYT WF, 1970, LANCET, V1, P893; IZENBERG N, 1984, CLIN PEDIATR, V23, P632, DOI 10.1177/000992288402301105; Kaufmann M. H., 1994, ATLAS MOUSE DEV; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LALWANI AK, 1995, AM J HUM GENET, V56, P75; LAM KSL, 1986, ACTA ENDOCRINOL-COP, V112, P305, DOI 10.1530/acta.0.1120305; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lee SMK, 1997, DEVELOPMENT, V124, P959; LEHMING N, 1995, P NATL ACAD SCI USA, V92, P10242, DOI 10.1073/pnas.92.22.10242; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; MASERA N, 1994, ARCH DIS CHILD, V70, P51, DOI 10.1136/adc.70.1.51; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; NARTA N, 1997, DEV BIOL, V189, P270; Oliver G, 1995, DEVELOPMENT, V121, P4045; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; REEVES DL, 1941, J HOPKINS HOSPITAL B, V69, P61; Rhinn M, 1998, DEVELOPMENT, V125, P845; RMOIN DL, 1976, GROWTH PROBLEMS CLIN, P15; ROESSMANN U, 1989, J CLIN NEURO-OPHTHAL, V9, P156; ROESSMANN U, 1987, J NEUROPATH EXP NEUR, V46, P597, DOI 10.1097/00005072-198709000-00008; SAMBROOK J, 1989, MOL CLONINB LAB MANU; SAMOKHVALOV IM, 1994, DOKL AKAD NAUK, V334, P12; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Smith ST, 1996, DEVELOPMENT, V122, P3141; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; THOMAS P, IN PRESS S QUANTITAT, V62; THOMAS PQ, 1995, J BIOL CHEM, V270, P3869, DOI 10.1074/jbc.270.8.3869; VALENTINO KL, 1982, J NEUROCYTOL, V11, P583, DOI 10.1007/BF01262426; Varlet I, 1997, DEVELOPMENT, V124, P1033; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Wales JKH, 1996, ACTA PAEDIATR, V85, P391, DOI 10.1111/j.1651-2227.1996.tb14044.x; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WEBB GC, 1993, GENOMICS, V18, P464, DOI 10.1006/geno.1993.1505; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; YOUNG ID, 1985, CLIN GENET, V28, P225; Zaias B, 1978, Trans Am Neurol Assoc, V103, P273; ZHADANOV AB, 1995, DEV DYNAM, V202, P354, DOI 10.1002/aja.1002020405	58	513	530	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					125	133		10.1038/477	http://dx.doi.org/10.1038/477			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620767				2022-12-27	WOS:000073865100018
J	[Anonymous]				[Anonymous]			Be fruitful and immortalize	NATURE GENETICS			English	Editorial Material																		Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PERIS T, IN PRESS LANCET; Robine JM, 1998, SCIENCE, V279, P1834; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6	7	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					103	104						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620756				2022-12-27	WOS:000073865100001
J	Perry, WL; Hustad, CM; Swing, DA; O'Sullivan, TN; Jenkins, NA; Copeland, NG				Perry, WL; Hustad, CM; Swing, DA; O'Sullivan, TN; Jenkins, NA; Copeland, NG			The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a(18H) mice	NATURE GENETICS			English	Article							MOTH-EATEN; RECEPTOR; MOUSE; GENE; POLYUBIQUITINATION; DEGRADATION; PATHOLOGY; MUTATIONS; PATHWAY; DOMAIN	Non-agouti-lethal 18H (a(18H)) mice are dark agouti with black pinna hairs. What makes these mice unique is that they develop a spectrum of immunological diseases not seen in other agouti mutant mice(1). On the JU/Ct background, a(18H) mice develop an inflammatory disease of the large intestine, On the C57BL/6J background, they develop a fatal disease characterized by pulmonary chronic interstitial inflammation and alveolar proteinosis, inflammation of the glandular stomach and skin resulting in scarring due to constant itching, and hyperplasia of lymphoid cells, haematopoietic cells and the forestomach epithelium. Previous studies suggested that the a(18H) mutation results from a paracentric inversion that affects two loci: agouti and another, as yet unidentified locus designated itchy (the provisional gene symbol is Itch), that is responsible for the immunological phenotype of a(18H) mice(1). Here we confirm that a(18H) results from an inversion and show that Itch encodes a novel E3 ubiquitin protein ligase, a protein involved in ubiquitin-mediated protein degradation. Our results indicate that ubiquitin-dependent proteolysis is an important mediator of the immune response in vivo and provide evidence for itch's role in inflammation and the regulation of epithelial and haematopoietic cell growth.	NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Mammalian Genet Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Copeland, NG (corresponding author), NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Mammalian Genet Lab, Frederick, MD 21702 USA.	copeland@ncifcrf.gov						CATTANACH BM, 1987, MOUSE NEWS LETT, V77, P123; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DAVID M, 1995, MOL CELL BIOL, V15, P7050; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; FERRY WL, 1995, GENETICS, V140, P267; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; HUSTAD CM, 1995, GENETICS, V140, P255; Jiao HY, 1997, EXP HEMATOL, V25, P592; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MIYAZAWA K, 1994, BLOOD, V83, P137; MORI S, 1995, BIOCHEM BIOPH RES CO, V213, P32, DOI 10.1006/bbrc.1995.2094; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; MORI S, 1993, J BIOL CHEM, V268, P577; Piao XH, 1996, P NATL ACAD SCI USA, V93, P14665, DOI 10.1073/pnas.93.25.14665; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SIDMAN CL, 1978, J IMMUNOL, V121, P2392; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; VRIELING HD, 1994, P NATL ACAD SCI USA, V91, P170; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203	25	268	278	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					143	146		10.1038/ng0298-143	http://dx.doi.org/10.1038/ng0298-143			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462742				2022-12-27	WOS:000071779500021
J	Kleeberger, SR; Levitt, RC; Zhang, LY; Longphre, M; Harkema, L; Jedlicka, A; Eleff, SM; DiSilvestre, D; Holroyd, KJ				Kleeberger, SR; Levitt, RC; Zhang, LY; Longphre, M; Harkema, L; Jedlicka, A; Eleff, SM; DiSilvestre, D; Holroyd, KJ			Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; TNF-ALPHA; AIRWAY INFLAMMATION; EXPOSURE; CYTOTOXICITY; RESPONSES; TRAITS; MOUSE; GENE	Exposures to the common air pollutant ozone (O-3) cause decrements in pulmonary function and induce airway inflammation that is characterized by infiltration of polymorphonuclear neutrophils (PMNs; refs 1-4). Because of the impact that O-3 may have on public health, it is critical to identify susceptibility factors. Highly reproducible, significant inter-individual variations in human pulmonary function responses to O-3 support the hypothesis that genetic background is an important determinant(5,6). Initial analysis of PMN responses to O-3 exposure in segregant populations derived from inflammation-prone (susceptible) C57BL/6J (B6) and inflammation-resistant C3H/HeJ (C3) inbred mice indicated that susceptibility was controlled by a locus we termed Inf2 (ref. 7). Subsequent analyses with recombinant inbred strains suggested that a more complex interaction of genes is involved(8). In this report, we identify a quantitative trait locus (QTL) for O-3 susceptibility on chromosome 17. Candidate genes for the locus include Tnf, the gene encoding the proinflammatory cytokine tumour necrosis factor-alpha (Tnf). Antibody neutralization of the protein product of this putative candidate gene significantly protected against O-3 injury in susceptible mice. These results strongly support linkage of O-3 susceptibility to a QTL on chromosome 17 and Tnf as a candidate gene.	JOHNS HOPKINS MED INST,DEPT ANESTHESIOL CRIT CARE MED,BALTIMORE,MD 21205; MAGAININ PHARMACEUT,MAGAININ INST MOL MED,PLYMOUTH,PA 19462; MICHIGAN STATE UNIV,COLL VET MED,DEPT PATHOL,E LANSING,MI 48824	Johns Hopkins University; Johns Hopkins Medicine; Michigan State University	Kleeberger, SR (corresponding author), JOHNS HOPKINS MED INST,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD 21205, USA.		Kleeberger, Steven R/F-1807-2019	Kleeberger, Steven R/0000-0003-2948-8452; Holroyd, Kenneth/0000-0001-6050-3935	NHLBI NIH HHS [HL-51697] Funding Source: Medline; NIEHS NIH HHS [ES-03819, ES-03505] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819, P01ES003505] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agostini C, 1996, AM J RESP CRIT CARE, V153, P1359, DOI 10.1164/ajrccm.153.4.8616567; ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; *CAS W RES U DEP E, 1994, STAT AN GEN EP REL 2; Casale TB, 1996, AM J RESP CELL MOL, V15, P35, DOI 10.1165/ajrcmb.15.1.8679220; Claudio E, 1996, EXP CELL RES, V224, P63, DOI 10.1006/excr.1996.0111; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; DISILVESTRE D, 1995, MAMM GENOME, V6, P281, DOI 10.1007/BF00352417; ELSTON RC, 1984, GENETICS, V108, P733; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; KLEEBERGER SR, 1993, AM J PHYSIOL, V264, pL15, DOI 10.1152/ajplung.1993.264.1.L15; Kleeberger SR, 1995, TOXICOL LETT, V82-3, P295, DOI 10.1016/0378-4274(95)03564-8; KLEEBERGER SR, 1993, AM J PHYSIOL, V264, pL21, DOI 10.1152/ajplung.1993.264.1.L21; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LINCOLN S, 1992, MAPPING GENES CONTRO; Longphre M, 1996, J APPL PHYSIOL, V80, P1322, DOI 10.1152/jappl.1996.80.4.1322; LUKACS NW, 1995, J IMMUNOL, V154, P5411; MANLY KF, 1996, MAP MANAGER QT; MCDONNELL WF, 1985, AM REV RESPIR DIS, V131, P36; SHAH A, 1995, CLIN EXP ALLERGY, V25, P1038; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Silver L.M., 1995, MOUSE GENETICS CONCE; SMART SJ, 1994, AM J PHYSIOL, V266, pL238, DOI 10.1152/ajplung.1994.266.3.L238; VISNER GA, 1990, J BIOL CHEM, V265, P2856; WEINMANN GG, 1995, AM J RESP CRIT CARE, V151, P33, DOI 10.1164/ajrccm.151.1.7812569	30	150	152	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					475	478		10.1038/ng1297-475	http://dx.doi.org/10.1038/ng1297-475			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398854				2022-12-27	WOS:A1997YJ92400033
J	Mayer, U; Saher, G; Fassler, R; Bornemann, A; Echtermeyer, F; vonderMark, H; Miosge, N; Poschl, E; vonderMark, K				Mayer, U; Saher, G; Fassler, R; Bornemann, A; Echtermeyer, F; vonderMark, H; Miosge, N; Poschl, E; vonderMark, K			Absence of integrin alpha 7 causes a novel form of muscular dystrophy	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; MYOTENDINOUS JUNCTION; CYTOPLASMIC DOMAINS; LAMININ; EXPRESSION; GENE; MYOBLASTS; BINDING; MOTILITY	Integrin alpha 7 beta 1 is a specific cellular receptor for the basement membrane protein laminin-l (refs 1,2), as well as for the laminin isoforms -2 and -4 (ref. 3). The alpha 7 subunit is expressed mainly in skeletal and cardiac muscle(4) and has been suggested to be involved in differentiation and migration processes during myogenesis(5,6). Three cytoplasmic and two extracellular splice variants that have been described are developmentally regulated and expressed in different sites in the muscle(7-9). In adult muscle, the alpha 7A and alpha 7B subunits are concentrated in myotendinous junctions(10) but can also be detected in neuromuscular junctions and along the sarcolemmal membrane(11). To study the potential involvement of alpha 7 integrin during myogenesis and its role in muscle integrity and function, we generated a null allele of the alpha 7 gene (Itga7) in the germline of mice by homologous recombination in embryonic stent(ES) cells. Surprisingly, mice homozygous for the mutation are viable and fertile, indicating that the alpha 7 beta 1 integrin is riot essential far myogenesis. However, histological analysis of skeletal muscle revealed typical symptoms of a progressive muscular dystrophy starting soon after birth, but with a distinct variability in different muscle types. The observed histopathological changes strongly indicate an impairment of function of the myotendinous junctions, These findings demonstrate that alpha 7 beta 1 integrin represents an indispensable linkage between the muscle fibre and the extracellular matrix that is independent of the dystrophin-dystroglycan complex-mediated interaction of: the cytoskeleton with the muscle basement membrane.	UNIV TUBINGEN,INST BRAIN RES,D-72076 TUBINGEN,GERMANY; UNIV ERLANGEN NURNBERG,INST EXPT MED,D-91054 ERLANGEN,GERMANY; UNIV GOTTINGEN,INST HISTOL,D-37075 GOTTINGEN,GERMANY	Eberhard Karls University of Tubingen; University of Erlangen Nuremberg; University of Gottingen	Mayer, U (corresponding author), MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,GERMANY.		Saher, Gesine/AAH-1826-2021; Miosge, Nicolai/E-3244-2010	Saher, Gesine/0000-0003-3507-9604; Mayer, Ulrike/0000-0003-2328-0052				BAO ZZ, 1993, J CELL SCI, V106, P579; BRABANT MC, 1993, DEV BIOL, V157, P49, DOI 10.1006/dbio.1993.1111; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; COLLO G, 1993, J BIOL CHEM, V268, P19019; Echtermeyer F, 1996, J BIOL CHEM, V271, P2071, DOI 10.1074/jbc.271.4.2071; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KARNOVSKY M, 1965, ACTA HISTOCHEM, V88, P25; KRAMER RH, 1991, CELL REGUL, V2, P805, DOI 10.1091/mbc.2.10.805; LAW DJ, 1993, AM J PATHOL, V142, P1513; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Settles DL, 1996, MUSCLE NERVE, V19, P147, DOI 10.1002/(SICI)1097-4598(199602)19:2<147::AID-MUS4>3.0.CO;2-E; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Talts JF, 1997, INT J DEV BIOL, V41, P39; TIDBALL JG, 1994, DEV BIOL, V163, P447, DOI 10.1006/dbio.1994.1161; VOLK T, 1990, CELL, V63, P525, DOI 10.1016/0092-8674(90)90449-O; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Ziober BL, 1996, J BIOL CHEM, V271, P22915, DOI 10.1074/jbc.271.37.22915; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773	30	357	369	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					318	323		10.1038/ng1197-318	http://dx.doi.org/10.1038/ng1197-318			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354797				2022-12-27	WOS:A1997YD66700027
J	Cranston, A; Bocker, T; Reitmair, A; Palazzo, J; Wilson, T; Mak, T; Fishel, R				Cranston, A; Bocker, T; Reitmair, A; Palazzo, J; Wilson, T; Mak, T; Fishel, R			Female embryonic lethality in mice nullizygous for both Msh2 and p53	NATURE GENETICS			English	Letter							CELL-CYCLE CHECKPOINT; GENE; TUMORIGENESIS; PROTEIN; TUMORS; INACTIVATION; DEFICIENCY; MUTATIONS; SPECTRUM; CANCER	The mutator hypothesis of tumorigenesis suggests that loss of chromosomal stability or maintenance functions results in elevated mutation rates, leading to the accumulation of the numerous mutations required for multistep carcinogenesis' The human DNA mismatch repair (MMR) genes are highly conserved homologues of the Escherichia coli MutHLS system, which contribute to genomic stability by surveillance and repair of replication misincorporation errors and exogenous DNA damage(2), Mutations in one of these MMR genes, hMSH2, account for about half of all cases of genetically linked hereditary non-polyposis colorectal cancer(3,4). Loss of function of p53 has also been proposed to increase cellular hypermutability, thereby accelerating carcinogenesis(5), although a clear role for p53 in genomic instability remains controversial(2). p53 is mutated frequently in a wide range of human cancers, including colonic tumours(6), Both Msh2- and p53-targeted knockout mice are viable and susceptible to cancer(7-11). Here we demonstrate that combined Msh(2) and p53 ablation (Msh2(-/-)p53(-/-)) results in developmental arrest of all female embryos at 9.5 days. In contrast, male Msh2(-/-)p53(-/-) mice are viable, but succumb to tumours significantly earlier (t(1/2) is 73 days) than either Msh2(-/-) or p53(-/-) littermates. Furthermore, the frequency of microsatellite instability (MSI) in tumours from Msh2(-/-)p53(-/-) mice is not significantly different than in Msh2(-/-) mice. Synergism in tumorigenesis and independent segregation of the MSI phenotype suggest that Msh2 and p53 are not genetically epistatic.	THOMAS JEFFERSON UNIV,KIMMEL CANC CTR,DEPT IMMUNOL & MICROBIOL,GENET & MOL BIOL PROGRAM,PHILADELPHIA,PA 19107; UNIV TORONTO,AMGEN INST ONTARIO CANC INST,TORONTO,ON M5G 2M9,CANADA; THOMAS JEFFERSON UNIV,DEPT PATHOL,PHILADELPHIA,PA 19107	Jefferson University; University of Toronto; Jefferson University					NATIONAL CANCER INSTITUTE [R01CA056542, F32CA073134, R01CA067007] Funding Source: NIH RePORTER; NCI NIH HHS [CA73134, CA56542, R01 CA067007, CA67007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BLYTH K, 1995, ONCOGENE, V10, P1717; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; HAWN MT, 1995, CANCER RES, V55, P3721; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; LAHTI MN, 1994, AM J HUM GENET, V55, P659; LIN D, 1992, P NATL ACAD SCI USA, V89, P9210, DOI 10.1073/pnas.89.19.9210; LOEB LA, 1991, CANCER RES, V51, P3075; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marra G, 1996, ONCOGENE, V13, P2189; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; PURDIE CA, 1994, ONCOGENE, V9, P603; RASTAN S, 1994, CURR OPIN GENET DEV, V4, P292, DOI 10.1016/S0959-437X(05)80056-5; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; TAGAKI N, 1974, EXP CELL RES, V86, P127; TAYLOR JH, 1960, J BIOPHYS BIOCHEM CY, V7, P455, DOI 10.1083/jcb.7.3.455; THEILER K, 1972, P168; WILLIAMS BO, 1994, COLD SPRING HARB SYM, V59, P449, DOI 10.1101/SQB.1994.059.01.050; WILLIAMS BO, 1994, CELL, V79, P329	29	65	65	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					114	118		10.1038/ng0997-114	http://dx.doi.org/10.1038/ng0997-114			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288110				2022-12-27	WOS:A1997XU72400030
J	Lee, B; Thirunavukkarasu, K; Zhou, L; Pastore, L; Baldini, A; Hecht, J; Geoffroy, V; Ducy, P; Karsenty, G				Lee, B; Thirunavukkarasu, K; Zhou, L; Pastore, L; Baldini, A; Hecht, J; Geoffroy, V; Ducy, P; Karsenty, G			Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia	NATURE GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; TGF-BETA-SUPERFAMILY; SRY-RELATED GENE; DROSOPHILA SEGMENTATION; CAMPOMELIC DYSPLASIA; RUNT; FAMILY; MICRODELETION; EXPRESSION; MEMBER		UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT MOL GENET,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DIV MED GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas System	Lee, B (corresponding author), BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030, USA.		Pastore, Lucio/AAF-3487-2019; K, Thirunavukkarasu/AAA-7615-2019; Geoffroy, Valerie/P-1521-2014; Pastore, Lucio/F-4668-2010; genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015	Pastore, Lucio/0000-0001-6894-9317; Geoffroy, Valerie/0000-0003-3920-7482; Baldini, Antonio/0000-0002-5330-0256				Ahn MY, 1996, GENE, V168, P279, DOI 10.1016/0378-1119(95)00751-2; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baldini A, 1994, Methods Mol Biol, V33, P75; DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Francomano CA, 1996, CURR OPIN GENET DEV, V6, P301, DOI 10.1016/S0959-437X(96)80006-2; GELB BD, 1995, AM J MED GENET, V58, P200, DOI 10.1002/ajmg.1320580222; GERGEN JP, 1985, DEV BIOL, V109, P321, DOI 10.1016/0012-1606(85)90459-2; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Innis MA, 1990, PCR PROTOCOLS GUIDE; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jones K. L., 1997, SMITHS RECOGNIZABLE; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; MUNDLOS S, 1995, HUM MOL GENET, V4, P71, DOI 10.1093/hmg/4.1.71; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rousseau F, 1996, HORM RES, V45, P108, DOI 10.1159/000184768; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; TSAI CC, 1994, DEVELOPMENT, V120, P1671; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0	30	417	438	4	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					307	310		10.1038/ng0797-307	http://dx.doi.org/10.1038/ng0797-307			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207800				2022-12-27	WOS:A1997XG60900030
J	Pastural, E; Barrat, FJ; DufourcqLagelouse, R; Certain, S; Sanal, O; Jabado, N; Seger, R; Griscelli, C; Fischer, A; DesaintBasile, G				Pastural, E; Barrat, FJ; DufourcqLagelouse, R; Certain, S; Sanal, O; Jabado, N; Seger, R; Griscelli, C; Fischer, A; DesaintBasile, G			Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene	NATURE GENETICS			English	Article							UNCONVENTIONAL MYOSIN; PARTIAL ALBINISM; IMMUNODEFICIENCY; INVOLVEMENT; LOCUS		HOP NECKER ENFANTS MALAD,INSERM U429,UNITE RECH DEV NORMAL & PATHOL SYST IMMUNITAIRE,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,UNITE IMMUNOL & HEMATOL PEDIAT,F-75743 PARIS 15,FRANCE; HACETTEPE CHILDRENS HOSP MED CTR,ANKARA,TURKEY; UNIV KINDERSPITAL ZURICH,ABT IMMUNOL HAMATOL,CH-8032 ZURICH,SWITZERLAND	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; University Children's Hospital Zurich			Jabado, Nada/AAN-4026-2020; de Saint Basile, Genevieve/G-9731-2017	DOGNIAUX, Stephanie/0000-0003-3309-1204; de Saint Basile, Genevieve/0000-0002-1913-5269				Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Barrat FJ, 1996, AM J HUM GENET, V59, P625; BEJAOUI M, 1989, ARCH FR PEDIATR, V46, P733; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELEJALDE BR, 1979, AM J MED GENET, V3, P65, DOI 10.1002/ajmg.1320030112; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans L. L., 1995, Molecular Biology of the Cell, V6, p145A; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; HARALDSSON A, 1991, EUR J PEDIATR, V150, P419, DOI 10.1007/BF02093723; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; HURVITZ H, 1993, EUR J PEDIATR, V152, P402, DOI 10.1007/BF01955897; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; Maniatis T., 1982, MOL CLONING; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOORE KJ, 1995, CYTOGENET CELL GENET, V69, P53, DOI 10.1159/000133937; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; STROBEL MC, 1990, MOL CELL BIOL, V10, P501, DOI 10.1128/MCB.10.2.501; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; WINDHORST DB, 1973, J INVEST DERMATOL, V60, P529, DOI 10.1111/1523-1747.ep12703609	26	332	339	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					289	292		10.1038/ng0797-289	http://dx.doi.org/10.1038/ng0797-289			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207796				2022-12-27	WOS:A1997XG60900026
J	Martinson, JJ; Chapman, NH; Rees, DC; Liu, YT; Clegg, JB				Martinson, JJ; Chapman, NH; Rees, DC; Liu, YT; Clegg, JB			Global distribution of the CCR5 gene 32-basepair deletion	NATURE GENETICS			English	Article							DISEASES; HIV	A mutant allele of the beta-chemokine receptor gene CCR5 bearing a 32-basepair (bp) deletion (denoted Delta ccr5) which prevents cell invasion by the primary transmitting strain of HIV-1 has recently been characterized(1-3). Homozygotes for the mutation are resistant to infection, even after repeated high-risk exposures(1,4), but this resistance appears not to be total, as isolated cases of HIV-positive deletion homozygotes are now emerging(5), The consequence of the heterozygous state is not clear, but it may delay the progression to AIDS in infected individuals(2,3,6,7). A gene frequency of approximately 10% was found for Delta ccr5 in populations of European descent, but no mutant alleles were reported in indigenous non-European populations, As the total number of non-European samples surveyed was small in comparison with the Europeans the global distribution of this mutation is far from clear. We have devised a rapid PCR assay for Delta ccr5 and used it to screen 3,342 individuals from a globally-distributed range of populations. We find that Delta ccr5 is not confined to people of European descent but is found at frequencies of 2-5% throughout Europe, the Middle East and the Indian subcontinent (Fig. 1). Isolated occurrences are seen elsewhere throughout the world, but these most likely represent recent European gene flow into the indigenous populations, The inter-population differences in Delta ccr5 frequency may influence the pattern of HIV transmission and so will need to be incorporated into future predictions of HIV levels.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Martinson, JJ (corresponding author), JOHN RADCLIFFE HOSP,INST MOL MED,MRC,MOL HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.		; Rees, David/B-6789-2011	Martinson, Jeremy/0000-0003-4673-7238; Rees, David/0000-0003-3647-1050	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COX DW, 1995, METABOLIC MOL BASES, P4125; Cox MJ, 1996, BRIT J HAEMATOL, V92, P1022, DOI 10.1046/j.1365-2141.1996.4961037.x; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEGRUTTOLA V, 1989, J CLIN EPIDEMIOL, V42, P849, DOI 10.1016/0895-4356(89)90098-X; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Fauci AS, 1996, NAT MED, V2, P966, DOI 10.1038/nm0996-966; FLINT J, 1993, HUM GENET, V91, P91; Hill CM, 1996, NATURE, V382, P668, DOI 10.1038/382668a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kimura M., 1983, NEUTRAL THEORY MOL E; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0	32	422	442	0	40	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					100	103		10.1038/ng0597-100	http://dx.doi.org/10.1038/ng0597-100			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140404				2022-12-27	WOS:A1997WX02400031
J	Motley, AM; Hettema, EH; Hogenhout, EM; Brites, P; tenAsbroek, ALMA; Wijburg, FA; Baas, F; Heijmans, HS; Tabak, HF; Wanders, RJA; Distel, B				Motley, AM; Hettema, EH; Hogenhout, EM; Brites, P; tenAsbroek, ALMA; Wijburg, FA; Baas, F; Heijmans, HS; Tabak, HF; Wanders, RJA; Distel, B			Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor	NATURE GENETICS			English	Article							MAMMALIAN-CELL MUTANT; SACCHAROMYCES-CEREVISIAE; IMPORT DEFICIENCIES; DISORDERS; REPEAT; FAMILY; COMPLEMENTATION; THIOLASE; MEMBER; BIOGENESIS	Rhizomelic chondrodysplasia punctata (RCDP) is an autosomal recessive disease characterized clinically by a disproportionately short stature primarily affecting the proximal parts of the extremities, typical dysmorphic facial appearance, congenital contractures and severe growth and mental retardation. Although some patients have single enzyme deficiencies, the majority of RCDP patients (86%) belong to a single complementation group (CG11, also known as complementation group I, Amsterdam nomenclature(1)). Cells from CG11 show a tetrad of biochemical abnormalities: a deficiency of i) dihydroxyacetonephosphate acyltransferase, ii) alkyldihydroxyacetonephosphate synthase, iii) phytanic acid alpha-oxidation and iv) inability to import peroxisomal thiolase. These deficiencies indicate involvement of a component required for correct targeting of these peroxisomal proteins. Deficiencies in peroxisomal targeting are also found in Saccharomyces cerevisiae pex5 and pex7 mutants(2-6), which show differential protein import deficiencies corresponding to two peroxisomal targeting sequences (PTS1 and PTS2). These mutants lack their PTS1 and PTS2 receptors, respectively. Like S. cerevisiae pex7 cells, RCDP cells from CG11 cannot import a PTSZ reporter protein(7). Here we report the cloning of PEX7 encoding the human PTSZ receptor, based on its similarity to two yeast orthologues. All RCDP patients from CG11 with detectable PEX7 mRNA were found to contain mutations in PEX7. A mutation resulting in C-terminal truncation of PEX7 cosegregates with the disease and expression of PEX7 in RCDP fibroblasts from CG11 rescues the PTSZ protein import deficiency. These findings prove that mutations in PEX7 cause RCDP, CG11.	UNIV AMSTERDAM,ACAD MED CTR,DEPT BIOCHEM,NL-1100 DE AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,NL-1100 DE AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT PEDIAT,NL-1100 DE AMSTERDAM,NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam			Brites, Pedro/K-4231-2013; Baas, Frank/F-9574-2010	Brites, Pedro/0000-0003-1754-1543; Baas, Frank/0000-0003-3912-5428; Wijburg, Frits/0000-0002-0950-1368				Amara J F, 1992, Trends Cell Biol, V2, P145, DOI 10.1016/0962-8924(92)90101-R; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; ELGERSMA Y, 1975, J BIOL CHEM, V271, P263; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; HEUS JJ, 1990, CURR GENET, V18, P517, DOI 10.1007/BF00327022; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; VANDERLEIJ I, 1992, J CELL BIOL, V119, P153, DOI 10.1083/jcb.119.1.153; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	33	213	215	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					377	380		10.1038/ng0497-377	http://dx.doi.org/10.1038/ng0497-377			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090382				2022-12-27	WOS:A1997WQ38900015
J	Greenfield, A; Scott, D; Pennisi, D; Ehrmann, I; Ellis, P; Cooper, L; Simpson, E; Koopman, P				Greenfield, A; Scott, D; Pennisi, D; Ehrmann, I; Ellis, P; Cooper, L; Simpson, E; Koopman, P			An H-YDb epitope is encoded by a novel mouse Y chromosome gene	NATURE GENETICS			English	Article							CLASS-I MOLECULES; X-INACTIVATION; EXPRESSION; ANTIGEN; REGION; MICE; DIFFERENTIATION; PEPTIDE; TPR; SPERMATOGENESIS	Rejection of male tissue grafts by genotypically identical female mice has been explained by the existence of a male-specific transplantation antigen, H-Y (ref. 1), but the molecular nature of H-Y antigen has remained obscure. Hya, the murine locus controlling H-Y expression, has been localized to Delta Sxr(b), a deletion interval of the short arm of the Y chromosome(2). In mice, H-Y antigen comprises at least four distinct epitopes, each recognized by a specific T lymphocyte clone. It has recently been shown that one of these epitopes, H-YKk, is a peptide encoded by the Y-linked Smcy gene, presented at the cell surface with the H-2K(k) major histocompatibility complex (MHC) molecule(3). However, deletion mapping and the analysis of variable inactivation of H-Y epitopes has suggested that the Hya locus may be genetically complex(4,5). Here we describe a novel mouse Y chromosome gene which we call Uty (ubiquitously transcribed tetratricopeptide repeat gene on the Y chromosome). We identify the peptide WMHHNMDLI derived from the UTY protein as an H-Y epitope, H-YDb. Our data formally demonstrate that H-Y antigen is the product of more than one gene on the Y chromosome.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, MRC, CTR CLIN SCI, LONDON W12 0NN, ENGLAND; UNIV QUEENSLAND, DEPT ANAT SCI, BRISBANE, QLD 4072, AUSTRALIA; UNIV QUEENSLAND, CTR CELLULAR & MOL BIOL, BRISBANE, QLD 4072, AUSTRALIA	Imperial College London; University of Queensland; University of Queensland			Koopman, Peter A/C-9416-2009; Greenfield, Andy/F-5099-2017	Koopman, Peter A/0000-0001-6939-0914; Greenfield, Andy/0000-0002-1477-1776; Pennisi, David/0000-0001-8247-2965; Simpson, Elizabeth/0000-0002-2118-3139				AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; BISHOP CE, 1988, SEX DETERMINATION MO, P119; BURGOYNE P, 1993, SEX CHROMOSOMES SEX, P353; BURGOYNE PS, 1993, DEVELOPMENT, V117, P341; CAPEL B, 1993, NAT GENET, V5, P301, DOI 10.1038/ng1193-301; EICHWALD EJ, 1955, TRANSPLAN B, V2, P121; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FENECH M, 1991, NUCLEIC ACIDS RES, V19, P6737, DOI 10.1093/nar/19.24.6737; GAVIN MA, 1994, EUR J IMMUNOL, V24, P2124, DOI 10.1002/eji.1830240929; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; KentFirst MG, 1996, NAT GENET, V14, P128, DOI 10.1038/ng1096-128; KING TR, 1994, GENOMICS, V24, P159, DOI 10.1006/geno.1994.1593; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; MCLAREN A, 1988, P NATL ACAD SCI USA, V85, P6442, DOI 10.1073/pnas.85.17.6442; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; MITCHELL MJ, 1992, GENOMICS, V12, P26, DOI 10.1016/0888-7543(92)90402-E; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SCOTT D, 1991, IMMUNOGENETICS, V33, P54, DOI 10.1007/BF00211696; SCOTT DM, 1992, IMMUNOGENETICS, V36, P86, DOI 10.1007/BF00215284; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; SIMPSON E, 1995, EUR J IMMUNOL, V25, P2813, DOI 10.1002/eji.1830251015; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5	32	154	160	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1996	14	4					474	478		10.1038/ng1296-474	http://dx.doi.org/10.1038/ng1296-474			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944031				2022-12-27	WOS:A1996VV73000027
J	Davies, HG; Richter, RJ; Keifer, M; Broomfield, CA; Sowalla, J; Furlong, CE				Davies, HG; Richter, RJ; Keifer, M; Broomfield, CA; Sowalla, J; Furlong, CE			The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin	NATURE GENETICS			English	Article							ENZYMATIC-HYDROLYSIS; CHLORPYRIFOS-OXON; ARYLESTERASE; TOXICITY; METABOLITES; RESISTANCE; PARATHION; RATS		UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT OCCUPAT & ENVIRONM MED,SEATTLE,WA 98195; USAMRICD,ABERDEEN,MD	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle								ARNZTEN CJ, 1982, HERBICIDE RESISTANCE, P194; BENKE GM, 1975, TOXICOL APPL PHARM, V31, P254, DOI 10.1016/0041-008X(75)90161-1; BURNETT WT, 1994, TOXICOLOGIST, V14, P390; COSTA LG, 1990, TOXICOL APPL PHARM, V103, P66, DOI 10.1016/0041-008X(90)90263-T; COSTA LG, 1987, NATO ASI SERIES H, V13, P263; FURLONG CE, 1989, ANAL BIOCHEM, V180, P242, DOI 10.1016/0003-2697(89)90424-7; FURLONG CE, 1988, AM J HUM GENET, V43, P230; Gomaa H M, 1969, Residue Rev, V29, P171; HAMA H, 1980, APPL ENTOMOL ZOOL, V15, P249, DOI 10.1303/aez.15.249; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; KITCHEN BJ, 1973, BIOCHEM J, V135, P93, DOI 10.1042/bj1350093; LADU BN, 1986, ANN BIOL CLIN-PARIS, V44, P369; LI WF, 1993, J TOXICOL ENV HEALTH, V40, P337, DOI 10.1080/15287399309531798; LI WF, 1995, TOXICOL LETT, V76, P219, DOI 10.1016/0378-4274(95)80006-Y; MAIN AR, 1956, CAN J BIOCHEM PHYS, V34, P197; MALLINCKRODT MG, 1988, TOXICOL ENVIRON CHEM, V18, P79; MCCOLLIS.SB, 1974, FOOD COSMET TOXICOL, V12, P45, DOI 10.1016/0015-6264(74)90321-6; MUELLER RF, 1983, AM J HUM GENET, V35, P393; MURPHY SD, 1980, TOXICOLOGY BASIC SCI, P357; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; Serrato M, 1995, J CLIN INVEST, V96, P3005, DOI 10.1172/JCI118373; SHISHIDO T, 1972, PESTIC BIOCHEM PHYS, V2, P39, DOI 10.1016/0048-3575(72)90005-3; SMOLEN A, 1991, DRUG METAB DISPOS, V19, P107; STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788; TAFURI J, 1987, ANN EMERG MED, V16, P193, DOI 10.1016/S0196-0644(87)80015-X; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; *WHO, 1986, WHOVBC86926; World Health Organization (WHO), 1990, PUBL HLTH IMP PEST U; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	29	507	525	0	46	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					334	336		10.1038/ng1196-334	http://dx.doi.org/10.1038/ng1196-334			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896566				2022-12-27	WOS:A1996VQ14600031
J	Li, YH; Behringer, RR				Li, YH; Behringer, RR			Esx1 is an X-chromosome-imprinted regulator of placental development and fetal growth	NATURE GENETICS			English	Article							MOUSE; CELLS; TISSUES	In marsupials and mice, the paternally derived X chromosome is preferentially inactivated in the placental tissues of female embryos(1-4). We show here that the X-linked homeobox gene Esx1 (refs 5,6), whose expression is restricted to extraembryonic tissues, is a chromosomally imprinted regulator of placental morphogenesis and trophoblast differentiation. Heterozygous female mice that inherited a mutant Esx1 allele from their father developed normally. Heterozygous females that inherited the Esx1 mutation from their mother, however, were born 20% smaller than normal and are identical in phenotype to hemizygous mutant males and homozygous mutant females. Although Esx1 mutant embryos were initially comparable in size with controls at 13.5 days post coitum (dpc), their placentas were significantly larger. Defects in the morphogenesis of the labyrinthine layer were observed as early as 11.5 dpc. Subsequently, vascularization abnormalities developed at the maternal-fetal interface, causing fetal growth retardation. These results identify Esx1 as the first essential X-chromosome-imprinted regulator of placental development that influences fetal growth, and may aid our understanding human placental insufficiency syndromes.	Univ Texas, Md Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Behringer, RR (corresponding author), Univ Texas, Md Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.	bhr@molgen.mda.uth.tmc.edu			NICHD NIH HHS [HD30284] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030284] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Branford WW, 1997, MECH DEVELOP, V65, P87, DOI 10.1016/S0925-4773(97)00058-0; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; DAVIES J, 1968, ACTA ANAT, V69, P542; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; HERNANDE.D, 1974, CELL TISSUE RES, V148, P381; JOLLIE WP, 1964, J ULTRA MOL STRUCT R, V10, P27, DOI 10.1016/S0022-5320(64)90018-8; Kaufman M.H., 1992, ATLAS MOUSE DEV; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li YH, 1997, DEV BIOL, V188, P85, DOI 10.1006/dbio.1997.8640; LOKE YW, 1995, HUMAN IMPLANTATION; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MULLER HK, 1994, CELL IMMUNOL, V157, P263, DOI 10.1006/cimm.1994.1221; TAGAKI N, 1975, NATURE, V256, P640; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; VANDEBERG JL, 1987, ISOZYMES CURRENT TOP, V15; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	20	185	187	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					309	311		10.1038/3129	http://dx.doi.org/10.1038/3129			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806555				2022-12-27	WOS:000076698100030
J	Zhou, HY; Kuang, J; Zhong, L; Kuo, WL; Gray, JW; Sahin, A; Brinkley, BR; Sen, S				Zhou, HY; Kuang, J; Zhong, L; Kuo, WL; Gray, JW; Sahin, A; Brinkley, BR; Sen, S			Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; POLO-LIKE KINASE; PROTEIN-KINASE; BREAST-CANCER; CHROMOSOME SEGREGATION; DNA-SEQUENCES; EXPRESSION; AURORA; YEAST; LOCALIZATION	The centrosomes are thought to maintain genomic stability through the establishment of bipolar spindles during cell division, ensuring equal segregation of replicated chromosomes to two daughter cells. Deregulated duplication and distribution of centrosomes have been implicated in chromosome segregation abnormalities, leading to aneuploidy seen in many cancer cell types. Here, we report that STK15 (also known as BTAK and aurora2), encoding a centrosome-associated kinase, is amplified and overexpressed in multiple human tumour cell types, and is involved in the induction of centrosome duplication-distribution abnormalities and aneuploidy in mammalian cells. STK15 amplification has been previously detected in breast tumour cell lines(1) and in colon tumours(2); here, we report its amplification in approximately 12% of primary breast tumours, as well as in breast, ovarian, colon, prostate, neuroblastoma and cervical cancer cell lines. Additionally, high expression of STK15 mRNA was detected in tumour cell lines without evidence of gene amplification. Ectopic expression of STK15 in mouse NIH 3T3 cells led to the appearance of abnormal centrosome number (amplification) and transformation in vitro. Finally, overexpression of STK15 in near diploid human breast epithelial cells revealed similar centrosome abnormality, as well as induction of aneuploidy. These findings suggest that STK15 is a critical kinase-encoding gene, whose overexpression leads to centrosome amplification, chromosomal instability and transformation in mammalian cells.	Univ Texas, MD Anderson Cancer Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; Univ Texas, MD Anderson Cancer Ctr, Div Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of California System; University of California San Francisco	Sen, S (corresponding author), Univ Texas, MD Anderson Cancer Ctr, Div Pathol & Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ssen@mdacc.tmc.edu			NATIONAL CANCER INSTITUTE [R01CA041424, R37CA041424, R01CA061979, P01CA064255] Funding Source: NIH RePORTER; NCI NIH HHS [CA 64255, CA 61979, CA 41424] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Bockmuhl U, 1996, LARYNGO RHINO OTOL, V75, P408, DOI 10.1055/s-2007-997605; Boveri T, 1914, ORIGIN MALIGNANT TUM; BUENDIA B, 1992, J CELL BIOL, V116, P1431, DOI 10.1083/jcb.116.6.1431; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; ISOLA JJ, 1995, AM J PATHOL, V147, P905; IWABUCHI H, 1995, CANCER RES, V55, P6172; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KELLOGG DR, 1995, MOL BIOL CELL, V6, P1673, DOI 10.1091/mbc.6.12.1673; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Larramendy ML, 1997, AM J PATHOL, V150, P685; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Orr-Weaver TL, 1998, NATURE, V392, P223, DOI 10.1038/32520; Reznikoff CA, 1996, SEMIN ONCOL, V23, P571; SCHLEGEL J, 1995, CANCER RES, V55, P6002; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; SolinasToldo S, 1996, CANCER RES, V56, P3803; SOULE HD, 1990, CANCER RES, V50, P6075; TAAGEPERA S, 1995, EXP CELL RES, V221, P249, DOI 10.1006/excr.1995.1373; VANDRE DD, 1984, P NATL ACAD SCI-BIOL, V81, P4439, DOI 10.1073/pnas.81.14.4439; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Yanai A, 1997, ONCOGENE, V14, P2943, DOI 10.1038/sj.onc.1201144; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727	34	1107	1180	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					189	193		10.1038/2496	http://dx.doi.org/10.1038/2496			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771714				2022-12-27	WOS:000076231300023
J	Lorson, CL; Strasswimmer, J; Yao, JM; Baleja, JD; Hahnen, E; Wirth, B; Le, T; Burghes, AHM; Androphy, EJ				Lorson, CL; Strasswimmer, J; Yao, JM; Baleja, JD; Hahnen, E; Wirth, B; Le, T; Burghes, AHM; Androphy, EJ			SMN oligomerization defect correlates with spinal muscular atrophy severity	NATURE GENETICS			English	Article							MOTOR-NEURON GENE; MOLECULAR ANALYSIS; DELETIONS; PHENOTYPE; 5Q13	Spinal muscular atrophy (SMA) is a motor-neuron disorder resulting from anterior-horn-cell death. The autosomal recessive form has a carrier frequency of 1 in 50 and is the most common genetic cause of infant death. SMA is categorized as types I-III, ranging from severe to mild, based upon age of onset and clinical course. Two closely flanking copies of the survival motor neuron (SMN) gene are on chromosome 5913 (ref. 1). The telomeric SMN (SMN1) copy is homozygously deleted or converted in >95% of SMA patients, while a small number of SMA disease alleles contain missense mutations within the carboxy terminus. We have identified a modular oligomerization domain within exon 6 of SMN1. All previously identified missense mutations map within or immediately adjacent to this domain. Comparison of wild-type to mutant SMN proteins of type I, II and III SMA patients showed a direct correlation between oligomerization and clinical type. Moreover, the most abundant centromeric SMN product, which encodes exons 1-6 but not 7, demonstrated reduced self-association. These findings identify decreased SMN self-association as a biochemical defect in SMA, and imply that disease severity is proportional to the intracellular concentration of oligomerization-competent SMN proteins.	New England Med Ctr, Dept Dermatol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem Med, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; University of Bonn; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Androphy, EJ (corresponding author), New England Med Ctr, Dept Dermatol, 750 Washington St, Boston, MA 02111 USA.		Wirth, Brunhilde/H-3192-2019	Burghes, Arthur/0000-0001-9031-1555; Androphy, Elliot/0000-0002-8104-0703; Wirth, Brunhilde/0000-0003-4051-5191; strasswimmer, john/0000-0002-5790-2633				Brahe C, 1996, HUM MOL GENET, V5, P1971, DOI 10.1093/hmg/5.12.1971; Breiding DE, 1996, VIROLOGY, V221, P34, DOI 10.1006/viro.1996.0350; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; BUSSAGLIA E, 1995, NAT GENET, V11, P355; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; DiDonato CJ, 1997, ANN NEUROL, V41, P230, DOI 10.1002/ana.410410214; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hahnen E, 1997, HUM MOL GENET, V6, P821, DOI 10.1093/hmg/6.5.821; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Parsons DW, 1996, HUM MOL GENET, V5, P1727, DOI 10.1093/hmg/5.11.1727; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Talbot K, 1997, HUM MOL GENET, V6, P497, DOI 10.1093/hmg/6.3.497; vanderSteege G, 1996, AM J HUM GENET, V59, P834; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257	25	396	407	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					63	66		10.1038/ng0598-63	http://dx.doi.org/10.1038/ng0598-63			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590291				2022-12-27	WOS:000073346700019
J	Morrison, C; Smith, GCM; Stingl, L; Jackson, SP; Wagner, EF; Wang, ZQ				Morrison, C; Smith, GCM; Stingl, L; Jackson, SP; Wagner, EF; Wang, ZQ			Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis	NATURE GENETICS			English	Article							DEPENDENT PROTEIN-KINASE; COMBINED IMMUNE-DEFICIENCY; STRAND BREAK REPAIR; SCID MUTATION; POLY(ADP-RIBOSE) POLYMERASE; MICE; REARRANGEMENT; DIFFERENTIATION; THYMOCYTES; RADIATION	Poly(ADP-ribose) polymerase (PARP) and DNA-dependent protein kinase (DNA-PK) are DNA break-activated molecules(1,2). Although mice that lack PARP display no gross phenotype and normal DNA excision repair(3), they exhibit high levels of sister chromatid exchange(4), indicative of elevated recombination rates. Mutation of the gene for DNA-PK catalytic subunit (Prkdc) causes defective antigen receptor V(D)J recombination and arrests B-and T-lymphocyte development in severe combined immune-deficiency (SCID) mice(5,6). SCID V(D)J recombination can be partly rescued in T-lymphocytes by either DNA-damaging agents (gamma-irradiation and bleomycin)(7,8) or a null mutation of the p53 gene(9-10), possibly because of transiently elevated DNA repair activity in response to DNA damage or to delayed apoptosis in the absence of p53. To determine whether the increased chromosomal recombination observed in PARP-deficient cells affects SCID V(D)J recombination, we generated mice lacking both PARP and DNA-PK. Here, we show that thymocytes of SCID mice express both CD4 and CD8 co-receptors, bypassing the SCID block. Double-mutant T-cells in the periphery express TCR beta, which is attributable to productive TCR beta joints. Double-mutant mice develop a high frequency of T-cell lymphoma. These results demonstrate that increased recombination activity after the loss of PARP anti-recombinogenic function can rescue V(D)J recombination in SCID mice and indicate that PARP and DNA-PK cooperate to minimize genomic damage caused by DNA strand breaks.	RES INST MOL PATHOL,A-1030 VIENNA,AUSTRIA; UNIV CAMBRIDGE,WELLCOME TRUST CRC INST,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 1QR,ENGLAND; INT AGCY RES CANC,F-69008 LYON,FRANCE	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Cambridge; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC)			Morrison, Ciaran/B-6568-2008; Jackson, Stephen Philip/R-4548-2019; Morrison, Ciaran/AAH-2034-2019; Dry, Kate/I-2328-2014	Morrison, Ciaran/0000-0003-2401-7029; Jackson, Stephen Philip/0000-0001-9317-7937; Morrison, Ciaran/0000-0003-2401-7029; Wagner, Erwin F/0000-0001-7872-0196	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agarwal ML, 1997, ONCOGENE, V15, P1035, DOI 10.1038/sj.onc.1201274; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CARROLL AM, 1989, J IMMUNOL, V143, P1087; DANSKA JS, 1994, SCIENCE, V266, P450, DOI 10.1126/science.7524150; Danska JS, 1996, MOL CELL BIOL, V16, P5507; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Levelt CN, 1995, IMMUNITY, V3, P667, DOI 10.1016/1074-7613(95)90056-X; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Livak F, 1996, J EXP MED, V184, P419, DOI 10.1084/jem.184.2.419; MURPHY WJ, 1994, J IMMUNOL, V153, P1004; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; SHALL S, 1995, BIOCHIMIE, V77, P313, DOI 10.1016/0300-9084(96)88140-5; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; ZUNIGAPFLUCKER JC, 1994, J EXP MED, V180, P1517, DOI 10.1084/jem.180.4.1517	28	156	167	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					479	482		10.1038/ng1297-479	http://dx.doi.org/10.1038/ng1297-479			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398855				2022-12-27	WOS:A1997YJ92400034
J	Foster, MW; Eisenbraun, AJ; Carter, TH				Foster, MW; Eisenbraun, AJ; Carter, TH			Communal discourse as a supplement to informed consent for genetic research	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DECISION-MAKING; ATAXIA LOCUS; POPULATION; DISEASE; SAMPLES; FAMILY; SEARCH; PATENT; DNA	Genetic technologies present unique problems for the practice of informed consent. They provide information that may affect a study participant's family or kindred, which may be identifiable as an ethnic or locally isolated population. That information may be used to construct adverse perceptions of such identifiable populations, including non-participants who may not have been informed of or consented to the analyses. To address collective implications of genetic research, we describe a process that can supplement individual consent. Our approach engages pre-existing social units in discourses about proposed research. Communal discourses can influence individuals' decisions to participate in research studies.	OKLAHOMA ONCOL INC, TULSA, OK 74104 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT MED, WILLIAM K WARREN MED RES INST, OKLAHOMA CITY, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Foster, MW (corresponding author), UNIV OKLAHOMA, DEPT ANTHROPOL, NORMAN, OK 73019 USA.			Carter, Thomas/0000-0001-7796-2986	NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR002618] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG010302] Funding Source: Medline; NINR NIH HHS [NR02618] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		[Anonymous], 1946, M WEBER ESSAYS SOCIO; [Anonymous], 1986, HIST THEORY INFORM C; CAPLAN AL, 1994, JUSTICE HUMAN GENOME, P30; CHRISTAKIS NA, 1992, SOC SCI MED, V35, P1079, DOI 10.1016/0277-9536(92)90220-K; Clayton EW, 1995, J LAW MED ETHICS, V23, P375, DOI 10.1111/j.1748-720X.1995.tb01381.x; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; DYER O, 1995, BRIT MED J, V311, P1452, DOI 10.1136/bmj.311.7018.1452a; Ellis NA, 1996, HUM MOL GENET, V5, P1457, DOI 10.1093/hmg/5.Supplement_1.1457; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; FOUCAULT M, 1973, BIRTH CLINIC; FREEMAN WL, 1994, CAMB Q HEALTHC ETHIC, V3, P510, DOI 10.1017/S0963180100005399; GOLDWORTH A, 1995, CAMB Q HEALTHC ETHIC, V4, P296, DOI 10.1017/S0963180100006046; Good B, 1994, MED RATIONALITY EXPE; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Hubbard R, 1996, NEW ENGL J MED, V334, P1192, DOI 10.1056/NEJM199605023341812; Kuczewski MG, 1996, HASTINGS CENT REP, V26, P30, DOI 10.2307/3528574; Lehrman S, 1996, NATURE, V384, P500, DOI 10.1038/384500a0; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Lynch HT, 1997, CANCER, V79, P2219, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y; McKeigue PM, 1997, AM J HUM GENET, V60, P188; MCPHERSON EC, 1995, NURS CONNECT, V8, P36; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; PARKER LS, 1995, TRENDS GENET, V11, P520, DOI 10.1016/S0168-9525(00)89164-7; Powers Madison, 1993, IRB, V15, P7, DOI 10.2307/3564322; Reilly PR, 1997, NAT GENET, V15, P16, DOI 10.1038/ng0197-16; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; Scott DA, 1996, AM J HUM GENET, V59, P385; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; Shriver MD, 1997, AM J HUM GENET, V60, P957; Strass E, 1996, AM J HUM GENET, V59, P471; Szabo CI, 1997, AM J HUM GENET, V60, P1013; THOMSON G, 1995, AM J HUM GENET, V57, P487; WEBER W, 1996, FAMILIAL CANC MANAGE; WEIR RF, 1995, IRB, V17, P1; Wolf SM, 1995, J LAW MED ETHICS, V23, P345, DOI 10.1111/j.1748-720X.1995.tb01376.x	36	35	35	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1997	17	3					277	279		10.1038/ng1197-277	http://dx.doi.org/10.1038/ng1197-277			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YD667	9354789				2022-12-27	WOS:A1997YD66700019
J	Jay, P; Rougeulle, C; Massacrier, A; Moncla, A; Mattei, MG; Malzac, P; Roeckel, N; Taviaux, S; Lefranc, JLB; Cau, P; Berta, P; Lalande, M; Muscatelli, F				Jay, P; Rougeulle, C; Massacrier, A; Moncla, A; Mattei, MG; Malzac, P; Roeckel, N; Taviaux, S; Lefranc, JLB; Cau, P; Berta, P; Lalande, M; Muscatelli, F			The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region	NATURE GENETICS			English	Article							NUCLEAR-PROTEIN; MOUSE-BRAIN; YAC CONTIG; SNRPN GENE; EXPRESSION; 15Q11-Q13; LOCUS; CLUSTER; REPEATS	Prader-Willi syndrome (PWS) is a neurogenetic disorder that results from the absence of a normal paternal contribution to the 15q11-13 region(1-3) The clinical manifestations of PWS are a transient severe hypotonia in the newborn period, with mental retardation, hypogonadism and obesity observed later in development(4). Five transcripts with exclusive expression from the paternal allele have been isolated, but none of these has been shown to be involved in PWS5,6. In this study, we report the isolation and characterization of NDN, a new human imprinted gene, NDN is exclusively expressed from the paternal allele in the tissues analysed and is located in the PWS region. It encodes a putative protein homologous to the mouse brain-specific NECDIN protein(7), NDN; as in mouse, expression in brain is restricted to post-mitotic neurons. NDN displays several characteristics of an imprinted locus, including allelic DNA methylation and asynchronous DNA replication, A complete lack of NDN expression in PWS brain and fibroblasts indicates that the gene is expressed exclusively from the paternal allele in these tissues and suggests a possible role of this new gene in PWS.	INSERM,U406,F-13385 MARSEILLE,FRANCE; CTR RECH BIOCHIM MACROMOL,CNRS,ERS 115,INSERM,U249,F-34033 MONTPELLIER,FRANCE; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; BIOL CELLULAIRE LAB,F-13385 MARSEILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute			Jay, Philippe/ABD-9223-2020; Jay, Philippe/I-7116-2016; Muscatelli, Françoise/P-4650-2016; Cau, Pierre/M-3541-2016	Jay, Philippe/0000-0003-0156-5700; Jay, Philippe/0000-0003-0156-5700; Muscatelli, Françoise/0000-0003-4001-6528; Rougeulle, Claire/0000-0003-3861-4940; Mattei, Marie-Genevieve/0000-0002-6027-7058				AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; BERGELEFRANC JL, 1993, HUM MOL GENET, V5, P1637; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; GASTALDI M, 1997, MOL BRAIN RES, V192, P222; GLATT K, 1994, GENOMICS, V19, P157, DOI 10.1006/geno.1994.1027; Glenn CC, 1996, AM J HUM GENET, V58, P335; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; HOLM VA, 1993, PEDIATRICS, V91, P398; HORSTHEMKE B, 1995, GENOMIC IMPRINTING C, P295; HUNTRISS JD, 1994, MOL BIOL REP, V20, P19, DOI 10.1007/BF00999851; Jay P, 1997, GENOMICS, V39, P104, DOI 10.1006/geno.1996.4470; LALANDE M, 1997, ANNU REV GENET, V30, P173; LASALLE JM, 1995, NAT GENET, V9, P386, DOI 10.1038/ng0495-386; Maruyama E, 1996, BIOCHEM J, V314, P895, DOI 10.1042/bj3140895; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; Moore DD, 1995, GLOB MOB SURV; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; Mutirangura A., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139-a; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Ning Y, 1996, GENOME RES, V6, P742, DOI 10.1101/gr.6.8.742; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; UETSUKI T, 1996, J BIOL CHEM, V12, P918; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WALKER AP, 1992, HUM MOL GENET, V1, P579, DOI 10.1093/hmg/1.8.579; WATRIN F, IN PRESS EUR J HUM G	31	201	206	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					357	361		10.1038/ng1197-357	http://dx.doi.org/10.1038/ng1197-357			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354807				2022-12-27	WOS:A1997YD66700037
J	Cormier, RT; Hong, KH; Halberg, RB; Hawkins, TL; Richardson, P; Mulherkar, R; Dove, WF; Lander, ES				Cormier, RT; Hong, KH; Halberg, RB; Hawkins, TL; Richardson, P; Mulherkar, R; Dove, WF; Lander, ES			Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis	NATURE GENETICS			English	Letter							MOUSE SMALL-INTESTINES; ENHANCING FACTOR; ADENOMATOUS POLYPOSIS; MAJOR MODIFIER; NEOPLASIA; MUTATION; LOCUS; GENE; LOCALIZATION; PROTEIN	Individuals inheriting the same mutation predisposing to cancer may show very different outcomes, ranging from early aggressive cancer to disease-free survival. Experimental mouse models can provide a powerful tool to identify factors in the environment and genetic background that account for such modifications. The Min mouse strain(1), in which the Apc(Min) mutation disrupts the mouse homologue of the human familial polyposis gene(2), develops intestinal neoplasms whose multiplicity is strongly affected by genetic background(3). We previously mapped(4,5) a strong modifier locus, Mom1 (modifier of Min-1), to a 4-cM region on mouse chromosome 4 containing a candidate gene Pla2g2a encoding a secretory phospholipase(6). Here, we report that a cosmid transgene overexpressing Pla2g2a caused a reduction in tumour multiplicity and size, comparable to that conferred by a single copy of the resistance allele of Mom1. These results offer strong evidence that this secretory phospholipase can provide active tumour resistance, The association of Pla2g2a with Mom1 thus withstands a strong functional test and is likely to represent the successful identification of a polymorphic quantitative trait locus in mammals.	UNIV WISCONSIN,MCARDLE LAB CANC RES,MADISON,WI 53706; UNIV WISCONSIN,GENET LAB,MADISON,WI 53706; WHITEHEAD INST BIOMED RES,CAMBRIDGE CTR 9,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; CANC RES INST,LAB GENET ENGN,MUMBAI,INDIA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)					NATIONAL CANCER INSTITUTE [R01CA063677, R37CA063677] Funding Source: NIH RePORTER; NCI NIH HHS [CA07075, CA63677, CA50585] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1996, J BIOL, V215, P403; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DOVE WF, 1987, GENETICS, V116, P5; Dove WF, 1997, CANCER RES, V57, P812; Dudley ME, 1996, INT J CANCER, V65, P249, DOI 10.1002/(SICI)1097-0215(19960117)65:2<249::AID-IJC20>3.0.CO;2-7; Gould KA, 1997, P NATL ACAD SCI USA, V94, P5848, DOI 10.1073/pnas.94.11.5848; Gould KA, 1996, GENETICS, V144, P1769; Gould KA, 1996, GENETICS, V144, P1777; Gould KA, 1996, CELL GROWTH DIFFER, V7, P1361; HALBERG R, 1992, J MOL BIOL, V228, P840, DOI 10.1016/0022-2836(92)90868-K; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; LANDER ES, 1989, GENETICS, V121, P185; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; MULHERKAR R, 1991, HISTOCHEMISTRY, V96, P367, DOI 10.1007/BF00271358; MULHERKAR R, 1993, FEBS LETT, V317, P263, DOI 10.1016/0014-5793(93)81289-C; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; PEETERS T, 1975, GUT, V16, P553, DOI 10.1136/gut.16.7.553; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; Rhodin J.A., 1974, HISTOLOGY TEXT ATLAS; Sambrook J., 2002, MOL CLONING LAB MANU; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; Spirio LN, 1996, CANCER RES, V56, P955; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tischfield JA, 1996, GENOMICS, V32, P328, DOI 10.1006/geno.1996.0126; Tomlinson IPM, 1996, ANN HUM GENET, V60, P369, DOI 10.1111/j.1469-1809.1996.tb00434.x; WAGLE A, 1989, CELL BIOL INT REP, V13, P309, DOI 10.1016/0309-1651(89)90154-9	29	269	278	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					88	91		10.1038/ng0997-88	http://dx.doi.org/10.1038/ng0997-88			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288104				2022-12-27	WOS:A1997XU72400024
J	Klesert, TR; Otten, AD; Bird, TD; Tapscott, SJ				Klesert, TR; Otten, AD; Bird, TD; Tapscott, SJ			Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP	NATURE GENETICS			English	Article							MESSENGER-RNA; TRIPLET REPEAT; RETROVIRAL VECTORS; GENE-TRANSFER; CTG REPEAT; TRANSCRIPTION; PROTEIN; MUSCLE; MYOD; MUTATION	Myotonic dystrophy, or dystrophia myotonica (DM), is an autosomal dominant multisystem disorder caused by the expansion of a CTC trinucleotide repeat in the 3' untranslated region of the DMPK protein kinase gene on chromosome 19q13.3 (refs 1-3). Although the DM mutation was identified more than five years ago, the pathogenic mechanisms underlying this most prevalent form of hereditary adult neuromuscular disease remain elusive(4). Previous work from our laboratory demonstrated that a DNase I-hypersensitive site located adjacent to the repeats on the wild-type allele is eliminated by repeat expansion(5), indicating that large CTG-repeat arrays may be associated with a local chromatin environment that represses gene expression, Here we report that the hypersensitive site contains an enhancer element that regulates transcription of the adjacent DMAHP(6) homeobox gene. Analysis of DMAHP expression in the cells of DM patients with loss of the hypersensitive sire revealed a two- to fourfold reduction in steady-state DMAHP transcript levels relative to wild-type controls. Allele-specific analysis of DMAHP expression showed that steady-state transcript levels from the expanded allele were greatly reduced in comparison to those from the wildtype allele, Together, these results demonstrate that CTG-repeat expansions can suppress local gene expression and implicate DMAHP in DM pathogenesis.	FRED HUTCHINSON CANC RES CTR,DIV MOL MED,SEATTLE,WA 98104; FRED HUTCHINSON CANC RES CTR,DIV CLIN RES,SEATTLE,WA 98104; UNIV WASHINGTON,SCH MED,DEPT PATHOL,SEATTLE,WA 98105; UNIV WASHINGTON,SCH MED,DEPT NEUROL,SEATTLE,WA 98105; VET ADM PUDGET SOUND HLTH CARE SYST,NEUROL SECT,SEATTLE,WA 98108	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Tapscott, Stephen/0000-0002-0319-0968				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BHAGWATI S, 1996, BIOCHIM BIOPHYS ACTA, V137, P155; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BRASLER AR, 1989, CURRENT PROTOCOLS MO; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GILMAN M, 1993, CURRENT PROTOCOLS MO; Godde JS, 1996, J BIOL CHEM, V271, P15222, DOI 10.1074/jbc.271.25.15222; Harris S, 1996, HUM MOL GENET, V5, P1417, DOI 10.1093/hmg/5.Supplement_1.1417; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303; Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NOVELLI G, 1993, BIOCHEM MOL BIOL INT, V29, P291; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Thornton C. A., 1996, American Journal of Human Genetics, V59, pA33; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434	31	197	201	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					402	406		10.1038/ng0897-402	http://dx.doi.org/10.1038/ng0897-402			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241282				2022-12-27	WOS:A1997XM90900027
J	Olaisen, B; Stenersen, M; Mevag, B				Olaisen, B; Stenersen, M; Mevag, B			Identification by DNA analysis of the victims of the August 1996 Spitsbergen civil aircraft disaster	NATURE GENETICS			English	Article							AMPLIFICATION; LOCI	Disaster victim identification traditionally relies on the combined efforts of police, dentists and pathologists, comparing ante mortem (AM) information from the missing persons with post mortem (PM) data from the dead bodies. In Western countries, dental evidence has ordinarily played the major role(1-3). DNA analysis has been used successfully in a number of large accidents to associate body parts and for purposes of identification, by comparing victims' DNA profiles with those of relatives(4-6). However, DNA typing is still not generally regarded as an essential part of disaster victim identification. Facing the August 1996 Spitsbergen aircraft accident in which 141 Russians and Ukrainians died and anticipating scanty ante mortem dental data, it was decided to use DNA profile analysis as the primary identification method. Material collected at the scene from all body parts, and blood samples from relatives were analysed at eight polymorphic microsatellite and minisatellite loci. DNA profile comparisons enabled us to sort the 257 typed body parts into 141 individuals, as well as identifying the 139 victims for whom reference samples were available. Identification by DNA analysis was then followed by comparisons of traditional AM and PM data, and within day 20 of the accident the identities of all victims were confidently established. This investigation indicates that it might be feasible to replace traditional identification efforts with DNA typing.			Olaisen, B (corresponding author), UNIV OSLO, INST FORENS MED, RIKSHOSP, N-0027 OSLO, NORWAY.							AKANE A, 1991, FORENSIC SCI INT, V49, P81, DOI 10.1016/0379-0738(91)90174-H; Clark D H, 1994, Int Dent J, V44, P241; Clayton TM, 1995, FORENSIC SCI INT, V76, P7, DOI 10.1016/0379-0738(95)01787-9; CORACH D, 1995, ELECTROPHORESIS, V16, P1617, DOI 10.1002/elps.11501601267; Dupuy BM, 1996, ADV FOREN H, V6, P127; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; GILCHRIST J, 1992, CRIMINAL POLICE REV, V498, P23; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KIMPTON C, 1994, INT J LEGAL MED, V106, P302, DOI 10.1007/BF01224776; Kimpton CP, 1996, ELECTROPHORESIS, V17, P1283, DOI 10.1002/elps.1150170802; LUDES B, 1994, J FORENSIC SCI, V39, P1147; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOODY GH, 1994, AM J FOREN MED PATH, V15, P63, DOI 10.1097/00000433-199403000-00014; MOSTAD PF, 1996, SAND696 NR NORW COMP; OLAISEN B, 1993, EXS, V67, P63; SCHNEIDER PM, 1991, FORENSIC SCI INT, V49, P1, DOI 10.1016/0379-0738(91)90166-G; SOLHEIM T, 1992, INT J LEGAL MED, V104, P339, DOI 10.1007/BF01369554; WHITAKER JP, 1995, BIOTECHNIQUES, V18, P670	21	69	70	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					402	405		10.1038/ng0497-402	http://dx.doi.org/10.1038/ng0497-402			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090388				2022-12-27	WOS:A1997WQ38900021
J	Pshezhetsky, AV; Richard, C; Michaud, L; Igdoura, S; Wang, SP; Elsliger, MA; Qu, JY; Leclerc, D; Gravel, R; Dallaire, L; Potier, M				Pshezhetsky, AV; Richard, C; Michaud, L; Igdoura, S; Wang, SP; Elsliger, MA; Qu, JY; Leclerc, D; Gravel, R; Dallaire, L; Potier, M			Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis	NATURE GENETICS			English	Article							CULTURED HUMAN-FIBROBLASTS; ACID-PHOSPHATASE; BACTERIAL SIALIDASES; CONSERVED SEQUENCES; BETA-GALACTOSIDASE; ESCHERICHIA-COLI; NEURAMINIDASE; GENE; PROTEIN; CELLS	Sialidase (neuraminidase, EC 3.2.1.18) catalyses the hydrolysis of terminal sialic acid residues of glyconjugates. Sialidase has been well studied in viruses and bacteria where it destroys the sialic acid-containing receptors at the surface of host cells(1-3), and mobilizes bacterial nutrients(4). In mammals, three types of sialidases, lysosomal, plasma membrane and cytosolic, have been described(5-7). For lysosomal sialidase in humans, the primary genetic deficiency results in an autosomal recessive disease, sialidosis, associated with tissue accumulation and urinary excretion of sialylated oligosaccharides and glycolipids. Sialidosis includes two main clinical variants: late-onset, sialidosis type I, characterized by bilateral macular cherry-red spots and myoclonus(8,9), and infantile-onset, sialidosis type II, characterized by skeletal dysplasia, mental retardation and hepatosplenomegaly(10-12). We report the identification of human lysosomal sialidase cDNA, its cloning, sequencing and expression. Examination of six sialidosis patients revealed three mutations, one frameshift insertion and two missense. We mapped the lysosomal sialidase gene to human chromosome 6 (6p21.3), which is consistent with the previous chromosomal assignment of this gene in proximity to the HLA locus.	MCGILL UNIV, DEPT PEDIAT & HUMAN GENET, MONTREAL CHILDRENS HOSP, RES INST, MONTREAL, PQ, CANADA	McGill University	Pshezhetsky, AV (corresponding author), UNIV MONTREAL, HOP ST JUSTINE, DEPT PEDIAT, SERV GENET MED, 3175 CHEMIN ST CATHERINE, MONTREAL, PQ H3T 1C5, CANADA.		Leclerc, Daniel/AAB-4524-2021; Leclerc, Daniel/B-6375-2012	Leclerc, Daniel/0000-0002-9766-8941; A, Pshezhetsky/0000-0002-6612-1062; Elsliger, Marc Andre/0000-0002-1989-7626				AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; BECK M, 1984, EUR J PEDIATR, V143, P135, DOI 10.1007/BF00445802; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; COWAN NJ, 1983, MOL CELL BIOL, V3, P1738, DOI 10.1128/MCB.3.10.1738; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; DAGROSA RM, 1988, BIOCHEM BIOPH RES CO, V157, P770, DOI 10.1016/S0006-291X(88)80316-4; DURAND P, 1977, HELV PAEDIATR ACTA, V32, P391; FERRARI J, 1994, GLYCOBIOLOGY, V4, P367, DOI 10.1093/glycob/4.3.367; GALEN JE, 1992, INFECT IMMUN, V60, P406, DOI 10.1128/IAI.60.2.406-415.1992; GOTTSCHALK A, 1949, NATURE, V164, P232, DOI 10.1038/164232a0; GOTTSCHALK S, 1989, EMBO J, V8, P3215, DOI 10.1002/j.1460-2075.1989.tb08480.x; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HIRAIWA M, 1993, J BIOCHEM-TOKYO, V114, P901, DOI 10.1093/oxfordjournals.jbchem.a124274; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; LEMIEUX N, 1992, CYTOGENET CELL GENET, V59, P311, DOI 10.1159/000133277; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LICHTER P, 1992, HUMAN CYTOGENETICS P, V1, P157; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; Maniatis T., 1982, MOL CLONING; MIYAGI T, 1990, J BIOCHEM-TOKYO, V107, P794, DOI 10.1093/oxfordjournals.jbchem.a123127; MIYAGI T, 1993, J BIOL CHEM, V268, P26435; NEOTE K, 1990, J BIOL CHEM, V265, P20799; OBRIEN JS, 1978, CLIN GENET, V14, P55; OOHIRA T, 1985, HUM GENET, V70, P341, DOI 10.1007/BF00295374; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; ROTHE B, 1991, MOL GEN GENET, V226, P190, DOI 10.1007/BF00273603; SAMOLLOW PB, 1987, IMMUNOGENETICS, V26, P188, DOI 10.1007/BF00365910; SCHNEIDERJAKOB HR, 1991, BIOL CHEM H-S, V372, P443, DOI 10.1515/bchm3.1991.372.1.443; SOSA MA, 1993, J BIOL CHEM, V268, P12537; TILL JS, 1987, J CLIN NEURO-OPHTHAL, V7, P40; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; VARGHESE JN, 1988, J MOL BIOL, V200, P201, DOI 10.1016/0022-2836(88)90344-0; VERHEIJEN FW, 1983, BIOCHEM BIOPH RES CO, V117, P470, DOI 10.1016/0006-291X(83)91224-X; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; WOMACK JE, 1981, SCIENCE, V212, P63, DOI 10.1126/science.7209520	41	167	171	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					316	320		10.1038/ng0397-316	http://dx.doi.org/10.1038/ng0397-316			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054950				2022-12-27	WOS:A1997WK38600027
J	Lee, MP; Hu, RJ; Johnson, LA; Feinberg, AP				Lee, MP; Hu, RJ; Johnson, LA; Feinberg, AP			Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements	NATURE GENETICS			English	Article							FACTOR-II GENE; WILMS-TUMOR; IGF2; H19; RELAXATION; EXPRESSION; DNA	Genomic imprinting is an epigenetic chromosomal modification in the gamete or zygote causing preferential expression of a specific parental allele in somatic cells of the offspring. We and others have identified three imprinted human genes on 11p15.5, IGF2 (refs 1-4), H19 (refs 1,5), and p57(KIP2) (ref. 6), although the latter gene is separated by 700 kb from the other two, and it is unclear whether there are other imprinted genes within this large interval. We previously mapped an embryonal tumour suppressor gene to this region(7), as well as five balanced germline chromosomal rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS)(8), a condition characterized by prenatal overgrowth and cancer. We isolated the upstream exons of the previously identified gene KVLQT1, which causes the familial cardiac defect long-QT (LQT) syndrome. We found that KVLQT1 spans much of the interval between p57(KIP2) and IGF2, and that it is also imprinted. We demonstrated that the gene is disrupted by chromosomal chromosomal translocation in an embryonal rhabdoid tumour. Furthermore, the lack of parent-of-origin effect in LQT syndrome appears to be due to relative lack of imprinting in the affected tissue, cardiac muscle, representing a novel mechanism for variable penetrance of a human disease gene.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054358, CA54358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Chung WY, 1996, HUM MOL GENET, V5, P1101, DOI 10.1093/hmg/5.8.1101; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; FEINBERG AP, 1994, J CELL SCI S, V18, P7; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HATADA H, 1996, NAT GENET, V14, P171; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; Mannens M., 1994, European Journal of Human Genetics, V2, P3; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1994, HUM MOL GENET, V3, P1297, DOI 10.1093/hmg/3.8.1297; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; THOMPSON JS, IN PRESS CANC RES; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	28	263	282	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					181	185		10.1038/ng0297-181	http://dx.doi.org/10.1038/ng0297-181			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020845				2022-12-27	WOS:A1997WF08700019
J	Felsenfeld, AL				Felsenfeld, AL			Defining the boundaries of zebrafish developmental genetics	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; LARVAL CUTICLE; ZYGOTIC LOCI; FLOOR PLATE; CHROMOSOME; MUTATION; PATTERN	The first systematic, functional screens to identify the genes involved in vertebrate embryogenesis have been completed in the zebrafish, Danio rerio. In an extraordinary issue of the journal Development, devoted entirely to the results of these screens, over 500 mutant loci, many with multiple alleles, are described and classified according to the phenotypes they produce. Each class defines a small number of genes that act together to determine the proper development of many features of vertebrate anatomy, from the determination of body plan to the development of discrete organs and cell types.			Felsenfeld, AL (corresponding author), NAT STRUCT BIOL,545 NATL PRESS BLDG,WASHINGTON,DC 20045, USA.							Abdelilah S, 1996, DEVELOPMENT, V123, P217; Baier H, 1996, DEVELOPMENT, V123, P415; Brand M, 1996, DEVELOPMENT, V123, P129; Brand M, 1996, DEVELOPMENT, V123, P179; Chen JN, 1996, DEVELOPMENT, V123, P293; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Driever W, 1996, DEVELOPMENT, V123, P37; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Granato M, 1996, DEVELOPMENT, V123, P399; Haffter P, 1996, DEVELOPMENT, V123, P1; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Jiang YJ, 1996, DEVELOPMENT, V123, P205; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kane DA, 1996, DEVELOPMENT, V123, P47; Karlstrom RO, 1996, DEVELOPMENT, V123, P461; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KENE DA, 1996, DEVELOPMENT, V123, P57; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; KNAPIK EW, 1996, DEVELOPMENT, V123, P421; Malicki J, 1996, DEVELOPMENT, V123, P275; Malicki J, 1996, DEVELOPMENT, V123, P263; Mullins MC, 1996, DEVELOPMENT, V123, P81; MUNSTERBERG AE, 1995, DEVELOPMENT, V121, P651; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Odenthal J, 1996, DEVELOPMENT, V123, P391; Odenthal J, 1996, DEVELOPMENT, V123, P103; Pack M, 1996, DEVELOPMENT, V123, P321; Piotrowski T, 1996, DEVELOPMENT, V123, P345; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Ransom DG, 1996, DEVELOPMENT, V123, P311; Schier AF, 1996, DEVELOPMENT, V123, P165; Schilling TF, 1996, DEVELOPMENT, V123, P329; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; STANIER DYR, 1996, DEVELOPMENT, V123, P285; Stemple DL, 1996, DEVELOPMENT, V123, P117; Trowe T, 1996, DEVELOPMENT, V123, P439; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinstein BM, 1996, DEVELOPMENT, V123, P303; WEISCHAUS E, 1984, W ROUXS ARCH DEV BIO, V193, P296; Whitfield TT, 1996, DEVELOPMENT, V123, P241	48	16	16	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					258	263		10.1038/ng1196-258	http://dx.doi.org/10.1038/ng1196-258			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896553				2022-12-27	WOS:A1996VQ14600018
J	Saxena, R; Brown, LG; Hawkins, T; Alagappan, RK; Skaletsky, H; Reeve, MP; Reijo, R; Rozen, S; Dinulos, MB; Disteche, CM; Page, DC				Saxena, R; Brown, LG; Hawkins, T; Alagappan, RK; Skaletsky, H; Reeve, MP; Reijo, R; Rozen, S; Dinulos, MB; Disteche, CM; Page, DC			The DAZ gene cluster on the human Y chromosome arose from an autosomal gene that was transposed, repeatedly amplified and pruned	NATURE GENETICS			English	Article							AFRICAN POPULATIONS; SEX DETERMINATION; DNA; LOCALIZATION; PROBE; MAP; DROSOPHILA; INTERVAL-6; HAPLOTYPES; DELETIONS	It is widely believed that most or all Y-chromosomal genes were once shared with the X chromosome. The DAZ gene is a candidate for the human Y-chromosomal Azoospermia Factor (AZF). We report multiple copies of DAZ (>99% identical in DNA sequence) clustered in the AZF region and a functional DAZ homologue (DAZH) on human chromosome 3. The entire gene family appears to be expressed in germ cells. Sequence analysis indicates that the Y-chromosomal DAZ cluster arose during primate evolution by (i) transposing the autosomal gene to the Y, (ii) amplifying and pruning exons within the transposed gene and (iii) amplifying the modified gene. These results challenge prevailing views of sex chromosome evolution, suggesting that acquisition of autosomal fertility genes is an important process in Y chromosome evolution.	MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02142; MIT,WHITEHEAD INST,CTR GENOME RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle			Saxena, Richa/AAG-7279-2020; Rozen, Steven G./J-5939-2013	Saxena, Richa/0000-0003-2233-1065; Reijo Pera, Renee/0000-0002-6487-1329; Rozen, Steven G./0000-0002-4288-0056				Affara N, 1996, CYTOGENET CELL GENET, V73, P33; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; Bull J.J., 1983, EVOLUTION SEX DETERM; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burgoyne PS, 1996, NATURE, V381, P740, DOI 10.1038/381740a0; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; CHARLESWORTH D, 1980, GENET RES, V35, P205, DOI 10.1017/S0016672300014051; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HACKSTEIN JHP, 1995, TRENDS GENET, V11, P195, DOI 10.1016/S0168-9525(00)89043-5; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JOHNSON MD, 1989, AM J OBSTET GYNECOL, V161, P1732, DOI 10.1016/0002-9378(89)90959-9; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; LUCOTTE G, 1991, MOL CELL PROBE, V5, P359, DOI 10.1016/S0890-8508(06)80007-1; LUCOTTE G, 1989, AM J HUM GENET, V45, P16; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MENKE D, IN PRESS AM J HUM GE; NGO KY, 1986, AM J HUM GENET, V38, P407; Ohno S., 1967, SEX CHROMOSOMES SEX; PAGE DC, 1987, DEVELOPMENT, V101, P151; PALMER S, 1995, NAT GENET, V10, P472, DOI 10.1038/ng0895-472; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; SEBOUN E, 1986, COLD SPRING HARB SYM, V51, P237, DOI 10.1101/SQB.1986.051.01.029; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SKARE J, 1990, AM J MED GENET, V36, P394, DOI 10.1002/ajmg.1320360405; SPURDLE A, 1992, AM J HUM GENET, V50, P107; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; Winge O, 1927, J GENET, V18, P1, DOI 10.1007/BF03052599	44	360	377	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					292	299		10.1038/ng1196-292	http://dx.doi.org/10.1038/ng1196-292			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896558				2022-12-27	WOS:A1996VQ14600023
J	Brownlie, A; Donovan, A; Pratt, SJ; Paw, BH; Oates, AC; Brugnara, C; Witkowska, HE; Sassa, S; Zon, LI				Brownlie, A; Donovan, A; Pratt, SJ; Paw, BH; Oates, AC; Brugnara, C; Witkowska, HE; Sassa, S; Zon, LI			Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia	NATURE GENETICS			English	Article							ERYTHROID 5-AMINOLEVULINATE SYNTHASE; GLOBIN SYNTHESIS; MESSENGER-RNA; ANEMIA; MUTATION; CELLS; HEME; HEMOCHROMATOSIS; IDENTIFICATION; PYRIDOXINE	Many human anaemias are caused by defects in haemoglobin synthesis. The zebrafish mutant sauternes (sau) has a microcytic, hypochromic anaemia, suggesting that haemoglobin production is perturbed. During embryogenesis, sau mutants have delayed erythroid maturation and abnormal globin gene expression. Using positional cloning techniques, we show that sau encodes the erythroid-specific isoform of delta-aminolevulinate synthase (ALAS2; also known as ALAS-E), the enzyme required for the first step in haem biosynthesis. As mutations in ALAS2 cause congenital sideroblastic anaemia (CSA) in humans, sau represents the first animal model of this disease.	Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Div Hematol Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Ludwig Inst Canc Res, Melbourne, Vic, Australia; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Rockefeller Univ, New York, NY 10021 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Ludwig Institute for Cancer Research; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Rockefeller University	Zon, LI (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Div Hematol Oncol, Boston, MA 02115 USA.	zon@rascal.med.harvard.edu	Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713; Paw, Barry/0000-0002-0492-1419; Cutts, Alison/0000-0002-4986-573X	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR006505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049216, R01DK053298] Funding Source: NIH RePORTER; NCRR NIH HHS [RR06505] Funding Source: Medline; NIDDK NIH HHS [P50 DK49216-05, 1RO1 DK53298-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; BARRON R, 1989, GASTROENTEROLOGY, V96, P1204, DOI 10.1016/0016-5085(89)91642-9; BATES G, 1998, METHODS MOL BIOL YAC, P139; BOTTOMLEY SS, 1992, AM J HEMATOL, V41, P76, DOI 10.1002/ajh.2830410203; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; Bridges KR, 1995, BLOOD PRINCIPLES PRA; BURGER PE, 1994, BLOOD, V83, P1808; CATTON WT, 1951, BLOOD, V6, P39, DOI 10.1182/blood.V6.1.39.39; Chan FY, 1997, BLOOD, V89, P688, DOI 10.1182/blood.V89.2.688; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; DABNEY BJ, 1977, ARCH BIOCHEM BIOPHYS, V179, P106, DOI 10.1016/0003-9861(77)90092-3; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Driever W, 1996, DEVELOPMENT, V123, P37; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; FUKUSHIMA D, 1994, FOOD BIOTECHNOL, V8, P83, DOI 10.1080/08905439409549872; GOFF DJ, 1992, GENOMICS, V14, P200, DOI 10.1016/S0888-7543(05)80309-X; Gomori G, 1936, AM J PATHOL, V12, P655; Gong ZY, 1997, GENE, V201, P87, DOI 10.1016/S0378-1119(97)00431-9; Haffter P, 1996, DEVELOPMENT, V123, P1; Harigae H, 1998, BLOOD, V91, P798, DOI 10.1182/blood.V91.3.798.798_798_805; HUNT T, 1972, J MOL BIOL, V66, P471, DOI 10.1016/0022-2836(72)90427-5; JOHNSON SL, 1995, GENETICS, V139, P1727; Johnson SL, 1996, GENETICS, V142, P1277; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1383; Orkin S., 1987, MOL BASIS BLOOD DISE, P106; Ota T, 1996, GENET ANAL-BIOMOL E, V12, P173, DOI 10.1016/1050-3862(95)00133-6; PETERS WE, 1983, BRIT J HAEMATOL, V53, P201; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; PORTER PN, 1979, EXP HEMATOL, V7, P11; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Ransom DG, 1996, DEVELOPMENT, V123, P311; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rowley A.F., 1988, P19; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; SASSA S, 1995, BLOOD PRINCIPLES PRA, P1388; SILVERMAN GA, 1998, METHODS MOL BIOL YAC, P145; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; THEIN SL, 1993, BLOOD, V82, P961; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Westerfield M, 1993, ZEBRAFISH BOOK; WHEBY MS, 1987, FUNDAMENTALS CLIN HE, P212; WHITE JM, 1971, BRIT J HAEMATOL, V20, P263, DOI 10.1111/j.1365-2141.1971.tb07037.x; WHITE JM, 1973, BRIT J HAEMATOL, V24, P481, DOI 10.1111/j.1365-2141.1973.tb01674.x; Yaouanq J, 1997, LANCET, V349, P1475, DOI 10.1016/S0140-6736(05)63756-7; Yin XH, 1998, BLOOD CELL MOL DIS, V24, P41, DOI 10.1006/bcmd.1998.0169; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhong TP, 1998, GENOMICS, V48, P136, DOI 10.1006/geno.1997.5155	57	182	190	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					244	250		10.1038/3049	http://dx.doi.org/10.1038/3049			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806542				2022-12-27	WOS:000076698100017
J	Deeb, SS; Fajas, L; Nemoto, M; Pihlajamaki, J; Mykkanen, L; Kuusisto, J; Laakso, M; Fujimoto, W; Auwerx, J				Deeb, SS; Fajas, L; Nemoto, M; Pihlajamaki, J; Mykkanen, L; Kuusisto, J; Laakso, M; Fujimoto, W; Auwerx, J			A Pro12Ala substitution in PPAR gamma 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity	NATURE GENETICS			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; GLUCOSE-TOLERANCE; GENE-EXPRESSION; RESISTANCE; OBESITY; TRANSCRIPTION; ADIPOGENESIS; PROMOTER	The peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a transcription factor that has a pivotal role in adipocyte differentiation and expression of adipocyte-specific genes(1-3) The PPAR gamma 1 and gamma 2 isoforms result from alternative splicing(4) and have ligand-dependent and -independent activation domains. PPAR gamma 2 has an additional 28 amino acids at its amino terminus that renders its ligand-independent activation domain 5-10-fold more effective than that of PPAR gamma 1. Insulin stimulates the ligand-independent activation of PPAR gamma 1 and gamma 2 (ref. 5), however, obesity and nutritional factors only influence the expression of PPAR gamma 2 in human adipocytes(6). Here, we report that a relatively common Pro12Ala substitution in PPAR gamma 2 is associated with lower body mass index (BMI; P=0.027; 0.015) and improved insulin sensitivity among middle-aged and elderly Finns. A significant odds ratio (4.35, P=0.028) for the association of the Pro/Pro genotype with type 2 diabetes was observed among Japanese Americans. The PPAR gamma 2 Ala allele showed decreased binding affinity to the cognate promoter element and reduced ability to transactivate responsive promoters. These findings suggest that the PPAR gamma 2 Pro12Ala variant may contribute to the observed variability in BMI and insulin sensitivity in the general population.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Inst Pasteur, Dept Atherosclerose, U325 INSERM, F-59019 Lille, France; Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Kuopio University Hospital; University of Eastern Finland	Deeb, SS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.		Coll, Lluis Fajas/C-8567-2014	Auwerx, Johan/0000-0002-5065-5393; Fajas, Lluis/0000-0002-1283-9503; Pihlajamaki, Jussi/0000-0002-6241-6859	NHLBI NIH HHS [HL30086] Funding Source: Medline; NIDDK NIH HHS [DK3117, DK 17047] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auwerx J, 1996, J MOL MED, V74, P347, DOI 10.1007/BF00210629; Beamer BA, 1997, BIOCHEM BIOPH RES CO, V233, P756, DOI 10.1006/bbrc.1997.6540; BOUCHARD C, 1995, INT J OBES REL METAB, V19, P510; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; FRIED MG, 1983, NUCLEIC ACIDS RES, V11, P141, DOI 10.1093/nar/11.1.141; FUJIMOTO WY, 1989, DIABETES METAB REV, V5, P607, DOI 10.1002/dmr.5610050706; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; KAHN CR, 1995, NATURE, V373, P384; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LAAKSO M, 1988, DIABETES CARE, V11, P449, DOI 10.2337/diacare.11.6.449; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Meirhaeghe A, 1998, HUM MOL GENET, V7, P435, DOI 10.1093/hmg/7.3.435; MYKKANEN L, 1990, DIABETES CARE, V13, P1099, DOI 10.2337/diacare.13.11.1099; MYKKANEN L, 1994, METABOLISM, V43, P523, DOI 10.1016/0026-0495(94)90088-4; NEVIN DN, 1994, ARTERIOSCLER THROMB, V14, P869, DOI 10.1161/01.ATV.14.6.869; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Norman RA, 1997, AM J HUM GENET, V60, P166; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230	30	1093	1160	1	34	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					284	287		10.1038/3099	http://dx.doi.org/10.1038/3099			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806549				2022-12-27	WOS:000076698100024
J	Kohl, S; Marx, T; Giddings, I; Jagle, H; Jacobson, SG; Apfelstedt-Sylla, E; Zrenner, E; Sharpe, LT; Wissinger, B				Kohl, S; Marx, T; Giddings, I; Jagle, H; Jacobson, SG; Apfelstedt-Sylla, E; Zrenner, E; Sharpe, LT; Wissinger, B			Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel	NATURE GENETICS			English	Article							FUNCTIONAL EXPRESSION; CHROMOSOMAL LOCALIZATION; RETINITIS-PIGMENTOSA; ROD; CLONING	Total colourblindness (OMIM 216900), also referred to as rod monochromacy (RM) or complete achromatopsia, is a rare, autosomal recessive inherited and congenital disorder characterized by photophobia, reduced visual acuity, nystagmus and the complete inability to discriminate between colours(1). Electroretinographic recordings show that in RM, rod photoreceptor function is normal, whereas cone photoreceptor responses are absent. The locus for RM has been mapped to chromosome 2q11 (ref. 2), however the gene underlying RM has not yet been identified. Recently a suitable candidate gene, CNGA3, encoding the alpha-subunit of the cone photoreceptor cCMP-gated cation channel, a key component of the phototransduction pathway, has been cloned and assigned to human chromosome 2q11 (refs 3,4). We report the identification of missense mutations in CNGA3 in five families with RM. Homozygous mutations are present in two families, whereas the remaining families show compound heterozygous mutations. In all cases, the segregation pattern of the mutations is consistent with the autosomal recessive inheritance of the disease and all mutations affect amino acids that are highly conserved among cyclic nucleotide gated channels (CNC) in various species. This is the first report of a colour vision disorder caused by defects other than mutations in the cone pigment genes, and implies at least in this instance a common genetic basis for phototransduction in the three different cone photoreceptors of the human retina.	Univ Tubingen, Augenklin, Genet Mol Lab, D-72076 Tubingen, Germany; Univ Tubingen, Augenklin, Psychophys Lab, Forschungsstelle Expt Ohpthalmol, D-72076 Tubingen, Germany; Univ Tubingen, Inst Pathol, D-72076 Tubingen, Germany; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Pennsylvania; Pennsylvania Medicine	Wissinger, B (corresponding author), Univ Tubingen, Augenklin, Genet Mol Lab, Schleichstr 12-16, D-72076 Tubingen, Germany.		Jägle, Herbert/GPP-2945-2022	Kohl, Susanne/0000-0002-6438-6331; Jacobson, Samuel/0000-0003-2122-169X; Giddings, Ian/0000-0003-1078-5780	NEI NIH HHS [EY-05627] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arbour NC, 1997, HUM MOL GENET, V6, P689, DOI 10.1093/hmg/6.5.689; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BROWN RL, 1995, BIOCHEMISTRY-US, V34, P8365, DOI 10.1021/bi00026a018; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; PITTLER SJ, 1992, J BIOL CHEM, V267, P6257; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; SHARPE LT, 1990, NIGHT VISION BASIC C; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Wissinger B, 1997, EUR J NEUROSCI, V9, P2512, DOI 10.1111/j.1460-9568.1997.tb01680.x; WISSINGER B, IN PRESS GENOMICS; Yu WP, 1996, FEBS LETT, V393, P211, DOI 10.1016/0014-5793(96)00889-7; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	17	250	259	1	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					257	259		10.1038/935	http://dx.doi.org/10.1038/935			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662398				2022-12-27	WOS:000074565900021
J	Kazazian, HH; Moran, JV				Kazazian, HH; Moran, JV			The impact of L1 retrotransposons on the human genome	NATURE GENETICS			English	Article							HUMAN TRANSPOSABLE ELEMENT; RNA-BINDING PROTEIN; REVERSE TRANSCRIPTION; RIBONUCLEOPROTEIN-PARTICLES; LINE-1 ELEMENT; SPASTIC MOUSE; GENE FAMILY; FACTOR YY1; ALU RNA; INSERTION	The 'master' human mobile element, the L1 retrotransposon, has come of age as a biological entity. Knowledge of how it retrotransposes in vivo, how its proteins act to retrotranspose other poly A elements and the extent of its role in shaping the human genome should emerge rapidly over the next few years. We review the impact of retrotransposons and how new insight is likely to lead to important practical applications for these intriguing mobile elements.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazazian, HH (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.							ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Argeson AC, 1996, GENETICS, V142, P557; BECKER KG, 1993, HUM MOL GENET, V2, P1697, DOI 10.1093/hmg/2.10.1697; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; BRATTHAUER GL, 1992, ONCOGENE, V7, P507; CHANG DY, 1995, MOL CELL BIOL, V15, P2109; CHANG DY, 1993, J BIOL CHEM, V268, P6423; CHANG DY, 1994, MOL CELL BIOL, V14, P3949, DOI 10.1128/MCB.14.6.3949; Dhellin O, 1997, EMBO J, V16, P6590, DOI 10.1093/emboj/16.21.6590; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Eickbush TH, 1997, SCIENCE, V277, P911, DOI 10.1126/science.277.5328.911; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; GPORMAN MA, 1997, EMBO J, V16, P6548; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUROSE K, 1995, NUCLEIC ACIDS RES, V23, P3704, DOI 10.1093/nar/23.18.3704; Kuster JE, 1997, MAMM GENOME, V8, P673, DOI 10.1007/s003359900535; LEIBOLD DM, 1990, P NATL ACAD SCI USA, V87, P6990, DOI 10.1073/pnas.87.18.6990; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; MARTIN SL, 1995, GENE, V153, P261, DOI 10.1016/0378-1119(94)00785-Q; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; MCMILLAN JP, 1993, P NATL ACAD SCI USA, V90, P11533, DOI 10.1073/pnas.90.24.11533; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; MIKI Y, 1992, CANCER RES, V52, P643; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Perou CM, 1997, GENOMICS, V42, P366, DOI 10.1006/geno.1997.4740; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WOODSAMUELS P, 1989, GENOMICS, V4, P290, DOI 10.1016/0888-7543(89)90332-7; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	68	389	402	5	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					19	24		10.1038/ng0598-19	http://dx.doi.org/10.1038/ng0598-19			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590283				2022-12-27	WOS:000073346700011
J	Cheung, VG; Gregg, JP; Gogolin-Ewens, KJ; Bandong, J; Stanley, CA; Baker, L; Higgins, MJ; Nowak, NJ; Shows, TB; Ewens, WJ; Spielman, RS				Cheung, VG; Gregg, JP; Gogolin-Ewens, KJ; Bandong, J; Stanley, CA; Baker, L; Higgins, MJ; Nowak, NJ; Shows, TB; Ewens, WJ; Spielman, RS			Linkage-disequilibrium mapping without genotyping	NATURE GENETICS			English	Article							SULFONYLUREA RECEPTOR GENE; DNA MISMATCH CORRECTION; FAMILIAL HYPERINSULINISM; ASHKENAZI JEWS; HYBRIDIZATION; MUTATIONS; REPAIR	Genomic mismatch scanning (GMS) is a technique that enriches for regions of identity by descent (IBD) between two individuals without the need for genotyping or sequencing. Regions of IBD selected by GMS are mapped by hybridization to a microarray containing ordered clones of genomic DNA from chromosomes of interest. Here we demonstrate the feasibility and efficacy of this form of linkage-mapping, using congenital hyperinsulinism (HI), an autosomal recessive disease, whose relatively high frequency in Ashkenazi Jews suggests a founder effect. The gene responsible (SUR1) encodes the sulfonylurea receptor, which maps to chromosome 11p15.1. We show that the combination of CMS and hybridization of IBD products to a chromosome-11 microarray correctly maps the HI gene to a 2-Mb region, thereby demonstrating linkage-disequilibrium mapping without genotyping.	Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Endocrinol, Dept Pediat, Philadelphia, PA 19104 USA; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept pediat & Biol Chem, Los Angeles, CA 90095 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Roswell Pk Canc Inst, Dept Human Genet, Buffalo, NY 14263 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Roswell Park Cancer Institute	Cheung, VG (corresponding author), Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	STANLEY, CHARLES/0000-0003-4881-9392	NCRR NIH HHS [RR-00240] Funding Source: Medline; NHGRI NIH HHS [HGO1141] Funding Source: Medline; NIDDK NIH HHS [DK46618] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046618] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; AU KG, 1992, J BIOL CHEM, V267, P12142; Ayyagari R, 1996, GENOME RES, V6, P504, DOI 10.1101/gr.6.6.504; CASNA NJ, 1986, NUCLEIC ACIDS RES, V14, P7285, DOI 10.1093/nar/14.18.7285; Cheung VG, 1998, GENOMICS, V47, P1, DOI 10.1006/geno.1997.5082; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; EWENS WJ, 1981, P NATL ACAD SCI-BIOL, V78, P3748, DOI 10.1073/pnas.78.6.3748; GLASER B, 1995, HUM MOL GENET, V4, P879, DOI 10.1093/hmg/4.5.879; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; JORDE LB, 1995, AM J HUM GENET, V56, P11; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; McAllister L, 1998, GENOMICS, V47, P7, DOI 10.1006/geno.1997.5083; Mirzayans F, 1997, AM J HUM GENET, V61, P111, DOI 10.1086/513894; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; QIN S, 1993, GENOMICS, V16, P580, DOI 10.1006/geno.1993.1233; Qin SZ, 1996, P NATL ACAD SCI USA, V93, P3149, DOI 10.1073/pnas.93.7.3149; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SEDAT JW, 1967, J MOL BIOL, V26, P537, DOI 10.1016/0022-2836(67)90321-X; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Smith J, 1996, P NATL ACAD SCI USA, V93, P4374, DOI 10.1073/pnas.93.9.4374; Stanley C A, 1976, Adv Pediatr, V23, P315; SU SS, 1988, J BIOL CHEM, V263, P6829; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548	29	62	69	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					225	230		10.1038/ng0398-225	http://dx.doi.org/10.1038/ng0398-225			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500543				2022-12-27	WOS:000072325000019
J	Weinrich, SL; Pruzan, R; Ma, LB; Ouellette, M; Tesmer, VM; Holt, SE; Bodnar, AG; Lichtsteiner, S; Kim, NW; Trager, JB; Taylor, RD; Carlos, R; Andrews, WH; Wright, WE; Shay, JW; Harley, CB; Morin, GB				Weinrich, SL; Pruzan, R; Ma, LB; Ouellette, M; Tesmer, VM; Holt, SE; Bodnar, AG; Lichtsteiner, S; Kim, NW; Trager, JB; Taylor, RD; Carlos, R; Andrews, WH; Wright, WE; Shay, JW; Harley, CB; Morin, GB			Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT	NATURE GENETICS			English	Article							EXPRESSION; DNA; POLYMERASES; MECHANISM; CANCER; ENZYME; VECTOR; CELLS; GENES	The maintenance of chromosome termini, or telomeres, requires the action of the enzyme telomerase, as conventional DNA polymerases cannot fully replicate the ends of linear molecules(1-4). Telomerase is expressed and telomere length is maintained in human germ cells and the great majority of primary human tumours(5,6). However, telomerase is not detectable in most normal somatic cells; this corresponds to the gradual telomere loss observed with each cell division(7-9). It has been proposed that telomere erosion eventually signals entry into senescence or cell crisis and that activation of telomerase is usually required for immortal cell proliferation(10). In addition to the human telomerase RNA component (hTR; ref, 11), TP1/TLP1 (refs 12,13), a protein that is homologous to the p80 protein associated with the Tetrahymena enzyme(14), has been identified in humans. More recently, the human telomerase reverse transcriptase (hTRT; refs 15, 16), which is homologous to the reverse transcriptase (RT)like proteins associated with the Euplotes aediculatus (Ea_p123), Saccharomyces cerevisiae (Est2p) and Schizosaccharomyces pombe (SpTrt1) telomerases(15,17), has been reported to be a telomerase protein subunit. A catalytic function has been demonstrated for Est2p in the RT-like class but not for p80 or its homologue(17,18). We now report that in vitro transcription and translation of hTRT when co-synthesized or mixed with hTR reconstitutes telomerase activity that exhibits enzymatic properties like those of the native enzyme, Single amino-acid changes in conserved telomerase-specific and RT motifs reduce or abolish activity, providing direct evidence that hTRT is the catalytic protein component of telomerase. Normal human diploid cells transiently expressing hTRT possessed telomerase activity, demonstrating that hTRT is the limiting component necessary for restoration of telomerase activity in these cells. The ability to reconstitute telomerase permits further analysis of its biochemical and biological roles in cell aging and carcinogenesis.	GERON CORP,MENLO PK,CA 94025; UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235	Geron Corporation; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Morin, Gregg B/E-9123-2012; Shay, Jerry W/F-7878-2011	Morin, Gregg B/0000-0001-8949-4374; 	NATIONAL INSTITUTE ON AGING [R01AG007992] Funding Source: NIH RePORTER; NIA NIH HHS [AG05747, AG07992] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Autexier C, 1996, EMBO J, V15, P5928, DOI 10.1002/j.1460-2075.1996.tb00979.x; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; COLLINS K, 1995, CELL, V81, P677, DOI 10.1016/0092-8674(95)90529-4; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HARRINGTON I, 1997, SCIENCE, V274, P973; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; LIN JH, 1994, GENE, V147, P287, DOI 10.1016/0378-1119(94)90083-3; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Morin GB, 1997, EUR J CANCER, V33, P750, DOI 10.1016/S0959-8049(97)00061-0; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; NAKAYAMA JI, 1997, CELL, V88, P1; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; PEREZ HD, 1994, J BIOL CHEM, V269, P22485; PRUZAN R, 1990, J BIOL CHEM, V265, P2804; SHAY JW, 1997, EUR J CANCER, V33, P777; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0	31	814	891	0	40	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					498	502		10.1038/ng1297-498	http://dx.doi.org/10.1038/ng1297-498			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398860				2022-12-27	WOS:A1997YJ92400039
J	Dahme, M; Bartsch, U; Martini, R; Anliker, B; Schachner, M; Mantei, N				Dahme, M; Bartsch, U; Martini, R; Anliker, B; Schachner, M; Mantei, N			Disruption of the mouse L1 gene leads to malformations of the nervous system	NATURE GENETICS			English	Article							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CEREBELLAR NEURONS; PERIPHERAL-NERVES; CLINICAL SPECTRUM; N-CAM; EXPRESSION; ANTIBODIES; SHOW; HYDROCEPHALUS	The adhesion molecule L1 is a member of the immunoglobulin superfamily(1). L1 is involved in various recognition processes in the CNS and PNS2,3, and binding to LI can activate signal transduction pathways(4,5). Mutations in the human LI gene are associated with a variable phenotype, including mental retardation and anomalous development of the nervous system, referred to as 'CRASH' (corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus)(6). We generated an animal model of these conditions by gene targetting, Mutant mice were smaller than wild-type and were less sensitive to touch and pain, and their hind-legs appeared weak and uncoordinated, The size of the corticospinal tract was reduced and, depending on genetic background, the lateral ventricles were often enlarged, Non-myelinating Schwann cells formed processes not associated with axons and showed reduced association with axons, In vitro, neurite outgrowth on an L1 substrate and fasciculation were impaired, The mutant mouse described here will help to elucidate the functions of L1 in the nervous system and how these depend on genetic influences.	ETH HONGGERBERG, SWISS FED INST TECHNOL, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND; UNIV WURZBURG, DEPT NEUROL, DEV NEUROBIOL SECT, D-97080 WURZBURG, GERMANY; UNIV HAMBURG, ZENTRUM MOL NEUROBIOL, D-20246 HAMBURG, GERMANY	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf				Martini, Rudolf/0000-0002-5463-5592				APPEL F, 1993, J NEUROSCI, V13, P4764; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; BIXBY JL, 1990, J CELL BIOL, V111, P2725, DOI 10.1083/jcb.111.6.2725; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; Doherty P, 1996, PERSPECT DEV NEUROBI, V4, P157; FISCHER G, 1986, J NEUROSCI, V6, P605; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Holm J, 1996, EUR J NEUROSCI, V8, P1613, DOI 10.1111/j.1460-9568.1996.tb01306.x; Kadmon G, 1997, DIFFERENTIATION, V61, P143, DOI 10.1046/j.1432-0436.1997.6130143.x; KLINZ SG, 1995, J NEUROCHEM, V65, P84; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; MAH C, 1980, J COMP PHYSIOL PSYCH, V94, P1160, DOI 10.1037/h0077742; Maness PF, 1996, PERSPECT DEV NEUROBI, V4, P169; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1995, J NEUROSCI, V15, P4488; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; REIS LFL, 1994, EMBO J, V13, P4798, DOI 10.1002/j.1460-2075.1994.tb06805.x; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SCHRANDERSTUMPEL C, 1995, AM J MED GENET, V57, P107, DOI 10.1002/ajmg.1320570122; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2	28	388	391	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1997	17	3					346	349		10.1038/ng1197-346	http://dx.doi.org/10.1038/ng1197-346			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354804				2022-12-27	WOS:A1997YD66700034
J	Bilaud, T; Brun, C; Ancelin, K; Koering, CE; Laroche, T; Gilson, E				Bilaud, T; Brun, C; Ancelin, K; Koering, CE; Laroche, T; Gilson, E			Telomeric localization of TRF2, a novel human telobox protein	NATURE GENETICS			English	Article							CHROMOSOMES; CHROMATIN; MYB	Natural chromosomal ends are stabilized by proteins that bind duplex telomeric DNA repeats. In human cells, the TTAGGG Repeat factor 1 (TRF1) was identified by two independent studies, one screening for factors that bind duplex telomeric DNA(1,2) and the other screening for proteins containing a particular Myb motif called the telobox, which is required for telomeric repeat recognition (Fig. 1a; refs 3-5). A second human open reading frame, orf2, contains a telobox sequence and encodes a polypeptide that specifically recognizes mammalian telomeric repeat DNA in vitro(3). We show that two proteins of 65 and 69 kD, expressed in HeLa cells, contain the orf2 telobox sequence. These proteins are collectively termed TRF2. Affinity-purified antibodies specific for anti-TRF2 label the telomeres of intact human chromosomes, strengthening the correlation between occurrence of telobox and telomere-repeat recognition in vivo.	ECOLE NORMALE SUPER LYON,BIOL CELLULAIRE & MOL LAB,CNRS,UMR 49,F-69364 LYON 07,FRANCE; SWISS INST EXPT CANC RES,CH-1066 EPALINGES,SWITZERLAND	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Swiss Institute Experimental Cancer Research			Ancelin, Katia/R-1719-2019; Brun, Christine/B-4922-2008	Brun, Christine/0000-0002-5563-6765; Ancelin, Katia/0000-0002-2117-9754				ALFONSO PJ, 1994, J MOL BIOL, V236, P189, DOI 10.1006/jmbi.1994.1128; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Broccoli D, 1997, HUM MOL GENET, V6, P69, DOI 10.1093/hmg/6.1.69; Brun C, 1997, TRENDS CELL BIOL, V7, P317, DOI 10.1016/S0962-8924(97)01092-1; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; GASSER SM, 1987, EXP CELL RES, V173, P85, DOI 10.1016/0014-4827(87)90334-X; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Lipsick JS, 1996, ONCOGENE, V13, P223; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; MUYLDERMANS S, 1994, NUCLEIC ACIDS RES, V22, P5635, DOI 10.1093/nar/22.25.5635; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	19	391	404	0	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					236	239		10.1038/ng1097-236	http://dx.doi.org/10.1038/ng1097-236			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326951				2022-12-27	WOS:A1997XZ55500037
J	Pereira, L; Andrikopoulos, K; Tian, J; Lee, SY; Keene, DR; Ono, R; Reinhardt, DP; Sakai, LY; Biery, NJ; Bunton, T; Dietz, HC; Ramirez, F				Pereira, L; Andrikopoulos, K; Tian, J; Lee, SY; Keene, DR; Ono, R; Reinhardt, DP; Sakai, LY; Biery, NJ; Bunton, T; Dietz, HC; Ramirez, F			Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome	NATURE GENETICS			English	Article							DEVELOPING MOUSE AORTA; MICROFIBRILS; MUTATIONS; ORGANIZATION; COMPONENT; EXPRESSION; DELETION; REVEALS; MATRIX	Aortic aneurysm and dissection account for about 2% of all deaths in industrialized countries; they are also components of several genetic diseases, including Marfan syndrome (MFS)(1). The vascular phenotype of MFS results from mutations in fibrillin-1 (FBN1), the major constituent of extracellular microfibrils(2,3). Microfibrils, either associated with or devoid of elastin, give rise to a variety of extracellular networks in elastic and non-elastic tissues(3). It is believed that microfibrils regulate elastic fibre formation by guiding tropo-elastin deposition during embryogenesis and early post-natal life(4). Hence, vascular disease in MFS is thought to result when FBN1 mutations preclude elastic fibre maturation by disrupting microfibrillar assembly, Here we report a gene-targetting experiment in mice that indicates that fibrillin-1 microfibrils are predominantly engaged in tissue homeostasis rather than elastic matrix assembly. This finding, in turn, suggests that aortic dilation is due primarily to the failure by the microfibrillar array of the adventitia to sustain physiological haemodynamic stress, and that disruption of the elastic network of the media is a secondary event.	CUNY MT SINAI SCH MED,BROOKDALE CTR DEV & MOL BIOL,NEW YORK,NY 10029; UNIV SAO PAULO,INST BIOCIENCIAS,DEPT BIOL,BR-05508 SAO PAULO,BRAZIL; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,CUTANEOUS BIOL RES CTR,BOSTON,MA 02129; SHRINERS HOSP CHILDREN,PORTLAND,OR 97201; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOL BIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT COMPARAT MED & PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Universidade de Sao Paulo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University			Reinhardt, Dieter P/A-3102-2008; Pereira, Lygia V/C-1049-2012	Reinhardt, Dieter P/0000-0001-6535-9872; Pereira, Lygia V/0000-0002-0002-725X	NIAMS NIH HHS [AR41135, AR42044] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; DAVIS EC, 1994, J CELL SCI, V107, P727; DAVIS EC, 1993, LAB INVEST, V68, P89; DIETZ HC, 1994, ADV HUM GENET, V22, P153; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; GAUSE WC, 1989, PCR PRIMER LAB MANUA, P293; Hogan B, 1994, MANIPULATING MOUSE E; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P935; HURLE JM, 1994, J CELL SCI, V107, P2623; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; KEENE DR, IN PRESS J HISTOCHEM; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SAMBROOK E, 1989, MOL CLONING LAB MANU; Tilson MD, 1990, CAUSE MANAGEMENT ANE, P97; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	27	292	304	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					218	222		10.1038/ng1097-218	http://dx.doi.org/10.1038/ng1097-218			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326947				2022-12-27	WOS:A1997XZ55500033
J	Albrecht, U; Sutcliffe, JS; Cattanach, BM; Beechey, CV; Armstrong, D; Eichele, G; Beaudet, AL				Albrecht, U; Sutcliffe, JS; Cattanach, BM; Beechey, CV; Armstrong, D; Eichele, G; Beaudet, AL			Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons	NATURE GENETICS			English	Letter							PRADER-WILLI SYNDROMES; FACTOR-II GENE; PROTEIN; CLONING; ORIGIN	Angelman syndrome (AS) is a human genetic disorder characterized by mental retardation, seizures, inappropriate laughter, abnormal gait, tremor and ataxia(1-3). There is strong genetic evidence that the disorder is associated with a maternally expressed, imprinted gene mapping to chromosome 15q11-13. Affected patients demonstrate varied molecular abnormalities including large maternal deletions, uniparental paternal disomy (UPD), imprinting mutations(4) and loss of function mutations of E6-associated-protein (E6-AP) ubiquitin-protein ligase (UBE3A)(5,6). All of these abnormalities are associated with loss of maternal expression of UBE3A. Although mutations in UBE3A cause AS, indicating that maternal-specific expression of UBE3A is essential for a normal phenotype, evidence for maternal-specific expression of UBE3A has been lacking(7,8). Using mice with partial paternal UPD encompassing Ube3a to differentiate maternal and paternal expression, we found by in situ hybridization that expression of Ube3a in Purkinje cells, hippocampal neurons and mitral cells of the olfactory bulb in UPD mice was markedly reduced compared to non-UPD littermates. In contrast, expression of Ube3a in other regions of the brain was only moderately or not at all reduced in UPD mice. The major phenotypic features of AS correlate with the loss of maternal-specific expression of Ube3a in hippocampus and cerebellum as revealed in the mouse model.	BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT BIOCHEM, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA; MRC, MAMMALIAN GENET UNIT, DIDCOT OX11 0RD, OXON, ENGLAND	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; MRC Harwell			Sutcliffe, James S/C-1348-2012; Albrecht, Urs/A-9831-2011	Sutcliffe, James S/0000-0001-5200-6007; Albrecht, Urs/0000-0002-0663-8676				Albrecht U, 1997, MOL CELLULAR METHODS, P23; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KYRIAKIDES T, 1992, ACTA NEUROPATHOL, V83, P675, DOI 10.1007/BF00299421; LEDBETTER DH, 1995, METABOLIC MOL BASES, P811; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; REIS A, 1994, AM J HUM GENET, V54, P741; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; VANHILLE B, 1993, BIOCHEM BIOPH RES CO, V197, P15, DOI 10.1006/bbrc.1993.2434; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; ZACKOWSKI JL, 1993, AM J MED GENET, V46, P7, DOI 10.1002/ajmg.1320460104	23	375	383	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					75	78		10.1038/ng0997-75	http://dx.doi.org/10.1038/ng0997-75			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288101				2022-12-27	WOS:A1997XU72400021
J	Thornton, CA; Wymer, JP; Simmons, Z; McClain, C; Moxley, RT				Thornton, CA; Wymer, JP; Simmons, Z; McClain, C; Moxley, RT			Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene	NATURE GENETICS			English	Article							TRIPLET REPEAT; REGION; MUTATION; MUSCLE; CELLS	Myotonic dystrophy, or dystrophia myotonica (DM), is a highly variable multisystem disease in which the classic adult-onset form displays progressive muscle wasting, cataracts, heart block, gonadal atrophy,insulin resistance and neuropsychiatric impairment. Its genetic basis is an expansion of CTG trinucleotide repeats in the DMPK protein kinase gene(1-5). Among the triplet repeat expansion disorders, DM is distinguished by the extended length of the repeat tract (5-13 kb in postmortem tissue(6,7)) and its location in the 3' untranslated region of the gene that contains it(8). The pathophysiological mechanism for multisystem degeneration in DM is not understood. In contrast to the profound muscle wasting that characterizes advanced DM, only minor histopathological abnormalities have occurred in DMPK knockout mice or in mice that overexpress a human DMPK transgene(9,10), making it unlikely that changes in DMPK activity provide a unitary explanation for the disease. A DNAse hypersensitive site that maps 0.7 kb downstream (centromeric) from the CTC repeats is eliminated on DM chromosomes(11). This finding indicates that the repeat expansion may alter the adjacent chromatin structure and raises the possibility that it may also affect the expression of flanking genes. An interesting candidate flanking gene is DMAHP, a recently discovered homeodomain-encoding gene(12). We show here that DMAHP expression in myoblasts, muscle and myocardium is reduced by the DM mutation in cis, and the magnitude of this effect depends on the extent of CTG repeat expansion. These observations support the hypothesis that DMAHP participates in the pathophysiology of DM.	PENN STATE UNIV,COLL MED,DIV NEUROL,HERSHEY,PA 17033; UNIV ROCHESTER,SCH MED & DENT,DEPT PEDIAT,ROCHESTER,NY 14642	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester	Thornton, CA (corresponding author), UNIV ROCHESTER,SCH MED & DENT,DEPT NEUROL,ROCHESTER,NY 14642, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG010463] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00044] Funding Source: Medline; NIA NIH HHS [P60AG10463] Funding Source: Medline; NINDS NIH HHS [NS01558] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Godde JS, 1996, J BIOL CHEM, V271, P15222, DOI 10.1074/jbc.271.25.15222; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303; Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P699	23	180	186	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					407	409		10.1038/ng0897-407	http://dx.doi.org/10.1038/ng0897-407			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241283				2022-12-27	WOS:A1997XM90900028
J	Aitman, TJ; Gotoda, T; Evans, AL; Imrie, H; Heath, KE; Trembling, PM; Truman, H; Wallace, CA; Rahman, A; Dore, C; Flint, J; Kren, V; Zidek, V; Kurtz, TW; Pravenec, M; Scott, J				Aitman, TJ; Gotoda, T; Evans, AL; Imrie, H; Heath, KE; Trembling, PM; Truman, H; Wallace, CA; Rahman, A; Dore, C; Flint, J; Kren, V; Zidek, V; Kurtz, TW; Pravenec, M; Scott, J			Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats	NATURE GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; RECOMBINANT INBRED STRAINS; NITRIC-OXIDE SYNTHASE; UPPER-BODY OBESITY; INSULIN-RESISTANCE; BLOOD-PRESSURE; GENETIC-MAP; LINKAGE MAP; APOLIPOPROTEIN; CHROMOSOME-4	Coronary heart disease, hypertension, non-insulin-dependent diabetes and obesity are major causes of ill health in industrial societies, Disturbances of carbohydrate and lipid metabolism are a common feature of these disorders(1-9). The bases for these disturbances and their roles in disease pathogenesis are poorly understood, The spontaneously hypertensive rat (SHR), a widely used animal model of essential hypertension(10), has a global defect in insulin action on glucose metabolism and shows reduced catecholamine action on lipolysis in fat cells(11-14). In our study we used cellular defects in carbohydrate and lipid metabolism to dissect the genetics of defective insulin and catecholamine action in the SHR strain. In a genome screen for loci linked to insulin and catecholamine action, we identified two quantitative trait loci (QTLs) for defective insulin action, on chromosomes 4 and 12. We found that the major (and perhaps only) genetic determinant of defective control of lipolysis in SHR maps to the same region of chromosome 4. These linkage results were ascertained in at least two independent crosses. As the SHR strain manifests many of the defining features of human metabolic Syndrome X, in which hypertension associates with insulin resistance, dyslipidaemia and abdominal obesity, the identification of genes for defective insulin and catecholamine action in SHR may facilitate gene identification in this syndrome and in related human conditions, such as type-2 diabetes and familial combined hyperlipidaemia.	HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0NN,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED STAT & EVALUAT,LONDON W12 0NN,ENGLAND; INST MOL MED,OXFORD OX3 9DU,ENGLAND; CHARLES UNIV,FAC MED 1,DEPT BIOL,PRAGUE 12800 2,CZECH REPUBLIC; ACAD SCI CZECH REPUBL,INST PHYSIOL,CR-14220 PRAGUE 4,CZECH REPUBLIC; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143	Imperial College London; Imperial College London; University of Oxford; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of California System; University of California San Francisco	Aitman, TJ (corresponding author), HAMMERSMITH HOSP,MRC,CTR CLIN SCI,MOL MED GRP,LONDON W12 0NN,ENGLAND.		Pravenec, Michal/B-1666-2012; Heath, K. E./ABG-4658-2020; Zidek, Vaclav/C-6685-2012; Heath, Karen Elise/K-7760-2014; Dore, Caroline J/J-4716-2012	Pravenec, Michal/0000-0001-9197-5871; Heath, K. E./0000-0002-5816-7044; Heath, Karen Elise/0000-0002-5816-7044; Dore, Caroline J/0000-0001-9796-4970; Aitman, Timothy/0000-0002-7875-4502; Trembling, Paul/0000-0002-5016-4607				Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; BECKERS MC, 1994, GENOMICS, V23, P685, DOI 10.1006/geno.1994.1557; Belknap JK, 1996, BEHAV GENET, V26, P149, DOI 10.1007/BF02359892; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; DECINGOLANI GEC, 1988, METABOLISM, V37, P318, DOI 10.1016/0026-0495(88)90130-8; Dohi Y, 1996, HYPERTENSION, V28, P732, DOI 10.1161/01.HYP.28.5.732; EVANS DJ, 1984, J CLIN INVEST, V74, P1515, DOI 10.1172/JCI111565; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GOLDMUNTZ EA, 1995, MAMM GENOME, V6, P459, DOI 10.1007/BF00360654; GORDON RD, 1995, NAT GENET, V11, P6, DOI 10.1038/ng0995-6; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; HUBNER N, 1995, MAMM GENOME, V6, P758, DOI 10.1007/BF00354306; HUNT SC, 1989, ARTERIOSCLEROSIS, V9, P335, DOI 10.1161/01.ATV.9.3.335; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; Kirkwood TBL, 1979, BIOMETRICS, V35, P908; KLOCKE R, 1993, GENOMICS, V18, P568, DOI 10.1016/S0888-7543(05)80358-1; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MARTIN ML, 1991, J CLIN INVEST, V88, P609, DOI 10.1172/JCI115345; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MCLAUGHLIN MG, 1995, CIRCULATION, V92, P1; PATERNOSTRO G, 1995, CARDIOVASC RES, V30, P205, DOI 10.1016/0008-6363(95)00019-4; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Pravenec M, 1996, MAMM GENOME, V7, P117, DOI 10.1007/s003359900031; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; Reaven Gerald M., 1996, New England Journal of Medicine, V334, P374; REAVEN GM, 1989, DIABETES, V38, P1155, DOI 10.2337/diabetes.38.9.1155; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; RIESS O, 1994, GENOMICS, V19, P298, DOI 10.1006/geno.1994.1061; RODBELL M, 1964, J BIOL CHEM, V239, P375; SCHERRER U, 1994, J CLIN INVEST, V94, P2511, DOI 10.1172/JCI117621; Scott J, 1996, NATURE, V379, P113, DOI 10.1038/379113a0; Simon JS, 1996, MAMM GENOME, V7, P380, DOI 10.1007/s003359900109; Todd JA, 1996, NATURE, V384, P407, DOI 10.1038/384407a0; YAMORI Y, 1984, HDB HYPERTENSION, V4, P224	47	131	135	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					197	201		10.1038/ng0697-197	http://dx.doi.org/10.1038/ng0697-197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171835				2022-12-27	WOS:A1997XB54300024
J	Liaw, D; Marsh, DJ; Li, J; Dahia, PLM; Wang, SI; Zheng, ZM; Bose, S; Call, KM; Tsou, HC; Peacocke, M; Eng, C; Parsons, R				Liaw, D; Marsh, DJ; Li, J; Dahia, PLM; Wang, SI; Zheng, ZM; Bose, S; Call, KM; Tsou, HC; Peacocke, M; Eng, C; Parsons, R			Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome	NATURE GENETICS			English	Article							LHERMITTE-DUCLOS DISEASE	Cowden disease (CD) is an autosomal dominant cancer predisposition syndrome associated with an elevated risk for tumours of the breast, thyroid and skin(1-2). Lhermitte-Duclos disease (LDD) cosegregates with a subset of CD families and is associated with macrocephaly, ataxia and dysplastic cerebellar gangliocytomatosis(3-4). The common feature of these diseases is a predisposition to hamartomas, benign tumours containing differentiated but disorganized cells indigenous to the tissue of origin. Linkage analysis has determined that a single locus within chromosome 10q23 is likely to be responsible for both of these diseases(5). A candidate tumour suppressor gene (PTEN) within this region is mutated in sporadic brain, breast and prostate cancer(6). Another group has independently isolated the same gene, termed MMAC1, and also found somatic mutations throughout the gene in advanced sporadic cancers(7). Mutational analysis of PTEN in CD kindreds has identified germline mutations in four of five families, We found nonsense and missense mutations that are predicted to disrupt the protein tyrosine/dual-specificity phosphatase domain of this gene. Thus, PTEN appears to behave as a tumour suppressor gene in the germline. Our data also imply that PTEN may play a role in organizing the relationship of different cell types within an organ during development.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT DERMATOL,NEW YORK,NY 10032; CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 2QQ,ENGLAND; GENOME THERAPEUT CORP,WALTHAM,MA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Columbia University; Columbia University; Columbia University			Pinheiro, Maísa/E-7424-2012; Marsh, Deborah J/I-1491-2014	Marsh, Deborah J/0000-0001-5899-4931; Parsons, Ramon/0000-0002-6656-3514; Eng, Charis/0000-0002-3693-5145				CARLSON HE, 1986, AM J HUM GENET, V38, P908; ENG C, 1994, J MED GENET, V31, P458, DOI 10.1136/jmg.31.6.458; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; ENG C, IN PRESS J GENET COU; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LLOYD KM, 1963, ANN INTERN MED, V58, P136, DOI 10.7326/0003-4819-58-1-136; Longy M, 1996, ANN GENET-PARIS, V39, P35; MALLORY SB, 1995, DERMATOL CLIN, V13, P27, DOI 10.1016/S0733-8635(18)30103-7; Marsh DJ, 1997, CANCER RES, V57, P500; MULVIHILL JJ, 1977, CANCER, V40, P1867, DOI 10.1002/1097-0142(197710)40:4+<1867::AID-CNCR2820400816>3.0.CO;2-P; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; PADBERG GW, 1991, ANN NEUROL, V29, P517, DOI 10.1002/ana.410290511; STARINK TM, 1986, CLIN GENET, V29, P222; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4	16	1560	1615	1	84	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					64	67		10.1038/ng0597-64	http://dx.doi.org/10.1038/ng0597-64			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140396				2022-12-27	WOS:A1997WX02400023
J	Parsons, TJ; Muniec, DS; Sullivan, K; Woodyatt, N; AllistonGreiner, R; Wilson, MR; Berry, DL; Holland, KA; Weedn, VW; Gill, P; Holland, MM				Parsons, TJ; Muniec, DS; Sullivan, K; Woodyatt, N; AllistonGreiner, R; Wilson, MR; Berry, DL; Holland, KA; Weedn, VW; Gill, P; Holland, MM			A high observed substitution rate in the human mitochondrial DNA control region	NATURE GENETICS			English	Article							RECENT AFRICAN ORIGIN; MTDNA; EVOLUTION; SEQUENCE; IDENTIFICATION; POPULATIONS; REMAINS; POLYMORPHISM; BOTTLENECK; DIVERSITY	The rate and pattern of sequence substitutions in the mitochondrial DNA (mtDNA) control region (CR) is of central importance to studies of human evolution and to forensic identity testing. Here, we report a direct measurement of the intergenerational substitution rate in the human CR. We compared DNA sequences of two CR hypervariable segments from close maternal relatives, from 134 independent mtDNA lineages spanning 327 generational events. Ten substitutions were observed, resulting in an empirical rate of 1/33 generations, or 2.5/site/Myr. This is roughly twenty-fold higher than estimates derived from phylogenetic analyses. This disparity cannot be accounted for simply by substitutions at mutational hot spots, suggesting additional factors that produce the discrepancy between very near-term and long-term apparent rates of sequence divergence. The data also indicate that extremely rapid segregation of CR sequence variants between generations is common in humans, with a very small mtDNA bottleneck. These results have implications for forensic applications and studies of human evolution.	FORENS SCI SERV INC, BIRMINGHAM, W MIDLANDS, ENGLAND; FBI LAB, WASHINGTON, DC 20535 USA; GETTYSBURG COLL, DEPT CHEM, GETTYSBURG, PA 17325 USA	Forensic Science Service UK; Gettysburg College	Parsons, TJ (corresponding author), ARMED FORCES INST PATHOL, OFF ARMED FORCES MED EXAMINER, ARMED FORCES DNA IDENTIFICAT LAB, ROCKVILLE, MD 20850 USA.		Gill, Peter/C-3056-2009					Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Bendall KE, 1996, AM J HUM GENET, V59, P1276; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHEN YS, 1995, AM J HUM GENET, V57, P133; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; Gemmell NJ, 1996, MOL BIOL EVOL, V13, P798, DOI 10.1093/oxfordjournals.molbev.a025640; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; HOLLAND MM, 1994, ADV FORENSIC HAEMOGE, P399; HOLLINGUM J, 1995, IND ROBOT, V22, P3; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1992, HUM GENET, V90, P117; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Miller KWP, 1996, INT J LEGAL MED, V109, P107, DOI 10.1007/BF01369668; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nachman MW, 1996, GENETICS, V142, P953; NEI M, 1992, MOL BIOL EVOL, V9, P1176; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PESOLE G, 1992, MOL BIOL EVOL, V9, P587; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; POULTON J, 1995, AM J HUM GENET, V57, P224; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; *SAS I, 1991, SAS PROC GUID REL 6; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; SULLIVAN KM, 1992, INT J LEGAL MED, V105, P83, DOI 10.1007/BF02340829; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Templeton AR, 1996, GENETICS, V144, P1263; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WILLS C, 1995, EVOLUTION, V49, P593, DOI 10.1111/j.1558-5646.1995.tb02296.x; WILSON MR, 1993, CRIME LAB DIGEST, V20, P68; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907	54	352	360	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					363	368		10.1038/ng0497-363	http://dx.doi.org/10.1038/ng0497-363			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090380				2022-12-27	WOS:A1997WQ38900013
J	Schug, MD; Mackay, TFC; Aquadro, CF				Schug, MD; Mackay, TFC; Aquadro, CF			Low mutation rates of microsatellite loci in Drosophila melanogaster	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; TANDEM REPEAT LOCI; POLYGENIC MUTATION; INBRED STRAINS; MODERN HUMANS; POLYMORPHISM; POPULATIONS; DIVERGENCE; EVOLUTION; DNA	Analysis of variation at microsatellite DNA loci is widely used in studies of parentage(1), linkage(2) and evolutionary history(3-5). The utility of microsatellites is primarily due to high levels of allelic diversity. believed to reflect mutation rates orders of magnitude higher than base pair substitutions at single-copy genes. For humans(6-14). mice(15-16), rats(17) and pigs(18) microsatellite mutation rates have been estimated at 10(-3)-10(-5). However. a recent study comparing microsatellite variation in humans with non-human primates suggests that microsatellite mutation rates may vary considerably across taxa(19,20). We measured mutation rates of 24 microsatellite loci in mutation accumulation lines of Drosophila melanogaster. Surprisingly, only a single mutation was detected after screening 157,680 allele-generations. yielding an estimated average mutation rate per locus of 6.3 x 10(-6), a mutation rate considerably lower than reported for various mammals. We propose that the comparatively low mutation rate is primarily a function of short microsatellite repeat lengths in the D. melanogaster genome.	N CAROLINA STATE UNIV,DEPT GENET,RALEIGH,NC 27695	University of North Carolina; North Carolina State University	Schug, MD (corresponding author), CORNELL UNIV,GENET & DEV SECT,BIOTECHNOL BLDG,ITHACA,NY 14853, USA.				NIGMS NIH HHS [GM 17872, GM 45344, R01 GM036431, GM 36431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Casella G, 1992, STAT INFERENCE; CHANG BHJ, 1994, P NATL ACAD SCI USA, V91, P827, DOI 10.1073/pnas.91.2.827; Cooper KW, 1950, BIOL DROSOPHILA, P1; DALLAS JF, 1992, MAMM GENOME, V3, P452, DOI 10.1007/BF00356155; DEITRICH W, 1992, GENETICS, V131, P423; DOVER G, 1995, NAT GENET, V10, P254, DOI 10.1038/ng0795-254; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; ELLEGREN H, 1995, MAMM GENOME, V6, P376, DOI 10.1007/BF00364807; England PR, 1996, GENET RES, V67, P285, DOI 10.1017/S0016672300033760; GLOOR GB, 1993, GENETICS, V135, P81; GOLDSTEIN DB, 1995, NUCLEIC ACIDS RES, V23, P3882, DOI 10.1093/nar/23.19.3882; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; MACKAY TFC, 1994, GENETICS, V136, P937; MACKAY TFC, 1995, GENETICS, V139, P849; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; MAHTANI MM, 1993, HUM MOL GENET, V2, P431, DOI 10.1093/hmg/2.4.431; NUZHDIN SV, 1994, GENET RES, V63, P139, DOI 10.1017/S0016672300032249; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; ROY MS, 1994, MOL BIOL EVOL, V11, P553; RUBENSZTEIN DC, 1995, NAT GENET, V10, P337; SERIKAWA T, 1992, GENETICS, V131, P701; SINGH RS, 1989, ANNU REV GENET, V23, P425, DOI 10.1146/annurev.ge.23.120189.002233; Sonnenblick B., 1950, BIOL DROSOPHILA, P62; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	37	190	196	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					99	102		10.1038/ng0197-99	http://dx.doi.org/10.1038/ng0197-99			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988178				2022-12-27	WOS:A1997WA37300030
J	Stoffers, DA; Zinkin, NT; Stanojevic, V; Clarke, WL; Habener, JF				Stoffers, DA; Zinkin, NT; Stanojevic, V; Clarke, WL; Habener, JF			Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR EXPRESSION; INSULIN GENE; GLUCOSE-CONCENTRATION; CONGENITAL ABSENCE; DIABETES-MELLITUS; HOMEOBOX FACTOR; FACTOR STF-1; ISLET CELLS; HOMEODOMAIN; INSUFFICIENCY	The homeodomain protein IPF1 (also known as IDX1, STF1 and PDX1; see Methods) is critical for development of the pancreas in mice and is a key factor for the regulation of the insulin gene in the beta-cells of the endocrine pancreas(1-6). Targeted disruption of the Ipf1 gene encoding IPF1 in transgenic mice results in a failure of the pancreas to develop (pancreatic agenesis)(4,7). Here, we report the identification of a single nucleotide deletion within codon 63 of the human IPF1 gene (13q12.1) in a patient with pancreatic agenesis. The patient is homozygous for the point deletion, whereas both parents are heterozygotes for the same mutation. The deletion was not found in 184 chromosomes from normal individuals, indicating that the mutation is unlikely to be a rare polymorphism. The point deletion causes a frame shift at the C-terminal border of the transactivation domain of IPF1 resulting in the translation of 59 novel codons before termination, aminoproximal to the homeodomain essential for DNA binding, Expression of mutant IPF1 in Cos-1 cells confirms the expression of a prematurely terminated truncated protein of 16 kD. Thus, the affected patient should have no functional IPF1 protein. Given the essential role of IPF1 in pancreas development, it is likely that this autosomal recessive mutation is the cause of the pancreatic agenesis phenotype in this patient. Thus, IPF1 appears to be a critical regulator of pancreas development in humans as well as mice.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,LAB MOL ENDOCRINOL,HOWARD HUGHES MED INST,BOSTON,MA 02114; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA 22908	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Virginia			Stoffers, Doris/H-6157-2012					CARROLL PB, 1992, PANCREAS, V7, P21, DOI 10.1097/00006676-199201000-00004; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; DODGE JA, 1977, ARCH DIS CHILD, V52, P411, DOI 10.1136/adc.52.5.411; DOUROV N, 1969, ARCH FR PEDIATR, V26, P641; HOWARD CP, 1980, J PEDIATR-US, V97, P786, DOI 10.1016/S0022-3476(80)80270-8; INOUE H, 1996, GENE DIABETES, V45, P789; JONNSON J, 1994, NATURE, V371, P606; LEMONS JA, 1979, PEDIATRICS, V64, P255; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Lu M, 1996, ENDOCRINOLOGY, V137, P2959, DOI 10.1210/en.137.7.2959; MEHES K, 1976, ACTA PAEDIATR HUNG, V17, P175; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Moore DD, 1995, GLOB MOB SURV; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; PEERS B, 1995, MOL CELL BIOL, V15, P7091; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sambrook J., 2002, MOL CLONING LAB MANU; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; SHERWOOD WG, 1995, PEDIATR RES, V8, P360; STOFFEL M, GENOMICS, V28, P125; WIDNESS JA, 1982, J PEDIATR-US, V100, P926, DOI 10.1016/S0022-3476(82)80517-9; WINTER WE, 1986, J PEDIATR-US, V109, P465, DOI 10.1016/S0022-3476(86)80119-6; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; WRIGHT NM, 1993, AM J DIS CHILD, V147, P607	29	809	845	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					106	110		10.1038/ng0197-106	http://dx.doi.org/10.1038/ng0197-106			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988180				2022-12-27	WOS:A1997WA37300032
J	Semina, EV; Reiter, R; Leysens, NJ; Alward, WLM; Small, KW; Datson, NA; SiegelBartelt, J; BierkeNelson, D; Bitoun, P; Zabel, BU; Carey, JC; Murray, JC				Semina, EV; Reiter, R; Leysens, NJ; Alward, WLM; Small, KW; Datson, NA; SiegelBartelt, J; BierkeNelson, D; Bitoun, P; Zabel, BU; Carey, JC; Murray, JC			Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome	NATURE GENETICS			English	Article							IN-SITU HYBRIDIZATION; MESSENGER-RNA; CLEFT-PALATE; EVOLUTIONARY CONSERVATION; WAARDENBURG SYNDROME; HOMEODOMAIN PROTEIN; EXPRESSION PATTERNS; MOUSE EMBRYO; MAJOR LOCUS; BOX GENE	Rieger syndrome (RIEG) is an autosomal-dominant human disorder that includes anomalies of the anterior chamber of the eye, dental hypoplasia and a protuberant umbilicus. We report the human cDNA and genomic characterization of a new homeobox gene, RIEG, causing this disorder. Six mutations in RIEG were found in individuals with the disorder. The cDNA sequence of Rieg, the murine homologue of RIEG, has also been isolated and shows strong homology with the human sequence. In mouse embryos Rieg mRNA localized in the periocular mesenchyme, maxillary and mandibular epithelia, and umbilicus, all consistent with RIEG abnormalities. The gene is also expressed in Rathke's pouch, vitelline vessels and the limb mesenchyme. RIEG characterization provides opportunities for understanding ocular, dental and umbilical development and the pleiotropic interactions of pituitary and limb morphogenesis.	UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT BIOL SCI,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV CALIF LOS ANGELES,MED CTR,DEPT OPHTHALMOL,JULES STEIN EYE INST,LOS ANGELES,CA 90095; LEIDEN UNIV,SECTIE ANTHROPOGENET,SYLVIUS LAB,NL-2333 AL LEIDEN,NETHERLANDS; HOSP SICK CHILDREN,DEPT CLIN GENET,TORONTO,ON M5G 1X8,CANADA; DULUTH CLIN,DULUTH,MN 55805; HOP JEAN VERDIER,F-93143 BONDY,FRANCE; UNIV MAINZ,KLINIKUM JOHANNES GUTENBERG,DEPT PEDIAT,D-55101 MAINZ,GERMANY; UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,SALT LAKE CITY,UT 84132	University of Iowa; University of Iowa; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Leiden University; Leiden University - Excl LUMC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Johannes Gutenberg University of Mainz; Utah System of Higher Education; University of Utah			Datson, Nicole A./O-8797-2014; Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Bitoun, Pierre/0000-0001-6557-6826; Datson, Nicole/0000-0003-2887-0238	NIDCR NIH HHS [DE08559, DE09170] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, P50DE009170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alkemade P., 1969, DYSGENESIS MESODERMA; ASSONBATRES MA, 1994, P NATL ACAD SCI USA, V91, P1318, DOI 10.1073/pnas.91.4.1318; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CRAWFORD RA, 1967, BRIT J OPHTHALMOL, V51, P438, DOI 10.1136/bjo.51.7.438; DARWIN C, 1893, ANIMALS PLANTS DOMES, V1, P434; DATSON N, IN PRESS AM J HUM GE; Dixon J, 1996, NAT GENET, V12, P130; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; EIBERG H, 1987, CLIN GENET, V32, P129; FEINGOLD M, 1969, PEDIATRICS, V44, P564; FITCH N, 1978, J MED GENET, V15, P30, DOI 10.1136/jmg.15.1.30; GASSER DL, 1991, J CRAN GENET DEV BIO, V11, P366; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; HANES SD, 1994, MOL CELL BIOL, V14, P3364, DOI 10.1128/MCB.14.5.3364; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEON E, 1995, HUM MOL GENET, V4, P1435, DOI 10.1093/hmg/4.8.1435; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; JURILOFF DM, 1995, MAMM GENOME, V6, P63, DOI 10.1007/BF00303246; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KAROLYI J, 1994, J CRANIOFAC GENET DE, V13, P1; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KRESPI YP, 1979, AM J GASTROENTEROL, V71, P608; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; MURRAY JC, 1990, AM J HUM GENET, V46, P486; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; NOHNO T, 1993, DEV BIOL, V158, P254, DOI 10.1006/dbio.1993.1184; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PASTERIS NG, 1994, CELL, V79, P669; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Phillips JC, 1996, AM J HUM GENET, V59, P613; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Rieger H, 1935, Z AUGENHEILKD, V86, P333; ROGERS RC, 1988, P GREENWOOD GENET CT, V7, P9; SADEGHIN.A, 1974, J PEDIATR-US, V85, P644, DOI 10.1016/S0022-3476(74)80507-X; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SCHNEITZ K, 1993, GENE DEV, V7, P114, DOI 10.1101/gad.7.1.114; SEMINA E, IN PRESS AM J HUM GE; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1994, NEURON, V13, P81; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Slaney SF, 1996, AM J HUM GENET, V58, P923; SLAVKIN HC, 1993, AM J MED GENET, V47, P689, DOI 10.1002/ajmg.1320470521; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THEILER K, 1989, HOUSE MOUSE; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; VOSSIUS A, 1883, KLIN MONATSBL AUGENH, V21, P233; Winter RM, 1996, NAT GENET, V12, P124, DOI 10.1038/ng0296-124; ZHAO GQ, 1994, MECH DEVELOP, V48, P245, DOI 10.1016/0925-4773(94)90063-9	72	702	726	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					392	399		10.1038/ng1296-392	http://dx.doi.org/10.1038/ng1296-392			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944018				2022-12-27	WOS:A1996VV73000014
J	Redmond, TM; Yu, S; Lee, E; Bok, D; Hamasaki, D; Chen, N; Goletz, P; Ma, JX; Crouch, RK; Pfeifer, K				Redmond, TM; Yu, S; Lee, E; Bok, D; Hamasaki, D; Chen, N; Goletz, P; Ma, JX; Crouch, RK; Pfeifer, K			Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle	NATURE GENETICS			English	Article							PIGMENT-EPITHELIUM; BINDING-PROTEIN; GENE-TRANSFER; VITAMIN-A; MICROSOMAL PROTEIN; MOUSE RETINA; CELLS; MICE; ISOMERASE; RHODOPSIN	Mutation of RPE65 can cause severe blindness from birth or early childhood, and RPE65 protein is associated with retinal pigment epithelium (RPE) vitamin A metabolism. Here. we show that Rpe65-deficient mice exhibit changes in retinal physiology and biochemistry. Outer segment discs of rod photoreceptors in Rpe65(-/-) mice are disorganized compared with those of Rpe65(+/+) and Rpe65(+/-) mice. Rod function, as measured by electroretinography, is abolished in Rpe65(-/-) mice, although cone function remains. Rpe65(-/-) mice lack rhodopsin, but not opsin apoprotein. Furthermore, all-trans-retinyl esters over-accumulate in the RPE of Rpe65(-/-) mice, whereas 11-cis-retinyl esters are absent. Disruption of the RPE-based metabolism of all-trans-retinyl esters to 11-cis-retinal thus appears to underlie the Rpe65(-/-) phenotype, although cone pigment regeneration may be dependent on a separate pathway.	NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL 33101 USA; Med Univ S Carolina, Storm Eye Inst, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Bascom Palmer Eye Institute; University of Miami; Medical University of South Carolina	Redmond, TM (corresponding author), NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	redmond@helix.nih.gov			NATIONAL EYE INSTITUTE [R01EY000444, P30EY000331, R37EY000444, R01EY012231] Funding Source: NIH RePORTER; NEI NIH HHS [EY12231, EY00444, EY00331] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; BARRY RJ, 1989, J BIOL CHEM, V264, P9231; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; BENNETT J, 1994, INVEST OPHTH VIS SCI, V35, P2535; BERNSTEIN PS, 1987, J BIOL CHEM, V262, P16848; BRIDGES CDB, 1982, METHOD ENZYMOL, V81, P463; BRIDGES CDB, 1989, VISION RES, V29, P1711, DOI 10.1016/0042-6989(89)90153-3; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; GOLDSTEIN EB, 1967, VISION RES, V7, P837, DOI 10.1016/0042-6989(67)90004-1; GOLDSTIEN EB, 1973, VISION RES, V83, P527; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; HELLER J, 1976, AM J OPHTHALMOL, V81, P93, DOI 10.1016/0002-9394(76)90198-7; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498; LAI YL, 1982, NATURE, V298, P848, DOI 10.1038/298848a0; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Liou GI, 1998, J NEUROSCI, V18, P4511; MA JX, IN PRESS BIOCH BIOPH; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; NOY N, 1991, BIOCHEMISTRY-US, V30, P6380, DOI 10.1021/bi00240a005; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; PEACHEY NS, 1993, NEUROSCI LETT, V162, P9, DOI 10.1016/0304-3940(93)90547-X; ROBISON WG, 1977, INVEST OPHTH VIS SCI, V16, P1110; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1994, BIOCHEMISTRY-US, V33, P3106, DOI 10.1021/bi00176a045; Saari John C., 1994, P351; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; Sullivan DM, 1996, INVEST OPHTH VIS SCI, V37, P766; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WIGGERT B, 1977, BIOCHIM BIOPHYS ACTA, V498, P366, DOI 10.1016/0304-4165(77)90275-6; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Wright AF, 1997, NAT GENET, V17, P132, DOI 10.1038/ng1097-132; YOUNG RW, 1970, INVEST OPHTH VISUAL, V9, P524	48	746	768	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					344	351		10.1038/3813	http://dx.doi.org/10.1038/3813			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843205				2022-12-27	WOS:000077199600020
J	Shimodaira, H; Filosi, N; Shibata, H; Suzuki, T; Radice, P; Kanamaru, R; Friend, SH; Kolodner, RD; Ishioka, C				Shimodaira, H; Filosi, N; Shibata, H; Suzuki, T; Radice, P; Kanamaru, R; Friend, SH; Kolodner, RD; Ishioka, C			Functional analysis of human MLH1 mutations in Saccharomyces cevevisiae	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; COLON-CANCER; CEREVISIAE; YEAST; GENETICS; HOMOLOG; GENES; HNPCC	Hereditary non-polyposis colorectal cancer (HNPCC; OMIM 120435-6) is a cancer-susceptibility syndrome(1) linked to inherited defects in human mismatch repair (MMR) genes(2). Germline missense human MLH1 (hMLH1) mutations are frequently detected in HNPCC (ref. 3), making functional characterization of mutations in hMLH1 critical to the development of genetic testing for HNPCC. Here, we describe a new method for detecting mutations in hMLHI using a dominant mutator effect of hMLH1 cDNA expressed in Saccharomyces cerevisiae. The majority of hMLH1 missense mutations identified in HNPCC patients abolish the dominant mutator effect. Furthermore, PCR amplification of hMLHI cDNA from mRNA from a HNPCC patient, followed by in vivo recombination into a gap expression vector, allowed detection of a heterozygous loss-of-function missense mutation in hMLH1 using this method. This functional assay offers a simple method for detecting and evaluating pathogenic mutations in hMLH1.	Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; Dana Farber Canc Inst, Charles A Dana Div Human Canc Genet, Boston, MA 02115 USA; Ist Nazl Tumori, Div Expt Oncol, I-20133 Milan, Italy; Fred Hutchinson Canc Res Ctr, Seattle Project, Seattle, WA 98109 USA	Tohoku University; Harvard University; Dana-Farber Cancer Institute; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fred Hutchinson Cancer Center	Ishioka, C (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.		; Radice, Paolo/O-3119-2013	Ishioka, Chikashi/0000-0002-3023-1227; Radice, Paolo/0000-0001-6298-4111	NIGMS NIH HHS [GM44704] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; HENDERSON ST, 1993, GENETICS, V134, P57; Ishioka C, 1997, P NATL ACAD SCI USA, V94, P2449, DOI 10.1073/pnas.94.6.2449; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; Lynch HT, 1996, INT J CANCER, V69, P38, DOI 10.1002/(SICI)1097-0215(19960220)69:1<38::AID-IJC9>3.0.CO;2-X; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Pensotti V, 1997, GENE CHROMOSOME CANC, V19, P135; REENAN RAG, 1992, GENETICS, V132, P975; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Viel A, 1997, GENE CHROMOSOME CANC, V18, P8, DOI 10.1002/(SICI)1098-2264(199701)18:1<8::AID-GCC2>3.0.CO;2-7	20	117	121	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					384	389		10.1038/1277	http://dx.doi.org/10.1038/1277			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697702				2022-12-27	WOS:000075107600024
J	Kolquist, KA; Ellisen, LW; Counter, CM; Meyerson, M; Tan, LK; Weinberg, RA; Haber, DA; Gerald, WL				Kolquist, KA; Ellisen, LW; Counter, CM; Meyerson, M; Tan, LK; Weinberg, RA; Haber, DA; Gerald, WL			Expression of TERT in early premalignant lesions and a subset of cells in normal tissues	NATURE GENETICS			English	Article							TELOMERASE ACTIVITY; HUMAN BREAST; CANCER; RNA	Activation of telomerase, the enzyme that synthesizes the telomere ends of linear chromosomes, has been implicated in human cell immortalization and cancer cell pathogenesis. Enzyme activity is undetectable in most normal cells and tissues, but present in immortal cells and cancer tissues(1-3). While expression of TERC, the RNA component of telomerase, is widespread(4-6), the restricted expression pattern of TERT, the telomerase catalytic subunit gene, is correlated with telomerase activity(7-9), and its ectopic expression in telomerase-negative cells is sufficient to reconstitute telomerase activity(10-12) and extend cellular lifespan(13). We have used in situ hybridization to study TERT expression at the single-cell level in normal tissues and in various stages of tumour progression. In normal tissues, including some that are known to be telomerase-negative, TERT mRNA was present in specific subsets of cells thought to have long-term proliferative capacity. This included mitotically inactive breast lobular epithelium in addition to some actively regenerating cells such as the stratum basale of the skin. TERT expression appeared early during tumorigenesis in vivo, beginning with early pre-invasive changes in human breast and colon tissues and increasing mRNA present within individual cells and in the number of expressing cells within a neoplastic lesion. The physiological expression of TERT within normal epithelial cells that retain of tumorigenesis have implications for the regulation of telomerase expression and for the identification of cells that may be targets for malignant transformation.	Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute	Gerald, WL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	geraldw@mskcc.org	Meyerson, Matthew L/E-7123-2012; Ellisen, Leif W/AAA-6572-2022	Ellisen, Leif W/0000-0003-0444-7910; Counter, Christopher M/0000-0003-0748-3079	NCI NIH HHS [CA 58596, CA 68273, CA 39826] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068273, R35CA039826, R01CA058596, R37CA058596] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avilion AA, 1996, CANCER RES, V56, P645; BELAIR CD, 1997, P NATL ACAD SCI USA, V94, P13667; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; CHADENEAU C, 1995, CANCER RES, V55, P2533; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Greaves M, 1996, TRENDS GENET, V12, P127, DOI 10.1016/0168-9525(96)30016-4; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Hiyama E, 1996, INT J ONCOL, V9, P453; Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 1997, CANCER RES, V57, P610; Lee SB, 1997, NAT GENET, V17, P309, DOI 10.1038/ng1197-309; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Ramakrishnan S, 1998, CANCER RES, V58, P622; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Takubo K, 1997, J SURG ONCOL, V66, P88, DOI 10.1002/(SICI)1096-9098(199710)66:2<88::AID-JSO3>3.0.CO;2-H; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Yashima K, 1998, CLIN CANCER RES, V4, P229; Yasumoto S, 1996, ONCOGENE, V13, P433	30	351	382	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					182	186		10.1038/554	http://dx.doi.org/10.1038/554			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620778				2022-12-27	WOS:000073865100029
J	Macchia, PE; Lapi, P; Krude, H; Pirro, MT; Missero, C; Chiovato, L; Souabni, A; Baserga, M; Tassi, V; Pinchera, A; Fenzi, G; Gruters, A; Busslinger, M; Di Lauro, R				Macchia, PE; Lapi, P; Krude, H; Pirro, MT; Missero, C; Chiovato, L; Souabni, A; Baserga, M; Tassi, V; Pinchera, A; Fenzi, G; Gruters, A; Busslinger, M; Di Lauro, R			PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis	NATURE GENETICS			English	Article							PAIRED DOMAIN; GENES; TRANSCRIPTION; RECOGNITION; ISOFORMS; PROTEINS; SITE	Permanent congenital hypothyroidism (CH) is a common disease that occurs in 1 of 3,000-4,000 newborns. Except in rare cases due to hypothalamic or pituitary defects, CH is characterized by elevated levels of thyroid-stimulating hormone (TSH) resulting from reduced thyroid function. When thyroid hormone therapy is not initiated within the first two months of life, CH can cause severe neurological, mental and motor damage(1,2). In 80-85% of cases, CH is associated with and presumably is a consequence of thyroid dysgenesis (TD). In these cases, the thyroid gland can be absent (agenesis, 35-40%), ectopically located (30-45%) and/or severely reduced in size (hypoplasia, 5%), Familial cases of TD are rare, even though ectopic or absent thyroid has been occasionally observed in siblings(3). The pathogenesis of TD is still largely unknown. Although a genetic component has been suggested, mutations in the gene encoding the receptor for the thyroid-stimulating hormone (TSHR) have been identified in only two cases of TD with hypoplasia(4,5). We report mutations in the coding region of PAX8 in two sporadic patients and one familial case of TD. All three point mutations are located in the paired domain of PAX8 and result in severe reduction of the DNA-binding activity of this transcription factor. These genetic alterations implicate PAX8 in the pathogenesis of TD and in normal thyroid development.	Staz Zool A Dohrn, Naples, Italy; Univ Pisa, Ist Endocrinol, Pisa, Italy; Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Reggio Calabria, Fac Med & Chirurg Catanzaro, Cattedra Pediat, Calabria, Italy; Ist Sci Casa Sollievo Sofferenza, Div Unita Ric Endocrinol, San Giovanni Rotondo, Italy; Univ Naples Federico II, Cattedra Endocrinol, Naples, Italy; Humboldt Univ, Virchow Klinikum, Klin & Poliklin Kinderheilkunde, Berlin, Germany	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Pisa; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Universita Mediterranea di Reggio Calabria; IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; Humboldt University of Berlin	Di Lauro, R (corresponding author), Staz Zool A Dohrn, Naples, Italy.	rdilauro@unina.it	Chiovato, Luca/K-6617-2016; Di Lauro, Roberto/A-2746-2012; Busslinger, Meinrad J./J-1249-2016; Macchia, Paolo Emidio/AGZ-2839-2022; Macchia, Paolo Emidio/B-7391-2012; chiovato, luca/AAC-9003-2019	Chiovato, Luca/0000-0001-7457-7353; Di Lauro, Roberto/0000-0001-9493-3036; Busslinger, Meinrad J./0000-0002-9111-9351; Macchia, Paolo Emidio/0000-0001-6503-6942; Macchia, Paolo Emidio/0000-0001-6503-6942; Missero, Caterina/0000-0003-0905-5123; Tassi, Vittorio/0000-0003-3536-4480	Telethon [D.067, E.0254] Funding Source: Medline	Telethon(Fondazione Telethon)		Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DUSSAULT JH, 1975, J PEDIATR-US, V86, P670, DOI 10.1016/S0022-3476(75)80349-0; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; GLORIEUX J, 1985, J PEDIATR-US, V107, P913, DOI 10.1016/S0022-3476(85)80187-6; GRUTERS A, 1996, BAILLIERE CLIN PAEDI, V4, P1; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Mckusick V.A., 1994, MENDELIAN INHERITANC; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POLEEV A, 1995, EUR J BIOCHEM, V228, P899, DOI 10.1111/j.1432-1033.1995.tb20338.x; ROSSI DL, 1995, J BIOL CHEM, V270, P23139, DOI 10.1074/jbc.270.39.23139; ROVET JF, 1995, J PEDIATR-US, V126, P380, DOI 10.1016/S0022-3476(95)70452-3; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; STUART ET, 1995, HUM MOL GENET, V4, P1717, DOI 10.1093/hmg/4.suppl_1.1717; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	20	353	369	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					83	86		10.1038/ng0598-83	http://dx.doi.org/10.1038/ng0598-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590296				2022-12-27	WOS:000073346700024
J	Rafael, JA; Tinsley, JM; Potter, AC; Deconinck, AE; Davies, KE				Rafael, JA; Tinsley, JM; Potter, AC; Deconinck, AE; Davies, KE			Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice	NATURE GENETICS			English	Article							MUSCULAR-DYSTROPHY; MDX MOUSE	Duchenne muscular dystrophy (DMD) is a progressive muscle wasting disease usually resulting in death of patients by their early twenties'. In contrast, mice lacking dystrophin (Dmd(mdx)), appear physically normal despite their underlying muscle pathology(2,3). Mice deficient for both dystrophin and the dystrophin-related protein, utrophin, (Dmd(mdx);Utrn(-/-) mice) die between 6 and 20 weeks of age suffering from severe muscle weakness with joint contractures, pronounced growth retardation and kyphosis, suggesting that dystrophin and utrophin play complementary roles(4,5). The exact cause of death in these mice was not determined. Here we show that expression of a truncated utrophin transgene solely within the skeletal muscle of these mutants prevents premature death and the development of any clinical phenotype, In the absence of full-length dystrophin and utrophin, the presence of truncated utrophin also decreases muscle fibre regeneration, relocalizes the dystrophin protein complex to the sarcolemma and re-establishes a normal expression pattern of developmental muscle proteins. These data suggest that Dmd(mdx);Utrn(-/-) mice succumb to a skeletal muscle defect and that their reduced lifespan is not due to cardiac or neurogenic components, The phenotypic rescue observed demonstrates that the Dmd(mdx);Utrn(-/-) mice are an ideal model for testing gene delivery protocols for the expression of utrophin or dystrophin in skeletal muscle.	Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	University of Oxford	Davies, KE (corresponding author), Univ Oxford, Dept Biochem, Genet Unit, South Pk Rd, Oxford OX1 3QU, England.		Rafael-Fortney, Jill/E-3909-2011					BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216; Dubowitz V., 1995, MUSCLE DISORDERS CHI; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Gilbert R, 1998, BIOCHEM BIOPH RES CO, V242, P244, DOI 10.1006/bbrc.1997.7936; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; Melacini P, 1996, CIRCULATION, V94, P3168, DOI 10.1161/01.CIR.94.12.3168; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1991, J CELL BIOL, V115, P1688; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; TINSLEY JM, 1993, NEUROMUSCULAR DISORD, V3, P537, DOI 10.1016/0960-8966(93)90111-V; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0	18	174	180	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					79	82		10.1038/ng0598-79	http://dx.doi.org/10.1038/ng0598-79			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590295				2022-12-27	WOS:000073346700023
J	Yamasaki, L; Bronson, R; Williams, BO; Dyson, NJ; Harlow, E; Jacks, T				Yamasaki, L; Bronson, R; Williams, BO; Dyson, NJ; Harlow, E; Jacks, T			Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice	NATURE GENETICS			English	Article							S-PHASE ENTRY; FIBROBLASTS LEADS; CHIMERIC MICE; APOPTOSIS; GENE; RB; EXPRESSION; MOUSE; OVEREXPRESSION; INDUCTION	Mutation of the retinoblastoma tumour-suppressor gene (RB) leads to the deregulation of many proteins and transcription factors that interact with the retinoblastoma gene product (pRB), including members of the E2F transcription factor family(1,2). As pRB is known to repress E2F transcriptional activity and overexpression of E2F is sufficient for cell cycle progression, it is thought that pRB suppresses growth in part by repressing E2F-mediated transcription(3). Previously, we reported that loss of E2f1 in mice results in tissue-specific tumour induction and tissue atrophy(4), demonstrating that E2F-1 normally controls growth both positively and negatively in a tissue-specific fashion(4,5). To determine whether E2F-1 deregulation-as a result of loss of pRB-promotes proliferation in vivo, we have tested whether loss of E2f1 interferes with the pituitary and thyroid tumorigenesis that occurs in Rb1(+/-) mice(6-9). We have found that loss of E2f1 reduces the frequency of pituitary and thyroid tumours, and greatly lengthens the lifespan of Rb1(+/-); E2f1(-/-) animals, demonstrating that E2F-1 is an important downstream target of pRB during tumorigenesis. Furthermore. loss of E2f1 reduces a previously reported strain-dependent difference in Rb1(+/-) lifespan(9,10), suggesting that E2f1 or an E2F-1-regulated gene acts as a genetic modifier between the 129/Sv and C57BL/6 strains.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Tufts Univ, Sch Vet Med, Dept Pathol, USDA,Human Nutr Res Ctr Aging, Boston, MA 02111 USA; MIT, Ctr Canc Res, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Tufts University; United States Department of Agriculture (USDA); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Yamasaki, L (corresponding author), Columbia Univ, Dept Biol Sci, 1102 Fairchild Bldg,1212 Amsterdam Ave, New York, NY 10027 USA.		Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301				Bronson R., 1990, GENETIC EFFECTS AGIN, VII, P279; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; HARRISON DJ, 1995, ONCOGENE, V10, P1615; Horowitz Jonathan M., 1995, Molecular and Cellular Differentiation, V3, P275; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; HU NP, 1994, ONCOGENE, V9, P1021; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Nip J, 1997, MOL CELL BIOL, V17, P1049, DOI 10.1128/MCB.17.3.1049; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4	28	248	251	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					360	364		10.1038/ng0498-360	http://dx.doi.org/10.1038/ng0498-360			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537419				2022-12-27	WOS:000072755500019
J	Aaltonen, J; Bjorses, P; Perheentupa, J; HorelliKuitunen, N; Palotie, A; Peltonen, L; Lee, YS; Francis, F; Hennig, S; Thiel, C; Lehrach, H; Yaspo, ML				Aaltonen, J; Bjorses, P; Perheentupa, J; HorelliKuitunen, N; Palotie, A; Peltonen, L; Lee, YS; Francis, F; Hennig, S; Thiel, C; Lehrach, H; Yaspo, ML			An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains	NATURE GENETICS			English	Article							HUMAN DNA; PHOSPHOFRUCTOKINASE GENE; CODING REGIONS; SEQUENCES; PROTEIN; IDENTIFICATION; CANDIDIASIS; AUTOANTIGEN; MODEL; EXON	Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is the only described systemic autoimmune disease with established monogenic background, and the first autoimmune disorder localized outside the major histocompatibility complex (MHC) region. The primary biochemical defect in APECED is unknown. We have isolated a novel gene, AIRE, encoding for a putative nuclear protein featuring two PHD-type zinc-finger motifs, suggesting its involvement in transcriptional regulation. Five mutations in AIRE are reported in individuals with this disorder. This is the first report of a single-gene defect causing a systemic human autoimmune disease, providing a tool for exploring the molecular basis of autoimmunity.	UNIV HELSINKI,INST BIOMED,DEPT HUMAN MOL GENET,FIN-00300 HELSINKI,FINLAND; UNIV HELSINKI,HOSP CHILDREN & ADOLESCENTS,HELSINKI,FINLAND; UNIV HELSINKI,DEPT CLIN CHEM,SF-00100 HELSINKI,FINLAND; UNIV HELSINKI,DEPT BIOMED,SF-00100 HELSINKI,FINLAND; MAX PLANCK INST MOL GENET,D-14195 BERLIN,GERMANY	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Max Planck Society			Francis, Fiona/B-5854-2016					AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; Aaltonen J, 1997, GENOME RES, V7, P820, DOI 10.1101/gr.7.8.820; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; AHONEN P, 1988, J CLIN ENDOCR METAB, V66, P1152, DOI 10.1210/jcem-66-6-1152; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bjorses P, 1996, AM J HUM GENET, V59, P879; BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CAMPBELL RD, 1993, CURR OPIN IMMUNOL, V5, P887, DOI 10.1016/0952-7915(93)90101-W; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ELSON A, 1990, GENOMICS, V7, P47, DOI 10.1016/0888-7543(90)90517-X; Fidel Paul L. Jr., 1994, Trends in Microbiology, V2, P202, DOI 10.1016/0966-842X(94)90112-I; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GE Q, 1995, J CLIN INVEST, V96, P1730, DOI 10.1172/JCI118218; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Heiskanen M, 1996, TRENDS GENET, V12, P379, DOI 10.1016/0168-9525(96)30083-8; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; KROHN K, 1992, LANCET, V339, P770, DOI 10.1016/0140-6736(92)91894-E; KULP D, 1996, ISMB, V4, P134; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEVANON D, 1995, BIOCHEM MOL BIOL INT, V35, P929; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; THOMAS A, 1994, IMA J MATH APPL MED, V11, P149; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	34	846	865	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					399	403		10.1038/ng1297-399	http://dx.doi.org/10.1038/ng1297-399			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398840				2022-12-27	WOS:A1997YJ92400019
J	Markel, P; Shu, P; Ebeling, C; Carlson, GA; Nagle, DL; Smutko, JS; Moore, KJ				Markel, P; Shu, P; Ebeling, C; Carlson, GA; Nagle, DL; Smutko, JS; Moore, KJ			Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; DEFICIENT MICE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; SUSCEPTIBILITY; INTERVALS	Congenic breeding strategies are becoming increasingly important as a greater number of complex trait linkages are identified. Traditionally, the development od a congenic strain Ras been a time-consuming endeavour, requiring ten generations of backcrosses. The recent advent of a dense molecular genetic map of the mouse permits methods that can reduce the time needed for congenic-strain production by 18-24 months. We present a theoretical evaluation of marker-assisted congenic production and provide the empirical data that support it. We present this 'speed congenic' method in a user-friendly manner to encourage other investigators to pursue this or similar methods of congenic production.	MILLENNIUM PHARMACEUT,CAMBRIDGE,MA 02139; MCLAUGHLIN RES INST,GREAT FALLS,MT 59405	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; McLaughlin Research Institute for Biomedical Sciences, Inc.								GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Green EL., 1966, BIOL LAB MOUSE; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Markel PD, 1997, GENOME RES, V7, P92, DOI 10.1101/gr.7.2.92; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Silver L.M., 1995, MOUSE GENETICS CONCE; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Threadgill DW, 1997, MAMM GENOME, V8, P441, DOI 10.1007/s003359900464; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	15	310	318	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					280	284		10.1038/ng1197-280	http://dx.doi.org/10.1038/ng1197-280			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354790				2022-12-27	WOS:A1997YD66700020
J	David, G; Abbas, N; Stevanin, G; Durr, A; Yvert, G; Cancel, G; Weber, C; Imbert, G; Saudou, F; Antoniou, E; Drabkin, H; Gemmill, R; Giunti, P; Benomar, A; Wood, N; Ruberg, M; Agid, Y; Mandel, JL; Brice, A				David, G; Abbas, N; Stevanin, G; Durr, A; Yvert, G; Cancel, G; Weber, C; Imbert, G; Saudou, F; Antoniou, E; Drabkin, H; Gemmill, R; Giunti, P; Benomar, A; Wood, N; Ruberg, M; Agid, Y; Mandel, JL; Brice, A			Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR-ATAXIA; PALLIDOLUYSIAN ATROPHY DRPLA; MACHADO-JOSEPH DISEASE; PIGMENTARY MACULAR DYSTROPHY; RETINAL DEGENERATION; CHROMOSOME 3P12-P21.1; HUNTINGTONS-DISEASE; SEQUENCES; LOCUS; ANTICIPATION	The gene for spinocerebellar ataxia 7 (SCA7) has been mapped to chromosome 3q12-13. By positional cloning, we have identified a new gene of unknown function containing a CAG repeat that is expanded in SCA7 patients. On mutated alleles, CAG repeat size is highly variable, ranging from 38 to 130 repeats, whereas on normal alleles it ranges from 7 to 17 repeats. Gonadal instability in SCA7 is greater than that observed in any of the seven known neuro-degenerative diseases caused by translated CAG repeat expansions, and is markedly associated with paternal transmissions. SCA7 is the first such disorder in which the degenerative process also affects the retina.	HOP LA PITIE SALPETRIERE, INSERM U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, FEDERAT NEUROL, F-75651 PARIS 13, FRANCE; ULP, INSERM, IGBMC, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE; UNIV COLORADO, HLTH SCI CTR, DENVER, CO 80262 USA; INST NEUROL, LONDON WC1N 3BG, ENGLAND; HOP SPECIAL, SERV NEUROL, RABAT, MOROCCO	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of London; University College London; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat			Brice, Alexis/A-2170-2009; SAUDOU, Frédéric/L-3454-2014; Wood, Nicholas W/C-2505-2009; Stevanin, Giovanni/E-5038-2016; brice, alexis/AAE-8275-2019; Giunti, Paola/E-5526-2012	SAUDOU, Frédéric/0000-0001-6107-1046; Wood, Nicholas W/0000-0002-9500-3348; Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Giunti, Paola/0000-0003-3508-4788; Yvert, Gael/0000-0003-1955-4786; Cancel-Tassin, Geraldine/0000-0002-9583-6382	NHGRI NIH HHS [R01 HG000358] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000358] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; BERCIANO J, 1982, J NEUROL SCI, V53, P253, DOI 10.1016/0022-510X(82)90011-9; CANCEL G, 1995, AM J HUM GENET, V57, P809; Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; David G, 1996, AM J HUM GENET, V59, P1328; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Durr A, 1996, CURR OPIN NEUROL, V9, P290; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IKEUCHI T, 1995, SEMIN CELL BIOL, V6, P37, DOI 10.1016/1043-4682(95)90013-6; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Jobsis GJ, 1997, J NEUROL NEUROSUR PS, V62, P367, DOI 10.1136/jnnp.62.4.367; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krols L, 1997, HUM GENET, V99, P225, DOI 10.1007/s004390050344; LEEFLANG EP, 1995, HUM MOL GENET, V4, P1519; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandel JL, 1997, NATURE, V386, P767, DOI 10.1038/386767a0; Maniatis T, 1989, MOL CLONING; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ruberg M, 1997, J NEUROCHEM, V68, P2098; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Stevanin G, 1996, HUM MOL GENET, V5, P1887, DOI 10.1093/hmg/5.12.1887; Stevanin G, 1997, AM J HUM GENET, V60, P1548; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	44	615	640	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					65	70		10.1038/ng0997-65	http://dx.doi.org/10.1038/ng0997-65			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288099				2022-12-27	WOS:A1997XU72400019
J	Winter, H; Rogers, MA; Langbein, L; Stevens, HP; Leigh, IM; Labreze, C; Roul, S; Taieb, A; Krieg, T; Schweizer, J				Winter, H; Rogers, MA; Langbein, L; Stevens, HP; Leigh, IM; Labreze, C; Roul, S; Taieb, A; Krieg, T; Schweizer, J			Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix	NATURE GENETICS			English	Article							HUMAN TYPE-I; ICHTHYOSIS BULLOSA; INTERMEDIATE FILAMENTS; ROD DOMAIN; GENE; SEQUENCE; SIEMENS; 2E; EXPRESSION; FOLLICLE	Pathogenic mutations in a large number of human epithelial keratins have been well characterized. However, analogous mutations in the hard alpha-keratins of hair and nail have not yet been described. Monilethrix is a rare autosomal dominant hair defect with variable expression. Hairs from affected individuals show a beaded structure of alternating elliptical nodes and constrictions (internodes). These internodes exhibit a high propensity to weathering and fracture. Strong evidence that trichocyte keratin defects might underlie this hair disorder was provided by genetic linkage analyses that mapped this disease to the type-ii keratin gene cluster on 12q13. All affected individuals from a four-generation British family with monilethrix, previously linked to the type-it keratin gene cluster, as well as three unrelated single monilethrix patients, exhibited a heterozygous point mutation in the gene far type-Il hair cortex keratin hHb6, leading to lysine substitution of a highly conserved glutamic acid residue in the helix termination motif (Glu 410 Lys). In a three-generation French family with monilethrix of a milder and variable phenotype, we detected another heterozygous point mutation in the same glutamic acid codon of hHb6, which resulted in a conservative aspartic acid substitution (Glu 410 Asp). These mutations provide the first direct evidence for involvement of hair keratins in hair disease.	GERMAN CANC RES CTR,DIV CELL BIOL,D-69120 HEIDELBERG,GERMANY; ACAD DEPT DERMATOL,LONDON E1 2AT,ENGLAND; ROYAL LONDON SCH MED & DENT,LONDON E1 2AT,ENGLAND; HOP PELLEGRIN ENFANTS,UNITE DERMATOL PEDIAT,F-33076 BORDEAUX,FRANCE; UNIV COLOGNE,DEPT DERMATOL,D-50924 COLOGNE,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); University of London; Queen Mary University London; CHU Bordeaux; University of Cologne	Winter, H (corresponding author), GERMAN CANC RES CTR,DIV TUMOUR CELL REGULAT,NEUENHEIMER FELD 280,D-69120 HEIDELBERG,GERMANY.		Rogers, Michael A./J-9803-2012; TAIEB, ALAIN/AAB-1085-2021	Rogers, Michael A./0000-0002-3728-2107; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DEBERKER DAR, 1993, BRIT J DERMATOL, V128, P327; FINK P, 1995, BBA-GENE STRUCT EXPR, V1264, P12, DOI 10.1016/0167-4781(95)00122-W; GUMMER CI, 1981, BRIT J DERMATOL, V105, P529, DOI 10.1111/j.1365-2133.1981.tb00796.x; HATZFELD M, 1991, J CELL SCI, V99, P351; HEALY E, 1995, HUM MOL GENET, V4, P2399, DOI 10.1093/hmg/4.12.2399; HEID HW, 1986, DIFFERENTIATION, V32, P101, DOI 10.1111/j.1432-0436.1986.tb00562.x; ITO M, 1990, J INVEST DERMATOL, V95, P186, DOI 10.1111/1523-1747.ep12477967; Korge B. P., 1996, Journal of Investigative Dermatology, V106, P843; KREMER H, 1994, J INVEST DERMATOL, V103, P286, DOI 10.1111/1523-1747.ep12394414; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; MCKEE GM, 1961, J CUTAN DIS SYPH, V34, P444; MCKEE GM, 1961, J CUTAN DIS INCL SYP, V34, P506; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1994, J INVEST DERMATOL, V103, P277, DOI 10.1111/1523-1747.ep12394307; POWELL B, 1992, DEVELOPMENT, V114, P417; Richard G, 1996, J INVEST DERMATOL, V107, P812, DOI 10.1111/1523-1747.ep12330568; ROCK B, 1992, TXB DERMATOLOGY, P1353; ROGERS MA, 1995, EXP CELL RES, V220, P357, DOI 10.1006/excr.1995.1326; Rogers MA, 1997, DIFFERENTIATION, V61, P187, DOI 10.1046/j.1432-0436.1997.6130187.x; Rogers MA, 1996, J INVEST DERMATOL, V107, P633, DOI 10.1111/1523-1747.ep12584243; ROGERS MA, 1995, MOL BIOL REP, V20, P155, DOI 10.1007/BF00990548; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; STEINERT PM, 1993, BIOCHEM BIOPH RES CO, V197, P840, DOI 10.1006/bbrc.1993.2555; STEINERT PM, 1995, INTERMEDIATE FILAMEN, P145; Stevens HP, 1996, J INVEST DERMATOL, V106, P795, DOI 10.1111/1523-1747.ep12346400; WINTER H, 1994, EXP CELL RES, V212, P190, DOI 10.1006/excr.1994.1134	26	145	150	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					372	374		10.1038/ng0897-372	http://dx.doi.org/10.1038/ng0897-372			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241275				2022-12-27	WOS:A1997XM90900020
J	Qian, F; Germino, FJ; Cai, YQ; Zhang, XB; Somlo, S; Germino, GG				Qian, F; Germino, FJ; Cai, YQ; Zhang, XB; Somlo, S; Germino, GG			PKD1 interacts with PKD2 through a probable coiled-coil domain	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; PROTEIN; LOCUS	Autosomal dominant polycystic kidney disease (ADPKD) describes a group of at least three genetically distinct disorders with almost identical clinical features(1-6) that collectively affects 1:1,000 of the population(7). Affected individuals typically develop large cystic kidneys and approximately one half develop end-stage renal disease by their seventh decade. It has been suggested that the diseases result from defects in interactive factors involved in a common pathway. The recent discovery of the genes for the two most common forms of ADPKD has provided an opportunity to test this hypothesis(5,6,8-10). We describe a previously unrecognized coiled-coil domain within the C terminus of the PKD1 gene product, polycystin, and demonstrate that it binds specifically to the C terminus of PKD2. Homotypic interactions involving the C terminus of each are also demonstrated. We show that naturally occurring pathogenic mutations of PKD1 and PKD2 disrupt their associations. We have characterized the structural basis of their heterotypic interactions by deletional and site-specific mutagenesis. Our data suggest that PKD1 and PKD2 associate physically in vivo and may be partners of a common signalling cascade involved in tubular morphogenesis.	JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV NEPHROL, BALTIMORE, MD 21205 USA; UNIV MED & DENT NEW JERSEY, DEPT MED, NEW BRUNSWICK, NJ 08901 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MED, BRONX, NY 10461 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOL GENET, DIV NEPHROL, BRONX, NY 10461 USA	Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine				Germino, Gregory/0000-0002-3609-5588				BOGDANOVA N, 1995, HUM GENET, V95, P645; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Essers L, 1996, TRENDS GENET, V12, P449, DOI 10.1016/0168-9525(96)99997-7; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Peral B, 1996, AM J HUM GENET, V58, P86; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; WARD CJ, 1994, CELL, V77, P881	19	530	543	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					179	183		10.1038/ng0697-179	http://dx.doi.org/10.1038/ng0697-179			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171830				2022-12-27	WOS:A1997XB54300019
J	Weil, D; Kussel, P; Blanchard, S; Levy, G; LeviAcobas, F; Drira, M; Ayadi, H; Petit, C				Weil, D; Kussel, P; Blanchard, S; Levy, G; LeviAcobas, F; Drira, M; Ayadi, H; Petit, C			The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene	NATURE GENETICS			English	Article							MUTATION; LOCALIZATION; EXPRESSION; HOMOLOG; PATIENT; PROTEIN; MOTOR; IV	Hereditary non-syndromic profound deafness affects about 1 in 2000 children prior to language acquisition. In 80% of the cases, the mode of transmission is autosomal recessive. The number of genes involved in these recessive forms of isolated deafness (DFNB genes) has been estimated to between 30 and 100. So far, ten DFNB genes have been mapped to human chromosomes, one of which has been isolated(2). By linkage analysis of a single family whose members were affected with profound deafness, some of them presenting with vestibular dysfunction, DFNB2 has been mapped to chromosome 11q13 (ref. 3), The gene responsible for a form of Usher syndrome type I, USH1B, has been assigned to the same chromosomal region(4). Usher syndrome associates profound congenital deafness and vestibular dysfunction with retinitis pigmentosa. In the homologous murine region are located the shaker-1 mutations responsible for deafness and vestibular dysfunction. It has been demonstrated that the murine shaker-1 and human USH1B phenotypes result from mutations in the gene encoding myosin-VIIA(5,6). Based on mapping data as well as on the similarities between the phenotypes of DFNB2-affected patients and shaker-1 mouse mutants, we have proposed that a defective myosin-VIIA may also be responsible for DFNB2 (ref. 1). Sequence analysis of each of the coding exons of the myosin-VIIA gene (MYO7A) was thus undertaken in the DFNB2-affected family. In the last nucleotide of exon 15, a G to A transition was detected, a type of mutation that is known to decrease the efficiency of splicing(7-14). Accordingly, this result shows that different mutations in MYO7A result in either an isolated or a syndromic form of deafness.	INST PASTEUR, CNRS URA 1968, UNITE GENET DEFICITS SENSORIELS, F-75724 PARIS 15, FRANCE; FAC MED, LAB IMMUNOL & BIOL MOL, SFAX 3029, TUNISIA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Sfax				Petit, Christine/0000-0002-9069-002X				ANDREWS LG, 1992, J BIOL CHEM, V267, P7834; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; LIND B, 1993, BLOOD, V82, P2423; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SAHLY I, 1997, IN PRESS ANAT EMBRYO; SATOKATA I, 1995, HUM MOL GENET, V4, P1993, DOI 10.1093/hmg/4.10.1993; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; Tamagawa Y, 1996, HUM MOL GENET, V5, P849, DOI 10.1093/hmg/5.6.849; Vale Ronald D., 1993, P175; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	28	302	316	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1997	16	2					191	193		10.1038/ng0697-191	http://dx.doi.org/10.1038/ng0697-191			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171833				2022-12-27	WOS:A1997XB54300022
J	Harrington, JJ; VanBokkelen, G; Mays, RW; Gustashaw, K; Willard, HF				Harrington, JJ; VanBokkelen, G; Mays, RW; Gustashaw, K; Willard, HF			Formation of de novo centromeres and construction of first-generation human artificial microchromosomes	NATURE GENETICS			English	Article							ALPHA-SATELLITE DNA; YEAST CENTROMERE; CENP-C; DROSOPHILA MINICHROMOSOME; FUNCTIONAL-ANALYSIS; MOLECULAR-CLONING; FISSION YEAST; GENE-TRANSFER; HUMAN-CELLS; CHROMOSOMES	We have combined long synthetic arrays of alpha satellite DNA with telomeric DNA and genomic DNA to generate artificial chromosomes in human HT1080 cells. The resulting linear microchromosomes contain exogenous alpha satellite DNA, are mitotically and cytogenetically stable in the absence of selection for up to six months in culture, bind centromere proteins specific for active centromeres, and are estimated to be 6-10 megabases in size, approximately one-fifth to one-tenth the size of endogenous human chromosomes. We conclude that this strategy results in the formation of de novo centromere activity and that the microchromosomes so generated contain all of the sequence elements required for stable mitotic chromosome segregation and maintenance. This first-generation system for the construction of human artificial chromosomes should be suitable for dissecting the sequence requirements of human centromeres, as well as developing constructs useful for therapeutic applications.	CASE WESTERN RESERVE UNIV,DEPT GENET,SCH MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,SCH MED,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106; ATHERSYS INC,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland					NHGRI NIH HHS [HG00107] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; [Anonymous], 1996, B MED ETHICS; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; BEACH D, 1980, NATURE, V284, P185, DOI 10.1038/284185a0; BLOOM K, 1993, CELL, V73, P621, DOI 10.1016/0092-8674(93)90242-I; BLOOM KS, 1982, CELL, V29, P305, DOI 10.1016/0092-8674(82)90147-7; BROWN KE, 1994, HUM MOL GENET, V3, P1227, DOI 10.1093/hmg/3.8.1227; CLARKE L, 1990, MOL CELL BIOL, V10, P1863, DOI 10.1128/MCB.10.5.1863; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; FEATHERSTONE T, 1993, GENOMICS, V17, P267, DOI 10.1006/geno.1993.1321; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; FRIEDMANN T, 1994, GENE THER, V1, P217; GREIG GM, 1992, GENOMICS, V12, P573, DOI 10.1016/0888-7543(92)90450-7; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; HAHN PJ, 1992, GENET ANAL-BIOMOL E, V9, P17, DOI 10.1016/1050-3862(92)90025-Z; HAHNENBERGER KM, 1989, P NATL ACAD SCI USA, V86, P577, DOI 10.1073/pnas.86.2.577; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HEARD JM, 1987, MOL CELL BIOL, V7, P2425, DOI 10.1128/MCB.7.7.2425; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; HOFER BHOFE, 1987, EUR J BIOCHEM, V67, P307; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; LARIN Z, 1994, HUM MOL GENET, V3, P689, DOI 10.1093/hmg/3.5.689; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; MANN C, 1983, P NATL ACAD SCI-BIOL, V80, P228, DOI 10.1073/pnas.80.1.228; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MCGEADY ML, 1986, DNA-J MOLEC CELL BIO, V5, P289, DOI 10.1089/dna.1986.5.289; McGuigan A, 1996, NUCLEIC ACIDS RES, V24, P2271, DOI 10.1093/nar/24.12.2271; MUNZ PL, 1991, VIROLOGY, V183, P160, DOI 10.1016/0042-6822(91)90129-Y; MURPHY TD, 1995, CELL, V81, P139, DOI 10.1016/0092-8674(95)90378-X; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; NABEL GJ, 1993, P NATL ACAD SCI USA, V90, P11307, DOI 10.1073/pnas.90.23.11307; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; PERALES JC, 1994, EUR J BIOCHEM, V226, P255, DOI 10.1111/j.1432-1033.1994.tb20049.x; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; SADLER JR, 1980, GENE, V8, P279, DOI 10.1016/0378-1119(80)90005-0; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; SALIER JP, 1989, BIOTECHNIQUES, V7, P30; Sambrook J., 1989, MOL CLONING; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STRAUSS M, 1994, GENE THER, V1, P156; Sullivan B. A., 1996, American Journal of Human Genetics, V59, pA14; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; SUN TQ, 1994, NAT GENET, V8, P33, DOI 10.1038/ng0994-33; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Taylor SS, 1996, CHROMOSOMA, V105, P70, DOI 10.1007/BF02509516; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; TYLERSMITH C, 1993, CURR OPIN GENET DEV, V3, P390, DOI 10.1016/0959-437X(93)90110-B; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; WAYE JS, 1986, MOL CELL BIOL, V6, P3156, DOI 10.1128/MCB.6.9.3156; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; Willard HF, 1996, P NATL ACAD SCI USA, V93, P6847, DOI 10.1073/pnas.93.14.6847; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WILSON JH, 1982, MOL CELL BIOL, V2, P1258, DOI 10.1128/MCB.2.10.1258; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	63	532	653	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					345	355		10.1038/ng0497-345	http://dx.doi.org/10.1038/ng0497-345			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090378				2022-12-27	WOS:A1997WQ38900011
J	Li, QY; NewburyEcob, RA; Terrett, JA; Wilson, DI; Curtis, ARJ; Yi, CH; Gebuhr, T; Bullen, PJ; Robson, SC; Strachan, T; Bonnet, D; Lyonnet, S; Young, ID; Raeburn, JA; Buckler, AJ; Law, DJ; Brook, JD				Li, QY; NewburyEcob, RA; Terrett, JA; Wilson, DI; Curtis, ARJ; Yi, CH; Gebuhr, T; Bullen, PJ; Robson, SC; Strachan, T; Bonnet, D; Lyonnet, S; Young, ID; Raeburn, JA; Buckler, AJ; Law, DJ; Brook, JD			Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family	NATURE GENETICS			English	Article							CONSERVED PROTEIN MOTIF; HEART-HAND SYNDROME; MESODERM FORMATION; DROSOPHILA-MELANOGASTER; INSITU HYBRIDIZATION; WAARDENBURG SYNDROME; MOUSE BRACHYURY; OPTOMOTOR-BLIND; GRAM SYNDROME; SYNDROME MAPS	Holt-Gram syndrome is a developmental disorder affecting the heart and upper limb, the gene for which was mapped to chromosome 12 two years ago. We have now identified a gene for this disorder (HOS1). The gene (TBX5) is a member of the Brachyury (T) family corresponding to the mouse Tbx5 gene. We have identified six mutations, three in HOS families and three in sporadic HOS cases. Each of the mutations introduces a premature stop codon in the TBX5 gene product. Tissue in situ hybridization studies on human embryos from days 26 to 52 of gestation reveal expression of TBX5 in heart and limb. consistent with a role in human embryonic development.	UNIV NOTTINGHAM, QUEENS MED CTR, SCH MED, DEPT GENET, NOTTINGHAM NG7 2UH, ENGLAND; UNIV NOTTINGHAM, CITY HOSP, NHS TRUST, CTR GENET MED, NOTTINGHAM NG5 1PB, ENGLAND; ROYAL HOSP SICK CHILDREN, DEPT CLIN GENET, BRISTOL BS2 8JJ, AVON, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT FETAL MED, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; HOP NECKER ENFANTS MALAD, DEPT PEDIAT, INSERM U393, F-75743 PARIS, FRANCE; MASSACHUSETTS GEN HOSP, DEPT NEUROGENET, CHARLESTOWN, MA USA	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Bristol Royal Hospital For Children; Newcastle University - UK; Newcastle University - UK; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital			Lyonnet, Stanislas/H-5483-2017; Wilson, David/A-6264-2010	Lyonnet, Stanislas/0000-0001-5426-9417; Wilson, David/0000-0001-8779-2060; Brook, John David/0000-0002-5946-6740	NHGRI NIH HHS [HG00209] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; Agulnik SI, 1996, GENETICS, V144, P249; ARMOUR JAL, 1994, HUM MOL GENET, V3, P599, DOI 10.1093/hmg/3.4.599; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BAMSHAD M, 1995, HUM MOL GENET, V4, P1973, DOI 10.1093/hmg/4.10.1973; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Bellus GA, 1996, NAT GENET, V14, P174, DOI 10.1038/ng1096-174; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; BONNET D, 1994, NAT GENET, V6, P405, DOI 10.1038/ng0494-405; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Burn J, 1996, CURR OPIN GENET DEV, V6, P322, DOI 10.1016/S0959-437X(96)80009-8; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; DELAFUENTE SR, 1980, HUM GENET, V55, P43; Dixon J, 1996, NAT GENET, V12, P130; DRIESEN MS, 1991, GENOMICS, V11, P1079, DOI 10.1016/0888-7543(91)90035-D; Edwards YH, 1996, GENOME RES, V6, P226, DOI 10.1101/gr.6.3.226; ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; FRIEDMAN WF, 1992, HEART DIS TXB CARDIO, V2, P865; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HOLT M, 1960, BRIT HEART J, V22, P236; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JAMIESON CR, 1994, NAT GENET, V8, P357, DOI 10.1038/ng1294-357; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Larsen WJ, 1993, HUMAN EMBRYOLOGY, P479; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; Li QY, 1996, GENOMICS, V32, P218, DOI 10.1006/geno.1996.0108; LI QY, 1988, CHINESE J PLANT PATH, V18, P225; Lyons GE, 1996, CURR OPIN GENET DEV, V6, P454, DOI 10.1016/S0959-437X(96)80067-0; MOORMAN AFM, 1993, HISTOCHEM J, V25, P251, DOI 10.1007/BF00159117; Morrison K, 1996, HUM MOL GENET, V5, P669, DOI 10.1093/hmg/5.5.669; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Notenboom RGE, 1996, DEVELOPMENT, V122, P321; Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671; PASTERIS NG, 1994, CELL, V79, P669; PFLUGFELDER GO, 1990, GENETICS, V126, P91; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; PFLUGFELDER GO, 1992, P NATL ACAD SCI USA, V89, P1199, DOI 10.1073/pnas.89.4.1199; PYERITZ RE, 1992, HEART DIS TXB CARDIO, V2, P1622; REARDON W, 1994, NAT GENET, V8, P95; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SILENGO MC, 1990, CLIN GENET, V38, P105; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SOOTHILL PW, 1994, LANCET, V343, P1096, DOI 10.1016/S0140-6736(94)90205-4; STOTTLER CJ, 1995, AM J HUM GENET SA56, V57; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; SWAROOP A, 1993, CYTOGENET CELL GENET, V64, P292, DOI 10.1159/000133595; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TEMTAMY S, 1978, BIRTH DEFECTS, V14, P241; TERRETT JA, 1994, NAT GENET, V6, P401, DOI 10.1038/ng0494-401; TERRETT JA, 1995, AM J HUM GENET, V59, P1337; THIERFELDER L, 1995, CURRENT PROTOCOLS HU, V2; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; VERMA RS, 1989, HUMAN CHROMOSOMES MA; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WARREN W, 1995, CURRENT PROTOCOLS HU, V2; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WILLISON K, 1990, TRENDS GENET, V6, P104, DOI 10.1016/0168-9525(90)90106-G; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707	86	674	691	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1997	15	1					21	29						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988164				2022-12-27	WOS:A1997WA37300016
J	Sanpei, K; Takano, H; Igarashi, S; Sato, T; Oyake, M; Sasaki, H; Wakisaka, A; Tashiro, K; Ishida, Y; Ikeuchi, T; Koide, R; Saito, M; Sato, A; Tanaka, T; Hanyu, S; Takiyama, Y; Nishizawa, M; Shimizu, N; Nomura, Y; Segawa, M; Iwabuchi, K; Eguchi, I; Tanaka, H; Takahashi, H; Tsuji, S				Sanpei, K; Takano, H; Igarashi, S; Sato, T; Oyake, M; Sasaki, H; Wakisaka, A; Tashiro, K; Ishida, Y; Ikeuchi, T; Koide, R; Saito, M; Sato, A; Tanaka, T; Hanyu, S; Takiyama, Y; Nishizawa, M; Shimizu, N; Nomura, Y; Segawa, M; Iwabuchi, K; Eguchi, I; Tanaka, H; Takahashi, H; Tsuji, S			Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT	NATURE GENETICS			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DOMINANT CEREBELLAR-ATAXIA; CAG REPEAT; DISEASE; DNA; TRINUCLEOTIDE; ANTICIPATION; HYBRIDIZATION; AMPLIFICATION; HETEROGENEITY	Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant, neurodegenerative disorder that affects the cerebellum and other areas of the central nervous system. We have devised a novel strategy, the direct identification of repeat expansion and cloning technique (DIRECT), which allows selective detection of expanded CAG repeats and cloning of the genes involved. By applying DIRECT, we identified an expanded CAG repeat Of the gene for SCA2. CAG repeats of normal alleles range in size from 15 to 24 repeat units, while those of SCA2 chromosomes are expanded to 35 to 59 repeat units. The SCA2 cDNA is predicted to code for 1,313 amino acids - with the CAG repeats coding for a polyglutamine tract. DIRECT is a robust strategy for identification of pathologically expanded trinucleotide repeats and will dramatically accelerate the search for causative genes of neuropsychiatric diseases caused by trinucleotide repeat expansions.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT PATHOL,NIIGATA 951,JAPAN; HOKKAIDO UNIV,SCH MED,DEPT PATHOL 1,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN; NIIGATA UNIV,SCH MED,DEPT PSYCHIAT,NIIGATA 951,JAPAN; JICHI MED SCH,DEPT NEUROL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; TEIKYO UNIV,SCH MED,ICHIHARA HOSP,DEPT NEUROL,ICHIHARA 29901,JAPAN; SEGAWA NEUROL CLIN CHILDREN,CHIYODA KU,TOKYO 101,JAPAN; KANAGAWA REHABIL CTR,DEPT NEUROL & PSYCHIAT,ATSUGI,KANAGAWA 24301,JAPAN	Niigata University; Niigata University; Hokkaido University; Niigata University; Jichi Medical University; Teikyo University				Sato, Toshiya/0000-0001-7844-9930				BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BASSETT AS, 1994, AM J HUM GENET, V54, P864; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; IHARA T, 1994, JPN J HUM GENET, V39, P305, DOI 10.1007/BF01874049; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; ONODERA O, 1995, AM J HUM GENET, V57, P1050; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PULST SM, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8c; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANPEI K, 1995, BIOCHEM BIOPH RES CO, V212, P341, DOI 10.1006/bbrc.1995.1975; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Takano H, 1996, AM J HUM GENET, V58, P1212; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; 1993, CELL, V72, P971	37	624	643	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					277	284		10.1038/ng1196-277	http://dx.doi.org/10.1038/ng1196-277			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896556				2022-12-27	WOS:A1996VQ14600021
J	Burris, J; Cook-Deegan, R; Alberts, B				Burris, J; Cook-Deegan, R; Alberts, B			The Human Genome Project after a decade: policy issues	NATURE GENETICS			English	Editorial Material								The Human Genome Project began a decade ago, its early momentum fueled by two reports. A report from the National Research Council (NRC) in February 1998 endorsed the project and provided the basis for the first joint plan by the National institutes of Health (NIH) and the Department of Energy (DOE). A report from the Office of Technology Assessment (OTA) in April 1988, provided Congress with a means to assess the roles of NIH and DOE. Both reports highlighted the importance of genomics and emphasized the need for a concerted research program. The committees did not predict the large investment of private funds or the extensive patenting of sequences, and they underestimated the rate of progress. Overall, though, the consensus-building provided by the committees helped to set the blueprint for one of the great success stories in modern biology.	Marine Biol Lab, Woods Hole, MA 02543 USA; Natl Acad Sci, Washington, DC 20418 USA	Marine Biological Laboratory - Woods Hole; National Academies of Sciences, Engineering & Medicine	Burris, J (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.			Cook-Deegan, Robert/0000-0002-8251-4237				ALBERTS BM, 1985, CELL, V41, P337, DOI 10.1016/S0092-8674(85)80001-5; BALTIMORE D, 1988, AM ASS ADV SCI ANN M; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; SANGER F, 1988, ANNU REV BIOCHEM, V57, P1, DOI 10.1146/annurev.bi.57.070188.000245; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463	5	10	10	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					333	335		10.1038/3803	http://dx.doi.org/10.1038/3803			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843203				2022-12-27	WOS:000077199600018
J	Vicart, P; Caron, A; Guicheney, P; Li, ZL; Prevost, MC; Faure, A; Chateau, D; Chapon, F; Tome, F; Dupret, JM; Paulin, D; Fardeau, M				Vicart, P; Caron, A; Guicheney, P; Li, ZL; Prevost, MC; Faure, A; Chateau, D; Chapon, F; Tome, F; Dupret, JM; Paulin, D; Fardeau, M			A missense mutation in the alpha B-crystallin chaperone gene causes a desmin-related myopathy	NATURE GENETICS			English	Article							INTERMEDIATE FILAMENTS; ACCUMULATION; PROTEINS; SEQUENCE; TISSUES; STORAGE; ACTIN; LENS	Desmin-related myopathies (DRM) are inherited neuromuscular disorders characterized by adult onset and delayed accumulation of aggregates of desmin, a protein belonging to the type III intermediate filament Family, in the sarcoplasma of skeletal and cardiac muscles(1,2). In this paper, we have mapped the locus for DRM in a large French pedigree to a 26-cM interval in chromosome 11q21-23. This region contains the alpha B-crystallin gene (CRYAB), a candidate gene encoding a 20-kD protein that is abundant in lens and is also present in a number of non-ocular tissues, including cardiac and skeletal muscle(3,4). alpha B-crystallin is a member of the small heat shock protein (shsp) family and possesses molecular chaperone activity(5). We identified an R120G missense mutation in CRYAB that co-segregates with the disease phenotype in this family. Muscle cell lines transfected with the mutant CRYAB cDNA showed intracellular aggregates that contain both desmin and alpha B-crystallin as observed in muscle fibers from DRM patients. These results are the first to identify a defect in a molecular chaperone as a cause for an inherited human muscle disorder.	Inst Pasteur, F-75015 Paris, France; Univ Paris 07, UFR Biochim, F-75005 Paris, France; Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U153, F-75013 Paris, France; Genethon, F-91002 Evry, France; CHU Cote Nacre, Neuropathol Lab, F-14033 Caen, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Vicart, P (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.	pvicart@pasteur.fr	Li, Zhenlin/E-3937-2016; Guicheney, Pascale/D-1034-2017	Guicheney, Pascale/0000-0002-7663-2050; LI, Zhenlin/0000-0002-3706-4505				Baeta AM, 1996, ACTA NEUROPATHOL, V92, P499, DOI 10.1007/s004010050552; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; BERTINI E, 1991, ACTA NEUROPATHOL, V81, P632, DOI 10.1007/BF00296373; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Djabali K, 1997, J CELL SCI, V110, P2759; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; FARDEAU M, 1978, REV NEUROL, V134, P411; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Goebel HH, 1996, NEUROMUSCULAR DISORD, V6, P383, DOI 10.1016/0960-8966(96)85105-4; Graw J, 1997, BIOL CHEM, V378, P1331; Gyapay Gabor, 1996, Methods (Orlando), V9, P91, DOI 10.1006/meth.1996.0012; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOROWITZ SH, 1994, MUSCLE NERVE, V17, P151, DOI 10.1002/mus.880170204; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; JEANPIERRE C, 1993, MAMM GENOME, V4, P104, DOI 10.1007/BF00290434; Kato S, 1997, AM J PATHOL, V151, P611; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Liao JH, 1998, BIOCHEM BIOPH RES CO, V244, P131, DOI 10.1006/bbrc.1998.8226; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Lobrinus JA, 1998, NEUROMUSCULAR DISORD, V8, P77, DOI 10.1016/S0960-8966(98)00005-4; Martin JL, 1997, CIRCULATION, V96, P4343; Neufer PD, 1998, AM J PHYSIOL-CELL PH, V274, pC341, DOI 10.1152/ajpcell.1998.274.2.C341; RAPPAPORT L, 1988, FEBS LETT, V231, P421, DOI 10.1016/0014-5793(88)80863-9; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; van de Klundert FAJM, 1998, EUR J CELL BIOL, V75, P38, DOI 10.1016/S0171-9335(98)80044-7; Vicart P, 1996, HUM GENET, V98, P422, DOI 10.1007/s004390050233; Vignal Alain, 1993, V1, P211	30	878	907	1	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					92	95		10.1038/1765	http://dx.doi.org/10.1038/1765			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731540				2022-12-27	WOS:000075671400028
J	Castellani, LW; Weinreb, A; Bodnar, J; Goto, AM; Doolittle, M; Mehrabian, M; Demant, P; Lusis, AJ				Castellani, LW; Weinreb, A; Bodnar, J; Goto, AM; Doolittle, M; Mehrabian, M; Demant, P; Lusis, AJ			Mapping a gene for combined hyperlipidaemia in a mutant mouse strain	NATURE GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; RECOMBINANT CONGENIC STRAINS; TRAITS	Familiar combined hyperlipidaemia (FCHL) is a common, multifactorial disorder associated with elevated levels of plasma triglyceride, cholesterol, or both(1-3). A characteristic feature is increased secretion of very low density lipoproteins (VLDL) and apolipoprotein B (apoB; refs 3,4). Although FCHL is the most common cause of premature coronary artery disease (CAD), accounting for over 10% of cases, its aetiology remains largely unknown(3-6). One powerful approach to the dissection of complex genetic traits involves the use of animal models' We have identified a mouse strain, HcB-19/Dem (HcB-19), which exhibits hypertriglyceridaemia, hypercholesterolaemia and elevated levels of plasma apoB. Like FCHL patients, HcB-19 mice also exhibit increased secretion of triglyceride-rich lipoproteins, and their hyperlipidaemia becomes progressively more severe with age. It is likely that the hyperlipidaemia results from a mutation of a novel gene that arose during development of strain HcB-19. We mapped the hyperlipidaemia gene (Hyplip1) to the distal portion of mouse chromosome 3. This region is syntenic to human chromosome 1q21-q23, which has recently been shown to harbour a gene associated with FCHL in families from a Finnish isolate (see accompanying manuscript by Pajukanta et al., ref. 8).	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Wadsworth Vet Adm, Los Angeles, CA 90073 USA; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Netherlands Cancer Institute	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	jlusis@medicine.medsch.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042488, P01HL028481, R37HL042488] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42488, HL28481] Funding Source: Medline; NIGMS NIH HHS [GM08243] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; BRUNZELL JD, 1983, J LIPID RES, V24, P147; Collin GB, 1996, MAMM GENOME, V7, P68, DOI 10.1007/s003359900017; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; DOOLITTLE MH, 1987, J LIPID RES, V28, P1326; FALCONER DS, 1991, INTRO QUANTITATIVE G; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; KHAN BV, 1990, BIOCHIM BIOPHYS ACTA, V1044, P297, DOI 10.1016/0005-2760(90)90073-7; Kwiterovich Peter O. Jr., 1993, Current Opinion in Lipidology, V4, P133, DOI 10.1097/00041433-199304000-00009; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; PAJVKANTA P, 1997, ARTERIOSCLER THROMB, V17, P841; Silver L.M., 1995, MOUSE GENETICS CONCE; VALERA A, 1994, J BIOL CHEM, V269, P6267; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; Welch CL, 1996, J LIPID RES, V37, P1406	18	88	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					374	377		10.1038/ng0498-374	http://dx.doi.org/10.1038/ng0498-374			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537422				2022-12-27	WOS:000072755500022
J	Postlethwait, JH; Yan, YL; Gates, MA; Horne, S; Amores, A; Brownlie, A; Donovan, A; Egan, ES; Force, A; Gong, ZY; Goutel, C; Fritz, A; Kelsh, R; Knapik, E; Liao, E; Paw, B; Ransom, D; Singer, A; Thomson, M; Abduljabbar, TS; Yelick, P; Beier, D; Joly, JS; Larhammar, D; Rosa, F; Westerfield, M; Zon, LI; Johnson, SL; Talbot, WS				Postlethwait, JH; Yan, YL; Gates, MA; Horne, S; Amores, A; Brownlie, A; Donovan, A; Egan, ES; Force, A; Gong, ZY; Goutel, C; Fritz, A; Kelsh, R; Knapik, E; Liao, E; Paw, B; Ransom, D; Singer, A; Thomson, M; Abduljabbar, TS; Yelick, P; Beier, D; Joly, JS; Larhammar, D; Rosa, F; Westerfield, M; Zon, LI; Johnson, SL; Talbot, WS			Vertebrate genome evolution and the zebrafish gene map	NATURE GENETICS			English	Article							NEURAL CREST; EXPRESSION; MUTATIONS	In chordate phylogeny, changes in the nervous system. jaws. and appendages transformed meek filter feeders into fearsome predators(1). Gene duplication is thought to promote such innovation(2). Vertebrate ancestors probably had single copies of genes now found in multiple copies in vertebrates(3) and gene maps suggest that this occurred by polyploidization(2-7). It has been suggested that one genome duplication event occurred before, and one after the divergence of ray-finned and lobe-finned fishes(5). Holland et at, however. have argued that because various vertebrates have several HOX clusters. two rounds of duplication occurred before the origin of jawed fishes(3). Such gene-number data. however. do not distinguish between tandem duplications and polyploidization events, nor whether independent duplications occurred in different lineages. To investigate these matters. we mapped 144 zebrafish genes and compared the resulting map with mammalian maps. Comparison revealed large conserved chromosome segments. Because duplicated chromosome segments in zebrafish often correspond with specific chromosome segments in mammals. it is likely that two polyploidization events occurred prior to the divergence of fish and mammal lineages. This zebrafish gene map will facilitate molecular identification of mutated zebrafish genes, which can suggest functions for human genes known only by sequence.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; NYU, Med Ctr, Skirball Inst, Dev Genet Program, New York, NY 10016 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Natl Univ Singapore, Dept Zool, Singapore 117548, Singapore; Ecole Normale Super, F-75231 Paris, France; Univ Bath, Sch Biol & Biochem, Dev Biol Programme, Bath BA2 7AY, Avon, England; Massachusetts Gen Hosp, Charlestown, MA USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Lab Genet Poissons, Jouy En Josas, France; Uppsala Univ, Dept Med Pharmacol, Uppsala, Sweden; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Forsyth Dent Ctr, Dept Cytokine Biol, Boston, MA 02115 USA	University of Oregon; New York University; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; National University of Singapore; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Bath; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Uppsala University; Washington University (WUSTL); Harvard University; Forsyth Institute	Postlethwait, JH (corresponding author), Univ Oregon, Inst Neurosci, 1254, Eugene, OR 97403 USA.	jpostle@oregon.uoregon.edu	Rosa, Frederic/L-5990-2017; Abduljabbar, Tariq/E-6491-2017; Yelick, Pamela/AAP-5826-2020; Kelsh, Robert/B-6445-2008; Yan, Yi/GSO-3046-2022; Knapik, Ela W./J-6172-2014; Gong, Zhiyuan/H-8794-2012	Kelsh, Robert/0000-0002-9381-0066; Knapik, Ela W./0000-0002-2977-3619; Gong, Zhiyuan/0000-0002-9660-5260; Amores, Angel/0000-0002-9307-3609; Liao, Eric/0000-0001-6385-7448; Paw, Barry/0000-0002-0492-1419; Cutts, Alison/0000-0002-4986-573X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012349, R01RR010715] Funding Source: NIH RePORTER; NCRR NIH HHS [R01RR10715, R01RR12349] Funding Source: Medline; NICHD NIH HHS [P01HD22486] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; ALEXANDRE D, 1996, DEVELOPMENT, V122, P7835; Brady KP, 1997, GENOME RES, V7, P1085, DOI 10.1101/gr.7.11.1085; Driever W, 1996, DEVELOPMENT, V123, P37; EKKER M, 1992, DEVELOPMENT, V116, P1001; Elgar G, 1996, TRENDS GENET, V12, P145, DOI 10.1016/0168-9525(96)10018-4; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Haffter P, 1996, DEVELOPMENT, V123, P1; Henion PD, 1996, DEV GENET, V18, P11; HOLLAND PWH, 1994, DEVELOPMENT, P125; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Johnson SL, 1996, GENETICS, V142, P1277; Kasahara M, 1996, P NATL ACAD SCI USA, V93, P9096, DOI 10.1073/pnas.93.17.9096; Katsanis N, 1996, GENOMICS, V35, P101, DOI 10.1006/geno.1996.0328; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; Knapik EW, 1996, DEVELOPMENT, V123, P451; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Meyer A, 1998, NATURE, V391, P225, DOI 10.1038/34530; MOLVEN A, 1992, INT J DEV BIOL, V36, P229; MORIZOT DC, 1990, PROG CLIN BIOL RES, V344, P207; NORTHCUTT RG, 1983, Q REV BIOL, V58, P1, DOI 10.1086/413055; Ohno S., 1970, EVOLUTION GENE DUPLI; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Prince VE, 1998, DEVELOPMENT, V125, P407; RILEY BB, 1995, P NATL ACAD SCI USA, V92, P5997, DOI 10.1073/pnas.92.13.5997; RUDDLE FH, 1994, DEVELOPMENT, P155; Sampath K, 1996, BIOCHEM BIOPH RES CO, V219, P565, DOI 10.1006/bbrc.1996.0274; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	671	693	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					345	349		10.1038/ng0498-345	http://dx.doi.org/10.1038/ng0498-345			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537416				2022-12-27	WOS:000072755500016
J	Rouquier, S; Taviaux, S; Trask, BJ; Brand-Arpon, V; van den Engh, G; Demaille, J; Giorgi, D				Rouquier, S; Taviaux, S; Trask, BJ; Brand-Arpon, V; van den Engh, G; Demaille, J; Giorgi, D			Distribution of olfactory receptor genes in the human genome	NATURE GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN-COUPLED RECEPTORS; ODORANT RECEPTORS; CHROMOSOMES; FAMILY; MAP; HUMAN-CHROMOSOME-17; EXPRESSION; CLUSTER	We demonstrate that members of the olfactory receptor (OR) gene family are distributed on all but a few human chromosomes. Through FISH analysis, we show that OR sequences reside at move than 25 locations in the human genome. Their distribution is biased for terminal bands. Flow-sorted chromosomes were used to isolate 87 OR sequences derived from 16 chromosomes. Their sequence-relationships are indicative of the inter- and intrachromosomal duplications responsible for OR family expansion. The human genome has accumulated a striking number of dysfunctional copies: 72% of the sequences are pseudogenes. ORF-containing sequences predominate on chromosomes 7, 16 and 17.	CNRS, CRBM, F-34293 Montpellier 5, France; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Washington; University of Washington Seattle	Giorgi, D (corresponding author), CNRS, CRBM, ERS 155,1919 Route Mende, F-34293 Montpellier 5, France.	domi@crbm.cnrs-mop.fr						BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BRANDRIFF BF, 1994, GENOMICS, V23, P582, DOI 10.1006/geno.1994.1546; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; FAN WF, 1995, GENOMICS, V27, P119, DOI 10.1006/geno.1995.1013; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; GOOLD RD, 1993, HUM MOL GENET, V2, P1271, DOI 10.1093/hmg/2.8.1271; Gruen JR, 1996, GENOMICS, V36, P70, DOI 10.1006/geno.1996.0427; KORENBERG JR, 1995, GENOMICS, V29, P364, DOI 10.1006/geno.1995.9993; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; LEMIEUX N, 1992, CYTOGENET CELL GENET, V59, P311, DOI 10.1159/000133277; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; MARCHESE A, 1994, GENOMICS, V23, P609, DOI 10.1006/geno.1994.1549; Mefford H, 1997, HUM GENET, V100, P138, DOI 10.1007/s004390050479; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Ressler Kerry J., 1994, Current Opinion in Neurobiology, V4, P588, DOI 10.1016/0959-4388(94)90061-2; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; ROUQUIER S, 1995, NUCLEIC ACIDS RES, V23, P4415, DOI 10.1093/nar/23.21.4415; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SCHURMANS S, 1993, CYTOGENET CELL GENET, V63, P200, DOI 10.1159/000133534; SELBIE LA, 1992, MOL BRAIN RES, V13, P159, DOI 10.1016/0169-328X(92)90057-I; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; TRASK B, 1998, HUM MOL GENET; TRASK BJ, 1991, SOMAT CELL MOLEC GEN, V17, P117, DOI 10.1007/BF01232970; Van Rhee A M, 1995, Drug Des Discov, V13, P133	35	173	196	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					243	250		10.1038/ng0398-243	http://dx.doi.org/10.1038/ng0398-243			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500546				2022-12-27	WOS:000072325000022
J	Pingault, V; Bondurand, N; Kuhlbrodt, K; Goerich, DE; Prehu, MO; Puliti, A; Herbarth, B; Hermans-Borgmeyer, I; Legius, E; Matthijs, G; Amiel, J; Lyonnet, S; Ceccherini, I; Romeo, G; Smith, JC; Read, AP; Wegner, M; Goossens, M				Pingault, V; Bondurand, N; Kuhlbrodt, K; Goerich, DE; Prehu, MO; Puliti, A; Herbarth, B; Hermans-Borgmeyer, I; Legius, E; Matthijs, G; Amiel, J; Lyonnet, S; Ceccherini, I; Romeo, G; Smith, JC; Read, AP; Wegner, M; Goossens, M			SOX10 mutations in patients with Waardenburg-Hirschsprung disease	NATURE GENETICS			English	Article							ENDOTHELIN-B RECEPTOR; PAIRED DOMAIN; HMG BOX; GENE; MEGACOLON; MICE; MELANOCYTES; ASSOCIATION; TYPE-2; MOUSE	Waardenburg syndrome (WS; deafness with pigmentary abnormalities) and Hirschsprung's disease (HSCR; aganglionic megacolon) are congenital disorders caused by defective function of the embryonic neural crest(1,2). WS and HSCR are associated in patients with Waardenburg-Shah syndrome (WS4), whose symptoms are reminiscent of the white coat-spotting and aganglionic megacolon displayed by the mouse mutants Dom (Dominant megacolon), piebald-lethal(s(l)) and lethal spotting (Is). The s(l) and Is phenotypes are caused by mutations in the genes encoding the Endothelin-B receptor (Ednrb) and Endothelin 3 (Edn3), respectively(3,4). The identification of Sox10 as the gene mutated in Dom mice (B.H. et al., manuscript submitted) prompted us to analyse the role of its human homologue SOx10 in neural crest defects. Here we show that patients from four families with WS4 have mutations in SOx10, whereas no mutation could be detected in patients with HSCR alone. These mutations are likely to result in haploinsufficiency of the SOx10 product. Our findings further define the locus heterogeneity of Waardenburg-Hirschsprung syndromes. and point to an essential role of SOx10 in the development of two neural crest-derived human cell lineages.	Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Hop Necker Enfants Malad, INSERM, U393, F-75743 Paris, France; Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Hamburg; University Medical Center Hamburg-Eppendorf; Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Manchester	Goossens, M (corresponding author), Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France.	goossens@im3.inserm.fr	Puliti, Aldamaria/K-7866-2016; Bondurand, Nadege/H-4737-2017; Ceccherini, Isabella/P-8195-2014; amiel, jeanne/AGX-1124-2022; Lyonnet, Stanislas/H-5483-2017; Puliti, Aldamaria/AAF-5400-2021; Legius, Eric/H-1735-2011; amiel, jeanne/H-3501-2017	Puliti, Aldamaria/0000-0001-9310-6514; Bondurand, Nadege/0000-0002-1531-1544; Ceccherini, Isabella/0000-0001-8732-1955; Lyonnet, Stanislas/0000-0001-5426-9417; amiel, jeanne/0000-0001-5973-4728; Matthijs, Gert/0000-0001-6710-1912; Pingault, Veronique/0000-0001-7064-0765; Wegner, Michael/0000-0002-4586-3294				AMBANI LM, 1983, J PEDIATR-US, V102, P802, DOI 10.1016/S0022-3476(83)80267-4; BADNER JA, 1990, AM J HUM GENET, V46, P568; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Chakravarti A, 1996, HUM MOL GENET, V5, P303; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; FRIED K, 1980, CLIN GENET, V18, P91; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; HOTH CF, 1993, AM J HUM GENET, V52, P455; Kapur RP, 1996, DEV BIOL, V174, P360, DOI 10.1006/dbio.1996.0080; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; MEIRE F, 1987, AM J MED GENET, V27, P683, DOI 10.1002/ajmg.1320270322; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; PAVAN WJ, 1995, GENOME RES, V5, P29, DOI 10.1101/gr.5.1.29; Pringault V, 1997, GENOMICS, V39, P86, DOI 10.1006/geno.1996.4476; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Puliti A, 1996, NEUROREPORT, V7, P489, DOI 10.1097/00001756-199601310-00027; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STEEL KP, 1989, DEVELOPMENT, V107, P453; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; vanHoute LPA, 1995, J BIOL CHEM, V270, P30516, DOI 10.1074/jbc.270.51.30516; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4	31	617	638	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					171	173		10.1038/ng0298-171	http://dx.doi.org/10.1038/ng0298-171			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462749				2022-12-27	WOS:000071779500028
J	Gu, SM; Thompson, DA; Srikumari, CRS; Lorenz, B; Finckh, U; Nicoletti, A; Murthy, KR; Rathmann, M; Kumaramanickavel, G; Denton, MJ; Gal, A				Gu, SM; Thompson, DA; Srikumari, CRS; Lorenz, B; Finckh, U; Nicoletti, A; Murthy, KR; Rathmann, M; Kumaramanickavel, G; Denton, MJ; Gal, A			Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy	NATURE GENETICS			English	Article							EPITHELIAL MEMBRANE-RECEPTOR; RNA SPLICE JUNCTIONS; PIGMENT-EPITHELIUM; BINDING PROTEIN; MICROSOMAL PROTEIN; GENE-MUTATIONS; EXPRESSION; CLONING	Autosomal recessive childhood-onset severe retinal dystrophy (arCSRD) designates a heterogeneous group of disorders affecting rod and cone photoreceptors simultaneously(1). The most severe cases are termed Leber congenital amaurosis (LCA), while the less aggressive forms are usually considered juvenile retinitis pigmentosa. Recently, mutations in the retinal-specific guanylate cyclase gene were found in patients with LCA(2). Disease genes implicated in other forms of arCSRD are expected to encode proteins present in the neuroretina or in the retinal pigment epithelium (RPE). The RPE, a monolayer of cells separating the vascular-rich choroid and the neuroretina, is in intimate contact with the outer segments of rods and cones via the microvilli surrounding the photoreceptors. The RPE expresses a tissue-specific and evolutionarily highly conserved 61 kD protein (RPE65) present at high levels in vivo(3-6). Although the function of RPE65 is not yet known, an important role in the RPE/photoreceptor vitamin-A cycle is suggested by the fact that RPE65 associates both with serum retino(-binding protein(7,8) and with the RPE-specific 11-cis retinol dehydrogenase, an enzyme active in the synthesis of the visual pigment chromophore 11-cis retinal(9). Here we report that the analysis of RPE65 in a collection of about 100 unselected retinal-dystrophy patients of different ethnic origin revealed five that are likely to be pathogenic mutations, including a missense mutation (Pro363Thr), two point mutations affecting splicing (912+1G-->T and 65+5G-->A) and two small re-arrangements (ins144T and 831del8) on a total of nine alleles of five patients with arCSRD. In contrast to other genes whose defects have been implicated in degenerative retinopathies, RPE65 is the first disease gene in this group of inherited disorders that is expressed exclusively in the RPE, and may play a role in vitamin-A metabolism of the retina.	UNIV HAMBURG,KRANKENHAUS EPPENDORF,INST HUMANGENET,D-22529 HAMBURG,GERMANY; UNIV MICHIGAN,SCH MED,DEPT OPHTHALMOL,ANN ARBOR,MI 48105; UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48105; UNIV POSTGRAD INST BASIC MED SCI,DEPT GENET,CHENNAI,INDIA; UNIV REGENSBURG,KLIN AUGENHEILKUNDE,ABT PADIAT OPHTHALMOL STRABISMOL & OPHTHALMOGENET,D-93042 REGENSBURG,GERMANY; PRABA EYE CLIN & RES CTR,BANGALORE 560070,KARNATAKA,INDIA; MED RES FDN,SANKARA NETHRALAYA,CHENNAI,INDIA; UNIV OTAGO,DEPT BIOCHEM,DUNEDIN,NEW ZEALAND	University of Hamburg; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Regensburg; University of Otago			KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021	KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301; Thompson, Debra/0000-0003-3485-0794	NEI NIH HHS [EY09193] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009193] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAVIK CO, 1991, J BIOL CHEM, V266, P14978; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; BUNGE S, 1996, METH MOL G, V8, P26; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL CP, 1994, GENOMICS, V20, P509, DOI 10.1006/geno.1994.1212; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Heckenlively J., 1988, RETINITIS PIGMENTOSA, P107; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEUTELT J, 1995, CLIN GENET, V47, P122; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422	16	504	519	1	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					194	197		10.1038/ng1097-194	http://dx.doi.org/10.1038/ng1097-194			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326941				2022-12-27	WOS:A1997XZ55500027
J	Iida, S; Rao, PH; Butler, M; Corradini, P; Boccadoro, M; Klein, B; Chaganti, RSK; DallaFavera, R				Iida, S; Rao, PH; Butler, M; Corradini, P; Boccadoro, M; Klein, B; Chaganti, RSK; DallaFavera, R			Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma	NATURE GENETICS			English	Article							INTERFERON REGULATORY FACTOR; STIMULATED RESPONSE ELEMENT; PLASMA-CELL LEUKEMIA; FACTOR FAMILY; TRANSCRIPTION FACTOR; C-MYC; LINES; GENE; MEMBER; REARRANGEMENTS	The pathogenesis of multiple myeloma (MM), an incurable tumour causing the deregulated proliferation of terminally differentiated B cells, is unknown(1). Chromosomal translocations (14q1) affecting band 14q32 and unidentified partner chromosomes are common in this tumour, suggesting that they may cause the activation of novel oncogenes(2,3). By cloning the chromosomal breakpoints in an MM cell line, we show that the 14q+ translocation represents a t(6;14)(p25;q32) and that this aberration is recurrent in MM, as it was found in two of eleven MM cell lines, The translocation juxtaposes the immunoglobulin heavy-chain (IgH) locus to MUM1 (multiple myeloma oncogene 1)/IRF4 gene, a member of the interferon regulatory factor (IRF) family known to be active in the control of B-cell proliferation and differentiation, As a result, the MUM1/IRF4 gene is overexpressed-an event that may contribute to tumorigenesis, as MUM1/IRF4 has oncogenic activity in vitro. These findings identify a novel genetic alteration associated with MM, with implications for the pathogenesis and diagnostics of this tumour.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, DIV ONCOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, DIV ONCOL, NEW YORK, NY 10032 USA; MEM SLOAN KETTERING CANC CTR, CELL BIOL PROGRAM, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT HUMAN GENET, NEW YORK, NY 10021 USA; UNIV TURIN, DEPT MED & ONCOL, TURIN, ITALY; UNIV MONTPELLIER, INST MOL GENET, F-34059 MONTPELLIER, FRANCE	Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Turin; Universite de Montpellier			Corradini, Paolo/N-7584-2017	Corradini, Paolo/0000-0002-9186-1353; Boccadoro, Mario/0000-0001-8130-5209	NATIONAL CANCER INSTITUTE [R01CA044029, R01CA034775] Funding Source: NIH RePORTER; NCI NIH HHS [CA-44029, CA-34775] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Barlogie B, 1997, SEMIN HEMATOL, V34, P67; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Calasanz MJ, 1997, GENE CHROMOSOME CANC, V18, P84, DOI 10.1002/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.3.CO;2-9; Chesi M, 1996, BLOOD, V88, P674, DOI 10.1182/blood.V88.2.674.bloodjournal882674; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DEWALD GW, 1985, BLOOD, V66, P380; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; ETON O, 1989, LEUKEMIA, V3, P729; GAIDANO G, 1997, PRINCIPLES PRACTICE, P2131; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Iida S, 1996, BLOOD, V88, P1787; JERNBERG H, 1987, INT J CANCER, V40, P811, DOI 10.1002/ijc.2910400618; KLEIN B, 1989, BLOOD, V73, P517; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; NERI A, 1989, J EXP MED, V170, P1715, DOI 10.1084/jem.170.5.1715; NERI A, 1993, BLOOD, V81, P128; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TANIWAKI M, 1994, BLOOD, V84, P2283, DOI 10.1182/blood.V84.7.2283.bloodjournal8472283; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; ZHANG XG, 1994, BLOOD, V83, P3654	30	236	244	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1997	17	2					226	230		10.1038/ng1097-226	http://dx.doi.org/10.1038/ng1097-226			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326949	Green Accepted			2022-12-27	WOS:A1997XZ55500035
J	Irvine, AD; Corden, LD; Swensson, O; Swensson, B; Moore, JE; Frazer, DG; Smith, FJD; Knowlton, RG; Christophers, E; Rochels, R; Uitto, J; McLean, WHI				Irvine, AD; Corden, LD; Swensson, O; Swensson, B; Moore, JE; Frazer, DG; Smith, FJD; Knowlton, RG; Christophers, E; Rochels, R; Uitto, J; McLean, WHI			Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy	NATURE GENETICS			English	Article							EXPRESSION; DISEASE; DIFFERENTIATION; LINKAGE; CELLS	The intermediate filament cytoskeleton of corneal epithelial cells is composed of cornea-specific keratins K3 and K12 (refs 1,2). Meesmann's corneal dystrophy (MCD) is an autosomal dominant disorder causing fragility of the anterior corneal epithelium(3,4), where K3 and K12 are specifically expressed(5). We postulated that dominant-negative mutations in these keratins might be the cause of MCD. K3 was mapped to the type-II keratin gene cluster on 12q; and K12 to the type-I keratin cluster on 17q using radiation hybrids. We obtained linkage to the K12 locus in Meesmann's original German kindred (Z(max) = 7.53; theta = 0) and we also showed that the phenotype segregated with either the K12 or the K3 locus in two Northern Irish pedigrees. Heterozygous missense mutations in K3 (E509K) and in K12 (V143L; R135T) completely co-segregated with MCD in the families and were not found in 100 normal unrelated chromosomes. All mutations occur in the highly conserved keratin helix boundary motifs, where dominant mutations in other keratins have been found to severely compromise cytoskeletal function, leading to keratinocyte fragility phenotypes. Our results demonstrate for the first time the molecular basis of Meesmann's corneal dystrophy.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL & CUTANEOUS BIOL,EPITHELIAL GENET GRP,PHILADELPHIA,PA 19107; BELFAST CITY HOSP,DEPT DERMATOL,BELFAST BT9 7AB,ANTRIM,NORTH IRELAND; UNIV DUNDEE,INST MED SCI,DEPT PHYSIOL & ANAT,CANC RES CAMPAIGN LABS,CRC,CELL STRUCT RES GRP,DUNDEE DD1 4HN,SCOTLAND; CHRISTIAN ALBRECHTS UNIV KIEL,DEPT OPHTHALMOL,D-24105 KIEL,GERMANY; ROYAL GRP HOSP,DEPT OPHTHALMOL,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MOL PHARMACOL & BIOCHEM,PHILADELPHIA,PA 19107	Jefferson University; Belfast City Hospital; University of Dundee; University of Kiel; Jefferson University			Irvine, Alan D/A-3982-2008; McLean, William HI/C-6352-2009	Irvine, Alan D/0000-0002-9048-2044; McLean, William Henry Irwin/0000-0001-5539-5757	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CHALOINDUFAU C, 1990, CELL DIFFER DEV, V32, P97, DOI 10.1016/0922-3371(90)90103-4; Christiano A M, 1996, Exp Dermatol, V5, P1, DOI 10.1111/j.1600-0625.1996.tb00086.x; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; FINE BS, 1977, AM J OPHTHALMOL, V83, P633, DOI 10.1016/0002-9394(77)90128-3; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; ISHIDAYAMAMOTO A, 1991, J INVEST DERMATOL, V97, P959, DOI 10.1111/1523-1747.ep12491885; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; KAO WWY, 1994, J BIOL CHEM, V269, P24627; KLINGE EM, 1987, J MOL EVOL, V24, P319, DOI 10.1007/BF02134130; Lane E. Birgitte, 1993, P237; LEVY E, 1991, NEW ENGL J MED, V325, P1780; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; MCKUSICK VA, 1997, OMIM ON LINE MENDELI; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Meesmann A, 1939, KLIN MONATSBL AUGENH, V103, P361; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800; QUINLAN RA, 1994, INTERMEDIATE FILAMEN; RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shearman AM, 1996, HUM MOL GENET, V5, P1667, DOI 10.1093/hmg/5.10.1667; SKRETTING G, 1992, BIOCHEM BIOPH RES CO, V182, P583, DOI 10.1016/0006-291X(92)91772-I; Small KW, 1996, AM J OPHTHALMOL, V121, P384, DOI 10.1016/S0002-9394(14)70434-9; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47; SUN TT, 1984, TRANSFORMED PHENOTYP, P169; TOMA NMG, 1995, HUM MOL GENET, V4, P2395, DOI 10.1093/hmg/4.12.2395; TREMBLAY M, 1982, CAN J OPHTHALMOL, V17, P24; Vance JM, 1996, AM J HUM GENET, V58, P757	30	173	182	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					184	187		10.1038/ng0697-184	http://dx.doi.org/10.1038/ng0697-184			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171831				2022-12-27	WOS:A1997XB54300020
J	Tomizuka, K; Yoshida, H; Uejima, H; Kugoh, H; Sato, K; Ohguma, A; Hayasaka, M; Hanaoka, K; Oshimura, M; Ishida, I				Tomizuka, K; Yoshida, H; Uejima, H; Kugoh, H; Sato, K; Ohguma, A; Hayasaka, M; Hanaoka, K; Oshimura, M; Ishida, I			Functional expression and germline transmission of a human chromosome fragment in chimaeric mice	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOME; DEVELOPMENTAL REGULATION; MONOCLONAL-ANTIBODIES; LINE TRANSMISSION; STEM-CELLS; GENE; MOUSE; SEQUENCE; CHAIN; CLONES	Human chromosomes or chromosome fragments derived from normal fibroblasts were introduced into mouse embryonic stem (ES) cells via microcell-mediated chromosome transfer (MMCT) and viable chimaeric mice were produced from them. Transferred chromosomes were stably retained, and human genes, including immunoglobulin (Ig) kappa, heavy, lambda genes, were expressed in proper tissue-specific manner in adult chimaeric tissues. In the case of a human chromosome (hChr.) 2-derived fragment, it was found to be transmitted to the offspring through the germline. Our study demonstrates that MMCT allows for introduction of very large amounts of foreign genetic material into mice. This novel procedure will facilitate the functional analyses of human genomes in vivo.	KIRIN BREWERY CO LTD,CENT LABS KEY TECHNOL,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN; TOTTORI UNIV,FAC MED,SCH LIFE SCI,DEPT MOL & CELL GENET,YONAGO,TOTTORI 683,JAPAN; KITASATO UNIV,SCH SCI,DEPT BIOSCI,MOL EMBRYOL LAB,SAGAMIHARA,KANAGAWA 228,JAPAN	Kirin Brewery Company Limited; Tottori University; Kitasato University								BENHAM FJ, 1983, EMBO J, V2, P1963, DOI 10.1002/j.1460-2075.1983.tb01685.x; BERCHTOLD MW, 1985, P NATL ACAD SCI USA, V82, P1414, DOI 10.1073/pnas.82.5.1414; Brown W, 1996, CURR OPIN GENET DEV, V6, P281, DOI 10.1016/S0959-437X(96)80003-7; COOK GP, 1994, NAT GENET, V7, P162, DOI 10.1038/ng0694-162; DEVLIN BH, 1989, J BIOL CHEM, V264, P13896; DEWEY MJ, 1977, P NATL ACAD SCI USA, V74, P5564, DOI 10.1073/pnas.74.12.5564; Dieken ES, 1996, NAT GENET, V12, P174, DOI 10.1038/ng0296-174; DORIN JR, 1992, HUM MOL GENET, V1, P53, DOI 10.1093/hmg/1.1.53; EPSTEIN CJ, 1982, P NATL ACAD SCI-BIOL, V79, P4376, DOI 10.1073/pnas.79.14.4376; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; FOURNIER REK, 1977, P NATL ACAD SCI USA, V74, P319, DOI 10.1073/pnas.74.1.319; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; GROPP A, 1983, J EXP ZOOL, V228, P253, DOI 10.1002/jez.1402280210; HANAOKA K, 1986, DEV GROWTH DIFFER, V28, P223; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HATTORI M, 1985, NUCLEIC ACIDS RES, V13, P7813, DOI 10.1093/nar/13.21.7813; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; HUNT P, 1995, HUM MOL GENET, V4, P2007, DOI 10.1093/hmg/4.11.2007; ILLMENSEE K, 1979, P NATL ACAD SCI USA, V76, P879, DOI 10.1073/pnas.76.2.879; ILLMENSEE K, 1978, P NATL ACAD SCI USA, V75, P1914, DOI 10.1073/pnas.75.4.1914; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; JONSSON JJ, 1991, NUCLEIC ACIDS RES, V19, P5015, DOI 10.1093/nar/19.18.5015; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; KLEIN R, 1993, EUR J IMMUNOL, V23, P3248, DOI 10.1002/eji.1830231231; KOI M, 1989, JPN J CANCER RES, V80, P413, DOI 10.1111/j.1349-7006.1989.tb02329.x; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; LOWE JB, 1985, J BIOL CHEM, V260, P3413; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146; PRITCHARD C, 1986, EMBO J, V5, P979, DOI 10.1002/j.1460-2075.1986.tb04312.x; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SIMINOVITCH KA, 1985, NATURE, V316, P260, DOI 10.1038/316260a0; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; TOMATSU S, 1989, GENE, V80, P353; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; Uchida Masaki, 1995, Animal Science and Technology, V66, P361; WAGNER SD, 1994, EUR J IMMUNOL, V24, P2672, DOI 10.1002/eji.1830241116; WATANABE S, 1995, BIOCHEM BIOPH RES CO, V213, P130, DOI 10.1006/bbrc.1995.2107; WILLIAMS SC, 1993, EUR J IMMUNOL, V23, P1456, DOI 10.1002/eji.1830230709; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; YAMAUCHITAKIHARA K, 1989, P NATL ACAD SCI USA, V86, P3504, DOI 10.1073/pnas.86.10.3504; [No title captured]	48	208	284	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					133	143		10.1038/ng0697-133	http://dx.doi.org/10.1038/ng0697-133			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171824				2022-12-27	WOS:A1997XB54300013
J	Kas, K; Voz, ML; Roijer, E; Astrom, AK; Meyen, E; Stenman, G; VandeVen, WJM				Kas, K; Voz, ML; Roijer, E; Astrom, AK; Meyen, E; Stenman, G; VandeVen, WJM			Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ENCODING GENE; FUSION; TUMOR; LYMPHOMA; LIBRARY; LAZ3	Pleiomorphic adenoma of the salivary glands is a benign epithelial tumour occurring primarily in the major and minor salivary glands(1). It is by far the most common type of salivary gland tumour. Microscopically, pleiomorphic adenomas show a marked histological diversity with epithelial, myoepithelial and mesenchymal components in a variety of patterns. In addition to a cytogenetic subgroup with normal karyotypes, pleiomorphic adenomas are characterized by recurrent chromosome rearrangements, particularly reciprocal translocations, with breakpoints at 8q12, 3p21, and 12q13-15, in that order of frequency(2,3). The most common abnormality is a reciprocal t(3;8)(p21;q12). We here demonstrate that the t(3;8)(p21;q12) results in promoter swapping between PLAG1, a novel, developmentally regulated zinc finger gene at 8q12, and the constitutively expressed gene for beta-catenin (CTNNB1), a protein interface functioning in the WG/WNT signalling pathway and specification of cell fate during embryogenesis(4). Fusions occur in the 5'-non-coding regions of both genes, exchanging regulatory control elements while preserving the coding sequences. Due to the t(3;8)(p21;q12), PLAG1 is activated and expression levels of CTNNB1 are reduced. Activation of PLAG1 was also observed in an adenoma with a variant translocation t(8;15)(q12;q14). Our results indicate that PLAG1 activation due to promoter swapping is a crucial event in salivary gland tumourigenesis.	CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOL ONCOL LAB,B-3000 LOUVAIN,BELGIUM; FLANDERS INTERUNIV INST BIOTECHNOL,B-3000 LOUVAIN,BELGIUM; GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT PATHOL,CANC GENET LAB,S-41345 GOTHENBURG,SWEDEN	KU Leuven; Sahlgrenska University Hospital; University of Gothenburg								ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTSCHUL SF, 1990, J MOL BIOL, V17, P166; APLAN PD, 1992, BLOOD, V79, P1327; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BULLERDIEK J, 1993, CANCER GENET CYTOGEN, V65, P27, DOI 10.1016/0165-4608(93)90054-P; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; DALLERY E, 1995, ONCOGENE, V10, P2171; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Galieque-Zouitina S, 1996, LEUKEMIA, V10, P579; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KRAUS C, 1994, GENOMICS, V23, P272, DOI 10.1006/geno.1994.1493; LADANYI M, 1994, CANCER RES, V54, P2837; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nollet F, 1996, GENOMICS, V32, P413, DOI 10.1006/geno.1996.0136; ROIJER E, IN PRESS GENES CHROM; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J., 2002, MOL CLONING LAB MANU; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SCHOENMAKERS EFPM, 1994, GENOMICS, V20, P210, DOI 10.1006/geno.1994.1155; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Waldron CA., 1991, SURG PATHOLOGY SALIV, P165; WOOD S, 1992, CYTOGENET CELL GENET, V59, P243, DOI 10.1159/000133260; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; [No title captured]	28	264	273	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					170	174		10.1038/ng0297-170	http://dx.doi.org/10.1038/ng0297-170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020842				2022-12-27	WOS:A1997WF08700016
J	Matthews, D; Fry, L; Powles, A; Weber, J; McCarthy, M; Fisher, E; Davies, K; Williamson, R				Matthews, D; Fry, L; Powles, A; Weber, J; McCarthy, M; Fisher, E; Davies, K; Williamson, R			Evidence that a locus for familial psoriasis maps to chromosome 4q	NATURE GENETICS			English	Letter							SUSCEPTIBILITY; POLYMORPHISMS; GENETICS; 17Q; DNA		ST MARYS HOSP,DEPT DERMATOL,LONDON W2 1NY,ENGLAND; MARSHFIELDS MED RES FDN,MARSHFIELDS,WI 54449; UNIV OXFORD,DEPT BIOCHEM,OXFORD OX1 3QV,ENGLAND; ROYAL CHILDRENS HOSP,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA	Imperial College London; University of Oxford; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Matthews, D (corresponding author), ST MARYS HOSP,UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,SCH MED,DEPT BIOCHEM & MOL GENET,LONDON W2 1PG,ENGLAND.		Fisher, Elizabeth MC/C-2168-2008; McCarthy, Mark/M-3763-2015	Fisher, Elizabeth MC/0000-0003-2850-9936; McCarthy, Mark/0000-0002-4393-0510				BRANDRUP F, 1982, ACTA DERM-VENEREOL, V62, P229; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; FARBER EM, 1974, ARCH DERMATOL, V109, P207, DOI 10.1001/archderm.109.2.207; FRY L, 1992, ATLAS PSORIASIS; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HELLGREN I, 1967, PREVALENCE SEX AGE O; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HUDSON T, 1995, SCIENCE, V270, P5244; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lomholt G, 1963, PSORIASIS PREVALENCE; MATTHEWS D, 1995, J MED GENET, V32, P546, DOI 10.1136/jmg.32.7.546; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAIR RP, 1995, HUM HERED, V45, P219, DOI 10.1159/000154293; NORLIND R, 1953, ACTA RHEUMATOL SCAND, V1, P135; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; WEBER JL, 1989, AM J HUM GENET, V44, P388	20	170	178	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					231	233		10.1038/ng1096-231	http://dx.doi.org/10.1038/ng1096-231			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841203				2022-12-27	WOS:A1996VL44600037
J	Savukoski, M; Klockars, T; Holmberg, V; Santavuori, P; Lander, ES; Peltonen, L				Savukoski, M; Klockars, T; Holmberg, V; Santavuori, P; Lander, ES; Peltonen, L			CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis	NATURE GENETICS			English	Article							JANSKY-BIELSCHOWSKY DISEASE; THIOESTERASE; ASSIGNMENT	The neuronal ceroid lipofuscinoses (NCLs) represent a group of common recessive inherited neurodegenerative disorders of childhood, with an incidence of 1:12,500 live births(1). They are characterized by accumulation of autofluorescent lipopigments in various tissues. Several forms of NCLs have been identified, based on age at onset, progression of disease, neurophysiological and histopathological findings and separate genetic loci(2-9) All types of NCL cause progressive visual and mental decline, motor disturbance, epilepsy and behavioral changes, and lead to premature death. One of the subtypes, Finnish variant late infantile neuronal ceroid lipofuscinosis (vLINCL; MIM256731) affects children at 4-7 years of age(10,11). The first symptom is motor clumsiness, followed by progressive visual failure, mental and motor deterioration and later by myoclonia and seizures. We have previously reported linkage for vLINCL on chromosome 13 (ref. 5) and constructed a long-range physical map over the region(12). Here, we report the positional cloning of a novel gene, CLN5, underlying this severe neurological disorder. The gene encodes a putative transmembrane protein which shows no homology to previously reported proteins. Sequence analysis of DNA samples from patients with three different haplotypes revealed three mutations; one deletion, one nonsense and one missense mutation, suggesting that mutations in this gene are responsible for vLINCL.	Univ Helsinki, Dept Med Genet, Helsinki 00300, Finland; Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki 00300, Finland; Univ Helsinki, Hosp Children & Adolescents, Dept Neurol, Helsinki 00300, Finland; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Massachusetts Institute of Technology (MIT); Whitehead Institute	Peltonen, L (corresponding author), Univ Helsinki, Dept Med Genet, Mannerheimintie 166, Helsinki 00300, Finland.	Leena.Peltonen@ktl.fi						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; Klockars T, 1996, GENOMICS, V35, P71, DOI 10.1006/geno.1996.0324; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Maniatis T., 1982, MOL CLONING LAB MANU; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; REESE MG, 1996, P PAC S BIOC; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; SANTAVUORI P, 1982, NEUROPEDIATRICS, V13, P135, DOI 10.1055/s-2008-1059612; SANTAVUORI P, 1993, J INHERIT METAB DIS, V16, P230, DOI 10.1007/BF00710251; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; SHARP J, HUM MOL GENET, V6, P591; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; SOLOVYEV VV, 1994, COMPUT APPL BIOSCI, V10, P661; SYVANEN AC, 1993, AM J HUM GENET, V52, P46; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; Varilo T, 1996, AM J HUM GENET, V58, P506; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; [No title captured]	24	211	214	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					286	288		10.1038/975	http://dx.doi.org/10.1038/975			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662406				2022-12-27	WOS:000074565900029
J	McCormick, C; Leduc, Y; Martindale, D; Mattison, K; Esford, LE; Dyer, AP; Tufaro, F				McCormick, C; Leduc, Y; Martindale, D; Mattison, K; Esford, LE; Dyer, AP; Tufaro, F			The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate	NATURE GENETICS			English	Article							HERPES-SIMPLEX VIRUS; HEREDITARY MULTIPLE EXOSTOSES; GLYCOPROTEIN-C; GENE; PROTEOGLYCANS; BIOSYNTHESIS; BINDING; MUTANTS	Hereditary multiple exostoses (HME) is an autosomal dominant disorder characterized by the formation of cartilage-capped tumours (exostoses) that develop from the growth plate of endochondral bone(1). This condition can lead to skeletal abnormalities, short stature and malignant transformation of exostoses to chondrosarcomas(2,3) or osteosarcomas(4,5). Linkage analyses have identified three different genes for HME, EXT1 on 8q24.1, EXT2 on 11p11-13 and EXT3 on 19p (refs 6-9). Most HME cases have been attributed to missense or frameshift mutations in these tumour-supressor genes, whose functions have remained obscure. Here, we show that EXT1 is an ER-resident type II transmembrane glycoprotein whose expression in cells results in the alteration of the synthesis and display of cell surface heparan sulfate glycosaminoglycans (GAGs). Two EXT1 variants containing aetiologic missense mutations(10) failed to alter cell-surface glycosaminoglycans, despite retaining their ER-localization.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Tufaro, F (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	tufaro@unixg.ubc.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722				AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; COOK A, 1993, AM J HUM GENET, V53, P71; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Hecht JT, 1997, AM J HUM GENET, V60, P80; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; Schamhart DHJ, 1997, UROL RES, V25, pS89, DOI 10.1007/BF00941994; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tuszynski GP, 1997, ACTA HAEMATOL-BASEL, V97, P29; Van Hul W, 1998, GENOMICS, V47, P230, DOI 10.1006/geno.1997.5101; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796	30	305	323	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					158	161		10.1038/514	http://dx.doi.org/10.1038/514			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620772				2022-12-27	WOS:000073865100023
J	Hagstrom, SA; North, MA; Nishina, PM; Berson, EL; Dryja, TP				Hagstrom, SA; North, MA; Nishina, PM; Berson, EL; Dryja, TP			Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with Retinitis pigmentosa	NATURE GENETICS			English	Article							ROD PHOSPHODIESTERASE; OCULAR FINDINGS; ALPHA-SUBUNIT; BETA-SUBUNIT; RHODOPSIN; MOUSE; IDENTIFICATION; FAMILY; DNA	A recessive mutation in the tub gene causes obesity, deafness and retinal degeneration in tubby mice(1-4). The tub gene is a member of a family of tubby-like genes (TULPs) that encode proteins of unknown function. Members of this family have been identified in plants, vertebrates and invertebrates(4). The TULP proteins share a conserved carboxy-terminal region of approximately 200 amino-acid residues(5). Here we report the analysis of the human gene TULP?, which is expressed specifically in the retina(5). Upon analysing 162 patients with nonsyndromic recessive retinitis pigmentosa (RP) and 374 simplex cases of RP, we found two who were compound heterozygotes for mutations that cosegregated with disease in the respective families. Three of the mutations are missense changes affecting the conserved C-terminal region; the fourth mutation affects a splice donor site upstream of this region. Our data suggest that mutations in TULP1 are a rare cause of recessive RP and indicate that TULP1 has an essential role in the physiology of photoreceptors.	Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Ocular Mol Genet Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; Sequana Therapeut Inc, La Jolla, CA 92037 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Jackson Laboratory	Dryja, TP (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Ocular Mol Genet Inst, 243 Charles St, Boston, MA 02114 USA.				NEI NIH HHS [EY00169, EY08683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000169, R01EY008683, R37EY000169] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; BAYES M, 1995, HUM MUTAT, V5, P228, DOI 10.1002/humu.1380050307; BERSON EL, 1991, AM J OPHTHALMOL, V111, P614, DOI 10.1016/S0002-9394(14)73708-0; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BERSON EL, 1979, AM J OPHTHALMOL, V87, P460, DOI 10.1016/0002-9394(79)90231-9; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; KNOWLES JA, 1994, HUM MOL GENET, V3, P1401, DOI 10.1093/hmg/3.8.1401; KUMARAMANICKAVEL G, 1994, NAT GENET, V8, P10, DOI 10.1038/ng0994-10; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Sandberg MA, 1996, INVEST OPHTH VIS SCI, V37, P1693; SHUGART YY, 1995, AM J HUM GENET, V57, P499	24	161	163	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					174	176		10.1038/ng0298-174	http://dx.doi.org/10.1038/ng0298-174			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462750				2022-12-27	WOS:000071779500029
J	Lee, SB; Kolquist, KA; Nichols, K; Englert, C; Maheswaran, S; Ladanyi, M; Gerald, WL; Haber, DA				Lee, SB; Kolquist, KA; Nichols, K; Englert, C; Maheswaran, S; Ladanyi, M; Gerald, WL; Haber, DA			The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour	NATURE GENETICS			English	Article							FACTOR-A-CHAIN; GROWTH-FACTOR; WILMS-TUMOR; GENE-PRODUCT; TRANSCRIPTION FACTOR; SUBNUCLEAR LOCALIZATION; SUPPRESSOR WT1; FUSION; BINDING; RECEPTOR	Chromosomal translocations resulting in chimaeric transcription factors underlie specific malignancies, but few authentic target genes regulated by these fusion proteins have been identified. Desmoplastic small round-cell tumour (DSRT) is a multiphenotypic primitive tumour characterized by massive reactive fibrosis surrounding nests of tumour cells(1). The t(11;22)(p13;q12) chromosomal translocation that defines DSRT produces a chimaeric protein containing the potential transactivation domain of the Ewing-sarcoma protein (EWS) fused to zinc fingers 2-4 of the Wilms tumour suppressor and transcriptional repressor WT1 (refs 2,3). By analogy with other EWS fusion products, the EWS-WT1 chimaera may encode a transcriptional activator whose target genes overlap with those repressed by WT1 (ref. 4). To characterize its functional properties, we generated osteosarcoma cell lines with tightly regulated inducible expression of EWS-WT1. Expression of EWS-WT1 induced the expression of endogenous platelet-derived growth factor-A (PDGFA), a potent secreted mitogen and chemoattractant whose promoter contains the many potential WT1-binding sites(5,6). Native PDGFA was not regulated by wild-type WT1, indicating a difference in target gene specificity between this tumour suppressor and its oncogenic derivative. PDGFA was expressed within tumour cells in primary DSRT specimens, but it was absent in Wilms tumours expressing WT1 and Ewing sarcomas with an EWS-Fli translocation. We conclude that the oncogenic fusion of EWS to WT1 in DSRT results in the induction of PDGFA, a potent fibroblast growth factor that contributes to the characteristic reactive fibrosis associated with this unique tumour.	MASSACHUSETTS GEN HOSP,CTR CANC,CHARLESTOWN,MA 02129; HARVARD UNIV,SCH MED,CHARLESTOWN,MA 02129; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021	Harvard University; Massachusetts General Hospital; Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center			Ladanyi, Marc/AAG-8585-2019; Nichols, Kim/AAP-8592-2020	Nichols, Kim/0000-0002-5581-6555; Lee, Sean/0000-0001-6211-3498; Englert, Christoph/0000-0002-5931-3189	NATIONAL CANCER INSTITUTE [T32CA060376, R01CA068273, F32CA071167] Funding Source: NIH RePORTER; NCI NIH HHS [CA 68273, CA60376, CA71167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anan K, 1996, SURGERY, V119, P333, DOI 10.1016/S0039-6060(96)80120-6; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; EMING SA, 1995, J INVEST DERMATOL, V105, P756, DOI 10.1111/1523-1747.ep12325550; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; GERALD WL, 1991, AM J SURG PATHOL, V15, P499, DOI 10.1097/00000478-199106000-00001; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; LADANYI M, 1994, CANCER RES, V54, P2837; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; RABBOTTS TJ, 1994, MATIRE, V372, P143; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; REDDY JC, 1995, J BIOL CHEM, V270, P29976; Rorsman F, 1992, GROWTH FACTORS, V7, DOI 10.3109/08977199209046928; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; TAKIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P1686, DOI 10.1073/pnas.88.5.1686; VIGNAUD JM, 1994, CANCER RES, V54, P5455; WANG ZY, 1993, P NATL ACAD SCI USA, V90, P8896, DOI 10.1073/pnas.90.19.8896; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	31	126	135	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					309	313		10.1038/ng1197-309	http://dx.doi.org/10.1038/ng1197-309			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354795				2022-12-27	WOS:A1997YD66700025
J	Mihalik, SJ; Morrell, JC; Kim, D; Sacksteder, KA; Watkins, PA; Gould, SJ				Mihalik, SJ; Morrell, JC; Kim, D; Sacksteder, KA; Watkins, PA; Gould, SJ			Identification of PAHX, a Refsum disease gene	NATURE GENETICS			English	Article							PEROXISOMAL TARGETING SIGNAL; PROTEIN IMPORT; 3-KETOACYL-COA THIOLASE; BIOGENESIS; OXIDATION; DISORDERS	Refsum disease is an autosomal recessive disorder characterized by retinitis pigmentosa, peripheral polyneuropathy, cerebellar ataxia and increased cerebrospinal fluid protein(1). Biochemically, the disorder is defined by two related properties: pronounced accumulation of phytanic acid and selective loss of the peroxisomal dioxygenase required for alpha-hydroxylation of phytanoyl-CoA(2). Decreased phytanic-acid oxidation is also observed in human cells lacking PEX7, the receptor for the type-2 peroxisomal targetting signal (PTS2; refs 3,4), suggesting that the enzyme defective in Refsum disease is targetted to peroxisomes by a PTS2. We initially identified the human PAHX and mouse Pahx genes as expressed sequence tags (ESTs) capable of encoding PTS2 proteins. Human PAHX is targetted to peroxisomes, requires the PTS2 receptor for peroxisomal localization, interacts with the PTS2 receptor in the yeast two-hybrid assay and has intrinsic phytanoyl-CoA alpha-hydroxylase activity that requires the dioxygenase cofactor iron and cosubstrate 2-oxoglutarate. Radiation hybrid data place PAHX on chromosome 10 between the markers D10S249 and D10S466, a region previously implicated in Refsum disease by homozygosity mapping(5). We find that both Refsum disease patients examined are homozygous for inactivating mutations in PAHX, demonstrating that mutations in PAHX can cause Refsum disease.	JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205	Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University				Watkins, Paul A./0000-0002-3246-1405	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787, R01DK051149] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51149, DK45787] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; deVet ECJM, 1997, J BIOL CHEM, V272, P798, DOI 10.1074/jbc.272.2.798; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jansen GA, 1997, NEW ENGL J MED, V337, P133, DOI 10.1056/NEJM199707103370215; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MIHALIK SJ, 1995, EUR J BIOCHEM, V232, P545, DOI 10.1111/j.1432-1033.1995.tb20842.x; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; NADAL N, 1995, HUM MOL GENET, V4, P1963, DOI 10.1093/hmg/4.10.1963; Reuber BE, 1997, J BIOL CHEM, V272, P6766, DOI 10.1074/jbc.272.10.6766; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; Steinberg D., 1995, METABOLIC MOL BASES, P2351; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TRANCHANT C, 1993, NEUROLOGY, V43, P2044, DOI 10.1212/WNL.43.10.2044; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; Watkins PA, 1996, J LIPID RES, V37, P2288; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	24	180	184	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					185	189		10.1038/ng1097-185	http://dx.doi.org/10.1038/ng1097-185			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326939				2022-12-27	WOS:A1997XZ55500025
J	Gray, MD; Shen, JC; KamathLoeb, AS; Blank, A; Sopher, BL; Martin, GM; Oshima, J; Loeb, LA				Gray, MD; Shen, JC; KamathLoeb, AS; Blank, A; Sopher, BL; Martin, GM; Oshima, J; Loeb, LA			The Werner syndrome protein is a DNA helicase	NATURE GENETICS			English	Letter							ESCHERICHIA-COLI RECQ; GENETIC-CHARACTERIZATION; BINDING-PROTEIN; CELLS; RECOMBINATION; HOMOLOG	Werner syndrome (WS) is an uncommon autosomal recessive disorder characterized by premature aging. The clinical manifestations of WS, including atherosclerosis and osteoporosis, appear early in adulthood, and death in the fourth to sixth decade commonly ensues from myocardial infarction or cancer(1,2). In accord with the aging phenotype, cells from WS patients have a reduced replicative life span in culture(3), Genomic instability is observed at the cytogenetic level in the form of chromosome breaks and translocations(4) and at the molecular level by multiple large deletions(5). The Werner syndrome gene (WRN) has recently been cloned(6), The predicted product is a 1,432-amino-acid protein whose central domain is homologous to members of the RecQ family of DNA helicases, Such homology does not necessarily mean that WRN encodes an active helicase. For example, the Saccharomyces cerevisiae RAD26 gene protein(7) and the human transcription-repair coupling factor CSB (Cockayne syndrome B)(8) are highly homologous to known helicases, yet neither encodes an active helicase. Moreover, the Bloom's syndrome gene (BLM)(9), discovered before WRN, is also homologous to the RecQ family of DNA helicases, though we still await demonstration that it encodes an active helicase, Here we report that the WS protein does indeed catalyze DNA unwinding.	UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NCI NIH HHS [1-F32-CA67482] Funding Source: Medline; NIA NIH HHS [AG017151, AG08303] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA067482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008303] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berenblum I, 1938, BIOCHEM J, V32, P295, DOI 10.1042/bj0320295; BOEHMER PE, 1993, J BIOL CHEM, V268, P1220; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GEBHART E, 1988, HUM GENET, V80, P135, DOI 10.1007/BF00702855; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; LOHMAN TM, 1993, J BIOL CHEM, V268, P2269; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; MARTIN GM, 1970, LAB INVEST, V23, P86; MATSON SW, 1986, J BIOL CHEM, V261, P169; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; Oshima J, 1996, HUM MOL GENET, V5, P1909, DOI 10.1093/hmg/5.12.1909; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Yu CE, 1997, AM J HUM GENET, V60, P330; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	27	498	508	0	36	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					100	103		10.1038/ng0997-100	http://dx.doi.org/10.1038/ng0997-100			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288107				2022-12-27	WOS:A1997XU72400027
J	Wilson, RB; Roof, DM				Wilson, RB; Roof, DM			Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; FRIEDREICHS ATAXIA; CRITICAL REGION; PET MUTANTS; VITAMIN-E; PROTEIN; RNA; MUTATIONS; MENADIONE; MEDICINE	Friedreich's ataxia (FRDA) is an autosomal recessive degenerative disorder that primarily affects the nervous system and heart. Patients with FRDA have point mutations or trinucleotide repeat expansions in both alleles of FRDA, which encodes a protein termed frataxin. We show that the yeast frataxin homologue, which we have named YFH1, localizes to mitochondria and is required to maintain mitochondrial DNA, The YFH1-homologous domain of frataxin functions in yeast and a disease-associated missense mutation of this domain, or the corresponding domain in YFH1, reduces function. Our data suggest that mitochondrial dysfunction contributes to FRDA pathophysiology.	UNIV PENN,DEPT PHYSIOL,PHILADELPHIA,PA 19104	University of Pennsylvania	Wilson, RB (corresponding author), UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104, USA.							Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P646, DOI 10.1017/S0317167100035228; BARBEAU A, 1980, CAN J NEUROL SCI, V7, P455, DOI 10.1017/S0317167100023064; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; CARVAJAL JJ, 1995, HUM MOL GENET, V4, P1411, DOI 10.1093/hmg/4.8.1411; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; GARN H, 1994, J IMMUNOL METHODS, V168, P253, DOI 10.1016/0022-1759(94)90062-0; GENGA A, 1986, J BIOL CHEM, V261, P9328; JAHN B, 1995, J CLIN MICROBIOL, V33, P661, DOI 10.1128/JCM.33.3.661-667.1995; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KOOBS DH, 1978, ARCH PATHOL LAB MED, V102, P66; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L; Mastrogiacomo F, 1996, NEURODEGENERATION, V5, P27, DOI 10.1006/neur.1996.0004; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; MONTERMINI L, 1995, AM J HUM GENET, V57, P1061; MUELLER DM, 1987, CURR GENET, V11, P359, DOI 10.1007/BF00378178; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Rose MD., 1990, METHODS YEAST GENETI; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; SANYAL A, 1995, MOL GEN GENET, V246, P56, DOI 10.1007/BF00290133; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1984, P NATL ACAD SCI-BIOL, V81, P8, DOI 10.1073/pnas.81.1.8; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; TAPPEL AL, 1972, ANN NY ACAD SCI, V203, P12, DOI 10.1111/j.1749-6632.1972.tb27851.x; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604; [No title captured]	33	300	312	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					352	357		10.1038/ng0897-352	http://dx.doi.org/10.1038/ng0897-352			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241271				2022-12-27	WOS:A1997XM90900016
J	Zhuchenko, O; Bailey, J; Bonnen, P; Ashizawa, T; Stockton, DW; Amos, C; Dobyns, WB; Subramony, SH; Zoghbi, HY; Lee, CC				Zhuchenko, O; Bailey, J; Bonnen, P; Ashizawa, T; Stockton, DW; Amos, C; Dobyns, WB; Subramony, SH; Zoghbi, HY; Lee, CC			Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha(1A)-voltage-dependent calcium channel	NATURE GENETICS			English	Article							CAG REPEAT; P-TYPE; CHROMOSOME 19P; CA2+ CHANNELS; GENE; DISEASE; NEURONS; MAPS; ATROPHY; REGION	A polymorphic CAG repeat was identified in the human alpha(1A) voltage-dependent calcium channel subunit, To test the hypothesis that expansion of this CAG repeat could be the cause of an inherited progressive ataxia, we genotyped a large number of unrelated controls and ataxia patients. Eight unrelated patients with late onset ataxia had alleles with larger repeat numbers (21-27) compared to the number of repeats (4-16) in 475 non-ataxia individuals, Analysis of the repeat length in families of the affected individuals revealed that the expansion segregated with the phenotype in every patient, We identified six isoforms of the human alpha(1A) calcium channel subunit. The CBG repeat is within the open reading frame and is predicted to encode glutamine in three of the isoforms. We conclude that a small polyglutamine expansion in the human alpha(1A) calcium channel is most likely the cause of a newly classified autosomal dominant spinocerebellar ataxia, SCAG.	BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA; UNIV TEXAS, MD ANDERSON CANC CTR, HOUSTON, TX 77030 USA; VET AFFAIRS MED CTR, HOUSTON, TX 77030 USA; UNIV MINNESOTA, SCH MED, DEPT NEUROL & PEDIAT, MINNEAPOLIS, MN 55455 USA; UNIV MISSISSIPPI, MED CTR, JACKSON, MS 39216 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center			Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; Zoghbi, Huda/0000-0002-0700-3349	NINDS NIH HHS [NS27699] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Diriong S, 1995, GENOMICS, V30, P605, DOI 10.1006/geno.1995.1284; Elliott MA, 1996, ANN NEUROL, V39, P100, DOI 10.1002/ana.410390115; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOH JY, 1992, BRAIN RES, V587, P233, DOI 10.1016/0006-8993(92)91002-V; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KRAMER PL, 1995, AM J HUM GENET, V57, P182; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARGOLIS RL, 1995, SOMAT CELL MOLEC GEN, V21, P279, DOI 10.1007/BF02255782; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1994, J NEUROSCI, V14, P2844; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PEREZREYES E, 1994, FEBS LETT, V342, P119, DOI 10.1016/0014-5793(94)80484-2; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STEVANIN G, 1994, AM J HUM GENET, V54, P11; Subramony SH, 1996, MOVEMENT DISORD, V11, P174, DOI 10.1002/mds.870110210; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; TWELLS R, 1994, HUM MOL GENET, V3, P177, DOI 10.1093/hmg/3.1.177; VAHEDI K, 1995, ANN NEUROL, V37, P289, DOI 10.1002/ana.410370304; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; ZOGHBI HY, IN PRESS ADV HUM GEN	44	1277	1326	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1997	15	1					62	69		10.1038/ng0197-62	http://dx.doi.org/10.1038/ng0197-62			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988170				2022-12-27	WOS:A1997WA37300022
J	Yu, RN; Ito, M; Saunders, TL; Camper, SA; Jameson, JL				Yu, RN; Ito, M; Saunders, TL; Camper, SA; Jameson, JL			Role of Ahch in gonadal development and gametogenesis	NATURE GENETICS			English	Article							ADRENAL HYPOPLASIA CONGENITA; HYPOGONADOTROPIC HYPOGONADISM; ENDOCRINE DEVELOPMENT; DAX-1; RECEPTOR; MICE; EXPRESSION; MUTATIONS; DOMAIN; CELLS	Ahch (also known as Dax1) encodes a transcription factor that has been implicated in sex determination and gonadal differentiation(1-3). Mutations in human AHC cause X-linked, adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism(4,5) (HH). Duplication of the Xp21 dosage-sensitive sex reversal (DSS) region, which contains the Ahch locus(1), and transgenic overexpression of Ahch (ref. 6) cause male-to-female sex reversal. Using Cre-mediated disruption of Ahch, we have generated a mouse model of AHC-HH that allows the function of Ahch to be examined in both males and females. Although Ahch has been postulated to function as an ovarian determination gene(2,6), the loss of Ahch function in females does not affect ovarian development or fertility. Ahch is instead essential for the maintenance of spermatogenesis. Lack of Ahch causes progressive degeneration of the testicular germinal epithelium independent of abnormalities in gonadotropin and testosterone production and results in male sterility. Ahch is thus not an ovarian determining gene, but rather has a critical role in spermatogenesis.	Northwestern Univ, Sch Med, Div Endocrinol Metab & Internal Med, Chicago, IL 60611 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	Northwestern University; University of Michigan System; University of Michigan	Jameson, JL (corresponding author), Northwestern Univ, Sch Med, Div Endocrinol Metab & Internal Med, 303 E Super St, Chicago, IL 60611 USA.	ljameson@nwu.edu		Saunders, Thom/0000-0003-2015-101X; Jameson, James/0000-0001-9538-4059; Camper, Sally/0000-0001-8556-3379	NICHD NIH HHS [U54-HD-29164, P30-HD-28048, P01-HD-21921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028048, U54HD029164] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; DUNN TB, 1970, JNCI-J NATL CANCER I, V44, P1323; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Lalli E, 1997, MOL ENDOCRINOL, V11, P1950, DOI 10.1210/me.11.13.1950; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; ROSSANT J, 1995, NAT MED, V1, P592, DOI 10.1038/nm0695-592; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Swain A, 1997, ACTA PAEDIATR, V86, P46; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wurst W., 1993, Gene targeting: a practical approach., P33; Yu RN, 1998, TRENDS ENDOCRIN MET, V9, P169, DOI 10.1016/S1043-2760(98)00048-4; Yu RN, 1998, MOL ENDOCRINOL, V12, P1010, DOI 10.1210/me.12.7.1010; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	23	350	363	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					353	357		10.1038/3822	http://dx.doi.org/10.1038/3822			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843206				2022-12-27	WOS:000077199600021
J	Bashir, R; Britton, S; Strachan, T; Keers, S; Vafiadaki, E; Lako, M; Richard, I; Marchand, S; Bourg, N; Argov, Z; Sadeh, M; Mahjneh, I; Marconi, G; Passos-Bueno, MR; Moreira, ED; Zatz, M; Beckmann, JS; Bushby, K				Bashir, R; Britton, S; Strachan, T; Keers, S; Vafiadaki, E; Lako, M; Richard, I; Marchand, S; Bourg, N; Argov, Z; Sadeh, M; Mahjneh, I; Marconi, G; Passos-Bueno, MR; Moreira, ED; Zatz, M; Beckmann, JS; Bushby, K			A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B	NATURE GENETICS			English	Article							PRIMARY ADHALINOPATHY; GAMMA-SARCOGLYCAN; MIYOSHI MYOPATHY; BETA-SARCOGLYCAN; VESICLE FUSION; CHROMOSOME 2P; LOCUS; MUTATIONS; CONSTRUCTION; LIBRARIES	The limb-girdle muscular dystrophies are a genetically heterogeneous group of inherited progressive muscle disorders that affect mainly the proximal musculature, with evidence for at least three autosomal dominant and eight autosomal recessive loci. The latter mostly involve mutations in genes encoding components of the dystrophin-associated complex; another form is caused by mutations in the gene for the muscle-specific protease calpain 3. Using a positional cloning approach, we have identified the gene for a form of limb-girdle muscular dystrophy that we previously mapped to chromosome 2p13 (LGMD2B). This gene shows no homology to any known mammalian gene, but its predicted product is related to the C. elegans spermatogenesis factor fer-l. We have identified two homozygous frameshift mutations in this gene, resulting in muscular dystrophy of either proximal or distal onset in nine families. The proposed name 'dysferlin' combines the role of the gene in producing muscular dystrophy with its C. elegans homology.	Univ Newcastle Upon Tyne, Dept Human Genet, Mol Genet Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Genethon CNRS, URA 1922, F-91000 Evry, France; Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel; Wolfson Hosp, Dept Neurol, Holon, Israel; Univ Florence, Dept Neurol & psychiat Sci, I-50121 Florence, Italy; Univ Sao Paulo, Dept Biol, BR-05508 Sao Paulo, Brazil	Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); Hebrew University of Jerusalem; University of Florence; Universidade de Sao Paulo	Bushby, K (corresponding author), Univ Newcastle Upon Tyne, Dept Human Genet, Mol Genet Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	kate.bushby@ncl.ac.uk	Moreira, Eloisa/K-9155-2014; Vafiadaki, Elizabeth/K-1171-2019; Zatz, Mayana/M-5338-2015; Beckmann, Jacques S/A-9772-2008; Richard, isabelle/J-8298-2013; Passos-Bueno, Maria Rita/I-6796-2016; Lako, Majlinda/B-6297-2013	Zatz, Mayana/0000-0003-3970-8025; Beckmann, Jacques S/0000-0002-9741-1900; Passos-Bueno, Maria Rita/0000-0002-9248-3008; lako, majlinda/0000-0003-1327-8573; Vafiadaki, Elizabeth/0000-0001-9931-7099	Telethon [1020] Funding Source: Medline	Telethon(Fondazione Telethon)		Achanzar WE, 1997, J CELL SCI, V110, P1073; ALLAMAND V, 1995, HUM MOL GENET, V4, P459, DOI 10.1093/hmg/4.3.459; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; Bashir R, 1996, GENOMICS, V33, P46, DOI 10.1006/geno.1996.0157; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bejaoui K, 1998, NEUROGENETICS, V1, P189, DOI 10.1007/s100480050028; Bernot A, 1997, NAT GENET, V17, P25; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BUSHBY KMD, 1997, DIAGNOSTIC CRITERIA, P17; Dincer P, 1997, ANN NEUROL, V42, P222, DOI 10.1002/ana.410420214; Eymard B, 1997, NEUROLOGY, V48, P1227, DOI 10.1212/WNL.48.5.1227; Fanin M, 1997, J MED GENET, V34, P973, DOI 10.1136/jmg.34.12.973; Fardeau M, 1996, BRAIN, V119, P295, DOI 10.1093/brain/119.1.295; FEINBERG AP, 1983, ANAL BIOCHEM, V32, P6; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Gingrich JC, 1996, GENOMICS, V32, P65, DOI 10.1006/geno.1996.0077; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Illarioshkin SN, 1996, BRAIN, V119, P1895, DOI 10.1093/brain/119.6.1895; Illarioshkin SN, 1997, GENOMICS, V42, P345, DOI 10.1006/geno.1997.4725; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Liu J, 1998, GENOMICS, V49, P23, DOI 10.1006/geno.1998.5204; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; Mahjneh I, 1996, NEUROMUSCULAR DISORD, V6, P483, DOI 10.1016/S0960-8966(96)00390-2; MAHJNEH I, 1992, NEUROMUSCULAR DISORD, V2, P277, DOI 10.1016/0960-8966(92)90060-J; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Ozawa E, 1998, MUSCLE NERVE, V21, P421, DOI 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.3.CO;2-W; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; PassosBueno MR, 1996, J MED GENET, V33, P97, DOI 10.1136/jmg.33.2.97; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; Piccolo F, 1996, HUM MOL GENET, V5, P2019, DOI 10.1093/hmg/5.12.2019; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SENTER L, 1995, BIOCHEM BIOPH RES CO, V206, P57, DOI 10.1006/bbrc.1995.1009; SHERMAN F, 1986, LABORATORY COURSE MA, P117; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; SORLMACHI H, 1995, J BIOL CHEM, V270, P31155; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weiler T, 1996, AM J HUM GENET, V59, P872; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755	48	498	517	0	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					37	42		10.1038/1689	http://dx.doi.org/10.1038/1689			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731527				2022-12-27	WOS:000075671400015
J	SanMiguel, P; Gaut, BS; Tikhonov, A; Nakajima, Y; Bennetzen, JL				SanMiguel, P; Gaut, BS; Tikhonov, A; Nakajima, Y; Bennetzen, JL			The paleontology of intergene retrotransposons of maize	NATURE GENETICS			English	Article							NUCLEOTIDE-SEQUENCE; HIGHER-PLANTS; DNA; GENE; GENOME; METHYLATION; EVOLUTION; REGIONS; RETROELEMENTS; RECOMBINATION	Retrotransposons, transposable elements related to animal retroviruses, are found in all eukaryotes investigated and make up the majority of many plant genomes(1-5). Their ubiquity points to their importance, especially in their contribution to the large-scale structure of complex genomes. The nature and frequency of retro-element appearance, activation and amplification are poorly understood in all higher eukaryotes. Here we employ a novel approach to determine the insertion dates for 17 of 23 retrotransposons found near the maize adh1 gene, and two others from unlinked sites in the maize genome, by comparison of long terminal repeat (LTR) divergences with the sequence divergence between adh1 in maize and sorghum. All retrotransposons examined have inserted within the last six million years, most in the last three million years. The structure of the adh? region appears to be standard relative to the other gene-containing regions of the maize genome, thus suggesting that retrotransposon insertions have increased the size of the maize genome from approximately 1200 Mb to 2400 Mb in the last three million years. Furthermore, the results indicate an increased mutation rate in retrotransposons compared with genes.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Genet Program, W Lafayette, IN 47907 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Irvine	Bennetzen, JL (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	maize@bilbo.bio.purdue.edu	Tikhonov, Alexander/I-1453-2012; SanMiguel, Phillip J/I-2196-2015	Tikhonov, Alexander/0000-0003-3808-9701; SanMiguel, Phillip J/0000-0002-3742-9527				Avramova Z, 1996, PLANT J, V10, P1163, DOI 10.1046/j.1365-313X.1996.10061163.x; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dooner HK, 1997, PLANT CELL, V9, P1633, DOI 10.1105/tpc.9.9.1633; FLAVELL AJ, 1992, NUCLEIC ACIDS RES, V20, P3639, DOI 10.1093/nar/20.14.3639; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; GAUT BS, 1993, P NATL ACAD SCI USA, V90, P5095, DOI 10.1073/pnas.90.11.5095; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; GAUT BS, 1994, MOL BIOL EVOL, V11, P620; GRANDBASTIEN MA, 1992, TRENDS GENET, V8, P103, DOI 10.1016/0168-9525(92)90198-D; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; HU WM, 1995, MOL GEN GENET, V248, P471, DOI 10.1007/BF02191647; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; JIN YK, 1989, P NATL ACAD SCI USA, V86, P6235, DOI 10.1073/pnas.86.16.6235; JOHNS MA, 1983, GENETICS, V105, P733; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LEWIN B, 1997, GENES, V6, P603; NEI M, 1986, MOL BIOL EVOL, V3, P418; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; SELKER EU, 1985, P NATL ACAD SCI USA, V82, P8114, DOI 10.1073/pnas.82.23.8114; Sokal RR, 1995, BIOMETRY; Turcich MP, 1996, SEX PLANT REPROD, V9, P65, DOI 10.1007/BF02153053; VOYTAS DF, 1992, P NATL ACAD SCI USA, V89, P7124, DOI 10.1073/pnas.89.15.7124; WHITE SE, 1994, P NATL ACAD SCI USA, V91, P11792, DOI 10.1073/pnas.91.25.11792; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder JA, 1996, BIOL CHEM, V377, P605	30	721	761	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					43	45		10.1038/1695	http://dx.doi.org/10.1038/1695			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731528				2022-12-27	WOS:000075671400016
J	Botto, M; Dell'Agnola, C; Bygrave, AE; Thompson, EM; Cook, HT; Petry, F; Loos, M; Pandolfi, PP; Walport, MJ				Botto, M; Dell'Agnola, C; Bygrave, AE; Thompson, EM; Cook, HT; Petry, F; Loos, M; Pandolfi, PP; Walport, MJ			Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies	NATURE GENETICS			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; MOLECULAR-BASIS; KERATINOCYTES; EXPRESSION; NEPHRITIS; ANTIGENS; BINDING; FAMILY; GENES	The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly Clq (ref, 1), is powerfully associated with the development of SLE, This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref, 2) and implies that Clq may play a key role in this respect. Clq-deficient (C1qa(-/-)) mice were generated by gene targeting and monitored for eight months. C1qa(-/-) mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa(-/-) mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in Clq-deficient mice compared with controls. The phenotype associated with Clq deficiency was modified by background genes. These findings are compatible with the hypothesis that Clq deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.	Imperial Coll Sci Technol & Med, Sch Med, Rheumatol Sect, London W12 0NN, England; Imperial Coll Sci Technol & Med, Sch Med, Dept Histopathol, London W12 0NN, England; Dept Histopathol, London W2 1NY, England; Inst Med Microbiol & Hyg, D-55101 Mainz, Germany; Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA	Imperial College London; Imperial College London; Memorial Sloan Kettering Cancer Center	Walport, MJ (corresponding author), Imperial Coll Sci Technol & Med, Sch Med, Rheumatol Sect, Hammersmith Campus, London W12 0NN, England.	mwalport@rpms.ac.uk		Walport, Mark/0000-0001-7220-5273				ANDREWS BS, 1978, J IMMUNOL METHODS, V22, P273, DOI 10.1016/0022-1759(78)90035-2; BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565; BOWNESS P, 1994, Q J MED, V87, P455; BURLINGAME RW, 1990, J IMMUNOL METHODS, V134, P187, DOI 10.1016/0022-1759(90)90380-E; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; GOLAN TD, 1992, J CLIN INVEST, V90, P1067, DOI 10.1172/JCI115922; JEVNIKAR AM, 1992, AM J PATHOL, V141, P743; Korb LC, 1997, J IMMUNOL, V158, P4525; LACHMANN PJ, 1987, CIBA F SYMP, V129, P149; LEFEBER WP, 1984, J CLIN INVEST, V74, P1545, DOI 10.1172/JCI111569; MCADAM RA, 1988, IMMUNOGENETICS, V27, P259, DOI 10.1007/BF00376120; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Petry F, 1997, HUM GENET, V100, P51, DOI 10.1007/s004390050464; PETRY F, 1995, J IMMUNOL, V155, P4734; Petry F, 1996, IMMUNOGENETICS, V43, P370, DOI 10.1007/BF02199805; ROSEN A, 1995, J EXP MED, V181, P1557, DOI 10.1084/jem.181.4.1557; Slingsby JH, 1996, ARTHRITIS RHEUM, V39, P663, DOI 10.1002/art.1780390419; Topaloglu R, 1996, KIDNEY INT, V50, P635, DOI 10.1038/ki.1996.359; TRINDER PKE, 1995, IMMUNOLOGY, V84, P638	20	1151	1197	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					56	59		10.1038/ng0598-56	http://dx.doi.org/10.1038/ng0598-56			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590289				2022-12-27	WOS:000073346700017
J	Arguello, JR; Little, AM; Pay, AL; Gallardo, D; Rojas, I; Marsh, SGE; Goldman, JM; Madrigal, JA				Arguello, JR; Little, AM; Pay, AL; Gallardo, D; Rojas, I; Marsh, SGE; Goldman, JM; Madrigal, JA			Mutation detection and typing of polymorphic loci through double-strand conformation analysis	NATURE GENETICS			English	Article							REGULATOR CFTR GENE; GENOMIC DNA; CYSTIC-FIBROSIS; HLA-A; AMPLIFICATION; SEQUENCE; ALLELES	Variations, such as nucleotide substitutions, deletions and insertions, within genes can affect the function of the gene product and in some cases be deleterious. Screening for known allelic variation is important for determining disease and gene associations'. Techniques which target specific mutations such as restriction enzyme polymorphism and oligonucleotide probe or PCR primer reactivity are useful for the detection of specific mutations, but these techniques are not generally effective for the identification of new mutations. Approaches for measuring changes in DNA conformation have been developed, based on the principle that DNA fragments which differ in nucleotide composition exhibit different mobilities after separation by polyacrylamide gel electrophoresis (PAGE; refs 2,3). Here we describe a conformation-based mutation detection system, double-strand conformation analysis (DSCA), which provides a simple means to detect genetic variants and to type complex polymorphic loci, We demonstrate the application of DSCA to detect genetic polymorphisms such as a single-nucleotide difference within DNA fragments of up to 979 base pairs in length. We present the application of DSCA in detecting four different mutations in the cystic fibrosis gene (CFTR) and 131 different alleles encoded by HLA class I genes.	Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; Royal Free Hosp, Dept Haematol, London NW3 2QG, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Haematol, London W12 0NN, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London	Madrigal, JA (corresponding author), Royal Free Hosp, Anthony Nolan Res Inst, Pond St, London NW3 2QG, England.		Marsh, Steven GE/C-1638-2008	Marsh, Steven GE/0000-0003-2855-4120; Stevens, Andrea/0000-0002-2892-7065; Gallardo, David/0000-0003-1615-4592				Arguello R, 1997, NUCLEIC ACIDS RES, V25, P2236, DOI 10.1093/nar/25.11.2236; BLASCZYK R, 1995, TISSUE ANTIGENS, V46, P86, DOI 10.1111/j.1399-0039.1995.tb02483.x; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; Dykes CW, 1996, BRIT J CLIN PHARMACO, V42, P683, DOI 10.1046/j.1365-2125.1996.00473.x; LAU M, 1994, INT CELL EXCHANGE, P467; MARSH SGE, 1997, P 12 INT HIST WORKSH, V1, P26; MYERS RM, 1985, NATURE, V313, P495, DOI 10.1038/313495a0; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Savage DA, 1996, TISSUE ANTIGENS, V47, P284, DOI 10.1111/j.1399-0039.1996.tb02555.x; VERLINGUE C, 1994, HUM GENET, V93, P429; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIMMERMAN PA, 1993, NUCLEIC ACIDS RES, V21, P4541, DOI 10.1093/nar/21.19.4541	12	84	91	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					192	194		10.1038/ng0298-192	http://dx.doi.org/10.1038/ng0298-192			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462755				2022-12-27	WOS:000071779500034
J	Martin, N; Boomsma, D; Machin, G				Martin, N; Boomsma, D; Machin, G			A twin-pronged attack on complex traits	NATURE GENETICS			English	Article							PSYCHIATRIC-ILLNESS; QUANTITATIVE TRAITS; MULTIPLE-SCLEROSIS; SEXUAL ORIENTATION; CLASSICAL TWIN; HUMAN-BEHAVIOR; PAIRS; LOCI; POWER; POLYMORPHISM	Before one starts the hunt for quantitative trait loci (QTLs) for a complex trait, it is necessary to show that the trait is genetically influenced. This evidence is most likely to come from the classical twin study-the demonstration that monozygotic twins are more similar for the trait than dizygotic twins. The strengths and weaknesses of twin studies are discussed, and it is suggested that, far from becoming irrelevant with advances in molecular biology, they can improve the efficiency of QTL detection and play an important role in unravelling developmental genetic mechanisms.	FREE UNIV AMSTERDAM,DEPT PSYCHOL,AMSTERDAM,NETHERLANDS; PERMANENTE MED GRP INC,NO CALIF REG,OAKLAND,CA	Vrije Universiteit Amsterdam; Permanente Medical Groups	Martin, N (corresponding author), PO ROYAL BRISBANE HOSP,QUEENSLAND INST MED RES,BRISBANE,QLD 4029,AUSTRALIA.		Boomsma, Dorret I/AAX-4470-2020	Martin, Nicholas/0000-0003-4069-8020				BAILEY JM, 1993, ARCH GEN PSYCHIAT, V50, P217; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; BAILEY JM, UNPUB SEX DIFFERENCE; Boomsma DI, 1996, BEHAV GENET, V26, P161, DOI 10.1007/BF02359893; BOOMSMA DI, 1989, BEHAV GENET, V19, P3; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Bulmer M. G., 1970, BIOL TWINNING MAN; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CAREY G, 1986, BEHAV GENET, V16, P319, DOI 10.1007/BF01071314; CHRISTENSEN K, 1995, BRIT MED J, V310, P432, DOI 10.1136/bmj.310.6977.432; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; COTE GB, 1991, AM J HUM GENET, V49, P120; DARLINGTON CD, 1970, HEREDITY, V25, P655, DOI 10.1038/hdy.1970.71; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; Eaves L, 1989, GENES CULTURE PERSON; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; EAVES LJ, 1977, BRIT J MATH STAT PSY, V30, P1, DOI 10.1111/j.2044-8317.1977.tb00722.x; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; GOODWIN DW, 1974, ARCH GEN PSYCHIAT, V31, P164; HEATH AC, IN PRESS PSYCHOL MED; Hennis BC, 1995, THROMB HAEMOSTASIS, V74, P1497; HESTON LL, 1966, BRIT J PSYCHIAT, V112, P819, DOI 10.1192/bjp.112.489.819; HOLM NV, 1980, J NATL CANCER I, V65, P285; Hopper J, 1996, BRIT MED J, V312, P943; HOPPER JL, 1994, NEW ENGL J MED, V330, P387, DOI 10.1056/NEJM199402103300603; Hudziak J, 1997, HDB PSYCHIAT GENETIC, P201; JINKS JL, 1970, PSYCHOL BULL, V73, P311, DOI 10.1037/h0029135; KAPRIO J, 1994, ANN MED, V26, P135, DOI 10.3109/07853899409147880; KENDLER KS, 1993, BEHAV GENET, V23, P21, DOI 10.1007/BF01067551; KENDLER KS, 1986, AM J PSYCHIAT, V143, P279; Kendler KS, 1996, BRIT J PSYCHIAT, V168, P68, DOI 10.1192/S0007125000298437; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; LOEHLIN JC, 1975, HEREDITY ENV PERSONA; Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; MAES HHM, 1997, IN PRESS BEHAV GENET; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; MARTIN NG, 1987, AM J HUM GENET, V40, P267; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; MCGUE M, 1992, PSYCHOL SCI, V3, P368, DOI 10.1111/j.1467-9280.1992.tb00049.x; MOLENAAR PCM, 1993, BEHAV GENET, V23, P519, DOI 10.1007/BF01068142; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; Neale MC, 1992, METHODOLOGY GENETIC; NEALE MC, 1997, MX STAT MODELING; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PHILLIPS DIW, 1993, LANCET, V341, P1008, DOI 10.1016/0140-6736(93)91086-2; PLOMIN R, 1987, BEHAV BRAIN SCI, V10, P1, DOI 10.1017/S0140525X00055941; PLOMIN R, 1990, PSYCHOL SCI, V6, P371; RENDE RD, 1990, BEHAV GENET, V20, P277, DOI 10.1007/BF01067795; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rowe D. C., 1994, LIMITS FAMILY INFLUE; STEVENSON J, 1992, BEHAV GENET, V22, P337, DOI 10.1007/BF01066665; TORREY EF, 1994, SCHIZOPHR B, V20, P425; TREJO V, 1994, MOL MED, V1, P62; TRUETT KR, 1994, BEHAV GENET, V24, P35, DOI 10.1007/BF01067927; VANDENOORD EJCG, 1995, J CHILD PSYCHOL PSYC, V36, P449; Vernon PA, 1997, J PERS SOC PSYCHOL, V72, P177	66	490	492	1	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					387	392		10.1038/ng1297-387	http://dx.doi.org/10.1038/ng1297-387			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	YJ924	9398838	Green Submitted			2022-12-27	WOS:A1997YJ92400017
J	Sauer, CG; Gehrig, A; WarnekeWittstock, R; Marquardt, A; Ewing, CC; Gibson, A; Lorenz, B; Jurklies, B; Weber, BHF				Sauer, CG; Gehrig, A; WarnekeWittstock, R; Marquardt, A; Ewing, CC; Gibson, A; Lorenz, B; Jurklies, B; Weber, BHF			Positional cloning of the gene associated with X-linked juvenile retinoschisis	NATURE GENETICS			English	Article							CELL-SURFACE PROTEIN; COAGULATION FACTOR-V; FACTOR-VIII; DICTYOSTELIUM-DISCOIDEUM; NERVOUS-SYSTEM; YAC CONTIG; SEQUENCE; CDNA; EXPRESSION; CHROMOSOME	X-linked juvenile retinoschisis (RS) is a recessively inherited vitreo-retinal degeneration characterized by macular pathology and intraretinal splitting of the retina. The RS gene has been localized to Xp22.2 to an approximately 1 Mb interval between DXS418 and DXS999/DXS7161. Mapping and expression analysis of expressed sequence tags have identified a novel transcript, designated XLRS1, within the centromeric RS locus that is exclusively expressed in retina. The predicted XLRS1 protein contains a highly conserved motif implicated in cell-cell interaction and thus may be active in cell adhesion processes during retinal development. Mutational analyses of XLRS1 in affected individuals from nine unrelated RS families revealed one nonsense, one frameshift, one splice acceptor and six missense mutations segregating with the disease phenotype in the respective families. These data provide strong evidence that the XLRS1 gene, when mutated, causes RS.	UNIV WURZBURG,INST HUMANGENET,D-97074 WURZBURG,GERMANY; UNIV SASKATCHEWAN,SASKATOON,SK S7K 0M7,CANADA; UNIV ESSEN GESAMTHSCH,AUGENKLIN,D-45147 ESSEN,GERMANY; UNIV REGENSBURG,AUGENKLIN,D-93042 REGENSBURG,GERMANY	University of Wurzburg; University of Saskatchewan; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg				Weber, Bernhard H.F./0000-0002-8808-7723				ALITALO T, 1987, CLIN GENET, V32, P192; ALITALO T, 1995, GENOMICS, V25, P691, DOI 10.1016/0888-7543(95)80012-B; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; ARDEN GB, 1988, AM J OPHTHALMOL, V105, P590; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P1256; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONDON GP, 1986, ARCH OPHTHALMOL-CHIC, V104, P576, DOI 10.1001/archopht.1986.01050160132029; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; DEUTMAN AF, 1977, HEREDITARY RETINAL C, P1043; ELDER B, 1993, GENOMICS, V16, P374, DOI 10.1006/geno.1993.1200; Ewing C C, 1970, Trans Ophthalmol Soc U K, V89, P29; FELBOR U, IN PRESS HUM MUTAT; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FORSIUS H, 1973, CAN J OPHTHALMOL, V8, P385; Fukuzawa M, 1996, PLANT CELL PHYSIOL, V37, P505, DOI 10.1093/oxfordjournals.pcp.a028973; *GEN COMP GROUP, 1996, PROGR MAN WISC PACK; George NDL, 1996, ARCH OPHTHALMOL-CHIC, V114, P274, DOI 10.1001/archopht.1996.01100130270007; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Haas J., 1898, ARCH AUGENHEILKD, V37, P343; Huopaniemi L, 1997, AM J HUM GENET, V60, P1139; IVES E J, 1970, American Journal of Human Genetics, V22, p17A; KANE WH, 1988, BLOOD, V71, P539; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; KAWANO K, 1981, GRAEFES ARCH CLIN EX, V217, P315; KELLNER U, 1990, GRAEF ARCH CLIN EXP, V228, P432, DOI 10.1007/BF00927256; KLJAVIN IJ, 1991, J NEUROSCI, V11, P2985; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LAROCCA D, 1991, CANCER RES, V51, P4994; MANSCHOT WA, 1972, ARCH OPHTHALMOL-CHIC, V88, P131; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; NEHLS M, 1994, ONCOGENE, V9, P2169; PENOTTI FE, 1991, J THEOR BIOL, V150, P385, DOI 10.1016/S0022-5193(05)80436-9; PEREZ JL, 1994, ONCOGENE, V9, P211; Reichenbach Andreas, 1995, P395; ROMMENS JM, 1993, HUM MOL GENET, V2, P901, DOI 10.1093/hmg/2.7.901; ROSEN SD, 1973, P NATL ACAD SCI USA, V70, P2554, DOI 10.1073/pnas.70.9.2554; SHEFFIELD JB, 1987, AM ZOOL, V27, P145; SPRINGER WR, 1984, CELL, V39, P557, DOI 10.1016/0092-8674(84)90462-8; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TRUETT MA, 1985, DNA-J MOLEC CELL BIO, V4, P333, DOI 10.1089/dna.1985.4.333; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; van de Vosse E, 1996, EUR J HUM GENET, V4, P101; WEBER BHF, 1995, CYTOGENET CELL GENET, V69, P35, DOI 10.1159/000133932; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111; YANOFF M, 1968, ARCH OPHTHALMOL-CHIC, V79, P49	52	355	380	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					164	170		10.1038/ng1097-164	http://dx.doi.org/10.1038/ng1097-164			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326935				2022-12-27	WOS:A1997XZ55500021
J	Hicks, GG; Shi, EG; Li, XM; Li, CH; Pawlak, M; Ruley, HE				Hicks, GG; Shi, EG; Li, XM; Li, CH; Pawlak, M; Ruley, HE			Functional genomics in mice by tagged sequence mutagenesis	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTALLY-REGULATED GENES; BINDING-PROTEIN; MOUSE EMBRYO; DNA METHYLATION; MESSENGER-RNA; DROSOPHILA; FUSION; KINASE; TRANSCRIPTION	Most mammalian genes will soon be characterized as cDNA sequences with little information about their function. To utilize this sequence information for large-scale functional studies,a gene trap retrovirus shuttle vector has been developed to disrupt genes expressed in murine embryonic stem (ES) cells. A library of mutant clones was isolated, and regions of genomic DMA adjacent to 400 independent provirus inserts were cloned and sequenced. The flanking sequences, designated 'promoter-proximal sequence tags', or PSTs, identified 63 specific genes and anonymous cDNAs disrupted as a result of virus integration. The efficiency of tagged sequence mutagenesis suggests that many of the 10,000-20,000 genes expressed in ES cells can be targeted, providing defined mutations for the analysis of gene functions in vivo. In addition, PSTs provide the first expressed sequence tags derived from genomic DNA, and define gene features such as exon boundaries and promoters that are missing from cDNA sequences.	VANDERBILT UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,NASHVILLE,TN 37232	Vanderbilt University				Hicks, Geoffrey/0000-0003-4688-2312				ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1643; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BRANDON EP, 1995, CURR BIOL, V5, P625, DOI 10.1016/S0960-9822(95)00127-8; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHANG W, 1993, VIROLOGY, V193, P737, DOI 10.1006/viro.1993.1182; Chen J, 1996, ONCOGENE, V12, P979; CHEN J, 1994, METH MOL G, V4, P123; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; CLAY FJ, 1993, P NATL ACAD SCI USA, V90, P4882, DOI 10.1073/pnas.90.11.4882; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; FENTON B, 1993, NATURE, V363, P637, DOI 10.1038/363637a0; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GIBBS RA, 1995, NAT GENET, V11, P121, DOI 10.1038/ng1095-121; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Green MC., 1989, GENETIC VARIANTS STR, P12; HICKS GG, 1995, METHOD ENZYMOL, V254, P263; HSIAO KC, 1991, NUCLEIC ACIDS RES, V19, P2787, DOI 10.1093/nar/19.10.2787; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; LAKE RJ, 1993, MOL CELL BIOL, V13, P7793, DOI 10.1128/MCB.13.12.7793; LEWIN B, 1975, CELL, V4, P77, DOI 10.1016/0092-8674(75)90113-0; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MONK M, 1987, DEVELOPMENT, V99, P371; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; NEHLS M, 1994, CURR BIOL, V4, P983, DOI 10.1016/S0960-9822(00)00222-0; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; REDDY S, 1992, P NATL ACAD SCI USA, V89, P6721, DOI 10.1073/pnas.89.15.6721; REITH AD, 1991, GENE DEV, V5, P1115, DOI 10.1101/gad.5.7.1115; RENDAHL KG, 1992, J NEUROSCI, V12, P390; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; Scherer CA, 1996, CELL GROWTH DIFFER, V7, P1393; SHIH CC, 1988, CELL, V53, P531, DOI 10.1016/0092-8674(88)90569-7; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; VONMELCHNER H, 1992, GENE DEV, V6, P919, DOI 10.1101/gad.6.6.919; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; WURST W, 1995, GENETICS, V139, P889; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x; [No title captured]	58	100	117	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					338	344		10.1038/ng0897-338	http://dx.doi.org/10.1038/ng0897-338			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241269				2022-12-27	WOS:A1997XM90900014
J	Nilsson, M; Krejci, K; Koch, J; Kwiatkowski, M; Gustavsson, P; Landegren, U				Nilsson, M; Krejci, K; Koch, J; Kwiatkowski, M; Gustavsson, P; Landegren, U			Padlock probes reveal single-nucleotide differences, parent of origin and in situ distribution of centromeric sequences in human chromosomes 13 and 21	NATURE GENETICS			English	Article							ALPHA-SATELLITE DNA; IN-SITU; LABELING PRINS; ORGANIZATION; LIGASE; OLIGONUCLEOTIDES; IDENTIFICATION; HYBRIDIZATION; CONSTRUCTION; POLYMORPHISM		DANISH CANC SOC,DEPT CYTOGENET,DK-8000 AARHUS C,DENMARK; UPPSALA CHILDRENS HOSP,DEPT CLIN GENET,UPPSALA,SWEDEN	Danish Cancer Society	Nilsson, M (corresponding author), UNIV UPPSALA,CTR BIOMED,DEPT MED GENET,BEIJER LAB,BOX 589,S-75123 UPPSALA,SWEDEN.		Landegren, Ulf D/A-8197-2019	Nilsson, Mats/0000-0001-9985-0387				BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; CHARLIEU JP, 1992, GENOMICS, V14, P515, DOI 10.1016/S0888-7543(05)80256-3; CONNOLLY BA, 1987, TETRAHEDRON LETT, V28, P463, DOI 10.1016/S0040-4039(00)95757-5; Finelli P, 1996, GENOMICS, V38, P325, DOI 10.1006/geno.1996.0635; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; GREIG GM, 1993, J MOL EVOL, V37, P464, DOI 10.1007/BF00160427; JORGENSEN AL, 1987, P NATL ACAD SCI USA, V84, P1075, DOI 10.1073/pnas.84.4.1075; KOCH J, 1995, CYTOGENET CELL GENET, V71, P142, DOI 10.1159/000134094; KOCH JE, 1989, CHROMOSOMA, V98, P259, DOI 10.1007/BF00327311; Kwiatkowski M, 1996, NUCLEIC ACIDS RES, V24, P4632, DOI 10.1093/nar/24.23.4632; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; LOU J, 1996, NUCLEIC ACIDS RES, V24, P3071; MARCAIS B, 1991, J MOL EVOL, V33, P42, DOI 10.1007/BF02100194; MARCAIS B, 1991, HUM GENET, V86, P311; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; OKeefe CL, 1996, HUM MOL GENET, V5, P1793, DOI 10.1093/hmg/5.11.1793; PELLESTOR F, 1994, HUM GENET, V94, P346; PELLESTOR F, 1995, HUM GENET, V95, P12; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SUND C, 1988, NUCLEOS NUCLEOT, V7, P655, DOI 10.1080/07328318808056303; TROWELL HE, 1993, HUM MOL GENET, V2, P1639, DOI 10.1093/hmg/2.10.1639; WEVRICK R, 1989, P NATL ACAD SCI USA, V86, P9394, DOI 10.1073/pnas.86.23.9394; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WU DY, 1989, GENE, V76, P245, DOI 10.1016/0378-1119(89)90165-0	25	127	143	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					252	255		10.1038/ng0797-252	http://dx.doi.org/10.1038/ng0797-252			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207789				2022-12-27	WOS:A1997XG60900019
J	Wojnowski, L; Zimmer, AM; Beck, TW; Hahn, H; Bernal, R; Rapp, UR; Zimmer, A				Wojnowski, L; Zimmer, AM; Beck, TW; Hahn, H; Bernal, R; Rapp, UR; Zimmer, A			Endothelial apoptosis in Braf-deficient mice	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASE; B-RAF; BLOOD-VESSELS; DIFFERENTIATION; VASCULOGENESIS; EXPRESSION; TUMORS; GROWTH; CELLS; MYC		NIMH,NATL HUMAN GENOME RES INST,GENET SECT,BETHESDA,MD 20892; NCI,FREDERICK CANC RES & DEV CTR,SAIC FREDERICK,INTRAMURAL RES SUPPORT PROGRAM,FREDERICK,MD 21702; UNIV WURZBURG,INST MED RADIAT & CELL RES,D-97078 WURZBURG,GERMANY	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Wurzburg			Bernal, Ricardo A/B-2124-2010; Zimmer, Andreas/B-8357-2009	Bernal, Ricardo A./0000-0001-5849-8647				ARENDS MJ, 1993, BRIT J CANCER, V68, P1127, DOI 10.1038/bjc.1993.492; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; LU XY, 1994, EMBO J, V13, P2592, DOI 10.1002/j.1460-2075.1994.tb06549.x; MODAK SP, 1972, EXP CELL RES, V75, P307, DOI 10.1016/0014-4827(72)90434-X; NODEN DM, 1990, ANN NY ACAD SCI, V588, P236, DOI 10.1111/j.1749-6632.1990.tb13214.x; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; PAWSON T, 1994, BIOCHEM SOC T, V22, P455, DOI 10.1042/bst0220455; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; REUTER CWM, 1995, J BIOL CHEM, V270, P7644, DOI 10.1074/jbc.270.13.7644; RISAU W, 1995, FASEB J, V9, P926, DOI 10.1096/fasebj.9.10.7615161; Sanders EJ, 1995, INT REV CYTOL, V163, P105, DOI 10.1016/S0074-7696(08)62210-X; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Troppmair J, 1992, Curr Top Microbiol Immunol, V182, P453; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; WYLLIE AH, 1987, BRIT J CANCER, V56, P251, DOI 10.1038/bjc.1987.186	24	250	264	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					293	297		10.1038/ng0797-293	http://dx.doi.org/10.1038/ng0797-293			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207797				2022-12-27	WOS:A1997XG60900027
J	Delbridge, ML; Harry, JL; Toder, R; ONeill, RJW; Ma, K; Chandley, AC; Graves, JAM				Delbridge, ML; Harry, JL; Toder, R; ONeill, RJW; Ma, K; Chandley, AC; Graves, JAM			A human candidate spermatogenesis gene, RBM1, is conserved and amplified on the marsupial Y chromosome	NATURE GENETICS			English	Article							RNA-BINDING PROTEIN; TESTIS-DETERMINING GENE; HNRNP-G; SEQUENCES; TSPY; SRY; LOCALIZATION; EVOLUTION; FAMILY; DELETION	Three genes, RBM1, DAZ and TSPY, map to a small region of the long arm of the human Y chromosome which is deleted in azoospermic men. RBM1, but not DAZ or TSPY, has a Y-linked homologue in marsupials which is transcribed in the testis. This suggests that RBM1 has been retained on the Y chromosome because of a critical male-specific function. Marsupial RBM1 is closely related to human RBM1, but, like the related autosomal gene hnRNPG, lacks the amplification of an exon. This suggests that RBM1 evolved from hnRNPG at least 130 million years ago and has undergone internal amplification in primates, as well as independent amplification in several eutherian lineages.	UNIV MELBOURNE,DEPT ZOOL,PARKVILLE,VIC 3052,AUSTRALIA; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Melbourne; University of Edinburgh	Delbridge, ML (corresponding author), LA TROBE UNIV,SCH GENET & HUMAN VARIAT,BUNDOORA,VIC 3083,AUSTRALIA.		Graves, Jennifer A.M./A-1387-2008	Graves, Jennifer/0000-0001-6480-7856				Affara N, 1996, CYTOGENET CELL GENET, V73, P33; ARNEMANN J, 1991, GENOMICS, V11, P108, DOI 10.1016/0888-7543(91)90107-P; CHANDLEY AC, 1989, J MED GENET, V26, P145, DOI 10.1136/jmg.26.3.145; CHANDLEY AC, 1994, HUM MOL GENET, V3, P1449, DOI 10.1093/hmg/3.suppl_1.1449; CHARLESWORTH B, 1993, CURR BIOL, V3, P466, DOI 10.1016/0960-9822(93)90359-V; Conrad C, 1996, CHROMOSOME RES, V4, P201, DOI 10.1007/BF02254960; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Elliott DJ, 1996, HUM MOL GENET, V5, P869, DOI 10.1093/hmg/5.7.869; ELLIOTT DJ, IN PRESS HUM MOL GEN; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; HARRY JL, 1995, NAT GENET, V11, P347, DOI 10.1038/ng1195-347; JAKUBICZKA S, 1993, GENOMICS, V17, P732, DOI 10.1006/geno.1993.1394; LAVAL SH, 1995, P NATL ACAD SCI USA, V92, P10403, DOI 10.1073/pnas.92.22.10403; LECONIAT M, 1992, HUM GENET, V88, P593, DOI 10.1007/BF00219352; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MANZ E, 1993, GENOMICS, V17, P726, DOI 10.1006/geno.1993.1393; MARDON G, 1989, SCIENCE, V243, P78, DOI 10.1126/science.2563173; MATTHEWS ME, 1992, GENOMICS, V13, P1267, DOI 10.1016/0888-7543(92)90045-T; NAGAMINE CM, 1994, GENET RES, V64, P151, DOI 10.1017/S001667230003281X; Najmabadi H, 1996, J CLIN ENDOCR METAB, V81, P2159, DOI 10.1210/jc.81.6.2159; O WS, 1988, NATURE, V331, P716; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RETIEF JD, 1995, P ROY SOC B-BIOL SCI, V259, P7, DOI 10.1098/rspb.1995.0002; Sambrook J., 2002, MOL CLONING LAB MANU; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; SCHEMPP W, 1983, HUM GENET, V63, P171, DOI 10.1007/BF00291539; SCHEMPP W, 1995, CHROMOSOME RES, V3, P227, DOI 10.1007/BF00713047; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; SOULARD M, 1993, NUCLEIC ACIDS RES, V21, P4210, DOI 10.1093/nar/21.18.4210; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Toder R, 1996, CHROMOSOME RES, V4, P295, DOI 10.1007/BF02263680; Wilcox SA, 1996, CHROMOSOME RES, V4, P397, DOI 10.1007/BF02257276; WILLIAMSON P, 1990, J REPROD FERTIL, V88, P549	41	96	102	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					131	136		10.1038/ng0297-131	http://dx.doi.org/10.1038/ng0297-131			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020837				2022-12-27	WOS:A1997WF08700011
J	Gourdon, G; Radvanyi, F; Lia, AS; Duros, C; Blanche, M; Abitbol, M; Junien, C; HofmannRadvanyi, H				Gourdon, G; Radvanyi, F; Lia, AS; Duros, C; Blanche, M; Abitbol, M; Junien, C; HofmannRadvanyi, H			Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY PATIENTS; DNA MISMATCH REPAIR; CTG REPEAT; TRINUCLEOTIDE REPEAT; (CTG)(N) REPEAT; TRIPLET REPEAT; EXPANSION; GENE; SIZE; SEX	Myotonic dystrophy (DM) is associated with the expansion of a (CTG)n trinucleotide repeat in the 3' untranslated region (UTR) of the DM protein kinase gene (DMPK)(1). The (CTG)n repeat is polymorphic and varies in size between 5 and 37 repeats in unaffected individuals' whereas in affected patients there are between 50 and 4,000 CTGs(2,3), The size of the (CTC)n repeat, which increases through generations, generally correlates with clinical severity and age of onset(4). The instability of the CTG repeat appears to depend on its size as well as on the sex of the transmitting parent(5-9). Moreover, mitotic instability analysis of different human DM tissues shows length mosaicism between different cell lineages(3,6,10-14). The molecular mechanisms of triplet instability remain elusive. To investigate the role of genomic sequences in instability, we produced transgenic mice containing a 45-kb genomic segment with a 55-CTG repeat cloned from a mildly affected patient. In contrast to other mouse models containing CAG repeats within cDNAs, these mice showed both intergenerational and somatic repeat instability(15-17).	HOP NECKER ENFANTS MALAD,INSERM UR383,LAMY,F-75743 PARIS 15,FRANCE; INST CURIE,UMR 144,CNRS,PARIS,FRANCE; UNIV PARIS 05,FAC NECKER,CTR RECH THERAPEUT OPHTALMOL,F-75270 PARIS 06,FRANCE; HOP AMBROISE PARE,BIOCHIM LAB,BOULOGNE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP			Gourdon, Genevieve/F-2996-2013	Gourdon, Genevieve/0000-0002-3319-1347; Radvanyi, Francois/0000-0002-5696-6424				ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; ASHIZAWA T, 1994, NEUROLOGY, V44, P120, DOI 10.1212/WNL.44.1.120; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BARCELO JM, 1993, HUM MOL GENET, V2, P705, DOI 10.1093/hmg/2.6.705; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; GOURDON G, 1994, NUCLEIC ACIDS RES, V22, P4139, DOI 10.1093/nar/22.20.4139; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; HARPER PS, 1992, AM J HUM GENET, V51, P10; HARRIS H, 1996, HUM MOL GENET, V5, P1417; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JANSEN G, 1994, AM J HUM GENET, V54, P575; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; WONG LJC, 1995, AM J HUM GENET, V56, P114	30	92	93	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					190	192		10.1038/ng0297-190	http://dx.doi.org/10.1038/ng0297-190			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020847				2022-12-27	WOS:A1997WF08700021
J	Kalaydjieva, L; Hallmayer, J; Chandler, D; Savov, A; Nikolova, A; Angelicheva, D; King, RHH; Ishpekova, B; Honeyman, K; Calafell, F; Shmarov, A; Petrova, J; Turnev, I; Hristova, A; Moskov, M; Stancheva, S; Petkova, I; Bittles, AH; Georgieva, V; Middleton, L; Thomas, PK				Kalaydjieva, L; Hallmayer, J; Chandler, D; Savov, A; Nikolova, A; Angelicheva, D; King, RHH; Ishpekova, B; Honeyman, K; Calafell, F; Shmarov, A; Petrova, J; Turnev, I; Hristova, A; Moskov, M; Stancheva, S; Petkova, I; Bittles, AH; Georgieva, V; Middleton, L; Thomas, PK			Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24	NATURE GENETICS			English	Letter							LINKAGE ANALYSIS; INHERITANCE		MED UNIV,LAB MOL PATHOL,BU-1431 SOFIA,BULGARIA; MED UNIV,DEPT NEUROL,BU-1431 SOFIA,BULGARIA; MED UNIV,DEPT OPHTHALMOL,BU-1431 SOFIA,BULGARIA; MED UNIV,DEPT MED GENET,BU-1431 SOFIA,BULGARIA; GRAYLANDS UWA CLIN RES UNIT,PERTH,WA 6010,AUSTRALIA; NEUROSCI & BRAIN RES FDN,CTR HYG,BU-1431 SOFIA,BULGARIA; ROYAL FREE HOSP,SCH MED,DEPT CLIN NEUROSCI,LONDON NW3 2PF,ENGLAND; UNIV BARCELONA,FAC BIOL,DEPT ANTHROPOL,E-08028 BARCELONA,SPAIN; CYPRUS INST NEUROL & GENET,CY-1683 NICOSIA,CYPRUS	Medical University Sofia; Medical University Sofia; Medical University Sofia; Medical University Sofia; University of Western Australia; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Barcelona	Kalaydjieva, L (corresponding author), EDITH COWAN UNIV,DEPT HUMAN BIOL,JOONDALUP CAMPUS,PERTH,WA 6027,AUSTRALIA.		Calafell, Francesc/C-8595-2014	Calafell, Francesc/0000-0002-1083-9438; Bittles, Alan/0000-0002-8176-2730				CORNELL J, 1984, CLIN GENET, V25, P163; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Fraser, 1995, GYPSIES; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Ionasescu VV, 1996, MUSCLE NERVE, V19, P319, DOI 10.1002/(SICI)1097-4598(199603)19:3<319::AID-MUS6>3.3.CO;2-H; Kenrick D., 1972, DESTINY EUROPES GYPS; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liegeois Jean-Pierre, 1994, ROMA GYPSIES TRAVELL; MARUSHIAKOKVA E, 1993, GYPSIES BULGARIA; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; POTT A, 1884, ZIGEUNER EUROPEN ASI; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777	17	164	170	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					214	217		10.1038/ng1096-214	http://dx.doi.org/10.1038/ng1096-214			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841199				2022-12-27	WOS:A1996VL44600033
J	Lefebvre, L; Viville, S; Barton, SC; Ishino, F; Keverne, EB; Surani, MA				Lefebvre, L; Viville, S; Barton, SC; Ishino, F; Keverne, EB; Surani, MA			Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest	NATURE GENETICS			English	Article							SILVER-RUSSELL-SYNDROME; EMBRYONIC STEM-CELLS; UNIPARENTAL DISOMY; DIAGNOSTIC-CRITERIA; ANGELMAN-SYNDROME; HUMAN PEG1/MEST; MICE LACKING; CHROMOSOME-7; MOUSE; EXPRESSION	Mest (also known as Peg1), an imprinted gene expressed only from the paternal allele during development, was disrupted by gene targeting in embryonic stem (ES) cells. The targeted mutation is imprinted and reversibly silenced by passage through the female germ line. Paternal transmission activates the targeted allele and causes embryonic growth retardation associated with reduced postnatal survival rates in mutant progeny. More significantly. Mest-deficient females show abnormal maternal behaviour and impaired placentophagia, a distinctive mammalian behaviour. Our results provide evidence for the involvement of an imprinted gene in the control of adult behaviour.	Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 226, Japan; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England	University of Cambridge; Tokyo Institute of Technology; University of Cambridge	Surani, MA (corresponding author), Wellcome CRC Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.	as10021@mole.bio.cam.ac.uk	Lefebvre, Louis/O-9309-2016	Lefebvre, Louis/0000-0001-5664-9480; Viville, Stephane/0000-0002-5088-3003	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ainscough J. F. X., 1996, Epigenetic mechanisms of gene regulation., P173; ALLEN ND, 1995, P NATL ACAD SCI USA, V92, P10782, DOI 10.1073/pnas.92.23.10782; BEECHEY CV, 1989, MOUSE NEWS LETT, V84, P82; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; CATTANACH BM, 1990, DEVELOPMENT, P63; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DICKINSON C, 1988, PHYSIOL BEHAV, V43, P313, DOI 10.1016/0031-9384(88)90193-X; Eggermann T, 1997, HUM GENET, V100, P415, DOI 10.1007/s004390050526; FRANZ JR, 1986, PHYSIOL BEHAV, V38, P629, DOI 10.1016/0031-9384(86)90256-8; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FUNDELE RH, 1994, DEV GENET, V15, P515, DOI 10.1002/dvg.1020150610; HAIG D, 1991, CELL, V64, P1045; HOGLUND P, 1994, AM J HUM GENET, V55, P747; HOLM VA, 1993, PEDIATRICS, V91, P398; John RM, 1996, CURR OPIN CELL BIOL, V8, P348, DOI 10.1016/S0955-0674(96)80008-1; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; KRISTAL MB, 1991, NEUROSCI BIOBEHAV R, V15, P425, DOI 10.1016/S0149-7634(05)80035-1; LANGLOIS S, 1995, J MED GENET, V32, P871, DOI 10.1136/jmg.32.11.871; LATHE R, 1987, GENE, V57, P193, DOI 10.1016/0378-1119(87)90122-3; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Lefebvre L, 1997, HUM MOL GENET, V6, P1907, DOI 10.1093/hmg/6.11.1907; Miyoshi N, 1998, P NATL ACAD SCI USA, V95, P1102, DOI 10.1073/pnas.95.3.1102; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishita Y, 1996, GENOMICS, V36, P539, DOI 10.1006/geno.1996.0502; NUMAN M, 1994, ACTA PAEDIATR, V83, P19, DOI 10.1111/j.1651-2227.1994.tb13261.x; PATTON MA, 1988, J MED GENET, V25, P557, DOI 10.1136/jmg.25.8.557; Preece MA, 1997, J MED GENET, V34, P6, DOI 10.1136/jmg.34.1.6; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; SADO T, 1993, DEV GROWTH DIFFER, V35, P551; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Thomas SA, 1997, CELL, V91, P583, DOI 10.1016/S0092-8674(00)80446-8; VOSS R, 1989, AM J HUM GENET, V45, P373; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224	42	439	449	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1998	20	2					163	169		10.1038/2464	http://dx.doi.org/10.1038/2464			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771709				2022-12-27	WOS:000076231300018
J	Neubauer, G; King, A; Rappsilber, J; Calvio, C; Watson, M; Ajuh, P; Sleeman, J; Lamond, A; Mann, M				Neubauer, G; King, A; Rappsilber, J; Calvio, C; Watson, M; Ajuh, P; Sleeman, J; Lamond, A; Mann, M			Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex	NATURE GENETICS			English	Article							POLYACRYLAMIDE GELS; IDENTIFICATION; GENOME; NANOELECTROSPRAY; HELICASE; U4/U6; BOX; U1	Many important cell mechanisms are carried our and regulated by multi-protein complexes, for example, transcription and RNA processing machinery, receptor complexes end cytoskeletal structures. Most of these complexes remain only partially characterized due to the difficulty of conventional protein analysis methods. The rapid expansion of DNA sequence databases now provides whole or partial gene sequences of model organisms, and recent advances in protein microcharacterization via mass spectrometry allow the possibility of linking these DNA sequences to the proteins in functional complexes(1). This approach has been demonstrated in organisms whose genomes have been sequenced(2), such as budding yeast. Here we report the first characterization of an entire mammalian multi-protein complex using these methods. The machinery that removes introns from mRNA percursors-the spliceosome-is a large multi-protein complex(3,4). Approximately half of the components excised from a two-dimensional gel separation of the spliceosome were found in protein sequence databases. Using nanoelectrospray mass spectrometry, the remainder were identified and cloned using public expressed sequence tag (EST) databases. Existing EST databases are thus already sufficiently complete to allow rapid characterization of large mammalian protein complexes via mass spectrometry.	European Mol Biol Lab, Prot & Peptide Grp, D-69115 Heidelberg, Germany; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland	European Molecular Biology Laboratory (EMBL); University of Dundee	Mann, M (corresponding author), Odense Univ, Dept Mol Biol, Campusvej 55, DK-5230 Odense, Denmark.	mann@cebi.ou.dk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Cinzia, Calvio/E-1353-2011; Mann, Matthias/A-3454-2013	Rappsilber, Juri/0000-0001-5999-1310; Cinzia, Calvio/0000-0003-1631-0452; Mann, Matthias/0000-0003-1292-4799; Watson, Mark/0000-0002-3557-101X; Sleeman, Judith/0000-0003-0345-6508; Lamond, Angus/0000-0001-6204-6045	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEGGS JD, 1995, PREMRNA PROCESSING, P79; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; CALVIO C, 1995, RNA, V1, P724; CARMOFONSECA M, 1992, J CELL BIOL, V117, P1, DOI 10.1083/jcb.117.1.1; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Lamond AI, 1997, TRENDS CELL BIOL, V7, P139, DOI 10.1016/S0962-8924(97)01031-3; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Lauber J, 1997, RNA, V3, P926; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Molnar GM, 1997, P NATL ACAD SCI USA, V94, P7831, DOI 10.1073/pnas.94.15.7831; Moore M., 1993, RNA WORLD, P303; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; ONO W, 1994, MOL CELL BIOL, V14, P7611, DOI 10.1128/MCB.14.11.7611; REED R, 1988, CELL, V53, P949, DOI 10.1016/S0092-8674(88)90489-8; REED R, 1990, P NATL ACAD SCI USA, V87, P8031, DOI 10.1073/pnas.87.20.8031; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SUKEGAWA J, 1995, J BIOL CHEM, V270, P15702, DOI 10.1074/jbc.270.26.15702; WILL CL, 1995, NUCL ACIDS MOL BIOL, P342; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	27	412	446	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1998	20	1					46	50		10.1038/1700	http://dx.doi.org/10.1038/1700			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731529				2022-12-27	WOS:000075671400017
J	Strom, TM; Nyakatura, G; Apfelstedt-Sylla, E; Hellebrand, H; Lorenz, B; Weber, BHF; Wutz, K; Gutwillinger, N; Ruther, K; Drescher, B; Sauer, C; Zrenner, E; Meitinger, T; Rosenthal, A; Meindl, A				Strom, TM; Nyakatura, G; Apfelstedt-Sylla, E; Hellebrand, H; Lorenz, B; Weber, BHF; Wutz, K; Gutwillinger, N; Ruther, K; Drescher, B; Sauer, C; Zrenner, E; Meitinger, T; Rosenthal, A; Meindl, A			An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness	NATURE GENETICS			English	Article							BETA-SUBUNIT; REGION; RP3	The locus for the incomplete form of X-linked congenital stationary night blindness (CSNB2) maps to a 1.1-Mb region in Xp11.23 between markers DXS722 and DXS255. We identified a retina-specific calcium channel alpha(1)-subunit gene (CACNA1F) in this region, consisting of 48 exons encoding 1966 amino acids and showing high homology to L-type calcium channel alpha(1)-subunits. Mutation analysis in 13 families with CSNB2 revealed nine different mutations in 10 families, including three nonsense and one frameshift mutation. These data indicate that aberrations in a voltage-gated calcium channel. presumably causing a decrease in neurotransmitter release from photoreceptor presynaptic terminals, are a frequent cause of CSNB2.	Univ Munich, Abt Med Genet, D-80336 Munchen, Germany; Univ Tubingen, Augenklin, D-72076 Tubingen, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Univ Regensburg, Augenklin, D-93042 Regensburg, Germany; Inst Humangenet, D-97074 Wurzburg, Germany	University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg	Meindl, A (corresponding author), Univ Munich, Abt Med Genet, Goethestr 29, D-80336 Munchen, Germany.	alfons@pedgen.med.uni-muenchen.de	Meitinger, Thomas/O-1318-2015	Meitinger, Thomas/0000-0002-8838-8403; Weber, Bernhard H.F./0000-0002-8808-7723				BECHHANSEN NT, 1993, AM J HUM GENET, V52, P71; BERGEN AAB, 1995, HUM MOL GENET, V4, P931, DOI 10.1093/hmg/4.5.931; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Craxton M, 1993, Methods Mol Biol, V23, P149; Fisher SE, 1997, GENOMICS, V45, P340, DOI 10.1006/geno.1997.4941; HOGAN K, 1994, GENOMICS, V24, P608, DOI 10.1006/geno.1994.1677; HOOD DC, 1990, VISION RES, V30, P51, DOI 10.1016/0042-6989(90)90127-7; LEIMEISTER C, IN PRESS MECH DEV; Lorenz B, 1996, KLIN MONATSBL AUGENH, V208, P48, DOI 10.1055/s-2008-1035167; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MIYAKE Y, 1987, INVEST OPHTH VIS SCI, V28, P1816; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ruether K, 1993, Ger J Ophthalmol, V2, P429; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; Sinnegger MJ, 1997, J BIOL CHEM, V272, P27686, DOI 10.1074/jbc.272.44.27686; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Witkovsky P, 1997, J NEUROSCI, V17, P7297	26	368	377	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					260	263		10.1038/940	http://dx.doi.org/10.1038/940			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662399				2022-12-27	WOS:000074565900022
J	Bergstrom, TF; Josefsson, A; Erlich, HA; Gyllensten, U				Bergstrom, TF; Josefsson, A; Erlich, HA; Gyllensten, U			Recent origin of HLA-DRB1 alleles and implications for human evolution	NATURE GENETICS			English	Article							HUMAN IA ANTIGENS; CLASS-II REGION; DR-BETA LOCI; NUCLEOTIDE SUBSTITUTION; MITOCHONDRIAL-DNA; OVERDOMINANT SELECTION; LINKAGE DISEQUILIBRIUM; COALESCENT PROCESS; GENE CONVERSION; POLYMORPHISM	The HLA class I and class II loci are the most highly polymorphic coding regions in the human genome. Based on the similarity of the coding sequences of alleles between species, it has been claimed that the HLA polymorphism is ancient and predates the separation of human (Homo) and chimpanzee (Pan), 4-7.4 Myr ago. Analysis of intron sequences, however, provides support for a more recent origin and for rapid generation of alleles at the HLA class II DRB1 locus. The human DRB1 alleles can be divided into groups (allelic lineages); most of these lineages have diverged from each other before the separation of Homo and Pan. Alleles within such a lineage, however, appear to be, on average, 250,000 years old, implying that the vast majority (greater than 90%) of the more than 135 contemporary human DRB1 alleles have been generated after the separation of Homo and Pan. The coalescence time of alleles within allelic lineages indicates that the effective population size (N-e) for early hominids (over the last 1 Myr) was approximately 10(4) individuals, similar to estimates based on other nuclear loci and mitochondrial DNA. With a single exception, the genetic mechanisms (gene conversion and point mutation) that have diversified the exon-2 sequences do not appear to extend into the adjacent intron sequences. The part of exon 2 encoding the beta-sheet evolves in concert with the surrounding introns, while the alpha-helix appears to have been subjected to gene conversion-like events, suggesting that such exchange events are highly localised and occur over extremely short sequence tracts.	Uppsala Univ, Ctr Biomed, Unit Med Genet, Dept Genet & Pathol, S-75123 Uppsala, Sweden; Roche Mol Syst Inc, Dept Human Genet, Alameda, CA 94501 USA	Uppsala University; Roche Holding	Gyllensten, U (corresponding author), Uppsala Univ, Ctr Biomed, Unit Med Genet, Dept Genet & Pathol, Box 589, S-75123 Uppsala, Sweden.	ulf.gyllensten@medgen.uu.se	Bergström, Tomas/B-4681-2017	Bergström, Tomas/0000-0002-7480-2669				ARDEN B, 1982, P NATL ACAD SCI-BIOL, V79, P2342, DOI 10.1073/pnas.79.7.2342; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; AYALA FJ, 1994, P NATL ACAD SCI USA, V91, P6787, DOI 10.1073/pnas.91.15.6787; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P188, DOI 10.1006/mpev.1996.0013; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHARLESWORTH B, 1993, GENETICS, V134, P1289; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; GORSKI J, 1986, NATURE, V322, P67, DOI 10.1038/322067a0; Gyllensten U, 1996, TISSUE ANTIGENS, V47, P212, DOI 10.1111/j.1399-0039.1996.tb02543.x; GYLLENSTEN UB, 1991, P NATL ACAD SCI USA, V88, P3686, DOI 10.1073/pnas.88.9.3686; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Hickson RE, 1997, J MOL EVOL, V45, P589, DOI 10.1007/PL00006263; HOLMES EC, 1989, J HUM EVOL, V18, P775, DOI 10.1016/0047-2484(89)90089-4; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HUDSON RR, 1988, GENETICS, V120, P831; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; JUKES T H, 1969, P21; KAPLAN NL, 1988, GENETICS, V120, P819; KAPLAN NL, 1989, GENETICS, V123, P887; KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LI WH, 1991, GENETICS, V129, P513; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Mack SJ, 1998, TISSUE ANTIGENS, V51, P41, DOI 10.1111/j.1399-0039.1998.tb02945.x; MARSH SGE, 1995, TISSUE ANTIGENS, V46, P258, DOI 10.1111/j.1399-0039.1995.tb03125.x; MAYER WE, 1988, EMBO J, V7, P2765, DOI 10.1002/j.1460-2075.1988.tb03131.x; MCCONNELL TJ, 1988, NATURE, V332, P651, DOI 10.1038/332651a0; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; NEI M, 1986, MOL BIOL EVOL, V3, P418; OHTA T, 1995, J MOL EVOL, V41, P115, DOI 10.1007/BF00170662; RIPLEY LS, 1991, MOL EVOLUTION MAJOR, P63; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satta Y, 1996, J MOL EVOL, V42, P648, DOI 10.1007/BF02338798; SATTA Y, 1991, MOL EVOLUTION MAJOR, P51; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; STROBECK C, 1983, GENETICS, V103, P545; Svensson AC, 1996, IMMUNOGENETICS, V43, P304, DOI 10.1007/BF02440998; SVENSSON AC, 1995, IMMUNOGENETICS, V41, P74; TAJIMA F, 1989, GENETICS, V123, P585; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TAKAHATA N, IN PRESS IMMUNOGENET; TITUSTRACHTENBERG EA, 1994, AM J HUM GENET, V55, P160; TROWSDALE J, 1995, IMMUNOGENETICS, V41, P1, DOI 10.1007/BF00188427; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WU SK, 1986, NATURE, V324, P676, DOI 10.1038/324676a0	53	126	128	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1998	18	3					237	242		10.1038/ng0398-237	http://dx.doi.org/10.1038/ng0398-237			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500545				2022-12-27	WOS:000072325000021
J	Wu, W; Cogan, JD; Pfaffle, RW; Dasen, JS; Frisch, H; O'Connell, SM; Flynn, SE; Brown, MR; Mullis, PE; Parks, JS; Phillips, JA; Rosenfeld, MG				Wu, W; Cogan, JD; Pfaffle, RW; Dasen, JS; Frisch, H; O'Connell, SM; Flynn, SE; Brown, MR; Mullis, PE; Parks, JS; Phillips, JA; Rosenfeld, MG			Mutations in PROP1 cause familial combined pituitary hormone deficiency	NATURE GENETICS			English	Article							AMES DWARF MICE; GENE; PIT-1; DF	Combined pituitary hormone deficiency (CPHD) in man denotes impaired production of growth hormone (CH) and one or more of the other five anterior pituitary hormones. Mutations of the pituitary transcription factor gene POU?FI (the human homologue of mouse Pit1) are responsible for deficiencies of GH, prolactin and thyroid stimulating hormone (TSH) in Snell and Jackson dwarf mice and in man, while the production of adrenocorticotrophic hormone (ACTH), luteinizing hormone (LH) and follicle stimulating hormone (FSH) is preserved, The Ames dwarf (df) mouse displays a similar phenotype, and appears to be epistatic to Snell and Jackson dwarfism. We have recently positionally cloned the putative Ames dwarf gene Prop? (ref. 1), which encodes a paired-like homeodomain protein that is expressed specifically in embryonic pituitary and is necessary for Pit? expression. In this report, we have identified four CPHD families with homozygosity or compound heterozygosity for inactivating mutations of PROP1. These mutations in the human PROP1 gene result in a gene product with reduced DNA-binding and transcriptional activation ability in comparison to the product of the murine df mutation. In contrast to individuals with POU1F1 mutations, those with PROP? mutations cannot produce LH and FSH at a sufficient level and do not enter puberty spontaneously. Our results identify a major cause of CPHD in humans and suggest a direct or indirect role for PROP? in the ontogenesis of pituitary gonadotropes, as well as somatotropes, lactotropes and caudomedial thyrotropes.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Rhein Westfal TH Aachen, Sch Med, Dept Pediat, D-52057 Aachen, Germany; Univ Vienna, Dept Pediat, Div Endocrinol, A-1090 Vienna, Austria; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Univ Bern, Dept Pediat, Div Endocrinol, Inselspital, CH-3010 Bern, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Diego; Vanderbilt University; RWTH Aachen University; University of Vienna; Emory University; University of Bern	Wu, W (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.		Parks, John/F-8570-2011		NIDDK NIH HHS [DK46312, DK52312] Funding Source: Medline; NIH HHS [GF 97-27] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052312, R01DK046312] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040; BARTKE A, 1965, GEN COMP ENDOCR, V5, P418, DOI 10.1016/0016-6480(65)90102-4; BARTKE A, 1979, GENETIC VARIATION HO, P111; BUCKWALTER MS, 1991, GENOMICS, V10, P515, DOI 10.1016/0888-7543(91)90430-M; COHEN LE, 1995, J CLIN ENDOCR METAB, V80, P679, DOI 10.1210/jc.80.2.679; Gage PJ, 1996, DEVELOPMENT, V122, P151; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; KAPPEN C, 1993, GENOMICS, V18, P54, DOI 10.1006/geno.1993.1426; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; Raskin S, 1996, HUM GENET, V98, P703, DOI 10.1007/s004390050289; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; TANG KC, 1993, ENDOCRINOLOGY, V132, P2518, DOI 10.1210/en.132.6.2518; TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56	13	382	392	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					147	149		10.1038/ng0298-147	http://dx.doi.org/10.1038/ng0298-147			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462743				2022-12-27	WOS:000071779500022
J	Nakayama, JI; Tahara, H; Tahara, E; Saito, M; Ito, K; Nakamura, H; Nakanishi, T; Tahara, E; Ide, T; Ishikawa, F				Nakayama, JI; Tahara, H; Tahara, E; Saito, M; Ito, K; Nakamura, H; Nakanishi, T; Tahara, E; Ide, T; Ishikawa, F			Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas	NATURE GENETICS			English	Article							DNA	Telomerase is a specialized type of reverse transcriptase which catalyzes the synthesis and extension of telomeric DNA (for review, see ref.1). This enzyme is highly active in most cancer cells, but is inactive in most somatic cells(2). This striking observation led to the suggestion that telomerase might be important for the continued growth(3) or progression(4) of cancer cells. However, little is known about the molecular mechanism of telomerase activation in cancer cells, Human telomerase reverse transcriptase (hTRT) has recently been identified as a putative human telomerase catalytic subunit(5,6). We transfected the gene encoding hTRT into telomerase-negative human normal fibroblast cells and demonstrated that expression of wild-type hTRT induces telomerase activity, whereas hTRT mutants containing mutations in regions conserved among other reverse transcriptases did not, Hepatocellular carcinoma (20 samples) and non-cancerous liver tissues (19 samples) were examined for telomerase activity and expression of hTRT, the human telomerase RNA component (hTR; encoded by TERC)(7) and the human telomerase-associated protein (hTLP1; encoded by TEP1)(8,9). A significant correlation between hTRT expression and telomerase activity was observed. These results indicate that the hTRT protein is the catalytic subunit of human telomerase, and that it plays a key role in the activation of telomerase in cancer cells.	Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 226, Japan; Hiroshima Univ, Sch Med, Dept Cellular & Mol Biol, Hiroshima 734, Japan; Hiroshima Univ, Sch Med, Dept Internal Med 1, Hiroshima 734, Japan; Hiroshima Univ, Sch Med, Dept Pathol 1, Hiroshima 734, Japan; Mitsubishi Chem Corp, Yokohama Res Ctr, Pharmaceut Lab 2, Aoba Ku, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Hiroshima University; Hiroshima University; Hiroshima University; Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical	Ishikawa, F (corresponding author), Tokyo Inst Technol, Dept Life Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 226, Japan.		Ishikawa, Fuyuki/AAU-4056-2021; Nakayama, Jun-ichi/C-6003-2011; Kowaltowski, Alicia J/H-8698-2012	Ishikawa, Fuyuki/0000-0002-5580-2305; Nakayama, Jun-ichi/0000-0002-5597-8239; 				BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Eickbush Thomas H., 1994, P121; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Ishikawa F, 1997, BIOCHEM BIOPH RES CO, V230, P1, DOI 10.1006/bbrc.1996.5928; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; MATSUO M, 1982, J GERONTOL, V37, P33, DOI 10.1093/geronj/37.1.33; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakashio R, 1997, INT J CANCER, V74, P141, DOI 10.1002/(SICI)1097-0215(19970422)74:2<141::AID-IJC1>3.0.CO;2-Z; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445; TAHARA H, 1995, CANCER RES, V55, P2734; Tatematsu K, 1996, ONCOGENE, V13, P2265; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x	21	570	616	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					65	68		10.1038/ng0198-65	http://dx.doi.org/10.1038/ng0198-65			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425903				2022-12-27	WOS:000071259600024
J	Singh, NA; Charlier, C; Stauffer, D; DuPont, BR; Leach, RJ; Melis, R; Ronen, GM; Bjerre, I; Quattlebaum, T; Murphy, JV; McHarg, ML; Gagnon, D; Rosales, TO; Peiffer, A; Anderson, VE; Leppert, M				Singh, NA; Charlier, C; Stauffer, D; DuPont, BR; Leach, RJ; Melis, R; Ronen, GM; Bjerre, I; Quattlebaum, T; Murphy, JV; McHarg, ML; Gagnon, D; Rosales, TO; Peiffer, A; Anderson, VE; Leppert, M			A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns	NATURE GENETICS			English	Article							FAMILIAL NEONATAL CONVULSIONS; KVLQT1 MUTATIONS; HETEROGENEITY; CHROMOSOME-8Q; CONFIRMATION; D20S19; REGION; LOCUS; PORE	Idiopathic generalized epilepsies account for about 40% of epilepsy up to age 40 and commonly have a genetic basis. One type is benign familial neonatal convulsions (BFNC), a dominantly inherited disorder of newborns. We have identified a sub-microscopic deletion of chromosome 20q13.3 that co-segregates with seizures in a BFNC family. Characterization of cDNAs spanning the deleted region identified one encoding a novel voltage-gated potassium channel, KCNQ2, which belongs to a new KQT-like class of potassium channels. Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation. This finding in BFNC provides additional evidence that defects in potassium channels are involved in the mammalian epilepsy phenotype.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; Malmo Univ Hosp, Dept Pediat, S-205021 Malmo, Sweden; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Childrens Mercy Hosp, Kansas City, MO 64108 USA; Neurol Grp PC, Norristown, PA 19401 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; Dr CA Janeway Hlth Ctr, St Johns, NF A1A 1R8, Canada; Univ Minnesota, Dept Epidemiol, Minneapolis, MN 55455 USA	Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health San Antonio; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; McMaster University; Lund University; Skane University Hospital; Medical University of South Carolina; Children's Mercy Hospital; Boston University; University of Minnesota System; University of Minnesota Twin Cities	Leppert, M (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.		Ronen, Gabriel M/AAS-3048-2021; Ronen, Gabriel M/AAS-5028-2021	Ronen, Gabriel M/0000-0002-7467-0627; Ronen, Gabriel M/0000-0002-7467-0627; Leach, Robin/0000-0002-3201-5579; Charlier, Carole/0000-0002-9694-094X	NCI NIH HHS [5P30 CA42014] Funding Source: Medline; NCRR NIH HHS [M01 RR00064] Funding Source: Medline; NINDS NIH HHS [R01 NS32666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CHANDY KG, 1995, HDB RECEPTORS CHANNE, P1; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Keating MT, 1996, CURR OPIN GENET DEV, V6, P326, DOI 10.1016/S0959-437X(96)80010-4; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEPPERT M, 1993, BRAIN PATHOL, V3, P357, DOI 10.1111/j.1750-3639.1993.tb00764.x; LEWIS TB, 1993, AM J HUM GENET, V53, P670; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; MALAFOSSE A, 1992, HUM GENET, V89, P54, DOI 10.1007/BF00207042; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; MELDRUM BS, 1995, EPILEPSIA, V36, P530; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Plouin P., 1994, IDIOPATHIC GEN EPILE, P39; Ptacek LJ, 1997, NEUROMUSCULAR DISORD, V7, P250, DOI 10.1016/S0960-8966(97)00046-1; RONEN GM, 1993, NEUROLOGY, V43, P1355, DOI 10.1212/WNL.43.7.1355; Russell MW, 1996, HUM MOL GENET, V5, P1319, DOI 10.1093/hmg/5.9.1319; RYAN SG, 1991, ANN NEUROL, V29, P469, DOI 10.1002/ana.410290504; Sanguinetti MC, 1997, NEUROPHARMACOLOGY, V36, P755, DOI 10.1016/S0028-3908(97)00029-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; STEINLEIN O, 1995, HUM GENET, V95, P411; Steinlein Ortrud, 1992, Human Molecular Genetics, V1, P325, DOI 10.1093/hmg/1.5.325; TYTGAT J, 1994, BIOCHEM BIOPH RES CO, V203, P513, DOI 10.1006/bbrc.1994.2212; VIGEVANO F, 1994, IDIOPATHIC GEN EPILE, P45; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Yokoyama M, 1996, DNA Res, V3, P311, DOI 10.1093/dnares/3.5.311	36	937	990	2	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					25	29		10.1038/ng0198-25	http://dx.doi.org/10.1038/ng0198-25			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425895				2022-12-27	WOS:000071259600016
J	Prows, DR; Shertzer, HG; Daly, MJ; Sidman, CL; Leikauf, GD				Prows, DR; Shertzer, HG; Daly, MJ; Sidman, CL; Leikauf, GD			Genetic analysis of ozone-induced acute lung injury in sensitive and resistant strains of mice	NATURE GENETICS			English	Article							INBRED MOUSE STRAINS; INDUCED INFLAMMATION; AIR-POLLUTION; RESPONSIVENESS; SUSCEPTIBILITY; DISEASE; ASTHMA; TRAITS	Epidemiological studies have found air pollution to be associated with excessive mortality, particularly death from respiratory and cardiovascular causes(1,2). Interpretation of these findings is controversial, however, because toxicological mechanisms controlling mortality are uncertain. Susceptibility to many air pollutants entails an oxidative stress response(3,4). Accordingly, the best-characterized oxidant air pollutant is ozone(5), which causes direct oxidative damage of lung biomolecules(6). An underlying characteristic derived from clinical and epidemiological studies of healthy and asthmatic individuals of all ages is marked variability in the respiratory effects of ozone(7-11). This susceptibility difference among humans suggests that genetic determinants may control predisposition to the harmful effects of ozone(12). Mice also vary considerably in their response to ozone(13-15), Moreover, ozone-induced differences in strain responses(16) indicate that susceptibility in mice can be genetically determined. Therefore, we used inbred mice to investigate the genetic determinants of acute lung injury, Recombinant inbred (RI) strains derived from A/J (A) mice (sensitive) and C57BL/6J (B) mice (resistant) showed a continuous phenotypic pattern, suggesting a multigenic trait. Quantitative trait locus and RI analyses suggested three major loci linked to ozone susceptibility. Differences in phenotype ratios among the reciprocal backcrosses were consistent with parental imprinting, These findings implicate various genetic and epigenetic factors in individual susceptibility to air pollution.	UNIV CINCINNATI, DEPT ENVIRONM HLTH, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, DEPT CELLULAR & MOL PHYSIOL, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, DEPT MED, CINCINNATI, OH 45267 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE CTR 9, CAMBRIDGE, MA 02142 USA; UNIV CINCINNATI, MED CTR, DEPT MOL GENET BIOCHEM & MICROBIOL, CINCINNATI, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Massachusetts Institute of Technology (MIT); Whitehead Institute; University System of Ohio; University of Cincinnati			Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Leikauf, George/0000-0002-4514-7060	NHLBI NIH HHS [R01-HL58275] Funding Source: Medline; NIEHS NIH HHS [R01-ES06562, R01-ES06677] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006677, R01ES006562] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		CATTANACH BM, 1994, J INHERIT METAB DIS, V17, P403, DOI 10.1007/BF00711356; CROSS CE, 1994, ENVIRON HEALTH PERSP, V102, P185, DOI 10.2307/3432237; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; GOLDSTEIN BD, 1973, ARCH ENVIRON HEALTH, V27, P412, DOI 10.1080/00039896.1973.10666416; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; KLEEBERGER SR, 1993, AM J PHYSIOL, V264, pL15, DOI 10.1152/ajplung.1993.264.1.L15; KLEEBERGER SR, 1990, AM J PHYSIOL, V258, pL313, DOI 10.1152/ajplung.1990.258.6.L313; KREIT JW, 1989, J APPL PHYSIOL, V66, P217, DOI 10.1152/jappl.1989.66.1.217; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LINCOLN S, 1992, MAPPING GENES CONTRO; LIPPMANN M, 1983, ADV MOD ENV TOXICOL, V5, P423; LIPPMANN M, 1993, ENV TOXICANTS HUMAN, P465; MANLY KF, 1991, MAMM GENOME, V1, P123, DOI 10.1007/BF02443789; MARSHALL JD, 1992, MAMM GENOME, V3, P669, DOI 10.1007/BF00444361; MCBRIDE DE, 1994, AM J RESP CRIT CARE, V149, P1192, DOI 10.1164/ajrccm.149.5.8173759; MCDONNELL WF, 1991, PHARMACOGENETICS, V1, P110, DOI 10.1097/00008571-199111000-00010; MUSTAFA MG, 1990, FREE RADICAL BIO MED, V9, P245, DOI 10.1016/0891-5849(90)90035-H; NESBITT MN, 1984, J LEUKOCYTE BIOL, V36, P357, DOI 10.1002/jlb.36.3.357; OSTRO B, 1993, ARCH ENVIRON HEALTH, V48, P336, DOI 10.1080/00039896.1993.9936722; PATERSON AH, 1991, GENETICS, V127, P181; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; POPE CA, 1995, INHAL TOXICOL, V7, P1, DOI 10.3109/08958379509014267; SAPIENZA C, 1992, GENETICS, V132, P241; SILVERMAN F, 1979, ENVIRON HEALTH PERSP, V29, P131, DOI 10.2307/3429055; SPEKTOR DM, 1988, AM REV RESPIR DIS, V138, P821, DOI 10.1164/ajrccm/138.4.821; STOKINGER H E, 1957, AMA Arch Ind Health, V15, P181; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; 1996, MAMM GENOME, V6, pS1	30	105	109	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1997	17	4					471	474		10.1038/ng1297-471	http://dx.doi.org/10.1038/ng1297-471			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398853				2022-12-27	WOS:A1997YJ92400032
J	Bernot, A; Clepet, C; Dasilva, C; Devaud, C; Petit, JL; Caloustian, C; Cruaud, C; Samson, D; Pulcini, F; Weissenbach, J; Heilig, R; Notarnicola, C; Domingo, C; Rozenbaum, M; Benchetrit, E; Topaloglu, R; Dewalle, M; Dross, C; Hadjari, P; Dupont, M; Demaille, J; Touitou, I; Smaoui, N; Nedelec, B; Mery, JP; Chaabouni, H; Delpech, M; Grateau, G				Bernot, A; Clepet, C; Dasilva, C; Devaud, C; Petit, JL; Caloustian, C; Cruaud, C; Samson, D; Pulcini, F; Weissenbach, J; Heilig, R; Notarnicola, C; Domingo, C; Rozenbaum, M; Benchetrit, E; Topaloglu, R; Dewalle, M; Dross, C; Hadjari, P; Dupont, M; Demaille, J; Touitou, I; Smaoui, N; Nedelec, B; Mery, JP; Chaabouni, H; Delpech, M; Grateau, G			A candidate gene for familial Mediterranean fever	NATURE GENETICS			English	Article							DNA; PROTEIN; EXONS; AMPLIFICATION; HYBRIDIZATION; CHROMOSOMES; PROGRAM; LINKAGE; FISH	Familiar Mediterranean fever (FMF) is an autosomal recessive disorder characterized by attacks of fever and serositis. In this paper, we define a minimal co-segregating region of 60 kb containing the FMF gene (MEFV) and identify four different transcript units within this region. One of these transcripts encodes a new protein (marenostrin) related to the ret-finger protein and to butyrophilin. Four conservative missense variations co-segregating with FMF have been found within the MEN candidate gene in 85% of the carrier chromosomes. These variations, which cluster at the carboxy terminal domain of the protein, were not present in 308 control chromosomes, including 162 validated non-carriers. We therefore propose that the sequence alterations in the marenostrin protein are responsible for the FMF disease.	HOP ARNAUD DE VILLENEUVE, BIOCHIM GENET LAB, F-34295 MONTPELLIER, FRANCE; UNIV PARIS 05, INST COCHIN GENET MOL, PARIS, FRANCE; SERV MALAD CONGENITALES & HEREDITAIRES, TUNIS, TUNISIA	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bernot, A (corresponding author), GENETHON, CNRS URA 1922, 1 RUE INT, F-91000 EVRY, FRANCE.		TOPALOGLU, Rezan/I-9095-2013; nedelec, brigitte/H-3002-2017; Notarnicola, Cecile/N-9032-2018	nedelec, brigitte/0000-0002-4487-9438; Notarnicola, Cecile/0000-0001-8363-1614; Topaloglu, Rezan/0000-0002-6423-0927; Steinbach, Delphine/0000-0001-7144-7908; Petit, Jean-Louis/0000-0002-8566-0571; Cruaud, Corinne/0000-0002-4752-7278				ADAMS MD, 1995, NATURE, V377, P3; AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P451; ALMEIDA MR, 1995, HUM GENET, V96, P350; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BELLINI M, 1993, EMBO J, V12, P107, DOI 10.1002/j.1460-2075.1993.tb05636.x; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; DANIELS M, 1995, AM J MED GENET, V55, P311, DOI 10.1002/ajmg.1320550313; Datson NA, 1996, NUCLEIC ACIDS RES, V24, P1105, DOI 10.1093/nar/24.6.1105; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Goguel AF, 1996, ANN GENET-PARIS, V39, P64; Gouzy J, 1996, TRENDS BIOCHEM SCI, V21, P493, DOI 10.1016/S0968-0004(96)30040-6; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; JACK LJW, 1990, J BIOL CHEM, V265, P14481; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; Kulp D, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P134; Levy EN, 1996, AM J HUM GENET, V58, P523; MOTT R, 1993, NUCLEIC ACIDS RES, V21, P1965, DOI 10.1093/nar/21.8.1965; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; ROGERS D, 1995, AM J MED GENET, V34, P168; ROSENBERG C, 1995, NAT GENET, V10, P477, DOI 10.1038/ng0895-477; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Sood R, 1997, GENOMICS, V42, P83, DOI 10.1006/geno.1997.4629; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; Touitou I, 1996, AM J HUM GENET, V59, P603; TSUGU H, 1994, GENOMICS, V24, P541, DOI 10.1006/geno.1994.1664; WIEGANT J, 1992, HUM MOL GENET, V1, P587, DOI 10.1093/hmg/1.8.587; Xu Y, 1994, Genet Eng (N Y), V16, P241	31	1133	1172	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					25	31						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288094				2022-12-27	WOS:A1997XU72400014
J	Jenuth, JP; Peterson, AC; Shoubridge, EA				Jenuth, JP; Peterson, AC; Shoubridge, EA			Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA; TRANSCRIPTION; SEGREGATION	Mammalian mitochondrial DNA (mtDNA) is a highly polymorphic, high-copy-number genome that is maternally inherited. New mutations in mtDNA segregate rapidly in the female germline due to a genetic bottleneck in early oogenesis(1-3) and as a result most individuals are homoplasmic for a single species of mtDNA. Sequence variants thus accumulate along maternal lineages without genetic recombination. Most of the extant variation in mtDNA in mammalian populations has been assumed to be neutral with respect to selection(4); however, comparisons of the ratio of replacement to silent nucleotide substitutions between species suggest that the evolution of mammalian mtDNA is not strictly neutral(5). To test directly whether polymorphic mtDNAs behave as neutral variants, we examined the segregation of two different mtDNA genotypes in the tissues of heteroplasmic mice. We find evidence for random genetic drift in some tissues, but in others strong, tissue-specific and age-related, directional selection for different mtDNA genotypes in the same animal. These surprising data suggest that the coding sequence of mtDNA may represent a compromise between the competing demands of different tissues and point to the existence of unknown, tissue-specific nuclear genes important in the interaction between the nuclear and mitochondrial genomes.	MONTREAL NEUROL INST,MONTREAL,PQ H3A 2B4,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3A 1B1,CANADA; MCGILL UNIV,MOL ONCOL GRP,MONTREAL,PQ H3A 1A1,CANADA	McGill University; McGill University; McGill University								ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BIRKY CW, 1983, GENETICS, V103, P513; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; DESTORDEUR E, 1989, MOL GEN GENET, V220, P127, DOI 10.1007/BF00260866; DUKES KR, 1995, THESIS U FLORIDA; HARDING AE, 1992, AM J HUM GENET, V50, P629; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KENNAWAY NG, 1990, PEDIATR RES, V28, P529; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Nachman MW, 1996, GENETICS, V142, P953; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; ZAJICEK G, 1985, LIVER, V5, P293	21	300	313	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					93	95		10.1038/ng0597-93	http://dx.doi.org/10.1038/ng0597-93			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140402				2022-12-27	WOS:A1997WX02400029
J	Comuzzie, AG; Hixson, JE; Almasy, L; Mitchell, BD; Mahaney, MC; Dyer, TD; Stern, MP; MacCluer, JW; Blangero, J				Comuzzie, AG; Hixson, JE; Almasy, L; Mitchell, BD; Mahaney, MC; Dyer, TD; Stern, MP; MacCluer, JW; Blangero, J			A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2	NATURE GENETICS			English	Article							APOLIPOPROTEIN-B GENE; OBESE GENE; PEDIGREE ANALYSIS; ADIPOSE-TISSUE; OB GENE; WEIGHT; EXPRESSION; PROTEIN; POLYMORPHISM; INHERITANCE	Obesity is a major predisposing factor for the development of several chronic diseases including non-insulin dependent diabetes mellitus (NIDDM) and coronary heart disease (CHD). Leptin is a serum protein which is secreted by adipocytes(1-4) and thought to play a role in the regulation of body fat(5-8). Leptin levels in humans have been found to be highly correlated with an individual's total adiposity(8,9). We performed a genome-wide scan and conducted multipoint linkage analysis using a general pedigree-based variance component approach to identify genes with measurable effects on quantitative variation in leptin levels in Mexican Americans. A microsatellite polymorphism, D2S1788, mapped to chromosome 2p21 (approximately 74 cM from the tip of the short arm) and showed strong evidence of linkage with serum leptin levels with a lod score of 4.95 (P = 9 x 10(-7)). This locus accounted for 47% of the variation in serum leptin levels, with a residual additive genetic component contributing an additional 24%. This region contains several potential candidate genes for obesity, including glucokinase regulatory protein (GCKR) and pro-opiomelanocortin (POMC). Our results show strong evidence of linkage of this region of chromosome 2 with serum leptin levels and indicate that this region could contain an important human obesity gene.	UNIV TEXAS, HLTH SCI CTR, DEPT MED, DIV CLIN EPIDEMIOL, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio	Comuzzie, AG (corresponding author), SW FDN BIOMED RES, DEPT GENET, POB 760549, SAN ANTONIO, TX 78245 USA.		Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021; Mitchell, Braxton/CAF-0876-2022	Hixson, James/0000-0002-0849-9315; Mitchell, Braxton/0000-0003-4920-4744	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522, P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015803] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45522, HL28972] Funding Source: Medline; NIGMS NIH HHS [GM15803] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS CI, 1994, AM J HUM GENET, V54, P535; Blangero J, 1996, 6 SW FDN BIOM RES PO; BOTTINI E, 1990, HUM BIOL, V62, P403; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Davis S, 1996, AM J HUM GENET, V58, P867; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Duggirala R, 1996, AM J HUM GENET, V59, P694; Frisancho AR, 1990, ANTHROPOMETRIC STAND; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Green P, 1990, DOCUMENTATION CRI MA; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; HASSTEDT SJ, 1989, AM J HUM GENET, V45, P917; HAUTANEN A, 1993, J INTERN MED, V234, P461, DOI 10.1111/j.1365-2796.1993.tb00779.x; HAZUDA HP, 1991, AM J CLIN NUTR, V53, pS1529, DOI 10.1093/ajcn/53.6.1529S; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Klein S, 1996, DIABETES, V45, P984, DOI 10.2337/diabetes.45.7.984; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; Ma ZM, 1996, CLIN CHEM, V42, P942; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MAHANEY MC, 1995, CIRCULATION, V92, P3240, DOI 10.1161/01.CIR.92.11.3240; MASUZAKI H, 1995, DIABETES, V44, P855, DOI 10.2337/diabetes.44.7.855; Mitchell BD, 1996, ARTERIOSCL THROM VAS, V16, P281, DOI 10.1161/01.ATV.16.2.281; Mitchell Braxton D., 1993, Ethnicity and Disease, V3, P22; MURAKAMI T, 1995, BIOCHEM BIOPH RES CO, V214, P1260, DOI 10.1006/bbrc.1995.2422; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; POULIOT MC, 1994, ARTERIOSCLER THROMB, V14, P527, DOI 10.1161/01.ATV.14.4.527; PRICE RA, 1990, HUM BIOL, V62, P747; RAJPUTWILLIAMS J, 1988, LANCET, V2, P1442; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; RICE T, 1993, AM J HUM GENET, V52, P967; SAHA N, 1993, CLIN GENET, V44, P113; WARNER JP, 1995, MAMM GENOME, V6, P532, DOI 10.1007/BF00356171; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	41	391	405	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					273	276		10.1038/ng0397-273	http://dx.doi.org/10.1038/ng0397-273			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054940				2022-12-27	WOS:A1997WK38600017
J	Garkavtsev, I; Kazarov, A; Gudkov, A; Riabowol, K				Garkavtsev, I; Kazarov, A; Gudkov, A; Riabowol, K			Suppression of the novel growth inhibitor p33(ING1) promotes neoplastic transformation	NATURE GENETICS			English	Article							CLONING; EXPRESSION; GENE; CELLS	Using a new strategy for tumour suppressor gene isolation based on subtractive hybridization and the subsequent selection of transforming 'genetic suppressor elements', we have cloned a novel gene called ING1 encoding a 33-kD protein (p33(ING1)) that displays characteristics of a tumour suppressor. Acute expression of transfected constructs encoding this gene inhibited cell growth while chronic expression of ING1 antisense constructs promoted cell transformation. Limited analyses of tumour cell lines show that mutation of the ING1 gene occurs in neuroblastoma cells and reduced expression was seen in some breast cancer cell lines. These results demonstrate that ING1 can act as a potent growth regulator in normal and in established cells and provide evidence for a role as a candidate tumour suppressor gene whose inactivation may contribute to the development of cancers.	UNIV CALGARY,DEPT MED BIOCHEM,CALGARY,AB T2N 4N1,CANADA; UNIV CALGARY,SO ALBERTA CANC RES,CALGARY,AB T2N 4N1,CANADA; UNIV ILLINOIS,DEPT GENET,CHICAGO,IL 60607	University of Calgary; University of Calgary; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Gudkov, Andrei/0000-0003-2548-0154	NATIONAL CANCER INSTITUTE [R01CA060730, R21CA062045] Funding Source: NIH RePORTER; NCI NIH HHS [CA60730, CA62045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OSSOVSKAYA V, IN PRESS P NATL ACAD; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Sambrook J., 2002, MOL CLONING LAB MANU; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360	16	278	348	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					415	420		10.1038/ng1296-415	http://dx.doi.org/10.1038/ng1296-415			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944021				2022-12-27	WOS:A1996VV73000017
J	Oh, J; Bailin, T; Fukai, K; Feng, GH; Ho, LL; Mao, JI; Frenk, E; Tamura, N; Spritz, RA				Oh, J; Bailin, T; Fukai, K; Feng, GH; Ho, LL; Mao, JI; Frenk, E; Tamura, N; Spritz, RA			Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles	NATURE GENETICS			English	Article							EXON AMPLIFICATION; PLATELETS; CHROMOSOME-19; POPULATION; SEQUENCES; STRATEGY; REGION; MAPS	Hermansky-Pudlak syndrome (HPS) is an often-fatal autosomal recessive disease in which albinism, bleeding, and lysosomal storage result from defects of diverse cytoplasmic organelles: melanosomes, platelet dense bodies, and lysosomes. HPS is the most common single-gene disorder in Puerto Rico, with an incidence of 1 in 1,800. We have identified the HPS gene by positional cloning, and found homozygous frameshifts in this gene in Puerto Rican, Swiss, Irish and Japanese HPS patients. The HPS polypeptide is a novel transmembrane protein that is likely to be a component of multiple cytoplasmic organelles and that is apparently crucial for their normal development and function. The different clinical phenotypes associated with the different HPS frameshifts we observed suggests that differentially truncated HPS polypeptides may have somewhat different consequences for subcellular function.	UNIV WISCONSIN, DEPT MED GENET, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT PEDIAT, MADISON, WI 53706 USA; GENOME THERAPEUT CORP, COLLABORAT RES DIV, WALTHAM, MA 02154 USA; CHU VAUDOIS, SERV DERMATOVENEREOL, LAUSANNE, SWITZERLAND; JUNTENDO UNIV, SCH MED, DEPT RESP MED, TOKYO 113, JAPAN	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Juntendo University			Fukai, Kazuyoshi/AAI-7365-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P189, DOI 10.1093/nar/24.1.189; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Dracopoli NC, 1994, CURRENT PROTOCOLS HU; FRENK E, 1982, J INVEST DERMATOL, V78, P141, DOI 10.1111/1523-1747.ep12506274; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FUKAI K, 1995, HUM MOL GENET, V4, P1665, DOI 10.1093/hmg/4.9.1665; HARDISTY RM, 1972, BRIT J HAEMATOL, V23, P679, DOI 10.1111/j.1365-2141.1972.tb03483.x; HARMON KR, 1994, J LAB CLIN MED, V123, P617; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HOLMSEN H, 1979, ANNU REV MED, V30, P119, DOI 10.1146/annurev.me.30.020179.001003; HOLMSEN H, 1972, BLOOD-J HEMATOL, V39, P197, DOI 10.1182/blood.V39.2.197.197; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; LATTION F, 1983, HELV PAEDIATR ACTA, V38, P495; Lee ST, 1995, MOL CELLS, V5, P668; Lyon M., 1989, GENETIC VARIANTS STR; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; OBRIEN EP, 1994, MAMM GENOME, V5, P356, DOI 10.1007/BF00356554; POIRIER C, 1994, MAMM GENOME, V5, pS266; SCHALLREUTER KU, 1993, DERMATOLOGY, V187, P248, DOI 10.1159/000247258; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WHITE JG, 1973, AM J PATHOL, V70, P329; WHITE JG, 1971, AM J PATHOL, V63, P319; WILDENBERG SC, 1995, AM J HUM GENET, V57, P755; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; [No title captured]; [No title captured]; [No title captured]	32	242	245	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					300	306		10.1038/ng1196-300	http://dx.doi.org/10.1038/ng1196-300			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896559				2022-12-27	WOS:A1996VQ14600024
J	Sango, K; McDonald, MP; Crawley, JN; Mack, ML; Tifft, CJ; Skop, E; Starr, CM; Hoffmann, A; Sandhoff, K; Suzuki, K; Proia, RL				Sango, K; McDonald, MP; Crawley, JN; Mack, ML; Tifft, CJ; Skop, E; Starr, CM; Hoffmann, A; Sandhoff, K; Suzuki, K; Proia, RL			Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis	NATURE GENETICS			English	Article							TAY-SACHS-DISEASE; TARGETED DISRUPTION; HEXA GENE; MODEL		NIDDKD, SECT BIOCHEM GENET, GENET & BIOCHEM BRANCH, NIH, BETHESDA, MD 20892 USA; NIMH, SECT BEHAV NEUROPHARMACOL, EXPT THERAPEUT BRANCH, NIH, BETHESDA, MD 20892 USA; CHILDRENS NATL MED CTR, DEPT MED GENET, WASHINGTON, DC 20010 USA; GLYKO INC, NOVATO, CA 94949 USA; UNIV BONN, INST ORGAN CHEM & BIOCHEM, D-53121 BONN, GERMANY; UNIV N CAROLINA, DEPT PATHOL & LAB MED, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, UNC NEUOSCI CTR, CHAPEL HILL, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Children's National Health System; BioMarin Pharmaceutical Inc.; Glyko Biomedical; University of Bonn; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270; McDonald, Michael P./0000-0002-9642-964X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024453] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-03110] Funding Source: Medline; NINDS NIH HHS [NS-24453] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APPLEGARTH DA, 1972, CLIN CHIM ACTA, V39, P258, DOI 10.1016/0009-8981(72)90327-0; CANTZ M, 1974, EUR J BIOCHEM, V47, P581, DOI 10.1111/j.1432-1033.1974.tb03729.x; FRATANTONI JC, 1968, P NATL ACAD SCI USA, V60, P699, DOI 10.1073/pnas.60.2.699; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; SINGH J, 1975, ENZYME, V19, P15, DOI 10.1159/000458968; Starr CM, 1996, J CHROMATOGR A, V720, P295, DOI 10.1016/0021-9673(95)00749-0; TANIIKE M, 1995, ACTA NEUROPATHOL, V89, P296; VOGLER C, 1990, AM J PATHOL, V136, P207; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975	12	163	166	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1996	14	3					348	352		10.1038/ng1196-348	http://dx.doi.org/10.1038/ng1196-348			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896570				2022-12-27	WOS:A1996VQ14600035
J	Strautnieks, SS; Bull, LN; Knisely, AS; Kocoshis, S; Dahl, N; Arnell, H; Sokal, E; Dahan, K; Childs, S; Ling, V; Tanner, MS; Kagalwalla, AF; Nemeth, A; Pawlowska, J; Baker, A; Mieli-Vergani, G; Freimer, NB; Gardiner, RM; Thompson, RJ				Strautnieks, SS; Bull, LN; Knisely, AS; Kocoshis, S; Dahl, N; Arnell, H; Sokal, E; Dahan, K; Childs, S; Ling, V; Tanner, MS; Kagalwalla, AF; Nemeth, A; Pawlowska, J; Baker, A; Mieli-Vergani, G; Freimer, NB; Gardiner, RM; Thompson, RJ			A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis	NATURE GENETICS			English	Article							BYLER-DISEASE; P-GLYCOPROTEIN; IDENTIFICATION; HETEROGENEITY; LOCUS; ACID; 18Q21-Q22; SECRETION; MUTATIONS; MEMBRANE	The progressive familiar intrahepatic cholestases (PFIC) are a group of inherited disorders with severe cholestatic liver disease from early infancy. A subgroup characterized by normal serum cholesterol and gamma-glutamyltranspeptidase (gamma GT) levels is genetically heterogeneous with loci on chromosomes 2q (PFIC2) and 18q. The phenotype of the PFIC2-linked group is consistent with defective bile acid transport at the hepatocyte canalicular membrane. The PFIC2 gene has now been identified by mutations in a positional candidate, BSEP, which encodes a liver-specific ATP-binding cassette (ABC) transporter, sister of p-glycoprotein (SPGP). The product of the orthologous rat gene has been shown to be an effective bile acid transporter in vitro. These data provide evidence that SPCP is the human bile salt export pump (BSEP).	UCL, Sch Med, Dept Paediat, London W1N 8AA, England; Univ Calif San Francisco, Dept Psychiat, Ctr Neurobiol & Psychiat, Neurogenet Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; Univ Texas, Med Branch, Div Surg Pathol, Galveston, TX 77550 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Univ Catholique Louvain, Dept Pediat, B-1348 Louvain, Belgium; Univ Catholique Louvain, Dept Med Genet, B-1348 Louvain, Belgium; British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; Huddinge Univ Hosp, Dept Pediat, S-14186 Huddinge, Sweden; Childrens Mem Hlth Inst, Warsaw, Poland; Kings Coll London Hosp, Dept Child Hlth, London, England; Kings Coll London, Sch Med & Dent, London, England; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA	University of London; University College London; UCL Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uppsala University; Universite Catholique Louvain; Universite Catholique Louvain; British Columbia Cancer Agency; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Karolinska Institutet; Children's Memorial Health Institute; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Thompson, RJ (corresponding author), UCL, Sch Med, Dept Paediat, Mortimer St, London W1N 8AA, England.	richard.j.thompson@kcl.ac.uk	Thompson, Richard J/B-7954-2009; Mieli-Vergani, Giorgina/G-5616-2011; Childs, Sarah/AAG-5111-2021	Thompson, Richard J/0000-0001-5652-0150; Mieli-Vergani, Giorgina/0000-0002-8215-4489; Pawlowska, Joanna/0000-0003-1154-8824; Childs, Sarah/0000-0003-2261-580X; Sokal, Etienne/0000-0001-5597-4708; Nemeth, Antal/0000-0002-6229-5882	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050697] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK50697] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; ALONSO EM, 1994, J PEDIATR GASTR NUTR, V18, P128, DOI 10.1097/00005176-199402000-00002; Arnell H, 1997, HUM GENET, V100, P378, DOI 10.1007/s004390050519; BROWN RS, 1995, P NATL ACAD SCI USA, V92, P5421, DOI 10.1073/pnas.92.12.5421; Bull LN, 1997, HEPATOLOGY, V26, P155; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; CARLTON VEH, 1995, HUM MOL GENET, V4, P1049, DOI 10.1093/hmg/4.6.1049; CHEN CJ, 1990, J BIOL CHEM, V265, P506; Childs S, 1998, CANCER RES, V58, P4160; CHILDS S, 1995, CANCER RES, V55, P2029; CLAYTON RJ, 1969, AM J DIS CHILD, V117, P112, DOI 10.1001/archpedi.1969.02100030114014; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; JACQUEMIN E, 1994, EUR J PEDIATR, V153, P424; JAVITT NB, 1967, GASTROENTEROLOGY, V53, P171; MAGGIORE G, 1987, J PEDIATR-US, V111, P251, DOI 10.1016/S0022-3476(87)80079-3; Marinelli RA, 1997, HEPATOLOGY, V26, P1081, DOI 10.1002/hep.510260539; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; NIELSEN IM, 1986, ACTA PAEDIATR SCAND, V75, P1010, DOI 10.1111/j.1651-2227.1986.tb10332.x; Popper H, 1970, Hum Pathol, V1, P1, DOI 10.1016/S0046-8177(70)80002-8; RAYMOND M, 1989, P NATL ACAD SCI USA, V86, P6488, DOI 10.1073/pnas.86.17.6488; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Strautnieks SS, 1996, J MED GENET, V33, P833, DOI 10.1136/jmg.33.10.833; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; Suchy FJ, 1997, FASEB J, V11, P199, DOI 10.1096/fasebj.11.4.9068608; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003	37	766	791	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					233	238		10.1038/3034	http://dx.doi.org/10.1038/3034			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806540				2022-12-27	WOS:000076698100015
J	Wang, ZG; Ruggero, D; Ronchetti, S; Zhong, S; Gaboli, M; Rivi, R; Pandolfi, PP				Wang, ZG; Ruggero, D; Ronchetti, S; Zhong, S; Gaboli, M; Rivi, R; Pandolfi, PP			Pml is essential for multiple apoptotic pathways	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; FAS-MEDIATED APOPTOSIS; NECROSIS-FACTOR-ALPHA; RING FINGER DOMAIN; RETINOIC ACID; RAR-ALPHA; INTERFERON-GAMMA; DNA-DAMAGE; ICE-LIKE; CELLS	The PML gene of acute promyelocytic leukaemia (APL) encodes a cell growth and tumour suppressor, however, the mechanisms by which PML suppresses tumorigenesis are poorly understood. We show here that Pml is required for Fas- and caspase-dependent DNA-damage-induced apoptosis. We also found that Pml is essential for induction of programmed cell death by Fas, tumour necrosis factor a (TNF), ceramide and type I and II interferons (IFNs). As a result, Pml(-/-) mice and cells are protected from the lethal effects of ionizing radiation and anti-fas antibody. Pml is required for caspase 1 and caspase 3 activation upon exposure to these stimuli. The PML-RAR alpha fusion protein of APL renders haemopoietic progenitor cells resistant to Fas-, TNF- and IFN-induced apoptosis with a lack of caspase 3 activation, thus acting as a Pml dominant-negative product. These results demonstrate that Pml is a mediator of multiple apoptotic signals, and implicate inhibition of apoptosis in the pathogenesis of APL.	Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, Mem Sloan Kettering Canc Ctr,Dept Human Genet, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, Mem Sloan Kettering Canc Ctr,Mol Biol Program, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Cornell Univ, Grad Sch Med Sci, Sloan Kettering Div, Mem Sloan Kettering Canc Ctr,Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		Ronchetti, Simona/L-2325-2013	Ronchetti, Simona/0000-0002-5639-4243	NCI NIH HHS [CA-08748, CA 71692] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA071692, P30CA008748, R01CA071692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; HONG SH, 1997, P NATL ACAD SCI USA, V94, P9038; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kalantry S, 1997, J CELL PHYSIOL, V173, P288, DOI 10.1002/(SICI)1097-4652(199711)173:2<288::AID-JCP38>3.3.CO;2-Q; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LAVAU C, 1995, ONCOGENE, V11, P871; Lenardo M J, 1997, Semin Immunol, V9, P1, DOI 10.1006/smim.1996.0050; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; MACIEJEWSKI J, 1995, BLOOD, V85, P3183, DOI 10.1182/blood.V85.11.3183.bloodjournal85113183; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NasonBurchenal K, 1996, BLOOD, V88, P3926, DOI 10.1182/blood.V88.10.3926.bloodjournal88103926; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Penninger JM, 1998, ADV IMMUNOL, V68, P51, DOI 10.1016/S0065-2776(08)60558-1; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; SELLERI C, 1995, J CELL PHYSIOL, V165, P538, DOI 10.1002/jcp.1041650312; Smyth MJ, 1996, BIOCHEM J, V316, P25, DOI 10.1042/bj3160025; Stadler M, 1995, ONCOGENE, V11, P2565; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Wang ZG, 1998, SCIENCE, V279, P1547; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7	41	471	491	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					266	272		10.1038/3073	http://dx.doi.org/10.1038/3073			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806545				2022-12-27	WOS:000076698100020
J	Blacker, D; Wilcox, MA; Laird, NM; Rodes, L; Horvath, SM; Go, RCP; Perry, R; Watson, B; Bassett, SS; McInnis, MG; Albert, MS; Hyman, BT; Tanzi, RE				Blacker, D; Wilcox, MA; Laird, NM; Rodes, L; Horvath, SM; Go, RCP; Perry, R; Watson, B; Bassett, SS; McInnis, MG; Albert, MS; Hyman, BT; Tanzi, RE			Alpha-2 macroglobulin is genetically associated with Alzheimer disease	NATURE GENETICS			English	Article							RECEPTOR-RELATED PROTEIN; APOLIPOPROTEIN-E; DEGRADATION; ALPHA(2)-MACROGLOBULIN; BINDING; COMPLEX; ALLELE	Alpha-2-macroglobulin (alpha-M-2; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits. Analysis of a deletion in the A2M gene at the 5' splice site of 'exon II' of the bait region (exon 18) revealed that inheritance of the deletion (A2M-2) confers increased risk for AD (Mantel-Haenzel odds ratio=3.56, P=0.001). The sibship disequilibrium test (SDT) also revealed a significant association between A2M and AD (P=0.00009). These values were comparable to those obtained for the APOE-epsilon 4 allele in the same sample, but in contrast to APOE-epsilon 4. A2M-2 did not affect age of onset. The observed association of A2M with AD did not appear to account for the previously published linkage of AD to chromosome 12, which we were unable to confirm in this sample. A2M, LRP1 (encoding the alpha-M-2 receptor) and the genes for two other LRP ligands, APOE and APP (encoding the amyloid P-protein precursor), have now all been genetically linked to AD, suggesting that these proteins may participate in a common neuropathogenic pathway leading to AD.	Massachusetts Gen Hosp, Genet & Aging Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; Univ Alabama, Dept Epidemiol, Birmingham, AL USA; Johns Hopkins Med Inst, Dept Psychiat, Baltimore, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Medicine	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Genet & Aging Unit, Boston, MA 02114 USA.		Tanzi, Rudolph/AAE-9622-2019; McInnis, Melvin G/F-6963-2012	Tanzi, Rudolph/0000-0002-7032-1454; McInnis, Melvin G/0000-0002-0375-6247	NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH051066, U01MH046281, K21MH001118] Funding Source: NIH RePORTER; NIMH NIH HHS [U01 MH46281, K21 MH01118, U01 MH51066] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; BLACKER D, 1994, ARCH NEUROL-CHICAGO, V51, P1198, DOI 10.1001/archneur.1994.00540240042014; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Blacker D, 1998, ARCH NEUROL-CHICAGO, V55, P294, DOI 10.1001/archneur.55.3.294; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Du YS, 1997, J NEUROCHEM, V69, P299; Du YS, 1998, J NEUROCHEM, V70, P1182; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; HOLLENBACH E, IN PRESS NEUROLOGY; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; KRAUTER K, 1995, NATURE, V377, P321; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; LOPES MB, 1993, FEBS LETT, V338, P301; MATTHIJS G, 1991, NUCLEIC ACIDS RES, V19, P5102, DOI 10.1093/nar/19.18.5102; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Narita M, 1997, J NEUROCHEM, V69, P1904; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Qiu WQ, 1996, J BIOL CHEM, V271, P8443, DOI 10.1074/jbc.271.14.8443; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WU WS, 1998, IN PRESS JAMA; Zhang ZY, 1996, AMYLOID, V3, P156, DOI 10.3109/13506129609045515	33	543	562	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					357	360		10.1038/1243	http://dx.doi.org/10.1038/1243			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697696				2022-12-27	WOS:000075107600018
J	Concannon, P; Gogolin-Ewens, KJ; Hinds, DA; Wapelhorst, B; Morrison, VA; Stirling, B; Mitra, M; Farmer, J; Williams, SR; Cox, NJ; Bell, GI; Risch, N; Spielman, RS				Concannon, P; Gogolin-Ewens, KJ; Hinds, DA; Wapelhorst, B; Morrison, VA; Stirling, B; Mitra, M; Farmer, J; Williams, SR; Cox, NJ; Bell, GI; Risch, N; Spielman, RS			A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS; GENE REGION; 15Q26 IDDM3; LOCUS; ASSOCIATION; MARKERS; DISEASE; PAIRS; HLA	During the past decade, the genetics of type 1 (insulin-dependent) diabetes mellitus (IDDM) has been studied extensively and the disorder has become a paradigm for genetically complex diseases. Previous genome screens(1,2) and studies focused on candidate genes(3-9) have provided evidence for genetic linkage between polymorphic DNA markers and 15 putative IDDM susceptibility loci, designated IDDM1-IDDM15. We have carried out a second-generation screen of the genome for linkage and analysed the data by multipoint linkage methods. An initial panel of 212 affected sibpairs (ASPs) was genotyped for 438 markers spanning all autosomes, and an additional 467 ASPs were used for follow-up genotyping. Other than the well-established linkage with the HLA region at chromosome 6p21.3, there was only one region, located on chromosome Iq and not previously reported, where the log likelihood ratio (lod) was greater than 3. Lods between 1.0 and 1.8 were found in six other regions, three of which have been reported in other studies. Another reported region(10), on chromosome 6q and loosely linked to HLA, also had an elevated led. Little or no support was found for most reported IDDM loci (lods were less than 1), despite larger sample sizes in the present study.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Virginia Mason Res Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Pennsylvania; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Stanford University; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	Spielman, RS (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.			Concannon, Patrick/0000-0002-5801-1859; Hinds, David/0000-0002-4911-803X; Martin, Beth/0000-0002-9661-014X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046627, R01DK046635, R01DK046618] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046635, DK 46635, DK46627, DK46618] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1988, AM J HUM GENET, V42, P167; CUDWORTH AG, 1975, BRIT MED J, V3, P133, DOI 10.1136/bmj.3.5976.133; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Davies JL, 1996, HUM MOL GENET, V5, P1071, DOI 10.1093/hmg/5.7.1071; Delepine M, 1997, AM J HUM GENET, V60, P174; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Holmans P, 1997, AM J HUM GENET, V60, P657; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LaPorte R., 1995, DIABETES AM, V2nd ed, P37; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; NERUP J, 1974, LANCET, V2, P864; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Owerbach D, 1997, DIABETES, V46, P1069, DOI 10.2337/diabetes.46.6.1069; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1987, AM J HUM GENET, V40, P1; ROWE RE, 1995, NAT GENET, V10, P240, DOI 10.1038/ng0695-240; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	33	281	286	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					292	296		10.1038/985	http://dx.doi.org/10.1038/985			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662408				2022-12-27	WOS:000074565900031
J	Yang, T; Adamson, TE; Resnick, JL; Leff, S; Wevrick, R; Francke, U; Jenkins, NA; Copeland, NG; Brannan, CI				Yang, T; Adamson, TE; Resnick, JL; Leff, S; Wevrick, R; Francke, U; Jenkins, NA; Copeland, NG; Brannan, CI			A mouse model for Prader-Willi syndrome imprinting-centre mutations	NATURE GENETICS			English	Article							ANGELMAN SYNDROME; SNRPN GENE; UNIPARENTAL DISOMY; PARENTAL ORIGIN; EXPRESSED GENE; POLYPEPTIDE-N; PROTEIN-N; DELETIONS; REGION; HUMAN-CHROMOSOME-15	Imprinting in the 15q11-q13 region involves an 'imprinting centre' (IC), mapping in part to the promoter and first exon of SNRPN. Deletion of this IC abolishes local paternally derived gene expression and results in Prader-Willi syndrome (PWS). We have created two deletion mutations in mice to understand PWS and the mechanism of this IC. Mice harbouring an intragenic deletion in Snrpn are phenotypically normal, suggesting that mutations of SNRPN are not sufficient to induce PWS. Mice with a larger deletion involving both Snrpn and the putative PWS-IC lack expression of the imprinted genes Zfp127 (mouse homologue of ZNF127) Ndn and Ipw, and manifest several phenotypes common to PWS infants. These data demonstrate that both the position of the IC and its role in the coordinate expression of genes is conserved between mouse and human, and indicate that the mouse is a suitable model system in which to investigate the molecular mechanisms of imprinting in this region of the genome.	Univ Florida, Coll Med, Dept Microbiol & Mol Genet, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Mammalian Genet, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Inst Brain, Gainesville, FL 32610 USA; Cell Genesys Inc, Foster City, CA 94404 USA; Univ Alberta, Heritage Med Res Ctr 659, Dept Med Genet, Edmonton, AB T6G 2S2, Canada; Stanford Univ, Sch Med, Dept Genet, Beckman Ctr Mol & Genet Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr Mol & Genet Med, Stanford, CA 94305 USA; NCI, Frederick Canc Res & Dev Ctr, Mammalian Genet Lab, ABL Basic Res Program, Frederick, MD 21702 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cell Genesys Inc; University of Alberta; Stanford University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Brannan, CI (corresponding author), Univ Florida, Coll Med, Dept Microbiol & Mol Genet, Gainesville, FL 32610 USA.			Wevrick, Rachel/0000-0002-3343-5794	NIGMS NIH HHS [GM55272] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Church G M, 1985, Prog Clin Biol Res, V177, P17; CLAYTONSMITH J, 1992, J MED GENET, V29, P412, DOI 10.1136/jmg.29.6.412; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; Hogan B, 1994, MANIPULATING MOUSE E; HOLM VA, 1993, PEDIATRICS, V91, P398; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LI S, 1989, P NATL ACAD SCI USA, V86, P9778, DOI 10.1073/pnas.86.24.9778; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MCALLISTER G, 1989, EMBO J, V8, P1177, DOI 10.1002/j.1460-2075.1989.tb03489.x; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1992, ANN NEUROL, V32, P512, DOI 10.1002/ana.410320406; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; RUBENSTEIN JLR, 1990, NUCLEIC ACIDS RES, V18, P4833, DOI 10.1093/nar/18.16.4833; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; SCHMAUSS C, 1990, J BIOL CHEM, V265, P10733; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; STEITZ JA, 1990, STRUCTURE FUNCTION M, P115; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SZABO P, 1994, DEVELOPMENT, V120, P1651; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Wevrick R, 1997, HUM MOL GENET, V6, P325, DOI 10.1093/hmg/6.2.325; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308	44	242	246	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					25	31		10.1038/ng0598-25	http://dx.doi.org/10.1038/ng0598-25			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590284				2022-12-27	WOS:000073346700012
J	Russell, DW; Hirata, RK				Russell, DW; Hirata, RK			Human gene targeting by viral vectors	NATURE GENETICS			English	Article							INTERFERON-INDUCIBLE GENE; ADENO-ASSOCIATED VIRUS; EMBRYONIC STEM-CELLS; ADENOASSOCIATED VIRUS; HOMOLOGOUS RECOMBINATION; RETROVIRAL VECTORS; MAMMALIAN-CELLS; DNA; TRANSDUCTION; INTEGRATION	Stable transduction of mammalian cells typically involves random integration of viral vectors by non-homologous recombination. Here we report that Vectors based on adeno-associated virus (AAV) can efficiently modify homologous human chromosomal target sequences. Bath integrated neomycin phosphotransferase genes and the hypoxanthine phosphoribosyltransferase gene were targeted by AAV vectors. Site-specific genetic modifications could be introduced into approximately 1% of cells, with the highest targeting rates occurring in normal human fibroblasts. These results suggest that AAV vectors could be used to introduce specific genetic changes into the genomic DNA of a wide variety of mammalian cells. including therapeutic gene targeting applications.	Univ Washington, Sch Med, Markey Mol Med Ctr, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Sch Med, Markey Mol Med Ctr, Seattle, WA 98195 USA.	drussell@u.washington.edu	Wilson, Matthew H/K-3193-2013		NIDDK NIH HHS [R01 DK055759, R01 DK055759-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055759] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bertran J, 1996, J VIROL, V70, P6759, DOI 10.1128/JVI.70.10.6759-6766.1996; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; ELLIS J, 1989, MOL CELL BIOL, V9, P1621, DOI 10.1128/MCB.9.4.1621; FUJIOKA K, 1993, NUCLEIC ACIDS RES, V21, P407, DOI 10.1093/nar/21.3.407; GANGULY A, 1994, P NATL ACAD SCI USA, V91, P7365, DOI 10.1073/pnas.91.15.7365; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; ITZHAKI JE, 1991, NUCLEIC ACIDS RES, V19, P3835, DOI 10.1093/nar/19.14.3835; Koeberl DD, 1997, P NATL ACAD SCI USA, V94, P1426, DOI 10.1073/pnas.94.4.1426; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; LEBKOWSKI JS, 1988, MOL CELL BIOL, V8, P3988, DOI 10.1128/MCB.8.10.3988; MCLAUGHLIN SK, 1988, J VIROL, V62, P1963, DOI 10.1128/JVI.62.6.1963-1973.1988; MITANI K, 1995, SOMAT CELL MOLEC GEN, V21, P221, DOI 10.1007/BF02255777; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; PATEL PI, 1986, MOL CELL BIOL, V6, P393, DOI 10.1128/MCB.6.2.393; PORTER ACG, 1993, EUR J BIOCHEM, V218, P273, DOI 10.1111/j.1432-1033.1993.tb18375.x; RASHEED S, 1974, CANCER, V33, P10257; ROSSITER BJF, 1991, PCR PRACTICAL APPROA, P67; RUSSELL DW, 1994, P NATL ACAD SCI USA, V91, P8915, DOI 10.1073/pnas.91.19.8915; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMBROOK J, 1989, LAB HDB; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; SAMULSKI RJ, 1992, EMBO J, V11, P1228; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THYAGARAJAN B, 1995, NUCLEIC ACIDS RES, V23, P2784, DOI 10.1093/nar/23.14.2784; WALSH CE, 1992, P NATL ACAD SCI USA, V89, P7257, DOI 10.1073/pnas.89.15.7257; WANG Q, 1993, MOL CELL BIOL, V13, P918, DOI 10.1128/MCB.13.2.918; ZHENG H, 1990, NATURE, V344, P170, DOI 10.1038/344170a0; ZIMMER A, 1989, NATURE, V338, P150, DOI 10.1038/338150a0; ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402	36	240	262	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1998	18	4					325	330		10.1038/ng0498-325	http://dx.doi.org/10.1038/ng0498-325			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537413	Green Accepted			2022-12-27	WOS:000072755500013
J	Laan, M; Paabo, S				Laan, M; Paabo, S			Demographic history and linkage disequilibrium in human populations	NATURE GENETICS			English	Article							FINNISH POPULATION; LINEAGES; FINLAND; GENES	In the human genome, linkage disequilibrium (LD)-the nonrandom association of alleles at chromosomal loci(1)-has been studied mainly in regions surrounding disease genes on affected chromosomes2-6. Consequently, little information is available on the distribution of LD across anonymous genomic regions in the general population. However, demographic history is expected to influence the extent of overall LD across the genome, so a population that has been of constant size will display higher levels of LD than a population that has expanded(7). In support of this, the extent of LD between anonymous loci on chromosome 4 in chimpanzees (as a model of a population of constant size) has been compared to that in Finns (as a model of an expanded population; refs 8,9) and found to exhibit more LD than in the latter population. In Europe, studies of mitochondrial (mt) DNA sequences have suggested that most populations have experienced expansion(10), whereas the Saami in northern Fenno-Scandinavia have been of constant size (Table 1). Thus, in northern Europe, populations with radically different demographic histories live in close geographic proximity to each other. We studied the allelic associations between anonymous microsatellite loci on the X chromosome in the Saami and neighbouring populations and found dramatically higher levels of LD in the Saami than in other populations in the region. This indicates that whereas recently expanded populations, such as the Finns, are well suited to map single disease genes affected by recent mutations, populations that have been of constant size, such as the Saami, may be much better suited to map genes for complex traits that are caused by older mutations.	UNIV MUNICH,INST ZOOL,D-80021 MUNICH,GERMANY	University of Munich			Peng, Bo/A-6920-2009; Laan, Maris/A-4100-2011	Peng, Bo/0000-0001-8225-2284; Laan, Maris/0000-0002-8519-243X				CrouauRoy B, 1996, HUM MOL GENET, V5, P1131, DOI 10.1093/hmg/5.8.1131; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; NORIO R, 1973, ANN CLIN RES, V5, P109; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; RAYMOND M, 1994, GENEPOP VERSION 1 0; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SLATKIN M, 1994, GENETICS, V137, P331; Solantie R., 1988, FENNOSCANDIA ARCHAEO, V5, P3; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; TAJIMA F, 1989, GENETICS, V123, P597; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, IN PRESS HUM HERED; Thompson EA, 1997, AM J HUM GENET, V60, P197; Varilo T, 1996, AM J HUM GENET, V58, P506; Watson E, 1996, AM J HUM GENET, V59, P437; Weir B. S., 1996, GENETIC DATA ANAL	25	146	147	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					435	438		10.1038/ng1297-435	http://dx.doi.org/10.1038/ng1297-435			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398845				2022-12-27	WOS:A1997YJ92400024
J	Ellegren, H; Fridolfsson, AK				Ellegren, H; Fridolfsson, AK			Male-driven evolution of DNA sequences in birds	NATURE GENETICS			English	Article							HUMAN Y-CHROMOSOME; MOLECULAR EVOLUTION; GENES; POLYMORPHISM; RATES	Assuming that new mutations arise mainly during DNA replication, sequence evolution in mammals has been seen as 'male driven' (ref. 1) because of the many more cell divisions in spermatogenesis than in oogenesis. Molecular support for this idea has been obtained from the observation of higher substitution rates in genes on the Y than on the X chromosome of primates and rodents(2-4), which are species with male heterogamety, but has not been confirmed by the reciprocal analysis of organisms with female heterogamety. The recent suggestion that an intrinsic reduction in the X-chromosome mutation rate may be confounded with male effects in previous comparisons(5), and the paradoxical finding of low levels of polymorphism on the primate Y chromosome(6-8) indicate that the idea of male-biased mutation rate needs to be re-examined. We have analysed the molecular evolution of the gene CHD, which is present on the Z and W sex chromosomes of birds. The substitution rate at synonymous positions, as well as in intron DNA, was considerably higher on the Z chromosome than on the female-specific W chromosome, with an estimated male-to-female bias in mutation rate (alpha(m)) of 3.9-6.5. Thus, evolution appears to be male driven in birds-a situation that supports a neutral model of molecular evolution.			Ellegren, H (corresponding author), SWEDISH UNIV AGR SCI,CTR BIOMED,DEPT ANIM BREEDING & GENET,BOX 597,S-75124 UPPSALA,SWEDEN.							Burrows W, 1997, NATURE, V385, P125, DOI 10.1038/385125a0; CHANG BHJ, 1994, P NATL ACAD SCI USA, V91, P827, DOI 10.1073/pnas.91.2.827; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Huang W, 1997, J MOL EVOL, V44, P463, DOI 10.1007/PL00006166; Jones R.C., 1993, Oxford Reviews of Reproductive Biology, V15, P233; Kumar S., 1993, MEGA MOL EVOLUTIONAR; LI WH, 1989, MOL BIOL EVOL, V6, P424; LI WH, 1991, FUNDAMENTALS MOL EVO; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; SHIMMIN LC, 1994, J MOL EVOL, V39, P569, DOI 10.1007/BF00160402; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; WOLFE KH, 1993, J MOL EVOL, V37, P441, DOI 10.1007/BF00178874	21	184	192	0	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					182	184		10.1038/ng1097-182	http://dx.doi.org/10.1038/ng1097-182			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326938				2022-12-27	WOS:A1997XZ55500024
J	Jeffs, B; Clark, JS; Anderson, NH; Gratton, J; Brosnan, MJ; Gauguier, D; Reid, JL; Macrae, IM; Dominiczak, AF				Jeffs, B; Clark, JS; Anderson, NH; Gratton, J; Brosnan, MJ; Gauguier, D; Reid, JL; Macrae, IM; Dominiczak, AF			Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; HYPERTENSIVE-RATS; ARTERY OCCLUSION; PRONE	Ischaemic stroke is a complex disorder caused by a combination of genetic and environmental factors. clinical and epidemiological studies have provided strong evidence for genetic influences in the development of human stroke(1-3) and several mendelian traits featuring stroke have been described(4,5). The genetic analysis of the non-mendelian, common ischaemic stroke in humans is hindered by the late onset of the disease and the mode of inheritance, which is complex, polygenic and multifactorial. An important approach to the study of such polygenic diseases is the use of appropriate animal models in which individual contributing factors can be recognized and analysed(6,7). The spontaneously hypertensive stroke-prone rat (SHRSP) is an experimental model of stroke characterized by a high frequency of spontaneous strokes(8) as well as an increased sensitivity to experimentally induced focal cerebral ischaemia(9,10). Rubattu et al.(11) performed a genome-wide screen in an F-2 cross obtained by mating SHRSP and SHR, in which latency to stroke on Japanese rat diet was used as a phenotype. This study identified three major quantitative trait loci (QTLs), STR-1-3. Of these, STR-2 and 3 conferred a protective effect against stroke in the presence of SHRSP alleles and STR-2 co-localized with the genes encoding for atrial natriuretic tic and brain natriuretic factors(11). Our investigation was designed to identify the genetic component responsible for large infarct volumes in the SHRSP in response to a focal ischaemic insult by performance of a genome scan in an F-2 cross derived from the SHRSP and the normotensive reference strain, WKY rat. We identified a highly significant QTL on rat chromosome 5 with a lod score trf 16.6 which accounts for 67% of the total variance, co-localizes with the genes encoding atrial and brain natriuretic factor and is blood pressure independent.	UNIV GLASGOW, WESTERN INFIRM,DEPT MED & THERAPEUT, GLASGOW G11 6NT, LANARK, SCOTLAND; UNIV GLASGOW, WELLCOME SURG INST, GLASGOW G61 1QH, LANARK, SCOTLAND; WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7LD, ENGLAND	University of Glasgow; University of Glasgow; University of Oxford; Wellcome Centre for Human Genetics			Dominiczak, Anna F/P-9390-2017; Gauguier, Dominique/G-2190-2016; Dominiczak, Anna F/D-2262-2009	Dominiczak, Anna F/0000-0003-4913-3608; Gauguier, Dominique/0000-0001-6156-9530; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERTS MJ, 1991, STROKE, V22, P276, DOI 10.1161/01.STR.22.2.276; Arribas SM, 1996, STROKE, V27, P1118, DOI 10.1161/01.STR.27.6.1118; BRASS LM, 1992, STROKE, V23, P221, DOI 10.1161/01.STR.23.2.221; Clark JS, 1996, HYPERTENSION, V28, P898, DOI 10.1161/01.HYP.28.5.898; COYLE P, 1983, STROKE, V14, P605, DOI 10.1161/01.STR.14.4.605; COYLE P, 1991, BLOOD VESSELS, V28, P183; COYLE P, 1984, STROKE, V15, P711, DOI 10.1161/01.STR.15.4.711; DAVIDSON AO, 1995, HYPERTENSION, V26, P452, DOI 10.1161/01.HYP.26.3.452; DOMINICZAK AF, 1994, NEWS PHYSIOL SCI, V9, P246; DOMINICZAK AF, 1993, AM J HYPERTENS, V6, P1003, DOI 10.1093/ajh/6.12.1003; ESTRADA V, 1994, AM J HYPERTENS, V7, P1085, DOI 10.1093/ajh/7.12.1085; Gunel M, 1996, NAT GENET, V13, P384, DOI 10.1038/ng0896-384; JACEWICZ M, 1992, HYPERTENSION, V19, P47, DOI 10.1161/01.HYP.19.1.47; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KIELY DK, 1993, STROKE, V24, P1366, DOI 10.1161/01.STR.24.9.1366; Konig JFR, 1963, RAT BRAIN STEREOTAXI; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; OKAMOTO K, 1974, CIRC RES, V34, pI143; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; QUIRION R, 1986, P NATL ACAD SCI USA, V83, P174, DOI 10.1073/pnas.83.1.174; Rawlings O., 1998, APPL REGRESSION ANAL, VSecond, P372, DOI DOI 10.1007/B98890; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Volpe M, 1996, J CLIN INVEST, V98, P256, DOI 10.1172/JCI118787	27	144	147	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					364	367		10.1038/ng0897-364	http://dx.doi.org/10.1038/ng0897-364			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241273				2022-12-27	WOS:A1997XM90900018
J	Jackson, RS; Creemers, JWM; Ohagi, S; RaffinSanson, ML; Sanders, L; Montague, CT; Hutton, JC; ORahilly, S				Jackson, RS; Creemers, JWM; Ohagi, S; RaffinSanson, ML; Sanders, L; Montague, CT; Hutton, JC; ORahilly, S			Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene	NATURE GENETICS			English	Article							CLEAVAGE; FURIN		UNIV CAMBRIDGE, DEPT MED, CAMBRIDGE CB2 2QQ, ENGLAND; UNIV CAMBRIDGE, DEPT CLIN BIOCHEM, CAMBRIDGE CB2 2QQ, ENGLAND; ADDENBROOKES HOSP, DEPT CLIN BIOCHEM, CAMBRIDGE CB2 2QQ, ENGLAND; UNIV LOUVAIN, MOL ONCOL LAB, CTR HUMAN GENET, B-3000 LOUVAIN, BELGIUM; FLANDERS INTERUNIV INST BIOTECHNOL, B-3000 LOUVAIN, BELGIUM; WAKAYAMA UNIV MED SCI, DEPT MED 1, WAKAYAMA 640, JAPAN; UNIV PARIS 05, INST COCHIN GENET MOL, INSERM CJF9208, GRP ETUD PHYSIOPATHOL ENDOCRINENNE, PARIS, FRANCE; UNIV COLORADO, HLTH SCI CTR, BARBARA DAVIS CTR CHILDHOOD DIABET, DENVER, CO 80262 USA	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wakayama Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Montague, Carl/0000-0001-5411-9291	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Creemers JWM, 1996, J BIOL CHEM, V271, P25284, DOI 10.1074/jbc.271.41.25284; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fricker LD, 1996, J BIOL CHEM, V271, P30619, DOI 10.1074/jbc.271.48.30619; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KRAWCZAK M, 1992, HUM GENET, V90, P41; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Ohagi S, 1996, DIABETES, V45, P897, DOI 10.2337/diabetes.45.7.897; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SCRIVER CR, 1995, METABOLIC MOL BASIS, P269; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Taylor NA, 1997, BIOCHEM J, V321, P367, DOI 10.1042/bj3210367; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; YI Z, 1993, J BIOL CHEM, V268, P5615; Zaidi FK, 1997, DIABETIC MED, V14, P228, DOI 10.1002/(SICI)1096-9136(199703)14:3<228::AID-DIA330>3.0.CO;2-N	22	781	802	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1997	16	3					303	306		10.1038/ng0797-303	http://dx.doi.org/10.1038/ng0797-303			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207799				2022-12-27	WOS:A1997XG60900029
J	Li, LH; Krantz, ID; Deng, Y; Genin, A; Banta, AB; Collins, CC; Qi, M; Trask, BJ; Kuo, WL; Cochran, J; Costa, T; Pierpont, MEM; Rand, EB; Piccoli, DA; Hood, L; Spinner, NB				Li, LH; Krantz, ID; Deng, Y; Genin, A; Banta, AB; Collins, CC; Qi, M; Trask, BJ; Kuo, WL; Cochran, J; Costa, T; Pierpont, MEM; Rand, EB; Piccoli, DA; Hood, L; Spinner, NB			Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1	NATURE GENETICS			English	Article							INTERLOBULAR BILE-DUCTS; DROSOPHILA-NOTCH; CELL-FATE; ARTERIOHEPATIC DYSPLASIA; PHYSICAL MAP; HOMOLOG; EXPRESSION; GENE; DELETION; PAUCITY	Alagille syndrome is an autosomal dominant disorder characterized by abnormal development of liver, heart, skeleton, eye, face and, less frequently, kidney. Analyses of many patients with cytogenetic deletions or rearrangements have mapped the gene to chromosome 20p12, although deletions are found in a relatively small proportion of patients (< 7%). We have mapped the human Jagged1 gene (JAG1), encoding a ligand for the developmentally important Notch transmembrane receptor, to the Alagille syndrome critical region within 20p12. The Notch intercellular signalling pathway has been shown to mediate cell fate decisions during development in invertebrates and vertebrates. We demonstrate four distinct coding mutations in JAG1 from four Alagille syndrome families, providing evidence that it is the causal gene for Alagille syndrome. All four mutations lie within conserved regions of the gene and cause translational frameshifts, resulting in gross alterations of the protein product. Patients with cytogenetically detectable deletions including JAG1 have Alagille syndrome, supporting the hypothesis that haploinsufficiency for this gene is one of the mechanisms causing the Alagille syndrome phenotype.	UNIV PENN,CHILDRENS HOSP,SCH MED,DIV HUMAN GENET,PHILADELPHIA,PA 19104; UNIV PENN,CHILDRENS HOSP,SCH MED,DIV GASTROENTEROL & NUTR,PHILADELPHIA,PA 19104; UNIV WASHINGTON,STOWERS INST MED RES,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MOL BIOTECHNOL,SEATTLE,WA 98195; FUDAN UNIV,INST GENET,SHANGHAI 200433,PEOPLES R CHINA; UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,DIV LIFE SCI,BERKELEY,CA 94720; UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV CALIF SAN FRANCISCO,CTR CANC,CANC GENET PROGRAM,SAN FRANCISCO,CA 94141; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stowers Institute for Medical Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fudan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Banta, Amy/0000-0002-1843-5059; Li, Linheng/0000-0001-9963-430X	NICHD NIH HHS [5 P30 HD288215] Funding Source: Medline; NIDDK NIH HHS [1R01DK53104-01, DK02338-03] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053104, K08DK002338] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bao ZZ, 1997, J NEUROSCI, V17, P1425; CONLON RA, 1995, DEVELOPMENT, V121, P1533; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DELAMO FF, 1992, DEVELOPMENT, V115, P737; Deleuze Jean-Francois, 1994, European Journal of Human Genetics, V2, P185; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; DHORNEPOLLET S, 1994, J MED GENET, V31, P453, DOI 10.1136/jmg.31.6.453; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KAHN E, 1986, HEPATOLOGY, V6, P890, DOI 10.1002/hep.1840060514; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; Krantz ID, 1997, J MED GENET, V34, P152, DOI 10.1136/jmg.34.2.152; Krantz ID, 1997, AM J MED GENET, V70, P80, DOI 10.1002/(SICI)1096-8628(19970502)70:1<80::AID-AJMG15>3.3.CO;2-H; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; LI L, IN PRESS IMMUNITY; LIEBER T, 1992, NEURON, V9, P847, DOI 10.1016/0896-6273(92)90238-9; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Muskavitch M.A.T., 1990, Current Topics in Developmental Biology, V24, P289, DOI 10.1016/S0070-2153(08)60091-5; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; NOVOTNY NM, 1981, AM J GASTROENTEROL, V75, P449; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PICCOLI DA, 1991, DIAGNOSIS MANAGEMENT, P1124; POLLET N, 1995, GENOMICS, V27, P467, DOI 10.1006/geno.1995.1078; RAND EB, 1995, AM J HUM GENET, V57, P1068; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; SCHNITTGER S, 1989, HUM GENET, V83, P239, DOI 10.1007/BF00285164; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; SPINNER NB, 1994, AM J HUM GENET, V55, P238; SPINNER NB, 1997, IN PRESS CYTOGENETIC; STOKKE T, 1995, GENOMICS, V26, P134, DOI 10.1016/0888-7543(95)80092-Z; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WATSON GH, 1973, ARCH DIS CHILD, V48, P459, DOI 10.1136/adc.48.6.459; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	54	870	927	2	31	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					243	251		10.1038/ng0797-243	http://dx.doi.org/10.1038/ng0797-243			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207788				2022-12-27	WOS:A1997XG60900018
J	Liu, XZ; Walsh, J; Mburu, P; KendrickJones, J; Cope, MJTV; Steel, KP; Brown, SDM				Liu, XZ; Walsh, J; Mburu, P; KendrickJones, J; Cope, MJTV; Steel, KP; Brown, SDM			Mutations in the myosin VIIA gene cause non-syndromic recessive deafness	NATURE GENETICS			English	Article								Genetic hearing impairment affects around 1 in every 2,000 births(1). The bulk (approximately 70%) of genetic deafness is non-syndromic, in which hearing impairment is not associated with any other abnormalities. Over 25 loci involved in nonsyndromic deafness have been mapped and mutations in connexin 26 have been identified as a cause of non-sydromic deafness(2). One locus for non-syndromic recessive deafness, DFNB2 (ref. 4), has been localized to the same chromosomal region, 11q14, as one of the loci, USH1B, underlying the recessive deaf-blind syndrome, Usher syndrome type 1b, which is characterized by profound congenital sensorineural deafness, constant vestibular dysfunction and prepubertal onset of retinitis pigmentosa. Recently, it has been shown that a gene encoding an unconventional myosin, myosin VIIA, underlies the mouse recessive deafness mutation, shaker-1 (ref. 5) as well as Usher syndrome type 1b(6). Mice with shaker-1 demonstrate typical neuroepithelial defects manifested by hearing loss and vestibular dysfunction but no retinal pathology. Differences in retinal patterns of expression may account for the variance in phenotype between shaker-1 mice and Usher type 1 syndrome(7). Nevertheless, the expression of MYO7A in the neuroepithelium suggests that it should be considered a candidate for non-syndromic deafness in the human population. By screening families with non-syndromic deafness from China. we have identified two families carrying MYO7A mutations.	MRC, MOUSE GENOME CTR, HARWELL OX11 0RD, BERKS, ENGLAND; MRC, MAMMALIAN GENET UNIT, HARWELL OX11 0RD, BERKS, ENGLAND; MRC, MOL BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND; UNIV CALIF BERKELEY, DEPT CELL & MOL BIOL, BERKELEY, CA 94720 USA; MRC, INST HEARING RES, NOTTINGHAM NG7 2RD, ENGLAND	MRC Laboratory Molecular Biology; University of California System; University of California Berkeley				Cope, Jamie/0000-0002-6960-8271				Anderson H, 1968, Acta Otolaryngol, V65, P535; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Fraser G. R, 1976, BIG 4 CAUSES POVERTY; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; LIU XZ, 1994, AM J MED GENET, V53, P192, DOI 10.1002/ajmg.1320530214; LIU XZ, 1994, ANN OTO RHINOL LARYN, V103, P428, DOI 10.1177/000348949410300602; LIU XZ, IN PRESS HUM MUTAT; MEREDITH R, 1992, J AUDIOL MED, V1, P11; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Solc CK, 1994, AUDIT NEUROSCI, V1, P63; Steel KP, 1996, CURR OPIN NEUROBIOL, V6, P520, DOI 10.1016/S0959-4388(96)80059-6; STEPHENS D, 1996, GENETICS HEARING IMP, P100; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074	19	350	368	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1997	16	2					188	190		10.1038/ng0697-188	http://dx.doi.org/10.1038/ng0697-188			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171832				2022-12-27	WOS:A1997XB54300021
J	Bonyadi, M; Rusholme, SAB; Cousins, FM; Su, HC; Biron, CA; Farrall, M; Akhurst, RJ				Bonyadi, M; Rusholme, SAB; Cousins, FM; Su, HC; Biron, CA; Farrall, M; Akhurst, RJ			Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice	NATURE GENETICS			English	Article							TGF-BETA; TARGETED DISRUPTION; COMPLEX TRAITS; MESSENGER-RNA; NEURAL-TUBE; MOUSE; RECEPTOR; LINKAGE; LOCALIZATION; DISSECTION	The transforming growth factor beta 1 (TGF beta 1) signalling pathway(1,2) is important in embryogenesis(3) and has been implicated in hereditary haemorrhagic telangiectasia (HHT)(4,5) atherosclerosis(6,7), tumorigenesis(8,9) and immunomodulation(10,11) ll. Therefore, identification of factors which modulate TGF beta 1 bioactivity in vivo is important. On a mixed genetic background, similar to 50% Tgfb1(-/-) conceptuses die midgestation from defective yolk sac vasculogenesis(3). The other half are developmentally normal but die three weeks postpartum(3,10,11). Intriguingly, the vascular defects of Tgfb1(-/-) mice share histological similarities to lesions seen in HHT patients(3-5) It has been suggested that dichotomy in Tgfb1(-/-) lethal phenotypes is due to maternal TGF beta 1 rescue of some, but not all, Tgfb1(-/-) embryos(12). Here we show that the Tgfb1(-/-) phenotype depends on the genetic background of the conceptus. In NIH/Ola, C57BL/6J/Ola and F1 conceptuses, Tgfb1(-/-) lethality can be categorized into three developmental classes. A major codominant modifier gene of embryo lethality was mapped to proximal mouse chromosome 5, using a genome scan for non-mendelian distribution of alleles in Tgfb1(-/-) neonatal animals which survive prenatal lethality. This gene accounts for around three quarters of the genetic effect between mouse strains and can, in part, explain the distribution of the three lethal phenotypes. This approach, using neonatal DNA samples, is generally applicable to identification of loci that influence the effect of early embryonic lethal mutations, thus furthering knowledge of genetic interactions that occur during early mammalian development in vivo.	BROWN UNIV,DIV BIOL & MED,PROVIDENCE,RI 02912; UNIV OXFORD,NUFFIELD DEPT MED,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND; UNIV GLASGOW,DUNCAN GUTHRIE INST,DEPT MED GENET,GLASGOW G3 8SJ,LANARK,SCOTLAND	Brown University; University of Oxford; Wellcome Centre for Human Genetics; University of Glasgow			Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110; Bonyadi, Mortaza/0000-0003-3216-2947; AKHURST, ROSEMARY/0000-0002-4474-9668				AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; Bonyadi M, 1996, GENOMICS, V33, P328, DOI 10.1006/geno.1996.0204; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; CUI W, 1996, GROWTH FACTORS CYTOK, P357; DICKINSON ME, 1990, GENOMICS, V6, P505, DOI 10.1016/0888-7543(90)90480-I; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; GAUTAM SC, 1993, ONCOL RES, V5, P423; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LAUREYS G, 1988, GENOMICS, V3, P224, DOI 10.1016/0888-7543(88)90083-3; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MARKOWITZ S, 1995, SCIENCE, V268, P1276; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MOCK BA, 1989, J IMMUNOL, V142, P1372; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; QURESHI ST, 1995, GENOMICS, V26, P165, DOI 10.1016/0888-7543(95)80099-8; RISCH N, 1993, AM J HUM GENET, V53, P702; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; SAUNDERS K B, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P157; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084	32	136	141	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					207	211		10.1038/ng0297-207	http://dx.doi.org/10.1038/ng0297-207			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020852				2022-12-27	WOS:A1997WF08700026
J	Wu, LJC; Wang, ZW; Tsan, JT; Spillman, MA; Phung, A; Xu, XL; Yang, MCW; Hwang, LY; Bowcock, AM; Baer, R				Wu, LJC; Wang, ZW; Tsan, JT; Spillman, MA; Phung, A; Xu, XL; Yang, MCW; Hwang, LY; Bowcock, AM; Baer, R			Identification of a RING protein that can interact in vivo with the BRCA1 gene product	NATURE GENETICS			English	Article							GLUTATHIONE-S-TRANSFERASE; OVARIAN-CANCER; ESCHERICHIA-COLI; FAMILIAL BREAST; LEUCINE ZIPPER; DNA-BINDING; MUTATIONS; PURIFICATION; EXPRESSION; POLYPEPTIDES	The hereditary breast and ovarian cancer gene, BRCA1, encodes a large polypeptide that contains the cysteine-rich RING motif, a zinc-binding domain found in a variety of regulatory proteins. Here we describe a novel protein that interacts in vivo with the N-terminal region of BRCA1. This BRCA1-associated RING domain (BARD1) protein contains an N-terminal RING motif, three tandem ankyrin repeats, and a C-terminal sequence with significant homology to the phylogenetically conserved BRCT domains that lie near the C terminus of BRCA1. The BARD1/BRCA1 interaction is disrupted by BRCA1 missense mutations that segregate with breast cancer susceptibility, indicating that BARD1 may be involved in mediating tumour suppression by BRCA1.	UNIV TEXAS,SW MED CTR,DEPT MICROBIOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PEDIAT,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,MCDERMOTT CTR HUMAN GROWTH & DEV,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,MOL IMMUNOL CTR,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Bowcock, Anne/0000-0001-8691-9090	NCI NIH HHS [CA60650] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060650] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BENNETT LM, 1995, GENOMICS, V29, P576, DOI 10.1006/geno.1995.9963; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; EASTON DF, 1993, AM J HUM GENET, V52, P678; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HARPER JW, 1993, CELL, V75, P805; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; HSU HL, 1994, P NATL ACAD SCI USA, V91, P3181, DOI 10.1073/pnas.91.8.3181; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sambrook J., 2002, MOL CLONING LAB MANU; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SHARAN SK, 1995, HUM MOL GENET, V4, P2275, DOI 10.1093/hmg/4.12.2275; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TSAN JT, IN PRESS YEAST 2 HYB	30	591	610	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					430	440		10.1038/ng1296-430	http://dx.doi.org/10.1038/ng1296-430			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944023				2022-12-27	WOS:A1996VV73000019
J	Salomon, R; Attie, T; Pelet, A; Bidaud, C; Eng, C; Amiel, J; Sarnacki, S; Goulet, O; Ricour, C; NihoulFekete, C; Munnich, A; Lyonnet, S				Salomon, R; Attie, T; Pelet, A; Bidaud, C; Eng, C; Amiel, J; Sarnacki, S; Goulet, O; Ricour, C; NihoulFekete, C; Munnich, A; Lyonnet, S			Germline mutations of the RET ligand GDNF are not sufficient to cause hirschsprung disease	NATURE GENETICS			English	Article							TYROSINE KINASE; NEUROTROPHIC FACTOR; GENE; CHROMOSOME-10; PROTOONCOGENE; NEURONS; MAPS		HOP ENFANTS MALAD,INST NECKER,FEDERAT GENET,CLIN CHIRURG INFANTILE,INSERM,U393,F-75743 PARIS 15,FRANCE; HOP ENFANTS MALAD,INST NECKER,SERV NUTR & GASTROENTEROL PEDIAT,F-75743 PARIS 15,FRANCE; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School			Lyonnet, Stanislas/H-5483-2017; ATTIE-BITACH, Tania/K-1453-2017; Sarnacki, Sabine/I-2692-2017; amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017	Lyonnet, Stanislas/0000-0001-5426-9417; ATTIE-BITACH, Tania/0000-0002-1155-3626; Sarnacki, Sabine/0000-0003-4304-5578; amiel, jeanne/0000-0001-5973-4728; PELET, Anastella/0000-0002-8353-1725; Eng, Charis/0000-0002-3693-5145				Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; EMANUEL B, 1965, J PEDIATR-US, V66, P437, DOI 10.1016/S0022-3476(65)80201-3; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; MOORE M, 1996, NATURE, V381, P785; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PASSARGE E, 1993, NAT GENET, V4, P325, DOI 10.1038/ng0893-325; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; RESCORLA FJ, 1992, ARCH SURG-CHICAGO, V127, P934; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHINDELHAUER D, 1995, GENOMICS, V28, P605, DOI 10.1006/geno.1995.1202; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; TAKAHASHI M, 1988, ONCOGENE, V3, P571; YIN L, 1994, EUR J HUM GENET, V4, P821	29	157	158	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					345	347		10.1038/ng1196-345	http://dx.doi.org/10.1038/ng1196-345			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896569				2022-12-27	WOS:A1996VQ14600034
J	Lauro, D; Kido, Y; Castle, AL; Zarnowski, MJ; Hayashi, H; Ebina, Y; Hayashi, H; Accili, D				Lauro, D; Kido, Y; Castle, AL; Zarnowski, MJ; Hayashi, H; Ebina, Y; Hayashi, H; Accili, D			Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue	NATURE GENETICS			English	Article							TRANSGENIC MICE; DIABETES-MELLITUS; BETA-CELL; RECEPTOR; RESISTANCE; NIDDM; GENE; EXPRESSION	Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and impaired beta cell function(1,2) Insulin resistance is inherited as a non-mendelian trait(3). In genetically predisposed individuals, resistance of skeletal muscle and adipose tissue to insulin action precedes the onset of clinical diabetes, and is thought to contribute to hyperglycaemia by leading to impaired beta cell function and increased hepatic glucose production(4,5). It is not clear whether beta cell and liver defects are also genetically determined(2). To test the hypothesis that insulin resistance in muscle and fat is sufficient to cause type 2 diabetes in the absence of intrinsic beta cell and liver abnormality, we generated transgenic mice that were insulin-resistant in skeletal muscle and adipose tissue. These mice developed all the prodromal features of type 2 diabetes hut, despite the compounded effect of peripheral insulin resistance and a mild impairment of beta cell function, failed to become diabetic. These findings indicate the need for a critical re-examination of the primary site(s) of insulin resistance in diabetes.	NICHHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tokushima University	Accili, D (corresponding author), NICHHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA.		Lauro, Davide/K-4683-2018	Hayashi, Hideki/0000-0003-4585-6542; Lauro, Davide/0000-0002-8597-4415				Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bogardus Clifton, 1996, P459; BOSCHERO AC, 1995, AM J PHYSIOL-ENDOC M, V268, pE336, DOI 10.1152/ajpendo.1995.268.2.E336; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; CHANG PY, 1994, J BIOL CHEM, V269, P16034; Cinti S, 1998, DIABETOLOGIA, V41, P171, DOI 10.1007/s001250050886; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; DiCola G, 1997, J CLIN INVEST, V99, P2538, DOI 10.1172/JCI119438; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; Kahn CR, 1996, ANNU REV MED, V47, P509; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; NISHIYAMA T, 1994, GENE, V141, P187, DOI 10.1016/0378-1119(94)90569-X; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TOLMAN EL, 1973, J BIOL CHEM, V248, P4552; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang LH, 1997, BIOCHEM BIOPH RES CO, V240, P446, DOI 10.1006/bbrc.1997.7677; WEBER TM, 1988, INSULIN RECEPTOR; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	23	104	113	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					294	298		10.1038/3112	http://dx.doi.org/10.1038/3112			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806552				2022-12-27	WOS:000076698100027
J	Naito, T; Matsuura, A; Ishikawa, F				Naito, T; Matsuura, A; Ishikawa, F			Circular chromosome formation in a fission yeast mutant defective in two ATM homologues	NATURE GENETICS			English	Article							ATAXIA-TELANGIECTASIA GENE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CHECKPOINT GENE; TELOMERASE; GENOME; TEL1	Telomeres, found at chromosomal ends, are essential for stable maintenance of linear chromosomes in eukaryotes. The ATM family of genes, including budding yeast TEL1 (refs 1,2), fission yeast rad3(+) (ref. 3) and human ATM (ref. 4), have been reported to be involved in telomere length regulation(5-7), although the significance of the telomere phenotypes observed with the mutated genes remains elusive. We have cloned tel1(+), another fission yeast ATM homologue, and found that a tel1rad3 double mutant lost all telomeric DNA sequences. Thus, the ATM homologues are essential in telomere maintenance. The mutant grew poorly and formed irregular-shaped colonies, probably due to chromosome instability, however, during prolonged culture of the double mutant, cells forming normal round-shaped colonies arose at a relatively high frequency. All three chromosomes in these derivative cells were circular and lacked telomeric sequences. To our knowledge, this is the first report of eukaryotic cells whose chromosomes are all circular. Upon meiosis, these derivative cells produced few viable spores. Therefore, the exclusively circular genome lacking telomeric sequences is proficient for mitotic growth, but does not permit meiosis.	Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Ishikawa, F (corresponding author), Tokyo Inst Technol, Dept Life Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.		Matsuura, Akira/AAO-1572-2021; Matsuura, Akira/J-3864-2017; Ishikawa, Fuyuki/AAU-4056-2021	Matsuura, Akira/0000-0002-2300-7227; Matsuura, Akira/0000-0002-2300-7227; Ishikawa, Fuyuki/0000-0002-5580-2305				Alfa C., 1993, EXPT FISSION YEAST; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Dahlen M, 1998, MOL BIOL CELL, V9, P611, DOI 10.1091/mbc.9.3.611; DINGWALL A, 1990, Methods (Orlando), V1, P160, DOI 10.1016/S1046-2023(05)80131-8; FAN JB, 1992, NUCLEIC ACIDS RES, V20, P5943, DOI 10.1093/nar/20.22.5943; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HABER JE, 1984, GENETICS, V106, P185; HIRAOKA N, 1984, PLANT CELL TISS ORG, V3, P349, DOI 10.1007/BF00043087; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; McClintock B, 1941, GENETICS, V26, P234; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; MIZUKAMI T, 1993, CELL, V73, P121, DOI 10.1016/0092-8674(93)90165-M; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; MORTIMER R K, 1990, Methods (Orlando), V1, P169, DOI 10.1016/S1046-2023(05)80132-X; MURAKAMI S, 1995, MOL GEN GENET, V246, P671, DOI 10.1007/BF00290712; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; NIWA O, 1985, CURR GENET, V9, P463, DOI 10.1007/BF00434051; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; SUGAWARA NF, 1989, DNA SEQUENCES TELOME; THERMAN E, 1993, HUMAN CHROMOSOMES	28	202	205	2	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					203	206		10.1038/2517	http://dx.doi.org/10.1038/2517			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771717				2022-12-27	WOS:000076231300026
J	Schwahn, U; Lenzner, S; Dong, J; Feil, S; Hinzmann, B; van Duijnhoven, G; Kirschner, R; Hemberger, M; Bergen, AAB; Rosenberg, T; Pinckers, AJLG; Fundele, R; Rosenthal, A; Cremers, FPM; Ropers, HH; Berger, W				Schwahn, U; Lenzner, S; Dong, J; Feil, S; Hinzmann, B; van Duijnhoven, G; Kirschner, R; Hemberger, M; Bergen, AAB; Rosenberg, T; Pinckers, AJLG; Fundele, R; Rosenthal, A; Cremers, FPM; Ropers, HH; Berger, W			Positional cloning of the gene for X-linked retinitis pigmentosa 2	NATURE GENETICS			English	Article							L1 SEQUENCE; YAC CONTIG; INSERTION; IDENTIFICATION; ELEMENT; TUBULIN; CELL; DNA; PHOTORECEPTORS; POLYMORPHISM	X-linked retinitis pigmentosa (XLRP) results from mutations in at least two different loci, designated RP2 and RP3, located at Xp11.3 and Xp21.1, respectively. The RP3 gene was recently isolated by positional cloning, whereas the RP2 locus was mapped genetically to a 5-cM interval. We have screened this region for genomic rearrangements by the YAC representation hybridization (YRH) technique and detected a LINE1 (L1) insertion in one XLRP patient. The L1 retrotransposition occurred in an intron of a novel gene that consisted of five exons and encoded a polypeptide of 350 amino acids. Subsequently, nonsense, missense and frameshift mutations, as well as two small deletions, were identified in six additional patients. The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin folding. Our data provide evidence that mutations in this gene, designated RP2, are responsible for progressive retinal degeneration.	Max Planck Inst Mol Genet, Berlin, Dahlem, Germany; Gesell Genomforsch MBH, MetaGen, Berlin, Germany; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Netherlands Ophthalm Res Inst, Dept Ophthalmogenet, NL-1100 AC Amsterdam, Netherlands; Natl Eye Clin Visually Impaired, Hellerup, Denmark; Univ Nijmegen Hosp, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Radboud University Nijmegen	Berger, W (corresponding author), Max Planck Inst Mol Genet, Berlin, Dahlem, Germany.		Bergen, Arthur/J-3637-2013; Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592; Hemberger, Myriam/0000-0003-3332-6958; Bergen, Arthur/0000-0002-6333-9576; Kirschner-Schwabe, Renate/0000-0001-6335-3274				Adam GIR, 1996, DEVELOPMENT, V122, P839; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BOCCACCIO C, 1990, GENE, V88, P181, DOI 10.1016/0378-1119(90)90030-U; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; COLEMAN MP, 1994, GENOMICS, V21, P337, DOI 10.1006/geno.1994.1274; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; ECONOMOUPACHNIS A, 1985, P NATL ACAD SCI USA, V9, P2857; Frantz SA, 1996, MAMM GENOME, V7, P865, DOI 10.1007/s003359900256; HAGEMANN T, 1994, GENOMICS, V21, P262, DOI 10.1006/geno.1994.1255; ISHIHARA A, 1997, BIOTECHNIQUES, V23, P120; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; MCCARTHY JEG, 1995, TRENDS BIOCHEM SCI, V20, P191, DOI 10.1016/S0968-0004(00)89006-4; MEINDL A, 1996, NAT GENET, V13, P36; MIKI Y, 1992, CANCER RES, V52, P643; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; MURESAN V, 1993, J CELL SCI, V104, P1229; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 1996, HUM MOL GENET, V5, P827, DOI 10.1093/hmg/5.6.827; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; SALE WS, 1988, CELL MOTIL CYTOSKEL, V9, P243, DOI 10.1002/cm.970090306; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SKOWRONSKI J, 1986, COLD SPRING HARB SYM, V51, P457, DOI 10.1101/SQB.1986.051.01.055; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Thiselton DL, 1996, GENOME RES, V6, P1093, DOI 10.1101/gr.6.11.1093; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; WATANABE M, 1991, J NEUROBIOL, V22, P85, DOI 10.1002/neu.480220109; WIRTH B, 1988, Genomics, V2, P263, DOI 10.1016/0888-7543(88)90011-0; WOODFORD BJ, 1989, CELL TISSUE RES, V256, P495	36	286	301	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	1998	19	4					327	332		10.1038/1214	http://dx.doi.org/10.1038/1214			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106AM	9697692				2022-12-27	WOS:000075107600014
J	Mein, CA; Esposito, L; Dunn, MG; Johnson, GCL; Timms, AE; Goy, JV; Smith, AN; Sebag-Montefiore, L; Merriman, ME; Wilson, AJ; Pritchard, LE; Cucca, F; Barnett, AH; Bain, SC; Todd, JA				Mein, CA; Esposito, L; Dunn, MG; Johnson, GCL; Timms, AE; Goy, JV; Smith, AN; Sebag-Montefiore, L; Merriman, ME; Wilson, AJ; Pritchard, LE; Cucca, F; Barnett, AH; Bain, SC; Todd, JA			A search for type 1 diabetes susceptibility genes in families from the United Kingdom	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; MELLITUS IDDM; 15Q26 IDDM3; INSULIN; LOCUS; REGION	Genetic analysis of a mouse model of major histocompatability complex (MHC)-associated autoimmune type 1 (insulin-dependent) diabetes mellitus (IDDM) has shown that the disease is caused by a combination of a major effect at the MHC and at least ten other susceptibility loci elsewhere in the genome(1,2) A genome-wide scan of 93 affected sibpair families (ASP) from the UK (UK93) indicated a similar genetic basis for human type 1 diabetes, with the major genetic component at the MHC locus (IDDM1) explaining 34% of the familial clustering of the disease (lambda(s) = 2.5; refs 3,4). In the present report, we have analysed a further 263 multiplex families from the same population (UK263) to provide a total UK data set of 356 ASP families (UK356). Only four regions of the genome outside IDDM1/MHC, which was stilt the only major locus detected, were not excluded at lambda(s) = 3 and lod=-2, of which two showed evidence of linkage: chromosome 10p13-p11 (maximum lod score (MLS) = 4.7, P = 3 x 10(-6), lambda(s) = 1.56) and chromosome 16q22-16q24 (MLS = 3.4, P = 6.5 x 10(-5), lambda(s) = 1.6) These and other novel regions, including chromosome 14q12-q21 and chromosome 19p13-19q13, could potentially harbour disease loci but confirmation and fine mapping cannot be pursued effectively using conventional linkage analysis. instead, more powerful linkage disequilibrium-based(5-7) and haplotype mapping approaches(8) must be used; such data is already emerging for several type 1 diabetes loci detected initially by linkage(6,8-13).	Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Birmingham, Birmingham Heartlands Hosp, Dept Med, Birmingham B9 5SS, W Midlands, England	University of Oxford; Wellcome Centre for Human Genetics; Heart of England NHS Foundation Trust; University of Birmingham	Todd, JA (corresponding author), Univ Oxford, Nuffield Dept Surg, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Wilson, Amanda/0000-0001-5681-9611; Mein, Charles/0000-0003-0811-9658; CUCCA, Francesco/0000-0002-7414-1995	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1988, AM J HUM GENET, V42, P167; CUCCA F, IN PRESS DIABETES; CUCCA F, IN PRESS NATURE GENE; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; Kristiansen OP, 1998, DIABETES, V47, P281, DOI 10.2337/diab.47.2.281; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; LYONS PA, INPRESS GENETICS AUT; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Morahan G, 1996, SCIENCE, V272, P1811, DOI 10.1126/science.272.5269.1811; NAKAGAWA Y, IN PRESS AM J HUM GE; Podolin PL, 1998, MAMM GENOME, V9, P283, DOI 10.1007/s003359900749; PRITCHARD LE, 1997, THESIS U OXFORD; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; RISCH N, 1993, AM J HUM GENET, V53, P702; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; THOMSON G, 1988, AM J HUM GENET, V43, P799; VANDEWALLE CL, 1993, DIABETOLOGIA, V36, P1155, DOI 10.1007/BF00401060; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	30	291	299	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					297	300		10.1038/991	http://dx.doi.org/10.1038/991			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662409				2022-12-27	WOS:000074565900032
J	Nickerson, DA; Taylor, SL; Weiss, KM; Clark, AG; Hutchinson, RG; Stengard, J; Salomaa, V; Vartiainen, E; Boerwinkle, E; Sing, CF				Nickerson, DA; Taylor, SL; Weiss, KM; Clark, AG; Hutchinson, RG; Stengard, J; Salomaa, V; Vartiainen, E; Boerwinkle, E; Sing, CF			DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene	NATURE GENETICS			English	Article							HUMAN GENOME; LPL GENE; POLYMORPHISMS; ATHEROSCLEROSIS; MUTATION; FAMILY	Lipoprotein lipase plays a central role in lipid metabolism and the gene that encodes this enzyme (LPL) is a candidate susceptibility gene for cardiovascular disease. Here we report the complete sequence of a fraction of the LPL gene for 71 individuals (142 chromosomes) from three populations that may have different histories affecting the organization of the sequence variation. Eighty-eight sites in this 9.7 kb vary among individuals from these three populations. Of these, 79 were single nucleotide substitutions and 9 sites involved insertion-deletion variations. The average nucleotide diversity across the region was 0.2% (or on average 1 variable site every 500 bp). At 34 of these sites, the variation was found in only one of the populations, reflecting the differing population and mutational histories. If LPL is a typical human gene, the pattern of sequence variation that exists in introns as well as exons, even for the small number of samples considered here, will present challenges for the identification of sites, or combinations of sites, that influence Variation in risk of disease in the population at large.	Univ Washington, Dept Mol Biotechnol, Seattle, WA 98125 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Mississippi; University of Mississippi Medical Center; Finland National Institute for Health & Welfare; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Nickerson, DA (corresponding author), Univ Washington, Dept Mol Biotechnol, Box 357730, Seattle, WA 98125 USA.	debnick@u.washington.edu		Sing, Charles/0000-0001-5872-7956; Clark, Andrew/0000-0001-7159-8511	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058238, R01HL058239, R01HL058240] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58240, HL58238, HL58239] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1990, AM J HUM GENET, V46, P649; CLARK AG, UNPUB AM J HUM GENET; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Crandall Keith A., 1996, P137; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Eng C, 1997, NAT BIOTECHNOL, V15, P422, DOI 10.1038/nbt0597-422; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FISHER KL, 1987, NUCLEIC ACIDS RES, V15, P7657, DOI 10.1093/nar/15.18.7657; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harding RM, 1997, AM J HUM GENET, V60, P772; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; HEINZMANN C, 1987, NUCLEIC ACIDS RES, V15, P6763, DOI 10.1093/nar/15.16.6763; KIRCHGESSNER TG, 1989, P NATL ACAD SCI USA, V86, P9647, DOI 10.1073/pnas.86.24.9647; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KRYGLYAK L, 1997, NAT GENET, V17, P21; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LI WH, 1991, GENETICS, V129, P513; LI WH, 1997, MOL EVOLUTION, P178; Murthy V, 1996, PHARMACOL THERAPEUT, V70, P101, DOI 10.1016/0163-7258(96)00005-8; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roberts RJ, 1997, NUCLEIC ACIDS RES, V25, P248, DOI 10.1093/nar/25.1.248; Rowen L, 1997, SCIENCE, V278, P605, DOI 10.1126/science.278.5338.605; SING CF, 1996, VARIATION HUMAN GENO, P211; TEMPLETON AR, 1996, VARIATION HUMAN GENO, P259; VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISS KM, 1997, GENETIC VARIATION HU; WIEBUSCH H, 1992, CIRCULATION, V86, P1; Zhang HF, 1996, BBA-LIPID LIPID MET, V1302, P159, DOI 10.1016/0005-2760(96)00059-8	41	404	429	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					233	240		10.1038/907	http://dx.doi.org/10.1038/907			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662394				2022-12-27	WOS:000074565900017
J	Town, M; Jean, G; Cherqui, S; Attard, M; Forestier, L; Whitmore, SA; Callen, DF; Gribouval, O; Broyer, M; Bates, GP; van't Hoff, W; Antignac, C				Town, M; Jean, G; Cherqui, S; Attard, M; Forestier, L; Whitmore, SA; Callen, DF; Gribouval, O; Broyer, M; Bates, GP; van't Hoff, W; Antignac, C			A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis	NATURE GENETICS			English	Article							YAC CLONES; TRANSPORT; VECTOR; MAP	Nephropathic cystinosis, an autosomal recessive disorder resulting from defective lysosomal transport of cystine, is the most common inherited cause of renal Fanconi syndrome. The cystinosis gene has been mapped to chromosome 17p13. We found that the locus D17S829 was homozygously deleted in 23 out of 70 patients, and identified a novel gene, CTNS, which mapped to the deletion interval. CTNS encodes an integral membrane protein, cystinosin, with features of a lysosomal membrane protein. Eleven different mutations, all predicted to cause loss of function of the protein, were found to segregate with the disorder.	INSERM U43, F-75015 Paris, France; Guys Hosp, UMDS, Div Med & Mol Genet, London SE1 9RT, England; Univ Paris 05, Hop Necker Enfants Malad, Serv Nephrol Pediat, F-75015 Paris, France; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; UCL, Sch Med, Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Womens & Childrens Hospital Australia; University of London; University College London; UCL Medical School	Antignac, C (corresponding author), INSERM U43, Tour Lavoisier,149 Rue Sevres, F-75015 Paris, France.	m.town@umds.ac.uk; antignac@necker.fr	ANTIGNAC, Corinne/H-8945-2017; Callen, David F/G-1975-2012; Gribouval, Olivier/A-7689-2015; Bates, Gillian P/E-1146-2012	ANTIGNAC, Corinne/0000-0002-9934-4940; Gribouval, Olivier/0000-0003-0238-8224; Bates, Gillian P/0000-0002-4041-6305; Cherqui, Stephanie/0000-0003-1240-5219				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P189, DOI 10.1093/nar/24.1.189; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Collo G, 1996, J NEUROSCI, V16, P2495; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; HARDWICK KG, 1990, NUCLEIC ACIDS RES, V18, P2177, DOI 10.1093/nar/18.8.2177; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Jean G, 1996, AM J HUM GENET, V58, P535; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEHRACH H., 1990, GENOME ANAL, P39; McDowell G, 1996, BIOCHEM MOL MED, V58, P135, DOI 10.1006/bmme.1996.0041; MCDOWELL GA, 1995, NAT GENET, V10, P246, DOI 10.1038/ng0695-246; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Peters U, 1997, EUR J HUM GENET, V5, P9, DOI 10.1159/000484725; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Song I, 1996, ARCH BIOCHEM BIOPHYS, V334, P67, DOI 10.1006/abbi.1996.0430; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671	28	420	430	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					319	324		10.1038/ng0498-319	http://dx.doi.org/10.1038/ng0498-319			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537412				2022-12-27	WOS:000072755500012
J	Knezevich, SR; McFadden, DE; Tao, W; Lim, JF; Sorensen, PHB				Knezevich, SR; McFadden, DE; Tao, W; Lim, JF; Sorensen, PHB			A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOMAL TRANSLOCATION; MOLECULAR-CLONING; FIBRO-SARCOMA; TEL GENE; AMPLIFICATION; TRANSCRIPTS; CHILDHOOD; VARIANT; FAMILY	Congenital (or infantile) fibrosarcoma (CFS) is a malignant tumour of fibroblasts that occurs in patients aged two years or younger. CFS is unique among human sarcomas in that it has an excellent prognosis and very low metastatic rate(1,2). CFS is histologically identical to adult-type fibrosarcoma (ATFS); however, ATFS is an aggressive malignancy of adults and older children that has a poor prognosis(3). We report a novel recurrent t(12;15)(p13;q25) rearrangement in CFS that may underlie the distinctive biological properties of this tumour. By cloning the chromosome breakpoints, we show that the rearrangement fuses the ETV6 (also known as TEL) gene from 12p13 with the 15q25 NTRK3 neurotrophin-3 receptor gene (also known as TRKC). Analysis of mRNA revealed the expression of ETV6-NTRK3 chimaeric transcripts in all three CFS tumours analysed. These were not detected in ATFS or infantile fibromatosis (IFB), a histologically similar but benign fibroblastic proliferation occurring in the same age-group as CFS. ETV6-NTRK3 fusion transcripts encode the helix-loop-helix (HLH) protein dimerization domain of ETV6 fused to the protein tyrosine kinase (PTK) domain of NTRK3. Our studies indicate that a chimaeric PTK is expressed in CFS and this may contribute to oncogenesis by dysregulation of NTRK3 signal transduction pathways. Moreover, ETV6-NTRK3 gene fusions provide a potential diagnostic marker for CFS.	British Columbia Childrens Hosp, Dept Pathol, Vancouver, BC V6H 3V4, Canada	BC Childrens Hospital; University of British Columbia	Sorensen, PHB (corresponding author), British Columbia Childrens Hosp, Dept Pathol, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.	psor@unixg.ubc.ca		McFadden, Deborah/0000-0002-0629-3436				Baens M, 1996, GENOME RES, V6, P404, DOI 10.1101/gr.6.5.404; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BONIN G, 1993, CANCER RES, V53, P3655; BUIJS A, 1995, ONCOGENE, V10, P1511; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Desmaze C, 1997, CANCER GENET CYTOGEN, V97, P12, DOI 10.1016/S0165-4608(96)00326-3; DRACOPOLI NC, 1996, CURRENT PROTOCOLS HU; ENZINGER FM, 1995, SOFT TISSUE TUMORS, P1; Fisher C, 1996, EUR J CANCER, V32A, P2094, DOI 10.1016/S0959-8049(96)00287-0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; ICHIKAWA H, 1994, CANCER RES, V54, P2865; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; MANDAHL N, 1989, CANCER GENET CYTOGEN, V40, P137, DOI 10.1016/0165-4608(89)90156-8; MCGREGOR LM, 1994, GENOMICS, V22, P267, DOI 10.1006/geno.1994.1383; PAPADOPOULOS P, 1995, CANCER RES, V55, P34; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; PIZZO PA, 1997, PRINCIPLES PRACTICE, P1; Raynaud S, 1996, BLOOD, V87, P2891, DOI 10.1182/blood.V87.7.2891.bloodjournal8772891; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHOFIELD DE, 1994, AM J SURG PATHOL, V18, P14, DOI 10.1097/00000478-199401000-00002; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Sorensen PHB, 1996, P NATL ACAD SCI USA, V93, P1038, DOI 10.1073/pnas.93.3.1038; SORENSEN PHB, 1993, DIAGN MOL PATHOL, V2, P147, DOI 10.1097/00019606-199309000-00002; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; SPELEMAN F, 1989, CANCER GENET CYTOGEN, V39, P21, DOI 10.1016/0165-4608(89)90224-0; Uphoff CC, 1997, LEUKEMIA, V11, P441, DOI 10.1038/sj.leu.2400571; VERMA RS, 1989, HUMAN CHROMOSOMES MA	30	552	581	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					184	187		10.1038/ng0298-184	http://dx.doi.org/10.1038/ng0298-184			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462753				2022-12-27	WOS:000071779500032
J	Moore, RC; Hope, J; McBride, PA; McConnell, I; Selfridge, J; Melton, DW; Manson, JC				Moore, RC; Hope, J; McBride, PA; McConnell, I; Selfridge, J; Melton, DW; Manson, JC			Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent	NATURE GENETICS			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE INCUBATION-TIME; PRP GENE; TRANSGENIC MICE; CONGENIC MICE; MOUSE; EXPRESSION; POLYMORPHISM; TRANSMISSION	Classical genetic analysis has identified Sinc/Prni as the major gene controlling mouse scrapie incubation time. Sinc/Pmi is linked to Prnp, the gene encoding the prion protein (PrP). Prnp alleles express distinct PrP protein variants, PrP A and PrP B, which arise from codon 108L/F and 189 T/V dimorphisms. Prnp genotype segregates with incubation time length which suggests, but does not prove, that incubation time is controlled by PrP dimorphisms, and that the Sinc/Prni and Prnp loci are congruent. We have used gene targetting to construct mice in which the endogenous Prnp allele has been modified to express PrP 8 instead of PrP A. Challenge with a mouse-adapted BSE strain results in dramatically shortened incubation times and demonstrates that PrP dimorphisms at codon 108 and/or 189 control incubation time, and that Sinc/Prni and Prnp are congruent.	Inst Anim Hlth, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Inst Anim Hlth, Compton Lab, Newbury RG20 7NN, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Manson, JC (corresponding author), Inst Anim Hlth, Neuropathogenesis Unit, Ogston Bldg,W Mains Rd, Edinburgh EH9 3JF, Midlothian, Scotland.	jean.manson@bbsrc.ac.uk	Hope, James/C-4966-2011	SELFRIDGE, JIM/0000-0003-2473-4386				BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Baybutt H, 1997, GENE, V184, P125, DOI 10.1016/S0378-1119(96)00600-2; BELL JE, 1993, BRIT MED BULL, V49, P738, DOI 10.1093/oxfordjournals.bmb.a072645; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CHANDLER RL, 1961, LANCET, V1, P1378; CREUTZFELDT HG, 1920, Z GESAMTE NEUROL PSY, V57, P247; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DICKINSON AG, 1964, HEREDITY, V19, P279, DOI 10.1038/hdy.1964.31; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Farquhar CF, 1996, J GEN VIROL, V77, P1941, DOI 10.1099/0022-1317-77-8-1941; FARQUHAR CF, 1989, J VIROL METHODS, V24, P215, DOI 10.1016/0166-0934(89)90023-2; FARQUHAR CF, 1993, P CONS BSE SCI VET C, P301; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; Fraser H., 1976, Slow virus diseases of animals and man,, P267; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; FRASER H, 1967, NATURE, V216, P1310, DOI 10.1038/2161310a0; GADJUSEK DC, 1957, NEW ENGL J MED, V257, P974; Gerstmann J., 1936, Z NEUROL, V154, P736, DOI [10.1007/BF02865827, DOI 10.1007/BF02865827]; Hainfellner JA, 1997, BRAIN PATHOL, V7, P547, DOI 10.1111/j.1750-3639.1997.tb01072.x; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; HUNTER N, 1992, J GEN VIROL, V73, P2751, DOI 10.1099/0022-1317-73-10-2751; Jakob A, 1921, Z GESAMTE NEUROL PSY, V64, P147, DOI 10.1007/BF02870932; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUGARESI E, 1986, NEW ENGL J MED, V315, P997, DOI 10.1056/NEJM198610163151605; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Manson J., 1992, Neurodegeneration, V1, P45; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; RACE RE, 1990, J GEN VIROL, V71, P493, DOI 10.1099/0022-1317-71-2-493; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; WESTAWAY D, 1991, NEURON, V7, P59, DOI 10.1016/0896-6273(91)90074-A; WESTAWAY D, 1987, CELL, V51, P561	54	158	159	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					118	125		10.1038/ng0298-118	http://dx.doi.org/10.1038/ng0298-118			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462739				2022-12-27	WOS:000071779500018
J	Seidner, G; Alvarez, MG; Yeh, JI; O'Driscoll, KR; Klepper, J; Stump, TS; Wang, D; Spinner, NB; Birnbaum, MJ; De Vivo, DC				Seidner, G; Alvarez, MG; Yeh, JI; O'Driscoll, KR; Klepper, J; Stump, TS; Wang, D; Spinner, NB; Birnbaum, MJ; De Vivo, DC			GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier	NATURE GENETICS			English	Article							GLUCOSE-TRANSPORTER GENE; EXPRESSION; ANTIBODIES; SEQUENCE; PROTEIN	The high metabolic requirements of the mammalian central nervous system require specialized structures for the facilitated transport of nutrients across the blood-brain barrier. Stereospecific high-capacity carriers, including those that recognize glucose, are key components of this barrier, which also protects the brain against noxious substances. Facilitated glucose transport in vertebrates is catalyzed by a family of carriers consisting of at least five functional isoforms with distinct tissue distributions, subcellular localizations and transport kinetics(1,2). Several of these transporters are expressed in the mammalian brain(3). GLUT-1, whose sequence was originally deduced from cDNAs cloned from human hepatoma and rat brain(4,5), is present at high levels in primate erythrocytes and brain endothelial cells. GLUT1 has been cloned and positionally mapped to the short arm of chromosome 1 (1p35-p31.3; refs 6-8). Despite substantial metabolic requirements of the central nervous system, no genetic disease caused by dysfunctional blood-brain barrier transport has been identified. Several years ago, we described two patients with infantile seizures, delayed development and acquired microcephaly who have normal circulating blood glucose, low-to-normal cerebrospinal fluid (CSF) lactate, but persistent hypoglycorrachia (low CSF glucose) and diminished transport of hexose into isolated red blood cells (RBC; ref. 9). These symptoms suggested the existence of a defect in glucose transport across the blood brain barrier. We now report two distinct classes of mutations as the molecular basis for the functional defect of glucose transport: hemizygosity of GLUT1 and nonsense mutations resulting in truncation of the GLUT-1 protein.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Cox Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan; Columbia Presbyterian Med Ctr, Dept Neurol, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Dept Pediat, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Inst Neurol, Colleen Giblin Labs Pediat Neurol Res, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Babies & Childrens Hosp, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; National Taiwan University; National Taiwan University Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, 415 Curie Blvd, Philadelphia, PA 19104 USA.			Birnbaum, Morris/0000-0001-9972-8680	NIDDK NIH HHS [DK 39615] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039615] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLARD WJ, 1985, J BIOL CHEM, V260, P8668; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; DAVIES A, 1987, J BIOL CHEM, V262, P9347; De Vivo D. C., 1995, INT PEDIAT, V10, P51; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; FUKUMOTO H, 1988, DIABETES, V37, P657, DOI 10.2337/diabetes.37.5.657; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; JAMES DE, 1995, NEWS PHYSIOL SCI, V10, P67, DOI 10.1152/physiologyonline.1995.10.2.67; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; SHOWS TB, 1987, DIABETES, V36, P546, DOI 10.2337/diabetes.36.4.546; WILLIAMS SA, 1988, J BIOL CHEM, V263, P19513	17	292	300	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					188	191		10.1038/ng0298-188	http://dx.doi.org/10.1038/ng0298-188			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462754				2022-12-27	WOS:000071779500033
J	Barlow, C; Brown, KD; Deng, CX; Tagle, DA; WynshawBoris, A				Barlow, C; Brown, KD; Deng, CX; Tagle, DA; WynshawBoris, A			Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways	NATURE GENETICS			English	Article							RADIATION-INDUCED APOPTOSIS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; P53 PROTEIN; DNA-DAMAGE; MICE; INSTABILITY; SUPPRESSION; INDUCTION; PARADIGM	Atm is part of a pathway that responds to DNA damage from ionizing radiation (IR). This pathway involves p53, as Atm-deficient cell lines and mice are defective in p53 induction after IR1-5. p53 is a multi-functional protein that simultaneously regulates distinct downstream pathways controlling cell-cycle progression and apoptosis(6,7). However, the mechanisms by which p53 differentially activates downstream pathways are unknown. To determine the relationship between Atm and p53, we examined cell-cycle and apoptotic responses in Atm-, p53- (ref. 8) and p21-deficient(9) mice after IR in the whole animal, As expected, p53 protein levels were not induced by IR in thymus of Atm-deficient mice. IR-induced cell-cycle checkpoint function was also defective, and induction of p21 was attenuated in thymus from Atm-deficient mice, However, IR-induced apoptosis and Bar induction were completely normal; both of which are mediated by p53. IR-induced thymic apoptosis was suppressed in Atm/p53 double-mutant mice but not in Atm/p21 double mutants, demonstrating p53 dependence and Atm independence. Thus, Atm deficiency results in lack of p53 induction by IR, but only selective disruption of p53-dependent functions, Our results support a model in which upstream effecters such as Atm selectively activate p53 to regulate specific downstream pathways, providing a mechanism for controlling distinct cell-cycle and apoptotic responses.	NIDDKD,LAB GENET DIS RES,NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892; NIDDKD,LAB GENE TRANSFER,NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892; NIDDKD,BIOCHEM & METAB LAB,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			deng, chuxia/N-6713-2016					Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Harlow E., 1988, ANTIBODIES LAB MANUA; HARPER JW, 1993, CELL, V75, P805; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KHANNA KK, 1993, ONCOGENE, V8, P3307; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lakin ND, 1996, ONCOGENE, V13, P2707; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Luna L.G., 1992, HISTOPATHOLOGICAL ME; MEYN MS, 1995, CANCER RES, V55, P5991; MEYN MS, 1994, INT J RADIAT BIOL, V66, pS141; MIYASHITA T, 1995, CELL, V80, P293; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; WHITE RA, 1990, CYTOMETRY, V11, P314, DOI 10.1002/cyto.990110214; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	31	185	187	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					453	456		10.1038/ng1297-453	http://dx.doi.org/10.1038/ng1297-453			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398849				2022-12-27	WOS:A1997YJ92400028
J	Nagamine, K; Peterson, P; Scott, HS; Kudoh, J; Minoshima, S; Heino, M; Krohn, KJE; Lalioti, MD; Mullis, PE; Antonarakis, SE; Kawasaki, K; Asakawa, S; Ito, F; Shimizu, N				Nagamine, K; Peterson, P; Scott, HS; Kudoh, J; Minoshima, S; Heino, M; Krohn, KJE; Lalioti, MD; Mullis, PE; Antonarakis, SE; Kawasaki, K; Asakawa, S; Ito, F; Shimizu, N			Positional cloning of the APECED gene	NATURE GENETICS			English	Article							DISEASE TYPE-I; PROTEIN; SEQUENCES; 21Q22.3; REGION; CDNA	Autoimmune polyglandular syndrome type I (APS 1, also called APECED) is an autosomal-recessive disorder that maps to human chromosome 21q22.3 between markers D21S49 and D21S171 by linkage studies. We have isolated a novel gene from this region, AIRE (autoimmune regulator), which encodes a protein containing motifs suggestive of a transcription factor including two zinc-finger (PHD-finger) motifs, a proline-rich region and three LXXLL motifs. Two mutations, a C-->T substitution that changes the Arg 257 (CGA) to a stop codon (TGA) and an A-->G substitution that changes the Lys 83 (AAG) to a Glu codon (GAG), were found in this novel gene in Swiss and Finnish APECED patients. The Arg257stop (R257X) is the predominant mutation in Finnish APECED patients, accounting for 10/12 alleles studied. These results indicate that this gene is responsible for the pathogenesis of APECED. The identification of the gene defective in APECED should facilitate the genetic diagnosis and potential treatment of the disease and further enhance our general understanding of the mechanisms underlying autoimmune diseases.	KEIO UNIV,SCH MED,DEPT MOL BIOL,SHINJUKU KU,TOKYO 160,JAPAN; SETSUNAN UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM,HIRAKATA,OSAKA 57301,JAPAN; TAMPERE UNIV HOSP,TAMPERE 33101,FINLAND; INST MED TECHNOL,TAMPERE 33101,FINLAND; UNIV GENEVA,SCH MED,DEPT GENET & MICROBIOL,LAB HUMAN MOL GENET,CH-1211 GENEVA 4,SWITZERLAND; CANTONAL HOSP GENEVA,DIV MED GENET,CH-1211 GENEVA 4,SWITZERLAND; UNIV BERN,DEPT PAEDIAT,BERN,SWITZERLAND	Keio University; Setsunan University; Tampere University; Tampere University Hospital; University of Geneva; University of Geneva; University of Bern			Peterson, Pärt/A-5788-2009; Antonarakis, Stylianos E/N-8866-2014; Scott, Hamish/B-2122-2009	Peterson, Pärt/0000-0001-6755-791X; Antonarakis, Stylianos E/0000-0001-8907-5823; Scott, Hamish/0000-0002-5813-631X; Ito, Fumiaki/0000-0002-4129-4899				AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; Bjorses P, 1996, AM J HUM GENET, V59, P879; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; Chen H, 1996, GENOME RES, V6, P747, DOI 10.1101/gr.6.8.747; Clemente MG, 1997, J CLIN ENDOCR METAB, V82, P1353, DOI 10.1210/jc.82.5.1353; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; GE Q, 1995, J CLIN INVEST, V96, P1730, DOI 10.1172/JCI118218; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Husebye ES, 1997, J CLIN ENDOCR METAB, V82, P147, DOI 10.1210/jc.82.1.147; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kudoh J, 1997, DNA Res, V4, P45, DOI 10.1093/dnares/4.1.45; Lalioti MD, 1996, GENOMICS, V35, P321, DOI 10.1006/geno.1996.0363; Nagamine K, 1997, BIOCHEM BIOPH RES CO, V235, P185, DOI 10.1006/bbrc.1997.6758; Nagamine K, 1996, BIOCHEM BIOPH RES CO, V225, P608, DOI 10.1006/bbrc.1996.1218; Nagamine K, 1997, GENOMICS, V42, P528, DOI 10.1006/geno.1997.4761; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; Scott HS, 1997, HUM GENET, V99, P616, DOI 10.1007/s004390050416; SCOTT HS, IN PRESS GENOMICS; SEEIG HP, 1995, ARTHRITIS RHEUM, V38, P1389; Thenot S, 1997, J BIOL CHEM, V272, P12062, DOI 10.1074/jbc.272.18.12062; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	29	984	1019	1	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					393	398		10.1038/ng1297-393	http://dx.doi.org/10.1038/ng1297-393			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398839				2022-12-27	WOS:A1997YJ92400018
J	Koutnikova, H; Campuzano, V; Foury, F; Dolle, P; Cazzalini, O; Koenig, M				Koutnikova, H; Campuzano, V; Foury, F; Dolle, P; Cazzalini, O; Koenig, M			Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin	NATURE GENETICS			English	Article							FRIEDREICHS ATAXIA; GENE; MUTATIONS; PROTEIN; DISEASE; CELLS	Friedreich's ataxia is due to loss of function mutations in the gene encoding frataxin (FRDA). Frataxin is a protein of unknown function. In situ hybridization analyses revealed that mouse frataxin expression correlates well with the main site of neurodegeneration, but the expression pattern is broader than expected from the pathology of the disease. Frataxin mRNA is predominantly expressed in tissues with a high metabolic rate, including liver, kidney, brown fat and heart. We found that mouse and yeast frataxin homologues contain a potential mitochondrial targeting sequence in their N-terminal domains and that disruption of the yeast gene results in mitochondrial dysfunction. Finally, tagging experiments demonstrate that human frataxin co-localizes with a mitochondrial protein. Friedreich's ataxia is therefore a mitochondrial disease caused by a mutation in the nuclear genome.	UNIV STRASBOURG 1, INST GENET & BIOL MOL & CELLULAIRE, INSERM, CNRS, F-67404 ILLKIRCH STRASBOU, FRANCE; UNIV CATHOLIQUE LOUVAIN, UNITE BIOCHIM PHYSIOL, B-1348 LOUVAIN, BELGIUM	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Catholique Louvain			Koutnikova, Hana/I-7758-2017; Campuzano, Victoria/ABG-7429-2020; Dolle, Pascal/A-8037-2010; CAMPUZANO, VICTORIA/K-7883-2019; Campuzano, V/G-1826-2014	Campuzano, Victoria/0000-0001-8128-2641; Dolle, Pascal/0000-0002-9294-9090; Campuzano, V/0000-0001-8128-2641				Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; CARVAJAL JJ, 1995, HUM MOL GENET, V4, P1411, DOI 10.1093/hmg/4.8.1411; Cossee M, 1997, NAT GENET, V15, P337, DOI 10.1038/ng0497-337; DECIMO D, 1995, GENE PROBES PRACTICA, V2, P183; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GORMAN CM, 1984, PHILOS T ROY SOC B, V307, P343, DOI 10.1098/rstb.1984.0137; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OPPENHEIMER DR, 1992, GREENFIELDS NEUROPAT, P1015; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; ROMEO G, 1983, AM J HUM GENET, V35, P523; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J, 1989, MOL CLONNING LAB MAN; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHREIBER V, 1994, GENE, V150, P411, DOI 10.1016/0378-1119(94)90466-9; SKRE H, 1975, CLIN GENET, V7, P287; Stryer L., 1988, BIOCHEMISTRY-US; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	27	389	401	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					345	351		10.1038/ng0897-345	http://dx.doi.org/10.1038/ng0897-345			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241270				2022-12-27	WOS:A1997XM90900015
J	Lefebvre, S; Burlet, P; Liu, Q; Bertrandy, S; Clermont, O; Munnich, A; Dreyfuss, G; Melki, J				Lefebvre, S; Burlet, P; Liu, Q; Bertrandy, S; Clermont, O; Munnich, A; Dreyfuss, G; Melki, J			Correlation between severity and SMN protein level in spinal muscular atrophy	NATURE GENETICS			English	Article							MOTOR-NEURON GENE; DELETIONS; INDIVIDUALS; 5Q13		HOP NECKER ENFANTS MALAD,INST NECKER,IFREM,INSERM U393,UNITE RECH HANDICAPS GENET LENFANT,F-75743 PARIS,FRANCE; UNIV PENN,HOWARD HUGHES MED INST,SCH MED,PHILADELPHIA,PA 19104; UNIV PENN,DEPT BIOCHEM & BIOPHYS,SCH MED,PHILADELPHIA,PA 19104	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania			Dreyfuss, Gideon/D-1218-2013; Lefebvre, Suzie/D-5092-2017	Dreyfuss, Gideon/0000-0001-8129-8774; 				ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Burglen L, 1997, AM J HUM GENET, V60, P72; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; CHANG JG, 1995, AM J HUM GENET, V57, P1503; COBBEN JM, 1995, AM J HUM GENET, V57, P805; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; POWERS MM, 1955, STAIN TECHNOL, V30, P83, DOI 10.3109/10520295509113749; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7	17	830	855	0	43	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					265	269		10.1038/ng0797-265	http://dx.doi.org/10.1038/ng0797-265			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207792				2022-12-27	WOS:A1997XG60900022
J	Koehler, KE; Boulton, CL; Collins, HE; French, RL; Herman, KC; Lacefield, SM; Madden, LD; Schuetz, CD; Hawley, RS				Koehler, KE; Boulton, CL; Collins, HE; French, RL; Herman, KC; Lacefield, SM; Madden, LD; Schuetz, CD; Hawley, RS			Spontaneous X chromosome MI and MII nondisjunction events in Drosophila melanogaster oocytes have different recombinational histories	NATURE GENETICS			English	Article							KINESIN-LIKE PROTEIN; GENETIC-ANALYSIS; DISTRIBUTIVE SEGREGATION; MEIOTIC MUTANTS; NOD; MECHANISMS; MUTATION; FEMALES; MEIOSIS; LOCALIZATION	Recent studies of human oocytes have demonstrated an enrichment for distal exchanges among meiosis I (MI) nondisjunction events and for proximal exchanges among meiosis II (MII) events. Our characterization of 103 cases of spontaneous X chromosome nondisjunction in Drosophila oocytes strongly parallels these observations. The recombinational histories of MI (97/103) and MII (6/103) nondisjunctional ova were strikingly different. MI nondisjunction occurred primarily in oocytes with non-exchange X chromosomes; of the few nondisjoining exchange bivalents, most carried distal crossovers. Thus, spontaneous MI nondisjunction reflects the failure of the achiasmate segregation systems. MII nondisjunction occurred only in oocytes with proximal exchanges. We propose several models to explain how very proximal exchanges might impair proper segregation.	UNIV CALIF DAVIS,DEPT GENET,SECT MOL & CELLULAR BIOL,DAVIS,CA 95616	University of California System; University of California Davis			French, Rachael/AAI-2427-2020	French, Rachael/0000-0001-9974-4293; Hawley, R. Scott/0000-0002-6478-0494				ABRUZZO MA, 1995, ENVIRON MOL MUTAGEN, V25, P38, DOI 10.1002/em.2850250608; AFSHAR K, 1995, J CELL BIOL, V131, P833, DOI 10.1083/jcb.131.4.833; AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; ANGELL RR, 1994, CYTOGENET CELL GENET, V65, P194, DOI 10.1159/000133631; ANGELL RR, 1995, CYTOGENET CELL GENET, V69, P266, DOI 10.1159/000133977; BAKER BS, 1972, GENETICS, V71, P255; Bickel SE, 1996, EMBO J, V15, P1451, DOI 10.1002/j.1460-2075.1996.tb00487.x; Bridges CB, 1916, GENETICS, V1, P1; CARPENTER AT, 1973, GENETICS, V73, P393; CARPENTER ATC, 1982, GENETICS, V101, P81; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; DERNBURG AF, 1996, CELL, V85, P135; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; GOLDSTEIN LSB, 1980, CHROMOSOMA, V78, P79, DOI 10.1007/BF00291909; GREEN MM, 1959, P NATL ACAD SCI USA, V45, P16, DOI 10.1073/pnas.45.1.16; Hartwell LW, 1982, RECENT ADV YEAST MOL, V1, P28; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hawley R.S., 1988, GENETIC RECOMBINATIO, P497; HAWLEY RS, 1993, ANNU REV GENET, V27, P281; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HAWLEY RS, 1993, TRENDS GENET, V9, P310; HAWLEY RS, 1993, DEV GENET, V13, P440; HUNT P, 1995, HUM MOL GENET, V4, P2007, DOI 10.1093/hmg/4.11.2007; JANG JK, 1995, SCIENCE, V268, P1917, DOI 10.1126/science.7604267; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; KNOWLES BA, 1991, P NATL ACAD SCI USA, V88, P7165, DOI 10.1073/pnas.88.16.7165; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MATTHIES HJG, IN PRESS J CELL BIOL; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; MERRIAM JR, 1964, GENETICS, V49, P109; MIYAZAKI WY, 1992, GENETICS, V132, P1047; NELSON CR, 1992, CELL MOTIL CYTOSKEL, V23, P34, DOI 10.1002/cm.970230105; NICKLAS RB, 1977, PHILOS T ROY SOC B, V277, P267, DOI 10.1098/rstb.1977.0017; NICKLAS RB, 1974, GENETICS, V78, P205; NOVITSKI E, 1955, J CELL COMPAR PHYSL, V45, P151, DOI 10.1002/jcp.1030450509; OTOUSA J, 1982, GENETICS, V102, P503; PETERSEN MB, 1992, AM J HUM GENET, V51, P516; RASOOLY RS, 1991, GENETICS, V129, P409; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; SANDLER L, 1968, GENETICS, V60, P525; SEARS ER, 1952, CHROMOSOMA, V4, P535, DOI 10.1007/BF00325789; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; STEWART RJ, 1990, P NATL ACAD SCI USA, V90, P5209; Sturtevant AH, 1936, GENETICS, V21, P554; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Weinstein A, 1936, GENETICS, V21, P155; WHITECOOPER H, 1993, J CELL SCI, V106, P1035; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P; ZHANG P, 1990, GENETICS, V125, P115; ZITRON AE, 1989, GENETICS, V122, P801	55	115	118	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					406	414		10.1038/ng1296-406	http://dx.doi.org/10.1038/ng1296-406			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944020				2022-12-27	WOS:A1996VV73000016
J	Zhu, ZQ; Yao, JB; Johns, T; Fu, K; De Bie, I; MacMillan, C; Cuthbert, AP; Newbold, RF; Wang, JC; Chevrette, M; Brown, GK; Brown, RM; Shoubridge, EA				Zhu, ZQ; Yao, JB; Johns, T; Fu, K; De Bie, I; MacMillan, C; Cuthbert, AP; Newbold, RF; Wang, JC; Chevrette, M; Brown, GK; Brown, RM; Shoubridge, EA			SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; FUNCTIONAL COMPLEMENTATION; MONOCHROMOSOME TRANSFER; MITOCHONDRIAL DISEASES; BIDIRECTIONAL PROMOTER; MOLECULAR ANALYSIS; MICROCELL HYBRIDS; COMMON-CAUSE; GENE	Leigh Syndrome (LS) is a severe neurological disorder characterized by bilaterally symmetrical necrotic lesions in subcortical brain regions that is commonly associated with systemic cytochrome c oxidase (COX) deficiency. COX deficiency is an autosomal recessive trait and most patients belong to a single genetic complementation group. DNA sequence analysis of the genes encoding the structural subunits of the COX complex has failed to identify a pathogenic mutation. Using microcell-mediated chromosome transfer, we mapped the gene defect in this disorder to chromosome 9q34 by complementation of the respiratory chain deficiency in patient fibroblasts. Analysis of a candidate gene (SURF1) of unknown function revealed several mutations, all of which predict a truncated protein. These data suggest a role for SURF1 in the biogenesis of the COX complex and define a new class of gene defects causing human neurodegenerative disease.	Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; Brunel Univ, Dept Biol & Biochem, Uxbridge UB8 3PH, Middx, England; McGill Univ, Dept Surg, Montreal Gen Hosp, Res Inst,Urol Div, Montreal, PQ H3A 2T5, Canada; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	McGill University; McGill University; Brunel University; McGill University; University of Oxford	Shoubridge, EA (corresponding author), Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.		De Bie, Isabelle/M-1793-2019					Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231; BONNEFOY N, 1994, P NATL ACAD SCI USA, V91, P11978, DOI 10.1073/pnas.91.25.11978; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; Brown RM, 1996, J INHERIT METAB DIS, V19, P752, DOI 10.1007/BF01799168; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COLOMBO P, 1992, P NATL ACAD SCI USA, V89, P6358, DOI 10.1073/pnas.89.14.6358; COMPTON T, 1993, J VIROL, V67, P3644, DOI 10.1128/JVI.67.6.3644-3648.1993; CUTHBERT AP, 1995, CYTOGENET CELL GENET, V71, P68, DOI 10.1159/000134066; Dahl H.-H. M., 1992, Human Mutation, V1, P97, DOI 10.1002/humu.1380010203; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; DORIN JR, 1992, HUM MOL GENET, V1, P53, DOI 10.1093/hmg/1.1.53; England NL, 1996, CARCINOGENESIS, V17, P1567, DOI 10.1093/carcin/17.8.1567; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; GIALLONGO A, 1989, MOL CELL BIOL, V9, P224, DOI 10.1128/MCB.9.1.224; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X; HAYASAKA K, 1989, J INHERIT METAB DIS, V12, P247, DOI 10.1007/BF01799214; HEISER WC, 1994, ANAL BIOCHEM, V217, P185, DOI 10.1006/abio.1994.1108; HUXLEY C, 1990, MOL CELL BIOL, V10, P605, DOI 10.1128/MCB.10.2.605; INNIS MA, 1990, PCR PROTOCOLS, P54; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KALIMO H, 1979, ANN NEUROL, V6, P200, DOI 10.1002/ana.410060304; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; LEBEAU MC, 1991, NUCLEIC ACIDS RES, V19, P1337, DOI 10.1093/nar/19.6.1337; Lee N, 1998, BBA-MOL BASIS DIS, V1406, P1, DOI 10.1016/S0925-4439(98)00003-9; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; LENNARD A, 1994, DNA CELL BIOL, V13, P1117, DOI 10.1089/dna.1994.13.1117; LENNARD AC, 1991, MOL CELL BIOL, V11, P1281, DOI 10.1128/MCB.11.3.1281; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; LOMBES A, 1991, NEUROLOGY, V41, P491, DOI 10.1212/WNL.41.4.491; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; MERANTE F, 1993, AM J HUM GENET, V53, P481; MORAES CT, 1991, AM J HUM GENET, V48, P492; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; MULERO JJ, 1993, GENETICS, V133, P509; Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221; Newbold Robert F., 1996, P53; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; ROBINSON BH, 1987, J PEDIATR-US, V110, P216, DOI 10.1016/S0022-3476(87)80157-9; Santorelli FM, 1997, ANN NEUROL, V42, P256, DOI 10.1002/ana.410420220; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; VANCOSTER R, 1991, J NEUROL SCI, V104, P97, DOI 10.1016/0022-510X(91)90222-S; VANERVEN PMM, 1987, CLIN NEUROL NEUROSUR, V89, P217, DOI 10.1016/S0303-8467(87)80020-3; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805	56	481	491	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1998	20	4					337	343		10.1038/3804	http://dx.doi.org/10.1038/3804			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843204				2022-12-27	WOS:000077199600019
J	Masternak, K; Barras, E; Zufferey, M; Conrad, B; Corthals, G; Aebersold, R; Sanchez, JC; Hochstrasser, DF; Mach, B; Reith, W				Masternak, K; Barras, E; Zufferey, M; Conrad, B; Corthals, G; Aebersold, R; Sanchez, JC; Hochstrasser, DF; Mach, B; Reith, W			A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients	NATURE GENETICS			English	Article							BARE LYMPHOCYTE SYNDROME; REGULATORY FACTOR; BINDING-PROTEIN; TRANSCRIPTION-FACTOR; X-BOX; COOPERATIVE BINDING; CDNA CLONING; NF-Y; COMPLEX; COMPLEMENTATION	Major histocompatibility class II (MHC-II) molecules are transmembrane proteins that have a central role in development and control of the immune system. They are encoded by a multigene family and their expression is tightly regulated. MHC-II deficiency (OMIM 209920) is an autosomal recessive immunodeficiency syndrome resulting from defects in trans-acting factors essential for transcription of MHC-II genes(1,2). There are four genetic complementation groups(3-5) (A, B, C and D), reflecting the existence of four MHC-II regulators(2). The factors defective in groups A (CIITA), C (RFX5) and D (RFXAP) have been identified(6-8). CIITA is a non-DNA-binding co-activator that controls the cell-type specificity and inducibility of MHC-II expression(6,9) RFX5 and RFXAP are two subunits of RFX, a multi-protein complex that binds the X box motif of MHC-II promoters(10,11). Mutations in the genes encoding RFX5 (RFX5) or RFXAP (RFXAP) abolish binding of RFX (refs 7,8,12), Similar to groups C and D, group B is characterized by a defect in RFX binding(2,10,11), and although it accounts for the majority of patients, the factor defective in group B has remained unknown. We report here the isolation of RFX by a novel single-step DNA-affinity purification approach and the identification of RFXANK, the gene encoding a third subunit of RFX. RFXANK restores MHC-II expression in cell lines from patients in group B and is mutated in these patients. RFXANK contains a protein-protein interaction region consisting of three ankyrin repeats. Its interaction with RFX5 and RFXAP is essential for binding of the RFX complex to MHC-II promoters.	Univ Geneva, Sch Med, Dept Genet & Microbiol, Louis Jeantet Lab Mol Genet, CH-1211 Geneva, Switzerland; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Hosp Geneva, Cent Lab Clin Chem, CH-1211 Geneva, Switzerland	University of Geneva; University of Washington; University of Washington Seattle; University of Geneva	Mach, B (corresponding author), Univ Geneva, Sch Med, Dept Genet & Microbiol, Louis Jeantet Lab Mol Genet, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Bernard.Mach@medecine.unige.ch; Walter.Reith@medecine.unige.ch	Corthals, Garry/G-9417-2016	Corthals, Garry/0000-0001-9423-5596				Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; DURAND B, 1994, MOL CELL BIOL, V14, P6839, DOI 10.1128/MCB.14.10.6839; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GYGI SG, IN PRESS ELECTROPHOR; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P6269, DOI 10.1093/nar/19.22.6269; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Latchman DS, 1996, NEW ENGL J MED, V334, P28, DOI 10.1056/NEJM199601043340108; LISOWSKAGROSPIERRE B, 1994, HUM MOL GENET, V3, P953, DOI 10.1093/hmg/3.6.953; LouisPlence P, 1997, J IMMUNOL, V159, P3899; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Moreno CS, 1997, J IMMUNOL, V158, P5841; REITH W, 1994, J BIOL CHEM, V269, P20020; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; REITH W, 1998, PRIMARY IMMUNODEFICI; Rosen FS, 1993, IMMUNODEFICIENCIES, P141; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; SEIDL C, 1992, J IMMUNOL, V148, P1576; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; Villard J, 1997, NEW ENGL J MED, V337, P748, DOI 10.1056/NEJM199709113371104; WATANABE H, 1993, MOL CELL BIOL, V13, P1385, DOI 10.1128/MCB.13.3.1385	30	229	239	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					273	277		10.1038/3081	http://dx.doi.org/10.1038/3081			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806546				2022-12-27	WOS:000076698100021
J	Ermolaeva, O; Rastogi, M; Pruitt, KD; Schuler, GD; Bittner, ML; Chen, YD; Simon, R; Meltzer, P; Trent, JM; Boguski, MS				Ermolaeva, O; Rastogi, M; Pruitt, KD; Schuler, GD; Bittner, ML; Chen, YD; Simon, R; Meltzer, P; Trent, JM; Boguski, MS			Data management and analysis for gene expression arrays	NATURE GENETICS			English	Article							SERIAL ANALYSIS; HYBRIDIZATION; GENOME; MICROARRAY; PATTERNS; MAP	Microarray technology makes it possible to simultaneously study the expression of thousands of genes during a single experiment. We have developed an information system, ArrayDB, to manage and analyse large-scale expression data. The underlying relational database was designed to allow flexibility in the nature and structure of data input and also in the generation of standard or customized reports through a web-browser interface. ArrayDB provides varied options for data retrieval and analysis tools that should facilitate the interpretation of complex hybridization results. A sampling of ArrayDB storage, retrieval and analysis capabilities is available (www.nhgri.nih.gov/DIR/LCG/15K/HTML/), along with information on a set of approximately 15,000 genes used to fabricate several widely used microarrays. Information stored in ArrayDB is used to provide integrated gene expression reports by linking array target sequences with NCBl's Entrez retrieval system, UniGene and KEGG pathway views. The integration of externa I information resources is essential in interpreting intrinsic patterns and relationships in large-scale gene expression data.	NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NCI, Biometr Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Boguski, MS (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.			Pruitt, Kim/0000-0001-7950-1374				Adams MD, 1996, BIOESSAYS, V18, P261, DOI 10.1002/bies.950180402; Berry M, 1997, DATA MINING TECHNIQU; BISHOP JO, 1974, CELL, V3, P341, DOI 10.1016/0092-8674(74)90048-8; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Chen Y., 1997, BIOMED OPTICS, V2, P364; de Saizieu A, 1998, NAT BIOTECHNOL, V16, P45, DOI 10.1038/nbt0198-45; DeRisi J, 1996, NAT GENET, V14, P457; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GALAU GA, 1974, CELL, V2, P9, DOI 10.1016/0092-8674(74)90003-8; Greenspun P, 1997, DATABASE BACKED WEB; GRESS TM, 1992, MAMM GENOME, V3, P609, DOI 10.1007/BF00352477; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; LENNON GG, 1991, TRENDS GENET, V7, P314, DOI 10.1016/0168-9525(91)90420-U; LEWIN B, 1974, GENE EXPRESSION, V1; LEWIN B, 1977, GENE EXPRESSION; Lewin B. M., 1974, GENE EXPRESSION, V2; Lewin B. M., 1970, MOL BASIS GENE EXPRE; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Taylor J. H., 1965, SELECTED PAPERS MOL; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359	29	238	271	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					19	23		10.1038/1670	http://dx.doi.org/10.1038/1670			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731524				2022-12-27	WOS:000075671400012
J	Kusumi, K; Sun, ES; Kerrebrock, AW; Bronson, RT; Chi, DC; Bulotsky, MS; Spencer, JB; Birren, BW; Frankel, WN; Lander, ES				Kusumi, K; Sun, ES; Kerrebrock, AW; Bronson, RT; Chi, DC; Bulotsky, MS; Spencer, JB; Birren, BW; Frankel, WN; Lander, ES			The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries	NATURE GENETICS			English	Article							ARTIFICIAL CHROMOSOME LIBRARY; GENE FAMILY; EMBRYOGENESIS; TRANSCRIPTION; SEGMENTATION; EXPRESSION; GENOME	Pudgy (pu) homozygous mice exhibit clear patterning defects at the earliest stages of somitogenesis, resulting in adult mice with severe vertebral and rib deformities(1). By positional cloning and complementation, we have determined that the pu phenotype is caused by a mutation in the delta-like 3 gene (Dll3), which is homologous to the Notch-ligand Delta in Drosophila. Histological and molecular marker analyses show that the pu mutation disrupts the proper formation of morphological borders in early somite formation and of rostral-caudal compartment boundaries within somites. Viability analysis also indicates an important role in early development. The results point to a key role for a Notch-signalling pathway in the initiation of patterning of vertebrate paraxial mesoderm.	Natl Inst Med Res, MRC, London NW7 1AA, England; MIT, Dept Biol, Cambridge, MA 02139 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Boston, MA 02111 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Jackson Lab, Bar Harbor, ME 04609 USA	MRC National Institute for Medical Research; Massachusetts Institute of Technology (MIT); Tufts University; Tufts University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Jackson Laboratory	Lander, ES (corresponding author), Natl Inst Med Res, MRC, Ridgeway, London NW7 1AA, England.		Kusumi, Kenro/J-2626-2012	Kusumi, Kenro/0000-0002-1458-4540; Spencer, Jessica/0000-0001-8156-514X				BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; CONLON RA, 1995, DEVELOPMENT, V121, P1533; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DIETRICH W, 1992, GENETICS, V131, P423; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; FAHRNER K, 1987, EMBO J, V6, P1265, DOI 10.1002/j.1460-2075.1987.tb02363.x; GRUNEBERG HANS, 1961, GENET RES, V2, P384, DOI 10.1017/S0016672300000860; Haldi ML, 1996, MAMM GENOME, V7, P767, DOI 10.1007/s003359900228; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Jen WC, 1997, DEVELOPMENT, V124, P1169; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kaufman M.H., 1992, ATLAS MOUSE DEV; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; OKA C, 1995, DEVELOPMENT, V121, P3291; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Sambrook J., 2002, MOL CLONING LAB MANU; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; WILKINSON DG, 1992, IN SITU HYBRIDIZATON; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0	30	234	248	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					274	278		10.1038/961	http://dx.doi.org/10.1038/961			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662403				2022-12-27	WOS:000074565900026
J	Matsuura, S; Tauchi, H; Nakamura, A; Kondo, N; Sakamoto, S; Endo, S; Smeets, D; Solder, B; Belohradsky, BH; Kaloustian, VMD; Oshimura, M; Isomura, M; Nakamura, Y; Komatsu, K				Matsuura, S; Tauchi, H; Nakamura, A; Kondo, N; Sakamoto, S; Endo, S; Smeets, D; Solder, B; Belohradsky, BH; Kaloustian, VMD; Oshimura, M; Isomura, M; Nakamura, Y; Komatsu, K			Positional cloning of the gene for Nijmegen breakage syndrome	NATURE GENETICS			English	Article							CHROMOSOMAL INSTABILITY; KINASE; SITES; YEAST	Nijmegen breakage syndrome (NBS), also known as ataxia-telangiectasia (AT) variant, is an autosomal recessive disorder characterized by microcephaly, growth retardation, severe combined immunodeficiency and a high incidence of lymphoid cancers. Cells from NBS patients display chromosome instability, hypersensitivity to ionizing radiation and abnormal cell-cycle regulation after irradiation, all of which are characteristics shared with AT. Recently, the NBS locus was mapped at 8q21 by two independent approaches, complementation studies(1) and linkage analysis(2). Here, we report the positional cloning of the NBS gene, NBS1, from an 800-kb candidate region. The gene comprises 50 kb and encodes a protein of 754 amino acids. The amino-terminal region of the protein shows weak homology to the yeast XRS2, MEK1, CDS1 and SPK1 proteins. The gene is expressed at high levels in the testes, suggesting that it might be involved in meiotic recombination. We detected the same 5-bp deletion in 13 individuals, and conclude that it is likely to be a founder mutation.	Hiroshima Univ, Dept Radiat Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan; Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands; Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; Tottori Univ, Sch Life Sci, Dept Mol & Cell Genet, Tottori 680, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan	Hiroshima University; Radboud University Nijmegen; University of Munich; McGill University; Tottori University; University of Tokyo	Komatsu, K (corresponding author), Hiroshima Univ, Dept Radiat Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan.	komatsu@ipc.hiroshima-u.ac.jp	Endo, Satoru/D-9091-2012; Matsuura, Shinya/U-4182-2017	Endo, Satoru/0000-0001-5961-681X; Matsuura, Shinya/0000-0001-5294-081X; Sakamoto, Shuichi/0000-0001-9396-9475				ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Helander HM, 1997, GENOMICS, V46, P112, DOI 10.1006/geno.1997.5004; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V242, P602, DOI 10.1006/bbrc.1997.7924; Matsuura S, 1997, AM J HUM GENET, V60, P1487, DOI 10.1086/515461; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; PARMENTIER M, 1987, EUR J BIOCHEM, V170, P207, DOI 10.1111/j.1432-1033.1987.tb13688.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Saar K, 1997, AM J HUM GENET, V60, P605; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; SOLOVYEV VV, 1994, 2 INT C INT SYST MOL, P354; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; WEEMAES CMR, 1981, ACTA PAEDIATR SCAND, V70, P557, DOI 10.1111/j.1651-2227.1981.tb05740.x; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Xu Y, 1994, Genet Eng (N Y), V16, P241	22	241	249	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					179	181		10.1038/549	http://dx.doi.org/10.1038/549			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620777				2022-12-27	WOS:000073865100028
J	Brais, B; Bouchard, JP; Xie, YG; Rochefort, DL; Chretien, N; Tome, FMS; Lafreniere, RG; Rommens, JM; Uyama, E; Nohira, O; Blumen, S; Korcyn, AD; Heutink, P; Mathieu, J; Duranceau, A; Codere, F; Fardeau, M; Rouleau, GA				Brais, B; Bouchard, JP; Xie, YG; Rochefort, DL; Chretien, N; Tome, FMS; Lafreniere, RG; Rommens, JM; Uyama, E; Nohira, O; Blumen, S; Korcyn, AD; Heutink, P; Mathieu, J; Duranceau, A; Codere, F; Fardeau, M; Rouleau, GA			Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy	NATURE GENETICS			English	Article							MESSENGER-RNA POLYADENYLATION; TRIPLET REPEATS; PROTEIN-II; MUTATIONS; FAMILIES; BINDING; DISEASE; HOXD13	Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disease with a world-wide distribution(1). It usually presents in the sixth decade with progressive swallowing difficulties (dysphagia), eyelid drooping (ptosis) and proximal limb weakness, Unique nuclear filament inclusions in skeletal muscle fibres are its pathological hallmark(2). We isolated the poly(A) binding protein 2 gene (PABP2) from a 217-kb candidate interval on chromosome 14q11 (B.B. et al., manuscript submitted). A (GCG)(6) repeat encoding a polyalanine tract located at the N terminus of the protein was expanded to (GCG)(8-13) in the 144 OPMD families screened, More severe phenotypes were observed in compound heterozygotes for the (GCG)(9) mutation and a (GCG)(7) allele that is found in 2% of the population, whereas homozygosity for the (GCG)(7) allele leads to autosomal recessive OPMD. Thus the (GCG)(7) allele is an example of a polymorphism which can act either as a modifier of a dominant phenotype or as a recessive mutation. Pathological expansions of the polyalanine tract may cause mutated PABP2 oligomers to accumulate as filament inclusions in nuclei.	McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; Hop Enfants Jesus, Dept Neurol Sci, Quebec City, PQ G1J 1Z4, Canada; Hop La Pitie Salpetriere, Inst Myol, INSERM U153, F-75013 Paris, France; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Kumamoto Univ, Sch Med, Dept Neurol, Kumamoto 860, Japan; Shizuoka Red Cross Hosp, Dept Neurol, Shizuoka, Japan; Hillel Yaffe Med Ctr, Dept Neurol, Hadera, Israel; Sackler Sch Med, Dept Neurol, IL-69978 Ramat Aviv, Israel; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Hop Chicoutimi, Chicoutimi, PQ G7H 5H6, Canada; Univ Montreal, Ctr Hosp, Montreal, PQ H2W 1T8, Canada; McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada	McGill University; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kumamoto University; Tel Aviv University; Sackler Faculty of Medicine; Erasmus University Rotterdam; Universite de Montreal; McGill University; Royal Victoria Hospital	Rouleau, GA (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mi32@musica.mcgill.ca	Korczyn, Amos D/C-3461-2017; Brais, Bernard/Y-3910-2019	Korczyn, Amos D/0000-0003-0125-2579; Heutink, Peter/0000-0001-5218-1737				Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BLUMEN SC, 1993, NEUROMUSCULAR DISORD, V3, P575, DOI 10.1016/0960-8966(93)90119-5; Bouchard JP, 1992, CAN J NEUROL SCI, V19, P296; BRAIS B, 1995, HUM MOL GENET, V4, P429, DOI 10.1093/hmg/4.3.429; BRUNET G, 1990, REV NEUROL, V146, P425; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FOROOD B, 1995, BIOCHEM BIOPH RES CO, V211, P7, DOI 10.1006/bbrc.1995.1770; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Lafreniere RG, 1997, NAT GENET, V15, P298, DOI 10.1038/ng0397-298; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; ROMMENS JM, 1994, P 3 INT WORKSH ID TR, P65; Rosenberg RN, 1996, NEW ENGL J MED, V335, P1222, DOI 10.1056/NEJM199610173351609; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Tome F, 1994, MYOLOGY, P1233; TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Warren ST, 1997, SCIENCE, V275, P408, DOI 10.1126/science.275.5298.408; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875	30	577	605	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1998	18	2					164	167		10.1038/ng0298-164	http://dx.doi.org/10.1038/ng0298-164			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462747	Green Published			2022-12-27	WOS:000071779500026
J	Meyers, EN; Lewandoski, M; Martin, GR				Meyers, EN; Lewandoski, M; Martin, GR			An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination	NATURE GENETICS			English	Article							TARGETED MUTATION; VERTEBRATE LIMB; NERVOUS-SYSTEM; GENE; MOUSE; DELETION; MICE; INITIATION; OUTGROWTH; EMBRYO	We describe a strategy for generating an allelic series of mutations at a given locus that requires the production of only one targetted mouse line. The 'allelogenic' mouse line we produced carries a hypomorphic allele of Fgf8, which can be converted to a null allele by mating to cre transgenic animals. The hypomorphic allele can also be reverted to wild-type by mating the allelogenic mice to flp transgenic animals, thereby generating a mouse line suitable for Cre-induced tissue-specific knockout experiments. Analysis of embryos carrying different combinations of these alleles revealed requirements for Fgf8 gene function during gastrulation, as well as cardiac, craniofacial, forebrain, midbrain and cerebellar development.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.			Lewandoski, Mark/0000-0002-1066-3735				BALLYCUIF L, 1995, CURR OPIN GENET DEV, V5, P450, DOI 10.1016/0959-437X(95)90048-L; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; GRAZIADEI PPC, 1992, NEUROSCIENCE, V46, P617, DOI 10.1016/0306-4522(92)90149-V; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Lee SMK, 1997, DEVELOPMENT, V124, P959; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWANDOSKI M, IN PRESS COLD SPRING; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; MAGIN TM, 1992, NUCLEIC ACIDS RES, V14, P379; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; Nagy A., 1993, Gene targeting: a practical approach., P147; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PUELLES L, 1996, MAMMALIAN DEV, P173; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; SAVAGE MP, 1993, DEV DYNAM, V198, P159, DOI 10.1002/aja.1001980302; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Vogel A, 1996, DEVELOPMENT, V122, P1737; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Wurst W., 1993, Gene targeting: a practical approach., P33	39	839	863	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					136	141		10.1038/ng0298-136	http://dx.doi.org/10.1038/ng0298-136			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462741				2022-12-27	WOS:000071779500020
J	May, WA; Arvand, A; Thompson, AD; Braun, BS; Wright, M; Denny, CT				May, WA; Arvand, A; Thompson, AD; Braun, BS; Wright, M; Denny, CT			EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic	NATURE GENETICS			English	Article							REPRESENTATIONAL DIFFERENCE ANALYSIS; EWS/FLI-1 FUSION GENE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATOR; EWING SARCOMA; NOTCH GENE; TRANSLOCATION; PROTEIN; TUMORS; TRANSFORMATION	EWS/FLI1, a fusion gene found in Ewing's sarcoma, encodes a transcriptional regulator and promotes cellular transformation by modulating the transcription of specific target genes, We have found that EWS/FLI1 and structurally related fusion proteins upregulate manic fringe (MFNG), a recently described member of the Fringe gene family instrumental in somatic development, MFNG is also expressed in human tumour-derived cell lines expressing EWS/FLI1. Overexpression of MFNG in NIH 3T3 cells renders them tumorigenic in mice with severe combined immunodeficiency disease (SCID), These data demonstrate that part of the oncogenic effect of EWS/FLI1 is to transcriptionally deregulate a member of a family of morphogenic genes.	UNIV CALIF LOS ANGELES,MED CTR,INST MOL BIOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,MED CTR,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,MED CTR,GWYNNE HAZEN MEM LABS,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90095; UNIV ALABAMA,SCH MED,DEPT PEDIAT,BIRMINGHAM,AL; UNIV ALABAMA,SCH MED,CTR COMPREHENS CANC,BIRMINGHAM,AL; UNIV CALIF LOS ANGELES,MED CTR,DEPT EXPT PATHOL LAB MED,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center					NATIONAL CANCER INSTITUTE [P01CA032737, P30CA013148] Funding Source: NIH RePORTER; NCI NIH HHS [CA32737, CA13148] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; BONIN G, 1993, CANCER RES, V53, P3655; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DORIT RL, 1993, MOL BIOL, V2; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fu XY, 1997, MOL CELL BIOL, V17, P1503, DOI 10.1128/MCB.17.3.1503; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LESSNICK SL, 1995, ONCOGENE, V10, P423; Look AT, 1995, ADV CANCER RES, V67, P25, DOI 10.1016/S0065-230X(08)60709-5; MAO X, 1994, J BIOL CHEM, V269, P17216; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; OHNO T, 1993, CANCER RES, V53, P5859; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Rohn JL, 1996, J VIROL, V70, P8071, DOI 10.1128/JVI.70.11.8071-8080.1996; SORENSEN PHB, 1993, DIAGN MOL PATHOL, V2, P147, DOI 10.1097/00019606-199309000-00002; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Thompson AD, 1996, ONCOGENE, V13, P2649; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8	29	132	141	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					495	497		10.1038/ng1297-495	http://dx.doi.org/10.1038/ng1297-495			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398859				2022-12-27	WOS:A1997YJ92400038
J	Graham, BH; Waymire, KG; Cottrell, B; Trounce, IA; MacGregor, GR; Wallace, DC				Graham, BH; Waymire, KG; Cottrell, B; Trounce, IA; MacGregor, GR; Wallace, DC			A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator	NATURE GENETICS			English	Article							MUSCLE ADP/ATP TRANSLOCATOR; EMBRYONIC STEM-CELLS; ADP ATP TRANSLOCASE; MUSCULAR-DYSTROPHY LOCUS; SYNTHASE BETA-SUBUNIT; SKELETAL-MUSCLE; MOLECULAR-CLONING; NUCLEAR GENES; DNA DISEASE; CARRIER	In an attempt to create an animal model of tissue-specific mitochondrial disease, we generated 'knockout' mice deficient in the heart/muscle isoform of the adenine nucleotide translocator (Ant1). Histological and ultrastructural examination of skeletal muscle from Anti null mutants revealed ragged-red muscle fibers and a dramatic proliferation of mitochondria, while examination of the heart revealed cardiac hypertrophy with mitochondrial proliferation. Mitochondria isolated from mutant skeletal muscle exhibited a severe defect in coupled respiration. Ant1 mutant adults also had a resting serum lactate level fourfold higher than that of controls, indicative of metabolic acidosis. Significantly, mutant adults manifested severe exercise intolerance. Therefore, Anti mutant mice have the biochemical, histological, metabolic and physiological characteristics of mitochondrial myopathy and cardiomyopathy.	EMORY UNIV, SCH MED, CTR MOL MED, ATLANTA, GA 30322 USA	Emory University			Graham, Brett/R-8685-2018; Trounce, Ian A/F-8338-2010	Graham, Brett/0000-0001-8451-8154; Trounce, Ian A/0000-0002-1070-8892	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKKER HD, 1993, J INHERIT METAB DIS, V16, P548, DOI 10.1007/BF00711678; BAKKER HD, 1993, PEDIATR RES, V33, P412; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BLAU DM, 1995, VIROLOGY, V210, P91, DOI 10.1006/viro.1995.1320; BROWN MD, 1994, J BIOENERG BIOMEMBR, V26, P273, DOI 10.1007/BF00763099; CHEN ST, 1990, SOMAT CELL MOLEC GEN, V16, P143, DOI 10.1007/BF01233044; CHUNG AB, 1992, J BIOL CHEM, V267, P21154; COZENS AL, 1989, J MOL BIOL, V206, P261, DOI 10.1016/0022-2836(89)90477-4; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; DUBOWITZ V, 1985, MUSCLE BIOPSY MODERN; Ellison JW, 1996, MAMM GENOME, V7, P25, DOI 10.1007/s003359900007; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; HARAGUCHI Y, 1994, J BIOL CHEM, V269, P9330; HARAGUCHI Y, 1993, GENOMICS, V16, P479, DOI 10.1006/geno.1993.1214; HATCHELL PL, 1973, GENETICS, V75, P191; KLINGENBERG M, 1992, BIOCHEM SOC T, V20, P547, DOI 10.1042/bst0200547; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; KU DH, 1990, J BIOL CHEM, V265, P16060; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; LI K, 1989, J BIOL CHEM, V264, P13998; LI K, 1990, J BIOL CHEM, V265, P20585; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Mills KA, 1996, MAMM GENOME, V7, P707, DOI 10.1007/s003359900296; Munnich A, 1996, EUR J PEDIATR, V155, P262; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; OMALLEY K, 1982, J BIOL CHEM, V257, P2097; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; PFANNER N, 1987, J BIOL CHEM, V262, P7528; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RASMUSSEN UB, 1986, BIOCHEM BIOPH RES CO, V138, P850, DOI 10.1016/S0006-291X(86)80574-5; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; SALMONS S, 1981, MUSCLE NERVE, V4, P94, DOI 10.1002/mus.880040204; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAMBRA UB, 1992, ATLAS PRENATAL MOUSE, V1; Servidei S, 1994, Adv Pediatr, V41, P1; SHANSKE S, 1994, CURR TOP BIOENERG, V17, P21; Sheehan D.C., 1980, THEORY PRACTICE HIST; SHINOHARA Y, 1993, BIOCHIM BIOPHYS ACTA, V1152, P192, DOI 10.1016/0005-2736(93)90248-X; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEELE BF, 1950, ARCH BIOCHEM, V25, P124; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WASSERMAN K, 1987, PRINCIPLES EXERCISE, P1; WIJMENGA C, 1993, HUM GENET, V92, P198; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376	53	405	419	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1997	16	3					226	234		10.1038/ng0797-226	http://dx.doi.org/10.1038/ng0797-226			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207786				2022-12-27	WOS:A1997XG60900016
J	Snyder, RO; Miao, CH; Patijn, GA; Spratt, SK; Danos, O; Nagy, D; Gown, AM; Winther, B; Meuse, L; Cohen, LK; Thompson, AR; Kay, MA				Snyder, RO; Miao, CH; Patijn, GA; Spratt, SK; Danos, O; Nagy, D; Gown, AM; Winther, B; Meuse, L; Cohen, LK; Thompson, AR; Kay, MA			Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors	NATURE GENETICS			English	Article							ADENOASSOCIATED VIRUS VECTORS; IN-VIVO; HEMOPHILIA-B; HUMAN ALPHA-1-ANTITRYPSIN; EXPRESSION; TRANSDUCTION; CELLS; DOGS; HEPATOCYTES; DISORDERS		UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; SOMATIX THERAPY CORP,ALAMEDA,CA 94501; UNIV WASHINGTON,PUGET SOUND BLOOD CTR,SEATTLE,WA 98104; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98104	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Kay, Mark/0000-0002-2799-2615	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53682] Funding Source: Medline; NIDDK NIH HHS [DK47754] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Afione SA, 1996, J VIROL, V70, P3235, DOI 10.1128/JVI.70.5.3235-3241.1996; ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; BARR D, 1995, GENE THER, V2, P151; Baskar JF, 1996, J VIROL, V70, P3207, DOI 10.1128/JVI.70.5.3207-3214.1996; BRAY GL, 1986, J LAB CLIN MED, V107, P269; CARTER BJ, 1990, HDB PARVOVIRUSES, V1, P155; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fisher KJ, 1996, J VIROL, V70, P520, DOI 10.1128/JVI.70.1.520-532.1996; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guo ZS, 1996, GENE THER, V3, P802; Kaplitt MG, 1996, ANN THORAC SURG, V62, P1669, DOI 10.1016/S0003-4975(96)00946-0; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; KAY MA, 1994, TRENDS GENET, V10, P253, DOI 10.1016/0168-9525(94)90173-2; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KAY MA, 1994, P NATL ACAD SCI USA, V91, P2353, DOI 10.1073/pnas.91.6.2353; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; KAY MA, 1992, HUM GENE THER, V3, P641, DOI 10.1089/hum.1992.3.6-641; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Lalwani AK, 1996, GENE THER, V3, P588; LI JP, IN PRESS J VIROL; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; MCLAUGHLIN SK, 1988, J VIROL, V62, P1963, DOI 10.1128/JVI.62.6.1963-1973.1988; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; Peeters MJTFDV, 1996, BIOTECHNIQUES, V20, P278; REINER AP, 1995, METABOLIC MOL BASES, V3, P3181; Schowalter DB, 1997, GENE THER, V4, P351, DOI 10.1038/sj.gt.3300398; SNYDER RO, 1996, CURRENT PROTOCOLS HU, V1, P1; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; Su H, 1996, HUM GENE THER, V7, P463, DOI 10.1089/hum.1996.7.4-463; THOMPSON AR, 1976, J LAB CLIN MED, V88, P922; THOMPSON AR, 1983, BLOOD, V62, P1027; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	36	488	534	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					270	276		10.1038/ng0797-270	http://dx.doi.org/10.1038/ng0797-270			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207793				2022-12-27	WOS:A1997XG60900023
J	Ye, BH; Cattoretti, G; Shen, QO; Zhang, JD; Hawe, N; deWaard, R; Leung, C; NouriShirazi, M; Orazi, A; Chaganti, RSK; Rothman, P; Stall, AM; Pandolfi, PP; DallaFavera, R				Ye, BH; Cattoretti, G; Shen, QO; Zhang, JD; Hawe, N; deWaard, R; Leung, C; NouriShirazi, M; Orazi, A; Chaganti, RSK; Rothman, P; Stall, AM; Pandolfi, PP; DallaFavera, R			The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation	NATURE GENETICS			English	Article							NON-HODGKINS-LYMPHOMA; FINGER ENCODING GENE; CENTER B-CELLS; INTERACTION MOTIF; IMMUNE-RESPONSES; BTB/POZ DOMAIN; DEFICIENT MICE; ZINC FINGERS; EXPRESSION; RECEPTOR	Structural alterations of the promoter region of the BCL-6 proto-oncogene represent the most frequent genetic alteration associated with non-Hodgkin lymphoma, a malignancy often deriving from germinal-centre B cells. The BCL-6 gene encodes a zinc-finger transcriptional repressor normally expressed in both B cells and CD4(+) T cells within germinal centres, but its precise function is unknown. We show that mice deficient in BCL-6 displayed normal B-cell, T-cell and lymphoid-organ development but have a selective defect in T-cell-dependent antibody responses. This defect included a complete lack of affinity maturation and was due to the inability of follicular B cells to proliferate and form germinal centres. In addition, BCL-6-deficient mice developed an inflammatory response in multiple organs characterized by infiltrations of eosinophils and IgE-bearing B lymphocytes typical of a Th2-mediated hyperimmune response. Thus, BCL-6 functions as a transcriptional switch that controls germinal centre formation and may also modulate specific T-cell-mediated responses. Altered expression of BCL-6 in lymphoma represents a deregulation of the pathway normally leading to B cell proliferation and germinal centre formation.	COLUMBIA UNIV,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT MICROBIOL,NEW YORK,NY 10032; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT BIOL MOL,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,CELL BIOL PROGRAM,NEW YORK,NY 10021; INDIANA UNIV,SCH MED,DEPT PATHOL & LAB MED,INDIANAPOLIS,IN 46202	Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis			Nouri-Shirazi, Mahyar/AAG-5663-2020; Cattoretti, Giorgio/H-2340-2011	orazi, attilio/0000-0002-1660-7013; O'Connor, Nicola/0000-0003-1981-3055; Cattoretti, Giorgio/0000-0003-3799-3221				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; BASTARD C, 1994, BLOOD, V83, P2423; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; CRABBE PA, 1970, LAB INVEST, V22, P448; Dalla-Favera Riccardo, 1996, P139; DELPRETE G, 1988, J IMMUNOL, V140, P4193; DEWEINDT C, 1993, GENE CHROMOSOME CANC, V8, P149, DOI 10.1002/gcc.2870080303; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Dhordain P, 1995, ONCOGENE, V11, P2689; DIBELLO PR, 1991, GENETICS, V129, P385; Flenghi L, 1996, AM J PATHOL, V148, P1543; GAIDANO G, IN PRESS BLOOD; Hardy RR, 1995, ANN NY ACAD SCI, V764, P19; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HONG R, 1987, NELSON TXB PEDIATRIC, P461; ISHIZAKA A, 1990, IMMUNOLOGY, V70, P414; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KOIKE M, 1994, INT ARCH ALLERGY IMM, V104, P1, DOI 10.1159/000236702; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LAM KP, 1994, J EXP MED, V180, P507, DOI 10.1084/jem.180.2.507; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; LOCOCO F, 1994, BLOOD, V83, P1757, DOI 10.1182/blood.V83.7.1757.bloodjournal8371757; LUNA LG, 1960, MANUAL HISTOLOGIC ST; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; MIKI T, 1994, BLOOD, V83, P26; Mombaerts P, 1995, Int Rev Immunol, V13, P43, DOI 10.3109/08830189509061737; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURRAY AB, 1990, VET PATHOL, V27, P274, DOI 10.1177/030098589002700409; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Orazi A, 1996, LAB INVEST, V75, P33; OTSUKI T, 1995, BLOOD, V85, P2877, DOI 10.1182/blood.V85.10.2877.bloodjournal85102877; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; Seyfert VL, 1996, ONCOGENE, V12, P2331; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; STALL AM, 1997, HDB EXPT IMMUNOLOGY, V2, pCH63; STEIN H, 1992, NEOPLASTIC HEMATOPAT, P675; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WELLS SM, 1994, J IMMUNOL, V153, P5503; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; YE BHH, 1993, CANCER RES, V53, P2732	63	639	665	3	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					161	170		10.1038/ng0697-161	http://dx.doi.org/10.1038/ng0697-161			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171827	Bronze			2022-12-27	WOS:A1997XB54300016
J	Aparicio, S; Hawker, K; Cottage, A; Mikawa, Y; Zuo, L; Venkatesh, B; Chen, E; Krumlauf, R; Brenner, S				Aparicio, S; Hawker, K; Cottage, A; Mikawa, Y; Zuo, L; Venkatesh, B; Chen, E; Krumlauf, R; Brenner, S			Organization of the Fugu rubripes Hox clusters: Evidence for continuing evolution of vertebrate Hox complexes	NATURE GENETICS			English	Article							HOMEOTIC TRANSFORMATIONS; GENE FAMILY; EXPRESSION; DROSOPHILA; GENOME; ACID	The clustered organization of. Hox genes provides a powerful opportunity to examine gene gain and loss in evolution because physical linkage is a key diagnostic feature which allows homology to be established unambiguously. Furthermore, Hox genes play a key role in determination of axial and appendicular skeletal morphology(1,2) and may be a key component of the evolution of diverse metazoan body forms. Despite suggestions that changes in Hox gene number played a role in evolution of metazoan body plans(3,4), there has been a general lack of evidence for such variation amongst gnathostomes (or indeed any vertebrate) and it has therefore been widely assumed that differential regulation may be the key element in all vertebrate Hox evolution. We have studied the Hox gene clusters of a teleost fish, Fugu rubripes, to test the possibility that Hox organization may have varied since the origin of jawed vertebrates. We have identified four Hox complexes in Fugu and found an unprecedented degree of variation when compared with tetrapod clusters. Our data show that: fugu clusters are widely variant with respect to length; at least nine genes have been lost; there is a new group-2 paralogue; and pseudo-gene remnants of group-1 and group-3 paralogues were found in the Hoxc complex, when compared with the present mammalian clusters. We show that gene loss after duplication of the prototypical vertebrate Hox clusters is a key feature of both tetrapod and fish evolution.	MRC CTR,IMPERIAL CANC RES FUND,CELL INTERACT UNIT,CAMBRIDGE CB2 2QH,ENGLAND; INST MOL SCI,LA JOLLA,CA 92037; SEQUANA THERAPEUT,LA JOLLA,CA 92037; IMCB,SINGAPORE 119260,SINGAPORE; PERKIN ELMER CORP,APPL BIOSYST DIV,ADV CTR GENET TECHNOL,FOSTER CITY,CA 94404; NATL INST MED RES,MRC,DEV NEUROBIOL LAB,LONDON NW7 1AA,ENGLAND; MRC HGMP RESOURCE CTR,CAMBRIDGE CB10 1SB,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Thermo Fisher Scientific; Applied Biosystems; MRC National Institute for Medical Research	Aparicio, S (corresponding author), WELLCOME CRC INST DEV BIOL & CANC RES,TENNIS COURT RD,CAMBRIDGE CB2 1QR,ENGLAND.		Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927; Aparicio, Samuel/0000-0002-0487-9599; Venkatesh, Byrappa/0000-0003-3620-0277	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; AKAM M, 1995, PHILOS T R SOC B, V349, P313, DOI 10.1098/rstb.1995.0119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; BURKE AC, 1995, DEVELOPMENT, V121, P333; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G, P284; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Misof BY, 1996, MOL PHYLOGENET EVOL, V5, P309, DOI 10.1006/mpev.1996.0026; Misof BY, 1996, J EXP ZOOL, V274, P193, DOI 10.1002/(SICI)1097-010X(19960215)274:3&lt;193::AID-JEZ6&gt;3.0.CO;2-J; Nelson J.S., 1994, FISHES WORLD, Vthird, P1; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; POLLOCK RA, 1995, P NATL ACAD SCI USA, V92, P4492, DOI 10.1073/pnas.92.10.4492; POLLOCK RA, 1992, CELL, V71, P911, DOI 10.1016/0092-8674(92)90388-S; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P2951, DOI 10.1093/nar/10.9.2951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYLER J C, 1980, NOAA (National Oceanic and Atmospheric Administration) Technical Report NMFS (National Marine Fisheries Service) Circular, P1; vanderHoeven F, 1996, MECH DEVELOP, V54, P9, DOI 10.1016/0925-4773(95)00455-6; Zeltser L, 1996, DEVELOPMENT, V122, P2475	29	123	134	2	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					79	83		10.1038/ng0597-79	http://dx.doi.org/10.1038/ng0597-79			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140399				2022-12-27	WOS:A1997WX02400026
J	Itzhaki, JE; Gilbert, CS; Porter, ACG				Itzhaki, JE; Gilbert, CS; Porter, ACG			Construction by gene targeting in human cells of a 'conditional' CDC2 mutant that rereplicates its DNA	NATURE GENETICS			English	Article							COLI LAC REPRESSOR; INTERFERON-INDUCIBLE GENE; HAMSTER OVARY CELLS; MAMMALIAN-CELLS; PROTEIN-KINASE; FISSION YEAST; S-PHASE; EUKARYOTIC CELLS; CYCLE REGULATION; ANIMAL-CELLS	We describe a novel gene targeting strategy for the genetic analysis of essential genes in mammalian cells and its use to study the role of the cell cycle control gene CDC2 in human cells. A cell line (HT2-19) was generated in which endogenous CDC2 gene expression and cell viability depend on the presence of an inducer in the growth medium. In the absence of inducer, HT2-19 cells undergo extensive DNA rereplication and apoptosis. Rereplication is indicative of a role for human CDC2 in a control mechanism, previously undetected in mammalian cells, that prevents premature entry into S-phase.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, MRC, CTR CLIN SCI, LONDON W12 0NN, ENGLAND; IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND	Imperial College London; Cancer Research UK					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADACHI Y, 1994, EMBO J, V13, P4153, DOI 10.1002/j.1460-2075.1994.tb06733.x; BORDES JC, 1995, CELL, V83, P1001; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; BRUNO S, 1992, CANCER RES, V52, P470; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DURSO G, 1995, CURR OPIN GENET DEV, V5, P12, DOI 10.1016/S0959-437X(95)90047-0; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; FORSBURG SL, 1991, ANNU REV CELL BIOL, V7, P227, DOI 10.1146/annurev.cb.07.110191.001303; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HAMAGUCHI JR, 1992, J CELL BIOL, V117, P1041, DOI 10.1083/jcb.117.5.1041; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Harlow E., 1988, ANTIBODIES LAB MANUA; Hayashi S, 1996, DEVELOPMENT, V122, P1051; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; HERZINGER T, 1995, ONCOGENE, V11, P2151; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; ITZHAKI JE, 1992, NAT GENET, V2, P283, DOI 10.1038/ng1292-283; ITZHAKI JE, 1991, NUCLEIC ACIDS RES, V19, P3835, DOI 10.1093/nar/19.14.3835; KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; LOCK RB, 1990, CANCER RES, V50, P3761; LOCK RB, 1992, CANCER RES, V52, P1817; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NORBURY C, 1994, BIOCHEM BIOPH RES CO, V202, P1400, DOI 10.1006/bbrc.1994.2086; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; ONGKEKO W, 1995, J CELL SCI, V108, P2897; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; Porter A. C. G., 1989, Technique, A Journal of Methods in Cell and Molecular Biology, V1, P53; PORTER ACG, 1993, EUR J BIOCHEM, V218, P273, DOI 10.1111/j.1432-1033.1993.tb18375.x; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TANG FJK, 1989, J HISTOCHEM CYTOCHEM, V37, P697, DOI 10.1177/37.5.2703705; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; TRAGANOS F, 1994, J CELL PHYSIOL, V158, P535, DOI 10.1002/jcp.1041580320; TSAI LH, 1993, ONCOGENE, V8, P1593; TSAO YP, 1992, CANCER RES, V52, P1823; USUI T, 1991, J CELL BIOL, V115, P1275, DOI 10.1083/jcb.115.5.1275; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093; WYBORSKI DL, 1991, NUCLEIC ACIDS RES, V19, P4647, DOI 10.1093/nar/19.17.4647; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4; YOSHIDA M, 1990, EXP CELL RES, V187, P150, DOI 10.1016/0014-4827(90)90129-X; Zhang Y, 1996, J BIOL CHEM, V271, P4266	68	141	148	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					258	265		10.1038/ng0397-258	http://dx.doi.org/10.1038/ng0397-258			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054937				2022-12-27	WOS:A1997WK38600014
J	Kumar, TR; Wang, Y; Lu, NF; Matzuk, MM				Kumar, TR; Wang, Y; Lu, NF; Matzuk, MM			Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility	NATURE GENETICS			English	Article							BETA-SUBUNIT GENE; MICE; EXPRESSION; PROLIFERATION; MUTATION	Follicle stimulating hormone (FSH) is a member of the glycoprotein hormone family that includes luteinizing hormone (LH). thyroid stimulating hormone, and chorionic gonadotropin. These heterodimeric hormones share a common a subunit and differ in their hormone-specific beta subunit. The biological activity is conferred only by the heterodimers. FSH and LH are synthesized in the same cells of the pituitary, the gonadotrophs(1,2). FSH receptors are localized to Sertoli cells of the testes and granulosa cells of the ovary(1,2). Minimal data has been accumulated so far involving human mutations in the FSH beta, LH beta, or the gonadotropin receptor genes. There are no known mouse strains with mutations in the FSH beta gene. To generate animal models for human diseases involving the gonadotropin signal transduction pathway, we produced mice deficient in the FSH beta subunit and therefore in FSH using ES cell technology. FSH-deficient females are infertile due to a block in folliculogenesis prior to antral follicle formation. Although FSH was predicted to be necessary for spermatogenesis and Sertoli cell growth in males, FSH-deficient males are fertile despite having small testes. Our findings have important implications for male contraceptive development in humans.	BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine					NATIONAL CANCER INSTITUTE [R01CA060651] Funding Source: NIH RePORTER; NCI NIH HHS [CA60651] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aittomaki K, 1996, J CLIN ENDOCR METAB, V81, P3722, DOI 10.1210/jc.81.10.3722; AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; ALDHOUS P, 1994, SCIENCE, V266, P1484, DOI 10.1126/science.7985014; Bousfield George R., 1994, P1749; CAMPER SA, 1995, BIOL REPROD, V52, P246, DOI 10.1095/biolreprod52.2.246; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Harlow E., 1988, ANTIBODIES LAB MANUA; Hogan B, 1994, MANIPULATING MOUSE E; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; KLUIN PM, 1984, ANAT EMBRYOL, V169, P73, DOI 10.1007/BF00300588; KUMAR TR, 1992, MOL ENDOCRINOL, V6, P81, DOI 10.1210/me.6.1.81; KUMAR TR, 1995, NEUROENDOCRINOLOGY, V61, P628, DOI 10.1159/000126889; Kumar TR, 1995, GENE, V166, P333, DOI 10.1016/0378-1119(95)00611-7; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Nishimori K, 1996, Rev Reprod, V1, P203, DOI 10.1530/revreprod/1.3.203; ORTH JM, 1984, ENDOCRINOLOGY, V115, P1248, DOI 10.1210/endo-115-4-1248; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Tapanainen JS, 1997, NAT GENET, V15, P205, DOI 10.1038/ng0297-205; World Health Organization, 1992, LAB MAN EX HUM SEM S	21	1006	1044	1	61	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1997	15	2					201	204		10.1038/ng0297-201	http://dx.doi.org/10.1038/ng0297-201			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020850				2022-12-27	WOS:A1997WF08700024
J	Fijneman, RJA; deVries, SS; Jansen, RC; Demant, P				Fijneman, RJA; deVries, SS; Jansen, RC; Demant, P			Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse	NATURE GENETICS			English	Article							RECOMBINANT CONGENIC STRAINS; TUMOR SUSCEPTIBILITY; LENGTH POLYMORPHISMS; GENETIC-MAP; MICE; RESOLUTION	Many complex traits, including susceptibility to lung cancer, are controlled by multiple genes - quantitative trait loci (QTLs). We facilitated the mapping of QTLs by making use of recombinant congenic strains (RCS)(1), a system of mouse inbred strains in which the genetic complexity is reduced, and by applying MQM-mapping(2-4) (multiple-QTL models or marker-QTL-marker), a multilocus method with an increased power of detecting of individual QTLs and interacting QTLs (epistasis). The mouse strain O20 develops significantly larger N-ethyl-N-nitrosourea induced lung tumours than mice of the RC strain OcB-9 (ref. 5); the latter share approximately 87.5% of their genes with strain O20 and 12.5% with strain B10.O20 (refs 6,7). QTL analysis of 222 (OcB-9 x O20) F2 mice revealed four new loci that influence susceptibility to lung cancer (Slue genes). They are involved in two significant, partly counteracting interactions which mask their individual main effects: Sluc1 (on chromosome 19) interacts with Sluc2 (chromosome 2), and Sluc3 (chromosome 6) interacts with Sluc4 (chromosome 11). Together with the data of van Wezel et al. in the accompanying report(8), our results indicate that I interactions between tumour susceptibility genes are a common phenomenon which complicates their mapping.	NETHERLANDS CANC INST,DIV MOL GENET,NL-1066 CX AMSTERDAM,NETHERLANDS; DLO,CTR PLANT BREEDING & REPROD RES,DEPT POPULAT BIOL,NL-6700 AA WAGENINGEN,NETHERLANDS	Netherlands Cancer Institute			Fijneman, Remond/X-4199-2019; Jansen, Ritsert C/C-1160-2013	Fijneman, Remond/0000-0003-2076-5521; Jansen, Ritsert C/0000-0003-2977-9110				DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; DEVEREUX TR, 1994, MAMM GENOME, V5, P749, DOI 10.1007/BF00292007; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; FESTING MFW, 1994, GENET RES, V64, P99, DOI 10.1017/S0016672300032705; FIJNEMAN RJA, 1994, ONCOGENE, V9, P1417; FIJNEMAN RJA, 1995, IMMUNOGENETICS, V41, P106, DOI 10.1007/BF00182320; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; JANSEN RC, 1994, GENETICS, V138, P871; JANSEN RC, 1994, GENETICS, V136, P1447; Jansen RC, 1996, TRENDS PLANT SCI, V1, P89, DOI 10.1016/S1360-1385(96)80040-9; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; OOMEN LCJM, 1983, INT J CANCER, V31, P447, DOI 10.1002/ijc.2910310409; OOMEN LCJM, 1991, EXP LUNG RES, V17, P283, DOI 10.3109/01902149109064419; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; RYAN J, 1987, J NATL CANCER I, V79, P1351; Stassen APM, 1996, MAMM GENOME, V7, P55, DOI 10.1007/s003359900013; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468	20	200	201	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					465	467		10.1038/ng1296-465	http://dx.doi.org/10.1038/ng1296-465			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944028				2022-12-27	WOS:A1996VV73000024
J	Tourtellotte, WG; Milbrandt, J				Tourtellotte, WG; Milbrandt, J			Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3	NATURE GENETICS			English	Article							PERIPHERAL NERVOUS-SYSTEM; TARGETED MUTATION; NEUROTROPHIN-3; AFFERENTS; LIMB; RAT; DIFFERENTIATION; DEPENDENCE; EXPRESSION; DEFICITS	Muscle spindles are skeletal muscle sensory organs that provide axial and limb position information (proprioception) to the central nervous system. Spindles consist of encapsulated muscle fibers (intrafusal fibers) that are innervated by specialized motor and sensory axons. Although the molecular mechanisms involved in spindle ontogeny are poorly understood, the innervation of a subset of developing myotubes (type I) by peripheral sensory afferents (group la) is a critical event for inducing intrafusal fiber differentiation and subsequent spindle formation(1-3) The Egr family of zinc-finger transcription factors, whose members include Egr1 (NGFI-A), Egr2 (Krox-20), Egr3 and Egr4 (NGFI-C), are thought to regulate critical genetic programs involved in cellular growth and differentiation (refs 4-8, and W.G.T. et al., manuscript submitted). Mice deficient in Egr3 were generated by gene targeting and had gait ataxia, increased frequency of perinatal mortality, scoliosis, resting tremors and ptosis. Although extrafusal skeletal muscle fibers appeared normal, Egr3-deficient animals lacked muscle spindles, a finding that is consistent with their profound gait ataxia. Egr3 was highly expressed in developing muscle spindles, but not in la afferent neurons or their terminals during developmental periods that coincided with the induction of spindle morphogenesis by sensory afferent axons. These results indicate that type I myotubes are dependent upon Egr3-mediated transcription for proper spindle development.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Lab Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.			Milbrandt, Jeffrey/0000-0002-5477-7689	NCI NIH HHS [CA13730] Funding Source: Medline; NIMH NIH HHS [MH1426] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001426] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; DUCHEN LW, 1977, J ANAT, V123, P763; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; KAWAMURA Y, 1977, J NEUROPATH EXP NEUR, V36, P853, DOI 10.1097/00005072-197709000-00009; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KUCERA J, 1995, J COMP NEUROL, V363, P307, DOI 10.1002/cne.903630211; KUCERA J, 1995, ANAT EMBRYOL, V192, P149; KUCERA J, 1992, ANAT EMBRYOL, V186, P301; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MITHANI S, 1987, PSYCHOPHARMACOLOGY, V93, P94, DOI 10.1007/BF02439593; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; O'Donovan KJ, 1998, J NEUROCHEM, V70, P1241; Ringstedt T, 1997, DEVELOPMENT, V124, P2603; SHAMI SK, 1993, PHLEBOLOGY, V8, P72, DOI 10.1177/026835559300800207; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Yamagata K, 1994, Learn Mem, V1, P140; ZELENA J, 1957, J EMBRYOL EXP MORPH, V5, P283	26	203	205	1	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1998	20	1					87	91		10.1038/1757	http://dx.doi.org/10.1038/1757			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115NK	9731539				2022-12-27	WOS:000075671400027
J	Ranum, LPW; Rasmussen, PF; Benzow, KA; Koob, MD; Day, JW				Ranum, LPW; Rasmussen, PF; Benzow, KA; Koob, MD; Day, JW			Genetic mapping of a second myotonic dystrophy locus	NATURE GENETICS			English	Article							CTG REPEAT; EXPANSION; MUTATION; MYOPATHY; REGION	We report the mapping of a second myotonic dystrophy locus, myotonic dystrophy type 2 (DM2). Myotonic dystrophy (DM) is a multi-system disease and the most common form of muscular dystrophy in adults'. In 1992, DM was shown to be caused by an expanded CTG repeat in the 3' untranslated region of the dystrophia myotonica-protein kinase gene (DMPK) on chromosome 19 (refs 2-6). Although several theories have been put forth to explain how the CTC expansion causes the broad spectrum of clinical features associated with DM, it is not understood how this mutation, which does not alter the protein-coding region of a gene, causes an affect at the cellular level(7,8). We have identified a five-generation family (MN1) with a generically distinct form of myotonic dystrophy. Affected members exhibit remarkable clinical similarity to DM (myotonia, proximal and distal limb weakness, frontal balding, cataracts and cardiac arrhythmias) but do not have the chromosome-19 CTG expansion. We have mapped the disease locus (DM2) of the MN1 family to a 10-cM region of chromosome 3q. Understanding the common molecular features of two different forms of the disease should shed right on the mechanisms responsible for the broad constellation of seemingly unrelated clinical features present in both diseases.	Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ranum, LPW (corresponding author), Univ Minnesota, Dept Neurol, Box 295 UMHC,420 Delaware St SE, Minneapolis, MN 55455 USA.	laura@gene.med.umn.edu		Day, John/0000-0002-0086-9529	NINDS NIH HHS [R01 NS35870] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbruzzese C, 1996, J NEUROL, V243, P715, DOI 10.1007/BF00873977; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Hamshere MG, 1996, TRENDS GENET, V12, P332, DOI 10.1016/S0168-9525(96)80002-3; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; ROWLAND LP, 1994, ANN NEUROL, V36, P803, DOI 10.1002/ana.410360526; Sobel E, 1996, AM J HUM GENET, V58, P1323; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a	17	183	189	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					196	198		10.1038/570	http://dx.doi.org/10.1038/570			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620781				2022-12-27	WOS:000073865100032
J	Semina, EV; Ferrell, RE; Mintz-Hittner, HA; Bitoun, P; Alward, WLM; Reiter, RS; Funkhauser, C; Daack-Hirsch, S; Murray, JC				Semina, EV; Ferrell, RE; Mintz-Hittner, HA; Bitoun, P; Alward, WLM; Reiter, RS; Funkhauser, C; Daack-Hirsch, S; Murray, JC			A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD	NATURE GENETICS			English	Article							SEGMENT MESENCHYMAL DYSGENESIS; PAX6 GENE; MUTATIONS; TRANSCRIPTION; HOMEODOMAIN; ANIRIDIA	We report here the identification of a new human homeobox gene, PITX3, and its involvement in anterior segment mesenchymal dysgenesis (ASMD) and congenital cataracts in humans. The PITX3 gene is the human homologue of the mouse Pitx3 gene and is a member of the RIEG/PITX homeobox gene family. The protein encoded by PITX3 shows 99% amino-acid identity to the mouse protein, with 100% identity in the homeodomain and approximately 70% overall identity to other members of this family. We mapped the human PITX3 gene to 10q25 using a radiation-hybrid panel. A collection of 80 DNA samples from individuals with various eye anomalies was screened for mutations in the PITX3 gene. We identified two mutations in independent patients. A 17-bp insertion in the 3'-end of the coding sequence, resulting in a frame shift, occured in a patient with ASMD and cataracts, and a G-->A substitution, changing a codon for serine into a codon for asparagine, in the 5'-end of the gene occured in a patient with congenital cataracts. Both mutations cosegregate with the disease phenotype in families, and neither were found in up to 300 control individuals studied, Further expression analysis of Pitx3 in the mouse supports a unique role in early ocular development, with later expression extending to the midbrain, tongue, incisors, sternum, vertebrae and limbs. These data strongly suggest a role for PITX3 in ASMD and cataracts and provide new evidence of the contribution of the RIEG/PITX gene family to the developmental program underpinning normal eye formation.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Texas, Houston Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; Hop Jean Verdier, F-93143 Bondy, France; Univ Pittsburgh, Dept Human Genet, Sch Publ Hlth, Pittsburgh, PA 15261 USA	University of Iowa; University of Iowa; University of Iowa; University of Texas System; University of Texas Health Science Center Houston; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	jeff-murrat@uiowa.edu	Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Daack-Hirsch, Sandra/0000-0003-1192-7154; Bitoun, Pierre/0000-0001-6557-6826	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009170] Funding Source: NIH RePORTER; NEI NIH HHS [EY08893] Funding Source: Medline; NIDCR NIH HHS [DE09170] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; FERRELL RE, 1982, AM J HUM GENET, V34, P245; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; HEATHCOTE JG, 1991, CAN J OPHTHALMOL, V26, P35; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KUMAR J, 1997, GENE DEV, V11, P2033; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; MARNER E, 1989, ACTA OPHTHALMOL, V67, P151; MARTHA A, 1995, HUM MUTAT, V6, P44, DOI 10.1002/humu.1380060109; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Prasad KSS, 1997, J BIOL CHEM, V272, P11457; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; ROESSLER BJ, 1993, J BIOL CHEM, V268, P26476; SARFARAZI M, 1997, HUM MOL GENET, V6, P16667; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302	23	294	313	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					167	170		10.1038/527	http://dx.doi.org/10.1038/527			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620774				2022-12-27	WOS:000073865100025
J	Cui, XM; De Vivo, I; Slany, R; Miyamoto, A; Firestein, R; Cleary, ML				Cui, XM; De Vivo, I; Slany, R; Miyamoto, A; Firestein, R; Cleary, ML			Association of SET domain and myotubularin-related proteins modulates growth control	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE CATALYSIS; DUAL-SPECIFICITY PHOSPHATASE; DROSOPHILA-TRITHORAX; ACUTE LEUKEMIAS; CRYSTAL-STRUCTURE; BINDING DOMAIN; GENE-PRODUCT; POLYCOMB; FAMILY; SITES	Several proteins that contribute to epigenetic mechanisms of gene regulation contain a characteristic motif of unknown function called the SET (Suvar3-9, Enhancer-of-zeste, Trithorax) domain. We have demonstrated that SET domains mediate highly conserved interactions with a specific family of proteins that display similarity with dual-specificity phosphatases (dsPTPases). These include myotubularin, the gene of which is mutated in a subset of patients with X-linked myotubular myopathy, and Sbf1, a newly isolated homologue of myotubularin. In contrast with myotubularin, Sbf1 lacks a functional catalytic domain which dephosphorylates phospho-tyrosine and serine-containing peptides in vitro. Competitive interference of endogenous SET domain-dsPTPase interactions by forced expression of Sbf1 induced oncogenic transformation of NIH 3T3 fibroblasts and impaired the in vitro differentiation of C2 myoblast cells. We conclude that myotubularin-type phosphatases link SET-domain containing components of the epigenetic regulatory machinery with signalling pathways involved in growth and differentiation.	Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	mcleary@cmgm.stanford.edu			NCI NIH HHS [CA55029] Funding Source: Medline; NIAID NIH HHS [AI-07290] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Butler LH, 1997, BLOOD, V89, P3361, DOI 10.1182/blood.V89.9.3361; CHINWALLA V, 1995, EMBO J, V14, P2056, DOI 10.1002/j.1460-2075.1995.tb07197.x; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; GUAN KL, 1991, J BIOL CHEM, V266, P17026; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; PIROTTA V, 1997, CURR OPIN GENET DEV, V7, P249; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Streuli M, 1996, CURR OPIN CELL BIOL, V8, P182, DOI 10.1016/S0955-0674(96)80064-0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tripoulas N, 1996, GENETICS, V143, P913; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Waring PM, 1997, CURR TOP MICROBIOL, V220, P1; WISHART MJ, 1995, J BIOL CHEM, V270, P26782, DOI 10.1074/jbc.270.45.26782; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; ZHOU G, 1994, J BIOL CHEM, V269, P28284	42	190	206	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1998	18	4					331	337		10.1038/ng0498-331	http://dx.doi.org/10.1038/ng0498-331			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZE078	9537414				2022-12-27	WOS:000072755500014
J	Ross, AJ; Waymire, KG; Moss, JE; Parlow, AF; Skinner, MK; Russell, LD; MacGregor, GR				Ross, AJ; Waymire, KG; Moss, JE; Parlow, AF; Skinner, MK; Russell, LD; MacGregor, GR			Testicular degeneration in Bclw-deficient mice	NATURE GENETICS			English	Article							SERTOLI CELLS; APOPTOSIS; MOUSE; EXPRESSION; REGULATORS; PROTEIN; ADULT; DEATH	To identify genes required for mammalian spermatogenesis, we screened lines of mutant mice created using a retroviral gene-trap system(1) for male infertility. Homozygous ROSA41 male mice exhibit sterility associated with progressive testicular degeneration. Germ-cell defects are first observed at 19 clays post-natal (p19). Spermatogenesis is blocked during late spermiogenesis in young adults. Gradual depletion of all stages of germ cells results in a Sertoli-cell-only phenotype by approximately six months of age. Subsequently, almost all Sertoli cells are lost from the seminiferous tubules and the Leydig cell population is reduced. Molecular analysis indicates that the gene mutated is Bclw, a death-protecting member of the Bcl2 family, The mutant allele of Bclw in ROSA41 does not produce a Bclw polypeptide. Expression of Bclw in the testis appears to be restricted to elongating spermatids and Sertoli cells. Potential roles for Bclw in testicular function are discussed.	Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Univ Edinburgh, BBSRC, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Harbor UCLA Med Ctr, Torrance, CA 90509 USA; Washington State Univ, Dept Genet & Cell Biol, Ctr Reprod Biol, Pullman, WA 99164 USA; So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	Emory University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Washington State University; Southern Illinois University System; Southern Illinois University	MacGregor, GR (corresponding author), Emory Univ, Sch Med, Ctr Mol Med, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.				NICHD NIH HHS [HD-24875] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM08367] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AYERLELIEVRE C, 1988, P NATL ACAD SCI USA, V85, P2628, DOI 10.1073/pnas.85.8.2628; CAILLEAU J, 1990, MOL CELL ENDOCRINOL, V69, P79, DOI 10.1016/0303-7207(90)90091-L; Chaudhary J, 1997, ENDOCRINOLOGY, V138, P667, DOI 10.1210/en.138.2.667; Clegg ED, 1990, HISTOLOGICAL HISTOPA, P277; DIRAMI G, 1995, ENDOCRINOLOGY, V136, P4439, DOI 10.1210/en.136.10.4439; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Gibson L, 1996, ONCOGENE, V13, P665; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; Mori C, 1997, DEV DYNAM, V208, P125; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; RUSSELL L, 1977, TISSUE CELL, V9, P751, DOI 10.1016/0040-8166(77)90040-4; Russell L. D., 1993, SERTOLI CELL; SHARPE RM, 1993, SERTOLI CELL, P391; SKINNER MK, 1993, SERTOLI CELL, P237; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; UAUSBEL FM, 1994, CURRENT PROTOCOLS MO; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	27	211	221	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1998	18	3					251	256		10.1038/ng0398-251	http://dx.doi.org/10.1038/ng0398-251			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA061	9500547				2022-12-27	WOS:000072325000023
J	Koob, MD; Benzow, KA; Bird, TD; Day, JW; Moseley, ML; Ranum, LPW				Koob, MD; Benzow, KA; Bird, TD; Day, JW; Moseley, ML; Ranum, LPW			Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; DOMINANT CEREBELLAR-ATAXIA; GENE; EXPANSION; DISEASE; LOCUS; MAP	Trinucleotide repeat expansions have been shown to cause a number of neurodegenerative diseases(1-6). A hallmark of most of these diseases is the presence of anticipation, a decrease in the age at onset in consecutive generations due to the tendency of the unstable trinucleotide repeat to lengthen when passed from one generation to the next(1). The involvement of trinucleotide repeat expansions in a number of other diseases -including familial spastic paraplegia(7), schizophrenia(8), bipolar affective disorder(9) and spinocerebellar ataxia type 7 (SCA7; ref. 10)-is suggested both by the presence of anticipation and by repeat expansion detection (RED)(10-12) analysis of genomic DNA samples. The involvement of trinucleotide expansions in these diseases, however, can be conclusively confirmed only by the isolation of the expansions present in these populations and detailed analysis to assess each expansion as a possible pathogenic mutation. We describe a novel procedure for quick isolation of expanded trinucleotide repeats and the corresponding flanking nucleotide sequence directly from small amounts of genomic DNA by a process of Repeat Analysis, Pooled isolation and Detection of individual clones containing expanded trinucleotide repeats (RAPID cloning). We have used this technique to clone the pathogenic SCA7 CAG expansion from an archived DNA sample of an individual affected with ataxia and retinal degeneration.	Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Vet Affairs Med Ctr, Seattle, WA 98108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Koob, MD (corresponding author), Univ Minnesota, Dept Neurol, Box 295 UMHC,420 Delaware St SE, Minneapolis, MN 55455 USA.			Day, John/0000-0002-0086-9529	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS033718, R01NS035870] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS35870, P01 NS33718] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1996, J BIOL, V215, P403; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; David G, 1996, AM J HUM GENET, V59, P1328; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; LINDBLAD K, 1994, NAT GENET, V7, P124, DOI 10.1038/ng0694-124; MARX JL, 1985, SCIENCE, V229, P150, DOI 10.1126/science.2990043; NEILSEN JE, 1997, HUM MOL GENET, V6, P1811; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ORUC L, 1997, AM J HUM GENET, V60, P732; OSTRANDER EA, 1992, P NATL ACAD SCI USA, V89, P3419, DOI 10.1073/pnas.89.8.3419; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1995, AM J HUM GENET, V57, P603; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	22	77	83	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					72	75		10.1038/ng0198-72	http://dx.doi.org/10.1038/ng0198-72			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425905				2022-12-27	WOS:000071259600026
J	Plug, AW; Peters, AHFM; Xu, Y; Keegan, KS; Hoekstra, MF; Baltimore, D; deBoer, P; Ashley, T				Plug, AW; Peters, AHFM; Xu, Y; Keegan, KS; Hoekstra, MF; Baltimore, D; deBoer, P; Ashley, T			ATM and RPA in meiotic chromosome synapsis and recombination	NATURE GENETICS			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; RAD51 PROTEIN; ATAXIA-TELANGIECTASIA; BINDING-PROTEIN; RECA PROTEIN; MEIOSIS; SINGLE; DNA	ATM is a member of the phosphatidylinositol 3-kinase (PIK)-like kinases, some of which are active in regulating DNA damage-induced mitotic cell-cycle checkpoints(1,2). ATM also plays a role in meiosis, Spermatogenesis in Atm(-/-)male mice is disrupted, with chromosome fragmentation leading to meiotic arrest(3): in human patients with ataxia-telangiectasia (A-T), gonadal atrophy is common. Immune-localization studies indicate that ATM is associated with sites along the synaptonemal complex (SC), the specialized structure along which meiotic recombination occurs(4). Recombination, preceded by pairing of homologous chromosomes, is thought to require heteroduplex formation between homologous DNA, followed by strand exchange. These early melotic steps (entailing the formation and processing of meiotic recombination intermediates with DNA-strand interruptions) require ssDNA-binding proteins such as replication protein A (RPA; refs 5-7). In somatic cells, DNA damage induces ATM-dependent phosphorylation of RpA(8,9). We demonstrate here that ATM and RPA co-localize along synapsed meiotic chromosomes and at sites where interactions between ectopic homologous chromosome regions appear to initiate. In Atm(-/-)meiotic prophase spermatocytes, immune-localization shows that RPA is present along synapsing chromosomes and at sites of fragmentation of the SC. These results suggest that RPA and ATM co-localize at sites where interhomologous-DNA interactions occur during meiotic prophase and where breaks associated with meiotic recombination take place after synapsis, implying a possible functional interaction between these two proteins.	YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; AGR UNIV WAGENINGEN,WAGENINGEN INST ANIM SCI,DEPT GENET,WAGENINGEN,NETHERLANDS; UNIV CALIF SAN DIEGO,DEPT BIOL,SAN DIEGO,CA 92093; ICOS CORP,BOTHELL,WA 98021; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Yale University; Wageningen University & Research; University of California System; University of California San Diego; Icos Corporation; Massachusetts Institute of Technology (MIT)				Peters, Antoine/0000-0002-0311-1887; Xu, Yang/0000-0001-5574-921X				ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; COX MM, 1982, J BIOL CHEM, V257, P8523; DEBOER P, 1986, CHROMOSOMA, V93, P326, DOI 10.1007/BF00327591; DOBSON MJ, 1994, J CELL SCI, V107, P2749; FLORY J, 1982, CELL, V28, P747, DOI 10.1016/0092-8674(82)90054-X; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; HOTTA Y, 1971, J MOL BIOL, V55, P337, DOI 10.1016/0022-2836(71)90322-6; HOTTA Y, 1966, P NATL ACAD SCI USA, V56, P1184, DOI 10.1073/pnas.56.4.1184; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Moses MJ, 1980, ANIMAL MODELS HUMAN, P169; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Peters AHFM, 1997, CHROMOSOME RES, V5, P313, DOI 10.1023/B:CHRO.0000038762.60086.ef; Plug AW, 1996, P NATL ACAD SCI USA, V93, P5920, DOI 10.1073/pnas.93.12.5920; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	28	112	115	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					457	461		10.1038/ng1297-457	http://dx.doi.org/10.1038/ng1297-457			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398850				2022-12-27	WOS:A1997YJ92400029
J	Rotig, A; deLonlay, P; Chretien, D; Foury, F; Koenig, M; Sidi, D; Munnich, A; Rustin, P				Rotig, A; deLonlay, P; Chretien, D; Foury, F; Koenig, M; Sidi, D; Munnich, A; Rustin, P			Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN	Friedreich ataxia (FRDA) is a common autosomal recessive degenerative disease (1/50,000 live births) characterized by a progressive gait and limb ataxia with lack of tendon reflexes in the legs, dysarthria and pyramidal weakness of the inferior limbs(1,2). Hypertrophic cardiomyopathy is observed in most FRDA patients. The gene associated with the disease has been mapped to chromosome 9q13 (ref. 3) and encodes a 210-amino-acid protein, frataxin. FRDA is caused primarily by a GAA repeat expansion within the first intron of the frataxin gene, which accounts for 98% of mutant alleles(4). The function of the protein is unknown, but an increased iron content has been reported in hearts of FRDA patients(5) and the mitochondria of yeast strains carrying a deleted frataxin gene counterpart (YFH1), suggesting that frataxin plays a major role in regulating mitochondrial iron transport(6.7). Here, we report a deficient activity of the iron-sulphur (Fe-S) cluster-containing subunits of mitochondrial respiratory complexes I, II and III in the endomyocardial biopsy of two unrelated FRDA patients. Aconitase, an iron-sulphur protein involved in iron homeostasis, was found to be deficient as well. Moreover, disruption of the YFH1 gene resulted in multiple Fe-S-dependent enzyme deficiencies in yeast. The deficiency of Fe-S-dependent enzyme activities in both FRDA patients and yeast should be related to mitochondrial iron accumulation, especially as Fe-S proteins are remarkably sensitive to free radicals(8). Mutated frataxin triggers aconitase and mitochondrial Fe-S respiratory enzyme deficiency in FRDA, which should therefore be regarded as a mitochondrial disorder.	HOP NECKER ENFANTS MALAD,INSERM,U393,DEPT GENET,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT,F-75743 PARIS 15,FRANCE; UNIV CATHOLIQUE LOUVAIN,UNITE BIOCHIM PHYSIOL,B-1348 LOUVAIN,BELGIUM; INST GENET & BIOL MOL & CELLULAIRE,INSERM,CNRS,F-67404 ILLKIRCH GRAFFENS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)			Rötig, Agnès/G-9592-2017	Rötig, Agnès/0000-0003-0589-0703				BABOCK M, 1997, SCIENCE, V276, P1709; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CEDARBAUM JM, 1986, NEUROCHEM PATHOL, V4, P43, DOI 10.1007/BF02834298; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Filla A, 1996, AM J HUM GENET, V59, P554; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HARDING AE, 1981, BRAIN, V104, P598; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jacq C, 1997, NATURE, V387, P75, DOI 10.1038/387s075; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; LI Y, 1996, NAT GENET, V11, P376; Paul R, 1996, TRENDS GENET, V12, P131; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V; SANCHEZCASIS G, 1977, CAN J NEUROL SCI, V3, P349	21	797	812	1	44	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					215	217		10.1038/ng1097-215	http://dx.doi.org/10.1038/ng1097-215			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326946				2022-12-27	WOS:A1997XZ55500032
J	Baes, M; Gressens, P; Baumgart, E; Carmeliet, P; Casteels, M; Fransen, M; Evrard, P; Fahimi, D; Declercq, PE; Collen, D; vanVeldhoven, PP; Mannaerts, GP				Baes, M; Gressens, P; Baumgart, E; Carmeliet, P; Casteels, M; Fransen, M; Evrard, P; Fahimi, D; Declercq, PE; Collen, D; vanVeldhoven, PP; Mannaerts, GP			A mouse model for Zellweger syndrome	NATURE GENETICS			English	Article							PEROXISOME BIOGENESIS DISORDERS; HEPATO-RENAL SYNDROME; PROTEIN IMPORT; MEMBRANE-PROTEINS; RAT-LIVER; RECEPTOR; GROWTH; MICE; ACID; IDENTIFICATION	The cerebro-hepato-renal syndrome of Zellweger is a fatal inherited disease caused by deficient import of peroxisomal matrix proteins. The pathogenic mechanisms leading to extreme hypotonia, severe mental retardation and early death are unknown. We generated a Zellweger animal model through inactivation of the murine Pxr1 gene (formally known as Pex5) that encodes the import receptor for most peroxisomal matrix proteins. Pxr1(-/-) mice lacked morphologically identifiable peroxisomes and exhibited the typical biochemical abnormalities of Zellweger patients. They displayed intrauterine growth retardation, were severely hypotonic at birth and died within 72 hours. Analysis of the neocortex revealed impaired neuronal migration and maturation and extensive apoptotic death of neurons.	HOP ROBERT DEBRE, SERV NEUROL PEDIAT, F-75019 PARIS, FRANCE; HOP ROBERT DEBRE, LAB NEUROL DEV, F-75019 PARIS, FRANCE; UNIV HEIDELBERG, INST ANAT & ZELLBIOL 2, D-6900 HEIDELBERG, GERMANY; VLAAMS INST BIOTECHNOL, CTR TRANSGENE TECHNOL & GENE THERAPY, LOUVAIN, BELGIUM; KATHOLIEKE UNIV LEUVEN, PHARMACOL LAB, B-3001 LOUVAIN, BELGIUM	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Flanders Institute for Biotechnology (VIB); KU Leuven	Baes, M (corresponding author), KATHOLIEKE UNIV LEUVEN, CLIN CHEM LAB, B-3001 LOUVAIN, BELGIUM.		Carmeliet, Peter/AAQ-5140-2020; gressens, pierre/M-7557-2017; Fransen, Marc/ADL-0723-2022; Baumgart-Vogt, Eveline/I-5945-2013; , Van Veldhoven Paul/U-6359-2019; Fransen, Marc/C-6262-2008	Carmeliet, Peter/0000-0001-7961-1821; gressens, pierre/0000-0002-0909-4221; Baumgart-Vogt, Eveline/0000-0002-8265-3763; , Van Veldhoven Paul/0000-0002-4478-2564; Fransen, Marc/0000-0001-9284-1197; Baes, Myriam/0000-0002-2525-2269				AGAMANOLIS DP, 1976, J NEUROPATH EXP NEUR, V35, P226, DOI 10.1097/00005072-197605000-00002; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BAUMGART E, 1989, J CELL BIOL, V108, P2221, DOI 10.1083/jcb.108.6.2221; BAUMGART E, 1994, PEROXISOMES, P37; BLANK ML, 1975, BIOCHIM BIOPHYS ACTA, V380, P208, DOI 10.1016/0005-2760(75)90007-7; BRAVERMAN N, 1995, HUM MOL GENET, V4, P1791, DOI 10.1093/hmg/4.suppl_1.1791; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; ESPEEL M, 1995, EUR J CELL BIOL, V67, P319; EVRARD P, 1978, ACTA NEUROPATHOL, V41, P109, DOI 10.1007/BF00689761; FAHIMI HD, 1969, J CELL BIOL, V43, P275, DOI 10.1083/jcb.43.2.275; FAHIMI HD, 1996, ELECT MICROSCOPIC CY, P491; Fransen M, 1996, ANAL BIOCHEM, V242, P26, DOI 10.1006/abio.1996.0423; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRESSENS P, 1992, J NEUROPATH EXP NEUR, V51, P206, DOI 10.1097/00005072-199203000-00010; HEYMANS HSA, 1983, NATURE, V306, P69, DOI 10.1038/306069a0; JOHNSON AB, 1976, J HISTOCHEM CYTOCHEM, V24, P725, DOI 10.1177/24.6.59773; JONES KM, 1994, CLIN CHEM, V40, P946; KALUZNY MA, 1985, J LIPID RES, V26, P135; Krisans SK, 1996, ANN NY ACAD SCI, V804, P142, DOI 10.1111/j.1749-6632.1996.tb18614.x; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; Mannaerts G. P., 1993, PEROXISOMES BIOL IMP, P19; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; POWERS JM, 1995, J NEUROPATH EXP NEUR, V54, P710, DOI 10.1097/00005072-199509000-00014; POWERS JM, 1989, J NEUROPATH EXP NEUR, V48, P270, DOI 10.1097/00005072-198905000-00005; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; ROELS F, 1995, FUNCTIONS BIOGENESIS, P271; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; Subramani S, 1996, J BIOL CHEM, V271, P32483, DOI 10.1074/jbc.271.51.32483; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANHOVE G, 1991, J BIOL CHEM, V266, P24670; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; VanVeldhoven PP, 1995, J INHERIT METAB DIS, V18, P125, DOI 10.1007/BF00711435; WANDERS RJA, 1993, PEROXISOMES BIOL IMP, P63; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; WIEMER EAC, 1989, EUR J CELL BIOL, V50, P407	47	217	219	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1997	17	1					49	57		10.1038/ng0997-49	http://dx.doi.org/10.1038/ng0997-49			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288097				2022-12-27	WOS:A1997XU72400017
J	Mansfield, TA; Simon, DB; Farfel, Z; Bia, M; Tucci, JR; Lebel, M; Gutkin, M; Vialettes, B; Christofilis, MA; KauppinenMakelin, R; Mayan, H; Risch, N; Lifton, RP				Mansfield, TA; Simon, DB; Farfel, Z; Bia, M; Tucci, JR; Lebel, M; Gutkin, M; Vialettes, B; Christofilis, MA; KauppinenMakelin, R; Mayan, H; Risch, N; Lifton, RP			Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21	NATURE GENETICS			English	Article							HYPERKALEMIA; SODIUM; STRATEGIES; GENE	Essential hypertension is a common multifactorial trait. The molecular basis of a number of rare diseases that alter blood pressure in humans has been established, identifying pathways that may be involved in more common forms of hypertension(1). Pseudohypoaldosteronism type II (PHAII, also known as familial hyperkalaemia and hypertension or Gordon's syndrome; OMIM #145260), is characterized by hyperkalaemia despite normal renal glomerular filtration, hypertension and correction of physiologic abnormalities by thiazide diuretics(2,3). Mild hyperchloremia, metabolic acidosis and suppressed plasma renin activity are variable associated findings. The pathogenesis of PHAII is unknown, although clinical studies indicate an abnormality in renal ion transport(4). As thiazide diuretics are among the most efficacious agents in the treatment of essential hypertension, understanding the pathogenesis of PHAII may be of relevance to more common forms of hypertension. Analysis of linkage in eight PHAII families showing autosomal dominant transmission demonstrates locus heterogeneity of this trait, with a multilocus lod score of 8.1 for linkage of PHAII to chromosomes 1q31-q42 and 17p11-q21. Interestingly, the chromosome-17 locus overlaps a syntenic interval in rat that contains a blood pressure quantitative trait locus (QTL). Our findings provide a first step toward identification of the molecular basis of PHAII.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MED,NEW HAVEN,CT 06510; TEL AVIV UNIV,SCH MED,CHAIM SHEBA MED CTR,DEPT MED E,IL-52621 TEL HASHOMER,ISRAEL; BROWN UNIV,SCH MED,DIV ENDOCRINOL & METAB,PROVIDENCE,RI 02908; HOP HOTEL DIEU,RES CTR,DEPT NEPHROL,QUEBEC CITY,PQ,CANADA; HYPERTENS & RENAL GRP,LIVINGSTON,NJ 07039; CHRU MARSEILLE,DIV ENDOCRINOL,MARSEILLE,FRANCE; UNIV HELSINKI,DEPT MED 3,HELSINKI,FINLAND; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Chaim Sheba Medical Center; Tel Aviv University; Brown University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Helsinki; Stanford University								BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; FARFEL Z, 1978, ARCH INTERN MED, V138, P1837, DOI 10.1001/archinte.138.12.1837; FARFEL Z, 1978, ARCH INTERN MED, V138, P1828, DOI 10.1001/archinte.138.12.1828; GORDON RD, 1970, AUST ANN MED, V4, P287; Gordon Richard D., 1995, P2111; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; ISENRING P, 1992, HYPERTENSION, V19, P371, DOI 10.1161/01.HYP.19.4.371; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MUHAMMAD S, 1994, J ENDOCRINOL INVEST, V17, P453, DOI 10.1007/BF03347738; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1985, ANAL HUMAN GENETIC L; PAVER W K, 1964, Med J Aust, V2, P305; SANJAD SA, 1982, PEDIATRICS, V69, P317; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Strautnieks SS, 1996, HUM MOL GENET, V5, P293, DOI 10.1093/hmg/5.2.293; THROCKMORTON DC, 1991, YALE J BIOL MED, V64, P247; VALIMAKI M, 1989, ACTA ENDOCRINOL-COP, V120, P331, DOI 10.1530/acta.0.1200331; [No title captured]	24	175	180	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1997	16	2					202	205		10.1038/ng0697-202	http://dx.doi.org/10.1038/ng0697-202			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171836				2022-12-27	WOS:A1997XB54300025
J	Rao, E; Weiss, B; Fukami, M; Rump, A; Niesler, B; Mertz, A; Muroya, K; Binder, G; Kirsch, S; Winkelmann, M; Nordsiek, G; Heinrich, U; Breuning, MH; Ranke, MB; Rosenthal, A; Ogata, T; Rappold, GA				Rao, E; Weiss, B; Fukami, M; Rump, A; Niesler, B; Mertz, A; Muroya, K; Binder, G; Kirsch, S; Winkelmann, M; Nordsiek, G; Heinrich, U; Breuning, MH; Ranke, MB; Rosenthal, A; Ogata, T; Rappold, GA			Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome	NATURE GENETICS			English	Article							HUMAN X-CHROMOSOME; Y-CHROMOSOME; SHORT ARM; WAARDENBURG SYNDROME; SEX DETERMINATION; HORMONE RECEPTOR; CRITICAL REGION; CODING REGIONS; DNA-SEQUENCES; ALPHA-SUBUNIT	Growth retardation resulting in short stature is a major concern for parents and due to its great variety of causes, a complex diagnostic challenge for clinicians. A major locus involved in linear growth has been implicated within the pseudoautosomal region (PAR1) of the human sex chromosomes. We have determined an interval of 170 kb of DNA within PAR1 which was deleted in 36 individuals with short stature and different rearrangements on Xp22 or Yp11.3, This deletion was not detected in any of the relatives with normal stature or in a further 30 individuals with rearrangements on Xp22 or Yp11.3 with normal height, We have isolated a homeobox-containing gene (SHOX) from this region, which has at least two alternatively spliced forms, encoding proteins with different patterns of expression. We also identified one functionally significant SHOX mutation by screening 91 individuals with idiopathic short stature. Our data suggest an involvement of SHOX in idiopathic growth retardation and in the short stature phenotype of Turner syndrome patients.	UNIV HEIDELBERG,INST HUMAN GENET,D-69120 HEIDELBERG,GERMANY; KEIO UNIV,DEPT PAEDIAT,TOKYO 160,JAPAN; INST MOL BIOTECHNOL,DEPT GENOME ANAL,D-07745 JENA,GERMANY; UNIV TUBINGEN,CHILDRENS HOSP,SECT PAEDIAT ENDOCRINOL,D-72070 TUBINGEN,GERMANY; UNIV HEIDELBERG,CHILDRENS HOSP,DEPT PAEDIAT,D-69120 HEIDELBERG,GERMANY; LEIDEN UNIV,DEPT HUMAN GENET,SYLVIUS LAB,NL-2300 RA LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,HOSP DIJKZIGT,DEPT CLIN GENET,NL-3015 GD ROTTERDAM,NETHERLANDS	Ruprecht Karls University Heidelberg; Keio University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Ruprecht Karls University Heidelberg; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC			Muroya, Koji/J-1304-2016; Breuning, Martijn H/E-3429-2010	Muroya, Koji/0000-0002-1810-9894; Ogata, Tsutomu/0000-0001-7178-9991; Rump, Andreas/0000-0001-7116-6364				ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BARBAUX S, 1995, HUM MOL GENET, V4, P1565, DOI 10.1093/hmg/4.9.1565; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P381, DOI 10.1530/jrf.0.0680381; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; CHENG T, 1994, J BIOL CHEM, V269, P30848; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; FERRARI D, 1994, BIOCHEM BIOPH RES CO, V205, P429, DOI 10.1006/bbrc.1994.2683; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GODDARD AD, 1995, NEW ENGL J MED, V333, P1093, DOI 10.1056/NEJM199510263331701; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HALL JG, 1990, PEDIATR CLIN N AM, V37, P1421; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HENKE A, 1991, AM J HUM GENET, V49, P811; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; KULHARYA AS, 1995, AM J MED GENET, V56, P16, DOI 10.1002/ajmg.1320560106; LEHRACH H, 1990, GENOME ANAL, V1; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LICHTER P, 1992, HUMAN CYTOGENETICS P; MAGENIS RE, 1984, J PEDIATR-US, V105, P916, DOI 10.1016/S0022-3476(84)80077-3; Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965; MARTIAL JA, 1979, SCIENCE, V205, P602, DOI 10.1126/science.377496; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; OGATA T, 1993, HUM GENET, V91, P551; OGATA T, 1992, J MED GENET, V29, P455; OGATA T, 1995, J MED GENET, V32, P831, DOI 10.1136/jmg.32.10.831; OGATA T, 1993, J MED GENET, V30, P918, DOI 10.1136/jmg.30.11.918; OGATA T, 1997, IN PRESS Y SPECIFIC; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372; Ranke MB, 1996, HORM RES, V45, P64, DOI 10.1159/000184851; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RIED K, 1995, GENOMICS, V29, P787, DOI 10.1006/geno.1995.9933; ROBINSON A, 1990, DEMOGRAPHY PREVALENC; ROSENFELD RG, 1994, ENDOCRINOLOGIST, V4, P351, DOI 10.1097/00019616-199409000-00006; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Rovescalli AC, 1996, P NATL ACAD SCI USA, V93, P10691, DOI 10.1073/pnas.93.20.10691; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHIEBEL K, 1993, NAT GENET, V3, P82, DOI 10.1038/ng0193-82; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THOMAS A, 1994, IMA J MATH APPL MED, V11, P149; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Ullrich O, 1930, Z KINDERHEILKD, V49, P271, DOI DOI 10.1007/BF02248090; Vogel F., 1997, HUMAN GENETICS; YASPO ML, 1995, HUM MOL GENET, V4, P1291, DOI 10.1093/hmg/4.8.1291; ZUFFARDI O, 1982, AM J MED GENET, V12, P175, DOI 10.1002/ajmg.1320120207; 1993, QIAGEN TGGE HDB	66	653	684	2	30	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					54	63		10.1038/ng0597-54	http://dx.doi.org/10.1038/ng0597-54			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140395				2022-12-27	WOS:A1997WX02400022
J	Good, DJ; Porter, FD; Mahon, KA; Parlow, AF; Westphal, H; Kirsch, IR				Good, DJ; Porter, FD; Mahon, KA; Parlow, AF; Westphal, H; Kirsch, IR			Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene	NATURE GENETICS			English	Article							HORMONE-RELEASING HORMONE; DEVELOPING NERVOUS-SYSTEM; MESSENGER-RNA; NEUROPEPTIDE-Y; MOUSE; EXPRESSION; PITUITARY; DEFICIENCY; LETHALITY; NSCL-2	The family of basic helix-loop-helix (bHLH) genes comprises transcription factors involved in many aspects of growth and development. We have previously described two bHLH transcription factors, Nhlh1 and Nhlh2 (originally named NSCL1 and NSCL2)(1-3). The nucleotide and predicted protein sequences of Nhlh1 and Nhlh2 are homologous within their bHLH domain where there are only three conservative amino acid differences(2,3). During murine embryogenesis, Nhlh1 and Nhlh2 share an overlapping but distinct pattern of expression in the developing nervous system(1,2). To improve our understanding of the role of these genes during neurogenesis, we have generated mice containing targeted deletions of both genes and here describe our results for Nhlh2. Loss of Nhlh2 results in a disruption of the hypothalamic-pituitary axis in mice. Male Nhlh2-/- mice are microphallic, hypogonadal and infertile with alterations in circulating gonadotropins, a defect spermatogenesis and a loss of instinctual male sexual behaviour. Female Nhlh2-/- mice reared alone are hypogonadal, but when reared in the presence of males, their ovaries and uteri develop normally and they are fertile. Both male and female homozygotes exhibit progressive adult-onset obesity. Nhlh2 is expressed in the ventral-medial and lateral hypothalamus, Rathke's pouch and in the anterior lobe of the adult pituitary. Our results support a role for Nhlh2 in the onset of puberty and the regulation of body weight metabolism.	NCI, ACQUIRED GENE REARRANGEMENT SECT, NIH, BETHESDA, MD 20889 USA; NICHHD, LAB MAMMALIAN GENES & DEV, NIH, BETHESDA, MD 20889 USA; UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, PITUITARY HORMONES & ANTISERA CTR, TORRANCE, CA 90509 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center								BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; BRAY GA, 1989, VITAM HORM, V45, P1; Bronson F.H., 1983, P175; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; CHARLTON HM, 1992, PROG BRAIN RES, V93, P321; CONLON RA, 1992, DEVELOPMENT, V116, P357; CROWLEY WF, 1991, RECENT PROG HORM RES, V47, P27; CULLER MD, 1986, ENDOCRINOLOGY, V118, P609, DOI 10.1210/endo-118-2-609; DEYEBENES EG, 1995, BRAIN RES, V674, P112, DOI 10.1016/0006-8993(94)01429-L; GOBEL V, 1992, CELL GROWTH DIFFER, V3, P143; HALPIN DMG, 1986, J REPROD FERTIL, V78, P119, DOI 10.1530/jrf.0.0780119; Hogan B, 1994, MANIPULATING MOUSE E; IKEDA M, 1995, BIOCHEM BIOPH RES CO, V207, P800, DOI 10.1006/bbrc.1995.1257; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; KOVACIC N, 1972, ENDOCRINOLOGY, V91, P910, DOI 10.1210/endo-91-4-910; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIPKOWITZ S, 1992, J BIOL CHEM, V267, P21065; LOPEZ FJ, 1991, P NATL ACAD SCI USA, V88, P4508, DOI 10.1073/pnas.88.10.4508; LOVE PE, 1992, P NATL ACAD SCI USA, V89, P9929, DOI 10.1073/pnas.89.20.9929; MATOCHIK JA, 1994, BEHAV BRAIN RES, V60, P141, DOI 10.1016/0166-4328(94)90141-4; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; OATES E, 1984, J BIOL CHEM, V259, P7421; PARKINSON WL, 1990, AM J PHYSIOL, V259, pR829, DOI 10.1152/ajpregu.1990.259.4.R829; REHBEIN M, 1986, BIOL CHEM H-S, V367, P695, DOI 10.1515/bchm3.1986.367.2.695; RUGH R, 1990, MOUSE ITS REPROD DEV, P1; Sambrock J, 1989, MOL CLONING LAB MANU, V1; TAKEUCHI T, 1986, J CLIN INVEST, V77, P1038, DOI 10.1172/JCI112357; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WRAY S, 1988, PEPTIDES, V9, P1151, DOI 10.1016/0196-9781(88)90103-9; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	94	97	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					397	401		10.1038/ng0497-397	http://dx.doi.org/10.1038/ng0497-397			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090387				2022-12-27	WOS:A1997WQ38900020
J	Silva, AJ; Frankland, PW; Marowitz, Z; Friedman, E; Lazlo, G; Cioffi, D; Jacks, T; Bourtchuladze, R				Silva, AJ; Frankland, PW; Marowitz, Z; Friedman, E; Lazlo, G; Cioffi, D; Jacks, T; Bourtchuladze, R			A mouse model for the learning and memory deficits associated with neurofibromatosis type I	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; TARGETED MUTATION; MICE; BEHAVIOR; HIPPOCAMPAL; EXPRESSION; NEURONS; BRAIN; FEAR; NF1	Neurofibromatosis type I (NF1) is one of the most commonly inherited neurological disorders in humans, affecting approximately one in 4,000 individuals(1-3). NF1 results in a complex cluster of developmental and tumour syndromes that include benign neurofibromas, hyperpigmentation of melanocytes and hamartomas of the iris. Some NF1 patients may also show neurologic lesions, such as optic pathway gliomas, dural ectasia and aqueduct stenosis(1-3). Importantly, learning disabilities occur in 30% to 45% of patients with NF1, even in the absence of any apparent neural pathology. The learning disabilities may include a depression in mean IQ scores, visuoperceptual problems and impairments in spatial cognitive abilities(4-9). Spatial learning has been assessed with a variety of cognitive tasks and the most consistent spatial learning deficits have been observed with the Judgement of Line Orientation test(4,7,10,11). It is important to note that some of these deficits could be secondary to developmental abnormalities(1) and other neurological problems, such as poor motor coordination and attentional deficits(9). Previous studies have suggested a role for neurofibromin in brain function. First, the expression of the Nf1 gene is largely restricted to neuronal tissues in the adult(12-14). Second, this GTPase activating protein may act as a negative regulator of neurotrophin-mediated signalling(15). Third, immunohistochemical studies suggest that activation of astrocytes may be common in the brain of NF1 patients(13). Here, we show that the Nf1(+/-) mutation also affects learning and memory in mice. As in humans, the learning and memory deficits of the Nf1(+/-) mice are restricted to specific types of learning, they are not fully penetrant, they can be compensated for with extended training, and they do not involve deficits in simple associative learning.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; MIT, HOWARD HUGHES MED INST, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Silva, AJ (corresponding author), COLD SPRING HARBOR LAB, POB 100, COLD SPRING HARBOR, NY 11724 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; DATSON MM, 1992, NEURON, V8, P415; EASTON DF, 1993, AM J HUM GENET, V53, P305; ELDRIDGE R, 1989, AM J DIS CHILD, V143, P833, DOI 10.1001/archpedi.1989.02150190083027; Eliason M J, 1988, Neurofibromatosis, V1, P17; ELIASON MJ, 1986, J DEV BEHAV PEDIATR, V7, P175; GUTMANN DH, 1992, ANN NEUROL, V31, P555, DOI 10.1002/ana.410310515; HOFMAN KJ, 1994, J PEDIATR-US, V124, pS1, DOI 10.1016/S0022-3476(05)83163-4; HUSON SM, 1994, NEUROFIBROMATOSES PA, P204; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JOY P, 1995, DEV MED CHILD NEUROL, V37, P906; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NORDLUND M, 1993, J NEUROSCI, V13, P1588; NORDLUND ML, 1995, J NEUROPATH EXP NEUR, V54, P588, DOI 10.1097/00005072-199507000-00013; NORTH K, 1993, J CHILD NEUROL, V8, P395, DOI 10.1177/088307389300800421; NORTH K, 1995, DEV MED CHILD NEUROL, V37, P427, DOI 10.1111/j.1469-8749.1995.tb12026.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; RICCARDI VM, 1992, NEUROFIBROMATOSIS PH, P195; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; VARNHAGEN CK, 1988, J DEV BEHAV PEDIATR, V9, P257; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	30	254	260	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					281	284		10.1038/ng0397-281	http://dx.doi.org/10.1038/ng0397-281			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054942				2022-12-27	WOS:A1997WK38600019
J	Vafiadis, P; Bennett, ST; Todd, JA; Nadeau, J; Grabs, R; Goodyer, CG; Wickramasinghe, S; Colle, E; Polychronakos, C				Vafiadis, P; Bennett, ST; Todd, JA; Nadeau, J; Grabs, R; Goodyer, CG; Wickramasinghe, S; Colle, E; Polychronakos, C			Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus	NATURE GENETICS			English	Article							DIABETES SUSCEPTIBILITY LOCUS; GENE; PROINSULIN; TOLERANCE; SELECTION; REGION; RISK; AUTOANTIBODIES; MINISATELLITE; TRANSCRIPTION	Type 1 diabetes or insulin-dependent diabetes mellitus (IDDM) is due to autoimmune destruction of pancreatic beta-cells. Genetic susceptibility to IDDM is encoded by several loci, one of which (IDDM2) maps to a variable number of tandem repeats (VNTR) minisatellite, upstream of the insulin gene (INS)(1-5). The short class 1 VNTR alleles (26-63 repeats) predispose to IDDM, while class III alleles (140-210 repeats) have a dominant protective effect(1-6). We have reported that, in human adult(4,6) and fetal(7) pancreas in vivo, class III alleles are associated with marginally lower INS mRNA levels than class I, suggesting transcriptional effects of the VNTR. These may be related to type 1 diabetes pathogenesis, as insulin is the only known beta-cell specific IDDM autoantigen. In search of a more plausible mechanism for the dominant effect of class III alleles, we analysed expression of insulin in human fetal thymus, a critical site for tolerance induction to self proteins. Insulin was detected in all thymus tissues examined and class III VNTR alleles were associated with 2- to 3-fold higher INS mRNA levels than class I. We therefore propose higher levels of thymic INS expression, facilitating immune tolerance induction, as a mechanism for the dominant protective effect of class III alleles.	MCGILL UNIV, MONTREAL CHILDRENS HOSP, RES INST, MONTREAL, PQ H3H 1P3, CANADA; MCGILL UNIV, DEPT PEDIAT, DIV ENDOCRINOL, MONTREAL, PQ H3H 1P3, CANADA; UNIV OXFORD, NUFFIELD DEPT SURG, WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7BN, ENGLAND; MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ H3G 1A4, CANADA; MONTREAL GEN HOSP, MONTREAL, PQ H3G 1A4, CANADA	McGill University; McGill University; University of Oxford; Wellcome Centre for Human Genetics; McGill University; McGill University			Polychronakos, Constantin/B-8151-2008; Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Polychronakos, Constantin/0000-0002-7624-6635	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANTONIA SJ, 1995, INT IMMUNOL, V7, P715, DOI 10.1093/intimm/7.5.715; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; BATANERO E, 1992, BRAIN BEHAV IMMUN, V6, P249, DOI 10.1016/0889-1591(92)90047-R; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BERG H, 1993, J IMMUNOL METHODS, V164, P221, DOI 10.1016/0022-1759(93)90315-X; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; DENNY P, IN PRESS DIABETES; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GRIFFIN AC, 1995, AM J PATHOL, V147, P845; HEATH WR, 1992, NATURE, V359, P547, DOI 10.1038/359547a0; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KEILACKER H, 1995, HORM METAB RES, V27, P90, DOI 10.1055/s-2007-979915; KELLER RJ, 1993, LANCET, V341, P927, DOI 10.1016/0140-6736(93)91215-8; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; MCGINNIS RE, 1995, DIABETES, V44, P1296, DOI 10.2337/diabetes.44.11.1296; MILLER JFAP, 1989, COLD SPRING HARB SYM, V54, P807; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; Owerbach D, 1996, DIABETES, V45, P544, DOI 10.2337/diabetes.45.5.544; POLYCHRONAKOS C, 1995, DIABETOLOGIA, V38, P715, DOI 10.1007/s001250050343; POSSELT AM, 1992, SCIENCE, V256, P1321, DOI 10.1126/science.1598576; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; RUDY G, 1995, MOL MED, V1, P625, DOI 10.1007/BF03401603; Saoudi A, 1996, IMMUNOL REV, V149, P195, DOI 10.1111/j.1600-065X.1996.tb00905.x; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SMRZKA OW, 1995, HUM MOL GENET, V4, P1945, DOI 10.1093/hmg/4.10.1945; UNDLIEN DE, 1995, DIABETES, V44, P620, DOI 10.2337/diabetes.44.6.620; Vafiadis P, 1996, J AUTOIMMUN, V9, P397, DOI 10.1006/jaut.1996.0054; VONHERRATH MG, 1994, J EXP MED, V180, P1901, DOI 10.1084/jem.180.5.1901; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542	37	628	649	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					289	292		10.1038/ng0397-289	http://dx.doi.org/10.1038/ng0397-289			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054944				2022-12-27	WOS:A1997WK38600021
J	Neyroud, N; Tesson, F; Denjoy, I; Leibovici, M; Donger, C; Barhanin, J; Faure, S; Gary, F; Coumel, P; Petit, C; Schwartz, K; Guicheney, P				Neyroud, N; Tesson, F; Denjoy, I; Leibovici, M; Donger, C; Barhanin, J; Faure, S; Gary, F; Coumel, P; Petit, C; Schwartz, K; Guicheney, P			A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome	NATURE GENETICS			English	Article							LONG QT SYNDROME; STRIA VASCULARIS; CARDIAC-ARRHYTHMIA; K+ CHANNEL; PROTEIN; LOCALIZATION; VOLTAGE; EXPRESSION; CLONING; CELLS	The Jervell and Lange-Nielsen (JLN) syndrome (MIM 220400) is an inherited autosomal recessive disease characterized by a congenital bilateral deafness associated with a QT prolongation on the electrocardiogram, syncopal attacks due to ventricular arrhythmias and a high risk of sudden death(1). JLN syndrome is a rare disease, which seems to affect less than one percent of all deaf children(2-4) Linkage to chromosome 11p15.5 markers was found by analysing four consanguinous families. Recombinants allowed us to map the JLN gene between D11S922 and D11S4146, to a 6-cM interval where KVLQT1, a potassium channel gene causing Romano-Ward (RW) syndrome, the dominant form of long QT syndrome, has been previously localized(5), An homozygous deletion-insertion event (1244, -7 +8) in the C-terminal domain of this gene was detected in three affected children of two families. We found that KVLQT1 is expressed in the stria vascularis of mouse inner ear by in situ hybridization. Taken together, our data indicate that KVLQT1 is responsible for both JLN and RW syndromes and has a key role not only in the ventricular repolarization but also in normal hearing, probably via the control of endolymph homeostasis.	GRP HOSP PITIE SALPETRIERE, INST MYOL, INSERM UR153, F-75013 PARIS, FRANCE; HOP LARIBOISIERE, SERV CARDIOL, F-75010 PARIS, FRANCE; CHATEAU COTES, F-78350 LES LOGES EN JOSAS, FRANCE; INST PASTEUR, CNRS URA 1968, MOL GENET UNIT, F-75015 PARIS, FRANCE; CNRS, INST PHARMACOL MOL & CELLULAIRE, F-06560 VALBONNE, FRANCE; GENETHON CNRS URA 1922, F-91002 EVRY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)			Leibovici, Michel/ABB-6745-2020; Tesson, Frederique/A-3218-2013; Neyroud, Nathalie/D-1013-2017; Guicheney, Pascale/D-1034-2017	Neyroud, Nathalie/0000-0003-3382-7680; Guicheney, Pascale/0000-0002-7663-2050; Petit, Christine/0000-0002-9069-002X				ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; DAUSSE E, 1995, CR ACAD SCI III-VIE, V318, P879; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRASER GR, 1964, ANN HUM GENET, V28, P133, DOI 10.1111/j.1469-1809.1964.tb00469.x; FRASER GR, 1964, Q J MED, V33, P361; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HOFFMAN EP, 1995, CELL, V80, P681, DOI 10.1016/0092-8674(95)90345-3; HONORE E, 1991, EMBO J, V10, P2805, DOI 10.1002/j.1460-2075.1991.tb07829.x; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JEFFERY S, 1992, LANCET, V339, P255, DOI 10.1016/0140-6736(92)90071-A; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; JIANG CA, 1994, NAT GENET, V8, P141, DOI 10.1038/ng1094-141; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MORI N, 1993, EUR ARCH OTO-RHINO-L, V250, P186; PERNOT C, 1972, ARCH MAL COEUR VAISS, V65, P261; PERNOT C, 1974, COEUR MED INTERNE, V13, P429; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tesson F, 1996, J MOL CELL CARDIOL, V28, P2051, DOI 10.1006/jmcc.1996.0198; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; WYMORE RS, 1994, GENOMICS, V20, P191, DOI 10.1006/geno.1994.1153	31	679	701	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1997	15	2					186	189		10.1038/ng0297-186	http://dx.doi.org/10.1038/ng0297-186			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF087	9020846				2022-12-27	WOS:A1997WF08700020
J	Hacia, JG; Brody, LC; Chee, MS; Fodor, SPA; Collins, FS				Hacia, JG; Brody, LC; Chee, MS; Fodor, SPA; Collins, FS			Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis	NATURE GENETICS			English	Article							OVARIAN-CANCER FAMILIES; BREAST-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; 185DELAG; LINKAGE	The ability to scan a large gene rapidly and accurately for all possible heterozygous mutations in large numbers of patient samples will be critical for the future of medicine. We have designed high-density arrays consisting of over 96,600 oligonucleotides 20-nucleotides (nt) in length to screen for a wide range of heterozygous mutations in the 3.45-kilobases (kb) exon 11 of the hereditary breast and ovarian cancer gene BRCA1. Reference and test samples were co-hybridized to these arrays and differences in hybridization patterns quantitated by two-colour analysis. Fourteen of fifteen patient samples with known mutations were accurately diagnosed, and no false positive mutations were identified in 20 control samples. Eight single nucleotide polymorphisms were also readily detected. DNA chip-based assays may provide a valuable new technology for high-throughput cost-efficient detection of genetic alterations.	NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; AFFYMETRIX,SANTA CLARA,CA 95051	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix								CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.0.CO;2-A; Durocher F, 1996, HUM MOL GENET, V5, P835, DOI 10.1093/hmg/5.6.835; EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HOULDSWORTH J, 1994, AM J PATHOL, V145, P1253; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; Offit K, 1996, LANCET, V347, P1643, DOI 10.1016/S0140-6736(96)91484-1; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; ROWELL S, 1994, AM J HUM GENET, V55, P861; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TONIN P, 1995, AM J HUM GENET, V57, P189; Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913	29	443	597	1	50	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					441	447		10.1038/ng1296-441	http://dx.doi.org/10.1038/ng1296-441			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944024				2022-12-27	WOS:A1996VV73000020
